<?xml version="1.0"?>

<!--
-
- Sequel Pro XML dump
- Version 4096
-
- http://www.sequelpro.com/
- http://code.google.com/p/sequel-pro/
-
- Host: 127.0.0.1 (MySQL 5.6.20)
- Database: oncokb
- Generation Time Time: 2014-12-17 19:40:15 +0000
-
-->

<mysqldump xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<database name="oncokb">

	<table_structure name="drug">
		<field field="drug_id" type="int(11)" null="NO" key="PRI" default="<null>" extra="auto_increment" />
		<field field="drug_name" type="varchar(255)" null="NO" key="" default="<null>" extra="" />
		<field field="description" type="text" null="YES" key="" default="<null>" extra="" />
		<field field="fda_approved" type="bit(1)" null="YES" key="" default="<null>" extra="" />

		<options name="drug" engine="InnoDB" version="10" row_format="Compact" rows="9287" avg_row_length="171" data_length="1589248" max_data_length="0" index_length="0" data_free="4194304" create_time="2014-12-16 13:56:34" update_time="<null>" collation="utf8_general_ci" create_options="" comment="" />
	</table_structure>

	<table_data name="drug">

	<row>
		<field name="drug_id">1</field>
		<field name="drug_name">Lepirudin</field>
		<field name="description">Lepirudin is identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2</field>
		<field name="drug_name">Cetuximab</field>
		<field name="description">Epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">3</field>
		<field name="drug_name">Dornase Alfa</field>
		<field name="description">Dornase alfa is a biosynthetic form of human deoxyribunuclease I (DNase I) enzyme. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. The 260-amino acid sequence of dornase alfa is identical to the endogenous human enzyme. Dornase alfa cleaves extracellular DNA to 5´-phosphodinucleotide and 5´-phosphooligonucleotide end products without affecting intracellular DNA. In individuals with cystic fibrosis, extracellular DNA, which is an extremely viscous anion, is released by degenerating leukocytes that accumulate during inflammatory responses to infections. Enzymatic breakdown of this extracellular DNA appears to reduce sputum viscosity and viscoelasticity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4</field>
		<field name="drug_name">Denileukin diftitox</field>
		<field name="description">A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">5</field>
		<field name="drug_name">Etanercept</field>
		<field name="description">Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of 934 amino acids</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6</field>
		<field name="drug_name">Bivalirudin</field>
		<field name="description">Bivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin. Once bound to the active site, thrombin cannot activate fibrinogen into fibrin, the crucial step in the formation of thrombus. It is administered intravenously. Because it can cause blood stagnation, it is important to monitor changes in hematocrit, activated partial thromboplastin time, international normalized ratio and blood pressure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7</field>
		<field name="drug_name">Leuprolide</field>
		<field name="description">Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer's disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">8</field>
		<field name="drug_name">Peginterferon alfa-2a</field>
		<field name="description">Human interferon 2a, is a covalent conjugate of recombinant alfa-2a interferon with a single branched bis-monomethoxy polyethylene glycol (PEG) chain. The PEG moiety is linked at a single site to the interferon alfa moiety via a stable amide bond to lysine. Peginterferon alfa-2a has an approximate molecular weight of 60,000 daltons. Interferon alfa-2a is produced using recombinant DNA technology in which a cloned human leukocyte interferon gene is inserted into and expressed in Escherichia coli. The resultant protein is 165 amino acids. The PEG strand protects the molecule in vivo from proteolytic breakdown, substantially increases its in vivo half-life, and reduces immunogenicity by wrapping around and physically hindering access to the protein portion of the molecule.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">9</field>
		<field name="drug_name">Alteplase</field>
		<field name="description">Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">10</field>
		<field name="drug_name">Sermorelin</field>
		<field name="description">Sermorelin acetate is the acetate salt of an amidated synthetic 29-amino acid peptide (GRF 1-29 NH 2 ) that corresponds to the amino-terminal segment of the naturally occurring human growth hormone-releasing hormone (GHRH or GRF) consisting of 44 amino acid residues</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">11</field>
		<field name="drug_name">Interferon alfa-n1</field>
		<field name="description">Purified, natural (n is for natural) glycosylated human interferon alpha proteins 166 residues</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">12</field>
		<field name="drug_name">Darbepoetin alfa</field>
		<field name="description">Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">13</field>
		<field name="drug_name">Urokinase</field>
		<field name="description">Low molecular weight form of human urokinase, that consists of an A chain of 2,000 daltons linked by a sulfhydryl bond to a B chain of 30,400 daltons. Recombinant urokinase plasminogen activator</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">14</field>
		<field name="drug_name">Goserelin</field>
		<field name="description">Goserelin is a synthetic hormone. In men, it stops the production of the hormone testosterone, which may stimulate the growth of cancer cells. In women, goserelin decreases the production of the hormone estradiol (which may stimulate the growth of cancer cells) to levels similar to a postmenopausal state. When the medication is stopped, hormone levels return to normal.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">15</field>
		<field name="drug_name">Reteplase</field>
		<field name="description">Human tissue plasminogen activator, purified, glycosylated, 355 residues purified from CHO cells. Retavase is considered a &quot;third-generation&quot; thrombolytic agent, genetically engineered to retain and delete certain portions of human tPA. Retavase is a deletion mutein of human tPA formed by deleting various amino acids present in endogenous human tPA. Retavase contains 355 of the 527 amino acids of native human tPA (amino acids 1-3 and 176-527), and retains the activity-related kringle-2 and serine protease domains of human tPA. Three domains are deleted from retavase - kringle-1, finger, and epidermal growth factor (EGF).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">16</field>
		<field name="drug_name">Epoetin alfa</field>
		<field name="description">Human erythropoietin (recombinant), produced by CHO cells.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">17</field>
		<field name="drug_name">Salmon Calcitonin</field>
		<field name="description">Synthetic peptide, 32 residues long formulated as a nasal spray.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">18</field>
		<field name="drug_name">Interferon alfa-n3</field>
		<field name="description">Purified, natural (n is for natural) human interferon alpha proteins (consists of 3 forms or polymorphisms including 2a, 2b and 2c). 166 residues, some are glycosylated (MW range from 16 kD to 27 kD).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">19</field>
		<field name="drug_name">Pegfilgrastim</field>
		<field name="description">PEGylated (at N terminus) form of human G-CSF (Granulocyte colony stimulating factor), 175 residues, produced from E. coli via bacterial fermentation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">20</field>
		<field name="drug_name">Sargramostim</field>
		<field name="description">Human, recombinant GM-CSF, expressed in yeast. Glycoprotein that is 127 residues. Substitution of Leu23 leads to a difference from native protein.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">21</field>
		<field name="drug_name">Secretin</field>
		<field name="description">This drug is the synthetic form of natural secretin.  It is prepared using solid phase peptide synthesis.  Secretin is a peptide hormone produced in the S cells of the duodenum. Its main effect is to regulate the pH of the small  intestine’s contents through the control of gastric acid secretion and buffering with bicarbonate. It was the first hormone to be discovered.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">22</field>
		<field name="drug_name">Peginterferon alfa-2b</field>
		<field name="description">Peginterferon alfa-2b is a covalent conjugate of recombinant alfa-2b interferon with monomethoxy polyethylene glycol (PEG). The average molecular weight of the PEG portion of the molecule is 12,000 daltons. The average molecular weight of the PEG-Intron molecule is approximately 31,000 daltons. The specific activity of peginterferon alfa-2b is approximately 0.7 x 108 IU/mg protein. Interferon alfa-2b is a water-soluble protein with a molecular weight of 19,271 daltons produced by recombinant DNA techniques. It is obtained from the bacterial fermentation of a strain of &lt;i&gt;Escherichia coli&lt;/i&gt; bearing a genetically engineered plasmid containing an interferon gene from human leukocytes. The PEG strand protects the molecule in vivo from proteolytic breakdown, substantially increases its in vivo half-life, and reduces immunogenicity by wrapping around and physically hindering access to the protein portion of the molecule.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">23</field>
		<field name="drug_name">Asparaginase</field>
		<field name="description">L-asparagine amidohydrolase from E. coli</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">24</field>
		<field name="drug_name">Thyrotropin Alfa</field>
		<field name="description">Thyrotropin alfa is a heterodimeric glycoprotein comprised of two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites and a beta subunit of 118 residues containing one N-linked glycosylation site. The amino acid sequence of thyrotropin alfa is identical to that of human pituitary thyroid stimulating hormone.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">25</field>
		<field name="drug_name">Antihemophilic Factor</field>
		<field name="description">Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">26</field>
		<field name="drug_name">Anakinra</field>
		<field name="description">Anakinra is a recombinant, nonglycosylated human interleukin-1 receptor antagonist (IL-1Ra). The difference  between anakinra and the native human IL-1Ra is that anakinra has an extra methionine residue at the amino terminus. It is manufactured by using the E. coli expression system. Anakinra is composed of 153 amino acid residues. FDA approved on November 14, 2001.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">27</field>
		<field name="drug_name">Gramicidin D</field>
		<field name="description">15 residue peptide isolated from Bacillus brevis. With alternating D and L amino acids</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">28</field>
		<field name="drug_name">Intravenous Immunoglobulin</field>
		<field name="description">Intravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation. The purification process includes cold alcohol fractionation, polyethylene glycol precipitation, and ion exchange chromatography. IVIg contains the same distribution of IgG antibody subclasses as is found in the general human population. IgG subclasses are fully represented in the following proportions: 70.3% IgG1, 24.7% IgG2, 3.1% IgG3, and 1.9% IgG4. IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">29</field>
		<field name="drug_name">Anistreplase</field>
		<field name="description">Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells. Eminase is a lyophilized (freeze-dried) formulation of anistreplase, the p-anisoyl derivative of the primary Lys-plasminogen-streptokinase activator complex (a complex of Lys-plasminogen and streptokinase). A p-anisoyl group is chemically conjugated to a complex of bacterial-derived streptokinase and human Plasma-derived Lys-plasminogen proteins.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">30</field>
		<field name="drug_name">Insulin Regular</field>
		<field name="description">Insulin regular is a 51 residue peptide hormone, composed of two amino acid chains covalently linked by disulfide bonds. The structure is identical to native human insulin. Recombinant insulin is synthesized by recombinant DNA techncology. Inserting the human insulin gene into the Escherichia coli bacteria or Saccharomyces cerevisiae produces insulin for human use.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">31</field>
		<field name="drug_name">Tenecteplase</field>
		<field name="description">Tissue plasminogen activator (tPA). Tenecteplase is a 527 amino acid glycoprotein developed by introducing the following modifications to the complementary DNA (cDNA) for natural human tPA: a substitution of threonine 103 with asparagine, and a substitution of asparagine 117 with glutamine, both within the kringle 1 domain, and a tetra-alanine substitution at amino acids 296-299 in the protease domain.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">32</field>
		<field name="drug_name">Menotropins</field>
		<field name="description">Mixture of luteinizing hormone and follicle stimulating hormone extracted from the urine of postmeonopausal women. Composed of LH with 2 subunits, alpha = 92 residues, beta = 121 residues and FSH with 2 subunits, alpha = 92 residues, beta=111 residues</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">33</field>
		<field name="drug_name">Interferon gamma-1b</field>
		<field name="description">Human Interferon gamma-1b (140 residues), produced from E. coli. Production of Actimmune is achieved by fermentation of a genetically engineered Escherichia coli bacterium containing the DNA which encodes for the human protein. Purification of the product is achieved by conventional column chromatography.   The sequence displayed is a cDNA sequence which codes for human interferon gamma, as described by Gray et. al. and not specifically interferon gamma 1b.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">34</field>
		<field name="drug_name">Interferon Alfa-2a, Recombinant</field>
		<field name="description">Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">35</field>
		<field name="drug_name">Desmopressin</field>
		<field name="description">Desmopressin is a chemical that is similar to Antidiuretic Hormone (ADH) which is found naturally in the body. It increases urine concentration and decreases urine production. Desmopressin is used to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions, allowing you to sleep through the night without awakening to urinate. It is also used to treat specific types of diabetes insipidus and conditions after head injury or pituitary surgery.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">36</field>
		<field name="drug_name">Coagulation factor VIIa</field>
		<field name="description">Recombinant human coagulation Factor VIIa (rFVIIa), intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade.1 NovoSeven is a vitamin K-dependent glycoprotein consisting of 406 amino acid residues. Cloned and expressed in hamster kidney cells, the protein is catalytically active in a two-chain form.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">37</field>
		<field name="drug_name">Oprelvekin</field>
		<field name="description">Oprelvekin, the active ingredient in Neumega® is recombinant Interleukin eleven, which is produced in Escherichia coli (E. coli) by recombinant DNA technology. The protein has a molecular mass of approximately 19,000 daltons, and is non-glycosylated. The polypeptide is 177 amino acids in length (the natural IL-11 has 178). This alteration has not resulted in measurable differences in bioactivity either in vitro or in vivo.    The primary hematopoietic activity of Neumega® is stimulation of megakaryocytopoiesis and thrombopoiesis. In mice and nonhuman primate studies Neumega® has shown potent thrombopoietic activity in compromised hematopoiesis, including moderately to severely myelosuppressed animals. In these studies, Neumega® improved platelet nadirs and accelerated platelet recoveries compared to controls.    In animal studies Oprelvekin also has non-hematopoetic activities. This includes the regulation of intestinal epithelium growth (enhanced healing of gastrointestinal lesions), ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">38</field>
		<field name="drug_name">Palifermin</field>
		<field name="description">Palifermin is a recombinant human keratinocyte growth factor (KGF). It is 140 residues long, and is produced using E. coli.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">39</field>
		<field name="drug_name">Glucagon recombinant</field>
		<field name="description">29 residue peptide hormone. Glucagon is synthesized in a special non- pathogenic laboratory strain of Escherichia coli bacteria that has been genetically altered by the addition of the gene for glucagons</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">40</field>
		<field name="drug_name">Aldesleukin</field>
		<field name="description">Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Genetic engineering techniques were used to modify the human IL-2 gene, and the resulting expression clone encodes a modified human interleukin-2. This recombinant form differs from native interleukin-2 in the following ways: a) Aldesleukin is not glycosylated because it is derived from E. coli; b) the molecule has no N-terminal alanine; the codon for this amino acid was deleted during the genetic engineering procedure; c) the molecule has serine substituted for cysteine at amino acid position 125.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">41</field>
		<field name="drug_name">Botulinum Toxin Type B</field>
		<field name="description">Neurotoxin produced by fermentation of clostridium botulinum type B. The protein exists in noncovalent association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin complex. The neurotoxin complex is recovered from the fermentation process and purified through a series of precipitation and chromatography steps.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">42</field>
		<field name="drug_name">Omalizumab</field>
		<field name="description">A recombinant DNA-derived humanized IgG1k monoclonal antibody that selectively binds to human immunoglobulin E (IgE). Xolair is produced by a Chinese hamster ovary cell suspension culture in a nutrient medium containing the antibiotic gentamicin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">43</field>
		<field name="drug_name">Lutropin alfa</field>
		<field name="description">Recombinant human luteinizing hormone produced in yeast with 2 subunits, alpha = 92 residues, beta = 121 residues</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">44</field>
		<field name="drug_name">OspA lipoprotein</field>
		<field name="description">Vaccine against Lyme disease that contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. It is conjugated with alum (aluminum hydroxide) as an adjuvant.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">45</field>
		<field name="drug_name">Insulin Lispro</field>
		<field name="description">Insulin lispro is a recombinant human insulin analogue produced in a specialized laboratory strain of Escherischia coli. Plasmid DNA transfected into the bacteria encodes for an analogue of human insulin that has a lysine at residuce B28 and proline at B29; these residues are reversed in endogenous human insulin. Reversal of these amino acid residues produces a rapid-acting insulin analogue. FDA approved on 1996.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">46</field>
		<field name="drug_name">Insulin Glargine</field>
		<field name="description">Insulin glargine is produced by recombinant DNA technology using a non-pathogenic laboratory strain of Escherichia coli (K12) as the production organism. It is an analogue of human insulin made by replacing the asparagine residue at position A21 of the A-chain with glycine and adding two arginines to the C-terminus (positions B31 and 32) of the B-chain. The resulting protein is soluble at pH 4 and forms microprecipitates at physiological pH 7.4. Small amounts of insulin glargine are slowly released from microprecipitates giving the drug a long duration of action (up to 24 hours) and no pronounced peak concentration.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">47</field>
		<field name="drug_name">Collagenase</field>
		<field name="description">The enzyme collagenase is derived from fermentation of Clostridium histolyticum</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">48</field>
		<field name="drug_name">Rasburicase</field>
		<field name="description">Rasburicase is a recombinant urate-oxidase enzyme produced by a genetically modified &lt;i&gt;Saccharomyces cerevisiae&lt;/i&gt; strain. The cDNA coding for rasburicase was cloned from a strain of &lt;i&gt;Aspergillus flavus&lt;/i&gt;.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">49</field>
		<field name="drug_name">Cetrorelix</field>
		<field name="description">Cetrorelix is a man-made hormone that blocks the effects of Gonadotropin Releasing Hormone (GnRH). GnRH controls another hormone that is called luteinizing hormone (LH), which is the hormone that starts ovulation during the menstrual cycle. When undergoing hormone treatment sometimes premature ovulation can occur, leading to eggs that are not ready for fertilization to be released. Cetrorelix does not allow the premature release of these eggs to occur.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">50</field>
		<field name="drug_name">Adalimumab</field>
		<field name="description">Adalimumab is a human monoclonal antibody against TNF-alpha. It is produced by recombinant DNA technology using a mammalian cell expression system. It consists of 1330 amino acids and has a molecular weight of approximately 148 kilodaltons.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">51</field>
		<field name="drug_name">Somatropin recombinant</field>
		<field name="description">Recombinant human growth hormone (somatotropin) 191 residues, MW 22.1 kD, synthesized in E. coli</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">52</field>
		<field name="drug_name">Imiglucerase</field>
		<field name="description">Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains of the glycoprotein so that they are predominantly terminated with mannose residues</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">53</field>
		<field name="drug_name">Abciximab</field>
		<field name="description">Abciximab is a Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein (GP) IIb/IIIa receptor of human platelets and inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules. It also binds to vitronectin (?v?3) receptor found on platelets and vessel wall endothelial and smooth muscle cells.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">54</field>
		<field name="drug_name">Drotrecogin alfa</field>
		<field name="description">Drotrecogin alfa is activated human protein C that is synthesized by recombinant DNA technology. It is a glycoprotein of approximately 55 kilodalton molecular weight, consisting of a heavy chain and a light chain linked by a disulfide bond.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">55</field>
		<field name="drug_name">Gemtuzumab ozogamicin</field>
		<field name="description">Recombinant humanized IgG4, kappa antibody conjugated with a cytotoxic antitumor antibiotic, calicheamicin, isolated from fermentation of a bacterium, Micromonospora echinospora ssp. calichensis. The antibody portion of Mylotarg binds specifically to the CD33 antigen, The anti-CD33 hP67.6 antibody is produced by mammalian cell suspension culture using a myeloma NS0 cell line.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">56</field>
		<field name="drug_name">Satumomab Pendetide</field>
		<field name="description">Tumor associated glycoprotein (TAG) 72 (B72.3) monoclonal antibody conjugated with Indium 111 for radioimaging colon tumors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">57</field>
		<field name="drug_name">Alpha-1-proteinase inhibitor</field>
		<field name="description">Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">58</field>
		<field name="drug_name">Pegaspargase</field>
		<field name="description">Pegylated L-asparagine amidohydrolase from E. coli. Pegylation substantially (by a factor of 4) extends the protein half life.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">59</field>
		<field name="drug_name">Interferon beta-1a</field>
		<field name="description">Human interferon beta (166 residues), glycosylated, MW=22.5kD. It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced. The amino acid sequence of Avonex is identical to that of natural human interferon beta.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">60</field>
		<field name="drug_name">Pegademase bovine</field>
		<field name="description">Bovine adenosine deaminase derived from bovine intestine that has been extensively pegylated for extended serum half life</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">61</field>
		<field name="drug_name">Human Serum Albumin</field>
		<field name="description">Human serum albumin isolated from expired blood plasma</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">62</field>
		<field name="drug_name">Eptifibatide</field>
		<field name="description">Synthetic cyclic hexapeptide that binds to platelet receptor glycoprotein and inhibits platelet aggregation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">63</field>
		<field name="drug_name">Serum albumin iodonated</field>
		<field name="description">A diagnostic radiopharmaceutical containing iodinated I 131 albumin for intravenous imaging. Following intravenous injection, radioiodinated albumin human is uniformly distributed throughout the intravascular pool within 10 minutes; extravascular distribution takes place more slowly (2 days). Indicated for use in determinations of total blood and plasma volumes, cardiac output, cardiac and pulmonary blood volumes and circulation times</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">64</field>
		<field name="drug_name">Infliximab</field>
		<field name="description">Tumor necrosis factor (TNF-alpha) binding antibody (chimeric IgG1). It is composed of human constant and murine variable regions. Infliximab is produced by a recombinant cell line cultured by continuous perfusion</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">65</field>
		<field name="drug_name">Follitropin beta</field>
		<field name="description">Human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">66</field>
		<field name="drug_name">Vasopressin</field>
		<field name="description">Antidiuretic hormone, also known as vasopressin, is a nine amino acid peptide secreted from the posterior pituitary. Antidiuretic hormone binds to receptors in the distal or collecting tubules of the kidney and promotes reabsorbtion of water back into the circulation</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">67</field>
		<field name="drug_name">Interferon beta-1b</field>
		<field name="description">Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">68</field>
		<field name="drug_name">Interferon alfacon-1</field>
		<field name="description">Interferon alfacon-1 is a recombinant non-naturally occurring type-I interferon. The 166-amino acid sequence of Interferon alfacon-1 was derived by scanning the sequences of several natural interferon alpha subtypes and assigning the most frequently observed amino acid in each corresponding position. Four additional amino acid changes were made to facilitate the molecular construction, and a corresponding synthetic DNA sequence was constructed using chemical synthesis methodology. Interferon alfacon-1 differs from interferon alfa-2b at 20/166 amino acids (88% homology), and comparison with interferon-beta shows identity at over 30% of the amino acid positions. Interferon alfacon-1 is produced in Escherichia coli (E. coli) cells that have been genetically altered by insertion of a synthetically constructed sequence that codes for Interferon alfacon-1. Prior to final purification, Interferon alfacon-1 is allowed to oxidize to its native state, and its final purity is achieved by sequenti...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">69</field>
		<field name="drug_name">Hyaluronidase</field>
		<field name="description">Highly purified sheep hyaluronidase for administration by injection into the vitreous of the eye.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">70</field>
		<field name="drug_name">Insulin, porcine</field>
		<field name="description">Insulin isolated from pig pancreas. Composed of alpha and beta chains, processed from pro-insulin. Forms a hexameric structure</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">71</field>
		<field name="drug_name">Trastuzumab</field>
		<field name="description">A recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein. Produced in CHO cell culture.*</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">72</field>
		<field name="drug_name">Rituximab</field>
		<field name="description">Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">73</field>
		<field name="drug_name">Basiliximab</field>
		<field name="description">A recombinant chimeric (murine/human) monoclonal antibody (IgG1k) that functions as an immunosuppressive agent, specifically binding to and blocking the interleukin-2 receptor a-chain (IL-2R alpha, also known as CD25 antigen) on the surface of activated T-lymphocytes. It is a 144 kDa glycoprotein obtained from fermentation of an established mouse myeloma cell line genetically engineered to express plasmids containing the human heavy and light chain constant region genes and mouse heavy and light chain variable region genes encoding the RFT5 antibody that binds selectively to the IL-2R alpha.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">74</field>
		<field name="drug_name">Muromonab</field>
		<field name="description">Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">75</field>
		<field name="drug_name">Digoxin Immune Fab</field>
		<field name="description">Digoxin Immune Fab is a sheep antibody (26-10) FAB fragment from sheep immunized with the digoxin derivative Digoxindicarboxymethylamine. It is used as an antidote for overdose of digoxin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">76</field>
		<field name="drug_name">Ibritumomab</field>
		<field name="description">Indium conjugated murine IgG1 kappa monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes. Ibritumomab is produced in Chinese hamster ovary cells and is composed of two murine gamma 1 heavy chains of 445 amino acids each and two kappa light chains of 213 amino acids each.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">77</field>
		<field name="drug_name">Tositumomab</field>
		<field name="description">Murine IgG2a lambda monoclonal antibody against CD20 antigen (2 heavy chains of 451 residues, 2 lambda chains of 220 residues). It is produced in an antibiotic-free culture of mammalian cells. It can be covalently linked to Iodine 131 (a radioactive isotope of iodine).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">78</field>
		<field name="drug_name">Pegvisomant</field>
		<field name="description">Pegvisomant is a highly selective growth hormone (GH) receptor antagonist.  It is used to treat acromegaly.  Unlike dopamine or somatostatin analogs (which inhibit growth hormone secretion), this drug actually blocks the hepatic (GH-mediated) production of insulin like growth factor (IGF-1), which is the main mediator of growth hormone activity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">79</field>
		<field name="drug_name">Botulinum Toxin Type A</field>
		<field name="description">Purified botulinum toxin from Clostridium botulinum, purified from culture via dialysis and acid precipitation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">80</field>
		<field name="drug_name">Pancrelipase</field>
		<field name="description">Pancrelipase is an enzyme mixture isolated from porcine or bovine pancreas, sometimes called pancreatin. It contains 3 enzymes: amylase, lipase, and a protease (chymotrypsin). Pancrelipase is marketed under several brand names such as Ultresa™ and Viokace™.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">81</field>
		<field name="drug_name">Streptokinase</field>
		<field name="description">Streptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">82</field>
		<field name="drug_name">Alemtuzumab</field>
		<field name="description">Humanized monoclonal antibody specific to lymphocyte antigens. It is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) that is directed against the 21-28 kD cell surface glycoprotein,CD52. The Campath-1H antibody is an IgG1 kappa with human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody (Campath-1G). Campath is produced in mammalian cell (Chinese hamster ovary) suspension culture in a medium containing neomycin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">83</field>
		<field name="drug_name">Alglucerase</field>
		<field name="description">Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains of the glycoprotein so that they are predominantly terminated with mannose residues</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">84</field>
		<field name="drug_name">Capromab</field>
		<field name="description">Murine IgG1 monoclonal antibody 7E11-C5.3 antibody conjugated to linker chelator peptide group for indium attachment</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">85</field>
		<field name="drug_name">Laronidase</field>
		<field name="description">Human recombinant alpha-L-iduronidase, 628 residues (mature form), produced by recombinant DNAtechnology in a Chinese hamster ovary cell line. Laronidase is a glycoprotein with a molecular weight of approximately 83 kD. The predicted amino acid sequence of the recombinant form, as well as the nucleotide sequence that encodes it, are identical to a polymorphic form of human a-L-iduronidase. It contains 6 N-linked oligosaccharide modification sites.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">86</field>
		<field name="drug_name">Cyclosporine</field>
		<field name="description">A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. Cyclosporine is produced as a metabolite by the fungus species Cordyceps militaris. (From Martindale, The Extra Pharmacopoeia, 30th ed).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">87</field>
		<field name="drug_name">Alefacept</field>
		<field name="description">Immunosuppressive dimeric fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 (LFA-3) linked to the Fc (hinge, CH2 and CH3 domains) portion of human IgG1. Produced by CHO cells, mW is 91.4 kD.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">88</field>
		<field name="drug_name">Felypressin</field>
		<field name="description">Synthetic analog of lypressin with more vasoconstrictor than antidiuretic action. It is used as a hemostatic.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">89</field>
		<field name="drug_name">Urofollitropin</field>
		<field name="description">Human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">90</field>
		<field name="drug_name">Efalizumab</field>
		<field name="description">Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a. Efalizumab has a molecular weight of approximately 150 kilodaltons and is produced in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">91</field>
		<field name="drug_name">Serum albumin</field>
		<field name="description">A sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren (a highly fluorinated small molecule) for contrast enhancement during indicated ultrasound imaging procedures.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">92</field>
		<field name="drug_name">Choriogonadotropin alfa</field>
		<field name="description">Recombinant human chorionic gonadotropin with 2 subunits, alpha = 92 residues, beta = 145 residues, each with N-and O-linked carbohydrate moieties linked to ASN-52 and ASN-78 (on alpha subunit) and ASN-13, ASN-30, SER-121, SER-127, SER-132 and SER-138 (on beta subunit). The primary structure of the alpha-chain of r-hCG is identical to that of the alpha-chain of hCG, FSH and LH.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">93</field>
		<field name="drug_name">Antithymocyte globulin</field>
		<field name="description">Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of T-cells.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">94</field>
		<field name="drug_name">Filgrastim</field>
		<field name="description">Filgrastim is a recombinant, non-pegylated human granulocyte colony stimulating factor (G-CSF) analogue manufactured by recombinant DNA technology using a strain of E. coli. It is marketed as the brand name Neupogen by Amgen. Chemically, it consists of 175 amino acid residues. The protein has an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analysis, except for the addition of an N-terminal methionine necessary for expression in E coli. Tbo-filgrastim, which is marketed by Sicor Biotech and FDA approved on August 29, 2012, contains the same active ingredient as Neupogen and is biologically similar, but it is formulated to be short-acting.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">95</field>
		<field name="drug_name">Coagulation Factor IX</field>
		<field name="description">Human Factor IX protein, produced by recombinant DNA technology for use in therapy of factor IX deficiency, known as hemophilia B or Christmas disease. Coagulation Factor IX (Recombinant) is a glycoprotein with an approximate molecular mass of 55,000 Da consisting of 415 amino acids in a single chain. It has a primary amino acid sequence that is identical to the Ala 148 allelic form of plasma-derived factor IX.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">96</field>
		<field name="drug_name">Becaplermin</field>
		<field name="description">Becaplermin is produced by recombinant DNA technology by insertion of the gene for the B chain of platelet derived growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin has a molecular weight of approximately 25 KD and is a homodimer composed of two identical polypeptide chains that are bound together by disulfide bonds</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">97</field>
		<field name="drug_name">Agalsidase beta</field>
		<field name="description">Recombinant human alpha-galactosidase A. The mature protein is composed of 2 subunits of 398 residues. Protein is glycosylated and produced by CHO cells</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">98</field>
		<field name="drug_name">Octreotide</field>
		<field name="description">Octreotide is the acetate salt of a cyclic octapeptide. It is a long-acting octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">99</field>
		<field name="drug_name">Interferon Alfa-2b, Recombinant</field>
		<field name="description">Interferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">100</field>
		<field name="drug_name">Abarelix</field>
		<field name="description">Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">101</field>
		<field name="drug_name">Oxytocin</field>
		<field name="description">Synthetic 9 residue cyclic peptide. The hormone is prepared synthetically to avoid possible contamination with vasopressin (ADH) and other small polypeptides with biologic activity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">102</field>
		<field name="drug_name">Natalizumab</field>
		<field name="description">Humanized IgG4k monoclonal antibody produced in murine myeloma cells. Natalizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to a4-integrin. Natalizumab was voluntarily withdrawn from U.S. market because of risk of Progressive multifocal leukoencephalopathy (PML). It was returned to market July, 2006.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">103</field>
		<field name="drug_name">Palivizumab</field>
		<field name="description">Humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV). Synagis is a composite of human (95%) and murine (5%) antibody sequences. The human heavy chain sequence was derived from the constant domains of human IgG1 and the variable framework regions of the VH genes Cor (1) and Cess (2). The human lightchain sequence was derived from the constant domain of Ck and the variable framework regions of the VL gene K104 withJk-4. Palivizumab is expressed from a stable murine (mouse) myeloma cell line (NS0). Palivizumab is composed of to heavy chains (50.6 kDa each) and two light chains (27.6 kDa each), contains 1-2% carbohydrate by weight and has a molecular weight of 147.7 kDa +/- 1 kDa (MALDI-TOF)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">104</field>
		<field name="drug_name">Daclizumab</field>
		<field name="description">Humanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">105</field>
		<field name="drug_name">Bevacizumab</field>
		<field name="description">A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">106</field>
		<field name="drug_name">Arcitumomab</field>
		<field name="description">Reduced Fab fragment of the murine IgG1 monoclonal antibody IMMU-4 (also called NP-4) with specificity for carcinoembryonic antigen (CEA) covalently labeled with Technitium 99. The molecule has a molecular weight of ~54,000 Daltons.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">107</field>
		<field name="drug_name">Pyridoxal Phosphate</field>
		<field name="description">This is the active form of vitamin B6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (pyridoxamine). [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">108</field>
		<field name="drug_name">Cyanocobalamin</field>
		<field name="description">Cyanocobalamin (commonly known as Vitamin B12) is the most chemically complex of all the vitamins. Cyanocobalamin's structure is based on a corrin ring, which, although similar to the porphyrin ring found in heme, chlorophyll, and cytochrome, has two of the pyrrole rings directly bonded. The central metal ion is Co (cobalt). Cyanocobalamin cannot be made by plants or by animals, as the only type of organisms that have the enzymes required for the synthesis of cyanocobalamin are bacteria and archaea. Higher plants do not concentrate cyanocobalamin from the soil and so are a poor source of the substance as compared with animal tissues. Cyanocobalamin is naturally found in foods including meat (especially liver and shellfish), eggs, and milk products. [HMDB]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">109</field>
		<field name="drug_name">Tetrahydrofolic acid</field>
		<field name="description">Tetrahydrofolic acid is a folic acid derivative. It is produced from dihydrofolic acid by dihydrofolate reductase.  It is converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. It is a coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids. It acts as a donor of a group with one carbon atom. It gets this carbon atom by sequestering formaldehyde produced in other processes.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">110</field>
		<field name="drug_name">L-Histidine</field>
		<field name="description">An essential amino acid that is required for the production of histamine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">111</field>
		<field name="drug_name">S-Adenosylmethionine</field>
		<field name="description">Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">112</field>
		<field name="drug_name">Pyruvic acid</field>
		<field name="description">An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">113</field>
		<field name="drug_name">L-Phenylalanine</field>
		<field name="description">An essential aromatic amino acid that is a precursor of melanin; dopamine; noradrenalin (norepinephrine), and thyroxine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">114</field>
		<field name="drug_name">Biotin</field>
		<field name="description">A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">115</field>
		<field name="drug_name">Choline</field>
		<field name="description">A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">116</field>
		<field name="drug_name">L-Lysine</field>
		<field name="description">L-Lysine (abbreviated as Lys or K) is an ?-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. This amino acid is an essential amino acid, which means that humans cannot synthesize it. Its codons are AAA and AAG.    L-Lysine is a base, as are arginine and histidine. The ?-amino group often participates in hydrogen bonding and as a general base in catalysis. Common posttranslational modifications include methylation of the ?-amino group, giving methyl-, dimethyl-, and trimethyllysine. The latter occurs in calmodulin. Other posttranslational modifications include acetylation. Collagen contains hydroxylysine which is derived from lysine by lysyl hydroxylase. O-Glycosylation of lysine residues in the endoplasmic reticulum or Golgi apparatus is used to mark certain proteins for secretion from the cell.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">117</field>
		<field name="drug_name">L-Arginine</field>
		<field name="description">An essential amino acid that is physiologically active in the L-form. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">118</field>
		<field name="drug_name">Vitamin C</field>
		<field name="description">A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">119</field>
		<field name="drug_name">Spermine</field>
		<field name="description">A biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">120</field>
		<field name="drug_name">L-Aspartic Acid</field>
		<field name="description">One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">121</field>
		<field name="drug_name">L-Ornithine</field>
		<field name="description">Ornithine is an amino acid produced in the urea cycle by the splitting off of urea from arginine. It is a central part of the urea cycle, which allows for the disposal of excess nitrogen. L-Ornithine is a precursor of citrulline and arginine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">122</field>
		<field name="drug_name">L-Glutamine</field>
		<field name="description">A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">123</field>
		<field name="drug_name">Adenosine monophosphate</field>
		<field name="description">Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2&amp;#39;-, 3&amp;#39;-, or 5&amp;#39;-position. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">124</field>
		<field name="drug_name">Alpha-Linolenic Acid</field>
		<field name="description">Alpha-linolenic acid (ALA) is a polyunsaturated omega-3 fatty acid. It is a component of many common vegetable oils and is important to human nutrition. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">125</field>
		<field name="drug_name">L-Serine</field>
		<field name="description">A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">126</field>
		<field name="drug_name">L-Methionine</field>
		<field name="description">A sulfur containing essential amino acid that is important in many body functions. It is a chelating agent for heavy metals. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">127</field>
		<field name="drug_name">L-Tyrosine</field>
		<field name="description">A non-essential amino acid. In animals it is synthesized from phenylalanine. It is also the precursor of epinephrine; thyroid hormones; and melanin. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">128</field>
		<field name="drug_name">Calcitriol</field>
		<field name="description">Calcitriol or 1,25-dihydroxycholecalciferol (abbreviated 1,25-(OH)&lt;sub&gt;2&lt;/sub&gt;-D3) is the active form of vitamin D found in the body (vitamin D3). Calcitriol is marketed under various trade names including Rocaltrol (Roche), Calcijex (Abbott) and Decostriol (Mibe, Jesalis). It is produced in the kidneys via 25-hydroxyvitamin D-1 &amp;alpha;-hydroxylase by conversion from 25-hydroxycholecalciferol (calcidiol). This is stimulated by a decrease in serum calcium, phosphate (PO&lt;sub&gt;4&lt;/sub&gt;&lt;sup&gt;3?&lt;/sup&gt;) and parathyroid hormone (PTH) levels. It regulates calcium levels by increasing the absorption of calcium and phosphate from the gastrointestinal tract, increasing calcium and phosphate reabsorption in the kidneys and inhibiting the release of PTH. Calcitriol is also commonly used as a medication in the treatment of hypocalcemia and osteoporosis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">129</field>
		<field name="drug_name">Xanthophyll</field>
		<field name="description">Xanthophylls are yellow pigments from the carotenoid group that are widespread in nature. They are present in egg yolk, algae, and petals of yellow flowers, among other sources. The xanthophylls include lutein, zeaxanthin, neoxanthin, violaxanthin, and ?- and ?-cryptoxanthin, of which lutein is the primary ingested one.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">130</field>
		<field name="drug_name">L-Cystine</field>
		<field name="description">A covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">131</field>
		<field name="drug_name">Succinic acid</field>
		<field name="description">A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley&amp;#39;s Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">132</field>
		<field name="drug_name">Riboflavin</field>
		<field name="description">Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">133</field>
		<field name="drug_name">N-Acetyl-D-glucosamine</field>
		<field name="description">The N-acetyl derivative of glucosamine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">134</field>
		<field name="drug_name">L-Glutamic Acid</field>
		<field name="description">A peptide that is a homopolymer of glutamic acid. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">135</field>
		<field name="drug_name">Glutathione</field>
		<field name="description">A tripeptide with many roles in cells.  It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">136</field>
		<field name="drug_name">Phosphatidylserine</field>
		<field name="description">Phosphatidylserine (PS) is a phospholipid nutrient found in fish, green leafy vegetables, soybeans and rice, and is essential for the normal functioning of neuronal cell membranes and activates Protein kinase C (PKC) which has been shown to be involved in memory function. In apoptosis, phosphatidylserine is transferred to the outer leaflet of the plasma membrane. This is part of the process by which the cell is targeted for phagocytosis. PS has been shown to slow cognitive decline in animal models. PS has been investigated in a small number of double-blind placebo trials and has been shown to increase memory performance in the elderly. Because of the potentail cognitive benefits of phosphatidylserine, the substance is sold as a dietary supplement to people who believe they can benefit from an increased intake.    The dietary supplement was originally processed from bovine sources however Prion disease scares in the 1990s outlawed this process, and a soy-based alternative was adopted.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">137</field>
		<field name="drug_name">Glycine</field>
		<field name="description">A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">138</field>
		<field name="drug_name">Calcidiol</field>
		<field name="description">The major circulating metabolite of vitamin D3 (cholecalciferol).  It is produced in the liver and is the best indicator of the body's vitamin D stores. It is effective in the treatment of rickets and osteomalacia, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">139</field>
		<field name="drug_name">Pyridoxal</field>
		<field name="description">The 4-carboxyaldehyde form of vitamin B 6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">140</field>
		<field name="drug_name">Creatine</field>
		<field name="description">An amino acid that occurs in vertebrate tissues and in urine.  In muscle tissue, creatine generally occurs as phosphocreatine.  Creatine is excreted as creatinine in the urine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">141</field>
		<field name="drug_name">L-Leucine</field>
		<field name="description">An essential branched-chain amino acid important for hemoglobin formation. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">142</field>
		<field name="drug_name">L-Tryptophan</field>
		<field name="description">An essential amino acid that is necessary for normal growth in infants and for nitrogen balance in adults. It is a precursor of indole alkaloids in plants. It is a precursor of serotonin (hence its use as an antidepressant and sleep aid). It can be a precursor to niacin, albeit inefficiently, in mammals. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">143</field>
		<field name="drug_name">L-Cysteine</field>
		<field name="description">A thiol-containing non-essential amino acid that is oxidized to form cystine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">144</field>
		<field name="drug_name">Thiamine</field>
		<field name="description">Thiamine or thiamin, also known as vitamin B1, is a colorless compound with the chemical formula C12H17N4OS. It is soluble in water and insoluble in alcohol. Thiamine decomposes if heated. Thiamine was first discovered by Umetaro Suzuki in Japan when researching how rice bran cured patients of Beriberi. Thiamine plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the effect of glucose and insulin on arterial smooth muscle cell proliferation. Thiamine plays an important role in helping the body convert carbohydrates and fat into energy. It is essential for normal growth and development and helps to maintain proper functioning of the heart and the nervous and digestive systems. Thiamine cannot be stored in the body; however, once absorbed, the vitamin is concentrated in muscle tissue.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">145</field>
		<field name="drug_name">Ergocalciferol</field>
		<field name="description">Ergocalciferol (Vitamin D2) is a derivative of ergosterol formed by ultraviolet rays breaking of the C9-C10 bond. It differs from cholecalciferol in having a double bond between C22 and C23 and a methyl group at C24. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">146</field>
		<field name="drug_name">gamma-Homolinolenic acid</field>
		<field name="description">A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">147</field>
		<field name="drug_name">L-Citrulline</field>
		<field name="description">Citrulline is an amino acid.  It is made from ornithine and carbamoyl phosphate in one of the central reactions in the urea cycle. It is also produced from arginine as a by-product of the reaction catalyzed by NOS family.  Its name is derived from citrullus, the Latin word for watermelon, from which it was first isolated.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">148</field>
		<field name="drug_name">L-Threonine</field>
		<field name="description">An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">149</field>
		<field name="drug_name">NADH</field>
		<field name="description">NADH is the reduced form of NAD+, and NAD+ is the oxidized form of NADH, A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). It forms NADP with the addition of a phosphate group to the 2' position of the adenosyl nucleotide through an ester linkage.(Dorland, 27th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">150</field>
		<field name="drug_name">Folic Acid</field>
		<field name="description">A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">151</field>
		<field name="drug_name">Icosapent</field>
		<field name="description">Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">152</field>
		<field name="drug_name">L-Alanine</field>
		<field name="description">A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">153</field>
		<field name="drug_name">L-Valine</field>
		<field name="description">A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">154</field>
		<field name="drug_name">Vitamin A</field>
		<field name="description">Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of carotenoids found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">155</field>
		<field name="drug_name">Vitamin E</field>
		<field name="description">A generic descriptor for all tocopherols and tocotrienols that exhibit alpha-tocopherol activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of isoprenoids. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">156</field>
		<field name="drug_name">Pyridoxine</field>
		<field name="description">Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosphate in the body. Pyridoxal 5-phosphate is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.  Although pyridoxine and vitamin B6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">157</field>
		<field name="drug_name">Lipoic Acid</field>
		<field name="description">A vitamin-like antioxidant. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">158</field>
		<field name="drug_name">L-Isoleucine</field>
		<field name="description">An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">159</field>
		<field name="drug_name">Aspartame</field>
		<field name="description">Flavoring agent sweeter than sugar, metabolized as phenylalanine and aspartic acid. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">160</field>
		<field name="drug_name">Cholecalciferol</field>
		<field name="description">Derivative of 7-dehydroxycholesterol formed by ultraviolet rays breaking of the C9-C10 bond. It differs from ergocalciferol in having a single bond between C22 and C23 and lacking a methyl group at C24. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">161</field>
		<field name="drug_name">Menadione</field>
		<field name="description">A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">162</field>
		<field name="drug_name">Adenosine triphosphate</field>
		<field name="description">An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">163</field>
		<field name="drug_name">L-Proline</field>
		<field name="description">A non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">164</field>
		<field name="drug_name">Adenine</field>
		<field name="description">A purine base and a fundamental unit of adenine nucleotides. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">165</field>
		<field name="drug_name">L-Asparagine</field>
		<field name="description">A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from aspartic acid and ammonia by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">166</field>
		<field name="drug_name">Pravastatin</field>
		<field name="description">Pravastatin is a cholesterol-lowering agent that belongs to a class of medications known as statins. It was derived from microbial transformation of mevastatin, the first statin discovered. It is a ring-opened dihydroxyacid with a 6’-hydroxyl group that does not require &lt;i&gt;in vivo&lt;/i&gt; activation. Pravastatin is one of the lower potency statins; however, its increased hydrophilicity is thought to confer advantages such as minimal penetration through lipophilic membranes of peripheral cells, increased selectivity for hepatic tissues, and a reduction in side effects compared with lovastatin and simvastatin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">167</field>
		<field name="drug_name">Fluvoxamine</field>
		<field name="description">Fluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. Though it is in the same class as other SSRI drugs, it is most often used to treat obsessive-compulsive disorder.  Fluvoxamine has been in use in clinical practice since 1983 and has a clinical trial database comprised of approximately 35,000 patients. It was launched in the US in December 1994 and in Japan in June 1999. As of the end of 1995, more than 10 million patients worldwide have been treated with fluvoxamine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">168</field>
		<field name="drug_name">Valsartan</field>
		<field name="description">Valsartan is an angiotensin-receptor blocker (ARB) that may be used to treat a variety of cardiac conditions including hypertension, diabetic nephropathy and heart failure. Valsartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Valsartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">169</field>
		<field name="drug_name">Ramipril</field>
		<field name="description">Ramipril is a prodrug belonging to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. Ramiprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Ramipril may be used in the treatment of hypertension, congestive heart failure, nephropathy, and to reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">170</field>
		<field name="drug_name">Masoprocol</field>
		<field name="description">A potent lipoxygenase inhibitor that interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">171</field>
		<field name="drug_name">Flunisolide</field>
		<field name="description">Flunisolide (marketed as AeroBid, Nasalide, Nasarel) is a corticosteroid often prescribed as treatment for allergic rhinitis.    The principle mechanism of action of flunisolide is to activate glucocorticoid receptors. It also has anti-inflammatory action.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">172</field>
		<field name="drug_name">Baclofen</field>
		<field name="description">Baclofen is a gamma-amino-butyric acid (GABA) derivative used as a skeletal muscle relaxant. Baclofen stimulates GABA-B receptors leading to decreased frequency and amplitude of muscle spasms. It is especially useful in treating muscle spasticity associated with spinal cord injury. It appears to act primarily at the spinal cord level by inhibiting spinal polysynaptic afferent pathways and, to a lesser extent, monosynaptic afferent pathways.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">173</field>
		<field name="drug_name">Amphetamine</field>
		<field name="description">Amphetamine is a chiral compound. The racemic mixture can be divided into its optical antipodes: levo- and dextro-amphetamine. Amphetamine is the parent compound of its own structural class, comprising a broad range of psychoactive derivatives, e.g., MDMA (Ecstasy) and the N-methylated form, methamphetamine. Amphetamine is a homologue of phenethylamine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">174</field>
		<field name="drug_name">Pentagastrin</field>
		<field name="description">A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">175</field>
		<field name="drug_name">Nicotine</field>
		<field name="description">Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">176</field>
		<field name="drug_name">Cevimeline</field>
		<field name="description">Cevimeline is a parasympathomimetic and muscarinic agonist, with particular effect on M3 receptors. It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren's syndrome. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">177</field>
		<field name="drug_name">Lorazepam</field>
		<field name="description">A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">178</field>
		<field name="drug_name">Esmolol</field>
		<field name="description">Esmolol (trade name Brevibloc) is a cardioselective beta1 receptor blocker with rapid onset, a very short duration of action, and no significant intrinsic sympathomimetic or membrane stabilising activity at therapeutic dosages.    Esmolol decreases the force and rate of heart contractions by blocking beta-adrenergic receptors of the sympathetic nervous system, which are found in the heart and other organs of the body. Esmolol prevents the action of two naturally occurring substances: epinephrine and norepinephrine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">179</field>
		<field name="drug_name">Bortezomib</field>
		<field name="description">Bortezomib (originally PS-341 and marketed as Velcade by Millennium Pharmaceuticals) is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">180</field>
		<field name="drug_name">Ethchlorvynol</field>
		<field name="description">Ethchlorvynol is a sedative and hypnotic drug. It has been used to treat insomnia, but has been largely superseded and is only offered where an intolerance or allergy to other drugs exists. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">181</field>
		<field name="drug_name">Carbidopa</field>
		<field name="description">An inhibitor of DOPA decarboxylase, preventing conversion of levodopa to dopamine. It is used in parkinson disease to reduce peripheral adverse effects of levodopa. It has no antiparkinson actions by itself. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">182</field>
		<field name="drug_name">Phentermine</field>
		<field name="description">A central nervous system stimulant and sympathomimetic with actions and uses similar to those of dextroamphetamine. It has been used most frequently in the treatment of obesity. [PubChem]. Some common brand names for phentermine are Adipex-P® and Suprenza™. Phentermine is also available in combination medications such as Qsymia®.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">183</field>
		<field name="drug_name">Indecainide</field>
		<field name="description">Indecainide is a rarely used antidysrhythmic. Indecainide has local anesthetic activity and belongs to the membrane stabilizing (Class 1) group of antiarrhythmic agents; it has electrophysiologic effects characteristic of the IC class of antiarrhythmics.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">184</field>
		<field name="drug_name">Tramadol</field>
		<field name="description">A narcotic analgesic proposed for moderate to severe pain. It may be habituating. [PubChem] Tramadol is also prepared as a variable release capsules, marketed under the brand name ConZip. For example, a 150 mg capsule will contain 37.5 mg of the immediate release form and 112.5 mg of the extended release form.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">185</field>
		<field name="drug_name">Betaxolol</field>
		<field name="description">A cardioselective beta-1-adrenergic antagonist with no partial agonist activity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">186</field>
		<field name="drug_name">Troglitazone</field>
		<field name="description">Troglitazone was withdrawn in 2000 due to risk of hepatotoxicity. It was superseded by pioglitazone and rosiglitazone.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">187</field>
		<field name="drug_name">Hydroxocobalamin</field>
		<field name="description">Injectable form of vitamin B 12 that has been used therapeutically to treat vitamin B 12 deficiency. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">188</field>
		<field name="drug_name">Caffeine</field>
		<field name="description">A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine&amp;#39;s most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes smooth muscle, stimulates cardiac muscle, stimulates diuresis, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide phosphodiesterases, antagonism of adenosine receptors, and modulation of intracellular calcium handling. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">189</field>
		<field name="drug_name">Succinylcholine</field>
		<field name="description">A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">190</field>
		<field name="drug_name">Sildenafil</field>
		<field name="description">Sildenfail is a vasoactive agent used to treat erectile dysfunction and reduce symptoms in patients with pulmonary arterial hypertension (PAH). Sildenafil elevates levels of the second messenger, cGMP, by inhibiting its breakdown via phosphodiesterase type 5 (PDE5). PDE5 is found in particularly high concentrations in the corpus cavernosum, erectile tissue of the penis. It is also found in the retina and vascular endothelium. Increased cGMP results in vasodilation which facilitates generation and maintenance of an erection. The vasodilatory effects of sildenafil also help reduce symptoms of PAH.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">191</field>
		<field name="drug_name">Dofetilide</field>
		<field name="description">Dofetilide is a class III antiarrhythmic agent that is approved by the Food and Drug Administration (FDA) for the maintenance of sinus rhythm in individuals prone to the formation of atrial fibrillation and flutter, and for the chemical cardioversion to sinus rhythm from atrial fibrillation and flutter. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">192</field>
		<field name="drug_name">Reserpine</field>
		<field name="description">An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">193</field>
		<field name="drug_name">Ticlopidine</field>
		<field name="description">Ticlopidine is an effective inhibitor of platelet aggregation. It is a prodrug that is metabolised to an active form, which blocks the ADP receptor that is involved in GPIIb/IIIa receptor activation leading to platelet aggregation. Ticlopidine is marketed under the brand name Ticlid and is indicated for patients who cannot take aspirin or in whom aspirin has not worked to prevent a thrombotic stroke. The FDA label includes a black-box warning of neutropenia, aplastic anemia, thrombotic thrombocytopenia purpura, and agranulocytosis, so it is necessary to monitor patients' WBC and platelets when they are taking ticlopidine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">194</field>
		<field name="drug_name">Trospium</field>
		<field name="description">Trospium is a urinary antispasmodic. It is sold under the brand name Sanctura in the US, and as Trosec in Canada. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">195</field>
		<field name="drug_name">Adapalene</field>
		<field name="description">Adapalene is a topical retinoid primarily used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions. It is currently marketed by Galderma under the trade names Differin in some countries, and Adaferin in India. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">196</field>
		<field name="drug_name">Midodrine</field>
		<field name="description">An ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">197</field>
		<field name="drug_name">Remikiren</field>
		<field name="description">Remikiren is an orally active, high specificity renin inhibitor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">198</field>
		<field name="drug_name">Pantoprazole</field>
		<field name="description">Pantoprazole is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">199</field>
		<field name="drug_name">Torasemide</field>
		<field name="description">Torasemide (rINN) or torsemide (USAN) is a pyridine-sulfonylurea type loop diuretic mainly used in the management of edema associated with congestive heart failure. It is also used at low doses for the management of hypertension. It is marketed under the brand name Demadex. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">200</field>
		<field name="drug_name">Citalopram</field>
		<field name="description">Citalopram hydrobromide belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Citalopram and its N-demethylated metabolites exist as a racemic mixture but its effects are largely due to the S-enantiomer, S-citalopram and S-demthylcitalopram. Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize &amp;alpha;- or &amp;beta;-adrenergic, dopamine D&lt;sub&gt;2&lt;/sub&gt; or histamine H&lt;sub&gt;1&lt;/sub&gt; receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and termina...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">201</field>
		<field name="drug_name">Eletriptan</field>
		<field name="description">Eletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">202</field>
		<field name="drug_name">Bethanidine</field>
		<field name="description">A guanidinium antihypertensive agent that acts by blocking adrenergic transmission.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">203</field>
		<field name="drug_name">Oxyphenonium</field>
		<field name="description">A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of atropine. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">204</field>
		<field name="drug_name">Isoetharine</field>
		<field name="description">Isoetharine is a selective adrenergic beta-2 agonist used as fast acting bronchodilator for emphysema, bronchitis and asthma. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">205</field>
		<field name="drug_name">Glimepiride</field>
		<field name="description">Glimepiride is the first III generation sulphonyl urea it is a very potent sulphonyl urea with long duration of action.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">206</field>
		<field name="drug_name">Diflorasone</field>
		<field name="description">Diflorasone is a topical corticosteroid used to treat itching and inflammation of the skin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">207</field>
		<field name="drug_name">Gadodiamide</field>
		<field name="description">Gadodiamide is a gadolinium based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. It is commonly marketed under the trade name Omniscan. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">208</field>
		<field name="drug_name">Guanadrel Sulfate</field>
		<field name="description">Guanadrel is a postganglionic adrenergic blocking agent. Uptake of guanadrel and storage in sympathetic neurons occurs via the norepinephrine pump or transporter.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">209</field>
		<field name="drug_name">Lovastatin</field>
		<field name="description">Lovastatin is a cholesterol-lowering agent that belongs to the class of medications called statins. It was the second agent of this class discovered. It was discovered by Alfred Alberts and his team at Merck in 1978 after screening only 18 compounds over 2 weeks. The agent, also known as mevinolin, was isolated from the fungi &lt;i&gt;Aspergillus terreus&lt;/i&gt;. Research on this compound was suddenly shut down in 1980 and the drug was not approved until 1987. Interesting, Akira Endo at Sankyo Co. (Japan) patented lovastatin isolated from &lt;i&gt;Monascus ruber&lt;/i&gt; four months before Merck. Lovastatin was found to be 2 times more potent than its predecessor, mevastatin, the first discovered statin. Like mevastatin, lovastatin is structurally similar to hydroxymethylglutarate (HMG), a substituent of HMG-Coenzyme A (HMG-CoA), a substrate of the cholesterol biosynthesis pathway via the mevalonic acid pathway. Lovastatin is a competitive inhibitor of HMG-CoA reductase with a binding affinity 20,000 times...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">210</field>
		<field name="drug_name">Enflurane</field>
		<field name="description">An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">211</field>
		<field name="drug_name">Pregabalin</field>
		<field name="description">Pregabalin is an anticonvulsant drug used for neuropathic pain, as an adjunct therapy for partial seizures, and in generalized anxiety disorder. It was designed as a more potent successor to gabapentin. Pregabalin is marketed by Pfizer under the trade name Lyrica. It is considered to have a dependence liability if misused, and is classified as a Schedule V drug in the U.S. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">212</field>
		<field name="drug_name">Temazepam</field>
		<field name="description">A benzodiazepine that acts as a gamma-aminobutyric acid modulator and anti-anxiety agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">213</field>
		<field name="drug_name">Methyclothiazide</field>
		<field name="description">A thiazide diuretic with properties similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p825)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">214</field>
		<field name="drug_name">Reboxetine</field>
		<field name="description">Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">215</field>
		<field name="drug_name">Milrinone</field>
		<field name="description">A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the ionotropic potency of amrinone. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">216</field>
		<field name="drug_name">Pipobroman</field>
		<field name="description">An antineoplastic agent that acts by alkylation. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">217</field>
		<field name="drug_name">Butabarbital</field>
		<field name="description">Butabarbital (trade name Butisol) is a prescription barbiturate sleep aid. Butabarbital has a particularly fast onset of effects and short duration of action compared to other barbiturates, which makes it useful for certain applications such as treating severe insomnia and relieving anxiety before surgical procedures; however it is also relatively dangerous particularly when combined with alcohol, and so is now rarely used, although it is still prescribed in some Eastern European and South American countries. Its short duration of action gives butabarbital a high abuse potential, comparable to secobarbital. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">218</field>
		<field name="drug_name">Alclometasone</field>
		<field name="description">Alclometasone is synthetic glucocorticoid steroid for topical use in dermatology as anti-inflammatory, antipruritic, antiallergic, antiproliferative and vasoconstrictive agent. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">219</field>
		<field name="drug_name">Butalbital</field>
		<field name="description">Butalbital, 5-allyl-5-isobutylbarbituric acid, is a barbiturate with an intermediate duration of action. It has the same chemical formula as talbutal but a different structure. Butalbital is often combined with other medications, such as acetaminophen or aspirin, and is commonly prescribed for the treatment of pain and headache. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">220</field>
		<field name="drug_name">Cladribine</field>
		<field name="description">An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">221</field>
		<field name="drug_name">Ranolazine</field>
		<field name="description">Ranolazine is an antianginal medication. On January 31, 2006, ranolazine was approved for use in the United States by the FDA for the treatment of chronic angina. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">222</field>
		<field name="drug_name">Mesalazine</field>
		<field name="description">An anti-inflammatory agent, structurally related to the salicylates, which is active in inflammatory bowel disease. It is considered to be the active moiety of sulphasalazine. (From Martindale, The Extra Pharmacopoeia, 30th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">223</field>
		<field name="drug_name">Benzatropine</field>
		<field name="description">Benzotropine is a centrally-acting, antimuscarinic agent used as an adjunct in the treatment of Parkinson’s disease. It may also be used to treat extrapyramidal reactions, such as dystonia and Parkinsonism, caused by antipsychotics (e.g. phenothiazines). Symptoms of Parkinson’s disease and extrapyramidal reactions arise from decreases in dopaminergic activity which creates an imbalance between dopaminergic and cholinergic activity. Anticholinergic therapy is thought to aid in restoring this balance leading to relief of symptoms. In addition to its anticholinergic effects, benztropine also inhibits the reuptake of dopamine at nerve terminals via the dopamine transporter. Benzotropine also produces antagonistic effects at the histamine H1 receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">224</field>
		<field name="drug_name">Ziprasidone</field>
		<field name="description">Ziprasidone (marketed as Geodon, Zeldox) was the fifth atypical antipsychotic to gain FDA approval (February 2001). Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania associated with bipolar disorder. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">225</field>
		<field name="drug_name">Methysergide</field>
		<field name="description">An ergot derivative that is a congener of lysergic acid diethylamide.  It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">226</field>
		<field name="drug_name">Cabergoline</field>
		<field name="description">Cabergoline, an ergot derivative, is a long-acting dopamine agonist and prolactin inhibitor. It is used to treat hyperprolactinemic disorders and Parkinsonian Syndrome. Cabergoline possesses potent agonist activity on dopamine D2 receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">227</field>
		<field name="drug_name">Phenytoin</field>
		<field name="description">An anticonvulsant that is used in a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">228</field>
		<field name="drug_name">Medrysone</field>
		<field name="description">Medrysone is a corticosteroid used in ophthalmology. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">229</field>
		<field name="drug_name">Diethylstilbestrol</field>
		<field name="description">A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">230</field>
		<field name="drug_name">Calcium Acetate</field>
		<field name="description">The chemical compound calcium acetate is the calcium salt of acetic acid. An older name is acetate of lime. The anhydrous form is very hygroscopic, therefore the monohydrate is the common form. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">231</field>
		<field name="drug_name">Anagrelide</field>
		<field name="description">Anagrelide is a drug used for the treatment of essential thrombocytosis (ET; essential thrombocythemia). It also has been used in the treatment of chronic myeloid leukemia. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">232</field>
		<field name="drug_name">Carmustine</field>
		<field name="description">A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">233</field>
		<field name="drug_name">Metoprolol</field>
		<field name="description">Metoprolol is a cardioselective &amp;beta;1-adrenergic blocking agent used for acute myocardial infarction (MI), heart failure, angina pectoris and mild to moderate hypertension. It may also be used for supraventricular and tachyarrhythmias and prophylaxis for migraine headaches. Metoprolol is structurally similar to bisoprolol, acebutolol and atenolol in that it has two substituents in the &lt;i&gt;para&lt;/i&gt; position of the benzene ring. The &amp;beta;1-selectivity of these agents is thought to be due in part to the large substituents in the &lt;i&gt;para&lt;/i&gt; position. At low doses, metoprolol selectively blocks cardiac &amp;beta;-1-adrenergic receptors with little activity against &amp;beta;2-adrenergic receptors of the lungs and vascular smooth muscle. Receptor selectivity decreases with higher doses. Unlike propranolol and pindolol, metoprolol does not exhibit membrane-stabilizing or intrinsic sympathomimetic activity. Membrane-stabilizing effects are only observed at doses much higher than those needed for &amp;b...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">234</field>
		<field name="drug_name">Crotamiton</field>
		<field name="description">Crotamiton is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. It is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">235</field>
		<field name="drug_name">Dicumarol</field>
		<field name="description">An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">236</field>
		<field name="drug_name">Ropinirole</field>
		<field name="description">Ropinirole is a non-ergoline dopamine agonist, manufactured by GlaxoSmithKline. It is used in the treatment of Parkinson's disease, and is also one of two medications in the United States with an FDA-approved indication for the treatment of restless legs syndrome (the other being Pramipexole). [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">237</field>
		<field name="drug_name">Chlorotrianisene</field>
		<field name="description">A powerful synthetic, non-steroidal estrogen. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">238</field>
		<field name="drug_name">Isradipine</field>
		<field name="description">Isradipine belongs to the dihydropyridine (DHP) class of calcium channel blockers (CCBs), the most widely used class of CCBs. It is structurally related to felodipine, nifedipine, and nimodipine and is the most potent calcium-channel blocking agent of the DHP class. Isradipine binds to calcium channels with high affinity and specificity and inhibits calcium flux into cardiac and arterial smooth muscle cells. It exhibits greater selectivity towards arterial smooth muscle cells owing to alternative splicing of the alpha-1 subunit of the channel and increased prevalence of inactive channels in smooth muscle cells. Isradipine may be used to treat mild to moderate essential hypertension.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">239</field>
		<field name="drug_name">Diatrizoate</field>
		<field name="description">A commonly used x-ray contrast medium.  As diatrizoate meglumine and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">240</field>
		<field name="drug_name">Betazole</field>
		<field name="description">A histamine H2 agonist used clinically to test gastric secretory function. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">241</field>
		<field name="drug_name">Topiramate</field>
		<field name="description">Topiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics, a division of Johnson &amp; Johnson. It is used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the prevention of migraines. [Wikipedia]. A combination product containing phentermine + topiramate extended-release called QSYMIA® is indicated for the management of obesity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">242</field>
		<field name="drug_name">Olmesartan</field>
		<field name="description">Olmesartan is an antihypertensive agent, which belongs to the class of medications called angiotensin II receptor blockers. It is indicated for the treatment of high blood pressure and is marketed under the name Olmetec®. The FDA label includes a black-box warning of injury and death to the fetus, so women of child-bearing age need to be warned and take the necessary precautions. Olmesartan is also contraindicated in diabetes mellitus patients taking aliskiren.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">243</field>
		<field name="drug_name">Amsacrine</field>
		<field name="description">Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">244</field>
		<field name="drug_name">Theophylline</field>
		<field name="description">A methylxanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Mechanistically, theophylline acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Theophylline is marketed under several brand names such as Uniphyl and Theochron, and it is indicated mainly for asthma, bronchospasm, and COPD.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">245</field>
		<field name="drug_name">Argatroban</field>
		<field name="description">Argatroban is a direct, selective thrombin inhibitor. The American College of Cardiologists (ACC) recommend using bivalirudin or argatroban in patients who have had, or at risk for, heparin induced thrombocytopenia (HIT) and are undergoing percutaneous coronary intervention. Argatroban is a non-heparin anticoagulant shown to both normalize platelet count in patients with HIT and prevent the formation of thrombi. Parental anticoagulants must be stopped and a baseline activated partial thromboplastin time must be obtained prior to administering argatroban.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">246</field>
		<field name="drug_name">Liothyronine</field>
		<field name="description">The L-triiodothyronine (T3, liothyronine) thyroid hormone is normally synthesized and secreted by the thyroid gland in much smaller quantities than L-tetraiodothyronine (T4, levothyroxine, L-thyroxine). Most T3 is derived from peripheral monodeiodination of T4 at the 5 position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">247</field>
		<field name="drug_name">Disopyramide</field>
		<field name="description">A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">248</field>
		<field name="drug_name">Lidocaine</field>
		<field name="description">A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">249</field>
		<field name="drug_name">Pamidronate</field>
		<field name="description">Pamidronic acid (INN) or pamidronate disodium (USAN), marketed as pamidronate disodium pentahydrate under the brand name Aredia, is a bisphosphonate. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">250</field>
		<field name="drug_name">Clemastine</field>
		<field name="description">An ethanolamine-derivative, first generation histamine H1 antagonist used in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">251</field>
		<field name="drug_name">Acarbose</field>
		<field name="description">An inhibitor of alpha glucosidase that retards the digestion and absorption of carbohydrates in the small intestine and hence reduces the increase in blood-glucose concentrations after a carbohydrate load. It is given orally to non-insulin dependent diabetes mellitus patients where diet modification or oral hypoglycemic agents do not control their condition. (From Martindale The Extra Pharmacopoeia, 31st ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">252</field>
		<field name="drug_name">Venlafaxine</field>
		<field name="description">Venlafaxine (Effexor) is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class first introduced by Wyeth in 1993. It is prescribed for the treatment of clinical depression and anxiety disorders. Due to the pronounced side effects and suspicions that venlafaxine may significantly increase the risk of suicide it is not recommended as a first line treatment of depression. However, it is often effective for depression not responding to SSRIs. Venlafaxine was the sixth most widely-used antidepressant based on the amount of retail prescriptions in the US (17.1 million) in 2006. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">253</field>
		<field name="drug_name">Conjugated Estrogens</field>
		<field name="description">Conjugated estrogens, a mixture of the water-soluble salts of sulfate esters from estrone, equilin, 17 ?-dihydroequilin, and other related steroids, may be derived from pregnant equine urine or yam and soy plants. Estrogens are important in the development and maintenance of the female reproductive system and secondary sex characteristics.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">254</field>
		<field name="drug_name">Travoprost</field>
		<field name="description">Travoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a synthetic prostaglandin F2alpha analogue. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">255</field>
		<field name="drug_name">Amcinonide</field>
		<field name="description">Amcinonide is a corticosteroid. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">256</field>
		<field name="drug_name">Atomoxetine</field>
		<field name="description">Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. This chemical is manufactured and marketed under the brand name Strattera; by Eli Lilly and Company and as a generic Attentin by Torrent Pharmaceuticals. There is currently no generic available within the United States due to patent restrictions. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">257</field>
		<field name="drug_name">Bleomycin</field>
		<field name="description">A complex of related glycopeptide antibiotics from &lt;i&gt;Streptomyces verticillus&lt;/i&gt; consisting of bleomycin A2 and B2 (B2 CAS # 9060-10-0). It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. Bleomycin A2 is used as the representative structure for Bleomycin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">258</field>
		<field name="drug_name">Chlorambucil</field>
		<field name="description">A nitrogen mustard alkylating agent used as antineoplastic agent for the treatment of various malignant and nonmalignant diseases. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">259</field>
		<field name="drug_name">Etomidate</field>
		<field name="description">Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">260</field>
		<field name="drug_name">Raltitrexed</field>
		<field name="description">Raltitrexed (brand name Tomudex&amp;reg;) is a chemotherapy drug manufactured AstraZeneca Company, is an antimetabolite used in chemotherapy. It is an inhibitor of thymidylate synthase.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">261</field>
		<field name="drug_name">Etonogestrel</field>
		<field name="description">Etonogestrel is a molecule used in hormonal contraceptives, most notably the subdermal implant Implanon. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">262</field>
		<field name="drug_name">Morphine</field>
		<field name="description">The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">263</field>
		<field name="drug_name">Ropivacaine</field>
		<field name="description">Ropivacaine is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">264</field>
		<field name="drug_name">Bupivacaine</field>
		<field name="description">A widely used local anesthetic agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">265</field>
		<field name="drug_name">Dapiprazole</field>
		<field name="description">Dapiprazole (U.S. trade name Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">266</field>
		<field name="drug_name">Tranexamic Acid</field>
		<field name="description">Antifibrinolytic hemostatic used in severe hemorrhage. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">267</field>
		<field name="drug_name">Desogestrel</field>
		<field name="description">A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">268</field>
		<field name="drug_name">Mitomycin</field>
		<field name="description">An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional alkylating agents causing cross-linking of DNA and inhibition of DNA synthesis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">269</field>
		<field name="drug_name">Talbutal</field>
		<field name="description">Talbutal, also called 5-allyl-5-sec-butylbarbituric acid, is a barbiturate with a short to intermediate duration of action. Talbutal is a schedule III drug in the U.S.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">270</field>
		<field name="drug_name">Bexarotene</field>
		<field name="description">Bexarotene (Targretin) is an antineoplastic agent indicated by the FDA for Cutaneous T cell lymphoma. It has been used off-label for lung cancer, breast cancer, and Kaposi's sarcoma. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">271</field>
		<field name="drug_name">Ibutilide</field>
		<field name="description">Ibutilide is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">272</field>
		<field name="drug_name">Vindesine</field>
		<field name="description">Vinblastine derivative with antineoplastic activity against cancer. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (antineoplastic combined chemotherapy protocols). [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">273</field>
		<field name="drug_name">Chlorthalidone</field>
		<field name="description">A benzenesulfonamide-phthalimidine that tautomerizes to a benzophenones form. It is considered a thiazide-like diuretic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">274</field>
		<field name="drug_name">Ethoxzolamide</field>
		<field name="description">A carbonic anhydrase inhibitor used as diuretic and  in glaucoma. It may cause hypokalemia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">275</field>
		<field name="drug_name">Pentobarbital</field>
		<field name="description">A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">276</field>
		<field name="drug_name">Valproic Acid</field>
		<field name="description">A fatty acid with anticonvulsant properties used in the treatment of epilepsy. The mechanisms of its therapeutic actions are not well understood. It may act by increasing gamma-aminobutyric acid levels in the brain or by altering the properties of voltage dependent sodium channels. Typically supplied in the sodium salt form (CAS number: 76584-70-8). Valproic Acid is also a histone deacetylase inhibitor and is under investigation for treatment of HIV and various cancers.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">277</field>
		<field name="drug_name">Zolmitriptan</field>
		<field name="description">Zolmitriptan is a synthetic tryptamine derivative and appears as a white powder that is readily soluble in water. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">278</field>
		<field name="drug_name">Acetaminophen</field>
		<field name="description">Acetaminophen, also known as paracetamol, is commonly used for its analgesic and antipyretic effects. Its therapeutic effects are similar to salicylates, but it lacks anti-inflammatory, antiplatelet, and gastric ulcerative effects.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">279</field>
		<field name="drug_name">Gefitinib</field>
		<field name="description">Gefitinib (originally coded ZD1839) is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iressa. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">280</field>
		<field name="drug_name">Codeine</field>
		<field name="description">An opioid analgesic related to morphine but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">281</field>
		<field name="drug_name">Dihydroergotamine</field>
		<field name="description">A 9,10alpha-dihydro derivative of ergotamine. It is used as a vasoconstrictor, specifically for the therapy of migraine disorders. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">282</field>
		<field name="drug_name">Amitriptyline</field>
		<field name="description">Amitriptyline hydrochloride is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, amitriptyline does not affect mood or arousal, but may cause sedation. In depressed individuals, amitriptyline exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as amitriptyline, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline. TCAs also down-regulate cerebral cortical &amp;beta;-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H&lt;sub&gt;1&lt;/sub&gt; receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptors and muscarinic receptors, which ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">283</field>
		<field name="drug_name">Floxuridine</field>
		<field name="description">An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection. Floxuridine is available as a sterile, nonpyrogenic, lyophilized powder for reconstitution. When administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">284</field>
		<field name="drug_name">Tolcapone</field>
		<field name="description">Tolcapone is a drug that inhibits the enzyme catechol-O-methyl transferase (COMT). It is used in the treatment of Parkinson's disease as an adjunct to levodopa/carbidopa medication. It is a yellow, odorless, non-hygroscopic, crystalline compound. Tolcapone is associated with a risk of hepatotoxicity. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">285</field>
		<field name="drug_name">Fluorometholone</field>
		<field name="description">A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">286</field>
		<field name="drug_name">Nitroprusside</field>
		<field name="description">Nitroprusside serves as a source of nitric oxide, a potent peripheral vasodilator that affects both arterioles and venules (venules more than arterioles). Nitroprusside is often administered intravenously to patients who are experiencing a hypertensive emergency. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">287</field>
		<field name="drug_name">Calcium Gluceptate</field>
		<field name="description">Calcium supplements such as calcium gluceptate are taken by individuals who are unable to get enough calcium in their regular diet or who have a need for more calcium. They are used to prevent or treat several conditions that may cause hypocalcemia (not enough calcium in the blood). The body needs calcium to make strong bones. Calcium is also needed for the heart, muscles, and nervous system to work properly.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">288</field>
		<field name="drug_name">Hydromorphone</field>
		<field name="description">An opioid analgesic derived from morphine and used mainly as an analgesic. It has a shorter duration of action and is more potent than morphine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">289</field>
		<field name="drug_name">Indomethacin</field>
		<field name="description">Indomethacin is a non-steroidal antiinflammatory agent (NSAIA) with antiinflammatory, analgesic and antipyretic activity. Its pharmacological effect is thought to be mediated through inhibition of the enzyme cyclooxygenase (COX), the enzyme responsible for catalyzes the rate-limiting step in prostaglandin synthesis via the arachidonic acid pathway.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">290</field>
		<field name="drug_name">Ethambutol</field>
		<field name="description">An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">291</field>
		<field name="drug_name">Metformin</field>
		<field name="description">Metformin is a biguanide antihyperglycemic agent used for treating non-insulin-dependent diabetes mellitus (NIDDM). It improves glycemic control by decreasing hepatic glucose production, decreasing glucose absorption and increasing insulin-mediated glucose uptake. Metformin is the only oral antihyperglycemic agent that is not associated with weight gain. Metformin may induce weight loss and is the drug of choice for obese NIDDM patients. When used alone, metformin does not cause hypoglycemia; however, it may potentiate the hypoglycemic effects of sulfonylureas and insulin. Its main side effects are dyspepsia, nausea and diarrhea. Dose titration and/or use of smaller divided doses may decrease side effects. Metformin should be avoided in those with severely compromised renal function (creatinine clearance &lt; 30 ml/min), acute/decompensated heart failure, severe liver disease and for 48 hours after the use of iodinated contrast dyes due to the risk of lactic acidosis. Lower doses should b...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">292</field>
		<field name="drug_name">Ipratropium bromide</field>
		<field name="description">A muscarinic antagonist structurally related to atropine but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">293</field>
		<field name="drug_name">Methadone</field>
		<field name="description">A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of morphine. It also has a depressant action on the cough center and may be given to control intractable cough associated with terminal lung cancer. Methadone is also used as part of the treatment of dependence on opioid drugs, although prolonged use of methadone itself may result in dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3).    In Australia methadone is a Schedule 8 (controlled) drug.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">294</field>
		<field name="drug_name">Olanzapine</field>
		<field name="description">Olanzapine is an atypical antipsychotic, approved by the FDA in 1996. Olanzapine is manufactured and marketed by the pharmaceutical company Eli Lilly and Company, whose patent for olanzapine proper ends in 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">295</field>
		<field name="drug_name">Atenolol</field>
		<field name="description">A cardioselective beta-adrenergic blocker possessing properties and potency similar to propranolol, but without a negative inotropic effect. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">296</field>
		<field name="drug_name">Pimecrolimus</field>
		<field name="description">Pimecrolimus is an immunomodulating agent used in the treatment of atopic dermatitis (eczema). It is currently available as a topical cream, once marketed by Novartis, (however Galderma will be promoting the molecule in Canada in early 2007) under the trade name Elidel. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">297</field>
		<field name="drug_name">Omeprazole</field>
		<field name="description">A highly effective inhibitor of gastric acid secretion used in the therapy of stomach ulcers and Zollinger-Ellison syndrome. Omeprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">298</field>
		<field name="drug_name">Metixene</field>
		<field name="description">Metixene (or methixene) is a anticholinergic used as an anti-parkinson drug. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">299</field>
		<field name="drug_name">Cetirizine</field>
		<field name="description">A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">300</field>
		<field name="drug_name">Terfenadine</field>
		<field name="description">In the U.S., Terfenadine was superseded by fexofenadine in the 1990s due to the risk of cardiac arrhythmia caused by QT interval prolongation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">301</field>
		<field name="drug_name">Diltiazem</field>
		<field name="description">A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions. It is also teratogenic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">302</field>
		<field name="drug_name">Protriptyline</field>
		<field name="description">Protriptyline hydrochloride is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, protriptyline does not affect mood or arousal, but may cause sedation. In depressed individuals, protriptyline exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. In addition, TCAs down-regulate cerebral cortical &amp;beta;-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H&lt;sub&gt;1&lt;/sub&gt; receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention),...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">303</field>
		<field name="drug_name">Aminohippurate</field>
		<field name="description">The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">304</field>
		<field name="drug_name">Alfuzosin</field>
		<field name="description">Alfuzosin (INN, provided as the hydrochloride salt) is an alpha-adrenergic blocker used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">305</field>
		<field name="drug_name">Trimethadione</field>
		<field name="description">An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">306</field>
		<field name="drug_name">Nitisinone</field>
		<field name="description">Nitisinone is a synthetic reversible inhibitor of 4-hydroxyphenylpyruvate dioxygenase. It is used in the treatment of hereditary tyrosinemia type 1. It is sold under the brand name Orfadin. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">307</field>
		<field name="drug_name">Clobazam</field>
		<field name="description">Clobazam belongs to the 1,5-benzodiazepine class of drugs and is expected to have a better side-effect profile compared to older 1,4-benzodiazepines. It has been marketed as an anxiolytic since 1975 and an anticonvulsant since 1984. The oral preparation was FDA approved on October 21, 2011. An oral suspension is expected to be available in 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">308</field>
		<field name="drug_name">Minoxidil</field>
		<field name="description">A potent direct-acting peripheral vasodilator (vasodilator agents) that reduces peripheral resistance and produces a fall in blood pressure. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">309</field>
		<field name="drug_name">Megestrol</field>
		<field name="description">17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">310</field>
		<field name="drug_name">Thioguanine</field>
		<field name="description">An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">311</field>
		<field name="drug_name">Methylergonovine</field>
		<field name="description">A homolog of ergonovine containing one more CH2 group. (Merck Index, 11th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">312</field>
		<field name="drug_name">Buclizine</field>
		<field name="description">Buclizine is an antihistamine of the piperazine derivative family. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">313</field>
		<field name="drug_name">Chlorzoxazone</field>
		<field name="description">A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">314</field>
		<field name="drug_name">Aminoglutethimide</field>
		<field name="description">An aromatase inhibitor that produces a state of &quot;medical&quot; adrenalectomy by blocking the production of adrenal steroids. It also blocks the conversion of androgens to estrogens. Aminoglutethimide has been used in the treatment of advanced breast and prostate cancer. It was formerly used for its weak anticonvulsant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p454)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">315</field>
		<field name="drug_name">Tetrahydrobiopterin</field>
		<field name="description">Tetrahydrobiopterin or BH4 is a cofactor in the synthesis of nitric oxide. It is also essential in the conversion of phenylalanine to tyrosine by the enzyme phenylalanine-4-hydroxylase; the conversion of tyrosine to L-dopa by the enzyme tyrosine hydroxylase; and conversion of tryptophan to 5-hydroxytryptophan via tryptophan hydroxylase. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">316</field>
		<field name="drug_name">Vinorelbine</field>
		<field name="description">Vinorelbine (Navelbine&amp;reg;) is an anti-mitotic chemotherapy drug that is given as a treatment for some types of cancer, including breast cancer and non-small cell lung cancer. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">317</field>
		<field name="drug_name">Clozapine</field>
		<field name="description">A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">318</field>
		<field name="drug_name">Sucralfate</field>
		<field name="description">A basic aluminum complex of sulfated sucrose. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">319</field>
		<field name="drug_name">Doxylamine</field>
		<field name="description">Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in parkinsonism. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">320</field>
		<field name="drug_name">Levonorgestrel</field>
		<field name="description">A synthetic progestational hormone with actions similar to those of progesterone and about twice as potent as its racemic or (+-)-isomer (norgestrel). It is used for contraception, control of menstrual disorders, and treatment of endometriosis. It is usually supplied in a racemic mixture (Norgestrel, 6533-00-2). Only the levonorgestrel isomer is active. Levonorgestrel is marketed mostly as a combination oral contraceptive under several brand names such as Alesse, Triphasil, and Min-Ovral.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">321</field>
		<field name="drug_name">Norepinephrine</field>
		<field name="description">Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">322</field>
		<field name="drug_name">Mirtazapine</field>
		<field name="description">Mirtazapine is an antidepressant introduced by Organon International in 1996 used for the treatment of moderate to severe depression. Mirtazapine has a tetracyclic chemical structure and is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). It is the only tetracyclic antidepressant that has been approved by the Food and Drug Administration to treat depression. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">323</field>
		<field name="drug_name">Meprobamate</field>
		<field name="description">A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of anxiety disorders, and also for the short-term management of insomnia but has largely been superseded by the benzodiazepines. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603) Meprobamate is a controlled substance in the U.S.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">324</field>
		<field name="drug_name">Thiethylperazine</field>
		<field name="description">A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">325</field>
		<field name="drug_name">Timolol</field>
		<field name="description">A beta-adrenergic antagonist similar in action to propranolol. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of migraine disorders and tremor. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">326</field>
		<field name="drug_name">Treprostinil</field>
		<field name="description">Treprostinil is a synthetic analogue of prostacyclin, used to treat pulmonary hypertension. Treprostinil is marketed as Remodulin&amp;reg;. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">327</field>
		<field name="drug_name">Colestipol</field>
		<field name="description">Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic. It may also may reduce triglyceride levels. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">328</field>
		<field name="drug_name">Trihexyphenidyl</field>
		<field name="description">One of the centrally acting muscarinic antagonists used for treatment of parkinsonian disorders and drug-induced extrapyramidal movement disorders and as an antispasmodic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">329</field>
		<field name="drug_name">Palonosetron</field>
		<field name="description">Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is the most effective of the 5-HT3 antagonists in controlling delayed CINV nausea and vomiting that appear more than 24 hours after the first dose of a course of chemotherapy and is the only drug of its class approved for this use by the U.S. Food and Drug Administration. As of 2008, it is the most recent 5-HT3 antagonist to enter clinical use. [wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">330</field>
		<field name="drug_name">Dydrogesterone</field>
		<field name="description">A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit ovulation. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">331</field>
		<field name="drug_name">Mexiletine</field>
		<field name="description">Antiarrhythmic agent pharmacologically similar to lidocaine. It may have some anticonvulsant properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">332</field>
		<field name="drug_name">Dexrazoxane</field>
		<field name="description">An antimitotic agent with immunosuppressive properties. Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection against anthracycline toxicity. It appears to inhibit formation of a toxic iron-anthracycline complex. [PubChem]  The Food and Drug Administration has designated dexrazoxane as an orphan drug for use in the prevention or reduction in the incidence and severity of anthracycline-induced cardiomyopathy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">333</field>
		<field name="drug_name">Amlodipine</field>
		<field name="description">Amlodipine is a long-acting 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, amlodipine prevents calcium-dependent myocyte contraction and vasoconstriction. A second proposed mechanism for the drug’s vasodilatory effects involves pH-dependent inhibition of calcium influx via inhibition of smooth muscle carbonic anhydrase. Some studies have shown that amlodipine also exerts inhibitory effects on voltage-gated N-type calcium channels. N-type calcium channels located in the central nervous system may be involved in nociceptive signaling and pain sensation. Amlodipine is used to treat hypertension and chronic stable angina.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">334</field>
		<field name="drug_name">Tacrine</field>
		<field name="description">A centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">335</field>
		<field name="drug_name">Oxyphencyclimine</field>
		<field name="description">Oxyphencyclimine is an anticholinergic drug (trade name Daricon) used in treating peptic ulcers.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">336</field>
		<field name="drug_name">Triamterene</field>
		<field name="description">A pteridine that is used as a mild diuretic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">337</field>
		<field name="drug_name">Valrubicin</field>
		<field name="description">Valrubicin (N-trifluoroacetyladriamycin-14-valerate, Valstar&amp;reg;) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">338</field>
		<field name="drug_name">Alseroxylon</field>
		<field name="description">A fat-soluble alkaloidal fraction extracted from the root of &lt;i&gt;Rauwolfia serpentina&lt;/i&gt;, containing reserpine and other nonadrenolytic amorphous alkaloids; used as a sedative in psychoses, in mild hypertension, and as an adjunct to more potent hypotensive drugs.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">339</field>
		<field name="drug_name">Procyclidine</field>
		<field name="description">A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">340</field>
		<field name="drug_name">Phenylephrine</field>
		<field name="description">Phenylephrine is a sympathomimetic amine that acts predominantly on &amp;alpha;-adrenergic receptors. It is mainly used to treat nasal congestion, but may also be useful in treating hypotension and shock, hypotension during spinal anaesthesia, prolongation of spinal anaesthesia, paroxysmal supraventricular tachycardia, symptomatic relief of external or internal hemorrhoids, and to increase blood pressure as an aid in the diagnosis of heart murmurs.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">341</field>
		<field name="drug_name">Carbimazole</field>
		<field name="description">An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">342</field>
		<field name="drug_name">Digoxin</field>
		<field name="description">A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone digoxigenin. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">343</field>
		<field name="drug_name">Sulpiride</field>
		<field name="description">A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">344</field>
		<field name="drug_name">Ethopropazine</field>
		<field name="description">Ethopropazine (also known as profenamine hydrochloride) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat parkinsonism. It is sold under the trade names Parsidol in the United States and Parsidan in Canada.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">345</field>
		<field name="drug_name">Nimodipine</field>
		<field name="description">Nimodipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nimodipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Compared to other calcium channel blocking agents, nimodipine exhibits greater effects on cerebral circulation than on peripheral circulation. Nimodipine is used to as an adjunct to improve the neurologic outcome following subarachnoid hemorrhage from ruptured intracranial aneurysm.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">346</field>
		<field name="drug_name">Beclometasone dipropionate</field>
		<field name="description">Beclometasone dipropionate is a prodrug of the free form, beclometasone (beclomethasone-17-monopropionate). An anti-inflammatory, synthetic corticosteroid, it is used topically as an anti-inflammatory agent and in aerosol form for the treatment of asthma and allergic rhinitis (seasonal and perennial). Beclometasone dipropionate is also being investigated for oral treatment in mild-to-moderate Crohn's disease of ileal or ileal-right colonic localisation and for &quot;topical&quot; use mild-to-moderate graft versus host disease. It is marketed under several brand names such as Qnasl (US) and Rivanase AQ (Canada).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">347</field>
		<field name="drug_name">Carisoprodol</field>
		<field name="description">A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">348</field>
		<field name="drug_name">Progesterone</field>
		<field name="description">The major progestational steroid that is secreted primarily by the corpus luteum and the placenta. Progesterone acts on the uterus, the mammary glands, and the brain. It is required in embryo implantation, pregnancy maintenance, and the development of mammary tissue for milk production. Progesterone, converted from pregnenolone, also serves as an intermediate in the biosynthesis of gonadal steroid hormones and adrenal corticosteroids. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">349</field>
		<field name="drug_name">Phenylpropanolamine</field>
		<field name="description">Phenylpropanolamine has been withdrawn in Canada. In November 2000, the Food and Drug Administration (FDA) issued a public health advisory against the use of the drug.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">350</field>
		<field name="drug_name">Sorafenib</field>
		<field name="description">Sorafenib (rINN), marketed as Nexavar by Bayer, is a drug approved for the treatment of advanced renal cell carcinoma (primary kidney cancer). It has also received &quot;Fast Track&quot; designation by the FDA for the treatment of advanced hepatocellular carcinoma (primary liver cancer), and has since performed well in Phase III trials.  Sorafenib is a small molecular inhibitor of Raf kinase, PDGF (platelet-derived growth factor), VEGF receptor 2 &amp; 3 kinases and c Kit the receptor for Stem cell factor. A growing number of drugs target most of these pathways. The originality of Sorafenib lays in its simultaneous targeting of the Raf/Mek/Erk pathway.;Multi-kinase inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">351</field>
		<field name="drug_name">Zoledronate</field>
		<field name="description">Zoledronate (zoledronic acid, marketed by Novartis under the trade names Zometa and Reclast) is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases.    An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture.    Zoledronate is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">352</field>
		<field name="drug_name">Nisoldipine</field>
		<field name="description">Nisoldipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nisoldipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Nisoldipine may be used in alone or in combination with other agents in the management of hypertension.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">353</field>
		<field name="drug_name">Eszopiclone</field>
		<field name="description">Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent (viz., a sedative) used as a treatment for insomnia. Eszopiclone is the active stereoisomer of zopiclone, and belongs to the class of drugs known as cyclopyrrones.    Its main selling point is that it is approved by the U.S. Food and Drug Administration for long-term use, unlike almost all other hypnotic sedatives, which are approved only for the relief of short-term (6-8 weeks) insomnia.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">354</field>
		<field name="drug_name">Ceruletide</field>
		<field name="description">Caerulein is a specific decapeptide similar in action and composition to the natural gastrointestinal peptide hormone cholecystokinin. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">355</field>
		<field name="drug_name">Alprazolam</field>
		<field name="description">A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of panic disorders, with or without agoraphobia, and in generalized anxiety disorders. (From AMA Drug Evaluations Annual, 1994, p238)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">356</field>
		<field name="drug_name">Dexbrompheniramine</field>
		<field name="description">Dexbrompheniramine maleate is an antihistamine used to treat allergic conditions such as hay fever or urticaria.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">357</field>
		<field name="drug_name">Ardeparin</field>
		<field name="description">Ardeparin, marketed under the US trade name Normiflo, is a low molecular weight heparin (LMWH) anticoagulant used for the prevention of postoperative venous thrombosis. Ardeparin is derived via peroxide degradation of heparin extracted from porcine intestinal mucosa. Its molecular weight ranges from 2000 to 15,000 with an average molecular weight of 5500 to 6500. Normiflo was withdrawn from the US market in March 2000.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">358</field>
		<field name="drug_name">Loxapine</field>
		<field name="description">An antipsychotic agent used in schizophrenia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">359</field>
		<field name="drug_name">Remoxipride</field>
		<field name="description">An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">360</field>
		<field name="drug_name">Carbachol</field>
		<field name="description">A slowly hydrolyzed cholinergic agonist that acts at both muscarinic and nicotinic receptors. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">361</field>
		<field name="drug_name">Rosiglitazone</field>
		<field name="description">Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl).    Like other thiazolidinediones, the mechanism of action of rosiglitazone is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR?. Rosiglitazone is a selective ligand of PPAR?, and has no PPAR?-binding action.    Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NF?B) levels fall and inhibitor (I?B) levels increase in patients on rosiglitazone.    Recent research has suggested that rosiglitazone may also be of benefit to a subset of patients with Alzheimer's disease not expressing the ApoE4 allele. This is the subject of a clinical trial currently underway.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">362</field>
		<field name="drug_name">Pramipexole</field>
		<field name="description">Pramipexole is a medication indicated for treating Parkinson's disease and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache or to counteract the problems with low libido experienced by some users of SSRI antidepressant drugs. Pramipexole has shown robust effects on pilot studies in bipolar disorder. Pramipexole is classified as a non-ergoline dopamine agonist.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">363</field>
		<field name="drug_name">Acetohexamide</field>
		<field name="description">A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">364</field>
		<field name="drug_name">Metocurine Iodide</field>
		<field name="description">Metocurine iodide is a benzylisoquinolinium competitive nondepolarizing neuromuscular blocking agent. It is used as an anesthesia adjunct to induce skeletal muscle relaxation and to reduce the intensity of muscle contractions in convulsive therapy Metocurine iodide has a moderate risk of inducing histamine release and has some ganglion blocking activity. Metocurine iodide can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">365</field>
		<field name="drug_name">Secobarbital</field>
		<field name="description">Secobarbital (marketed by Eli Lilly and Company under the brand names Seconal® and Tuinal) is a barbiturate derivative drug. It possesses anaesthetic, anticonvulsant, sedative and hypnotic properties. In the United Kingdom, it was known as Quinalbarbitone.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">366</field>
		<field name="drug_name">Miglustat</field>
		<field name="description">Miglustat is a drug used to treat Gaucher disease.    It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids.    It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase.    It is marketed under the trade name Zavesca.    Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">367</field>
		<field name="drug_name">Promazine</field>
		<field name="description">A phenothiazine with actions similar to chlorpromazine but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">368</field>
		<field name="drug_name">Spironolactone</field>
		<field name="description">A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">369</field>
		<field name="drug_name">Methylphenidate</field>
		<field name="description">A central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">370</field>
		<field name="drug_name">Methocarbamol</field>
		<field name="description">A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">371</field>
		<field name="drug_name">Hyoscyamine</field>
		<field name="description">Hyoscyamine is a chemical compound, a tropane alkaloid it is the levo-isomer to atropine. It is a secondary metabolite of some plants, particularly henbane (Hyoscamus niger.)  Hyoscyamine is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, pancreatitis, colic and cystitis. It has also been used to relieve some heart problems, control some of the symptoms of Parkinson's disease, as well as for control of respiratory secretions in end of life care.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">372</field>
		<field name="drug_name">Zolpidem</field>
		<field name="description">Zolpidem is a prescription short-acting nonbenzodiazepine hypnotic that potentiates gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, by binding to benzodiazepine receptors which are located on the gamma-aminobutyric acid receptors. Zolpidem is used for the short-term treatment of insomnia. It works quickly (usually within 15 minutes) and has a short half-life (2-3 hours). It is classified as an imidazopyridine. As an anticonvulsant and muscle relaxant, the beneficial effects start to emerge at 10 and 20 times the dose required for sedation, respectively. For that reason, it has never been approved for either muscle relaxation or seizure prevention. Recently, zolpidem has been cited in various medical reports mainly in the United Kingdom as waking persistent vegetative state (PVS) patients, and dramatically improving the conditions of people with brain injuries. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">373</field>
		<field name="drug_name">Triprolidine</field>
		<field name="description">First generation histamine H1 antagonist used in allergic rhinitis; asthma; and urticaria. It is a component of cough and cold medicines. It may cause drowsiness. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">374</field>
		<field name="drug_name">Streptozocin</field>
		<field name="description">An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">375</field>
		<field name="drug_name">Carboprost Tromethamine</field>
		<field name="description">A nonsteroidal abortifacient agent that is effective in both the first and second trimesters of pregnancy. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">376</field>
		<field name="drug_name">Prochlorperazine</field>
		<field name="description">A phenothiazine antipsychotic used principally in the treatment of nausea; vomiting; and vertigo. It is more likely than chlorpromazine to cause extrapyramidal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">377</field>
		<field name="drug_name">Cyproheptadine</field>
		<field name="description">A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">378</field>
		<field name="drug_name">Nitric Oxide</field>
		<field name="description">Nitric oxide or Nitrogen monoxide is a chemical compound with chemical formula NO. This gas is an important signaling molecule in the body of mammals including humans and is an extremely important intermediate in the chemical industry. It is also a toxic air pollutant produced by automobile engines and power plants.    Nitric oxide (NO) should not be confused with nitrous oxide (N2O), a general anaesthetic, or with nitrogen dioxide (NO2) which is another poisonous air pollutant.    The nitric oxide molecule is a free radical, which is relevant to understanding its high reactivity. It reacts with the ozone in air to form nitrogen dioxide, signalled by the appearance of the reddish-brown color.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">379</field>
		<field name="drug_name">Bendroflumethiazide</field>
		<field name="description">A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">380</field>
		<field name="drug_name">Allopurinol</field>
		<field name="description">A xanthine oxidase inhibitor that decreases uric acid production. It also acts as an antimetabolite on some simpler organisms. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">381</field>
		<field name="drug_name">Cerivastatin</field>
		<field name="description">On August 8, 2001 the U.S. Food and Drug Administration (FDA) announced that Bayer Pharmaceutical Division voluntarily withdrew Baycol from the U.S. market, due to reports of fatal Rhabdomyolysis, a severe adverse reaction from this cholesterol-lowering (lipid-lowering) product. It has also been withdrawn from the Canadian market.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">382</field>
		<field name="drug_name">Gemcitabine</field>
		<field name="description">Gemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar® by Eli Lilly and Company. As with fluorouracil and other analogues of pyrimidines, the drug replaces one of the building blocks of nucleic acids, in this case cytidine, during DNA replication. The process arrests tumor growth, as new nucleosides cannot be attached to the &quot;faulty&quot; nucleoside, resulting in apoptosis (cellular &quot;suicide&quot;).  Gemcitabine is used in various carcinomas: non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. It is being investigated for use in oesophageal cancer, and is used experimentally in lymphomas and various other tumor types.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">383</field>
		<field name="drug_name">Betamethasone</field>
		<field name="description">A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">384</field>
		<field name="drug_name">Teniposide</field>
		<field name="description">A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent cells from entering into the mitotic phase of the cell cycle, and lead to cell death. Teniposide acts primarily in the G2 and S phases of the cycle. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">385</field>
		<field name="drug_name">Epirubicin</field>
		<field name="description">An anthracycline which is the 4&amp;#39;-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">386</field>
		<field name="drug_name">Lansoprazole</field>
		<field name="description">Lansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products. Lansoprazole has been marketed for many years and is one of several PPI's available.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">387</field>
		<field name="drug_name">Dipivefrin</field>
		<field name="description">Dipivefrin is a prodrug of adrenaline, which is used to treat glaucoma. It is available as ophthalmic solution (eye drops).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">388</field>
		<field name="drug_name">Droperidol</field>
		<field name="description">A butyrophenone with general properties similar to those of haloperidol. It is used in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra  Pharmacopoeia, 29th ed, p593)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">389</field>
		<field name="drug_name">Levothyroxine</field>
		<field name="description">The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">390</field>
		<field name="drug_name">Meperidine</field>
		<field name="description">A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">391</field>
		<field name="drug_name">Loratadine</field>
		<field name="description">Loratadine is a derivative of azatadine and a second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (histamine H1 antagonists) it lacks central nervous system depressing effects such as drowsiness. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">392</field>
		<field name="drug_name">Prazosin</field>
		<field name="description">Prazosin is a selective &amp;alpha;-&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptor antagonist used to treat hypertension. It has also been used to decrease urinary obstruction and relieve symptoms associated with symptomatic benign prostatic hyperplasia. &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-Receptors mediate contraction and hypertrophic growth of smooth muscle cells. Antagonism of these receptors leads to smooth muscle relaxation in the peripheral vasculature and prostate gland. Prazosin has also been used in conjunction with cardiac glycosides and diuretics in the management of severe congestive heart failure. It has also been used alone or in combination with &amp;beta;-blockers in the preoperative management of signs and symptoms of pheochromocytoma.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">393</field>
		<field name="drug_name">Imipramine</field>
		<field name="description">Imipramine, the prototypical tricyclic antidepressant (TCA), is a dibenzazepine-derivative TCA. TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, imipramine does not affect mood or arousal, but may cause sedation. In depressed individuals, imipramine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as imipramine and amitriptyline, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline and desipramine. TCAs also down-regulate cerebral cortical &amp;beta;-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H&lt;sub&gt;1&lt;/sub&gt; receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptors and mus...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">394</field>
		<field name="drug_name">Acitretin</field>
		<field name="description">An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">395</field>
		<field name="drug_name">Verteporfin</field>
		<field name="description">Verteporfin, otherwise known as benzoporphyrin derivative (trade name Visudyne®), is a medication used as a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 693 nm in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to the endothelium and blockage of the vessels.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">396</field>
		<field name="drug_name">Nabumetone</field>
		<field name="description">Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) of the arylalkanoic acid family (which includes diclofenac). Marketed under the brand name Relafen, it has been shown to have a slightly lower risk of gastrointestinal side effects than most other non-selective NSAIDs.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">397</field>
		<field name="drug_name">Methylscopolamine</field>
		<field name="description">A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">398</field>
		<field name="drug_name">Metharbital</field>
		<field name="description">Metharbital was patented in 1905 by Emil Fischer working for Merck. It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy. It has similar properties to phenobarbital.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">399</field>
		<field name="drug_name">Sodium Tetradecyl Sulfate</field>
		<field name="description">An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">400</field>
		<field name="drug_name">Ketorolac</field>
		<field name="description">A pyrrolizine carboxylic acid derivative structurally related to indomethacin. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">401</field>
		<field name="drug_name">Picrotoxin</field>
		<field name="description">A noncompetitive antagonist at GABA-A receptors and thus a convulsant. Picrotoxin blocks the gamma-aminobutyric acid-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">402</field>
		<field name="drug_name">Quinine</field>
		<field name="description">An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">403</field>
		<field name="drug_name">Tenoxicam</field>
		<field name="description">Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">404</field>
		<field name="drug_name">Dronabinol</field>
		<field name="description">A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">405</field>
		<field name="drug_name">Montelukast</field>
		<field name="description">Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. It is usually administered orally. Montelukast blocks the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1 in the lungs and bronchial tubes by binding to it. This reduces the bronchoconstriction otherwise caused by the leukotriene, and results in less inflammation. Because of its method of operation, it is not useful for the treatment of acute asthma attacks. Again because of its very specific locus of operation, it does not interact with other allergy medications such as theophylline. Montelukast is marketed in United States and many other countries by Merck &amp;amp; Co. with the brand name Singulair®. It is available as oral tablets, chewable tablets, and oral granules. In India and other countries, it is also marketed under the brand name Montair&amp;reg;, produced by Indian company Cipla.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">406</field>
		<field name="drug_name">Fluoxetine</field>
		<field name="description">Fluoxetine hydrochloride is the first agent of the class of antidepressants known as selective serotonin-reuptake inhibitors (SSRIs). Fluoxetine is a racemic mixture of the R- and S- enantiomers and are of equivalent pharmacologic activity. Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize &amp;alpha;- or &amp;beta;-adrenergic, dopamine D&lt;sub&gt;2&lt;/sub&gt; or histamine H&lt;sub&gt;1&lt;/sub&gt; receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. The overall clinical effect of i...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">407</field>
		<field name="drug_name">Hexylcaine</field>
		<field name="description">Hexylcaine hydrochloride, also called cyclaine (Merck) or osmocaine, is a short-acting local anesthetic. It acts by inhibiting sodium channel conduction. Overdose can lead to headache, tinnitus, numbness and tingling around the mouth and tongue, convulsions, inability to breathe, and decreased heart function.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">408</field>
		<field name="drug_name">Methohexital</field>
		<field name="description">An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">409</field>
		<field name="drug_name">Chlordiazepoxide</field>
		<field name="description">An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">410</field>
		<field name="drug_name">Duloxetine</field>
		<field name="description">Duloxetine (brand names Cymbalta, Yentreve, and in parts of Europe, Xeristar or Ariclaim) is a drug which primarily targets major depressive disorder (MDD), generalized anxiety disorder (GAD), pain related to diabetic peripheral neuropathy and in some countries stress urinary incontinence (SUI). It is manufactured and marketed by Eli Lilly and Company.    Duloxetine has not yet been FDA approved for stress urinary incontinence or for fibromyalgia.    Duloxetine is a selective SNRI (selective serotonin-norepinephrine reuptake inhibitor). Duloxetine is a systemic drug therapy which affects the body as a whole. Known also under the code name LY248686, it is a potent dual reuptake inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE), possessing comparable affinities in binding to NE- and 5-HT transporter sites. It is a less potent inhibitor of dopamine reuptake.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">411</field>
		<field name="drug_name">Chlorpromazine</field>
		<field name="description">The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class, chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking dopamine receptors. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">412</field>
		<field name="drug_name">Lenalidomide</field>
		<field name="description">Lenalidomide (initially known as CC-5013 and marketed as Revlimid® by Celgene) is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic modality, but has also shown efficacy in the hematological disorders known as the myelodysplastic syndromes. [Wikipedia] FDA approved on December 27, 2005.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">413</field>
		<field name="drug_name">Raloxifene</field>
		<field name="description">A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">414</field>
		<field name="drug_name">Celecoxib</field>
		<field name="description">Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer under the brand name Celebrex. In some countries, it is branded Celebra. Celecoxib is available by prescription in capsule form.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">415</field>
		<field name="drug_name">Gallamine Triethiodide</field>
		<field name="description">A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of tubocurarine, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA Drug Evaluations Annual, 1992, p198)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">416</field>
		<field name="drug_name">Brimonidine</field>
		<field name="description">Brimonidine is a drug used to treat glaucoma. It acts via decreasing aqueous humor synthesis. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">417</field>
		<field name="drug_name">Nabilone</field>
		<field name="description">Nabilone is a synthetic cannabinoid with therapeutic use as an antiemetic and as an adjunct analgesic for neuropathic pain. It is a synthetic cannabinoid, which mimics the main ingredient of marijuana (THC) but it has more predictable side effects and causes no or minimal euphoria. Nabilone is not derived from the cannabis plant as is dronabinol.    In Canada, the United States, the United Kingdom and Mexico, nabilone is marketed as Cesamet. It was approved in 1985 by the United States FDA for treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics. Though it was approved by the FDA in 1985, the drug only began marketing in the United States in 2006. It is also approved for use in treatment of anorexia and weight loss in patients with AIDS.    Although it doesn't have the official indication (except in Mexico), nabilone is widely used as an adjunct therapy for chronic pain management. Numerous trials and case studies have demonstrate var...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">418</field>
		<field name="drug_name">Altretamine</field>
		<field name="description">An alkylating agent proposed as an antineoplastic. It also acts as a chemosterilant for male houseflies and other insects. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">419</field>
		<field name="drug_name">Sotalol</field>
		<field name="description">An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">420</field>
		<field name="drug_name">Buspirone</field>
		<field name="description">An anxiolytic agent and a serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the benzodiazepines, but it has an efficacy comparable to diazepam. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">421</field>
		<field name="drug_name">Miglitol</field>
		<field name="description">Miglitol is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to breakdown complex carbohydrates into glucose. It is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body.    Miglitol inhibits glycoside hydrolase enzymes called alpha-glucosidases. Since miglitol works by preventing digestion of carbohydrates, it lowers the degree of postprandial hyperglycemia. It must be taken at the start of main meals to have maximal effect. Its effect will depend on the amount of non-monosaccharide carbohydrates in a person's diet.    In contrast to acarbose (another alpha-glucosidase inhibitor), miglitol is systemically absorbed; however, it is not metabolized and is excreted by the kidneys.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">422</field>
		<field name="drug_name">Fosinopril</field>
		<field name="description">Fosinopril is a phosphinic acid-containing ester prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly hydrolyzed to fosinoprilat, its principle active metabolite. Fosinoprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Fosinopril may be used to treat mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">423</field>
		<field name="drug_name">Entacapone</field>
		<field name="description">Entacapone is a selective, reversible catechol-O-methyl transferase (COMT) inhibitor for the treatment of Parkinson's disease. It is a member of the class of nitrocatechols. When administered concomittantly with levodopa and a decarboxylase inhibitor (e.g., carbidopa), increased and more sustained plasma levodopa concentrations are reached as compared to the administration of levodopa and a decarboxylase inhibitor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">424</field>
		<field name="drug_name">Darifenacin</field>
		<field name="description">Darifenacin (Enablex®, Novartis) is a medication used to treat urinary incontinence.    Darifenacin works by blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions. It thereby decreases the urgency to urinate. It should not be used in people with urinary retention.    It is not known whether this selectivity for the M3 receptor translates into any clinical advantage when treating symptoms of overactive bladder syndrome.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">425</field>
		<field name="drug_name">Oxycodone</field>
		<field name="description">Semisynthetic derivative of codeine that acts as a narcotic analgesic more potent and addicting than codeine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">426</field>
		<field name="drug_name">Phenindione</field>
		<field name="description">An indandione that has been used as an anticoagulant. Phenindione has actions similar to warfarin, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">427</field>
		<field name="drug_name">Flutamide</field>
		<field name="description">An antiandrogen with about the same potency as cyproterone in rodent and canine species.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">428</field>
		<field name="drug_name">Tolmetin</field>
		<field name="description">A non-steroidal anti-inflammatory agent (anti-inflammatory agents, NON-steroidal) similar in mode of action to indomethacin. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">429</field>
		<field name="drug_name">Cimetidine</field>
		<field name="description">A histamine congener, it competitively inhibits histamine binding to histamine H2 receptors. Cimetidine has a range of pharmacological actions. It inhibits gastric acid secretion, as well as pepsin and gastrins output. It also blocks the activity of cytochrome P-450 which might explain proposals for use in neoadjuvant therapy. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">430</field>
		<field name="drug_name">Haloperidol</field>
		<field name="description">A phenyl-piperidinyl-butyrophenone that is used primarily to treat schizophrenia and other psychoses. It is also used in schizoaffective disorder, delusional disorders, ballism, and tourette syndrome (a drug of choice) and occasionally as adjunctive therapy in mental retardation and the chorea of huntington disease. It is a potent antiemetic and is used in the treatment of intractable hiccups. (From AMA Drug Evaluations Annual, 1994, p279)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">431</field>
		<field name="drug_name">Levallorphan</field>
		<field name="description">An opioid antagonist with properties similar to those of naloxone; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">432</field>
		<field name="drug_name">Tridihexethyl</field>
		<field name="description">Tridihexethyl is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. Tridihexethyl is an antimuscarinic, anticholinergic drug.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">433</field>
		<field name="drug_name">Triflupromazine</field>
		<field name="description">A phenothiazine used as an antipsychotic agent and as an antiemetic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">434</field>
		<field name="drug_name">Dextrothyroxine</field>
		<field name="description">The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">435</field>
		<field name="drug_name">Acetyldigitoxin</field>
		<field name="description">Cardioactive derivative of lanatoside A or of digitoxin used for fast digitalization in congestive heart failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">436</field>
		<field name="drug_name">Aminocaproic Acid</field>
		<field name="description">An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">437</field>
		<field name="drug_name">Dextromethorphan</field>
		<field name="description">The d-isomer of the codeine analog of levorphanol. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">438</field>
		<field name="drug_name">Cisplatin</field>
		<field name="description">Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">439</field>
		<field name="drug_name">Bentoquatam</field>
		<field name="description">Bentoquatam is a topical medication intended to act as a shield against exposure to the irritating substance urushiol, found in plants such as poison ivy or poison oak. Bentoquatam contains bentonite, a clay, and is only effective as long as the film is visible on the skin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">440</field>
		<field name="drug_name">Anisotropine Methylbromide</field>
		<field name="description">Anisotropine methylbromide is a quaternary ammonium compound. Its use as treatment adjunct in peptic ulcer has been replaced by the use of more effective agents. Depending on the dose, anisotropine methylbromide may reduce the motility and secretory activity of the gastrointestinal system, and the tone of the ureter and urinary bladder and may have a slight relaxant action on the bile ducts and gallbladder. In general, smaller doses of anisotropine methylbromide inhibit salivary and bronchial secretions, sweating, and accommodation; cause dilatation of the pupil; and increase the heart rate. Larger doses are required to decrease motility of the gastrointestinal and urinary tracts and to inhibit gastric acid secretion.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">441</field>
		<field name="drug_name">Trandolapril</field>
		<field name="description">Trandolapril is a non-sulhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to its biologically active diacid form, trandolaprilat, in the liver. Trandolaprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Trandolapril may be used to treat mild to moderate hypertension, to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, as an adjunct treatment for congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">442</field>
		<field name="drug_name">Carteolol</field>
		<field name="description">A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">443</field>
		<field name="drug_name">Bentiromide</field>
		<field name="description">Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. It is given by mouth as a noninvasive test. The amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. Headache and gastrointestinal disturbances have been reported in patients taking bentiromide. Bentiromide is not available in the U.S. or Canada (It was withdrawn in the US in October 1996).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">444</field>
		<field name="drug_name">Alitretinoin</field>
		<field name="description">An important regulator of gene expression during growth and development, and in neoplasms. Tretinoin, also known as retinoic acid and derived from maternal vitamin A, is essential for normal growth; and embryonic development. An excess of tretinoin can be teratogenic. It is used in the treatment of psoriasis; acne vulgaris; and several other skin diseases. It has also been approved for use in promyelocytic leukemia (leukemia, promyelocytic, acute). [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">445</field>
		<field name="drug_name">Metolazone</field>
		<field name="description">A quinazoline-sulfonamide that is considered a thiazide-like diuretic which is long-acting so useful in chronic renal failure. It also tends to lower blood pressure and increase potassium loss. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">446</field>
		<field name="drug_name">Oxaliplatin</field>
		<field name="description">Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. Oxaliplatin is marketed by Sanofi-Aventis under the trademark Eloxatin&amp;reg;.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">447</field>
		<field name="drug_name">Dibucaine</field>
		<field name="description">A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">448</field>
		<field name="drug_name">Lercanidipine</field>
		<field name="description">Lercanidipine is a calcium channel blocker of the dihydropyridine class.    It is sold under various commercial names including Zanidip.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">449</field>
		<field name="drug_name">Erlotinib</field>
		<field name="description">Erlotinib hydrochloride (trade name Tarceva, Genentech/OSIP, originally coded as OSI-774) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer.    Similar to gefitinib, erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. Erlotinib has recently been shown to be a potent inhibitor of JAK2V617F activity. JAK2V617F is a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia. The study suggests that erlotinib may be used for treatment of JAK2V617F-positive PV and other myeloproliferative disorders.;EGFR  Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">450</field>
		<field name="drug_name">Cyclophosphamide</field>
		<field name="description">Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. It has been used in the treatment of lymphoma and leukemia. Its side effect, alopecia, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">451</field>
		<field name="drug_name">Mephenytoin</field>
		<field name="description">Mephenytoin is a hydantoin-derivative anticonvulsant used to control various partial seizures. It is generally reserved for treatment of individuals refractory to less toxic agents. Mephenytoin and oxazolidinedione derivatives are associated with higher incidences of blood dyscrasias compared to other anticonvulsants. As such, these agents should not be used concurrently.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">452</field>
		<field name="drug_name">Rofecoxib</field>
		<field name="description">On September 30, 2004, Merck voluntarily withdrew rofecoxib from the market because of concerns about increased risk of heart attack and stroke associated with long-term, high-dosage use.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">453</field>
		<field name="drug_name">Chlormerodrin</field>
		<field name="description">Chlormerodrin is a mercurial compound with toxic side effects that was previously used as a diuretic. The radiolabeled form has been used as a diagnostic and research tool. It is no longer used and has been replaced with new classes of diuretic drugs.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">454</field>
		<field name="drug_name">Guanidine</field>
		<field name="description">A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">455</field>
		<field name="drug_name">Gadoversetamide</field>
		<field name="description">Gadoversetamide is a gadolinium compound used as a contrast agent in magnetic resonance imaging (MRI), particularly imaging of the brain, spine and liver. It is marketed under the trade name OptiMARK.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">456</field>
		<field name="drug_name">Toremifene</field>
		<field name="description">A first generation nonsteroidal selective estrogen receptor modulator (SERM) that is structurally related to tamoxifen. Like tamoxifen, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">457</field>
		<field name="drug_name">Nortriptyline</field>
		<field name="description">Nortriptyline hydrochloride, the &lt;i&gt;N&lt;/i&gt;-demethylated active metabolite of amitriptyline, is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, nortriptyline does not affect mood or arousal, but may cause sedation. In depressed individuals, nortriptyline exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Secondary amine TCAs, such as nortriptyline, are more potent inhibitors of norepinephrine reuptake than tertiary amine TCAs, such as amitriptyline. TCAs also down-regulate cerebral cortical &amp;beta;-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H&lt;sub&gt;1&lt;/sub&gt; receptors, &amp;alph...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">458</field>
		<field name="drug_name">Vincristine</field>
		<field name="description">Vincristine is an antitumor vinca alkaloid isolated from Vinca Rosea. It is marketed under several brand names, many of which have different formulations such as Marqibo and Vincasar. Vincristine is indicated for the treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, and acute panmyelosis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">459</field>
		<field name="drug_name">Benazepril</field>
		<field name="description">Benazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">460</field>
		<field name="drug_name">Amoxapine</field>
		<field name="description">Amoxapine, the &lt;i&gt;N&lt;/i&gt;-demethylated derivative of the antipsychotic agent loxapine, is a dibenzoxazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, amoxapine does not affect mood or arousal, but may cause sedation. In depressed individuals, amoxapine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. In addition, TCAs down-regulate cerebral cortical &amp;beta;-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H&lt;sub&gt;1&lt;/sub&gt; receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision,...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">461</field>
		<field name="drug_name">Fluorouracil</field>
		<field name="description">A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">462</field>
		<field name="drug_name">Pyridostigmine</field>
		<field name="description">A cholinesterase inhibitor with a slightly longer duration of action than neostigmine. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">463</field>
		<field name="drug_name">Adinazolam</field>
		<field name="description">Adinazolam (Deracyn®) is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">464</field>
		<field name="drug_name">Desoximetasone</field>
		<field name="description">A topical anti-inflammatory glucocorticoid used in dermatoses, skin allergies, psoriasis, etc. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">465</field>
		<field name="drug_name">Zafirlukast</field>
		<field name="description">Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled steroid and/or long-acting bronchodilator. It is available as a tablet and is usually dosed twice daily. Another leukotriene receptor antagonist is montelukast (Singulair), which is usually taken just once daily.    Zafirlukast blocks the action of the cysteinyl leukotrienes on the CysLT1 receptors, thus reducing constriction of the airways, build-up of mucus in the lungs and inflammation of the breathing passages.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">466</field>
		<field name="drug_name">Propylthiouracil</field>
		<field name="description">A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">467</field>
		<field name="drug_name">Pentostatin</field>
		<field name="description">A potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">468</field>
		<field name="drug_name">Methoxsalen</field>
		<field name="description">A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA adducts in the presence of ultraviolet A irradiation. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">469</field>
		<field name="drug_name">Piroxicam</field>
		<field name="description">A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">470</field>
		<field name="drug_name">Lamotrigine</field>
		<field name="description">Lamotrigine is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. For epilepsy it is used to treat partial seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Lamotrigine also acts as a mood stabilizer. It is the first medication since lithium granted Food and Drug Administration (FDA) approval for the maintenance treatment of bipolar type I. Chemically unrelated to other anticonvulsants, lamotrigine has relatively few side-effects and does not require blood monitoring. The exact way lamotrigine works is unknown. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">471</field>
		<field name="drug_name">Perflutren</field>
		<field name="description">Perflutren, a diagnostic drug that is intended to be used for contrast enhancement during the indicated echocardiographic procedures, is comprised of lipid-coated microspheres filled with octafluoropropane(OFP) gas. When exposed to ultrasound waves, the microspheres resonate and &quot;echo&quot; strong signals back to the ultrasound machine. The difference in density between the gas-filled bubbles and the blood around them creates an increased level of contrast visible in the resulting ultrasound image. During echocardiography, activated Perflutren enhances images of the inner edges or borders of the heart, producing an improved image that may enable physicians to better diagnose patients.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">472</field>
		<field name="drug_name">Hydroxyzine</field>
		<field name="description">A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite cetirizine, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">473</field>
		<field name="drug_name">Bosentan</field>
		<field name="description">Bosentan is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer&amp;reg;. Bosentan is used to treat pulmonary hypertension by blocking the action of endothelin molecules that would otherwise promote narrowing of the blood vessels and lead to high blood pressure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">474</field>
		<field name="drug_name">Doxapram</field>
		<field name="description">A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">475</field>
		<field name="drug_name">Benzthiazide</field>
		<field name="description">Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">476</field>
		<field name="drug_name">Methotrexate</field>
		<field name="description">An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of tetrahydrofolate dehydrogenase and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">477</field>
		<field name="drug_name">Carbamazepine</field>
		<field name="description">An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of phenytoin; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">478</field>
		<field name="drug_name">Cisatracurium Besylate</field>
		<field name="description">Cisatracurium Besylate is a nondepolarizing skeletal muscle relaxant for intravenous administration. Cisatracurium Besylate acts on cholinergic receptors, blocking neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors such as neostigmine. The neuromuscular block produced by cisatracurium besylate is readily antagonized by anticholinesterase agents once recovery has started. As with other nondepolarizing neuromuscular blocking agents, the more profound the neuromuscular block at the time of reversal, the longer the time required for recovery of neuromuscular function. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">479</field>
		<field name="drug_name">Succimer</field>
		<field name="description">A mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">480</field>
		<field name="drug_name">Cinnarizine</field>
		<field name="description">Cinnarizine is an anti-histaminic drug which is mainly used for the control of vomiting due to motion sickness. Cinnarizine was first synthesized by Janssen Pharmaceutica in 1955.    It acts by interfering with the signal transmission between vestibular apparatus of the inner ear and the vomiting centre of the hypothalamus. The disparity of signal processing between inner ear motion receptors and the visual senses is abolished, so that the confusion of brain whether the individual is moving or standing is reduced. Vomiting in motion sickness is actually a physiological compensatory mechanism of the brain to keep the individual from moving so that it can adjust to the signal perception.    Cinnarizine could be also viewed as a nootropic drug because of its vasorelaxating abilities (due to calcium channel blockage), which happen mostly in brain. It is also effectively combined with other nootropics, primarily piracetam; in such combination each drug potentiate the other in boosting brain...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">481</field>
		<field name="drug_name">Fondaparinux sodium</field>
		<field name="description">Fondaparinux (Arixtra) is a synthetic pentasaccharide  anticoagulant. Apart from the O-methyl group at the reducing end of the molecule, the identity and sequence of the five monomeric sugar units contained in fondaparinux is identical to a sequence of five monomeric sugar units that can be isolated after either chemical or enzymatic cleavage of the polymeric glycosaminoglycan heparin and heparan sulfate (HS). This monomeric sequence in heparin and HS is thought to form the high affinity binding site for the natural anti-coagulant factor, antithrombin III (ATIII). Binding of heparin/HS to ATIII has been shown to increase the anti-coagulant activity of antithrombin III 1000-fold. Fondaparinux potentiates the neutralizing action of ATIII on activated Factor X 300-fold. Fondaparinux may be used: to prevent venous thromboembolism in patients who have undergone orthopedic surgery of the lower limbs (e.g. hip fracture, hip replacement and knee surgery); to prevent VTE in patients undergoing ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">482</field>
		<field name="drug_name">Vinblastine</field>
		<field name="description">Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">483</field>
		<field name="drug_name">Propranolol</field>
		<field name="description">A widely used non-cardioselective beta-adrenergic antagonist. Propranolol is used in the treatment or prevention of many disorders including acute myocardial infarction, arrhythmias, angina pectoris, hypertension, hypertensive emergencies, hyperthyroidism, migraine, pheochromocytoma, menopause, and anxiety. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">484</field>
		<field name="drug_name">Atropine</field>
		<field name="description">An alkaloid, originally from Atropa belladonna, but found in other plants, mainly solanaceae. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">485</field>
		<field name="drug_name">Fenoprofen</field>
		<field name="description">An anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">486</field>
		<field name="drug_name">Fenfluramine</field>
		<field name="description">Fenfluramine was withdrawn from the U.S. market in 1997 after reports of heart valve disease and pulmonary hypertension, including a condition known as cardiac fibrosis.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">487</field>
		<field name="drug_name">Clonidine</field>
		<field name="description">Clonidine, an imidazoline-derivative hypotensive agent is a centrally-acting &amp;alpha;&lt;sub&gt;2&lt;/sub&gt;-adrenergic agonist. It crosses the blood-brain barrier and acts in the hypothalamus to induce a decrease in blood pressure. It may also be administered as an epidural infusion as an adjunct treatment in the management of severe cancer pain that is not relieved by opiate analgesics alone. Clonidine may be used for differential diagnosis of pheochromocytoma in hypertensive patients. Other uses for clonidine include prophylaxis of vascular migraine headaches, treatment of severe dysmenorrhea, management of vasomotor symptoms associated with menopause, rapid detoxification in the management of opiate withdrawal, treatment of alcohol withdrawal used in conjunction with benzodiazepines, management of nicotine dependence, topical use to reduce intraocular pressure in the treatment of open-angle and secondary glaucoma and hemorrhagic glaucoma associated with hypertension, and in the treatment of at...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">488</field>
		<field name="drug_name">Mazindol</field>
		<field name="description">Tricyclic anorexigenic agent unrelated to and less toxic than amphetamine, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">489</field>
		<field name="drug_name">Valdecoxib</field>
		<field name="description">Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">490</field>
		<field name="drug_name">Lactulose</field>
		<field name="description">A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">491</field>
		<field name="drug_name">L-Carnitine</field>
		<field name="description">Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">492</field>
		<field name="drug_name">Enalapril</field>
		<field name="description">Enalapril is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly metabolized in the liver to enalaprilat following oral administration. Enalaprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Enalapril may be used to treat essential or renovascular hypertension and symptomatic congestive heart failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">493</field>
		<field name="drug_name">Nizatidine</field>
		<field name="description">A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">494</field>
		<field name="drug_name">Diclofenac</field>
		<field name="description">A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">495</field>
		<field name="drug_name">Cinalukast</field>
		<field name="description">Used in the treatment of asthma, cinalukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. Cinalukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">496</field>
		<field name="drug_name">Fluticasone Propionate</field>
		<field name="description">Fluticasone propionate, a medium-potency synthetic corticosteroid, is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the treatment of asthma. Fluticasone proprionate is marketed under several different brand names such as Flonase®. Fluticasone propionate is also available as a combination product of azelastine hydrochloride and fluticasone propionate called Dymista™. Dymista™ is indicated in patients over 12 years old for symptomatic relief of seasonal allergic rhinitis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">497</field>
		<field name="drug_name">Lisuride</field>
		<field name="description">An ergot derivative that acts as an agonist at dopamine D2 receptors (dopamine agonists). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (serotonin agonists). [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">498</field>
		<field name="drug_name">Doxazosin</field>
		<field name="description">Doxazosin is a quinazoline-derivative that selectively antagonizes postsynaptic &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptors. It may be used to mild to moderate hypertension and in the management of symptomatic benign prostatic hyperplasia (BPH). &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-Receptors mediate contraction and hypertrophic growth of smooth muscle cells. Antagonism of these receptors leads to smooth muscle relaxation in the peripheral vasculature and prostate gland.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">499</field>
		<field name="drug_name">Fluocinolone Acetonide</field>
		<field name="description">A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732). It is also being investigatied by pSivida and Alimera, under the brand name Medidur, as a sustained release intraocular implant for the treatment of diabetic macular edema.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">500</field>
		<field name="drug_name">Ethosuximide</field>
		<field name="description">An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">501</field>
		<field name="drug_name">Amiloride</field>
		<field name="description">A pyrazine compound inhibiting sodium reabsorption through sodium channels in renal epithelial cells. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with diuretics to spare potassium loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">502</field>
		<field name="drug_name">Halobetasol Propionate</field>
		<field name="description">Halobetasol propionate is thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. It is used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">503</field>
		<field name="drug_name">Gadoteridol</field>
		<field name="description">Gadoteridol provides contrast enhancement of the brain, spine and surrounding tissues resulting in improved visualization (compared with unenhanced MRI) of lesions with abnormal vascularity or those thought to cause a disruption of the normal blood brain barrier. Gadoteridol can also be used for whole body contrast enhanced MRI including the head, neck, liver, breast, musculoskeletal system and soft tissue pathologies. n MRI, visualization of normal and pathological brain tissue depends in part on variations in the radiofrequency signal intensity that occur with changes in proton density, alteration of the T1, and variation in T2. When placed in a magnetic field, gadoteridol shortens the T1 relaxation time in tissues where it accumulates. Abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadoteridol in lesions such as neoplasms, abscesses, and subacute infarcts.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">504</field>
		<field name="drug_name">Labetalol</field>
		<field name="description">Blocker of both alpha- and beta-adrenergic receptors that is used as an antihypertensive. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">505</field>
		<field name="drug_name">Thiopental</field>
		<field name="description">A barbiturate that is administered intravenously for the induction of general anesthesia or for the production of complete anesthesia of short duration. It is also used for hypnosis and for the control of convulsive states. It has been used in neurosurgical patients to reduce increased intracranial pressure. It does not produce any excitation but has poor analgesic and muscle relaxant properties. Small doses have been shown to be anti-analgesic and lower the pain threshold. (From Martindale, The Extra Pharmacopoeia, 30th ed, p920)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">506</field>
		<field name="drug_name">Monobenzone</field>
		<field name="description">Monobenzone is the monobenzyl ether of hydroquinone used medically for depigmentation. Monobenzone occurs as a white, almost tasteless crystalline powder, soluble in alcohol and practically insoluble in water.    The topical application of monobenzone in animals increases the excretion of melanin from the melanocytes. The same action is thought to be responsible for the depigmenting effect of the drug in humans. Monobenzone may cause destruction of melanocytes and permanent depigmentation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">507</field>
		<field name="drug_name">Medroxyprogesterone</field>
		<field name="description">(6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">508</field>
		<field name="drug_name">Cisapride</field>
		<field name="description">In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">509</field>
		<field name="drug_name">Sulindac</field>
		<field name="description">Sulindac is a nonsteroidal anti-inflammatory agent (NSAIA) of the arylalkanoic acid class that is marketed in the U.S. by Merck as Clinoril. Like other NSAIAs, it may be used in the treatment of acute or chronic inflammatory conditions. Sulindac is a prodrug, derived from sulfinylindene, that is converted in vivo to an active sulfide compound by liver enzymes. The sulfide metabolite then undergoes enterohepatic circulation; it is excreted in the bile and then reabsorbed from the intestine. This is thought to help maintain constant blood levels with reduced gastrointestinal side effects. Some studies have shown sulindac to be relatively less irritating to the stomach than other NSAIA's except for drugs of the cyclooxygenase-2 (COX-2) inhibitor class. The exact mechanism of its NSAIA properties is unknown, but it is thought to act on enzymes COX-1 and COX-2, inhibiting prostaglandin synthesis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">510</field>
		<field name="drug_name">Cyclothiazide</field>
		<field name="description">As a diuretic, cyclothiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like cyclothiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of cyclothiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle. Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">511</field>
		<field name="drug_name">Metaraminol</field>
		<field name="description">An adrenergic agonist that acts predominantly at alpha adrenergic receptors and also stimulates the release of norepinephrine. It has been used primarily as a vasoconstrictor in the treatment of hypotension. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">512</field>
		<field name="drug_name">Butorphanol</field>
		<field name="description">A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">513</field>
		<field name="drug_name">Bisoprolol</field>
		<field name="description">Bisoprolol is a cardioselective &amp;beta;1-adrenergic blocking agent used for secondary prevention of myocardial infarction (MI), heart failure, angina pectoris and mild to moderate hypertension. Bisoprolol is structurally similar to metoprolol, acebutolol and atenolol in that it has two substituents in the &lt;i&gt;para&lt;/i&gt; position of the benzene ring. The &amp;beta;1-selectivity of these agents is thought to be due in part to the large substituents in the &lt;i&gt;para&lt;/i&gt; position. At lower doses (less than 20 mg daily), bisoprolol selectively blocks cardiac &amp;beta;1-adrenergic receptors with little activity against &amp;beta;2-adrenergic receptors of the lungs and vascular smooth muscle. Receptor selectivity decreases with daily doses of 20 mg or greater. Unlike propranolol and pindolol, bisoprolol does not exhibit membrane-stabilizing or sympathomimetic activity. Bisoprolol possesses a single chiral centre and is administered as a racemic mixture. Only &lt;i&gt;l&lt;/i&gt;-bisoprolol exhibits significant &amp;beta;-blo...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">514</field>
		<field name="drug_name">Candoxatril</field>
		<field name="description">Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), the active enantiomer of candoxatrilat (UK-69578), a potent neutral endopeptidase (NEP) inhibitor used in the treatment of chronic heart failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">515</field>
		<field name="drug_name">Paramethadione</field>
		<field name="description">Paramethadione is an anticonvulsant in the oxazolidinedione class. It is associated with fetal trimethadione syndrome, which is also known as paramethadione syndrome.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">516</field>
		<field name="drug_name">Imatinib</field>
		<field name="description">Imatinib is a small molecule kinase inhibitor used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It is occasionally referred to as CGP57148B or STI571 (especially in older publications). It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies.    It is the first member of a new class of agents that act by inhibiting particular tyrosine kinase enzymes, instead of non-specifically inhibiting rapidly dividing cells.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">517</field>
		<field name="drug_name">Triamcinolone</field>
		<field name="description">A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">518</field>
		<field name="drug_name">Oxandrolone</field>
		<field name="description">A synthetic hormone with anabolic and androgenic properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">519</field>
		<field name="drug_name">Nicardipine</field>
		<field name="description">A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">520</field>
		<field name="drug_name">Fluphenazine</field>
		<field name="description">A phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of chlorpromazine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">521</field>
		<field name="drug_name">Testosterone</field>
		<field name="description">Testosterone is a steroid sex hormone found in both men and women. In men, testosterone is produced primarily by the Leydig (interstitial) cells of the testes when stimulated by luteinizing hormone (LH). It functions to stimulate spermatogenesis, promote physical and functional maturation of spermatozoa, maintain accessory organs of the male reproductive tract, support development of secondary sexual characteristics, stimulate growth and metabolism throughout the body and influence brain development by stimulating sexual behaviors and sexual drive. In women, testosterone is produced by the ovaries (25%), adrenals (25%) and via peripheral conversion from androstenedione (50%). Testerone in women functions to maintain libido and general wellbeing. Testosterone exerts a negative feedback mechanism on pituitary release of LH and follicle-stimulating hormone (FSH). Testosterone may be further converted to dihydrotestosterone or estradiol depending on the tissue.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">522</field>
		<field name="drug_name">Niacin</field>
		<field name="description">A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has pellagra-curative, vasodilating, and antilipemic properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">523</field>
		<field name="drug_name">Clorazepate</field>
		<field name="description">A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">524</field>
		<field name="drug_name">Guanabenz</field>
		<field name="description">An alpha-2 selective adrenergic agonist used as an antihypertensive agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">525</field>
		<field name="drug_name">Alendronate</field>
		<field name="description">Alendronate is a nitrogen-containing, second generation bisphosphonate. Bisphosphonates were first used to treat Paget’s disease in 1971. This class of medications is comprised of inorganic pyrophosphate analogues that contain non-hydrolyzable P-C-P bonds. Similar to other bisphosphonates, alendronate has a high affinity for bone mineral and is taken up during osteoclast resorption. Alendronate inhibits farnesyl pyrophosphate synthetase, one of the enzymes in the mevalonic acid pathway involved in producing isoprenoid compounds that are essential for post-translational modification of small guanosine triphosphate (GTP)-binding proteins, such as Rho, Ras and Rab. Inhibition of this process interferes with osteoclast function and survival. Alendronate is used for the treatment of osteoporosis and Paget’s disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">526</field>
		<field name="drug_name">Clofarabine</field>
		<field name="description">Clofarabine is a purine nucleoside antimetabolite that is being studied in the treatment of cancer. It is marketed in the U.S. and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra.    Clofarabine is used in paediatrics to treat a type of leukaemia called relapsed or refractory acute lymphoblastic leukaemia (ALL), only after at least two other types of treatment have failed. It is not known if the drug extends life expectancy. Some investigations of effectiveness in cases of acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML) have been carried out.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">527</field>
		<field name="drug_name">Dexmedetomidine</field>
		<field name="description">An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">528</field>
		<field name="drug_name">Prednisone</field>
		<field name="description">A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">529</field>
		<field name="drug_name">Clofibrate</field>
		<field name="description">A fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">530</field>
		<field name="drug_name">Astemizole</field>
		<field name="description">Astemizole is a long-acting, non-sedating second generation antihistamine used in the treatment of allergy symptoms. It was withdrawn from market by the manufacturer in 1999 due to the potential to cause arrhythmias at high doses, especially when  when taken with CYP inhibitors or grapefruit juice.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">531</field>
		<field name="drug_name">Inulin</field>
		<field name="description">A starch found in the tubers and roots of many plants. Since it is hydrolyzable to fructose, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">532</field>
		<field name="drug_name">Adenosine</field>
		<field name="description">A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">533</field>
		<field name="drug_name">Simvastatin</field>
		<field name="description">Simvastatin is a lipid-lowering agent that is derived synthetically from the fermentation of Aspergillus terreus. It is a potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (hydroxymethylglutaryl COA reductases), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL receptors, it increases breakdown of LDL cholesterol. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">534</field>
		<field name="drug_name">Pemetrexed</field>
		<field name="description">Pemetrexed (brand name Alimta®) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma as well as non-small cell lung cancer.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">535</field>
		<field name="drug_name">Gonadorelin</field>
		<field name="description">Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">536</field>
		<field name="drug_name">Dyclonine</field>
		<field name="description">Dyclonine is an oral anaesthetic found in Sucrets, an over the counter throat lozenge. It is also found in some varieties of the Cepacol sore throat spray.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">537</field>
		<field name="drug_name">Propoxyphene</field>
		<field name="description">A narcotic analgesic structurally related to methadone. Only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">538</field>
		<field name="drug_name">Mitotane</field>
		<field name="description">A derivative of the insecticide  dichlorodiphenyldichloroethane that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">539</field>
		<field name="drug_name">Leucovorin</field>
		<field name="description">The active metabolite of folic acid. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">540</field>
		<field name="drug_name">Dyphylline</field>
		<field name="description">A theophylline derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">541</field>
		<field name="drug_name">Pentazocine</field>
		<field name="description">The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">542</field>
		<field name="drug_name">Magnesium Sulfate</field>
		<field name="description">A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">543</field>
		<field name="drug_name">Latanoprost</field>
		<field name="description">Latanoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes.    It is also known by the brand name of Xalatan manufactured by Pfizer.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">544</field>
		<field name="drug_name">Estrone</field>
		<field name="description">Estrone, one of the major mammalian estrogens, is an aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone. It is produced in vivo from androstenedione or from testosterone via estradiol. It is produced primarily in the ovaries, placenta, and in peripheral tissues (especially adipose tissue) through conversion of adrostenedione. Estrone may be further metabolized to 16-alpha-hydroxyestrone, which may be reduced to estriol by estradiol dehydrogenase.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">545</field>
		<field name="drug_name">Trazodone</field>
		<field name="description">A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">546</field>
		<field name="drug_name">Mecamylamine</field>
		<field name="description">A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">547</field>
		<field name="drug_name">Sevelamer</field>
		<field name="description">Sevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. When taken with meals, sevelamer binds to dietary phosphate and prevents its absorption. It is marketed by Genzyme under the trade name Renagel.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">548</field>
		<field name="drug_name">Acamprosate</field>
		<field name="description">Acamprosate, also known by the brand name Campral&amp;trade;, is a drug used for treating alcohol dependence. Acamprosate is thought to stabilize the chemical balance in the brain that would otherwise be disrupted by alcoholism, possibly by blocking glutaminergic N-methyl-D-aspartate receptors, while gamma-aminobutyric acid type A receptors are activated. Reports indicate that acamprosate only works with a combination of attending support groups and abstinence from alcohol. Certain serious side effects include allergic reactions, irregular heartbeats, and low or high blood pressure, while less serious side effects include headaches, insomnia, and impotence. Acamprosate should not be taken by people with kidney problems or allergies to the drug.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">549</field>
		<field name="drug_name">Metaxalone</field>
		<field name="description">Metaxalone (marketed by King Pharmaceuticals under the brand name Skelaxin®) is a muscle relaxant used to relax muscles and relieve pain caused by strains, sprains, and other musculoskeletal conditions. Its exact mechanism of action is not known, but it may be due to general central nervous system depression. It is considered to be a moderately strong muscle relaxant, with relatively low incidence of side effects. Skelaxin comes in an 800 mg scored tablet. It previously came in both 400 mg and 800 mg tablets. The 400 mg tablet has been discontinued. Possible side effects include nausea, vomiting, drowsiness and CNS side effects such as dizziness, headache, and irritability.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">550</field>
		<field name="drug_name">Verapamil</field>
		<field name="description">A calcium channel blocker that is a class IV anti-arrhythmia agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">551</field>
		<field name="drug_name">Trimethobenzamide</field>
		<field name="description">Trimethobenzamide is a novel antiemetic which prevents nausea and vomiting in humans. Its actions are unclear but most likely involves the chemoreceptor trigger zone (CTZ). In dogs pretreated with trimethobenzamide HCl, the emetic response to apomorphine is inhibited, while little or no protection is afforded against emesis induced by intragastric copper sulfate.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">552</field>
		<field name="drug_name">Flumethasone Pivalate</field>
		<field name="description">Flumethasone pivalate is a moderately potent difluorinated corticosteroid ester with anti-inflammatory, antipruritic and vasoconstrictive properties. As it is a privalate salt, its anti-inflammatory action is concentrated at the site of application. This local effect on diseased areas results in a prompt decrease in inflammation, exudation and itching.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">553</field>
		<field name="drug_name">Nilutamide</field>
		<field name="description">Nilutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate cancer. Nilutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). Consequently, Nilutamide blocks the action of androgens of adrenal and testicular origin that stimulate the growth of normal and malignant prostatic tissue. Prostate cancer is mostly androgen-dependent and can be treated with surgical or chemical castration. To date, antiandrogen monotherapy has not consistently been shown to be equivalent to castration.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">554</field>
		<field name="drug_name">Nafarelin</field>
		<field name="description">A potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">555</field>
		<field name="drug_name">Histamine Phosphate</field>
		<field name="description">Histamine stimulates gastric gland secretion, causing an increased secretion of gastric juice of high acidity. This action is probably due mainly to a direct action on parietal and chief gland cells.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">556</field>
		<field name="drug_name">Epinephrine</field>
		<field name="description">The active sympathomimetic hormone from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">557</field>
		<field name="drug_name">Sumatriptan</field>
		<field name="description">A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of migraine disorders. A transdermal patch version of sumatriptan is currently in phase I trials in the U.S. under the code name NP101 (NuPathe).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">558</field>
		<field name="drug_name">Pirenzepine</field>
		<field name="description">An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as cimetidine and ranitidine. It is generally well tolerated by patients. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">559</field>
		<field name="drug_name">Chlorpropamide</field>
		<field name="description">Chlorpropamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating ? cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic ? cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. Chlorpropamide is not recomm...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">560</field>
		<field name="drug_name">Aprepitant</field>
		<field name="description">Aprepitant, an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting (CI NV).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">561</field>
		<field name="drug_name">Galantamine</field>
		<field name="description">A benzazepine derived from norbelladine. It is found in galanthus and other amaryllidaceae. Galantamine is a cholinesterase inhibitor that has been used to reverse the muscular effects of gallamine triethiodide and tubocurarine, and has been studied as a treatment for Alzheimer's disease and other central nervous system disorders. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">562</field>
		<field name="drug_name">Tamoxifen</field>
		<field name="description">One of the selective estrogen receptor modulators (SERM) with tissue-specific activities for the treatment and prevention of estrogen receptor positive breast cancer. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the endometrium. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">563</field>
		<field name="drug_name">Isoflurophate</field>
		<field name="description">An irreversible cholinesterase inhibitor with actions similar to those of echothiophate. It is a powerful miotic used mainly in the treatment of glaucoma. Its vapor is highly toxic and it is recommended that only solutions in arachis oil be used therapeutically. (From Martindale, The Extra Pharmacopoeia, 29th ed, p1330)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">564</field>
		<field name="drug_name">Losartan</field>
		<field name="description">Losartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. Losartan and its longer acting metabolite, E-3174, lower blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); they compete with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Losartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of systolic dysfunction, myocardial infarction, coronary artery disease, and heart failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">565</field>
		<field name="drug_name">Thioridazine</field>
		<field name="description">A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p618)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">566</field>
		<field name="drug_name">Moricizine</field>
		<field name="description">An antiarrhythmia agent used primarily for ventricular rhythm disturbances. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">567</field>
		<field name="drug_name">Warfarin</field>
		<field name="description">Warfarin is an anticoagulant drug normally used to prevent blood clot formation as well as migration. Although originally marketed as a pesticide (d-Con, Rodex, among others), Warfarin has since become the most frequently prescribed oral coagulant in North America. Warfarin has several properties that should be noted when used medicinally, including its ability to cross the placental barrier during pregnancy which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. Additional adverse effects such as necrosis, purple toe syndrome, osteoporosis, valve and artery calcification, and drug interactions have also been documented with warfarin use. Warfarin does not actually affect blood viscosity, rather, it inhibits vitamin-k dependent synthesis of biologically active forms of various clotting factors in addition to several regulatory factors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">568</field>
		<field name="drug_name">Midazolam</field>
		<field name="description">A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients.  It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. [PubChem] Midazolam is a schedule IV drug in the United States.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">569</field>
		<field name="drug_name">Pentosan Polysulfate</field>
		<field name="description">A sulfated pentosyl polysaccharide with heparin-like properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">570</field>
		<field name="drug_name">Fludrocortisone</field>
		<field name="description">A synthetic mineralocorticoid with anti-inflammatory activity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">571</field>
		<field name="drug_name">Mycophenolate mofetil</field>
		<field name="description">Mycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent, inosine monophosphate dehydrogenase (IMPDH) inhibitor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">572</field>
		<field name="drug_name">Flurazepam</field>
		<field name="description">A benzodiazepine derivative used mainly as a hypnotic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">573</field>
		<field name="drug_name">Moexipril</field>
		<field name="description">Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">574</field>
		<field name="drug_name">Phentolamine</field>
		<field name="description">A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of raynaud disease and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">575</field>
		<field name="drug_name">Fluorescein</field>
		<field name="description">A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium, such as the aqueous humor, and is used therapeutically as a diagnostic aid in corneal injuries and corneal trauma. It has been approved by FDA for use in externally applied drugs and cosmetics. (From Merck Index, 12th ed; American Medical Association Drug Evaluations; 1995, p2275)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">576</field>
		<field name="drug_name">Daunorubicin</field>
		<field name="description">A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">577</field>
		<field name="drug_name">Furosemide</field>
		<field name="description">A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">578</field>
		<field name="drug_name">Ergotamine</field>
		<field name="description">A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">579</field>
		<field name="drug_name">Tizanidine</field>
		<field name="description">Tizanidine is a short-acting drug for the management of spasticity. Tizanidine is an agonist at a2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. In animal models, tizanidine has no direct effect on skeletal muscle fibers or the neuromuscular junction, and no major effect on monosynaptic spinal reflexes. The effects of tizanidine are greatest on polysynaptic pathways. The overall effect of these actions is thought to reduce facilitation of spinal motor neurons.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">580</field>
		<field name="drug_name">Nicergoline</field>
		<field name="description">An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">581</field>
		<field name="drug_name">Eplerenone</field>
		<field name="description">Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">582</field>
		<field name="drug_name">Icodextrin</field>
		<field name="description">Icodextrin is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">583</field>
		<field name="drug_name">Methazolamide</field>
		<field name="description">A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">584</field>
		<field name="drug_name">Naltrexone</field>
		<field name="description">Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of naloxone. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">585</field>
		<field name="drug_name">Tamsulosin</field>
		<field name="description">Tamsulosin is a selective antagonist at alpha-1A and alpha-1B-adrenoceptors in the prostate, prostatic capsule, prostatic urethra, and bladder neck. At least three discrete alpha1-adrenoceptor subtypes have been identified: alpha-1A, alpha-1B and alpha-1D; their distribution differs between human organs and tissue. Approximately 70% of the alpha1-receptors in human prostate are of the alpha-1A subtype. Blockage of these receptors causes relaxation of smooth muscles in the bladder neck and prostate.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">586</field>
		<field name="drug_name">Porfimer</field>
		<field name="description">The purified component of hematoporphyrin derivative, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (hematoporphyrin photoradiation); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of photodynamic therapy in the United States. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">587</field>
		<field name="drug_name">Sufentanil</field>
		<field name="description">An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">588</field>
		<field name="drug_name">Ibandronate</field>
		<field name="description">Ibandronate is a nitrogen-containing bisphosphonate in the same class as alendronate and risedronate. Ibandronate inhibits osteoclast-mediated bone resorption. All of the bisphosphonates prevent the breakdown of bone by bone cells called osteoclasts. In persons who are at high risk for osteoporosis, bisphosphonates not only result in increased amounts of bone and bone strength, they also reduce the risk of hip fractures and other bone fractures.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">589</field>
		<field name="drug_name">Diethylcarbamazine</field>
		<field name="description">An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">590</field>
		<field name="drug_name">Flurbiprofen</field>
		<field name="description">Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis. Flurbiprofen is structurally and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">591</field>
		<field name="drug_name">Apomorphine</field>
		<field name="description">A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">592</field>
		<field name="drug_name">Paroxetine</field>
		<field name="description">Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize &amp;alpha;- or &amp;beta;-adrenergic, dopamine D&lt;sub&gt;2&lt;/sub&gt; or histamine H&lt;sub&gt;1&lt;/sub&gt; receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. The overall clinical effect of increased mood and decreased anxiety is thought to be due to adaptive changes in neuronal fu...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">593</field>
		<field name="drug_name">Nedocromil</field>
		<field name="description">A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">594</field>
		<field name="drug_name">Norethindrone</field>
		<field name="description">A synthetic progestational hormone with actions similar to those of progesterone but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">595</field>
		<field name="drug_name">Azatadine</field>
		<field name="description">Antihistamines such as azatadine appear to compete with histamine for histamine H1- receptor sites on effector cells. The antihistamines antagonize those pharmacological effects of histamine which are mediated through activation of H1- receptor sites and thereby reduce the intensity of allergic reactions and tissue injury response involving histamine release.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">596</field>
		<field name="drug_name">Clodronate</field>
		<field name="description">A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">597</field>
		<field name="drug_name">Procaine</field>
		<field name="description">A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">598</field>
		<field name="drug_name">Lisinopril</field>
		<field name="description">Lisinopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Lisinopril may be used to treat hypertension and symptomatic congestive heart failure, to improve survival in certain individuals following myocardial infarction, and to prevent progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">599</field>
		<field name="drug_name">Methoxamine</field>
		<field name="description">An alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">600</field>
		<field name="drug_name">Imiquimod</field>
		<field name="description">Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. miquimod is also used to treat a skin condition of the face and scalp called actinic keratoses and certain types of skin cancer called superficial basal cell carcinoma.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">601</field>
		<field name="drug_name">Homatropine Methylbromide</field>
		<field name="description">Homatropine methylbromide is a quaternary ammonium muscarinic acetylcholine receptor antagonist belonging to the group of medicines called anti-muscarinics. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">602</field>
		<field name="drug_name">Trimipramine</field>
		<field name="description">Tricyclic antidepressant similar to imipramine, but with more antihistaminic and sedative properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">603</field>
		<field name="drug_name">Nitroglycerin</field>
		<field name="description">A volatile vasodilator which relieves angina pectoris by stimulating guanylate cyclase and lowering cytosolic calcium. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">604</field>
		<field name="drug_name">Rocuronium</field>
		<field name="description">Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.  Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is marketed under the trade name of Zemuron in the United States and Esmeron in most other countries.  There is considered to be a risk of allergic reaction to the drug in some patients (particularly those with asthma), but a similar incidence of allergic reactions has been observed by using other members of the same drug class (non-depolarizing neuromuscular blocking drugs). The ?-cyclodextrin derivative sugammadex (trade name Bridion) has been recently introduced as a novel agent to reverse the action of rocuronium.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">605</field>
		<field name="drug_name">Diphemanil Methylsulfate</field>
		<field name="description">Diphemanil Methylsulfate is a quaternary ammonium anticholinergic. It binds muscarinic acetycholine receptors and thereby decreases secretory excretion of stomach acids as well as saliva and sweat.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">606</field>
		<field name="drug_name">Nateglinide</field>
		<field name="description">Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to ? cells of the pancreas to stimulate insulin release. Nateglinide is an amino acid derivative that induces an early insulin response to meals decreasing postprandial blood glucose levels. It should only be taken with meals and meal-time doses should be skipped with any skipped meal. Approximately one month of therapy is required before a decrease in fasting blood glucose is seen. Meglitnides may have a neutral effect on weight or cause a slight increase in weight. The average weight gain caused by meglitinides appears to be lower than that caused by sulfonylureas and insulin and appears to occur only in those naïve to oral antidiabetic agents. Due to their mechanism of action, meglitinides may cause hypoglycemia although the risk is thought to be lower than that of sul...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">607</field>
		<field name="drug_name">Atracurium</field>
		<field name="description">A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">608</field>
		<field name="drug_name">Pralidoxime</field>
		<field name="description">Pralidoxime is an antidote to organophosphate pesticides and chemicals. Organophosphates bind to the esteratic site of acetylcholinesterase, which results initially in reversible inactivation of the enzyme. If given within 24 hours,after organophosphate exposure, pralidoxime reactivates the enzyme cholinesterase by cleaving the phosphate-ester bond formed between the organophosphate and acetylcholinesterase.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">609</field>
		<field name="drug_name">Risperidone</field>
		<field name="description">Risperidone, a benzisoxazole derivative, is an atypical antipsychotic drug with high affinity for 5-hydrotryptamine (5-HT) and dopamine D2 receptors. It is used primarily in the management of schizophrenia, inappropriate behavior in severe dementia and manic episodes associated with bipolar I disorder. Risperidone is effective for treating the positive and negative symptoms of schizophrenia owing to its affinity for its “loose” binding affinity for dopamine D2 receptors and additional 5-HT antagonism compared to first generation antipsychotics, which are strong, non-specific dopamine D2 receptor antagonists.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">610</field>
		<field name="drug_name">Esomeprazole</field>
		<field name="description">A highly effective inhibitor of gastric acid secretion used in the therapy of stomach ulcers and zollinger-ellison syndrome. The drug inhibits the H(+)-K(+)-ATPase (H(+)-K(+)-exchanging ATPase) in the proton pump of gastric parietal cells. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">611</field>
		<field name="drug_name">Meclizine</field>
		<field name="description">A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">612</field>
		<field name="drug_name">Riluzole</field>
		<field name="description">A glutamate antagonist (receptors, glutamate) used as an anticonvulsant (anticonvulsants) and to prolong the survival of patients with amyotrophic lateral sclerosis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">613</field>
		<field name="drug_name">Hydrocortisone</field>
		<field name="description">The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">614</field>
		<field name="drug_name">Mannitol</field>
		<field name="description">Mannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables. Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. As a result, cerebral edema, elevated intracranial pressure, and cerebrospinal fluid volume and pressure may be reduced. Mannitol may also be used for the promotion of diuresis before irreversible renal failure becomes established; the promotion of urinary excretion of toxic substances; as an Antiglaucoma agent; and as a renal function diagnostic aid.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">615</field>
		<field name="drug_name">Gadobenate Dimeglumine</field>
		<field name="description">Gadobenate Dimeglumine is an MRI contrast agent used primarily for MR imaging of the liver. It can also be used for visualizing the CNS and heart. In contrast to conventional extracellular fluid contrast agents, gadobenate dimeglumine is characterized by a weak and transient binding capacity to serum proteins. This binding leads to an increased relaxivity of gadobenate dimeglumine and, consequently, to a considerably increased signal intensity over that of other agents.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">616</field>
		<field name="drug_name">Zileuton</field>
		<field name="description">Leukotrienes are substances that induce numerous biological effects including augmentation of neutrophil and eosinophil migration, neutrophil and monocyte aggregation, leukocyte adhesion, increased capillary permeability, and smooth muscle contraction. These effects contribute to inflammation, edema, mucus secretion, and bronchoconstriction in the airways of asthmatic patients. Zileuton relieves such symptoms through its selective inhibition of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Specifically, it inhibits leukotriene LTB4, LTC4, LTD4, and LTE4 formation. Both the R(+) and S(-) enantiomers are pharmacologically active as 5-lipoxygenase inhibitors in in vitro systems.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">617</field>
		<field name="drug_name">Modafinil</field>
		<field name="description">Modafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. The exact mechanism of action is unclear, although in vitro studies have shown it to inhibit the reuptake of dopamine by binding to the dopamine reuptake pump, and lead to an increase in extracellular dopamine. Modafinil activates glutamatergic circuits while inhibiting GABA.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">618</field>
		<field name="drug_name">Deferoxamine</field>
		<field name="description">Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">619</field>
		<field name="drug_name">Scopolamine</field>
		<field name="description">An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">620</field>
		<field name="drug_name">Carbinoxamine</field>
		<field name="description">Carbinoxamine is a first generation antihistamine that competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. The product label for carbinoxamine as an over the counter cough and cold medicine is being modified to state &quot;do not use&quot; in children under 4 years of age in order to prevent and reduce misuse, as many unapproved carbinoxamine-containing preparations contained inappropriate labeling, which promoted unapproved uses (including management of congestion, cough, the common cold, and the use in children under 2 years of age), which can potentially cause serious health risks.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">621</field>
		<field name="drug_name">Etodolac</field>
		<field name="description">Etodolac is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its therapeutic effects are due to its ability to inhibit prostaglandin synthesis. It is indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">622</field>
		<field name="drug_name">Prilocaine</field>
		<field name="description">A local anesthetic that is similar pharmacologically to lidocaine. Currently, it is used most often for infiltration anesthesia in dentistry. (From AMA Drug Evaluations Annual, 1992, p165)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">623</field>
		<field name="drug_name">Epinastine</field>
		<field name="description">Epinastine is used for the prevention of itching associated with allergic conjunctivitis. It has a multi-action effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to control the allergic response, 2. prevents histamine binding to both the H1- and H2-receptors to stop itching and provide lasting protection, and 3. prevents the release of proinflammatory chemical mediators from the blood vessel to halt progression of the allergic response.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">624</field>
		<field name="drug_name">Tranylcypromine</field>
		<field name="description">A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">625</field>
		<field name="drug_name">Isoflurane</field>
		<field name="description">A stable, non-explosive inhalation anesthetic, relatively free from significant side effects. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">626</field>
		<field name="drug_name">Ethotoin</field>
		<field name="description">Ethotoin is a hydantoin derivative and anticonvulsant. Ethotoin exerts an antiepileptic effect without causing general central nervous system depression. The mechanism of action is probably very similar to that of phenytoin. The latter drug appears to stabilize rather than to raise the normal seizure threshold, and to prevent the spread of seizure activity rather than to abolish the primary focus of seizure discharges.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">627</field>
		<field name="drug_name">Tretinoin</field>
		<field name="description">Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">628</field>
		<field name="drug_name">Dolasetron</field>
		<field name="description">Dolasetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Dolasetron is a highly specific and selective serotonin 5-HT3 receptor antagonist. This drug has not shown to have activity at other known serotonin receptors, and has low affinity for dopamine receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">629</field>
		<field name="drug_name">Clopidogrel</field>
		<field name="description">Clopidogrel, an antiplatelet agent structurally and pharmacologically similar to ticlopidine, is used to inhibit blood clots in a variety of conditions such as peripheral vascular disease, coronary artery disease, and cerebrovascular disease. Clopidogrel is sold under the name Plavix by Sanofi and Bristol-Myers Squibb. The drug is an irreversible inhibitor of the P2Y12 adenosine diphosphate receptor found on the membranes of platelet cells. Clopidogrel use is associated with several serious adverse drug reactions such as severe neutropenia, various forms of hemorrhage, and cardiovascular edema.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">630</field>
		<field name="drug_name">Potassium Chloride</field>
		<field name="description">A white crystal or crystalline powder used as an electrolyte replenisher, in the treatment of hypokalemia, in buffer solutions, and in fertilizers and explosives.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">631</field>
		<field name="drug_name">Irinotecan</field>
		<field name="description">Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. It is a derivative of camptothecin that inhibits the action of topoisomerase I. Irinotecan prevents religation of the DNA strand by binding to topoisomerase I-DNA complex, and causes double-strand DNA breakage and cell death. It is a derivative of camptothecin. ;DNA Topoisomerase I Inhibitor; Cytotoxic</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">632</field>
		<field name="drug_name">Methimazole</field>
		<field name="description">A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">633</field>
		<field name="drug_name">Mometasone</field>
		<field name="description">Mometasone is a medium-potency synthetic corticosteroid with antiinflammatory, antipruritic, and vasoconstrictive properties. Studies in asthmatic patients have demonstrated that mometasone provides a favorable ratio of topical to systemic activity due to its primary local effect along with the extensive hepatic metabolism and the lack of active metabolites. Though effective for the treatment of asthma, glucocorticoids do not affect asthma symptoms immediately. Maximum improvement in symptoms following inhaled administration of mometasone furoate may not be achieved for 1 to 2 weeks or longer after starting treatment. he antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">634</field>
		<field name="drug_name">Metyrosine</field>
		<field name="description">An inhibitor of the enzyme tyrosine 3-monooxygenase, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma. (Martindale, The Extra Pharmacopoeia, 30th ed)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">635</field>
		<field name="drug_name">Benzquinamide</field>
		<field name="description">Benzquinamide is an antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">636</field>
		<field name="drug_name">Olopatadine</field>
		<field name="description">Used to treat allergic conjunctivitis (itching eyes), olopatadine inhibits the release of histamine from mast cells. It is a relatively selective histamine H1 antagonist that inhibits the in vivo and in vitro type 1 immediate hypersensitivity reaction including inhibition of histamine induced effects on human conjunctival epithelial cells.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">637</field>
		<field name="drug_name">Hydrocortamate</field>
		<field name="description">Hydrocortamate is a synthetic glucocorticoid used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">638</field>
		<field name="drug_name">Alprostadil</field>
		<field name="description">Alprostadil is produced endogenously and causes vasodilation by means of a direct effect on vascular and ductus arteriosus (DA) smooth muscle, preventing or reversing the functional closure of the DA that occurs shortly after birth. This results in increased pulmonary or systemic blood flow in infants. In infants, it is used for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. In adults, it is used for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">639</field>
		<field name="drug_name">Clidinium</field>
		<field name="description">Clidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. It inhibits muscarinic actions of acetylcholine at postganglionic parasympathetic neuroeffector sites. It is used for the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">640</field>
		<field name="drug_name">Etoposide</field>
		<field name="description">A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">641</field>
		<field name="drug_name">Hydroflumethiazide</field>
		<field name="description">A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p822)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">642</field>
		<field name="drug_name">Tirofiban</field>
		<field name="description">Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">643</field>
		<field name="drug_name">Oxcarbazepine</field>
		<field name="description">Oxcarbazepine is structurally a derivative of carbamazepine, adding an extra oxygen atom to the benzylcarboxamide group. This difference helps reduce the impact on the liver of metabolizing the drug, and also prevents the serious forms of anemia occasionally associated with carbamazepine. Aside from this reduction in side effects, it is thought to have the same mechanism as carbamazepine - sodium channel inhibition - and is generally used to treat partial seizures in epileptic children and adults.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">644</field>
		<field name="drug_name">Propiomazine</field>
		<field name="description">Propiomazine, an atypical antipsychotic agent, is used to treat both negative and positive symptoms of schizophrenia, acute mania with bipolar disorder, agitation, and psychotic symptoms in dementia. Future uses may include the treatment of obsessive-compulsive disorder and severe behavioral disorders in autism. Structurally and pharmacologically similar to clozapine, propiomazine binds to alpha(1), dopamine, histamine H1, muscarinic, and serotonin type 2 (5-HT2) receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">645</field>
		<field name="drug_name">Phenelzine</field>
		<field name="description">An irreversible non-selective inhibitor of monoamine oxidase. May be used to treat major depressive disorder.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">646</field>
		<field name="drug_name">Propantheline</field>
		<field name="description">A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">647</field>
		<field name="drug_name">Estradiol</field>
		<field name="description">Generally refers to the 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In humans, it is produced primarily by the cyclic ovaries and the placenta. It is also produced by the adipose tissue of men and postmenopausal women. The 17-alpha-isomer of estradiol binds weakly to estrogen receptors (receptors, estrogen) and exhibits little estrogenic activity in estrogen-responsive tissues. Various isomers can be synthesized. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">648</field>
		<field name="drug_name">Mefenamic acid</field>
		<field name="description">A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">649</field>
		<field name="drug_name">Cryptenamine</field>
		<field name="description">Cryptenamine is a mixture of closely related hypotensive alkaloids from Veratrum album (Liliaceae). It has been used in the treatment of hypertension but has largely been replaced by drugs with fewer adverse effects. Cryptenamine has a marked and re-producible depressor effect when given intravenously to hypertensive patients, however the mechanism of action is not known.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">650</field>
		<field name="drug_name">Marimastat</field>
		<field name="description">Used in the treatment of cancer, Marmiastat is an angiogenesis and metastasis inhibitor. As an angiogenesis inhibitor it limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">651</field>
		<field name="drug_name">Naproxen</field>
		<field name="description">An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">652</field>
		<field name="drug_name">Gadopentetate dimeglumine</field>
		<field name="description">A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see pentetic acid), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">653</field>
		<field name="drug_name">Perindopril</field>
		<field name="description">Perindopril is a nonsulfhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly metabolized in the liver to perindoprilat, its active metabolite, following oral administration. Perindoprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Perindopril may be used to treat mild to moderate essential hypertension, mild to moderate congestive heart failure, and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">654</field>
		<field name="drug_name">Uracil mustard</field>
		<field name="description">Nitrogen mustard derivative of uracil. It is a alkylating antineoplastic agent that is used in lymphatic malignancies, and causes mainly gastrointestinal and bone marrow damage. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">655</field>
		<field name="drug_name">Tripelennamine</field>
		<field name="description">A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat asthma; HAY fever; urticaria; and rhinitis; and also in veterinary applications. Tripelennamine is administered by various routes, including topically. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">656</field>
		<field name="drug_name">Primidone</field>
		<field name="description">An antiepileptic agent related to the barbiturates; it is partly metabolized to phenobarbital in the body and owes some of its actions to this metabolite. Adverse effects are reported to be more frequent than with phenobarbital. (From Martindale, The Extra Pharmacopoeia, 30th ed, p309)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">657</field>
		<field name="drug_name">Sulfasalazine</field>
		<field name="description">A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see mesalamine) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">658</field>
		<field name="drug_name">Candesartan</field>
		<field name="description">Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is administered orally as the prodrug, candesartan cilexetil, which is rapidly converted to its active metabolite, candesartan, during absorption in the gastrointestinal tract. Candesartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Candesartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">659</field>
		<field name="drug_name">Tolazoline</field>
		<field name="description">A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">660</field>
		<field name="drug_name">Tazarotene</field>
		<field name="description">Tazarotene (marketed as Tazorac®, Avage® and Zorac®) is a prescription topical retinoid sold as a cream or gel. This medication is approved for treatment of psoriasis, acne, and sun damaged skin (photodamage). [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">661</field>
		<field name="drug_name">Fenoldopam</field>
		<field name="description">A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">662</field>
		<field name="drug_name">Halazepam</field>
		<field name="description">Halazepam is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a trifluoromethyl derivative of nordazepam. While its structure may be similar to chlordiazepoxide and diazepam, it has both less toxicity and less tendency to cause paradoxical hostility and aggression than either of them. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">663</field>
		<field name="drug_name">Alfentanil</field>
		<field name="description">A short-acting opioid anesthetic and analgesic derivative of fentanyl. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">664</field>
		<field name="drug_name">Dicyclomine</field>
		<field name="description">A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">665</field>
		<field name="drug_name">Minaprine</field>
		<field name="description">Minaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states. Like most antidepressants minaprine antagonizes behavioral despair. Minaprine  is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">666</field>
		<field name="drug_name">Pentoxifylline</field>
		<field name="description">A methylxanthine derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">667</field>
		<field name="drug_name">Proparacaine</field>
		<field name="description">Proparacaine is a topical anesthetic drug of the amino ester group. It is available as its hydrochloride salt in ophthalmic solutions at a concentration of 0.5%. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">668</field>
		<field name="drug_name">Indapamide</field>
		<field name="description">A benzamide-sulfonamide-indole. It is called a thiazide-like diuretic but structure is different enough (lacking the thiazo-ring) so it is not clear that the mechanism is comparable. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">669</field>
		<field name="drug_name">Tropicamide</field>
		<field name="description">One of the muscarinic antagonists with pharmacologic action similar to atropine and used mainly as an ophthalmic parasympatholytic or mydriatic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">670</field>
		<field name="drug_name">Biperiden</field>
		<field name="description">A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">671</field>
		<field name="drug_name">Phenylbutazone</field>
		<field name="description">A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter&amp;#39;s syndrome (investigational indication). Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA Drug Evaluations Annual, 1994, p1822)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">672</field>
		<field name="drug_name">Fentanyl</field>
		<field name="description">A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">673</field>
		<field name="drug_name">Meloxicam</field>
		<field name="description">Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the symptoms of arthritis, primary dysmenorrhea, fever; and as an analgesic, especially where there is an inflammatory component. It is closely related to piroxicam. In Europe it is marketed under the brand names Movalis, Melox, and Recoxa. In North America it is generally marketed under the brand name Mobic. In Latin America, the drug is marketed as Tenaron. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">674</field>
		<field name="drug_name">Sodium lauryl sulfate</field>
		<field name="description">Sodium Lauryl Sulfate (SLS) is an anionic surfactant naturally derived from coconut and/or palm kernel oil. It usually consisting of a mixture of sodium alkyl sulfates, mainly the lauryl. SLS lowers surface tension of aqueous solutions and is used as fat emulsifier, wetting agent, and detergent in cosmetics, pharmaceuticals and toothpastes. It is also used in creams and pastes to properly disperse the ingredients and as research tool in protein biochemistry. SLS also has some microbicidal activity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">675</field>
		<field name="drug_name">Orciprenaline</field>
		<field name="description">A beta-adrenergic agonist used in the treatment of asthma and bronchospasms. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">676</field>
		<field name="drug_name">Propofol</field>
		<field name="description">Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">677</field>
		<field name="drug_name">Acetazolamide</field>
		<field name="description">One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">678</field>
		<field name="drug_name">Tadalafil</field>
		<field name="description">Tadalafil is an orally adminstered drug used to treat male erectile dysfunction (impotence). It is marketed worldwide under the brand name Cialis. It is a phosphodiesterase 5 (PDE5) inhibitor. Tadalafil's distinguishing pharmacologic feature is its longer half-life (17.5 hours) compared with Viagra and Levitra (4-5 hours). This longer half-life results in a longer duration of action and is, in part, responsible for the Cialis nickname of the &quot;weekend pill.&quot; This longer half-life also is the basis of current investigation for tadalafil's use in pulmonary arterial hypertension as a once-daily therapy. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">679</field>
		<field name="drug_name">Carprofen</field>
		<field name="description">Carprofen is a non-steroidal anti-inflammatory drug (NSAID) that is used by veterinarians as a supportive treatment for the relief of arthritic symptoms in geriatric dogs. Carprofen was previously used in human medicine for over 10 years (1985-1995). It was generally well tolerated, with the majority of adverse effects being mild, such as gastro-intestinal pain and nausea, similar to those recorded with aspirin and other non-steroidal anti-inflammatory drugs. It is no longer marketed for human usage, after being withdrawn on commercial grounds. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">680</field>
		<field name="drug_name">Disulfiram</field>
		<field name="description">A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">681</field>
		<field name="drug_name">Ethynodiol Diacetate</field>
		<field name="description">A synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">682</field>
		<field name="drug_name">Enprofylline</field>
		<field name="description">Enprofylline is a derivative of theophylline which shares bronchodilator properties. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. Long-term enprofylline administration may be associated with elevation in liver enzyme levels and unpredictable blood levels.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">683</field>
		<field name="drug_name">Menthol</field>
		<field name="description">Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. It is a waxy, crystalline substance, clear or white in color, which is solid at room temperature and melts slightly above. The main form of menthol occurring in nature is (-)-menthol, which is assigned the (1R,2S,5R) configuration. Menthol has local anesthetic and counterirritant qualities, and it is widely used to relieve minor throat irritation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">684</field>
		<field name="drug_name">Diazepam</field>
		<field name="description">A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">685</field>
		<field name="drug_name">Phenmetrazine</field>
		<field name="description">A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to dextroamphetamine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">686</field>
		<field name="drug_name">Trifluoperazine</field>
		<field name="description">A phenothiazine with actions similar to chlorpromazine. It is used as an antipsychotic and an antiemetic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">687</field>
		<field name="drug_name">Phensuximide</field>
		<field name="description">Phensuximide is an anticonvulsant in the succinimide class. It suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in petit mal seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">688</field>
		<field name="drug_name">Mifepristone</field>
		<field name="description">A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary cushing syndrome [PubChem]. The two marketed forms of mifepristone are Mifeprex® (mifepristone 200mg) and Korlym™ (mifepristone 300mg).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">689</field>
		<field name="drug_name">Brompheniramine</field>
		<field name="description">Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">690</field>
		<field name="drug_name">Loperamide</field>
		<field name="description">One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">691</field>
		<field name="drug_name">Progabide</field>
		<field name="description">Progabide is an analog and prodrug of gamma-aminobutyric acid. It is commonly used in the treatment of epilepsy. It has agonistic activity for both the GABAA and GABAB receptors. Progabide has been investigated for many diseases besides epilepsy, including Parkinson's disease, schizophrenia, clinical depression and anxiety disorder with varying success.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">692</field>
		<field name="drug_name">Clocortolone</field>
		<field name="description">Clocortolone is a medium potency corticosteroid that is often used as a topical cream for the relief of inflammatory oand pruritic (itching) arising from steroid-responsive dermatoses of the scalp.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">693</field>
		<field name="drug_name">Tolazamide</field>
		<field name="description">A sulphonylurea hypoglycemic agent with actions and uses similar to those of chlorpropamide. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">694</field>
		<field name="drug_name">Hydroxypropyl cellulose</field>
		<field name="description">Hydroxypropyl cellulose is an ether of cellulose where some of the hydroxyl groups of the cellulose have been hydroxypropylated forming -OCH2CH(OH)CH3 groups. Lacrisertis a formulation of hydroxypropyl cellulose that is used for artificial tears. It is used to treat syndromes characterized by insufficient tear production (keratoconjunctivitis sicca), recurrent corneal erosions, decreased corneal sensitivity, exposure and neuroparalytic keratitis, and as a lubricant for artificial eyes. As a food additive, hydroxypropyl cellulose is used as a thickener and as an emulsion stabilizer.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">695</field>
		<field name="drug_name">Dobutamine</field>
		<field name="description">A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">696</field>
		<field name="drug_name">Oxazepam</field>
		<field name="description">Oxazepam is an intermediate-acting benzodiazepine used to treat alcohol withdrawal and anxiety disorders. Oxazepam is also the metabolite of other benzodiazpines.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">697</field>
		<field name="drug_name">Donepezil</field>
		<field name="description">Donepezil (Aricept), is a centrally acting reversible acetyl cholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine. Donepezil is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, donepezil's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. Donepezil has been tested in other cognitive disorders including Lewy body dementia and Vascular dementia, but it is not currently approved for these indications. Donepezil has also been studied in patients with Mild Cognitive Impairment, schizophrenia, attention deficit disorder, post-coronary bypass cognitive impairment, cognitive impairment associated with multiple sclerosis, and Dow...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">698</field>
		<field name="drug_name">Nalbuphine</field>
		<field name="description">A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">699</field>
		<field name="drug_name">Flurandrenolide</field>
		<field name="description">A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive. (From Martindale, The Extra Pharmacopoeia, 30th ed, p733)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">700</field>
		<field name="drug_name">Cysteamine</field>
		<field name="description">Cysteamine is a radiation-protective agent that oxidizes in air to form cystamine. It can be given intravenously or orally to treat radiation sickness. The bitartrate and hydrochloride salt forms are indicated for the treatment of neuropathic cystinosis in patients 6 years old and older. [PubChem]. Cysteamine is marketed under several brand names such as Cystaran™, Procysbi, and Cystagon®.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">701</field>
		<field name="drug_name">Levamisole</field>
		<field name="description">An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">702</field>
		<field name="drug_name">Methylphenobarbital</field>
		<field name="description">A barbiturate that is metabolized to phenobarbital. It has been used for similar purposes, especially in epilepsy, but there is no evidence mephobarbital offers any advantage over phenobarbital. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">703</field>
		<field name="drug_name">Perphenazine</field>
		<field name="description">An antipsychotic phenothiazine derivative with actions and uses similar to those of chlorpromazine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">704</field>
		<field name="drug_name">Dacarbazine</field>
		<field name="description">An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">705</field>
		<field name="drug_name">Pseudoephedrine</field>
		<field name="description">An alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">706</field>
		<field name="drug_name">Temozolomide</field>
		<field name="description">Temozolomide (Temodar and Temodal) is an oral alkylating agent used for the treatment of refractory anaplastic astrocytoma -- a type of cancerous brain tumor. Temozolomide is not active until it is converted at physiologic pH to the active form, 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (MTIC).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">707</field>
		<field name="drug_name">Levorphanol</field>
		<field name="description">A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">708</field>
		<field name="drug_name">Aminolevulinic acid</field>
		<field name="description">A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">709</field>
		<field name="drug_name">Chlorphenesin</field>
		<field name="description">A centrally acting muscle relaxant. Its mode of action is unknown. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1203)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">710</field>
		<field name="drug_name">Drostanolone</field>
		<field name="description">Drostanolone (also known as dromostanolone) is a potent synthetic androgenic anabolic steroid similar to testosterone. Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in a combined hormone therapy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">711</field>
		<field name="drug_name">Penicillamine</field>
		<field name="description">3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson&amp;#39;s disease. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">712</field>
		<field name="drug_name">Prednisolone</field>
		<field name="description">A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">713</field>
		<field name="drug_name">Diflunisal</field>
		<field name="description">Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs. Diflunisal possesses anti-inflammatory, analgesic and antipyretic activity. Though its mechanism of action has not been clearly established, most of its actions appear to be associated with inhibition of prostaglandin synthesis via the arachidonic acid pathway. Diflunisal is used to relieve pain accompanied with inflammation and in the symptomatic treatment of rheumatoid arthritis and osteoarthritis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">714</field>
		<field name="drug_name">Vardenafil</field>
		<field name="description">Vardenafil (Levitra) is an oral therapy for the treatment of erectile dysfunction. It is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Penile erection is a hemodynamic process initiated by the relaxation of smooth muscle in the corpus cavernosum and its associated arterioles. During sexual stimulation, nitric oxide is released from nerve endings and endothelial cells in the corpus cavernosum. Nitric oxide activates the enzyme guanylate cyclase resulting in increased synthesis of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum. The cGMP in turn triggers smooth muscle relaxation, allowing increased blood flow into the penis, resulting in erection. The tissue concentration of cGMP is regulated by both the rates of synthesis and degradation via phosphodiesterases (PDEs). The most abundant PDE in the human corpus cavernosum is the cGMPspecific phosphodiesterase type 5 (PDE5); therefore, the ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">715</field>
		<field name="drug_name">Ranitidine</field>
		<field name="description">A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">716</field>
		<field name="drug_name">Tacrolimus</field>
		<field name="description">Tacrolimus (also FK-506 or Fujimycin) is an immunosuppressive drug whose main use is after organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It is also used in a topical preparation in the treatment of severe atopic dermatitis, severe refractory uveitis after bone marrow transplants, and the skin condition vitiligo. It was discovered in 1984 from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis. Tacrolimus is chemically known as a macrolide. It reduces peptidyl-prolyl isomerase activity by binding to the immunophilin FKBP-12 (FK506 binding protein) creating a new complex. This FKBP12-FK506 complex interacts with and inhibits calcineurin thus inhibiting both T-lymphocyte signal transduction and IL-2 transcription.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">717</field>
		<field name="drug_name">Benzphetamine</field>
		<field name="description">A sympathomimetic agent with properties similar to dextroamphetamine. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">718</field>
		<field name="drug_name">Alprenolol</field>
		<field name="description">One of the adrenergic beta-antagonists used as an antihypertensive, anti-anginal, and anti-arrhythmic agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">719</field>
		<field name="drug_name">Ritodrine</field>
		<field name="description">Adrenergic beta-agonist used to control premature labor. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">720</field>
		<field name="drug_name">Benzonatate</field>
		<field name="description">Benzonatate is a non-narcotic oral antitussive (cough suppressant) drug which works by anesthetizing the tissues of the lungs and pleura responsible for the cough reflex. It is chemically related to other ester anesthetics such as procaine. It has an anesthetic (numbing) action similar to that of benzocaine and &quot;numbs&quot; the stretch sensors in the lungs. It is the stretching of these sensors with breathing that causes the cough. It was approved by the FDA in 1958.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">721</field>
		<field name="drug_name">Dorzolamide</field>
		<field name="description">Dorzolamide is a carbonic anhydrase (CA) inhibitor. It is used in ophthalmic solutions (Trusopt) to lower intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">722</field>
		<field name="drug_name">Suprofen</field>
		<field name="description">An ibuprofen-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">723</field>
		<field name="drug_name">Terbutaline</field>
		<field name="description">A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">724</field>
		<field name="drug_name">Conivaptan</field>
		<field name="description">Conivaptan is a non-peptide inhibitor of antidiuretic hormone (vasopressin). It was approved in 2004 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH). Conivaptan inhibits both isotypes of the vasopressin receptor (V1a and V2).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">725</field>
		<field name="drug_name">Loteprednol</field>
		<field name="description">Loteprednol (as Loteprednol Etabonate) is a topical corticoid antiinflammatory. It is used in ophthalmic solution for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides. As a nasal spray, is used for the treatment and management of seasonal allergic rhinitis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">726</field>
		<field name="drug_name">Guaifenesin</field>
		<field name="description">An expectorant that also has some muscle relaxing action. It is used in many cough preparations. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">727</field>
		<field name="drug_name">Flupenthixol</field>
		<field name="description">Flupentixol is an antipsychotic neuroleptic drug. It is a thioxanthene, and therefore closely related to the phenothiazines. Its primary use is as a long acting injection given two or three weekly to people with schizophrenia who have a poor compliance with medication and suffer frequent relapses of illness. It is a D1 and D2 receptor antagonist.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">728</field>
		<field name="drug_name">Eprosartan</field>
		<field name="description">Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It acts on the renin-angiotensin system in two ways to decrease total peripheral resistance. First, it blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle, causing vascular dilatation. Second, it inhibits sympathetic norepinephrine production, further reducing blood pressure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">729</field>
		<field name="drug_name">Sirolimus</field>
		<field name="description">A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to immunophilins. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">730</field>
		<field name="drug_name">Chlorothiazide</field>
		<field name="description">A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">731</field>
		<field name="drug_name">Quinapril</field>
		<field name="description">Quinapril is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to quinaprilat (quinapril diacid) following oral administration. Quinaprilat is a competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Quinapril may be used to treat essential hypertension and congestive heart failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">732</field>
		<field name="drug_name">Clomifene</field>
		<field name="description">A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">733</field>
		<field name="drug_name">Isosorbide Dinitrate</field>
		<field name="description">A vasodilator used in the treatment of angina pectoris. Its actions are similar to nitroglycerin but with a slower onset of action. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">734</field>
		<field name="drug_name">Risedronate</field>
		<field name="description">Risedronate is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">735</field>
		<field name="drug_name">Pemirolast</field>
		<field name="description">Pemirolast potassium is a slightly yellow powder that is soluble in water. It is a mast cell stabilizer that acts as an antiallergic agent. As an ophthalmic aqueous sterile solution, pemirolast is used for the prevention of itching of the eyes caused by allergies such as hay fever, and allergic conjunctivitis. Pemirolast is potentially useful for prophylaxis of pulmonary hypersensitivity reactions to drugs such as paclitaxel.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">736</field>
		<field name="drug_name">Bumetanide</field>
		<field name="description">A sulfamyl diuretic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">737</field>
		<field name="drug_name">Mechlorethamine</field>
		<field name="description">A vesicant and necrotizing irritant destructive to mucous membranes. It was formerly used as a war gas. The hydrochloride is used as an antineoplastic in Hodgkin&amp;#39;s disease and lymphomas. It causes severe gastrointestinal and bone marrow damage. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">738</field>
		<field name="drug_name">Granisetron</field>
		<field name="description">A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">739</field>
		<field name="drug_name">Dienestrol</field>
		<field name="description">Dienestrol is a synthetic, non-steroidal estrogen. It is an estrogen receptor agonist. Estrogens work partly by increasing a normal clear discharge from the vagina and making the vulva and urethra healthy. Using or applying an estrogen relieves or lessens: dryness and soreness in the vagina, itching, redness, or soreness of the vulva. Conditions that are treated with vaginal estrogens include a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), and inflammation of the urethra (atrophic urethritis).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">740</field>
		<field name="drug_name">Sulfapyridine</field>
		<field name="description">Antibacterial, potentially toxic, used to treat certain skin diseases. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">741</field>
		<field name="drug_name">Oxybuprocaine</field>
		<field name="description">Oxybuprocaine is the name of a local anesthetic, which is used especially in ophthalmology and otolaryngology. Oxybuprocaine binds to sodium channels and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">742</field>
		<field name="drug_name">Iron Dextran</field>
		<field name="description">Iron dextran is a dark brown, slightly viscous liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. Iron Dextran is used for the treatment of patients with documented iron deficiency in which oral administration is unsatisfactory or impossible.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">743</field>
		<field name="drug_name">Testolactone</field>
		<field name="description">An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">744</field>
		<field name="drug_name">Benzylpenicilloyl Polylysine</field>
		<field name="description">Benzylpenicilloyl Polylysine is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant is a useful tool for evaluating allergic subjects.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">745</field>
		<field name="drug_name">Rimexolone</field>
		<field name="description">Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye. It is marketed as a 1% eye drop solution under the trade name Vexol</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">746</field>
		<field name="drug_name">Triazolam</field>
		<field name="description">Withdrawn in the United Kingdom due to risk of psychiatric adverse drug reactions. This drug continues to be available in the U.S. Internationally, triazolam is a Schedule IV drug under the Convention on Psychotropic Substances.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">747</field>
		<field name="drug_name">Ethanol</field>
		<field name="description">A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">748</field>
		<field name="drug_name">Remifentanil</field>
		<field name="description">Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid analgesic drug. It is given to patients during surgery to relieve pain and as an adjunct to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist. Hence, it causes a reduction in sympathetic nervous system tone, respiratory depression and analgesia.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">749</field>
		<field name="drug_name">Bitolterol</field>
		<field name="description">Bitolterol mesylate is a beta-2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and COPD. Bitolterol was withdrawn from the market by Elan Pharmaceuticals in 2001. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">750</field>
		<field name="drug_name">Methdilazine</field>
		<field name="description">Methdilazine is a phenothiazine compound with antihistaminic activity. It is used in the treatment of various dermatoses to relieve pruritus.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">751</field>
		<field name="drug_name">Ethacrynic acid</field>
		<field name="description">A compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">752</field>
		<field name="drug_name">Ondansetron</field>
		<field name="description">A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">753</field>
		<field name="drug_name">Bimatoprost</field>
		<field name="description">Bimatoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes. It binds to the prostanoid FP receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">754</field>
		<field name="drug_name">Tiagabine</field>
		<field name="description">Tiagabine is an anti-convulsive medication. It is also used in the treatment for panic disorder as are a few other anticonvulsants. Though the exact mechanism by which tiagabine exerts its effect on the human body is unknown, it does appear to operate as a selective GABA reuptake inhibitor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">755</field>
		<field name="drug_name">Cocaine</field>
		<field name="description">An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">756</field>
		<field name="drug_name">Quinidine</field>
		<field name="description">An optical isomer of quinine, extracted from the bark of the Cinchona tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular action potential, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">757</field>
		<field name="drug_name">Zonisamide</field>
		<field name="description">Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures. Zonisamide may be a carbonic anhydrase inhibitor although this is not one of the primary mechanisms of action. Zonisamide may act by blocking repetitive firing of voltage-gated sodium channels leading to a reduction of T-type calcium channel currents, or by binding allosterically to GABA receptors. This latter action may inhibit the uptake of the inhibitory neurotransmitter GABA while enhancing the uptake of the excitatory neurotransmitter glutamate.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">758</field>
		<field name="drug_name">Paricalcitol</field>
		<field name="description">Paricalcitol is a synthetic vitamin D analog. Paricalcitol has been used to reduce parathyroid hormone levels. Paricalcitol is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">759</field>
		<field name="drug_name">Repaglinide</field>
		<field name="description">Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to ? cells of the pancreas to stimulate insulin release. Repaglinide induces an early insulin response to meals decreasing postprandial blood glucose levels. It should only be taken with meals and meal-time doses should be skipped with any skipped meal. Approximately one month of therapy is required before a decrease in fasting blood glucose is seen. Meglitnides may have a neutral effect on weight or cause a slight increase in weight. The average weight gain caused by meglitinides appears to be lower than that caused by sulfonylureas and insulin and appears to occur only in those naïve to oral antidiabetic agents. Due to their mechanism of action, meglitinides may cause hypoglycemia although the risk is thought to be lower than that of sulfonylureas since their action is ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">760</field>
		<field name="drug_name">Anileridine</field>
		<field name="description">Anileridine is a synthetic opioid and strong analgesic medication. It is a narcotic pain reliever used to treat moderate to severe pain. Narcotic analgesics act in the central nervous system (CNS) to relieve pain. Some of their side effects are also caused by actions in the CNS.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">761</field>
		<field name="drug_name">Phenformin</field>
		<field name="description">A biguanide hypoglycemic agent with actions and uses similar to those of metformin. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">762</field>
		<field name="drug_name">Amantadine</field>
		<field name="description">An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">763</field>
		<field name="drug_name">Dinoprostone</field>
		<field name="description">Dinoprostone is a naturally occurring prostaglandin E2 (PGE2). It has important effects in labour. It also stimulates osteoblasts to release factors which stimualtes bone resorption by osteoclasts. As a prescription drug it is used as a vaginal suppository, to prepare the cervix for labour and to induce labour.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">764</field>
		<field name="drug_name">Almotriptan</field>
		<field name="description">Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Almotriptan does not prevent migraine attacks.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">765</field>
		<field name="drug_name">Ketotifen</field>
		<field name="description">A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">766</field>
		<field name="drug_name">Buprenorphine</field>
		<field name="description">Buprenorphine is a derivative of the opioid alkaloid thebaine that is a more potent (25 - 40 times) and longer lasting analgesic than morphine. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">767</field>
		<field name="drug_name">Levosimendan</field>
		<field name="description">Levosimendan is a calcium sensitiser used in the management of acutely decompensated congestive heart failure. It increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its effect by increasing calcium sensitivity of myocytes by binding to cardiac troponin C in a calcium-dependent manner. It also has a vasodilatory effect, by opening adenosine triphosphate (ATP)-sensitive potassium channels in vascular smooth muscle to cause smooth muscle relaxation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">768</field>
		<field name="drug_name">Cyclobenzaprine</field>
		<field name="description">Cyclobenzaprine is a skeletal muscle relaxant and a central nervous system (CNS) depressant. Cyclobenzaprine acts on the locus coeruleus where it results in increased norepinephrine release, potentially through the gamma fibers which innervate and inhibit the alpha motor neurons in the ventral horn of the spinal cord. It is structurally similar to Amitriptyline, differing by only one double bond.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">769</field>
		<field name="drug_name">Phenoxybenzamine</field>
		<field name="description">An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">770</field>
		<field name="drug_name">Etretinate</field>
		<field name="description">Etretinate is a medication used to treat severe psoriasis. It is a synthetic aromatic retinoid. The mechanism of action of etretinate is still incompletely understood although, like retinoic acid, it is thought to interfere with the terminal differentiation of keratinocytes. It is thought to bind to the retinoic acid receptors. Etretinate is also believed to enhance the binding of cAMP to the regulatory RI subunit of cAMP dependent protein kinases. It was removed from the United States market in 1998 and the Canadian market in 1996 as a psoriasis medication, due to the high risk of birth defects. Etretinate is now used to treat T-cell lymphomas. It also appears to inhibit NADH oxidase activity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">771</field>
		<field name="drug_name">Famotidine</field>
		<field name="description">A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">772</field>
		<field name="drug_name">Azacitidine</field>
		<field name="description">A pyrimidine nucleoside analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">773</field>
		<field name="drug_name">Misoprostol</field>
		<field name="description">A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">774</field>
		<field name="drug_name">Colesevelam</field>
		<field name="description">Colesevelam is a bile acid sequestrant. Colesevelam is used with exercise and diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and certain fatty substances in the blood. It works by binding bile acids in the intestine. Bile acids are made when cholesterol is broken down in the body. Removing these bile acids helps to lower blood cholesterol.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">775</field>
		<field name="drug_name">Mesoridazine</field>
		<field name="description">A phenothiazine antipsychotic with effects similar to chlorpromazine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">776</field>
		<field name="drug_name">Maprotiline</field>
		<field name="description">Maprotiline is a tetracyclic antidepressant with similar pharmacological properties to tricyclic antidepressants (TCAs). Similar to TCAs, maprotiline inhibits neuronal norepinephrine reuptake, possesses some anticholinergic activity, and does not affect monoamine oxidase activity. It differs from TCAs in that it does not appear to block serotonin reuptake. Maprotiline may be used to treat depressive affective disorders, including dysthymic disorder (depressive neurosis) and major depressive disorder. Maprotiline is effective at reducing symptoms of anxiety associated with depression.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">777</field>
		<field name="drug_name">Oxymetazoline</field>
		<field name="description">A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">778</field>
		<field name="drug_name">Salicyclic acid</field>
		<field name="description">A compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. Its salts, the salicylates, are used as analgesics.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">779</field>
		<field name="drug_name">Diethylpropion</field>
		<field name="description">A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">780</field>
		<field name="drug_name">Salmeterol</field>
		<field name="description">Salmeterol is a long-acting beta2-adrenergic receptor agonist drug that is currently prescribed for the treatment of asthma and chronic obstructive pulmonary disease COPD.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">781</field>
		<field name="drug_name">Meclofenamic acid</field>
		<field name="description">A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">782</field>
		<field name="drug_name">Methantheline</field>
		<field name="description">Methantheline is a synthetic antispasmodic. Antispasmodics are used to relieve cramps or spasms of the stomach, intestines, and bladder. Methantheline is used to treat intestine or stomach ulcers (peptic ulcer disease), intestine problems (irritable bowel syndrome), pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, or urinary problems (reflex neurogenic bladder in children).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">783</field>
		<field name="drug_name">Hexafluronium</field>
		<field name="description">Hexafluronium bromide is a neuromuscular blocking agent used in anesthesiology to prolong and potentiate the skeletal muscle relaxing action of suxamethonium during surgery. It is known to bind and block the activity of plasma cholinesterases.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">784</field>
		<field name="drug_name">Cycrimine</field>
		<field name="description">Cycrimine is a drug used to reduce levels of acetylcholine to return a balance with dopamine in the treatment and management of Parkinson's disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">785</field>
		<field name="drug_name">Demecarium</field>
		<field name="description">Demecarium bromid is an indirect-acting parasympathomimetic agent that is used to treat glaucoma. It is a cholinesterase inhibitor or an anticholinesterase. Cholinesterase inhibitors prolong the effect of acetylcholine, which is released at the neuroeffector junction of parasympathetic postganglion nerves, by inactivating the cholinesterases that break it down. Demecarium inactivates both pseudocholinesterase and acetylcholinesterase. In the eye, this causes constriction of the iris sphincter muscle (causing miosis) and the ciliary muscle. The outflow of the aqueous humor is facilitated, which leads to a reduction in intraocular pressure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">786</field>
		<field name="drug_name">Acetylsalicylic acid</field>
		<field name="description">The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Acetylsalicylic acid also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">787</field>
		<field name="drug_name">Phenprocoumon</field>
		<field name="description">Coumarin derivative that acts as a long acting oral anticoagulant. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">788</field>
		<field name="drug_name">Fulvestrant</field>
		<field name="description">Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">789</field>
		<field name="drug_name">Felbamate</field>
		<field name="description">Felbamate is an anticonvulsant drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. It has a weak inhibitory effect on GABA receptor binding sites.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">790</field>
		<field name="drug_name">Fexofenadine</field>
		<field name="description">Fexofenadine hydrochloride (Allegra) is an antihistamine drug used in the treatment of hayfever and similar allergy symptoms. It was developed as a successor of and alternative to terfenadine. Fexofenadine, like other second and third-generation antihistamines, does not readily pass through the blood-brain barrier, and so causes less drowsiness than first-generation histamine-receptor antagonists.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">791</field>
		<field name="drug_name">Naratriptan</field>
		<field name="description">Naratriptan is a triptan drug used for the treatment of migraine headaches. It is a selective 5-hydroxytryptamine1 receptor subtype agonist.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">792</field>
		<field name="drug_name">Rizatriptan</field>
		<field name="description">Rizatriptan is a triptan drug used for the treatment of migraine headaches. It is a selective 5-hydroxytryptamine1 receptor subtype agonist.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">793</field>
		<field name="drug_name">Hydrocodone</field>
		<field name="description">Narcotic analgesic related to codeine, but more potent and more addicting by weight. It is used also as cough suppressant. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">794</field>
		<field name="drug_name">Norgestimate</field>
		<field name="description">Norgestimate is a form of progesterone, which is a female hormone important for the regulation of ovulation and menstruation. Norgestimate is used with estradiol to treat the symptoms of menopause.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">795</field>
		<field name="drug_name">Carboplatin</field>
		<field name="description">An organoplatinum compound that possesses antineoplastic activity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">796</field>
		<field name="drug_name">Methylprednisolone</field>
		<field name="description">A prednisolone derivative with similar anti-inflammatory action. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">797</field>
		<field name="drug_name">Pindolol</field>
		<field name="description">A moderately lipophilic beta blocker (adrenergic beta-antagonists). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">798</field>
		<field name="drug_name">Mepivacaine</field>
		<field name="description">A local anesthetic that is chemically related to bupivacaine but pharmacologically related to lidocaine. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">799</field>
		<field name="drug_name">Zaleplon</field>
		<field name="description">Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">800</field>
		<field name="drug_name">Bromfenac</field>
		<field name="description">Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool to optimize surgical outcomes.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">801</field>
		<field name="drug_name">Apraclonidine</field>
		<field name="description">Apraclonidine, also known as iopidine, is a sympathomimetic used in glaucoma therapy. It is an alpha2-adrenergic agonist.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">802</field>
		<field name="drug_name">Ethiodized oil</field>
		<field name="description">Ethiodized oil is used by injection as a radio-opaque contrast agent. It is composed of iodine combined with ethyl esters of fatty acids of poppyseed oil, primarily as ethyl monoiodostearate and ethyl diiodostearate. The precise structure is not known.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">803</field>
		<field name="drug_name">Telmisartan</field>
		<field name="description">Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">804</field>
		<field name="drug_name">Desloratadine</field>
		<field name="description">Desloratadine is a second generation, tricyclic antihistamine that which has a selective and peripheral H1-antagonist action. It is the active descarboethoxy metabolite of loratidine (a second generation histamine). Desloratidine has a long-lasting effect and does not cause drowsiness because it does not readily enter the central nervous system.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">805</field>
		<field name="drug_name">Methyldopa</field>
		<field name="description">An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">806</field>
		<field name="drug_name">Alosetron</field>
		<field name="description">Alosetron is a 5-HT3 antagonist used only for the management of severe diarrhoea-predominant irritable bowel syndrome (IBS) in women. Alosetron has an antagonist action on the 5-HT3 receptors and thus may modulate serotonin-sensitive gastrointestinal (GI) processes. Alosetron was voluntarily withdrawn from the US market in November 2000 by the manufacturer due to numerous reports of severe adverse effects including ischemic colitis, severely obstructed or ruptured bowel, and death. In June 2002, the FDA approved a supplemental new drug application allowing the remarketing of the drug under restricted conditions of use.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">807</field>
		<field name="drug_name">Dactinomycin</field>
		<field name="description">A compound composed of a two cyclic peptides attached to a phenoxazine that is derived from streptomyces parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">808</field>
		<field name="drug_name">Selenium Sulfide</field>
		<field name="description">Selenium Sulfide is an antifungal agent as well as a cytostatic agent, slowing the growth of hyperproliferative cells in seborrhea. Selenium Sulfide is the active ingredient often used in shampoos for the treatment of dandruff, seborrheic dermatitis and tinea capitis, a fungal infection that is primarily a disease of preadolescent children.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">809</field>
		<field name="drug_name">Azelastine</field>
		<field name="description">Azelastine, a phthalazine derivative, is an antihistamine and mast cell stabilizer available as a nasal spray for hay fever and as eye drops for allergic conjunctivitis. Azelastine is also available as a combination product of azelastine hydrochloride and fluticasone propionate called Dymista™. Dymista™ is indicated in patient over 12 years old for symptomatic relief of seasonal allergic rhinitis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">810</field>
		<field name="drug_name">Ezetimibe</field>
		<field name="description">Ezetimibe is an anti-hyperlipidemic medication which is used to lower cholesterol levels. Specifically, it appears to bind to a critical mediator of cholesterol absorption, the Niemann-Pick C1-Like 1 (NPC1L1) protein on the gastrointestinal tract epithelial cells as well as in hepatocytes.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">811</field>
		<field name="drug_name">Edetic Acid</field>
		<field name="description">A chelating agent (chelating agents) that sequesters a variety of polyvalent cations. It is used in pharmaceutical manufacturing and as a food additive. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">812</field>
		<field name="drug_name">Dipyridamole</field>
		<field name="description">A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">813</field>
		<field name="drug_name">Ethinyl Estradiol</field>
		<field name="description">A semisynthetic alkylated estradiol with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally and is often used as the estrogenic component in oral contraceptives [PubChem]. Ethinyl estradiol is marketed mostly as a combination oral contraceptive under several brand names such as Alesse, Tri-Cyclen, Triphasil, and Yasmin. The FDA label includes a black box warning that states that combination oral contraceptives should not be used in women over 35 years old who smoke due to the increased risk of serious cardiovascular side effects.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">814</field>
		<field name="drug_name">Cyclopentolate</field>
		<field name="description">A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">815</field>
		<field name="drug_name">Ramelteon</field>
		<field name="description">Ramelteon is the first in a new class of sleep agents that selectively binds to the melatonin receptors in the suprachiasmatic nucleus (SCN). It is used for insomnia, particularly delayed sleep onset. Ramelteon has not been shown to produce dependence and has shown no potential for abuse.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">816</field>
		<field name="drug_name">Physostigmine</field>
		<field name="description">A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">817</field>
		<field name="drug_name">Isotretinoin</field>
		<field name="description">Isotretinoin is a medication used for the treatment of severe acne. It is sometimes used in prevention of certain skin cancers. It is a retinoid, meaning it derives from vitamin A and is found in small quantities naturally in the body. Isotretinoin binds to and activates nuclear retinoic acid receptors (RAR), thereby regulating cell proliferation and differentiation. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">818</field>
		<field name="drug_name">Formoterol</field>
		<field name="description">Formoterol is a long-acting (12 hours) beta2-agonist used in the management of asthma and/or chronic obstructive pulmonary disease (COPD). Inhaled formoterol works like other beta2-agonists, causing bronchodilatation through relaxation of the smooth muscle in the airway so as to treat the exacerbation of asthma.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">819</field>
		<field name="drug_name">Nandrolone phenpropionate</field>
		<field name="description">C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position. It is a schedule III drug in the U.S.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">820</field>
		<field name="drug_name">Dimenhydrinate</field>
		<field name="description">Dimenhydrinate (Dramamine, Gravol and Vertirosan) is an over-the-counter drug used to prevent motion sickness. It is closely related to diphenhydramine HCl, or Benadryl. It is primarily a H1-antagonist, but also possesses an antimuscarinic effect.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">821</field>
		<field name="drug_name">Glycopyrrolate</field>
		<field name="description">Glycopyrrolate is a synthetic anticholinergic agent with a quaternary ammonium structure. A muscarinic competitive antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">822</field>
		<field name="drug_name">Cytarabine</field>
		<field name="description">A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">823</field>
		<field name="drug_name">Dopamine</field>
		<field name="description">One of the catecholamine neurotransmitters in the brain.  It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">824</field>
		<field name="drug_name">Rivastigmine</field>
		<field name="description">Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">825</field>
		<field name="drug_name">Exemestane</field>
		<field name="description">Exemestane is an oral steroidal aromatase inhibitor used in the adjuvant treatment of hormonally-responsive (also called hormone-receptor-positive, estrogen-responsive) breast cancer in postmenopausal women. It acts as a false substrate for the aromatase enzyme, and is processed to an intermediate that binds irreversibly to the active site of the enzyme causing its inactivation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">826</field>
		<field name="drug_name">Oxaprozin</field>
		<field name="description">Oxaprozin is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">827</field>
		<field name="drug_name">Methyl aminolevulinate</field>
		<field name="description">Methyl aminolevulinate is a prodrug that is metabolised to Protoporphyrin IX (a photosensitizer) used in photodynamic therapy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">828</field>
		<field name="drug_name">Azathioprine</field>
		<field name="description">An immunosuppressive antimetabolite pro-drug. It is an imidazolyl derivative of 6-mercaptopurine and many of its biological effects are similar to those of the parent compound. Azathioprine is converted into 6-mercaptopurine in the body where it blocks purine metabolism and DNA synthesis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">829</field>
		<field name="drug_name">Auranofin</field>
		<field name="description">Auranofin is a organogold compound classified by the World Health Organization as an antirheumatic agent. Auranofin appears to induce heme oxygenase 1 (HO-1) mRNA. Heme oxygenase 1 is an inducible heme-degrading enzyme with anti-inflammatory properties.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">830</field>
		<field name="drug_name">Gabapentin</field>
		<field name="description">Gabapentin (brand name Neurontin) is a medication originally developed for the treatment of epilepsy. Presently, gabapentin is widely used to relieve pain, especially neuropathic pain. Gabapentin is well tolerated in most patients, has a relatively mild side-effect profile, and passes through the body unmetabolized.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">831</field>
		<field name="drug_name">Doxorubicin</field>
		<field name="description">Doxorubicin is a cytotoxic anthracycline antibiotic isolated from cultures of Streptomyces peucetius var. caesius. Doxorubicin binds to nucleic acids, presumably by specific intercalation of the planar anthracycline nucleus with the DNA double helix.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">832</field>
		<field name="drug_name">Frovatriptan</field>
		<field name="description">Frovatriptan (Frova®) is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe.[1] Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. It is available as 2.5 mg tablets.    Frovatriptan has mean terminal elimination half-life of approximately 26 hours, which is substantially longer than other triptans.    Frovatriptan is available only by prescription in the United States, where a secondary New Drug Approval (sNDA) was filed in July 2006[2] and which is currently pending.[3] The FDA anticipates completing its review of this application on or before the current PDUFA (Prescription Drug User Fee Act) review date of August 19, 2007. If the sNDA is approved, Frova® will be the only medication indicated in the U.S. for the short-term prevention of menstrual migraine (MM).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">833</field>
		<field name="drug_name">Hydrochlorothiazide</field>
		<field name="description">A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It has been used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">834</field>
		<field name="drug_name">Salbutamol</field>
		<field name="description">Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity. This lead to the development of levalbuterol, the single R-isomer of salbutamol. However, the high cost of levalbuterol compared to salbutamol has deterred wide-spread use of this enantiomerically pure version of the drug. Salbutamol is generally used for acute episodes of bronchospasm caused by bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders such as chronic obstructive pulmonary disorder (COPD). It is also used prophylactically for exercise-induced ast...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">835</field>
		<field name="drug_name">Levobupivacaine</field>
		<field name="description">Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted  pipecoloxylidide. It is the S-enantiomer of bupivacaine. Levobupivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Chirocaine. Compared to bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. It is approximately 13 per cent less potent (by molarity) than racemic bupivacaine.Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal anaesthesia in adults; and infiltration analgesia in children. Adverse drug reactions (ADRs) are rare when it is administered correctly. Most ADRs relate to administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia, however allergic reactions can rarely occur. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">836</field>
		<field name="drug_name">Cromoglicic acid</field>
		<field name="description">A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">837</field>
		<field name="drug_name">Hydroxyurea</field>
		<field name="description">An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">838</field>
		<field name="drug_name">Letrozole</field>
		<field name="description">Letrozole (INN, trade name Femara®) is an oral non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast cancer    Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production.  Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoe...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">839</field>
		<field name="drug_name">Busulfan</field>
		<field name="description">Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It is not a structural analog of the nitrogen mustards. It has been used in the palliative treatment of chronic myeloid leukemia (myeloid leukemia, chronic), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">840</field>
		<field name="drug_name">Ketoprofen</field>
		<field name="description">Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">841</field>
		<field name="drug_name">Edrophonium</field>
		<field name="description">A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">842</field>
		<field name="drug_name">Metyrapone</field>
		<field name="description">An inhibitor of the enzyme steroid 11-beta-monooxygenase. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of cushing syndrome. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">843</field>
		<field name="drug_name">Cinacalcet</field>
		<field name="description">Cinacalcet (INN) is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. It is sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe. Cinacalcet is used to treat hyperparathyroidism (elevated parathyroid hormone levels), a consequence of parathyroid tumors and chronic renal failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">844</field>
		<field name="drug_name">Clobetasol</field>
		<field name="description">A derivative of prednisolone with high glucocorticoid activity and low mineralocorticoid activity.  Absorbed through the skin faster than fluocinonide, it is used topically in treatment of psoriasis but may cause marked adrenocortical suppression. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">845</field>
		<field name="drug_name">Balsalazide</field>
		<field name="description">Balsalazide is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease. It is sold under the name &quot;Colazal&quot; in the US and &quot;Colazide&quot; in the UK.    The chemical name is (E)-5-[[-4-(2-carboxyethyl) aminocarbonyl] phenyl]azo] -2-hydroxybenzoic acid. It is usually administered as the disodium salt.    Balsalazide releases mesalazine, also known as 5-aminosalicylic acid, or 5-ASA, in the large intestine. Its advantage over that drug in the treatment of Ulcerative colitis is believed to be the delivery of the active agent past the small intestine to the large intestine, the active site of ulcerative colitis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">846</field>
		<field name="drug_name">Glyburide</field>
		<field name="description">Glyburide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating &amp;beta; cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic &amp;beta; cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. Glyburide has been show...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">847</field>
		<field name="drug_name">Guanfacine</field>
		<field name="description">A centrally acting antihypertensive agent. The drug lowers both systolic and diastolic blood pressure by activating the central nervous system alpha-2 adrenoreceptors, which results in reduced sympathetic outflow leading to reduced vascular tone. Its adverse reactions include dry mouth, sedation, and constipation. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">848</field>
		<field name="drug_name">Bethanechol</field>
		<field name="description">Bethanechol is a synthetic ester structurally and pharmacologically related to acetylcholine. A slowly hydrolyzed muscarinic agonist with no nicotinic effects, bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, cardiac rate changes, and bronchial spasms. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">849</field>
		<field name="drug_name">Isosorbide Mononitrate</field>
		<field name="description">Isosorbide mononitrate is a drug used principally in the treatment of angina pectoris[1] and acts by dilating the blood vessels so as to reduce the blood pressure. It is sold by AstraZeneca under the trade name Imdur.    Isosorbide mononitrate is used to for the the prophylactic treatment of angina pectoris; that is, it is taken in order to prevent or at least reduce the occurrence of angina. Research on Isosorbide mononitrate as a cervical ripener to reduce time at hospital to birth is supportive.    Isosorbide mononitrate is an active metabolite of isosorbide dinitrate and exerts qualitatively similar effects. Isosorbide mononitrate reduces the workload of the heart by producing venous and arterial dilation. By reducing the end diastolic pressure and volume, isosorbide mononitrate lowers intramural pressure, hence leading to an improvement in the subendocardial blood flow. The net effect when administering isosorbide mononitrate is therefore a reduced workload for the heart and an im...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">850</field>
		<field name="drug_name">Trichlormethiazide</field>
		<field name="description">A thiazide diuretic with properties similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p830)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">851</field>
		<field name="drug_name">Phytonadione</field>
		<field name="description">Phytonadione is often called vitamin K1. It is a fat-soluble vitamin that is stable to air and moisture but decomposes in sunlight. It is found naturally in a wide variety of green plants. Phylloquinone is also an antidote for coumatetralyl. Vitamin K is needed for the posttranslational modification of certain proteins, mostly required for blood coagulation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">852</field>
		<field name="drug_name">Felodipine</field>
		<field name="description">Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">853</field>
		<field name="drug_name">Mycophenolic acid</field>
		<field name="description">Mycophenolic acid is an an immunosuppresant drug and potent anti-proliferative, and can be used in place of the older anti-proliferative azathioprine. It is usually used as part of triple therapy including a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone. It is also useful in research for the selection of animal cells that express the E. coli gene coding for XGPRT (xanthine guanine phosphoribosyltransferase).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">854</field>
		<field name="drug_name">Amlexanox</field>
		<field name="description">Amlexanox is an antiallergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis. Amlexanox as a topical paste is a well tolerated treatment of recurrent aphthous ulcers. Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">855</field>
		<field name="drug_name">Methoxyflurane</field>
		<field name="description">An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with nitrous oxide to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (From AMA Drug Evaluations Annual, 1994, p180)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">856</field>
		<field name="drug_name">Irbesartan</field>
		<field name="description">Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">857</field>
		<field name="drug_name">Topotecan</field>
		<field name="description">An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA topoisomerases, type I. [PubChem];DNA Topoisomerase I Inhibitor; Cytotoxic</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">858</field>
		<field name="drug_name">Ethinamate</field>
		<field name="description">Ethinamate is a short-acting sedative-hypnotic medication used to treat insomnia. Regular use leads to tolerance, and it is usually not effective for more than 7 days. Structurally, it does not resemble the barbituates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">859</field>
		<field name="drug_name">Probenecid</field>
		<field name="description">The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">860</field>
		<field name="drug_name">Mercaptopurine</field>
		<field name="description">An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">861</field>
		<field name="drug_name">Cerulenin</field>
		<field name="description">Cerulenin is an antifungal antibiotic that inhibits sterol and fatty acid biosynthesis. In fatty acid synthesis, reported to bind in equimolar ratio to b-keto-acyl-ACP synthase. In sterol synthesis, inhibits HMG-CoA synthetase activity. It is also shown to inhibit feeding and induce dramatic weight loss in mice. It is found naturally in the Cephalosporium caerulensfungus. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">862</field>
		<field name="drug_name">Procainamide</field>
		<field name="description">A derivative of procaine with less CNS action. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">863</field>
		<field name="drug_name">Tolterodine</field>
		<field name="description">Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">864</field>
		<field name="drug_name">Selegiline</field>
		<field name="description">A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">865</field>
		<field name="drug_name">Carphenazine</field>
		<field name="description">Carphenazine is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">866</field>
		<field name="drug_name">Fenofibrate</field>
		<field name="description">An antilipemic agent which reduces both cholesterol and triglycerides in the blood. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">867</field>
		<field name="drug_name">Thalidomide</field>
		<field name="description">A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppresive and anti-angiogenic activity. It inhibits release of tumor necrosis factor-alpha from monocytes, and modulates other cytokine action. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">868</field>
		<field name="drug_name">Melphalan</field>
		<field name="description">An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - melphalan, the racemic mixture - merphalan, and the dextro isomer - medphalan; toxic to bone marrow, but little vesicant action; potential carcinogen. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">869</field>
		<field name="drug_name">Memantine</field>
		<field name="description">Memantine is an amantadine derivative with low to moderate-affinity for NMDA receptors. It is a noncompetitive NMDA receptor antagonist that binds preferentially to NMDA receptor-operated cation channels. It  blocks the effects of excessive levels of glutamate that may lead to neuronal dysfunction. It is under investigation for the treatment of Alzheimer's disease, but there has been no clinical support for the prevention or slowing of disease progression.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">870</field>
		<field name="drug_name">Lubiprostone</field>
		<field name="description">Lubiprostone is a medication used in the management of idiopathic chronic constipation. It is a bicyclic fatty acid (prostaglandin E1 derivative) which acts by specifically activating ClC-2 chloride channels on the apical aspect of gastrointestinal epithelial cells, producing a chloride-rich fluid secretion. These secretions soften the stool, increase motility, and promote spontaneous bowel movements (SBM).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">871</field>
		<field name="drug_name">Fluocinonide</field>
		<field name="description">A topical glucocorticoid used in the treatment of eczema. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">872</field>
		<field name="drug_name">Ergoloid mesylate</field>
		<field name="description">Ergoloid mesylate is a dihydrogenated ergot (Claviceps purpurea) derivative alkaloid used as a vasodilator agent.  Ergoloid Mesylate is the only vasodilator that has shown mild benefits in the treatment of vascular dementia.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">873</field>
		<field name="drug_name">Ibuprofen</field>
		<field name="description">Ibuprofen, a propionic acid derivative, is a prototypical nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">874</field>
		<field name="drug_name">Nitrendipine</field>
		<field name="description">A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">875</field>
		<field name="drug_name">Mimosine</field>
		<field name="description">3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">876</field>
		<field name="drug_name">Tocainide</field>
		<field name="description">An antiarrhythmic agent which exerts a potential- and frequency-dependent block of sodium channels. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">877</field>
		<field name="drug_name">Echothiophate</field>
		<field name="description">A potent, long-acting irreversible cholinesterase inhibitor used as an ocular hypertensive in the treatment of glaucoma. Occasionally used for accomodative esotropia.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">878</field>
		<field name="drug_name">Praziquantel</field>
		<field name="description">An anthelmintic used in most schistosome and many cestode infestations. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">879</field>
		<field name="drug_name">Oxybutynin</field>
		<field name="description">Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination, by decreasing muscle spasms of the bladder. It competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">880</field>
		<field name="drug_name">Acetophenazine</field>
		<field name="description">Acetophenazine is an antipsychotic drug of moderate-potency. It is used in the treatment of disorganized and psychotic thinking. It is also used to help treat false perceptions (e.g. hallucinations or delusions). It primarily targets the dopamine D2 receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">881</field>
		<field name="drug_name">Isoproterenol</field>
		<field name="description">Isopropyl analog of epinephrine; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">882</field>
		<field name="drug_name">Melatonin</field>
		<field name="description">Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958.  In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and lowering the body temperature.  Melatonin is also implicated in the regulation of mood, learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant.  Most of ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">883</field>
		<field name="drug_name">Glipizide</field>
		<field name="description">An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">884</field>
		<field name="drug_name">Clonazepam</field>
		<field name="description">An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of gamma-aminobutyric acid receptor responses. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">885</field>
		<field name="drug_name">Promethazine</field>
		<field name="description">A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">886</field>
		<field name="drug_name">Dihydrotachysterol</field>
		<field name="description">A vitamin D that can be regarded as a reduction product of vitamin D2. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">887</field>
		<field name="drug_name">Mequitazine</field>
		<field name="description">Mequitazine is a histamine H1 antagonist (antihistamine). It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">888</field>
		<field name="drug_name">Fludarabine</field>
		<field name="description">Fludarabine (marketed as fludarabine phosphate under the trade name Fludara) is a chemotherapy drug used in the treatment of hematological malignancies. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">889</field>
		<field name="drug_name">Perhexiline</field>
		<field name="description">2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">890</field>
		<field name="drug_name">Diphenhydramine</field>
		<field name="description">A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">891</field>
		<field name="drug_name">Atorvastatin</field>
		<field name="description">Atorvastatin (Lipitor) is a member of the drug class known as statins. It is used for lowering cholesterol. Atorvastatin is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-determining enzyme in cholesterol biosynthesis via the mevalonate pathway. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonate. Atorvastatin acts primarily in the liver. Decreased hepatic cholesterol levels increases hepatic uptake of cholesterol and reduces plasma cholesterol levels.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">892</field>
		<field name="drug_name">Etidronic acid</field>
		<field name="description">A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">893</field>
		<field name="drug_name">Deslanoside</field>
		<field name="description">Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">894</field>
		<field name="drug_name">Tegaserod</field>
		<field name="description">Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome. On March 30, 2007, the U.S. Food and Drug Administration requested that Novartis withdraw Zelnorm from shelves. The FDA alleges a relationship between prescriptions of the drug and increased risks of heart attack or stroke. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">895</field>
		<field name="drug_name">Vigabatrin</field>
		<field name="description">An analogue of gamma-aminobutyric acid, vigabatrin is an irreversible inhibitor of 4-aminobutyrate transaminase, the enzyme responsible for the catabolism of gamma-aminobutyric acid. (From Martindale The Extra Pharmacopoeia, 31st ed). Off-label uses include treatment of cocaine dependence.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">896</field>
		<field name="drug_name">Diphenoxylate</field>
		<field name="description">A meperidine congener used as an antidiarrheal, usually in combination with atropine. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity. This medication is classified as a Schedule V under the Controlled Substances Act by the Food and Drug Administration (FDA) and the DEA in the United States when used in preparations. When diphenoxylate is used alone, it is classified as a Schedule II.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">897</field>
		<field name="drug_name">Orlistat</field>
		<field name="description">Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. Orlistat works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">898</field>
		<field name="drug_name">Emedastine</field>
		<field name="description">Emedastine is an antihistamine used in eye drops to treat allergic conjunctivitis. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">899</field>
		<field name="drug_name">Pilocarpine</field>
		<field name="description">A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">900</field>
		<field name="drug_name">Benzocaine</field>
		<field name="description">A surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">901</field>
		<field name="drug_name">Iloprost</field>
		<field name="description">Iloprost is a synthetic analogue of prostacyclin PGI2. Iloprost dilates systemic and pulmonary arterial vascular beds. It is used to treat pulmonary arterial hypertension (PAH).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">902</field>
		<field name="drug_name">Deserpidine</field>
		<field name="description">Deserpidine is an ester alkaloid drug isolated from Rauwolfia canescens (family Apocynaceae) with antipsychotic and antihypertensive properties that has been used for the control of high blood pressure and for the relief of psychotic behavior.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">903</field>
		<field name="drug_name">Pentolinium</field>
		<field name="description">A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">904</field>
		<field name="drug_name">Ouabain</field>
		<field name="description">A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like digitalis. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-exchanging ATPase. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">905</field>
		<field name="drug_name">Dimethyl sulfoxide</field>
		<field name="description">A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during cryopreservation. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">906</field>
		<field name="drug_name">Hesperetin</field>
		<field name="description">Hesperetin belongs to the flavanone class of flavonoids. Hesperetin, in the form of its glycoside hesperidin, is the predominant flavonoid in lemons and oranges.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">907</field>
		<field name="drug_name">Fluvastatin</field>
		<field name="description">Fluvastatin is an antilipemic agent that competitively inhibits hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Fluvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease. It is also the first entirely synthetic HMG-CoA reductase inhibitor and is structurally distinct from the fungal derivatives of this therapeutic class.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">908</field>
		<field name="drug_name">Leflunomide</field>
		<field name="description">Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD (disease-modifying antirheumatic drug) class of drugs, which are chemically and pharmacologically very heterogeneous. Leflunomide was approved by FDA and in many other countries (e.g., Canada, Europe) in 1999.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">909</field>
		<field name="drug_name">Rosuvastatin</field>
		<field name="description">Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reducuase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">910</field>
		<field name="drug_name">Pimozide</field>
		<field name="description">A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to haloperidol for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">911</field>
		<field name="drug_name">Capecitabine</field>
		<field name="description">Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">912</field>
		<field name="drug_name">Arbutamine</field>
		<field name="description">Arbutamine, administered through a closed-loop, computer-controlled drug-delivery system, is indicated to elicit acute cardiovascular responses, similar to those produced by exercise, in order to aid in diagnosing the presence or absence of coronary artery disease in patients who cannot exercise adequately .</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">913</field>
		<field name="drug_name">Sertraline</field>
		<field name="description">Sertraline hydrochloride belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize &amp;alpha;- or &amp;beta;-adrenergic, dopamine D&lt;sub&gt;2&lt;/sub&gt; or histamine H&lt;sub&gt;1&lt;/sub&gt; receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. The overall clinical effect of increased mood and decreased anxiety is thought to be due to adaptive changes in neuronal function that leads to en...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">914</field>
		<field name="drug_name">Sibutramine</field>
		<field name="description">Sibutramine (trade name Meridia in the USA, Reductil in Europe and other countries), usually as sibutramide hydrochloride monohydrate, is an orally administered agent for the treatment of obesity. It is a centrally acting stimulant chemically related to amphetamines. Sibutramine is classified as a Schedule IV controlled substance in the United States. In October 2010, Sibutramine was withdrawn from Canadian and U.S. markets due to concerns that the drug increases the risk of heart attack and stroke in patients with a history of heart disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">915</field>
		<field name="drug_name">Levocabastine</field>
		<field name="description">Levocabastine is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">916</field>
		<field name="drug_name">Methyprylon</field>
		<field name="description">Methyprylon is a sedative of the piperidinedione derivative family. This medicine was used for treating insomnia, but is now rarely used as it has been replaced by newer drugs with less side effects, such as benzodiazepines. Methyprylon was withdrawn from the US market in June 1965 and the Canadian market in September 1990. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">917</field>
		<field name="drug_name">Trilostane</field>
		<field name="description">Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It was withdrawn from the United States market in April 1994. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">918</field>
		<field name="drug_name">Heparin</field>
		<field name="description">Unfractionated heparin (UH) is a heterogenous preparation of anionic, sulfated glycosaminoglycan polymers with weights ranging from 3000 to 30,000 Da. It is a naturally occurring anticoagulant released from mast cells. It binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin (factor IIa) and factor Xa. UH is different from low molecular weight heparin (LMWH) in the following ways: the average molecular weight of LMWH is about 4.5 kDa whereas it is 15 kDa for UH; UH requires continuous infusions; activated partial prothrombin time (aPTT) monitoring is required when using UH; and UH has a higher risk of bleeding and higher risk of osteoporosis in long term use. Unfractionated heparin is more specific than LMWH for thrombin. Furthermore, the effects of UH can typically be reversed by using protamine sulfate.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">919</field>
		<field name="drug_name">Papaverine</field>
		<field name="description">An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">920</field>
		<field name="drug_name">Chlorpheniramine</field>
		<field name="description">A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than promethazine. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">921</field>
		<field name="drug_name">Nifedipine</field>
		<field name="description">Nifedipine has been formulated as both a long- and short-acting 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nifedipine prevents calcium-dependent myocyte contraction and vasoconstriction. A second proposed mechanism for the drug’s vasodilatory effects involves pH-dependent inhibition of calcium influx via inhibition of smooth muscle carbonic anhydrase. Nifedipine is used to treat hypertension and chronic stable angina.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">922</field>
		<field name="drug_name">Trimethaphan</field>
		<field name="description">A nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">923</field>
		<field name="drug_name">Amiodarone</field>
		<field name="description">An antianginal and antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting Na,K-activated myocardial adenosine triphosphatase. There is a resulting decrease in heart rate and in vascular resistance. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">924</field>
		<field name="drug_name">Diazoxide</field>
		<field name="description">A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">925</field>
		<field name="drug_name">Gliclazide</field>
		<field name="description">Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating &amp;beta; cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic &amp;beta; cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. Gliclazide has been sh...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">926</field>
		<field name="drug_name">Phenacemide</field>
		<field name="description">Phenacemide is used to control certain seizures in the treatment of epilepsy. This medicine acts on the central nervous system (CNS) to reduce the number and severity of seizures.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">927</field>
		<field name="drug_name">Ambenonium</field>
		<field name="description">Ambenonium is a cholinesterase inhibitor used in the management of myasthenia gravis. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">928</field>
		<field name="drug_name">Tolbutamide</field>
		<field name="description">Tolbutamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It is structurally similar to acetohexamide, chlorpropamide and tolazamide and belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating ? cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic ? cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderl...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">929</field>
		<field name="drug_name">Anisindione</field>
		<field name="description">Anisindione is a synthetic anticoagulant and an indanedione derivative. It prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K-mediated gamma-carboxylation of precursor proteins.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">930</field>
		<field name="drug_name">Dutasteride</field>
		<field name="description">Dutasteride belongs to a class of drugs called 5-alpha-reductase inhibitors, which block the action of the 5-alpha-reductase enzymes that convert testosterone into dihydrotestosterone (DHT). Finasteride also belongs to this group, but while dutasteride inhibits both isoforms of 5-alpha reductase, finasteride inhibits only one. Even so, a clinical study done by GlaxoSmithKline, the EPICS trial, did not find dutasteride to be more effective than finasteride in treating BPH. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">931</field>
		<field name="drug_name">Bicalutamide</field>
		<field name="description">Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It binds to the androgen receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">932</field>
		<field name="drug_name">Rabeprazole</field>
		<field name="description">Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">933</field>
		<field name="drug_name">Prednicarbate</field>
		<field name="description">Prednicarbate is a relatively new topical corticosteroid drug. It is similar in potency to hydrocortisone. It is used in the treatment of inflammatory skin diseases, such as atopic dermatitis. It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a low potential to cause skin atrophy. The anti-inflammation action of corticosteroids is associated with the inhibition of the interleukin 1-alpha cytokine within keratinocytes. IL-1a is also found in fibroblasts, where it is responsible for proliferation, collagenase induction and IL-6 synthesis, which are related to skin thickness.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">934</field>
		<field name="drug_name">Pioglitazone</field>
		<field name="description">Pioglitazone is used for the treatment of diabetes mellitus type 2. Pioglitazone selectively stimulates nuclear receptor peroxisone proliferator-activated receptor gamma (PPAR-gamma). It modulates the transcription of the insulin-sensitive genes involved in the control of glucose and lipid metabolism in the lipidic, muscular tissues and in the liver.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">935</field>
		<field name="drug_name">Tiludronate</field>
		<field name="description">Tiludronate is a bisphosphonate characterized by a (4-chlorophenylthio) group on the carbon atom of the basic P-C-P structure common to all bisphosphonates.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">936</field>
		<field name="drug_name">Desoxycorticosterone Pivalate</field>
		<field name="description">Desoxycorticosterone Pivalate is a mineralocorticoid hormone and an analog of desoxycorticosterone. It is white, odorless, and stable in air. It is practically insoluble in water, sparingly soluble in acetone, slightly soluble in methanol, ether and vegetable oils. Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">937</field>
		<field name="drug_name">Doxacurium chloride</field>
		<field name="description">Doxacurium chloride is a long-acting, nondepolarizing skeletal muscle relaxant for intravenous administration.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">938</field>
		<field name="drug_name">Carvedilol</field>
		<field name="description">Carvedilol is a non-selective beta blocker indicated in the treatment of mild to moderate congestive heart failure (CHF). It blocks beta-1 and beta-2 adrenergic receptors as well as the alpha-1 adrenergic receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">939</field>
		<field name="drug_name">Sulfinpyrazone</field>
		<field name="description">A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">940</field>
		<field name="drug_name">Doxepin</field>
		<field name="description">Doxepin hydrochloride is a dibenzoxepin-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, doxepin does not affect mood or arousal, but may cause sedation. In depressed individuals, doxepin exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as doxepin and amitriptyline, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline and desipramine. TCAs also down-regulate cerebral cortical &amp;beta;-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H&lt;sub&gt;1&lt;/sub&gt; receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptors and muscarinic receptors, whi...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">941</field>
		<field name="drug_name">Amifostine</field>
		<field name="description">A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">942</field>
		<field name="drug_name">Dichlorphenamide</field>
		<field name="description">A carbonic anhydrase inhibitor that is used in the treatment of glaucoma. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">943</field>
		<field name="drug_name">Diphenylpyraline</field>
		<field name="description">Diphenylpyraline is an antihistamine. Antihistamines used in the treatment of allergy act by competing with histamine for H 1-receptor sites on effector cells. Antihistamines prevent, but do not reverse, responses mediated by histamine alone. Antihistamines antagonize, in varying degrees, most of the pharmacological effects of histamine, including urticaria and pruritus.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">944</field>
		<field name="drug_name">Flavoxate</field>
		<field name="description">A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">945</field>
		<field name="drug_name">Nefazodone</field>
		<field name="description">Nefazodone hydrochloride (trade name Serzone) is an antidepressant drug marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries, due to the small possibility of hepatic (liver) injury, which could lead to the need for a liver transplant, or even death. The incidence of severe liver damage is approximately 1 in 250,000 to 300,000 patient-years. On May 20, 2004, Bristol-Myers Squibb discontinued the sale of Serzone in the United States. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">946</field>
		<field name="drug_name">Desipramine</field>
		<field name="description">Desipramine hydrochloride is a dibenzazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, desipramine does not affect mood or arousal, but may cause sedation. In depressed individuals, desipramine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Secondary amine TCAs, such as desipramine and nortriptyline, are more potent inhibitors of norepinephrine reuptake than tertiary amine TCAs, such as amitriptyline and doxepine. TCAs also down-regulate cerebral cortical &amp;beta;-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H&lt;sub&gt;1&lt;/sub&gt; receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptors and muscar...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">947</field>
		<field name="drug_name">Thiamylal</field>
		<field name="description">A barbiturate that is administered intravenously for the production of complete anesthesia of short duration, for the induction of general anesthesia, or for inducing a hypnotic state. (From Martindale, The Extra Pharmacopoeia, 30th ed, p919)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">948</field>
		<field name="drug_name">Bupropion</field>
		<field name="description">A unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it does appear to block dopamine uptake. The hydrochloride is available as an aid to smoking cessation treatment. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">949</field>
		<field name="drug_name">Trimetrexate</field>
		<field name="description">A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against pneumocystis pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">950</field>
		<field name="drug_name">Bretylium</field>
		<field name="description">Bretylium blocks the release of noradrenaline from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation. The primary mode of action for bretylium is thought to be inhibition of voltage-gated K(+) channels. Recent evidence has shown that bretylium may also inhibit the Na,K-ATPase by binding to the extracellular K-site.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">951</field>
		<field name="drug_name">Halothane</field>
		<field name="description">A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. nitrous oxide is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">952</field>
		<field name="drug_name">Dinoprost Tromethamine</field>
		<field name="description">The tromethamine (THAM) salt of the naturally occurring prostaglandin F2 alpha, dinoprost tromethamine occurs as a white to off-white, very hygroscopic, crystalline powder. Dinoprost tromethamine may also be known as dinoprost trometamol, PGF2 alpha THAM, or prostaglandin F2 alpha tromethamine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">953</field>
		<field name="drug_name">Chloroprocaine</field>
		<field name="description">Chloroprocaine hydrochloride is a local anesthetic given by injection during surgical procedures and labor and delivery. Chloroprocaine, like other local anesthetics, blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse and by reducing the rate of rise of the action potential.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">954</field>
		<field name="drug_name">Terazosin</field>
		<field name="description">Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">955</field>
		<field name="drug_name">Calcium Chloride</field>
		<field name="description">Calcium chloride is an ionic compound of calcium and chlorine. It is highly soluble in water and it is deliquescent. It is a salt that is solid at room temperature, and it behaves as a typical ionic halide. It has several common applications such as brine for refrigeration plants, ice and dust control on roads, and in cement. It can be produced directly from limestone, but large amounts are also produced as a by-product of the Solvay process. Because of its hygroscopic nature, it must be kept in tightly-sealed containers. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">956</field>
		<field name="drug_name">Cilostazol</field>
		<field name="description">Cilostazol is a medication used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease. It is manufactured by Otsuka Pharmaceutical Co. under the trade name Pletal. Although drugs similar to cilostazol have increased the risk of death in patients with congestive heart failure, studies of significant size have not addressed people without the disease. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">957</field>
		<field name="drug_name">Procarbazine</field>
		<field name="description">An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin&amp;#39;s disease. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">958</field>
		<field name="drug_name">Arsenic trioxide</field>
		<field name="description">Arsenic trioxide is a chemotheraputic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents. It is suspected that arsenic trisulfide induces cancer cells to undergo apoptosis. Due to the toxic nature of arsenic, this drug carries significant health risks. The enzyme thioredoxin reductase has recently been identified as a target for arsenic trioxide.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">959</field>
		<field name="drug_name">Guanethidine</field>
		<field name="description">An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">960</field>
		<field name="drug_name">Moclobemide</field>
		<field name="description">A reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">961</field>
		<field name="drug_name">Orphenadrine</field>
		<field name="description">A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">962</field>
		<field name="drug_name">Phenobarbital</field>
		<field name="description">A barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">963</field>
		<field name="drug_name">Escitalopram</field>
		<field name="description">Escitalopram, the &lt;i&gt;S&lt;/i&gt;-enantiomer of citalopram, belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize &amp;alpha;- or &amp;beta;-adrenergic, dopamine D&lt;sub&gt;2&lt;/sub&gt; or histamine H&lt;sub&gt;1&lt;/sub&gt; receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT&lt;sub&gt;1A&lt;/sub&gt; and terminal autoreceptors. The overall clinical effect of increased mood and decreased anxiety is thought to be due to adaptive changes in neuron...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">964</field>
		<field name="drug_name">Cyclizine</field>
		<field name="description">A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">965</field>
		<field name="drug_name">Idarubicin</field>
		<field name="description">An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">966</field>
		<field name="drug_name">Chlormezanone</field>
		<field name="description">A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">967</field>
		<field name="drug_name">Rescinnamine</field>
		<field name="description">Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug. It is an alkaloid obtained from &lt;i&gt;Rauwolfia serpentina&lt;/i&gt; and other species of &lt;i&gt;Rauwolfia&lt;/i&gt;. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">968</field>
		<field name="drug_name">Ifosfamide</field>
		<field name="description">Ifosfamide is a chemotherapeutic agent chemically related to the nitrogen mustards and a synthetic analog of cyclophosphamide. It is active as an alkylating agent and an immunosuppresive agent.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">969</field>
		<field name="drug_name">Propafenone</field>
		<field name="description">An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">970</field>
		<field name="drug_name">Naloxone</field>
		<field name="description">A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">971</field>
		<field name="drug_name">Domperidone</field>
		<field name="description">A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">972</field>
		<field name="drug_name">Fluoxymesterone</field>
		<field name="description">An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">973</field>
		<field name="drug_name">Pergolide</field>
		<field name="description">Pergolide is a long-acting dopamine agonist approved in 1982 for the treatment of Parkinson’s Disease. It is an ergot derivative that acts on the dopamine D2 and D3, alpha2- and alpha1-adrenergic, and 5-hydroxytryptamine (5-HT) receptors. It was indicated as adjunct therapy with levodopa/carbidopa in the symptomatic treatment of parkinsonian syndrome. It was later found that pergolide increased the risk of cardiac valvulopathy. The drug was withdrawn from the US market in March 2007 and from the Canadian market in August 2007.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">974</field>
		<field name="drug_name">Iophendylate</field>
		<field name="description">Iophendylate is a mixture of isomers used as contrast medium, mainly for brain and spinal cord visualization. Iophendylate is a myelographic oil-ester (U.S. Patent 2,348,231). Iophendylate, which was never shown to be safe, was initially introduced for use in small amounts (1-2cc) for locating spinal tumors. It next appeared on the world scene for high volume (12-15cc), routine use, in diagnosing disc herniations. A number of clinicians have published on the dangers of oil myelography. In 1942 Van Wagenen (a neurosurgical colleague of Warrens, at the University of Rochester) identified Iophendylate as causing chemical meningitis in 30 patients where &quot;space-displacing masses within the spinal canal were suspected&quot;.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">975</field>
		<field name="drug_name">Ciclopirox</field>
		<field name="description">Ciclopirox (also called Loprox®, Penlac® and Stieprox®) is a synthetic antifungal agent for topical dermatologic use. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">976</field>
		<field name="drug_name">Desflurane</field>
		<field name="description">Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anaesthesia. Volatile agents such as desflurane may activate GABA channels and hyperpolarize cell membranes. In addition, they may inhibit certain calcium channels and therefore prevent release of neurotransmitters and inhibit glutamate channels. Volatile anesthetics easily partition into cellular membranes and could expand the volume of the cell membrane and subsequently distort channels necessary for sodium ion flux and the development of action potentials necessary for synaptic transmission. Desflurane preconditions human myocardium against ischemia through activation of mitochondrial K(ATP) channels, adenosine A1 receptor, and alpha and beta adrenoceptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">977</field>
		<field name="drug_name">Dexfenfluramine</field>
		<field name="description">Dexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug. It was for some years in the mid-1990s approved by the United States Food and Drug Administration for the purposes of weight loss. However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">978</field>
		<field name="drug_name">Oxymorphone</field>
		<field name="description">An opioid analgesic with actions and uses similar to those of morphine, apart from an absence of cough suppressant activity. It is used in the treatment of moderate to severe pain, including pain in obstetrics. It may also be used as an adjunct to anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1092)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">979</field>
		<field name="drug_name">Acebutolol</field>
		<field name="description">A cardioselective beta-adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">980</field>
		<field name="drug_name">Brinzolamide</field>
		<field name="description">Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor. Carbonic anhydrase (CA) is an enzyme found in many tissues of the body including the eye. It catalyzes the reversible reaction involving the hydration of carbon dioxide and the dehydration of carbonic acid. In humans, carbonic anhydrase exists as a number of isoenzymes, the most active being carbonic anhydrase II (CA-II). Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. The result is a reduction in intraocular pressure. Brinzolamide is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">981</field>
		<field name="drug_name">Flecainide</field>
		<field name="description">A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, flecainide exacerbates the arrhythmia and is not recommended for use in these patients. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">982</field>
		<field name="drug_name">Estramustine</field>
		<field name="description">A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">983</field>
		<field name="drug_name">Captopril</field>
		<field name="description">Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Captopril may be used in the treatment of hypertension.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">984</field>
		<field name="drug_name">Zopiclone</field>
		<field name="description">Zopiclone is a novel hypnotic agent used in the treatment of insomnia. Its mechanism of action is based on modulating benzodiazepine receptors. In addition to zopiclone's benzodiazepine pharmacological properties it also has some barbiturate like properties.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">985</field>
		<field name="drug_name">Tubocurarine</field>
		<field name="description">A neuromuscular blocker and active ingredient in curare; plant based alkaloid of Menispermaceae. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">986</field>
		<field name="drug_name">Bromocriptine</field>
		<field name="description">Bromocriptine mesylate is a semisynthetic ergot alkaloid derivative with potent dopaminergic activity. It is indicated for the management of signs and symptoms of Parkinsonian Syndrome. Bromocriptine also inhibits prolactin secretion and may be used to treat dysfunctions associated with hyperprolactinemia. It also causes sustained suppression of somatotropin (growth hormone) secretion in some patients with acromegaly. Bromocriptine has been associated with pulmonary fibrosis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">987</field>
		<field name="drug_name">Levetiracetam</field>
		<field name="description">Levetiracetam is an anticonvulsant medication used to treat epilepsy. Levetiracetam may selectively prevent hypersynchronization of epileptiform burst firing and propagation of seizure activity. Levetiracetam binds to the synaptic vesicle protein SV2A, which is thought to be involved in the regulation of vesicle exocytosis. Although the molecular significance of levetiracetam binding to synaptic vesicle protein SV2A is not understood, levetiracetam and related analogs showed a rank order of affinity for SV2A which correlated with the potency of their antiseizure activity in audiogenic seizure-prone mice.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">988</field>
		<field name="drug_name">Nadolol</field>
		<field name="description">A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for migraine disorders and for tremor. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">989</field>
		<field name="drug_name">Mitoxantrone</field>
		<field name="description">An anthracenedione-derived antineoplastic agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">990</field>
		<field name="drug_name">Flumazenil</field>
		<field name="description">Fumazenil is an imidazobenzodiazepine derivative and a potent benzodiazepine receptor antagonist that competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex, thereby reversing the effects of benzodiazepine on the central nervous system.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">991</field>
		<field name="drug_name">Lomustine</field>
		<field name="description">An alkylating agent of value against both hematologic malignancies and solid tumors. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">992</field>
		<field name="drug_name">Ridogrel</field>
		<field name="description">Ridogrel is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction. However, there currently are no clinical indications for preferential use of ridogrel over aspirin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">993</field>
		<field name="drug_name">Dezocine</field>
		<field name="description">Dezocine is a partial opiate drug and is used for pain management. Dezocine is a very effective alternative to fentanyl when administered during outpatient laparoscopy, although is associated with an increased incidence of postoperative nausea.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">994</field>
		<field name="drug_name">Levobunolol</field>
		<field name="description">A nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">995</field>
		<field name="drug_name">Fomepizole</field>
		<field name="description">Fomepizole is used as an antidote in confirmed or suspected methanol or ethylene glycol poisoning. Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">996</field>
		<field name="drug_name">Metipranolol</field>
		<field name="description">A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">997</field>
		<field name="drug_name">Estazolam</field>
		<field name="description">A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">998</field>
		<field name="drug_name">Finasteride</field>
		<field name="description">An orally active testosterone 5-alpha-reductase inhibitor. It is used as a surgical alternative for treatment of benign prostatic hyperplasia. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">999</field>
		<field name="drug_name">Anastrozole</field>
		<field name="description">Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. It is used both in adjuvant therapy (i.e. following surgery) and in metastatic breast cancer. It decreases the amount of estrogens that the body makes. Anastrozole belongs in the class of drugs known as aromatase inhibitors. It inhibits the enzyme aromatase, which is responsible for converting androgens (produced by women in the adrenal glands) to estrogens.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1000</field>
		<field name="drug_name">Dantrolene</field>
		<field name="description">Chemically, dantrolene is a hydantoin derivative, but does not exhibit antiepileptic activity like other hydantoin derivates such as phenytoin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1001</field>
		<field name="drug_name">Ketamine</field>
		<field name="description">A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (receptors, N-methyl-D-aspartate) and may interact with sigma receptors. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1002</field>
		<field name="drug_name">Budesonide</field>
		<field name="description">Budesonide is a glucocorticoid used in the management of asthma, the treatment of various skin disorders, and allergic rhinitis. [PubChem] The extended release oral tablet, marketed as Uceris, was FDA approved on January 14, 2013 for the management of ulcerative colitis. Budesonide is provided as a mixture of two epimers (22R and 22S). Interestingly, the 22R form is two times more active than the 22S epimer. The two forms do not interconvert.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1003</field>
		<field name="drug_name">Aminophylline</field>
		<field name="description">Aminophylline is a drug combination that contains theophylline and ethylenediamine in a 2:1 ratio. Once in the body, theophylline is released and acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Similar to other theophyllines, aminophylline is indicated for the treatment of lung diseases such as asthma, chronic bronchitis, and COPD. The majority of aminophylline medications are discontinued and the remaining medications on the market are in short supply.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1004</field>
		<field name="drug_name">Quetiapine</field>
		<field name="description">Quetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder. The antipsychotic effect of quetiapine is thought by some to be mediated through antagonist activity at dopamine and serotonin receptors. Specifically the D1 and D2 dopamine, the alpha 1 adrenoreceptor and alpha 2 adrenoreceptor, and 5-HT1A and 5-HT2 serotonin receptor subtypes are antagonized. Quetiapine also has an antagonistic effect on the histamine H1 receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1005</field>
		<field name="drug_name">Enoxaparin</field>
		<field name="description">Enoxaparin is a low molecular weight heparin. Enoxaparin is used to prevent and treat deep vein thrombosis or pulmonary embolism, and is given as a subcutaneous injection. Enoxaparin binds to and accelerates the activity of antithrombin III. By activating antithrombin III, enoxaparin preferentially potentiates the inhibition of coagulation factors Xa and IIa. Factor Xa catalyzes the conversion of prothrombin to thrombin, so enoxaparin's inhibition of this process results in decreased thrombin and ultimately the prevention of fibrin clot formation. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1006</field>
		<field name="drug_name">Mivacurium</field>
		<field name="description">Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1007</field>
		<field name="drug_name">Levomethadyl Acetate</field>
		<field name="description">A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1008</field>
		<field name="drug_name">Encainide</field>
		<field name="description">All drug products containing encainide hydrochloride. Encainide hydrochloride, formerly marketed as Enkaid capsules, was associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack. The manufacturer of Enkaid capsules voluntarily withdrew the product from the US market on December 16, 1991.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1009</field>
		<field name="drug_name">Paclitaxel</field>
		<field name="description">A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS brevifolia. It stabilizes microtubules in their polymerized form leading to cell death. [PubChem] ABI-007 (Abraxane) is the latest attempt to improve upon paclitaxel, one of the leading chemotherapy treatments. Both drugs contain the same active agent, but Abraxane is delivered by a nanoparticle technology that binds to albumin, a natural protein, rather than the toxic solvent known as Cremophor. It is thought that delivering paclitaxel with this technology will cause fewer hypersensitivity reactions and possibly lead to greater drug uptake in tumors.;Microtubule-Stabilizing Agents; Cytotoxic</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1010</field>
		<field name="drug_name">Pemoline</field>
		<field name="description">In 2005, the Food and Drug Administration (FDA) withdrew approval for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1011</field>
		<field name="drug_name">Diphenidol</field>
		<field name="description">Diphenidol is an antiemetic agent used in the treatment of vomiting and vertigo. Diphenidol overdose may result in serious toxicity in children.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1012</field>
		<field name="drug_name">Metoclopramide</field>
		<field name="description">A dopamine D2 antagonist that is used as an antiemetic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1013</field>
		<field name="drug_name">Dexamethasone</field>
		<field name="description">An anti-inflammatory 9-fluoro-glucocorticoid. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1014</field>
		<field name="drug_name">Levodopa</field>
		<field name="description">The naturally occurring form of dihydroxyphenylalanine and the immediate precursor of dopamine. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to dopamine. It is used for the treatment of parkinsonian disorders and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1015</field>
		<field name="drug_name">Sevoflurane</field>
		<field name="description">Sevoflurane (2,2,2-trifluoro-1-[trifluoromethyl]ethyl fluoromethyl ether), also called fluoromethyl, is a sweet-smelling, non-flammable, highly fluorinated methyl isopropyl ether used for induction and maintenance of general anesthesia. Together with desflurane, it is replacing isoflurane and halothane in modern anesthesiology. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1016</field>
		<field name="drug_name">Bromodiphenhydramine</field>
		<field name="description">Bromodiphenhydramine is an ethanolamine antihistamine with antimicrobial property. Bromodiphenhydramine is used in the control of cutaneous allergies. Ethanolamine antihistamines produce marked sedation in most patients</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1017</field>
		<field name="drug_name">Aripiprazole</field>
		<field name="description">Aripiprazole is an atypical antipsychotic medication used for the treatment of schizophrenia. It has also recently received FDA approval for the treatment of acute manic and mixed episodes associated with bipolar disorder. Aripiprazole appears to mediate its antipsychotic effects primarily by partial agonism at the D2 receptor. In addition to partial agonist activity at the D2 receptor, aripiprazole is also a partial agonist at the 5-HT1A receptor, and like the other atypical antipsychotics, aripiprazole displays an antagonist profile at the 5-HT2A receptor. Aripiprazole has moderate affinity for histamine and alpha adrenergic receptors, and no appreciable affinity for cholinergic muscarinic receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1018</field>
		<field name="drug_name">Chlorprothixene</field>
		<field name="description">Chlorprothixene is a typical antipsychotic drug of the thioxanthene (tricyclic) class. Chlorprothixene exerts strong blocking effects by blocking the 5-HT2 D1, D2, D3, histamine H1, muscarinic and alpha1 adrenergic receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1019</field>
		<field name="drug_name">Epoprostenol</field>
		<field name="description">A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1020</field>
		<field name="drug_name">Gemfibrozil</field>
		<field name="description">A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. These decreases occur primarily in the VLDL fraction and less frequently in the LDL fraction. Gemfibrozil increases HDL subfractions HDL2 and HDL3 as well as apolipoproteins A-I and A-II. Its mechanism of action has not been definitely established. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1021</field>
		<field name="drug_name">Clomipramine</field>
		<field name="description">Clomipramine, the 3-chloro analog of imipramine, is a dibenzazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, clomipramine does not affect mood or arousal, but may cause sedation. In depressed individuals, clomipramine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as clomipramine, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline and desipramine. TCAs also down-regulate cerebral cortical &amp;beta;-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H&lt;sub&gt;1&lt;/sub&gt; receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt;-adrenergic receptors and ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1022</field>
		<field name="drug_name">Chloroxine</field>
		<field name="description">Chloroxine is a synthetic antibacterial compound. Chloroxine is a compound used in some shampoos for the treatment of dandruff and seborrheic dermatitis of the scalp.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1023</field>
		<field name="drug_name">Bepridil</field>
		<field name="description">A long-acting, non selective, calcium channel blocker with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. [PubChem] It is no longer marketed in the United States, as it has been implicated in causing ventricular arrhythmias (ie. Torsade de pointes).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1024</field>
		<field name="drug_name">Decamethonium</field>
		<field name="description">Decamethonium is a short acting depolarizing muscle relaxant or neuromuscular blocking agent, and is used in anesthesia to induce paralysis. It is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1025</field>
		<field name="drug_name">Trimeprazine</field>
		<field name="description">A phenothiazine derivative that is used as an antipruritic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1026</field>
		<field name="drug_name">Isocarboxazid</field>
		<field name="description">An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1027</field>
		<field name="drug_name">Docetaxel</field>
		<field name="description">Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel binds to microtubules reversibly with high affinity and has a maximum stoichiometry of one mole docetaxel per mole tubulin in microtubules.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1028</field>
		<field name="drug_name">Iodixanol</field>
		<field name="description">Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1029</field>
		<field name="drug_name">Olsalazine</field>
		<field name="description">Olsalazine is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease and Ulcerative Colitis. Olsalazine is a derivative of salicylic acid. Inactive by itself (it is a prodrug), it is converted by the bacteria in the colon to mesalamine. Mesalamine works as an anti-inflammatory agent in treating inflammatory diseases of the intestines.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1030</field>
		<field name="drug_name">Gliquidone</field>
		<field name="description">Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is an ATP-dependent K+ (KATP) channel blocker. This block causes a depolarization which leads to activation of voltage-dependent Ca channels and Ca2+ influx, and eventually increases insulin release.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1031</field>
		<field name="drug_name">Mitiglinide</field>
		<field name="description">Mitiglinide is a drug for the treatment of type 2 diabetes .Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) (K(ATP)) channels in pancreatic beta-cells.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1032</field>
		<field name="drug_name">Ergonovine</field>
		<field name="description">An ergot alkaloid with uterine and vascular smooth muscle contractile properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1033</field>
		<field name="drug_name">Dasatinib</field>
		<field name="description">Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML). The main targets of Dasatinib, are BCRABL, SRC, Ephrins and GFR.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1034</field>
		<field name="drug_name">Lisdexamfetamine</field>
		<field name="description">Lisdexamfetamine (L-lysine-d-amphetamine) is a prodrug of the psychostimulant d-amphetamine coupled with the essential amino acid L-lysine. It was developed so that the amphetamine psychostimulant is released and activated more slowly as the prodrug molecule is hydrolyzed consequently cleaving off the amino acid-during the first pass through the intestines and/or the liver. Amphetamines target the trace amine-associated receptor 1 (TAAR1). Amphetamine is also believed to exert its effects by binding to the monoamine transporters (the dopamine transporter or DAT) and increasing extracellular levels of the biogenic amines dopamine, norepinephrine (noradrenaline) and serotonin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1035</field>
		<field name="drug_name">Eculizumab</field>
		<field name="description">Soliris is a formulation of eculizumab which is a recombinant humanized monoclonal IgG2/4;&amp;kappa; antibody produced by murine myeloma cell culture and purified by standard bioprocess technology. Eculizumab contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculizumab is composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1036</field>
		<field name="drug_name">Aliskiren</field>
		<field name="description">Aliskiren is a renin inhibitor. It was approved by the U.S. Food and Drug Administration in 2007 for the treatment of hypertension.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1037</field>
		<field name="drug_name">Lapatinib</field>
		<field name="description">Lapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.;EGFR and HER2 Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1038</field>
		<field name="drug_name">Desonide</field>
		<field name="description">A nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1039</field>
		<field name="drug_name">Sitagliptin</field>
		<field name="description">Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. This enzyme-inhibiting drug is to be used either alone or in combination with metformin or a thiazolidinedione for control of type 2 diabetes mellitus. The drug works to competitively inhibit a protein/enzyme, dipeptidyl peptidase 4 (DPP-4), that results in an increased amount of active incretins (GLP-1 and GIP), reduced amount of release of glucagon (diminishes its release) and increased release of insulin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1040</field>
		<field name="drug_name">Decitabine</field>
		<field name="description">Decitabine is indicated for treatment of patients with myelodysplastic syndrome (MDS). It is a chemical analogue of cytidine, a nucleoside present in DNA and RNA. Cells in the presence of Decitabine incorporate it into DNA during replication and RNA during transcription. The incorporation of Decitabine into DNA or RNA inhibits methyltransferase thereby causing demethylation in that sequence. This adversely affects the way that cell regulatory proteins are able to bind to the DNA/RNA substrate.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1041</field>
		<field name="drug_name">Kunecatechins</field>
		<field name="description">Kunecatechins is a partially purified fraction of the water extract of green tea leaves from Camellia sinensis (L.) O Kuntze. Kunecatechins are involved in the clearance of genital and perianal warts.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1042</field>
		<field name="drug_name">Paliperidone</field>
		<field name="description">Paliperidone is the primary active metabolite of the older antipsychotic risperidone. While its specific mechanism of action is unknown, it is believed that paliperidone and risperidone act via similar if not the same pathways. It has been proposed that the drug's therapeutic activity in schizophrenia is mediated through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism. Paliperidone is also active as an antagonist at alpha 1 and alpha 2 adrenergic receptors and H1 histaminergic receptors, which may explain some of the other effects of the drug. Paliperidone was approved by the FDA for treatment of schizophrenia on December 20, 2006.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1043</field>
		<field name="drug_name">Sunitinib</field>
		<field name="description">Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib inhibits cellular signaling by targeting multiple RTKs. These include all platelet-derived growth factor receptors (PDGF-R) and vascular endothelial growth factor receptors (VEGF-R). Sunitinib also inhibits KIT (CD117), the RTK that drives the majority of GISTs. In addition, sunitinib inhibits other RTKs including RET, CSF-1R, and flt3.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1044</field>
		<field name="drug_name">Panitumumab</field>
		<field name="description">Panitumumab (ABX-EGF) is a recombinant human IgG2 monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). This drug is an antineoplastic agent.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1045</field>
		<field name="drug_name">Ranibizumab</field>
		<field name="description">Ranibizumab is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli expression system in a nutrient medium containing the antibiotic tetracycline (tetracycline is not detectable in the final product). Ranibizumab is marketed under the name Lucentis®. It is indicated for the treatment of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1046</field>
		<field name="drug_name">Idursulfase</field>
		<field name="description">Idursulfase is a purified form of human iduronate-2-sulfatase, a lysosomal enzyme. Idursulfase is produced by recombinant DNA technology in a human cell line. Idursulfase is an enzyme that hydrolyzes the 2-sulfate esters of terminal iduronate sulfate residues from the glycosaminoglycans dermatan sulfate and heparan sulfate in the lysosomes of various cell types. Idursulfase is a 525-amino acid glycoprotein with a molecular weight of approximately 76 kilodaltons. The enzyme contains eight asparagine-linked glycosylation sites occupied by complex oligosaccharide structures. The enzyme activity of idursulfase is dependent on the post-translational modification of a specific cysteine to formylglycine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1047</field>
		<field name="drug_name">Alglucosidase alfa</field>
		<field name="description">Alglucosidase alfa consists of the human enzyme acid a-glucosidase (GAA), encoded by the most predominant of nine observed haplotypes of this gene. Alglucosidase alfa is produced by recombinant DNA technology in a Chinese hamster ovary cell line. Alglucosidase alfa degrades glycogen by catalyzing the hydrolysis of a-1,4- and a-1,6- glycosidic linkages of lysosomal glycogen.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1048</field>
		<field name="drug_name">Varenicline</field>
		<field name="description">Varenicline is a prescription medication used to treat smoking addiction. This medication is the first approved nicotinic receptor partial agonist. Specifically, varenicline is a partial agonist of the alpha4/beta2 subtype of the nicotinic acetylcholine receptor. In addition it acts on alpha3/beta4 and weakly on alpha3beta2 and alpha6-containing receptors. A full agonism was displayed on alpha7-receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1049</field>
		<field name="drug_name">Arformoterol</field>
		<field name="description">Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. The use of arformoterol is pending revision due to safety concerns in regards to an increased risk of severe exacerbation of asthma symptoms, leading to hospitalization as well as death in some patients using long acting beta agonists for the treatment of asthma.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1050</field>
		<field name="drug_name">Hydralazine</field>
		<field name="description">A direct-acting vasodilator that is used as an antihypertensive agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1051</field>
		<field name="drug_name">Exenatide</field>
		<field name="description">Exenatide, derived from a compound found in the saliva of the Gila monster, a large lizard native to the southwestern US, is a functional analog of Glucagon-Like Peptide-1 (GLP-1), a naturally occuring peptide.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1052</field>
		<field name="drug_name">Mecasermin</field>
		<field name="description">Mecasermin contains recombinant-DNA-engineered human insulin-like growth factor-1 (rhIGF-1). IGF-1 consists of 70 amino acids in a single chain with three intramolecular disulfide bridges and a molecular weight of 7649 daltons. The amino acid sequence of the product is identical to that of endogenous human IGF-1. The rhIGF-1 protein is synthesized in bacteria (E. coli) that have been modified by the addition of the gene for human IGF-1.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1053</field>
		<field name="drug_name">Pramlintide</field>
		<field name="description">Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. It is derived from amylin, a hormone that is released into the bloodstream, in a similar pattern as insulin, after a meal. Like insulin, amylin is deficient in individuals with diabetes.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1054</field>
		<field name="drug_name">Galsulfase</field>
		<field name="description">Galsufase is a variant form of the polymorphic human enzyme N-acetylgalactosamine 4-sulfatase of recombinant DNA origin. Galsulfase is a glycoprotein with a molecular weight of approximately 56 kD. The recombinant protein is comprised of 495 amino acids and contains six asparagine-linked glycosylation sites, four of which carry a bis mannose-6-phosphate manose7 oligosaccharide for specific cellular recognition. Post-translational modification of Cys53 produces the catalytic amino acid residue Ca-formylglycine, which is required for enzyme activity and is conserved in all members of the sulfatase enzyme family.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1055</field>
		<field name="drug_name">Nelarabine</field>
		<field name="description">Nelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. Nelarabine is a purine nucleoside analog converted to its corresponding arabinosylguanine nucleotide triphosphate (araGTP), resulting in inhibition of DNA synthesis and cytotoxicity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1056</field>
		<field name="drug_name">Abatacept</field>
		<field name="description">Abatacept is a soluble fusion protein, which links the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1). It is produced through recombinant DNA technology in mammalian cells. The drug has activity as a selective costimulation modulator with inhibitory activity on T lymphocytes. Although approved for the treatment of rheumatoid arthritis, Repligen has entered a slightly different formulation of CTLA4-Ig into clinical trials (RG2077).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1057</field>
		<field name="drug_name">Carbetocin</field>
		<field name="description">Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1058</field>
		<field name="drug_name">Lumiracoxib</field>
		<field name="description">Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug. On August 11, 2007, Australia's Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver failure. New Zealand and Canada have also followed suit in recalling the drug.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1059</field>
		<field name="drug_name">Cosyntropin</field>
		<field name="description">A synthetic peptide that is identical to the 24-amino acid segment at the N-terminal of adrenocorticotropic hormone. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1060</field>
		<field name="drug_name">Corticotropin</field>
		<field name="description">Corticotropin (ACTH or adrenocorticotropic hormone) is a polypeptide hormone produced and secreted by the pituitary gland. It is an important player in the hypothalamic-pituitary-adrenal axis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1061</field>
		<field name="drug_name">Dihydroergotoxine</field>
		<field name="description">Dihydroergotoxine is a cerebral vasodilator. Dihydroergotoxine is a mixture of three different ergotamantriones: dihydroergocornine, dihydroergocristine, and dihydroergocryptine. It has been proposed to be a neuroprotective agent. The mechanism of its therapeutic actions is not clear.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1062</field>
		<field name="drug_name">Fenoterol</field>
		<field name="description">An adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1063</field>
		<field name="drug_name">Glisoxepide</field>
		<field name="description">Glisoxepide is one of the sulphonamide-derived oral antidiabetic drugs. It inhibits the uptake of bile acids into isolated rat hepatocytes. However it inhibits taurocholate uptake only in the absence of sodium ions. Glisoxepide uptake could be further inhibited by blockers of the hepatocellular monocarboxylate transporter, by the loop diuretic bumetanide, by 4,4'-diisothiocyano-2,2'-stilbenedisulfonate (DIDS) and by sulphate.  These results are consistent with the transport of glisoxepide via the transport system for the unconjugated bile acid cholate.  (PMID:1618280, 9017793)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1064</field>
		<field name="drug_name">Pirbuterol</field>
		<field name="description">Pirbuterol is a beta-2 adrenergic bronchodilator. In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 Adrenergic receptors compared with isoproterenol. While it is recognized that beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10-50%. The precise function of these receptors has not been established.    The pharmacologic effects of beta adrenergic agonist drugs, including pirbuterol, are at least in proof attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (AlP) to cyclic-3† ,5†-adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivit...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1065</field>
		<field name="drug_name">Bismuth Subsalicylate</field>
		<field name="description">Bismuth subsalicylate is the active ingredient in the popular medication Pepto-Bismol that is used to treat nausea, heartburn, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract. It is also the main ingredient of Kaopectate. It displays anti-inflammatory action (due to salicylic acid) and also acts as an antacid and mild antibiotic.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1066</field>
		<field name="drug_name">Bevantolol</field>
		<field name="description">Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension. Mechanism of Action Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1067</field>
		<field name="drug_name">Glucosamine</field>
		<field name="description">Glucosamine is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies. It is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1068</field>
		<field name="drug_name">Practolol</field>
		<field name="description">A beta-adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1069</field>
		<field name="drug_name">Sulfadoxine</field>
		<field name="description">A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1070</field>
		<field name="drug_name">Rolitetracycline</field>
		<field name="description">A pyrrolidinylmethyl tetracycline. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1071</field>
		<field name="drug_name">Oxtriphylline</field>
		<field name="description">Oxtriphylline is the choline salt form of theophylline. Once in the body, theophylline is released and acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Its main physiological reponse is to dilate the bronchioles. As such, oxytriphylline is indicated mainly for asthma, bronchospasm, and COPD (i.e. all the same indications as the other theophyllines). It is marketed under the name Choledyl SA, and several forms of oxytriphylline have been discontinued. In the US, oxtriphylline is no longer available.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1072</field>
		<field name="drug_name">Insulin Aspart</field>
		<field name="description">Insulin aspart is a recombinant, biosynthetic, fast-acting insulin analogue. It has a single amino acid substitution at position B28 where proline is replaced with aspartic acid. This substitution decreases its propensity to form hexamers and gives it a higher rate of absorption following subcutaneous administration compared to native insulin. Insulin aspart is produced in a genetically modified strain of _Saccharomyces cerevisiae_ and harvested from a bioreactor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1073</field>
		<field name="drug_name">Insulin Detemir</field>
		<field name="description">Insulin detemir is a long-acting human insulin analogue used to maintain basal levels of insulin in diabetic individuals. It is produced using recombinant DNA technology in yeast cells. This insulin analogue has a 14-C fatty acid, myristic acid, bound to the lysine amino acid at position B29. The myristoyl side chain increases self-association and albumin binding. This along with slow systemic absorption from the injection site prolongs distribution of the hormone into tissues and results in a long duration of action. Novo Nordisk markets insulin detemir under the trade name Levemir.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1074</field>
		<field name="drug_name">Insulin Glulisine</field>
		<field name="description">Insulin glulisine is a biosynthetic, rapid-acting human insulin analogue produced in a non-pathogenic laboratory strain of _Escherichia coli_ (K12). This recombinant hormone differs from native human insulin in that the amino acid arginine at position B3 is replaced by lysine and the lysine at position B29 is replaced by glutamic acid. These structural modifications decrease hexamer formation, stabilize insulin glulisine monomers and increase the rate of absorption and onset of action compared to human insulin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1075</field>
		<field name="drug_name">Fosphenytoin</field>
		<field name="description">Fosphenytoin is a water-soluble phenytoin prodrug used only in hospitals for the treatment of epileptic seizures. It works by slowing down impulses in the brain that cause seizures. Its main mechanism is to block frequency-dependent, use-dependent and voltage-dependent neuronal sodium channels, and therefore limit repetitive firing of action potentials.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1076</field>
		<field name="drug_name">Kava</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1077</field>
		<field name="drug_name">St. John's Wort</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1078</field>
		<field name="drug_name">Polythiazide</field>
		<field name="description">A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p826)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1079</field>
		<field name="drug_name">Quinethazone</field>
		<field name="description">Quinethazone (INN, brand name Hydromox) is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1080</field>
		<field name="drug_name">Cefradine</field>
		<field name="description">A semi-synthetic cephalosporin antibiotic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1081</field>
		<field name="drug_name">Metocurine</field>
		<field name="description">Dimethyltubocurarinium (INN) or metocurine (USAN), also known as dimethyltubocurarine, is a non-depolarizing muscle relaxant. Patients on chronic anticonvulsant drugs are relatively resistant to metocurine.(PMID: 9915319)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1082</field>
		<field name="drug_name">Pancuronium</field>
		<field name="description">A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than curare but has less effect on the circulatory system and on histamine release.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1083</field>
		<field name="drug_name">Pipecuronium</field>
		<field name="description">Pipecuronium is a piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1084</field>
		<field name="drug_name">Vecuronium</field>
		<field name="description">Monoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1085</field>
		<field name="drug_name">Cilazapril</field>
		<field name="description">One of the angiotensin-converting enzyme inhibitors (ACE inhibitors) used for hypertension.  It is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1086</field>
		<field name="drug_name">Dihydroquinidine barbiturate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1087</field>
		<field name="drug_name">Forasartan</field>
		<field name="description">Forasartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. Forasartan competes with angiotensin II for binding at the AT1 receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1088</field>
		<field name="drug_name">Polystyrene sulfonate</field>
		<field name="description">Sodium polystyrene sulfonate is a medication used to treat abnormally high potassium levels. It may be taken orally or by rectum, as an enema, and functions as a potassium-binding resin in the intestines. It is also an effective topical microbicide and spermicide, inhibiting the genital transfection of, among others, HIV. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1089</field>
		<field name="drug_name">Potassium</field>
		<field name="description">Potassium is the major cation (positive ion) inside animal cells, while sodium is the major cation outside animal cells. The concentration differences of these charged particles causes a difference in electric potential between the inside and outside of cells, known as the membrane potential. The balance between potassium and sodium is maintained by ion pumps in the cell membrane. The cell membrane potential created by potassium and sodium ions allows the cell generate an action potential—a &quot;spike&quot; of electrical discharge. The ability of cells to produce electrical discharge is critical for body functions such as neurotransmission, muscle contraction, and heart function. Potassium is also an essential mineral needed to regulate water balance, blood pressure and levels of acidity.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1090</field>
		<field name="drug_name">Quinidine barbiturate</field>
		<field name="description">The administration of quinidine derivatives helps to observe various skin and mucosal reactions. A papulopurpuric eruption in a  patient (without thrombopenia) can be developed who is taking quinidine phenylethyl barbiturate intermittently and at reintroduction.(PMID: 9739909)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1091</field>
		<field name="drug_name">Saprisartan</field>
		<field name="description">Saprisartan is an AT1 receptor antagonist. It is based on medications of losartan's prototypical chemical structure. The mode of (functional) AT1 receptor antagonism has been characterized as insurmountable/noncompetitive for saprisartan.  It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism.(10579749)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1092</field>
		<field name="drug_name">Spirapril</field>
		<field name="description">Spirapril is an ACE inhibitor antihypertensive drug used to treat hypertension. Like many ACE inhibitors, this is a prodrug which is converted to the active metabolite spiraprilat following oral administration. ACE inhibitors are used primarily in treatment of hypertension and congestive heart failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1093</field>
		<field name="drug_name">Tasosartan</field>
		<field name="description">Tasosartan is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertension</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1094</field>
		<field name="drug_name">Amobarbital</field>
		<field name="description">A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1095</field>
		<field name="drug_name">Aprobarbital</field>
		<field name="description">Aprobarbital is a barbiturate derivative synthesized in the 1920s by Ernst Preiswerk. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia. Aprobarbital was never as widely used as more common barbiturate derivatives such as phenobarbital and is now rarely prescribed.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1096</field>
		<field name="drug_name">Butethal</field>
		<field name="description">Butethal is a sedative and a hypnotic drug.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1097</field>
		<field name="drug_name">Heptabarbital</field>
		<field name="description">Heptabarbital is an intermediate or short term barbiturate used mainly for sedation and hypnosis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1098</field>
		<field name="drug_name">Hexobarbital</field>
		<field name="description">A barbiturate that is effective as a hypnotic and sedative. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1099</field>
		<field name="drug_name">Lithium</field>
		<field name="description">Lithium was used during the 19th century to treat gout. Lithium salts such as lithium carbonate (Li2CO3), lithium citrate, and lithium orotate are mood stabilizers. They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they counteract both mania and depression. Lithium can also be used to augment other antidepressant drugs. It is also sometimes prescribed as a preventive treatment for migraine disease and cluster headaches. The active principle in these salts is the lithium ion Li+, which having a smaller diameter, can easily displace K+ and Na+ and even Ca+2, in spite of its greater charge, occupying their sites in several critical neuronal enzymes and neurotransmitter receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1100</field>
		<field name="drug_name">Mestranol</field>
		<field name="description">The 3-methyl ether of ethinyl estradiol. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL contraceptives. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1101</field>
		<field name="drug_name">Penbutolol</field>
		<field name="description">Penbutolol is a drug in the beta-blocker class used to treat hypertension. Penbutolol binds both beta-1 and beta-2 adrenergic receptors, rendering it a non-selective beta-blocker. Penbutolol can act as a partial agonist at beta adrenergic receptors, since it is a sympathomimetric drug. Penbutolol also demonstrates high binding affinity to the 5-hydroxytryptamine receptor 1A with antagonistic effects. This binding characteristic of penbutolol is being investigated for its implications in Antidepressant Therapy. Penbutolol is contraindicated in patients with cardiogenic shock, sinus bradycardia, second and third degree atrioventricular conduction block, bronchial asthma, and those with known hypersensitivity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1102</field>
		<field name="drug_name">Iohexol</field>
		<field name="description">Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1103</field>
		<field name="drug_name">Ephedra</field>
		<field name="description">Ephedra is an alkaloid chemical compound traditionally obtained from the plant &lt;i&gt;Ephedra sinica&lt;/i&gt;. The sale of ephedra-containing supplements was banned in the United States in 2004. The drug is still sold in Canada in OTC formulations.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1104</field>
		<field name="drug_name">Ephedrine</field>
		<field name="description">An alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1105</field>
		<field name="drug_name">Mephentermine</field>
		<field name="description">A sympathomimetic agent with mainly indirect effects on adrenergic receptors. It is used to maintain blood pressure in hypotensive states, for example, following spinal anesthesia. Although the central stimulant effects of mephentermine are much less than those of amphetamine, its use may lead to amphetamine-type dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1248)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1106</field>
		<field name="drug_name">Procaterol</field>
		<field name="description">A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1107</field>
		<field name="drug_name">Rasagiline</field>
		<field name="description">Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1108</field>
		<field name="drug_name">Aluminium</field>
		<field name="description">A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1109</field>
		<field name="drug_name">Calcium</field>
		<field name="description">Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. The skeleton acts as a major mineral storage site for the element and releases Ca2+ ions into the bloodstream under controlled conditions. Circulating calcium is either in the free, ionized form or bound to blood proteins such as serum albumin. Although calcium flow to and from the bone is neutral, about 5 mmol is turned over a day. Bone serves as an important storage point for calcium, as it contains 99% of the total body calcium.  Low calcium intake may also be a risk factor in the development of osteoporosis.  The best-absorbed form of calcium from a pill is a calcium salt like carbonate or phosphate. Calcium gluconate and calcium lactate are absorbed well by pregnant women. Seniors absorb calcium lactate, gluconate and citrate better unless they take their calcium supplement with a full breakfast.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1110</field>
		<field name="drug_name">Dihydroxyaluminium</field>
		<field name="description">Aluminium monostearate is an organic compound which is a salt of stearic acid and aluminium. It has the molecular formula Al(OH)2C18H35O2. It is also referred to as dihydroxyaluminium or dihydroxy(stearato)aluminium.    It is used to form gels in the packaging of pharmaceuticals, and in the preparation of colors for cosmetics. It is usually safe in commercial products, but aluminium may accumulate in the body.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1111</field>
		<field name="drug_name">Magnesium oxide</field>
		<field name="description">Magnesium oxide is an inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1112</field>
		<field name="drug_name">Magnesium</field>
		<field name="description">Magnesium hydroxide is used primarily in &quot;Milk of Magnesia&quot;, a white aqueous, mildly alkaline suspension of magnesium hydroxide formulated at about 8%w/v. Milk of magnesia is primarily used to alleviate constipation, but can also be used to relieve indigestion and heartburn. When taken internally by mouth as a laxative, the osmotic force of the magnesia suspension acts to draw fluids from the body and to retain those already within the lumen of the intestine, serving to distend the bowel, thus stimulating nerves within the colon wall, inducing peristalsis and resulting in evacuation of colonic contents.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1113</field>
		<field name="drug_name">Cortisone acetate</field>
		<field name="description">Cortisone acetate is a steroid hormone that has both glucocoriticoid and mineral corticoid activities. Corticosteroids are used to provide relief for inflamed areas of the body. They lessen swelling, redness, itching, and allergic reactions. They are often used as part of the treatment for a number of different diseases, such as severe allergies or skin problems, asthma, or arthritis. Endogenous glucocorticoids and some synthetic corticoids have high affinity to the protein transcortin (also called CBG, corticosteroid-binding protein), whereas all of them bind albumin. Glucocorticoids also bind to the cytosolic glucocorticoid receptor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1114</field>
		<field name="drug_name">Ginkgo biloba</field>
		<field name="description">The extract of the Ginkgo leaves contains flavonoid glycosides and terpenoids (ginkgolides, bilobalides) and has been used pharmaceutically for hundreds of years. It has many alleged nootropic properties, and is mainly used as memory and concentration enhancer, and anti-vertigo agent. Ginkgo extract seems to have three effects on the human body: it improves blood flow (including microcirculation in small capillaries) to most tissues and organs; it protects against oxidative cell damage from free radicals; and it blocks many of the effects of PAF (platelet aggregation, blood clotting) that have been related to the development of a number of cardiovascular, renal, respiratory and CNS (Central Nervous System) disorders.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1115</field>
		<field name="drug_name">Glycodiazine</field>
		<field name="description">Glycodiazine is used with diet to lower blood glucose by increasing the secretion of insulin from pancreas and increasing the sensitivity of peripheral tissues to insulin. The mechanism of action of glycodiazine in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glycodiazine likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. It is used for the concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1116</field>
		<field name="drug_name">Paramethasone</field>
		<field name="description">A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than hydrocortisone with supplementary fludrocortisone. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1117</field>
		<field name="drug_name">Mibefradil</field>
		<field name="description">Mibefradil was withdrawn from the market in 1998 because of potentially harmful interactions with other drugs.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1118</field>
		<field name="drug_name">Sodium bicarbonate</field>
		<field name="description">Sodium bicarbonate is a white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1119</field>
		<field name="drug_name">Yohimbine</field>
		<field name="description">A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1120</field>
		<field name="drug_name">Bezafibrate</field>
		<field name="description">Antilipemic agent that lowers cholesterol and triglycerides. It decreases low density lipoproteins and increases high density lipoproteins. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1121</field>
		<field name="drug_name">Colchicine</field>
		<field name="description">A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (periodic disease). [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1122</field>
		<field name="drug_name">Drospirenone</field>
		<field name="description">Drospirenone is a synthetic progestin that is an analog to spironolactone. It is found in a number of birth control formulations. Drospirenone differs from other synthetic progestins in that its pharmacological profile in preclinical studies shows it to be closer to the natural progesterone. As such it has anti-mineralocorticoid properties, counteracts the estrogen-stimulated activity of the renin-angiotensin-aldosterone system, and is not androgenic. It was shown in animal studies that drospirenone exhibits antiandrogenic activity judging from accessory sex gland growth in castrated, androgen-treated, juvenile rats.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1123</field>
		<field name="drug_name">Digitoxin</field>
		<field name="description">A cardiac glycoside sometimes used in place of digoxin. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1124</field>
		<field name="drug_name">Magnesium salicylate</field>
		<field name="description">Magnesium salicylate is a common analgesic and non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate muscular pain. It is also used to treat headaches, general back pain, and certain joint pains like arthritis.    It is found in a variety of over-the-counter (OTC) medications as an anti-inflammatory, primarily for back-pain relief. Magnesium Salicylate can be an effective OTC alternative to prescription NSAIDs, with both anti-inflamatory and pain-relieving effects.    Though the recommended doseage is 1160 mg every six hours, per package directions of the Doan's OTC brand (580 mg magnesium salicylate tetrahydrate, equivalent to 934.4 mg anhydrous magnesium salicylate), effective pain relief is often found with a half dosage, with reduced anti-inflammatory results.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1125</field>
		<field name="drug_name">Salicylate-sodium</field>
		<field name="description">Sodium salicylate is a sodium salt of salicylic acid. It can be prepared from sodium phenolate and carbon dioxide under higher temperature and pressure.    It is used in medicine as an analgesic and antipyretic. Sodium salicylate also acts as non-steroidal anti-inflammatory drug (NSAID) and induces apoptosis in cancer cells. It is also potential replacement for aspirin for people sensitive to it.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1126</field>
		<field name="drug_name">Salsalate</field>
		<field name="description">Salsalate is a nonsteroidal anti-inflammatory agent for oral administration. Salsalate's mode of action as an anti-inflammatory and antirheumatic agent may be due to inhibition of synthesis and release of prostaglandins. The usefulness of salicylic acid, the active in vivo product of salsalate, in the treatment of arthritic disorders has been established. In contrast to aspirin, salsalate causes no greater fecal gastrointestinal blood loss than placebo. Salsalate is readily soluble in the small intestine where it is partially hydrolyzed to two molecules of salicylic acid. A significant portion of the parent compound is absorbed unchanged and undergoes rapid esterase hydrolysis in the body. The parent compound has an elimination half-life of about 1 hour. Salicylic acid (the active metabolite) biotransformation is saturated at anti-inflammatory doses of salsalate. Such capacity limited biotransformation results in an increase in the half-life of salicylic acid from 3.5 to 16 or more hou...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1127</field>
		<field name="drug_name">Neostigmine</field>
		<field name="description">A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1128</field>
		<field name="drug_name">Trisalicylate-choline</field>
		<field name="description">Choline magnesium trisalicylate is a non-acetylated salicylate used widely as a nonsteroidal anti-inflammatory drug. Trisalicylate significantly reduces methotrexate renal clearance, displacing methotrexate from protein, increasing the fraction unbound by 28%.(PMID: 1728115, 1618240)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1129</field>
		<field name="drug_name">Methotrimeprazine</field>
		<field name="description">A phenothiazine with pharmacological activity similar to that of both chlorpromazine and promethazine. It has the histamine-antagonist properties of the antihistamines together with central nervous system effects resembling those of chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1130</field>
		<field name="drug_name">Ginseng</field>
		<field name="description">Ginseng is promoted as an adaptogen (a product that increases the body's resistance to stress), one which can to a certain extent be supported with reference to its anticarcinogenic and antioxidant properties. Ginseng is also known to contain phytoestrogens.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1131</field>
		<field name="drug_name">Danazol</field>
		<field name="description">A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1132</field>
		<field name="drug_name">Clenbuterol</field>
		<field name="description">A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1133</field>
		<field name="drug_name">Bambuterol</field>
		<field name="description">Bambuterol is a long acting beta-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1134</field>
		<field name="drug_name">Tiotropium</field>
		<field name="description">Tiotropium is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropium is a muscarinic receptor antagonist, on topical application it acts mainly on M3 muscarinic receptors located in the airways to produce smooth muscle relaxation, thus producing a bronchodilatory effect.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1135</field>
		<field name="drug_name">Ciclesonide</field>
		<field name="description">Ciclesonide is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1136</field>
		<field name="drug_name">Pranlukast</field>
		<field name="description">Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1137</field>
		<field name="drug_name">Theobromine</field>
		<field name="description">3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than theophylline and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1138</field>
		<field name="drug_name">Acenocoumarol</field>
		<field name="description">Acenocoumarol is a coumarin derivative used as an anticoagulant. Coumarin derivatives inhibit the reduction of vitamin K by vitamin K reductase. This prevents carboxylation of vitamin K-dependent clotting factors, II, VII, XI and X, and interferes with coagulation. Hematocrit, hemoglobin, international normalized ratio and liver panel should be monitored. Patients on acenocoumarol are prohibited from giving blood.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1139</field>
		<field name="drug_name">Antrafenine</field>
		<field name="description">Antrafenine is a piperazine derivative drug that acts as an analgesic and anti-inflammatory drug with similar efficacy to naproxen. It is not widely used as it has largely been replaced by newer drugs.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1140</field>
		<field name="drug_name">Testosterone Propionate</field>
		<field name="description">An ester of testosterone with a propionate substitution at the 17-beta position. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1141</field>
		<field name="drug_name">Nitroxoline</field>
		<field name="description">Nitroxoline is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections. It is a fluorquinolone that is active against bacterial gyrases.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1142</field>
		<field name="drug_name">Stepronin</field>
		<field name="description">Strepronin is a mucolytic drug. A mucolytic agent is any agent which dissolves thick mucus usually used to help relieve respiratory difficulties. The viscosity of mucous secretions in the lungs is dependent upon the concentrations of mucoprotein as well as the presence of disulfide bonds between these macromolecules and DNA.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1143</field>
		<field name="drug_name">Aminophenazone</field>
		<field name="description">A pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of cytochrome P-450 metabolic activity in liver function tests. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1144</field>
		<field name="drug_name">Alizapride</field>
		<field name="description">Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1145</field>
		<field name="drug_name">Ajmaline</field>
		<field name="description">An alkaloid found in the root of Rauwolfia serpentina, among other plant sources. It is a class Ia antiarrhythmic agent that apparently acts by changing the shape and threshold of cardiac action potentials. Ajmaline produces potent sodium channel blocking effects and a very short half-life which makes it a very useful drug for acute intravenous treatments. The drug has been very popular in some countries for the treatment of atrial fibrillation in patients with the Wolff–Parkinson–White syndrome and in well tolerated monomorphic ventricular tachycardias. It has also been used for many years as a drug to challenge the conduction system of the heart in cases of bundle branch block and syncope. In these cases, abnormal prolongation of the HV interval has been taken as a proof for infrahisian conduction defects tributary for permanent pacemaker implantation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1146</field>
		<field name="drug_name">Amrinone</field>
		<field name="description">Amrinone (or inamrinone) is a type 3 pyridine phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1147</field>
		<field name="drug_name">Oxybenzone</field>
		<field name="description">Oxybenzone is an organic compound used in sunscreens. It is a derivative of benzophenone. It forms colorless crystals that are readily soluble in most organic solvents. It is used as an ingredient in sunscreen and other cosmetics because it absorbs UV-A ultraviolet rays.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1148</field>
		<field name="drug_name">Aprindine</field>
		<field name="description">A cardiac depressant used in arrhythmias. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1149</field>
		<field name="drug_name">Almitrine</field>
		<field name="description">A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1150</field>
		<field name="drug_name">Allylestrenol</field>
		<field name="description">A synthetic steroid with progestational activity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1151</field>
		<field name="drug_name">Cholestyramine</field>
		<field name="description">Cholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Cholestyramine resin is quite hydrophilic, but insoluble in water.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1152</field>
		<field name="drug_name">Methadyl Acetate</field>
		<field name="description">A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1153</field>
		<field name="drug_name">19-norandrostenedione</field>
		<field name="description">19-Norandrostenedione refers to two steroid isomers that were once marketed as dietary supplements and mainly used by body builders. After 2005, 19-Norandrostenedione was regulated in the United States as a schedule III controlled substance, as well as banned from use in competitive sports by the World Anti-Doping Agency.      In the body 19-norandrostenedione is rapidly metabolized into nandrolone, also known as nortestosterone.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1154</field>
		<field name="drug_name">Antipyrine</field>
		<field name="description">An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1155</field>
		<field name="drug_name">Alfacalcidol</field>
		<field name="description">Alfacalcidol is an active metabolite of Vitamin D, which performs important functions in regulation of the calcium balance and the bone metabolism. Alfacalcidol is Vitamin D-hormone analog which is activated by the enzyme 25-hydroxylase in the liver for systemic and in osteoblasts for local D-hormone actions. It possesses a unique pattern of pleiotropic effects on, e.g. gut, bone, pararthyroids, muscle and brain. Alfacalcidol is superior to plain vitamin D (cholecalciferol) because the final kidney activation of the latter is regulated by a negative feedback mechanism. (PMID:17438884,17668216)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1156</field>
		<field name="drug_name">Glutethimide</field>
		<field name="description">A hypnotic and sedative. Its use has been largely superseded by other drugs. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1157</field>
		<field name="drug_name">Phenazopyridine</field>
		<field name="description">A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1158</field>
		<field name="drug_name">3-Methylthiofentanyl</field>
		<field name="description">3-Methyl-thiofentanyl is an opioid analgesic that is an analogue of fentanyl.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1159</field>
		<field name="drug_name">Gamma Hydroxybutyric Acid</field>
		<field name="description">Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries. It is currently regulated in the US and sold by Jazz Pharmaceuticals under the name Xyrem. However, it is important to note that GHB is a designated Orphan drug (in 1985). Today Xyrem is a Schedule III drug;  however GHB remains a Schedule I drug and the illicit use of Xyrem falls under penalties of Schedule I. GHB is a naturally occurring substance found in the central nervous system, wine, beef, small citrus fruits and almost all other living creatures in small amounts. It is used illegally under the street names Juice, Liquid Ecstasy or simply G, either as an intoxicant, or as a date rape drug. Xyrem is a central nervous system depressant that reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1160</field>
		<field name="drug_name">5-Methoxy-N,N-diisopropyltryptamine</field>
		<field name="description">5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a tryptamine derivative and shares many similarities with schedule I tryptamine hallucinogens such as alpha-ethyltryptamine, N,N-dimethyltryptamine, N,N-diethyltryptamine, bufotenine, psilocybin and psilocin. Since 1999, there has been a growing popularity of 5-MeO-DIPT among drug abusers. This substance is abused for its hallucinogenic effects.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1161</field>
		<field name="drug_name">MMDA</field>
		<field name="description">MMDA, or 3-methoxy-4,5-methylenedioxyamphetamine, is a stimulant and psychedelic drug of the amphetamine class. It also acts as an entheogen and an entactogen. MMDA bears resemblance to the psychopharmacologically active essential oils elemicin and myristicin found in nutmeg. The effects of MMDA includes feelings of euphoria and warmth, as well as realistic closed-eye visuals.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1162</field>
		<field name="drug_name">19-Nor-5-androstenedione</field>
		<field name="description">19-Nor-5-andorstenedione is a prohormone which has the potential to affect bodily levels of testosterone once metabolized in vivo. It is regulated in the United States as a schedule III controlled substance, and prohibited by the World Anti-Doping Agency for use in competitive sports.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1163</field>
		<field name="drug_name">Dimethylthiambutene</field>
		<field name="description">Dimethylthiambutene (N,N-Dimethyl-1-methyl-3,3-di-2-thienylallylamine, Dimethibutin, Ohton) is an opioid analgesic drug. It is now under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential, although little more information is available.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1164</field>
		<field name="drug_name">Bufotenine</field>
		<field name="description">A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1165</field>
		<field name="drug_name">Alpha-methyltryptamine</field>
		<field name="description">A stimulant and psychoactive drug which produces effects similar to 3,4-methylenedioxy-N-methylamphetamine (MDMA), despite being structurally dissimilar.   It was developed in the 1960's by Upjohn with the intention for use as an antidepressant. In the 1990's, alpha-methyltryptamine became regulated as a Schedule I controlled substance in the United states.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1166</field>
		<field name="drug_name">4-Methylaminorex</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1167</field>
		<field name="drug_name">19-Nor-4-androstenedione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1168</field>
		<field name="drug_name">Dihydroetorphine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1169</field>
		<field name="drug_name">1-Androstenedione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1170</field>
		<field name="drug_name">Heroin</field>
		<field name="description">A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Internationally, heroin is controlled under Schedules I and IV of the Single Convention on Narcotic Drugs. It is illegal to manufacture, possess, or sell heroin in the United States and the UK. However, under the name diamorphine, heroin is a legal prescription drug in the United Kingdom.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1171</field>
		<field name="drug_name">Beta-hydroxyfentanyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1172</field>
		<field name="drug_name">3,4-Methylenedioxymethamphetamine</field>
		<field name="description">An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1173</field>
		<field name="drug_name">19-Nor-5-androstenediol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1174</field>
		<field name="drug_name">5-androstenedione</field>
		<field name="description">5-androstenedione is a prohormone of testosterone. In the United States, the Controlled Substance Act is inclusive to anabolic steroids and their precursors. Thus 5-androstenedione is a controlled substance. The World Anti-Doping Agency also prohibits use of 5-androstenedione in athletes.      5-androstenedione is structurally similar to 4-androstenedione, with the exception of the positioning of a carbon-carbon double bond. 4-Androstenedione is a prohormone which is naturally produced in the body by the adrenal glands and gonads, and acts as precursor to testosterone, as well as estrone and estradiol. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1175</field>
		<field name="drug_name">2,5-Dimethoxy-4-(n)-propylthiophenethylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1176</field>
		<field name="drug_name">Bezitramide</field>
		<field name="description">Bezitramide is a narcotic analgesic which was discovered in 1961, clinically tested around the 1970's [1], and marketed under the name Burgodin(R). After cases of fatal overdose in the Netherlands in 2004 the drug was withdrawn from the market.     In the United States Bezitramide was never been approved for clinical use. It is presently an illegal substance classified under Schedule II of the Controlled Substances Act. [wiki]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1177</field>
		<field name="drug_name">Diethyltryptamine</field>
		<field name="description">Diethyltryptamine (DET) is an orally active hallucinogenic drug and psychedelic compound of moderate duration. DET is a substituted tryptamine, structurally similar to DMT and dipropyltryptamine (DPT). [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1178</field>
		<field name="drug_name">Dimenoxadol</field>
		<field name="description">Dimenoxadol is an opioid analgesic which produces typical opioid effects such as analgesia and sedation. It is structurally similar to methadone and is a benzilic acid derivative. In the United States it is classified as a Schedule I controlled drug.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1179</field>
		<field name="drug_name">Etonitazene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1180</field>
		<field name="drug_name">Fencamfamine</field>
		<field name="description">Fencamfamine (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite suppressant, but was later withdrawn for this application due to problems with dependence and abuse. It is around half the potency of dexamphetamine, and is prescribed at a dose of 10-60mg, although abusers of the drug tend to rapidly develop tolerance and escalate their dose. Reactivan is still rarely used for treating depressive day-time fatigue, lack of concentration and lethargy, particularly in individuals who have chronic medical conditions, as its favourable safety profile makes it the most suitable drug in some cases. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1181</field>
		<field name="drug_name">Furethidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1182</field>
		<field name="drug_name">2,5-Dimethoxyamphetamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1183</field>
		<field name="drug_name">Ethylmorphine</field>
		<field name="description">A narcotic analgesic and antitussive. It is metabolized in the liver by ethylmorphine-N-demethylase and used as an indicator of liver function. It is not marketed in the US but is approved for use in various countries around the world. In the US it is a schedule II drug (single-entity) and schedule III drug (in combination products).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1184</field>
		<field name="drug_name">2,5-Dimethoxy-4-ethylamphetamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1185</field>
		<field name="drug_name">Ethylmethylthiambutene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1186</field>
		<field name="drug_name">Acetorphine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1187</field>
		<field name="drug_name">Alpha-methylthiofentanyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1188</field>
		<field name="drug_name">Bolasterone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1189</field>
		<field name="drug_name">4-Methoxyamphetamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1190</field>
		<field name="drug_name">Betaprodine</field>
		<field name="description">An opioid analgesic chemically related to and with an action resembling that of meperidine, but more rapid in onset and of shorter duration. It has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1067)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1191</field>
		<field name="drug_name">17Alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1192</field>
		<field name="drug_name">Dioxaphetyl butyrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1193</field>
		<field name="drug_name">Haloxazolam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1194</field>
		<field name="drug_name">Codeine methylbromide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1195</field>
		<field name="drug_name">desmethylprodine</field>
		<field name="description">Desmethylprodine is an opioid analgesic which is a derivative of meperidine. It has the potency of morphine; however, it has been listed as a Schedule I controlled drug in the United States, and thus is not used clinically. It is known to be a designer drug, synthesized in 1977 for the purpose of recreational use. Illicit manufacturing of the drug has occurred.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1196</field>
		<field name="drug_name">17Alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1197</field>
		<field name="drug_name">Cyprenorphine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1198</field>
		<field name="drug_name">Delta1-dihydrotestosterone</field>
		<field name="description">Delta1-dihydrotestosterone is an anabolic steroid that differs from testosterone by having a 1,2-double bond instead of 4,5-double bond in its A ring. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1199</field>
		<field name="drug_name">Fenethylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1200</field>
		<field name="drug_name">Barbital</field>
		<field name="description">A long-acting barbiturate that depresses most metabolic processes at high doses. It is used as a hypnotic and sedative and may induce dependence. Barbital is also used in veterinary practice for central nervous system depression. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1201</field>
		<field name="drug_name">4-Bromo-2,5-dimethoxyamphetamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1202</field>
		<field name="drug_name">4-Hydroxytestosterone</field>
		<field name="description">4-Hydroxytestosterone is testosterone substituted with a hydroxy group on the fourth carbon atom. It is an anabolic steroid with no therapeutic indications, which is prohibited from use in sports by the World Anti-Doping Agency. [1]    Formestane (Lentaron) acts as a prohormone of 4-Hydroxytestosterone, as 4-Hydroxytestosterone is one of the many byproducts of formestane metabolism. It is specifically the 17-hydroxylated analog to formestane. [1] Like formestane, 4-hydroxytesterone has been patented for use in decreasing estrogen production in the body, but no such indication currently exists.  4-Hydroxytestosterone was first patented in 1955 by G.D Searle &amp; Company.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1203</field>
		<field name="drug_name">Cathine</field>
		<field name="description">Cathine (?-hydroxyamphetamine) is a monoamine alkaloid found in the shrub Catha edulis (khat). Cathine is a Schedule III drug under the Convention on Psychotropic Substances. In the United States, it is classified as a Schedule IV controlled substance. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1204</field>
		<field name="drug_name">Embutramide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1205</field>
		<field name="drug_name">Dimethyltryptamine</field>
		<field name="description">An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine. It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1206</field>
		<field name="drug_name">Camazepam</field>
		<field name="description">Camazepam is a benzodiazepine which is a dimethyl carbamate ester of tamzepam, a metabolite of diazepam. Similarly to other drugs in its class, it has antxiolytic, anticonvulsant, hypnotic, and skeletal muscle relaxant properties. However, unlike other benzodiapeines camazepam is predominantly anxiolytic and is relatively weak as an anticonvulsant, hypnotic and skeletal muscle relaxant. [Wikipedia]      Camazepam also has less side effects, such as impaired cognition and reaction times, compared to other benzodiazepines. However, impairment of cognition and disrupted sleep patterns will occur at doses higher than 40mg of carazepam. [Wikipedia] Camazepam is also believed to increase attention, and is associated with skin disorders.      In the United States camazepam is regulated as a Schedule IV controlled substance.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1207</field>
		<field name="drug_name">Aminorex</field>
		<field name="description">An amphetamine-like anorectic agent. It may cause pulmonary hypertension. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1208</field>
		<field name="drug_name">Dipipanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1209</field>
		<field name="drug_name">Ethylestrenol</field>
		<field name="description">An anabolic steroid with some progestational activity and little androgenic effect. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1210</field>
		<field name="drug_name">Chloral betaine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1211</field>
		<field name="drug_name">Dichloralphenazone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1212</field>
		<field name="drug_name">Barbituric acid derivative</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1213</field>
		<field name="drug_name">Etorphine</field>
		<field name="description">A narcotic analgesic morphinan used as a sedative in veterinary practice. In Hong Kong, Etorphine is regulated under Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance. It can only be used legally by health professionals and for university research purposes. The substance can be given by pharmacists under a prescription. In the US, Etorphine is listed as a Schedule I drug, although Etorphine hydrochloride is classified as Schedule II.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1214</field>
		<field name="drug_name">Alphamethadol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1215</field>
		<field name="drug_name">Alphameprodine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1216</field>
		<field name="drug_name">4-Hydroxy-19-nortestosterone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1217</field>
		<field name="drug_name">Difenoxin</field>
		<field name="description">Difenoxin is a 4-phenylpiperidine which is closely related to the opioid analgesic meperidine. Difenoxin alone is a USA Schedule I controlled drug, as it may be habit forming. However, it is listed as a Schedule IV controlled drug if combined with atropine, which is added to decrease deliberate misuse. Motofen(R) is a brand mixture which combines atropine sulfate and difenoxin hydrochloride. It is approved by the FDA to treat acute and chronic diarrhea.      Difenoxin is an active metabolite of the anti-diarrheal drug, diphenoxylate, which is also used in combination with atropine in the brand mixture Lomotil(R). It works mostly in the periphery and activates opioid receptors in the intestine rather than the central nervous system (CNS). [3] Difenoxin is also closely related to loperamide, but unlike loperamide it is still capable of crossing the blood brain barrier to produce weak sedative and analgesic effects. However, the antidiarrheal potency of difenoxin is much greater than its ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1218</field>
		<field name="drug_name">Diampromide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1219</field>
		<field name="drug_name">1-Androstenediol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1220</field>
		<field name="drug_name">Etoxeridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1221</field>
		<field name="drug_name">1-Phenylcyclohexylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1222</field>
		<field name="drug_name">3,4-Methylenedioxyamphetamine</field>
		<field name="description">An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1223</field>
		<field name="drug_name">Dehydrochloromethyltestosterone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1224</field>
		<field name="drug_name">Delorazepam</field>
		<field name="description">Delorazepam is a benzodiazepine which, like other drugs in its class, possesses anxiolytic, skeletal muscle relaxant, hypnotic and anticonvulsant properties. It may have adverse effects such as drowsiness, and cognitive impairments such as short term memory impairment. [4]        Delorazepam is an active metabolite of the benzodiazepine known as cloxazolam. It is a long acting benzodiazepine which makes it superior in this sense to lorazepam which is short acting. Lorazepam is also a major active metabolite of delorazepam. In addition to be long acting, delorazepam is relatively potent, with 1 mg of delorazepam being the equivalent of 10 mg diazepam. [Wikipedia]      Delorazepam has been approved for marketing in Italy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1225</field>
		<field name="drug_name">Hydromorphinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1226</field>
		<field name="drug_name">17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1227</field>
		<field name="drug_name">Furazabol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1228</field>
		<field name="drug_name">Benzoylecgonine</field>
		<field name="description">Benzoylecgonine is the major metabolite of cocaine. It is formed by hydrolysis of cocaine in the liver, catalysed by carboxylesterases. It is excreted in the urine of cocaine users after processing in the liver. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1229</field>
		<field name="drug_name">3,4,5-Trimethoxyamphetamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1230</field>
		<field name="drug_name">Benzethidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1231</field>
		<field name="drug_name">Tenocyclidine</field>
		<field name="description">Tenocyclidine (TCP, thienyl cyclohexylpiperidine) is a dissociative anesthetic drug with stimulant and hallucinogenic effects. It is similar in effects to phencyclidine but is considerably more potent. Due to its similarity in effects to PCP, TCP was placed into the Schedule I list of illegal drugs in the 1970s, although it was only briefly abused in the 1970s and 1980s and is now little known. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1232</field>
		<field name="drug_name">Clostebol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1233</field>
		<field name="drug_name">Betacetylmethadol</field>
		<field name="description">A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1234</field>
		<field name="drug_name">Clonitazene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1235</field>
		<field name="drug_name">5-Androstenediol</field>
		<field name="description">An intermediate in testosterone biosynthesis, found in the testis or the adrenal glands. Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted to testosterone by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-hydroxysteroid dehydrogenases). [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1236</field>
		<field name="drug_name">Ecgonine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1237</field>
		<field name="drug_name">4-Androstenediol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1238</field>
		<field name="drug_name">Clortermine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1239</field>
		<field name="drug_name">4-Methyl-2,5-dimethoxyamphetamine</field>
		<field name="description">A psychedelic phenyl isopropylamine derivative, commonly called DOM, whose mood-altering effects and mechanism of action may be similar to those of LSD. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1240</field>
		<field name="drug_name">Dextromoramide</field>
		<field name="description">An opioid analgesic structurally related to methadone and used in the treatment of severe pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1070)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1241</field>
		<field name="drug_name">3Alpha,17beta-dihydroxy-5alpha-androstane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1242</field>
		<field name="drug_name">Desomorphine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1243</field>
		<field name="drug_name">Acetyl-alpha-methylfentanyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1244</field>
		<field name="drug_name">Diethylthiambutene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1245</field>
		<field name="drug_name">Chlorhexadol</field>
		<field name="description">Chlorhexadol is a sedative and hypnotic which is regulated in the United States as a Schedule III controlled substance. It is a derivative of chloral hydrate.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1246</field>
		<field name="drug_name">Carfentanil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1247</field>
		<field name="drug_name">4-Androstenedione</field>
		<field name="description">A delta-4 C19 steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex.  Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1248</field>
		<field name="drug_name">4-Bromo-2,5-dimethoxyphenethylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1249</field>
		<field name="drug_name">Acetyldihydrocodeine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1250</field>
		<field name="drug_name">1-Piperidinocyclohexanecarbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1251</field>
		<field name="drug_name">17Alpha-methyl-4-hydroxynandrolone</field>
		<field name="description">17Alpha-methyl-4-hydroxynandrolone is a schedule 3 anabolic steroid.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1252</field>
		<field name="drug_name">Boldenone</field>
		<field name="description">Boldenone is an anabolic steroid developed for veterinary use, mostly for treatment of horses. It is not indicated for use in humans in the US and is only available through veterinary clinics.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1253</field>
		<field name="drug_name">Allylprodine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1254</field>
		<field name="drug_name">13Beta-ethyl-17beta-hydroxygon-4-en-3-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1255</field>
		<field name="drug_name">Flunitrazepam</field>
		<field name="description">A benzodiazepine with pharmacologic actions similar to those of diazepam that can cause anterograde amnesia. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1256</field>
		<field name="drug_name">Ethyl loflazepate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1257</field>
		<field name="drug_name">Alpha-ethyltryptamine</field>
		<field name="description">In the 1960's, alpha-ethyltryptamine(?ET), a non hydrazine reversible monoamine oxidase inhibitor, was developed in the United States by the Upjohn chemical company for use as an antidepressant. ?ET was an FDA approved antidepressant under the name Monase. However, in 1962, after the discovery of an unacceptable incidence of agranulocytosis, the development of Monase was halted and the drug was withdrawn from potential market use.     In 1993, the US Drug Enforcement Administration added ?ET to Schedule I of its Schedules of Controlled Substances, after an increasing incidence of its use as a recreational drug in the 1980's. Currently, ?ET is an illegal substance; however, it's activity is still under scientific investigation.     ?ET is a stimulant and hallucinogen, but it is less stimulating and hallucinogenic than alpha-methyltryptamine, a closely related compound. Instead, the effects of ?ET, a tryptamine derivative, more closely resemble the amphetamine derived drug 3,4-methylened...</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1258</field>
		<field name="drug_name">Drotebanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1259</field>
		<field name="drug_name">Diprenorphine</field>
		<field name="description">A narcotic antagonist similar in action to naloxone. It is used to remobilize animals after etorphine neuroleptanalgesia and is considered a specific antagonist to etorphine. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1260</field>
		<field name="drug_name">Rolicyclidine</field>
		<field name="description">Rolicyclidine (PCPy) is a dissociative anesthetic drug with hallucinogenic and sedative effects. Due to its similarity in effects to PCP, PCPy was placed into the Schedule I list of illegal drugs in the 1970s, although it has never been widely abused and is now little known.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1261</field>
		<field name="drug_name">Fenproporex</field>
		<field name="description">Fenproporex is an orally active stimulant drug, which was developed in the 1960s. It is used as an appetite suppressant and a treatment for obesity. However, due to an addictive potential, it is listed as an illicit substance in many countries. Structurally, fenproporex (N-2-cyanoethylamphetamine) falls within the phenylethamine and amphetamine chemical class of drugs. The N-2-cyanoethyl substituent was once believed to be resistant to cleavage, because fenproporex -- once recommended as an obesity treatment for patients with cardiovascular disease -- was originally claimed to lack stimulant properties. Contrary to the claim, research has demonstrated easy in vivo cleavage of the N-2-cyanothyl substituent to yield amphetamine as a metabolite. [5] However, in clinical practice, central nervous system stimulative effects are less notorious than with some other agents such as diethylpropion and mazindol. [7]    In the United States fenproporex was never approved by the FDA for clinical us...</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1262</field>
		<field name="drug_name">Dihydrocodeine</field>
		<field name="description">Dihydrocodeine is an opioid analgesic used as an alternative or adjunct to codeine to treat moderate to severe pain, severe dyspnea, and cough.     It is semi-synthetic, and was developed in Germany in 1908 during an international search to find a more effective antitussive agent -- the discovery of which would, in part, help contribute to reducing the spread of airborne infectious diseases such as tuburculosis. It was marketed in 1911. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1263</field>
		<field name="drug_name">Betameprodine</field>
		<field name="description">Betameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances. The stereoisomer alphameprodine is similarly classified, and was more widely used.     Betameprodine is a structural analogue of meperidine. It exerts physiological effects characteristic of opioids, such as analgesia, euphoria and sedation -- as well as itching, nausea, and respiratory depression.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1264</field>
		<field name="drug_name">Cloxazolam</field>
		<field name="description">Cloxazolam is a benzodiazepine with anxiolytic, sedative/hypnotic, muscle relaxant, and antiepileptic effects. [3] It is marketed in the Argentina, Australia, Portugal, Belgium, Switzerland, Luxembourg, Germany, Taiwan and Japan -- mainly for anti-anxiety. The usual dose of cloxazolam in adults is 3-12mg/day for anti-anxiety. [3]    Although less commonly noted, it has also been reported as clinically effective in the treatment of depression, schizophrenia, and neurosis. [4] As well, it has also been studied in Japan in doses of 15-30mg/day as an adjunct in the treatment of intractable epilepsy, for which it has demonstrated effectiveness. [3]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1265</field>
		<field name="drug_name">19-Nor-4-androstenediol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1266</field>
		<field name="drug_name">Alphacetylmethadol</field>
		<field name="description">A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1267</field>
		<field name="drug_name">Chlorphentermine</field>
		<field name="description">A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of dextroamphetamine. It has been implicated in lipid storage disorders and pulmonary hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1223)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1268</field>
		<field name="drug_name">Alpha-methylfentanyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1269</field>
		<field name="drug_name">Bromazepam</field>
		<field name="description">One of the benzodiazepines that is used in the treatment of anxiety disorders. [PubChem] It is a Schedule IV drug in the U.S. and Canada and under the Convention on Psychotropic Substances. It is a intermediate-acting benzodiazepines.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1270</field>
		<field name="drug_name">Clotiazepam</field>
		<field name="description">Clotiazepam is a benzodiazepine derivative, not approved for sale in the U.S. or Canada, but has been approved in the U.K. It is a schedule IV drug in Canada.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1271</field>
		<field name="drug_name">Cathinone</field>
		<field name="description">Cathinone (?-ketoamphetamine) is a monoamine alkaloid found in the shrub Catha edulis (Khat). Closely related to ephedrine, cathine and other amphetamines, it is probably the main contributor to the stimulant effect of Catha edulis. Cathinone differs from many other amphetamines in that its structure is a ketone. Other amphetamines to share this structure include the antidepressant bupropion and the stimulant methcathinone, among others. Internationally, cathinone is a Schedule I drug under the Convention on Psychotropic Substances. Circa 1993, the DEA added cathinone to the Controlled Substances Act's Schedule I in order to fulfill the requirements of international law. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1272</field>
		<field name="drug_name">Androstanedione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1273</field>
		<field name="drug_name">1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine</field>
		<field name="description">1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (PEPAP) is a synthetic analogue of meperidine. It is sold as a &quot;synthetic heroin.&quot;</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1274</field>
		<field name="drug_name">Chloral hydrate</field>
		<field name="description">A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1275</field>
		<field name="drug_name">Calusterone</field>
		<field name="description">A 17-alkylated orally active androgenic steroid. A Schedule IV drug in Canada.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1276</field>
		<field name="drug_name">Dihydromorphine</field>
		<field name="description">A semisynthetic analgesic used in the study of narcotic receptors. It has abuse potential. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1277</field>
		<field name="drug_name">3,4-Methylenedioxy-N-ethylamphetamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1278</field>
		<field name="drug_name">Fludiazepam</field>
		<field name="description">Fludiazepam is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a scheduled drug in the U.S., but is approved for use in Japan.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1279</field>
		<field name="drug_name">Codeine-N-oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1280</field>
		<field name="drug_name">Formebolone</field>
		<field name="description">Formebolone, a derivative of androstane [1], is an anabolic androgenic steroid. It is on the list of substances prohibited by the Word Anti-Doping Agency, and is regularly screened for in athletes. It is also classified by the US Drug Enforcement Administration as Schedule III drug in the Controlled Substances Act. It has been used experimentally in the treatment of growth retardation, and has been noted to increase bone mass. [1] Additionally, it has been patented for use in development of novel transdermal delivery systems for enhanced drug delivery.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1281</field>
		<field name="drug_name">Beta-hydroxy-3-methylfentanyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1282</field>
		<field name="drug_name">3-Methylfentanyl</field>
		<field name="description">3-Methylfentanyl (3-MF, mefentanyl) is an opioid analgesic that is an analogue of fentanyl. 3-Methylfentanyl is one of the most potent drugs that has been widely sold on the black market, estimated to be between 400-6000 times stronger than morphine depending on which isomer is used (with cis isomer being the more potent one). 3-Methylfentanyl was first discovered in 1974 [4] and subsequently appeared on the street as an alternative to the clandestinely produced fentanyl analogue ?-methylfentanyl. However it quickly became apparent that 3-methylfentanyl was much more potent than ?-methylfentanyl, and corespondingly even more dangerous. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1283</field>
		<field name="drug_name">17Alpha-methyl-delta1-dihydrotestosterone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1284</field>
		<field name="drug_name">Benzylmorphine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1285</field>
		<field name="drug_name">Attapulgite</field>
		<field name="description">Attapulgite is a magnesium aluminium phyllosilicate which occurs in a type of clay soil common to the Southeastern United States. When used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications. Until 2003, it was the active ingredient used in Kaopectate, before that product was reformulated with bismuth subsalicylate.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1286</field>
		<field name="drug_name">Kaolin</field>
		<field name="description">Kaolin is a layered silicate mineral. Kaolin is used in ceramics, medicine, coated paper, as a food additive, in toothpaste, as a light diffusing material in white incandescent light bulbs, and in cosmetics. Until the early 1990s it was the active substance of anti-diarrhoea medicine Kaopectate.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1287</field>
		<field name="drug_name">Dextroamphetamine</field>
		<field name="description">Dextroamphetamine is the dextrorotary stereoisomer of the amphetamine molecule, which can take two different forms. It is a slightly polar, weak base and is lipophilic.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1288</field>
		<field name="drug_name">Methamphetamine</field>
		<field name="description">Methamphetamine is a psychostimulant and sympathomimetic drug. It is a member of the amphetamine group of sympathomimetic amines. Methamphetamine can induce effects such as euphoria, increased alertness and energy, and enhanced self-esteem. It is a scheduled drug in most countries due to its high potential for addiction and abuse.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1289</field>
		<field name="drug_name">Metrizamide</field>
		<field name="description">Metrizamide is a solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1290</field>
		<field name="drug_name">Phendimetrazine</field>
		<field name="description">Phendimetrazine is a weight loss medication. Phendimetrazine is chemically related to amphetamines and is a Schedule III drug under the Convention on Psychotropic Substances. In the United States, phendimetrazine is a Schedule III controlled substance under the Uniform Controlled Substances Act of 1970.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1291</field>
		<field name="drug_name">Oxprenolol</field>
		<field name="description">A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1292</field>
		<field name="drug_name">Sulfamerazine</field>
		<field name="description">A sulfanilamide that is used as an antibacterial agent. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1293</field>
		<field name="drug_name">Sulfamethazine</field>
		<field name="description">A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1294</field>
		<field name="drug_name">Liotrix</field>
		<field name="description">Liotrix is a synthetically derived thyroid hormone replacement preparation. It consists of levothyroxine sodium (thyroxine, T4) and liothyronine sodium (triiodothyronine, T3) in a 4 to 1 ratio by weight. Liotrix was developed when it was believed that serum levels of both T4 and T3 were maintained by direct thyroidal secretion. It is now known that the thyroid gland secretes approximately ten times more T4 than T3 and that 80% of serum T3 is derived from deiodination of T4 in peripheral tissues. Administration of levothyroxine alone is sufficient for maintaining serum T4 and T3 levels in most patients and combination hormone replacement therapy generally offers no therapeutic advantage. In fact, administration of T3 may result in supratherapeutic levels of T3.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1295</field>
		<field name="drug_name">Thyroglobulin</field>
		<field name="description">Thyroglobulin is a thyroid hormone (enzyme) used by the thyroid gland to produce the thyroid hormones thyroxine (T4) and triiodothyronine (T3). The active form of thyroxine, triiodothyronine, is produced both within the thyroid gland and periphery by 5'-deiodinase. Patients with Hashimoto's thyroiditis or Graves' disease, frequently develop antibodies against thyroglobulin. Thyroglobulin is used to treat hypothyroidism.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1296</field>
		<field name="drug_name">Ursodeoxycholic acid</field>
		<field name="description">Ursodeoxycholic acid is an epimer of chenodeoxycholic acid (DB06777). It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1297</field>
		<field name="drug_name">Ketazolam</field>
		<field name="description">Ketazolam is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Ketazolam is not approved for sale in the United States or Canada.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1298</field>
		<field name="drug_name">Prazepam</field>
		<field name="description">Prazepam is a benzodiazepine that is used in the treatment of anxiety disorders. It is a schedule IV drug in the U.S.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1299</field>
		<field name="drug_name">Quazepam</field>
		<field name="description">Quazepam is a drug which is a benzodiazepine derivative. It induces impairment of motor function and has hypnotic properties. Quazepam is used to treat insomnia.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1300</field>
		<field name="drug_name">Everolimus</field>
		<field name="description">Everolimus is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mTOR inhibitors Everolimus' effect is solely on the mTORC1 protein and not on the mTORC2 protein.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1301</field>
		<field name="drug_name">Solifenacin</field>
		<field name="description">Solifenacin (rINN), marketed as solifenacin succinate under the trade name Vesicare, is a urinary antispasmodic of the anticholinergic class. It is used in the treatment of overactive bladder with urge incontinence. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1302</field>
		<field name="drug_name">Iron</field>
		<field name="description">A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1303</field>
		<field name="drug_name">Zinc</field>
		<field name="description">A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with anemia, short stature, hypogonadism, impaired wound healing, and geophagia. It is known by the symbol Zn.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1304</field>
		<field name="drug_name">Cinolazepam</field>
		<field name="description">Cinolazepam is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Cinolazepam is not approved for sale in the United States or Canada.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1305</field>
		<field name="drug_name">Nitrazepam</field>
		<field name="description">A benzodiazepine derivative used as an anticonvulsant and hypnotic.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1306</field>
		<field name="drug_name">Cilastatin</field>
		<field name="description">A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, imipenem, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1307</field>
		<field name="drug_name">Probucol</field>
		<field name="description">A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1308</field>
		<field name="drug_name">Tiaprofenic acid</field>
		<field name="description">Tiaprofenic acid is a non-steroidal anti-inflammatory drug of the arylpropionic acid (profen) class, used to treat pain, especially arthritic pain.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1309</field>
		<field name="drug_name">Propericiazine</field>
		<field name="description">Propericiazine is a phenothiazine of the piperidine group. It has been shown to reduce pathologic arousal and affective tension in some psychotic patients, while the symptoms of abnormal mental integration are relatively unaffected. It is a sedative phenothiazine with weak antipsychotic properties. It also has adrenolytic, anticholinergic, metabolic and endocrine effects and an action on the extrapyramidal system.  It is used as an adjunctive medication in some psychotic patients, for the control of residual prevailing hostility, impulsiveness and aggressiveness. Pericyazine, like other phenothiazines, is presumed to act principally in the subcortical areas, by producing what has been described as a central adrenergic blockade.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1310</field>
		<field name="drug_name">Deferasirox</field>
		<field name="description">Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1311</field>
		<field name="drug_name">Amyl Nitrite</field>
		<field name="description">Amyl Nitrite is an antihypertensive medicine. Amyl nitrite is employed medically to treat heart diseases such as angina and to treat cyanide poisoning. Like other alkyl nitrites, amyl nitrite is bioactive in mammals, being a vasodilator which is the basis of its use as a prescription medicine. As an inhalant, it also has psychoactive effect which has led to illegal drug use.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1312</field>
		<field name="drug_name">Erythrityl Tetranitrate</field>
		<field name="description">A vasodilator with general properties similar to nitroglycerin. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1020)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1313</field>
		<field name="drug_name">Acepromazine</field>
		<field name="description">Acepromazine is one of the phenothiazine derivative psychotropic drugs, used little in humans, however frequently in animals as a sedative and antiemetic.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1314</field>
		<field name="drug_name">Aceprometazine</field>
		<field name="description">Aceprometazine (INN) is a prescription drug with neuroleptic and anti-histamine properties. It is not widely prescribed. It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1315</field>
		<field name="drug_name">Alverine</field>
		<field name="description">Alverine is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not under voluntary control; it is the muscle present in places such as the gut and uterus. Alverine acts directly on the muscle in the gut, causing it to relax. This prevents the muscle spasms which occur in the gut in conditions such as irritable bowel syndrome and diverticular disease. It is used to  relieve cramps or spasms of the stomach and intestines. It is also useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also be used to help relieve period pain. Alverine is formulated as the citrate salt (5982-87-6).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1316</field>
		<field name="drug_name">Molindone</field>
		<field name="description">An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of clozapine. (From AMA Drug Evaluations Annual, 1994, p283)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1317</field>
		<field name="drug_name">Phenindamine</field>
		<field name="description">Phenindamine is an antihistamine. Phenindamine blocks the effects of the naturally occurring chemical histamine in your body. Antihistamines such as phenindamine appear to compete with histamine for histamine H1- receptor sites on effector cells. The antihistamines antagonize those pharmacological effects of histamine which are mediated through activation of H1- receptor sites and thereby reduce the intensity of allergic reactions and tissue injury response involving histamine release.  It is used to treat sneezing, runny nose, itching, watery eyes, hives, rashes, itching, and other symptoms of allergies and the common cold.  Symptoms of a phenindamine overdose include extreme sleepiness, confusion, weakness, ringing in the ears, blurred vision, large pupils, dry mouth, flushing, fever, shaking, insomnia, hallucinations, and possibly seizures.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1318</field>
		<field name="drug_name">Pheniramine</field>
		<field name="description">One of the histamine H1 antagonists with little sedative action. It is used in treatment of hay fever, rhinitis, allergic dermatoses, and pruritus. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1319</field>
		<field name="drug_name">Pipotiazine</field>
		<field name="description">Pipotiazine has actions similar to those of other phenothiazines. Among the different phenothiazine derivatives, it appears to be less sedating and to have a weak propensity for causing hypotension or potentiating the effects of CNS depressants and anesthetics. However, it produces a high incidence of extra pyramidal reactions. It is used for the maintenance treatment of chronic non-agitated schizophrenic patients. Symptoms of overdose include severe extrapyramidal manifestations, hypotension, lethargy and sedation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1320</field>
		<field name="drug_name">Thioproperazine</field>
		<field name="description">Thioproperazine is a potent neuroleptic with antipsychotic properties. Thioproperazine has a marked cataleptic and antiapomorphine activity associated with relatively slight sedative, hypothermic and spasmolytic effects. It is virtually without antiserotonin and hypotensive action and has no antihistaminic property. It is used for the  treatment of all types of acute and chronic schizophrenia, including those which did not respond to the usual neuroleptics; manic syndromes.  Overdosage may result in severe extrapyramidal symptoms with dysphagia, marked sialorrhea, persistent and rapidly increasing hyperthermia, pulmonary syndrome, state of shock with pallor and profuse sweating, which may be followed by collapse and coma. LD50 in mice is 70 mg/kg I.V., 120 mg/kg I.P., 500 mg/kg S.C. and 830 mg/kg P.O.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1321</field>
		<field name="drug_name">Thiothixene</field>
		<field name="description">A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1322</field>
		<field name="drug_name">Zuclopenthixol</field>
		<field name="description">A thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1323</field>
		<field name="drug_name">Isopropamide</field>
		<field name="description">Isopropamide iodide is a long-acting quaternary anticholinergic drug. It is used in the treatment of peptic ulcer and other gastrointestinal disorders marked by hyperacidity and hypermotility.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1324</field>
		<field name="drug_name">Pargyline</field>
		<field name="description">A monoamine oxidase inhibitor with antihypertensive properties. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1325</field>
		<field name="drug_name">Etoricoxib</field>
		<field name="description">Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2). This reduces the generation of prostaglandins (PGs) from arachidonic acid.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1326</field>
		<field name="drug_name">5-Fluorouridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1327</field>
		<field name="drug_name">SC-74020</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1328</field>
		<field name="drug_name">Methyl Nonanoate (Ester)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1329</field>
		<field name="drug_name">Alpha-Phosphoribosylpyrophosphoric Acid</field>
		<field name="description">The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1330</field>
		<field name="drug_name">Deoxy-2-Fluoro-B-D-Cellotrioside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1331</field>
		<field name="drug_name">2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1332</field>
		<field name="drug_name">2,2-Dimethylthiazolidine-4-Carboxylic Acid;(Dmt)Thiazolidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1333</field>
		<field name="drug_name">Clorocruoro Hem</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1334</field>
		<field name="drug_name">3,7,11,15-Tetramethyl-Hexadecan-1-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1335</field>
		<field name="drug_name">D-Sorbitol</field>
		<field name="description">A polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1336</field>
		<field name="drug_name">N-Methyl-Pyridoxal-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1337</field>
		<field name="drug_name">(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1338</field>
		<field name="drug_name">(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1339</field>
		<field name="drug_name">O1-Methyl-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1340</field>
		<field name="drug_name">Thymidine-5'-Phosphate</field>
		<field name="description">5-Thymidylic acid. A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1341</field>
		<field name="drug_name">3,6-Dihydroxy-Xanthene-9-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1342</field>
		<field name="drug_name">Genistein</field>
		<field name="description">An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.    Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in &lt;I&gt;Felmingia vestita&lt;/I&gt;, which is a plant traditionally used against worms. It has also been demonstrated to be effective against intestinal parasites such as the common liver fluke, pork trematode and poultry cestode. [Wikipedia]       Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women. [1]       Genistein can be found in food sources such as tofu, fava beans, soybeans, kudzu, and lupin. It is also p...</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1343</field>
		<field name="drug_name">N-Acetylmethionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1344</field>
		<field name="drug_name">(R)-Mesopram</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1345</field>
		<field name="drug_name">O1-Methyl-4-Deoxy-4-Thio-Beta-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1346</field>
		<field name="drug_name">7-Methyl-Gpppa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1347</field>
		<field name="drug_name">trans-2-hydroxycinnamic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1348</field>
		<field name="drug_name">Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1349</field>
		<field name="drug_name">4-Hydroxybenzoyl Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1350</field>
		<field name="drug_name">(5z)-5-(1h-Indol-3-Ylmethylene)-4h-Imidazol-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1351</field>
		<field name="drug_name">L-Guluronic Acid 6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1352</field>
		<field name="drug_name">Roflumilast</field>
		<field name="description">Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor. Due to its selective inhibition of the PDE4 isoenzyme in lung cells, roflumilast is indicated for the management of chronic obstrtuctive pulmonary disease (COPD) exacerbations. Treatment with Roflumilast is associated with an increase in psychiatric adverse reactions, including suicide and suicidal attempts.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1353</field>
		<field name="drug_name">2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1354</field>
		<field name="drug_name">1'-Deazo-Thiamin Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1355</field>
		<field name="drug_name">3-(1,10-Phenanthrol-2-Yl)-L-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1356</field>
		<field name="drug_name">Adenosine-5'-Diphosphate Monothiophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1357</field>
		<field name="drug_name">Phosphoribosyl Atp</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1358</field>
		<field name="drug_name">Trans-O-Hydroxy-Alpha-Methyl Cinnamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1359</field>
		<field name="drug_name">Lambda-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C9-Adamantane Ruthenium (Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1360</field>
		<field name="drug_name">(S)-Des-Me-Ampa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1361</field>
		<field name="drug_name">ZK-800270</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1362</field>
		<field name="drug_name">D-Myo-Inositol-Hexasulphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1363</field>
		<field name="drug_name">8-azaguanine</field>
		<field name="description">One of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1364</field>
		<field name="drug_name">Nanaomycin D</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1365</field>
		<field name="drug_name">Propyl Acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1366</field>
		<field name="drug_name">4-(Hydroxymercury)Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1367</field>
		<field name="drug_name">2,3-Dihydroxy-Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1368</field>
		<field name="drug_name">Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1369</field>
		<field name="drug_name">[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1370</field>
		<field name="drug_name">Methacrylyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1371</field>
		<field name="drug_name">Trinitrotoluene</field>
		<field name="description">A 2,4,6-trinitrotoluene is an explosive chemical that can cause skin irritation and other toxic consequences. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1372</field>
		<field name="drug_name">Fumarate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1373</field>
		<field name="drug_name">RU84687</field>
		<field name="description">RU84687 is a subnanomolar and Src SH2 selective binder.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1374</field>
		<field name="drug_name">Propyl Trihydrogen Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1375</field>
		<field name="drug_name">Benzene Hexacarboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1376</field>
		<field name="drug_name">6'-Methyl-Thiamin Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1377</field>
		<field name="drug_name">Chymostatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1378</field>
		<field name="drug_name">1-Hydroxy-1-Thio-Glycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1379</field>
		<field name="drug_name">4-[5-Pyridin-4-Yl-1h-[1,2,4]Triazol-3-Yl]-Pyridine-2-Carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1380</field>
		<field name="drug_name">N,N-dimethylarginine</field>
		<field name="description">Asymmetric dimethylarginine (ADMA) is a naturally occurring chemical found in blood plasma. It is a metabolic by-product of continual protein modification processes in the cytoplasm of all human cells. It is closely related to L-arginine, a conditionally-essential amino acid. ADMA interferes with L-arginine in the production of nitric oxide, a key chemical to endothelial and hence cardiovascular health. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1381</field>
		<field name="drug_name">Mannobiose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1382</field>
		<field name="drug_name">P-Cresol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1383</field>
		<field name="drug_name">Inhibitor Idd 384</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1384</field>
		<field name="drug_name">Bis(Adenosine)-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1385</field>
		<field name="drug_name">Indole Naphthyridinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1386</field>
		<field name="drug_name">Dithioerythritol</field>
		<field name="description">A compound that, along with its isomer, Cleland&amp;#39;s reagent (dithiothreitol), is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1387</field>
		<field name="drug_name">Ribavirin Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1388</field>
		<field name="drug_name">D-tartaric acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1389</field>
		<field name="drug_name">N-Hydroxy-4-Phosphono-Butanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1390</field>
		<field name="drug_name">7,9-Dihydro-1h-Purine-2,6,8(3h)-Trione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1391</field>
		<field name="drug_name">Cellotriose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1392</field>
		<field name="drug_name">Rutin</field>
		<field name="description">A flavonol glycoside found in many plants, including buckwheat; tobacco; forsythia; hydrangea; viola, etc. It has been used therapeutically to decrease capillary fragility. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1393</field>
		<field name="drug_name">(4e)-4-Aminohex-4-Enoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1394</field>
		<field name="drug_name">Aicar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1395</field>
		<field name="drug_name">1,2-Dichloro-Propane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1396</field>
		<field name="drug_name">2-(3,4-Dihydroxyphenyl)Acetic Acid</field>
		<field name="description">A deaminated metabolite of levodopa. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1397</field>
		<field name="drug_name">N-(2-Ferrocenylethyl)Maleimide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1398</field>
		<field name="drug_name">2,4-Dihydroxy-Trans Cinnamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1399</field>
		<field name="drug_name">Bis(5-Amidino-Benzimidazolyl)Methane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1400</field>
		<field name="drug_name">2-Bromo-6-Chloro-Purine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1401</field>
		<field name="drug_name">L-Alfa-Lysophosphatidylcholine, Lauroyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1402</field>
		<field name="drug_name">Dehydroepiandrosterone</field>
		<field name="description">Dehydroepiandrosterone (DHEA) is a major C19 steroid produced by the adrenal cortex. It is also produced in small quantities in the testis and the ovary. Dehydroepiandrosterone (DHEA) can be converted to testosterone; androstenedione; estradiol; and estrone. Most of DHEA is sulfated (dehydroepiandrosterone sulfate) before secretion.    In the United States, DHEA or DHEAS have been advertised with claims that they may be beneficial for a wide variety of ailments. DHEA and DHEAS are readily available in the United States, where they are marketed as over-the-counter dietary supplements.    In Canada, a prescription is required to buy DHEA.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1403</field>
		<field name="drug_name">2-Phosphoglyceric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1404</field>
		<field name="drug_name">Porphyrin Fe(Iii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1405</field>
		<field name="drug_name">2,3,4,5,6-Pentafluorobenzyl Alcohol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1406</field>
		<field name="drug_name">(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1407</field>
		<field name="drug_name">Udp-Alpha-D-Xylopyranose</field>
		<field name="description">The decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1408</field>
		<field name="drug_name">N-Methyl-Lysine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1409</field>
		<field name="drug_name">7,8-Diamino-Nonanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1410</field>
		<field name="drug_name">2-Propenyl-N-Acetyl-Neuramic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1411</field>
		<field name="drug_name">Bis(Adenosine)-5'-Pentaphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1412</field>
		<field name="drug_name">Cetyl-Trimethyl-Ammonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1413</field>
		<field name="drug_name">Thio-Maltopentaose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1414</field>
		<field name="drug_name">(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1415</field>
		<field name="drug_name">Analogue of Indinavir Drug</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1416</field>
		<field name="drug_name">Ethylbenzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1417</field>
		<field name="drug_name">{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1418</field>
		<field name="drug_name">Reduced Threonine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1419</field>
		<field name="drug_name">CRA_7806</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1420</field>
		<field name="drug_name">2-Aminophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1421</field>
		<field name="drug_name">Isocitric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1422</field>
		<field name="drug_name">3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1423</field>
		<field name="drug_name">(1s,3s,4s)-1,3,4-Triphospho-Myo-Inositol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1424</field>
		<field name="drug_name">(S)-Wiskostatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1425</field>
		<field name="drug_name">(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1426</field>
		<field name="drug_name">L-Phospholactate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1427</field>
		<field name="drug_name">3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1428</field>
		<field name="drug_name">3-Chloroalaninate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1429</field>
		<field name="drug_name">[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1430</field>
		<field name="drug_name">Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1431</field>
		<field name="drug_name">O-Phosphoethanolamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1432</field>
		<field name="drug_name">Allo-Isoleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1433</field>
		<field name="drug_name">2-Amino-4-Butyl-5-Propylselenazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1434</field>
		<field name="drug_name">CRA_17693</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1435</field>
		<field name="drug_name">(3r)-1-Acetyl-3-Methylpiperidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1436</field>
		<field name="drug_name">Pyoverdine-Chromophore</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1437</field>
		<field name="drug_name">Camphor</field>
		<field name="description">A bicyclic monoterpene ketone found widely in plants, especially cinnamomum camphora. It is used topically as a skin antipruritic and as an anti-infective agent. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1438</field>
		<field name="drug_name">N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1439</field>
		<field name="drug_name">D-Leucine</field>
		<field name="description">An essential branched-chain amino acid important for hemoglobin formation. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1440</field>
		<field name="drug_name">Coprogen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1441</field>
		<field name="drug_name">N-Benzyl-4-Sulfamoyl-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1442</field>
		<field name="drug_name">1,2-Dimethoxyethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1443</field>
		<field name="drug_name">Naphthalen-1-Yl-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1444</field>
		<field name="drug_name">3,3',5,5'-Tetraiodothyroacetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1445</field>
		<field name="drug_name">S-Adenosyl-L-Homocysteine</field>
		<field name="description">5&amp;#39;-S-(3-Amino-3-carboxypropyl)-5&amp;#39;-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1446</field>
		<field name="drug_name">4-Oxo-Nicotinamide-Adenine Dinucleotide Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1447</field>
		<field name="drug_name">3,4-Dihydroxy-1-Methylquinolin-2(1h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1448</field>
		<field name="drug_name">N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1449</field>
		<field name="drug_name">D-4-Phosphoerythronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1450</field>
		<field name="drug_name">3-Iodo-Tyrosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1451</field>
		<field name="drug_name">5-Hydroxy-2-(Hydroxymethyl)-4h-Pyran-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1452</field>
		<field name="drug_name">2-Methoxy-3-Isopropylpyrazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1453</field>
		<field name="drug_name">4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1454</field>
		<field name="drug_name">Acetoacetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1455</field>
		<field name="drug_name">Tatp</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1456</field>
		<field name="drug_name">(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1457</field>
		<field name="drug_name">Beta-(2-Naphthyl)-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1458</field>
		<field name="drug_name">Hemi-Babim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1459</field>
		<field name="drug_name">Methylumbelliferyl Sialic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1460</field>
		<field name="drug_name">Double Oxidized Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1461</field>
		<field name="drug_name">All-Trans Axerophthene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1462</field>
		<field name="drug_name">CRA_10991</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1463</field>
		<field name="drug_name">3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1464</field>
		<field name="drug_name">4-[3-Carboxymethyl-3-(4-Phosphonooxy-Benzyl)-Ureido]-4-[(3-Cyclohexyl-Propyl)-Methyl-Carbamoyl]Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1465</field>
		<field name="drug_name">Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester</field>
		<field name="description">Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1466</field>
		<field name="drug_name">Dihydroxyacetone</field>
		<field name="description">A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1467</field>
		<field name="drug_name">M-Cresol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1468</field>
		<field name="drug_name">Coa-S-Trimethylene-Acetyl-Tryptamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1469</field>
		<field name="drug_name">8-Amino-1,3-Dimethyl-3,7-Dihydropurine-2,6-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1470</field>
		<field name="drug_name">Glycerol-2-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1471</field>
		<field name="drug_name">Fusicoccin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1472</field>
		<field name="drug_name">2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1473</field>
		<field name="drug_name">Pantothenic acid</field>
		<field name="description">Pantothenic acid, also called pantothenate or vitamin B5 (a B vitamin), is a water-soluble vitamin discovered by Roger J. Williams in 1919. For many animals, pantothenic acid is an essential nutrient. Animals require pantothenic acid to synthesize coenzyme-A (CoA), as well as to synthesize and metabolize proteins, carbohydrates, and fats.  Pantothenic acid is the amide between pantoic acid and ?-alanine. Small quantities of pantothenic acid are found in nearly every food, with high amounts in whole-grain cereals, legumes, eggs, meat, royal jelly, avocado, and yogurt. It is commonly found as its alcohol analog, the provitamin panthenol, and as calcium pantothenate. Pantothenic acid is an ingredient in some hair and skin care products. Only the dextrorotatory (D) isomer of pantothenic acid possesses biologic activity. The levorotatory (L) form may antagonize the effects of the dextrorotatory isomer. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1474</field>
		<field name="drug_name">4-Flourobenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1475</field>
		<field name="drug_name">Dimethylallyl Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1476</field>
		<field name="drug_name">D-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1477</field>
		<field name="drug_name">4-Imino-5-Methidyl-2-Methylpyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1478</field>
		<field name="drug_name">1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1479</field>
		<field name="drug_name">Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1480</field>
		<field name="drug_name">Piclamilast</field>
		<field name="description">Piclamilast (RP-73,401), is a selective PDE4 inhibitor. It is comparable to other PDE4 inhibitors for its anti-inflammatory effects. It has been investigated for its applications to the treatment of conditions such as chronic obstructive pulmonary disease, bronchopulmonary dysplasia and asthma. It is a second generation compound that exhibits structural functionalities of the PDE4 inhibitors cilomilast and roflumilast. The structure for piclamilast was first elucidated in a 1995 European patent application.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1481</field>
		<field name="drug_name">Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1482</field>
		<field name="drug_name">I-5</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1483</field>
		<field name="drug_name">bis(molybdopterin)tungsten cofactor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1484</field>
		<field name="drug_name">Phenyl Boronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1485</field>
		<field name="drug_name">Quinolinic Acid</field>
		<field name="description">A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1486</field>
		<field name="drug_name">(2r)-2-(Aminomethyl)-2,4-Dihydroxy-5-Oxo-3-(2-Oxoethyl)-2,5-Dihydro-1h-Imidazol-3-Ium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1487</field>
		<field name="drug_name">Ethyl Dihydrogen Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1488</field>
		<field name="drug_name">4-Hydroxy-3-Methyl Butyl Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1489</field>
		<field name="drug_name">N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1490</field>
		<field name="drug_name">(4r)-7aza-7,8-Dihydrolimonene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1491</field>
		<field name="drug_name">2-(Trimethylammonium)Ethyl Thiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1492</field>
		<field name="drug_name">2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1493</field>
		<field name="drug_name">Monoisopropylphosphorylserine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1494</field>
		<field name="drug_name">10-{4-Dimethylamino-5-[4-Hydroxy-6-Methyl-5-(6-Methyl-5-Oxo-Tetrahydro-Pyran-2-Yloxy)-Tetrahydro-Pyrane-2-Yloxy]-6-Methyl-Tetrahydro-Pyran-2-Yloxy}-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1495</field>
		<field name="drug_name">N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1496</field>
		<field name="drug_name">Thiarsahydroxy-Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1497</field>
		<field name="drug_name">1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1498</field>
		<field name="drug_name">[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1499</field>
		<field name="drug_name">3h-Indole-5,6-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1500</field>
		<field name="drug_name">Adenosine-3'-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1501</field>
		<field name="drug_name">Pyridoxyl-Glutamic Acid-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1502</field>
		<field name="drug_name">2-Tridecanoyloxy-Pentadecanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1503</field>
		<field name="drug_name">Nz-(Dicarboxymethyl)Lysine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1504</field>
		<field name="drug_name">(1s,6s,7r,8r,8ar)-1,6,7,8-Tetrahydroxyindolizidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1505</field>
		<field name="drug_name">Threonine-Aspartic Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1506</field>
		<field name="drug_name">O3-Sulfonylgalactose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1507</field>
		<field name="drug_name">Phosphoenolpyruvate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1508</field>
		<field name="drug_name">Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1509</field>
		<field name="drug_name">L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1510</field>
		<field name="drug_name">Dithiane Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1511</field>
		<field name="drug_name">Beta-D-Glucopyranose Spirohydantoin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1512</field>
		<field name="drug_name">(3s)-Tetrahydrofuran-3-Yl (1r,2s)-3-[4-((1r)-2-{[(S)-Amino(Hydroxy)Methyl]Oxy}-2,3-Dihydro-1h-Inden-1-Yl)-2-Benzyl-3-Oxopyrrolidin-2-Yl]-1-Benzyl-2-Hydroxypropylcarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1513</field>
		<field name="drug_name">2-Amino-8-Methylquinazolin-4(3h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1514</field>
		<field name="drug_name">N-Butyl Isocyanide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1515</field>
		<field name="drug_name">2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1516</field>
		<field name="drug_name">Methylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1517</field>
		<field name="drug_name">Desulfo-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1518</field>
		<field name="drug_name">{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1519</field>
		<field name="drug_name">Tryptophanyl-5'amp</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1520</field>
		<field name="drug_name">4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1521</field>
		<field name="drug_name">L-2-Amino-4-(Guanidinooxy)Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1522</field>
		<field name="drug_name">(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1523</field>
		<field name="drug_name">4r-Fluoro-N6-Ethanimidoyl-L-Lysine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1524</field>
		<field name="drug_name">[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1525</field>
		<field name="drug_name">O-Acetylserine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1526</field>
		<field name="drug_name">6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1527</field>
		<field name="drug_name">1,2-Propanediol</field>
		<field name="description">A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1528</field>
		<field name="drug_name">2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1529</field>
		<field name="drug_name">4,6-Dideoxyglucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1530</field>
		<field name="drug_name">3'-Phosphate-Adenosine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1531</field>
		<field name="drug_name">3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1532</field>
		<field name="drug_name">Dimethylformamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1533</field>
		<field name="drug_name">N-Butylbenzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1534</field>
		<field name="drug_name">Oxidized Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1535</field>
		<field name="drug_name">N-Carbamyl-D-Valine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1536</field>
		<field name="drug_name">Isocitrate Calcium Complex</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1537</field>
		<field name="drug_name">3,4-Dihydrouracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1538</field>
		<field name="drug_name">(2s,3s,8s,9s)-3-Amino-9-Methoxy-2,6,8-Trimethyl-10-Phenyldeca-4,6-Dienoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1539</field>
		<field name="drug_name">Tetrabutylammonium Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1540</field>
		<field name="drug_name">Kaempherol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1541</field>
		<field name="drug_name">Bacteriochlorophyll A</field>
		<field name="description">A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1542</field>
		<field name="drug_name">5-Bromonicotinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1543</field>
		<field name="drug_name">5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1544</field>
		<field name="drug_name">Pimelic Acid</field>
		<field name="description">A group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1545</field>
		<field name="drug_name">Phosphoaspartate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1546</field>
		<field name="drug_name">[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1547</field>
		<field name="drug_name">4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1548</field>
		<field name="drug_name">Cordycepin Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1549</field>
		<field name="drug_name">Glucose-Uridine-C1,5'-Diphosphate</field>
		<field name="description">A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1550</field>
		<field name="drug_name">1-(Isopropylthio)-Beta-Galactopyranside</field>
		<field name="description">A non-metabolizable galactose analog that induces expression of the LAC operon. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1551</field>
		<field name="drug_name">Inositol 1,3,4,5-Tetrakisphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1552</field>
		<field name="drug_name">5'-Guanosine-Diphosphate-Monothiophosphate</field>
		<field name="description">Guanosine 5&amp;#39;-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1553</field>
		<field name="drug_name">3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1554</field>
		<field name="drug_name">RU79256</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1555</field>
		<field name="drug_name">Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1556</field>
		<field name="drug_name">1,4-Dithio-Alpha-D-Mannose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1557</field>
		<field name="drug_name">[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1558</field>
		<field name="drug_name">Acetylgalactosamine-4-Sulfate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1559</field>
		<field name="drug_name">Epothilone D</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1560</field>
		<field name="drug_name">Tropinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1561</field>
		<field name="drug_name">8-Azaxanthine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1562</field>
		<field name="drug_name">Bis(5-Amidino-2-Benzimidazolyl)Methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1563</field>
		<field name="drug_name">N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1564</field>
		<field name="drug_name">Benzophenone</field>
		<field name="description">Benzophenone is the organic compound. Substituted benzophenones such as oxybenzone and dioxybenzone are used in sunscreen.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1565</field>
		<field name="drug_name">(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1566</field>
		<field name="drug_name">3,4-Dihydroxycinnamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1567</field>
		<field name="drug_name">2-Methylpentane-1,2,4-Triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1568</field>
		<field name="drug_name">(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1569</field>
		<field name="drug_name">N-(Sulfanylacetyl)Tyrosylprolylmethioninamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1570</field>
		<field name="drug_name">2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1571</field>
		<field name="drug_name">D-Galctopyranosyl-1-On</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1572</field>
		<field name="drug_name">Inhibitor BEA369</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1573</field>
		<field name="drug_name">4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1574</field>
		<field name="drug_name">16,17-Androstene-3-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1575</field>
		<field name="drug_name">Deoxy-Bigchap</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1576</field>
		<field name="drug_name">Tl-3-093</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1577</field>
		<field name="drug_name">Hyperforin</field>
		<field name="description">Hyperforin is a phytochemical produced by some of the members of the plant genus Hypericum, notably Hypericum perforatum (St John's wort).</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1578</field>
		<field name="drug_name">N6-Benzyl Adenosine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1579</field>
		<field name="drug_name">5-N-Acetyl-Alpha-D-Neuraminic Acid</field>
		<field name="description">An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1580</field>
		<field name="drug_name">Aspartyl-Adenosine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1581</field>
		<field name="drug_name">M-Aminophenylboronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1582</field>
		<field name="drug_name">2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1583</field>
		<field name="drug_name">2s,3r-2-Amino-3-Methylpentanedioic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1584</field>
		<field name="drug_name">Nd1-Phosphonohistidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1585</field>
		<field name="drug_name">Toluene</field>
		<field name="description">A widely used industrial solvent. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1586</field>
		<field name="drug_name">Sucrose Octasulfate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1587</field>
		<field name="drug_name">1-Ethyl-Pyrrolidine-2,5-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1588</field>
		<field name="drug_name">5-Bromo-2'-Deoxyuridine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1589</field>
		<field name="drug_name">D-Xylitol</field>
		<field name="description">A five-carbon sugar alcohol derived from xylose by reduction of the carbonyl group. It is as sweet as sucrose and used as a noncariogenic sweetener. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1590</field>
		<field name="drug_name">2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1591</field>
		<field name="drug_name">3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1592</field>
		<field name="drug_name">Nicotinamide-Adenine-Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1593</field>
		<field name="drug_name">RU85493</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1594</field>
		<field name="drug_name">Alpha-Cyclodextrin (Cyclohexa-Amylose)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1595</field>
		<field name="drug_name">Adenosyl-Ornithine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1596</field>
		<field name="drug_name">N-Methylmesoporphyrin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1597</field>
		<field name="drug_name">2,2':6',2''-Terpyridine Platinum(Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1598</field>
		<field name="drug_name">Lipid Fragment</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1599</field>
		<field name="drug_name">D-Glucose in Linear Form</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1600</field>
		<field name="drug_name">S-Hydroxycysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1601</field>
		<field name="drug_name">Putrescine</field>
		<field name="description">A toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1602</field>
		<field name="drug_name">[Methyltelluro]Acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1603</field>
		<field name="drug_name">Pentanal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1604</field>
		<field name="drug_name">1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose</field>
		<field name="description">Includes ortho-, meta-, and para-nitrophenylgalactosides. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1605</field>
		<field name="drug_name">Xylose-Derived Lactam Oxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1606</field>
		<field name="drug_name">Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1607</field>
		<field name="drug_name">L-Xylulose 5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1608</field>
		<field name="drug_name">Benzhydroxamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1609</field>
		<field name="drug_name">2'-Chloro-Biphenyl-2,3-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1610</field>
		<field name="drug_name">Carboxymycobactin S</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1611</field>
		<field name="drug_name">Duroquinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1612</field>
		<field name="drug_name">Huperaine A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1613</field>
		<field name="drug_name">5-Chloryl-2,4,6-Quinazolinetriamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1614</field>
		<field name="drug_name">2,4-Dihydroxy-3,3-Dimethyl-Butyrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1615</field>
		<field name="drug_name">Dcka, 5,7-Dichlorokynurenic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1616</field>
		<field name="drug_name">5-Methylpyrrole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1617</field>
		<field name="drug_name">7-Hydroxystaurosporine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1618</field>
		<field name="drug_name">N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1619</field>
		<field name="drug_name">3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1620</field>
		<field name="drug_name">Ribose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1621</field>
		<field name="drug_name">Guanosine-2'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1622</field>
		<field name="drug_name">L-Histidine Beta Naphthylamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1623</field>
		<field name="drug_name">5-Amidino-Benzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1624</field>
		<field name="drug_name">Balanol Analog 2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1625</field>
		<field name="drug_name">6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1626</field>
		<field name="drug_name">Formic Acid</field>
		<field name="description">Formic acid (systematically called methanoic acid) is the simplest carboxylic acid. It is an important intermediate in chemical synthesis and occurs naturally, most famously in the venom of bee and ant stings. The principal use of formic acid is as a preservative and antibacterial agent in livestock feed. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1627</field>
		<field name="drug_name">(S)-blebbistatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1628</field>
		<field name="drug_name">4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1629</field>
		<field name="drug_name">3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1630</field>
		<field name="drug_name">RU78262</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1631</field>
		<field name="drug_name">1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1632</field>
		<field name="drug_name">2-Amino-N,3,3-Trimethylbutanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1633</field>
		<field name="drug_name">N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1634</field>
		<field name="drug_name">Gpi-1046</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1635</field>
		<field name="drug_name">1,N6-Ethenoadenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1636</field>
		<field name="drug_name">Inhibitor of P38 Kinase</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1637</field>
		<field name="drug_name">4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone</field>
		<field name="description">A phosphodiesterase inhibitor with antidepressant properties. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1638</field>
		<field name="drug_name">1,4-Butanediol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1639</field>
		<field name="drug_name">2-Aminoethanesulfonic Acid</field>
		<field name="description">A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1640</field>
		<field name="drug_name">3-Chlorophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1641</field>
		<field name="drug_name">5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1642</field>
		<field name="drug_name">3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1643</field>
		<field name="drug_name">7n-Methyl-8-Hydroguanosine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1644</field>
		<field name="drug_name">Cytidine-3'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1645</field>
		<field name="drug_name">Phosphonotyrosine</field>
		<field name="description">An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1646</field>
		<field name="drug_name">Phenylethane Boronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1647</field>
		<field name="drug_name">AL5424</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1648</field>
		<field name="drug_name">2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1649</field>
		<field name="drug_name">Di-Stearoyl-3-Sn-Phosphatidylethanolamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1650</field>
		<field name="drug_name">N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1651</field>
		<field name="drug_name">2-Thioethenamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1652</field>
		<field name="drug_name">Trifluoroacetonyl Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1653</field>
		<field name="drug_name">Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1654</field>
		<field name="drug_name">trans-urocanic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1655</field>
		<field name="drug_name">Guanosine-5'-Monophosphate</field>
		<field name="description">Guanosine 5&amp;#39;-monophosphate. A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1656</field>
		<field name="drug_name">O-Benzylsulfonyl-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1657</field>
		<field name="drug_name">2-Amino-3-[5-(Amino-Carboxy-Methyl)-2,3-Dihydro-Isoxazol-3-Ylsulfanyl]-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1658</field>
		<field name="drug_name">AMPCPR</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1659</field>
		<field name="drug_name">Aminoanthracene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1660</field>
		<field name="drug_name">6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1661</field>
		<field name="drug_name">7,9-Dimethylguanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1662</field>
		<field name="drug_name">Methyl alpha-D-mannoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1663</field>
		<field name="drug_name">Para-Iodo-D-Phenylalanine Hydroxamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1664</field>
		<field name="drug_name">3,6-Anhydro-D-Galactose-2-Sulfate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1665</field>
		<field name="drug_name">D-Mannuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1666</field>
		<field name="drug_name">2(S)-Amino-6-Boronohexanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1667</field>
		<field name="drug_name">4-[2-(3-Benzyloxycarbonylamino-4-Cyclohexyl-1-Hydroxy-2-Oxo-Butylamino)-5-Guanidino-Pentanoylamino]-4-(1-Carboxy-2-Cyclohexyl-Ethylcarbamoyl)-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1668</field>
		<field name="drug_name">N-Alpha-L-Acetyl-Arginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1669</field>
		<field name="drug_name">3-Fluoro-2-Methyl-Aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1670</field>
		<field name="drug_name">Thiamin Diphosphate</field>
		<field name="description">The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the pyruvate dehydrogenase complex and the ketoglutarate dehydrogenase complex. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1671</field>
		<field name="drug_name">6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1672</field>
		<field name="drug_name">Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1673</field>
		<field name="drug_name">Cholesterol-Sulfate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1674</field>
		<field name="drug_name">Tu-514</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1675</field>
		<field name="drug_name">Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1676</field>
		<field name="drug_name">N-(5'-Phosphopyridoxyl)-D-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1677</field>
		<field name="drug_name">2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1678</field>
		<field name="drug_name">5-Methylcytidine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1679</field>
		<field name="drug_name">3-Methylpyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1680</field>
		<field name="drug_name">3-Bromo-7-Nitroindazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1681</field>
		<field name="drug_name">2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1682</field>
		<field name="drug_name">5,10,15,20-Tetrakis(4-Sulpfonatophenyl)-21h,23h-Porphine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1683</field>
		<field name="drug_name">Gamma-Phenyl-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1684</field>
		<field name="drug_name">5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1685</field>
		<field name="drug_name">2-Aminoprop-2-Enamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1686</field>
		<field name="drug_name">Delta-Bis(2,2'-Bipyridine)Imidazole Ruthenium (Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1687</field>
		<field name="drug_name">5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1688</field>
		<field name="drug_name">2-Oxo-3-Pentenoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1689</field>
		<field name="drug_name">Br-Coeleneterazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1690</field>
		<field name="drug_name">Alpha-D-Glucose-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1691</field>
		<field name="drug_name">1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1692</field>
		<field name="drug_name">L-756,423</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1693</field>
		<field name="drug_name">Staurosporine</field>
		<field name="description">An indolocarbazole that is a potent protein kinase C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. (Biochem Biophys Res Commun 1995;214(3):1114-20)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1694</field>
		<field name="drug_name">N-(Phosphonoacetyl)-L-Ornithine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1695</field>
		<field name="drug_name">Monoazido-Mu-Oxo-Diiron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1696</field>
		<field name="drug_name">Compound 9</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1697</field>
		<field name="drug_name">Dihydrofolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1698</field>
		<field name="drug_name">R048-8071</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1699</field>
		<field name="drug_name">Imidazole-Derived Cellobiose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1700</field>
		<field name="drug_name">Amido Phenyl Pyruvic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1701</field>
		<field name="drug_name">Acetyl Dithranol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1702</field>
		<field name="drug_name">Alrestatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1703</field>
		<field name="drug_name">Fidarestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1704</field>
		<field name="drug_name">4-Amino-5-Hydroxymethyl-2-Methylpyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1705</field>
		<field name="drug_name">8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1706</field>
		<field name="drug_name">3-phenylpropionic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1707</field>
		<field name="drug_name">L-D-(a-Aminoadipoyl)-L-Cysteinyl-D-Valine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1708</field>
		<field name="drug_name">Furo[2,3d]Pyrimidine Antifolate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1709</field>
		<field name="drug_name">N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1710</field>
		<field name="drug_name">L-Alpha-Glycerophospho-D-Myo-Inositol-4,5-Bis-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1711</field>
		<field name="drug_name">N-Cyclohexyl-N'-(4-Iodophenyl)Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1712</field>
		<field name="drug_name">Alpha-Ribazole-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1713</field>
		<field name="drug_name">(6s)-5,6,7,8-Tetrahydrofolate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1714</field>
		<field name="drug_name">1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1715</field>
		<field name="drug_name">N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1716</field>
		<field name="drug_name">Swainsonine</field>
		<field name="description">An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1717</field>
		<field name="drug_name">1-Hexadecylsulfonyl Fluoride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1718</field>
		<field name="drug_name">2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1719</field>
		<field name="drug_name">2,4-Diamino-4,6-Dihydroxypyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1720</field>
		<field name="drug_name">D-Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1721</field>
		<field name="drug_name">S-Acetyl-Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1722</field>
		<field name="drug_name">4-Aminophthalhydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1723</field>
		<field name="drug_name">2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1724</field>
		<field name="drug_name">1,2-Dipalmitoyl-Phosphatidyl-Glycerole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1725</field>
		<field name="drug_name">N-(3-(Aminomethyl)Benzyl)Acetamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1726</field>
		<field name="drug_name">Amylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1727</field>
		<field name="drug_name">N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1728</field>
		<field name="drug_name">2-(1,1'-Biphenyl-4-Yl)Propanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1729</field>
		<field name="drug_name">1,2,4-Triazole-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1730</field>
		<field name="drug_name">2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1731</field>
		<field name="drug_name">3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid 4-Nitro-Phenyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1732</field>
		<field name="drug_name">Indirubin-3'-Monoxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1733</field>
		<field name="drug_name">Ribose-5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1734</field>
		<field name="drug_name">Gabaculine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1735</field>
		<field name="drug_name">N-Butyl-Benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1736</field>
		<field name="drug_name">(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid</field>
		<field name="description">The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1737</field>
		<field name="drug_name">AMPA</field>
		<field name="description">AMPA is a specific agonist for the AMPA receptor.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1738</field>
		<field name="drug_name">SU4984</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1739</field>
		<field name="drug_name">Adenosine-5-Diphosphoribose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1740</field>
		<field name="drug_name">Cyclohexanone</field>
		<field name="description">Cyclohexanone (also known as oxocyclohexane, pimelic ketone, ketohexamethylene, cyclohexyl ketone or ketocyclohexane) is a six-carbon cyclic molecule with a ketone functional group. It is a colorless, oily liquid with an acetone-like smell.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1741</field>
		<field name="drug_name">Cellobiose</field>
		<field name="description">A disaccharide consisting of two glucose units in beta (1-4) glycosidic linkage. Obtained from the partial hydrolysis of cellulose. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1742</field>
		<field name="drug_name">N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1743</field>
		<field name="drug_name">CRA_16847</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1744</field>
		<field name="drug_name">4-Deoxylactose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1745</field>
		<field name="drug_name">N7-Methyl-Formycin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1746</field>
		<field name="drug_name">Triglu-5-Formyl-Tetrahydrofolate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1747</field>
		<field name="drug_name">Delta-Amino Valeric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1748</field>
		<field name="drug_name">N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1749</field>
		<field name="drug_name">L-2-Amino-4-[2-Aminophenyl]-4-Oxobutanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1750</field>
		<field name="drug_name">WAY-151693</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1751</field>
		<field name="drug_name">2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1752</field>
		<field name="drug_name">Biliverdine Ix Alpha</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1753</field>
		<field name="drug_name">Butenoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1754</field>
		<field name="drug_name">(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1755</field>
		<field name="drug_name">6-Phosphogluconic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1756</field>
		<field name="drug_name">L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1757</field>
		<field name="drug_name">1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1758</field>
		<field name="drug_name">(Aminooxy)Acetic Acid</field>
		<field name="description">A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1759</field>
		<field name="drug_name">1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1760</field>
		<field name="drug_name">Bis-Benzamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1761</field>
		<field name="drug_name">Phosphoaminophosphonic Acid Guanylate Ester</field>
		<field name="description">A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of adenylate cyclase. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1762</field>
		<field name="drug_name">Dimethylglycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1763</field>
		<field name="drug_name">CRA_17312</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1764</field>
		<field name="drug_name">1-Aminocyclopropanecarboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1765</field>
		<field name="drug_name">(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1766</field>
		<field name="drug_name">3,5-Difluorobenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1767</field>
		<field name="drug_name">Norleucine Phosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1768</field>
		<field name="drug_name">CP-526423</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1769</field>
		<field name="drug_name">A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1770</field>
		<field name="drug_name">4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1771</field>
		<field name="drug_name">Cholesteryl Linoleate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1772</field>
		<field name="drug_name">5-Phospho-D-Arabinohydroxamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1773</field>
		<field name="drug_name">N-2-Thiophen-2-Yl-Acetamide Boronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1774</field>
		<field name="drug_name">Isatin</field>
		<field name="description">Isatin is an indole derivative. The compound was first obtained by Erdman and Laurent in 1841 as a product from the oxidation of Indigo dye by nitric acid and chromic acids. The compound is found in many plants and Schiff bases of Isatin are investigated for their pharmaceutical properties. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1775</field>
		<field name="drug_name">FR221647</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1776</field>
		<field name="drug_name">Cytidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1777</field>
		<field name="drug_name">Adenosine-2'-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1778</field>
		<field name="drug_name">S-azabisabolene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1779</field>
		<field name="drug_name">Methyl alpha-galactoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1780</field>
		<field name="drug_name">Fidarestat(Stereoisomer)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1781</field>
		<field name="drug_name">DMP450</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1782</field>
		<field name="drug_name">2-Chlorodideoxyadenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1783</field>
		<field name="drug_name">2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1784</field>
		<field name="drug_name">3,5-Dinitrocatechol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1785</field>
		<field name="drug_name">[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1786</field>
		<field name="drug_name">Leucine - Reduced Carbonyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1787</field>
		<field name="drug_name">2-Aminoethanimidic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1788</field>
		<field name="drug_name">Hadacidin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1789</field>
		<field name="drug_name">Protoporphyrin Ix Containing Co</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1790</field>
		<field name="drug_name">3-Hydroxyisoxazole-4-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1791</field>
		<field name="drug_name">Zk-806450</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1792</field>
		<field name="drug_name">6-Methylpurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1793</field>
		<field name="drug_name">Para-Isopropylaniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1794</field>
		<field name="drug_name">Daidzin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1795</field>
		<field name="drug_name">Olomoucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1796</field>
		<field name="drug_name">CP-271485</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1797</field>
		<field name="drug_name">6-Hydroxymethyl-7,8-Dihydropterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1798</field>
		<field name="drug_name">6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1799</field>
		<field name="drug_name">Butyramide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1800</field>
		<field name="drug_name">4-iodo-acetamido phenylboronic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1801</field>
		<field name="drug_name">Glycochenodeoxycholic Acid</field>
		<field name="description">A bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1802</field>
		<field name="drug_name">(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1803</field>
		<field name="drug_name">Adamantanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1804</field>
		<field name="drug_name">4-Carboxycinnamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1805</field>
		<field name="drug_name">Methylphosphonic Acid Diisopropyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1806</field>
		<field name="drug_name">[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1807</field>
		<field name="drug_name">Dihydroorotic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1808</field>
		<field name="drug_name">4-Hydroxy-3-Methoxybenzoate</field>
		<field name="description">A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. (J Biotechnol 1996;50(2-3):107-13). [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1809</field>
		<field name="drug_name">N-1-Methylheptylformamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1810</field>
		<field name="drug_name">[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1811</field>
		<field name="drug_name">Chlorophyll A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1812</field>
		<field name="drug_name">Xanthine</field>
		<field name="description">A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1813</field>
		<field name="drug_name">4-{2,6,8-Trioxo-9-[(2r,3s,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1814</field>
		<field name="drug_name">Cephalosporin Analog</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1815</field>
		<field name="drug_name">Molybdenum Cofactor</field>
		<field name="description">Absence of molybdenum cofactor leads to accumulation of toxic levels of sulphite and neurological damage usually leading to death within months of birth, due to the lack of active sulfite oxidase.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1816</field>
		<field name="drug_name">Diethyl 4-Methylbenzylphosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1817</field>
		<field name="drug_name">(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1818</field>
		<field name="drug_name">N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1819</field>
		<field name="drug_name">S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1820</field>
		<field name="drug_name">Pyridoxamine-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1821</field>
		<field name="drug_name">N-Isopropyl-N'-Hydroxyguanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1822</field>
		<field name="drug_name">1,2-Diacyl-Sn-Glycero-3-Phosphoinositol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1823</field>
		<field name="drug_name">Butan-1-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1824</field>
		<field name="drug_name">Atrazine Glutathione Conjugate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1825</field>
		<field name="drug_name">Cyclo-Tetrametavanadate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1826</field>
		<field name="drug_name">3-Amino-4-Oxybenzyl-2-Butanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1827</field>
		<field name="drug_name">Methionine Phosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1828</field>
		<field name="drug_name">K-252a</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1829</field>
		<field name="drug_name">3-Sulfinoalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1830</field>
		<field name="drug_name">2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1831</field>
		<field name="drug_name">Balanol Analog 8</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1832</field>
		<field name="drug_name">Sulfopyruvate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1833</field>
		<field name="drug_name">(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1834</field>
		<field name="drug_name">R-1,2-Propanediol</field>
		<field name="description">A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1835</field>
		<field name="drug_name">S-Butyryl-Cystein</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1836</field>
		<field name="drug_name">Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1837</field>
		<field name="drug_name">5'-O-(N-Ethyl-Sulfamoyl)Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1838</field>
		<field name="drug_name">2,5-Xylidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1839</field>
		<field name="drug_name">N-Sulfo-Flavin Mononucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1840</field>
		<field name="drug_name">Zinc Trihydroxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1841</field>
		<field name="drug_name">Propidium</field>
		<field name="description">Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1842</field>
		<field name="drug_name">N,N-Dimethyl-L-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1843</field>
		<field name="drug_name">Bromopurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1844</field>
		<field name="drug_name">9,10-Deepithio-9,10-Didehydroacanthifolicin</field>
		<field name="description">A specific inhibitor of phosphoserine/threonine protein phosphatase 1 and 2a. It is also a potent tumor promoter. (Thromb Res 1992;67(4):345-54 &amp; Cancer Res 1993;53(2):239-41)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1845</field>
		<field name="drug_name">1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1846</field>
		<field name="drug_name">D-Fructose-6-Phosphate (Open Form)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1847</field>
		<field name="drug_name">2,5-Dideoxy-2,5-Imino-D-Glucitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1848</field>
		<field name="drug_name">Co(Iii)-(Deuteroporphyrin Ix)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1849</field>
		<field name="drug_name">D-Glutamine</field>
		<field name="description">A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1850</field>
		<field name="drug_name">Malonic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1851</field>
		<field name="drug_name">Mercury Acetate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1852</field>
		<field name="drug_name">1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1853</field>
		<field name="drug_name">Phenylacetaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1854</field>
		<field name="drug_name">O-Trifluoromethylphenyl Anthranilic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1855</field>
		<field name="drug_name">Myristoyl-Coa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1856</field>
		<field name="drug_name">2'-Deoxyguanosine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1857</field>
		<field name="drug_name">Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1858</field>
		<field name="drug_name">Adenosine-5'-Ditungstate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1859</field>
		<field name="drug_name">(2s,3s)-1,4-Dimercaptobutane-2,3-Diol</field>
		<field name="description">A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1860</field>
		<field name="drug_name">2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1861</field>
		<field name="drug_name">N-Acetyl-D-Galactosamine 6-Sulfate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1862</field>
		<field name="drug_name">Equilin</field>
		<field name="description">An estrogenic steroid produced by horses. It has a total of four double bonds in the A- and B-ring. High concentration of euilin is found in the urine of pregnant mares. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1863</field>
		<field name="drug_name">N-Methylmesoporphyrin Containing Copper</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1864</field>
		<field name="drug_name">2',3'-Dideoxyadenosine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1865</field>
		<field name="drug_name">2-Oxalosuccinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1866</field>
		<field name="drug_name">(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1867</field>
		<field name="drug_name">2-Phenyl-Ethanol</field>
		<field name="description">An antimicrobial, antiseptic, and disinfectant that is used also as an aromatic essence and preservative in pharmaceutics and perfumery. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1868</field>
		<field name="drug_name">2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1869</field>
		<field name="drug_name">8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1870</field>
		<field name="drug_name">3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1871</field>
		<field name="drug_name">Uridine-Diphosphate-N-Acetylgalactosamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1872</field>
		<field name="drug_name">4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1873</field>
		<field name="drug_name">2-Bromoacetyl Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1874</field>
		<field name="drug_name">1,3-Dedimethyl-1,3-Divinyl Heme</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1875</field>
		<field name="drug_name">3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonylmethylbenzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1876</field>
		<field name="drug_name">Malonate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1877</field>
		<field name="drug_name">1,3-Butanediol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1878</field>
		<field name="drug_name">Acetone Cyanohydrin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1879</field>
		<field name="drug_name">6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1880</field>
		<field name="drug_name">7-Nitroindazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1881</field>
		<field name="drug_name">Pyridoxine-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1882</field>
		<field name="drug_name">Hexane-1,6-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1883</field>
		<field name="drug_name">N-Methyl-N-Propargyl-1(R)-Aminoindan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1884</field>
		<field name="drug_name">Pyrophosphate 2-</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1885</field>
		<field name="drug_name">Metanitrophenyl-Alpha-D-Galactoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1886</field>
		<field name="drug_name">6,7-Dioxo-5h-8-Ribitylaminolumazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1887</field>
		<field name="drug_name">Furoyl-Leucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1888</field>
		<field name="drug_name">S-Methylcysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1889</field>
		<field name="drug_name">Dpb-T</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1890</field>
		<field name="drug_name">N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1891</field>
		<field name="drug_name">3-Cyclohexyl-1-Propylsulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1892</field>
		<field name="drug_name">Al7089a</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1893</field>
		<field name="drug_name">4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1894</field>
		<field name="drug_name">2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1895</field>
		<field name="drug_name">Ly231514 Tetra Glu</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1896</field>
		<field name="drug_name">(2s,3s)-Trans-Dihydroquercetin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1897</field>
		<field name="drug_name">1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1898</field>
		<field name="drug_name">3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1899</field>
		<field name="drug_name">4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1900</field>
		<field name="drug_name">2-Fluoro-2-Deoxy-Beta-D-Galactopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1901</field>
		<field name="drug_name">5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1902</field>
		<field name="drug_name">Immucillin-G</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1903</field>
		<field name="drug_name">1,2-Dihydroxybenzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1904</field>
		<field name="drug_name">6-Hydroxy-D-Norleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1905</field>
		<field name="drug_name">Ethylisothiourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1906</field>
		<field name="drug_name">Methionine Sulfoxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1907</field>
		<field name="drug_name">Glycinamide Ribonucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1908</field>
		<field name="drug_name">Maltotetraose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1909</field>
		<field name="drug_name">4-(Methylsulfanyl)-2-Oxobutanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1910</field>
		<field name="drug_name">Laevulinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1911</field>
		<field name="drug_name">N-{(1s)-4-[Bis(2-Chloroethyl)Amino]-1-Methylbutyl}-N-(6-Chloro-2-Methoxy-9-Acridinyl)Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1912</field>
		<field name="drug_name">8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1913</field>
		<field name="drug_name">Cyclohexane Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1914</field>
		<field name="drug_name">4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1915</field>
		<field name="drug_name">7-Deazaguanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1916</field>
		<field name="drug_name">Hydrolyzed Cephalothin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1917</field>
		<field name="drug_name">3-Methyl-5-Sulfo-Pyrrolidine-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1918</field>
		<field name="drug_name">2-Ethoxyethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1919</field>
		<field name="drug_name">Cu-Bicyclam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1920</field>
		<field name="drug_name">O-Succinylbenzoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1921</field>
		<field name="drug_name">Iodophenyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1922</field>
		<field name="drug_name">(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1923</field>
		<field name="drug_name">Trifluoro-thiamin phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1924</field>
		<field name="drug_name">GM6001</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1925</field>
		<field name="drug_name">2'-Deoxyuridine</field>
		<field name="description">2&amp;#39;-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1926</field>
		<field name="drug_name">N-Bromoacetyl-Aminoethyl Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1927</field>
		<field name="drug_name">SR11254</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1928</field>
		<field name="drug_name">3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1929</field>
		<field name="drug_name">4-Oxosebacic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1930</field>
		<field name="drug_name">Platelet Activating Factor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1931</field>
		<field name="drug_name">Orotic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1932</field>
		<field name="drug_name">Glyceraldehyde-3-Phosphate</field>
		<field name="description">An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1933</field>
		<field name="drug_name">O2-Sulfo-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1934</field>
		<field name="drug_name">Ethyl-Trimethyl-Silane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1935</field>
		<field name="drug_name">Flufenamic Acid</field>
		<field name="description">An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1936</field>
		<field name="drug_name">Argininosuccinate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1937</field>
		<field name="drug_name">4-(Acetylamino)-3-Amino Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1938</field>
		<field name="drug_name">[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1939</field>
		<field name="drug_name">Dimethylallyl S-Thiolodiphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1940</field>
		<field name="drug_name">S-(2-Oxo)Pentadecylcoa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1941</field>
		<field name="drug_name">Porphobilinogen</field>
		<field name="description">Porphobilinogen is a pyrrole involved in porphyrin metabolism. It is generated by the enzyme ALA dehydratase, and converted into hydroxymethyl bilane by the enzyme porphobilinogen deaminase.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1942</field>
		<field name="drug_name">2,6-Dimethyl-7-Octen-2-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1943</field>
		<field name="drug_name">7-Keto-8-Aminopelargonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1944</field>
		<field name="drug_name">[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl] -Acetaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1945</field>
		<field name="drug_name">(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1946</field>
		<field name="drug_name">1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1947</field>
		<field name="drug_name">7,8-Dihydro-7,7-Dimethyl-6-Hydroxypterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1948</field>
		<field name="drug_name">Benzoylformic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1949</field>
		<field name="drug_name">(R)-Mandelic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1950</field>
		<field name="drug_name">Formycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1951</field>
		<field name="drug_name">5'-Deoxy-5'-Methylthioadenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1952</field>
		<field name="drug_name">2-Phenylamino-Ethanesulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1953</field>
		<field name="drug_name">Protoporphyrin Ix</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1954</field>
		<field name="drug_name">2-Amino-3-(4-Amino-1h-Indol-3-Yl)Propanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1955</field>
		<field name="drug_name">2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1956</field>
		<field name="drug_name">CRA_9334</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1957</field>
		<field name="drug_name">2-Aminopropanedioic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1958</field>
		<field name="drug_name">3-{2,6,8-Trioxo-9-[(2s,3s,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1959</field>
		<field name="drug_name">6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1960</field>
		<field name="drug_name">2,3-Di-O-Phytanly-3-Sn-Glycero-1-Phosphoryl-3'-Sn-Glycerol-1'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1961</field>
		<field name="drug_name">(5r,6s,7s,8s)-5-Hydroxymethyl-6,7,8-Trihydroxy-Tetrazolo[1,5-a]Piperidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1962</field>
		<field name="drug_name">N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1963</field>
		<field name="drug_name">1-Hydroxy-3-Methylbutane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1964</field>
		<field name="drug_name">2-Amino-6-Chloropyrazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1965</field>
		<field name="drug_name">5-Hydroxyamino-3-Methyl-Pyrrolidine-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1966</field>
		<field name="drug_name">Arginineamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1967</field>
		<field name="drug_name">Calcipotriol</field>
		<field name="description">Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1968</field>
		<field name="drug_name">5,10-Methylene-6-Hydrofolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1969</field>
		<field name="drug_name">N3, N4-Dimethylarginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1970</field>
		<field name="drug_name">(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1971</field>
		<field name="drug_name">Prostaglandin B2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1972</field>
		<field name="drug_name">4,5-Dehydro-D-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1973</field>
		<field name="drug_name">Palmitoyl-Linoleoyl Phosphatidylcholine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1974</field>
		<field name="drug_name">N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1975</field>
		<field name="drug_name">4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1976</field>
		<field name="drug_name">5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1977</field>
		<field name="drug_name">3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1978</field>
		<field name="drug_name">Methyl Methylsulfinylmethyl Sulfide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1979</field>
		<field name="drug_name">Beta-Galactose-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1980</field>
		<field name="drug_name">4-{2-(4-Fluoro-Benzyl)-6-Methyl-5-[(5-Methyl-Isoxazole-3-Carbonyl)-Amino]-4-Oxo-Heptanoylamino}-5-(2-Oxo-Pyrrolidin-3-Yl)-Pentanoic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1981</field>
		<field name="drug_name">Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1982</field>
		<field name="drug_name">Cyclic Guanosine Monophosphate</field>
		<field name="description">A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3&amp;#39;- and 5&amp;#39;-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1983</field>
		<field name="drug_name">1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1984</field>
		<field name="drug_name">Alpha-D-Galactose-1-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1985</field>
		<field name="drug_name">2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1986</field>
		<field name="drug_name">5,6-Dihydroxy-Nadp</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1987</field>
		<field name="drug_name">1-N-Acetyl-Beta-D-Glucosamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1988</field>
		<field name="drug_name">5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1989</field>
		<field name="drug_name">Heparin Disaccharide I-S</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1990</field>
		<field name="drug_name">EM-1745</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1991</field>
		<field name="drug_name">5-Iodo-2'-Deoxyuridine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1992</field>
		<field name="drug_name">1-Hydroxyamine-2-Isobutylmalonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1993</field>
		<field name="drug_name">2-[2-(2-Hydroxy-Ethoxy)-Ethoxy]-Ethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1994</field>
		<field name="drug_name">2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1995</field>
		<field name="drug_name">Carbenoxolone</field>
		<field name="description">An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">1996</field>
		<field name="drug_name">(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1997</field>
		<field name="drug_name">Flavin-N7 Protonated-Adenine Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1998</field>
		<field name="drug_name">Deoxyuridine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">1999</field>
		<field name="drug_name">(R)-2-Hydroxy-3-Sulfopropanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2000</field>
		<field name="drug_name">2-Aminothiazoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2001</field>
		<field name="drug_name">RU83876</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2002</field>
		<field name="drug_name">S-(D-Carboxybutyl)-L-Homocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2003</field>
		<field name="drug_name">Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2004</field>
		<field name="drug_name">Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2005</field>
		<field name="drug_name">N-Acetyl-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2006</field>
		<field name="drug_name">Mdl 101,146</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2007</field>
		<field name="drug_name">3,6,9,12,15-Pentaoxaheptadecane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2008</field>
		<field name="drug_name">O-Sialic Acid (Chair Conformation)</field>
		<field name="description">An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2009</field>
		<field name="drug_name">Selenocysteine</field>
		<field name="description">A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2010</field>
		<field name="drug_name">3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2011</field>
		<field name="drug_name">2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2012</field>
		<field name="drug_name">Fluoro-Phosphite Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2013</field>
		<field name="drug_name">Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2014</field>
		<field name="drug_name">N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2015</field>
		<field name="drug_name">Hirulog</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2016</field>
		<field name="drug_name">3-(Benzyloxy)Pyridin-2-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2017</field>
		<field name="drug_name">Heparin Disaccharide Iii-S</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2018</field>
		<field name="drug_name">4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2019</field>
		<field name="drug_name">Adenosine-5'-Rp-Alpha-Thio-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2020</field>
		<field name="drug_name">4-Imidazolmethylene-5-Imidazolone Chromophore</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2021</field>
		<field name="drug_name">Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2022</field>
		<field name="drug_name">LY374571</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2023</field>
		<field name="drug_name">9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2024</field>
		<field name="drug_name">Bis-Napthyl Beta-Ketophosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2025</field>
		<field name="drug_name">S-Methyl Thiocysteine Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2026</field>
		<field name="drug_name">4-Aminobenzoic Acid</field>
		<field name="description">A member of the vitamin B complex. It used to be common in sunscreening agents until found to also be a sensitizer. The potassium salt is used therapeutically in fibrotic skin disorders. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2027</field>
		<field name="drug_name">2'-Monophosphoadenosine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2028</field>
		<field name="drug_name">2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2029</field>
		<field name="drug_name">1,10-Phenanthroline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2030</field>
		<field name="drug_name">CRA_10762</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2031</field>
		<field name="drug_name">(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2032</field>
		<field name="drug_name">N-Acetyl-L-Citrulline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2033</field>
		<field name="drug_name">3-Aza-2,3-Dihydrogeranyl Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2034</field>
		<field name="drug_name">Nz-(1-Carboxyethyl)-Lysine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2035</field>
		<field name="drug_name">2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2036</field>
		<field name="drug_name">2,5-Dimethylpyrimidin-4-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2037</field>
		<field name="drug_name">Adenosine Monotungstate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2038</field>
		<field name="drug_name">Xylose-Derived Imidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2039</field>
		<field name="drug_name">Myricetin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2040</field>
		<field name="drug_name">D-Gluconhydroximo-1,5-Lactam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2041</field>
		<field name="drug_name">Guanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2042</field>
		<field name="drug_name">MMI-175</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2043</field>
		<field name="drug_name">Beta-D-Glucose</field>
		<field name="description">A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2044</field>
		<field name="drug_name">2'-Deoxyinosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2045</field>
		<field name="drug_name">Nor-N-Omega-Hydroxy-L-Arginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2046</field>
		<field name="drug_name">Namn</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2047</field>
		<field name="drug_name">Tolrestat</field>
		<field name="description">Tolrestat (INN) (AY-27773) is an aldose reductase inhibitor which was approved for the control of certain diabetic complications. While it was approved for marketed in several countries, it failed a Phase III trial in the U.S. due to toxicity and never received FDA approval. It was discontinued by Wyeth in 1997 because of the risk of severe liver toxicity and death. It was sold under the tradename Alredase. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2048</field>
		<field name="drug_name">(E)-2-Fluoro-P-Hydroxycinnamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2049</field>
		<field name="drug_name">Neopterin</field>
		<field name="description">A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2050</field>
		<field name="drug_name">Leucine Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2051</field>
		<field name="drug_name">3-Hydroxyphenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2052</field>
		<field name="drug_name">Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2053</field>
		<field name="drug_name">5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2054</field>
		<field name="drug_name">2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2055</field>
		<field name="drug_name">D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2056</field>
		<field name="drug_name">Oxiranpseudoglucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2057</field>
		<field name="drug_name">3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2058</field>
		<field name="drug_name">Methylethylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2059</field>
		<field name="drug_name">O-(2-Acetamido-2-Deoxy-Alpha-D-Galactopyranosyl)-L-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2060</field>
		<field name="drug_name">6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2061</field>
		<field name="drug_name">L-Rhamnitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2062</field>
		<field name="drug_name">5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2063</field>
		<field name="drug_name">4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2064</field>
		<field name="drug_name">5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2065</field>
		<field name="drug_name">2-Fluoroaniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2066</field>
		<field name="drug_name">1-Deoxy-1-Thio-Heptaethylene Glycol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2067</field>
		<field name="drug_name">12-Bromododecanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2068</field>
		<field name="drug_name">N-Valeric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2069</field>
		<field name="drug_name">6-O-Cyclohexylmethyl Guanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2070</field>
		<field name="drug_name">(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2071</field>
		<field name="drug_name">(1r,4s)-2-Azabornane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2072</field>
		<field name="drug_name">2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2073</field>
		<field name="drug_name">2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2074</field>
		<field name="drug_name">Tetrahydropyran</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2075</field>
		<field name="drug_name">Hydroxyethylcysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2076</field>
		<field name="drug_name">(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2077</field>
		<field name="drug_name">N-Octyl-2-Hydroxyethyl Sulfoxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2078</field>
		<field name="drug_name">2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2079</field>
		<field name="drug_name">2,4,6-Tribromophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2080</field>
		<field name="drug_name">(R,R)-2,3-Butanediol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2081</field>
		<field name="drug_name">Ethyl Oxo(Piperidin-1-Yl)Acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2082</field>
		<field name="drug_name">[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2083</field>
		<field name="drug_name">Uridine-5'-Diphosphate-Mannose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2084</field>
		<field name="drug_name">Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2085</field>
		<field name="drug_name">Thiopyrophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2086</field>
		<field name="drug_name">Geldanamycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2087</field>
		<field name="drug_name">Hexadecyl Octanoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2088</field>
		<field name="drug_name">Carboxyatractyloside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2089</field>
		<field name="drug_name">2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2090</field>
		<field name="drug_name">Quinaldic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2091</field>
		<field name="drug_name">4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2092</field>
		<field name="drug_name">Trehalose-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2093</field>
		<field name="drug_name">Cytidine-5'-Triphosphate</field>
		<field name="description">Cytidine 5&amp;#39;-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2094</field>
		<field name="drug_name">RU90395</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2095</field>
		<field name="drug_name">{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2096</field>
		<field name="drug_name">4-(2-Thienyl)Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2097</field>
		<field name="drug_name">Aminomethylcyclohexane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2098</field>
		<field name="drug_name">2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2099</field>
		<field name="drug_name">(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2100</field>
		<field name="drug_name">3-O-Methylfructose in Linear Form</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2101</field>
		<field name="drug_name">N-Octane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2102</field>
		<field name="drug_name">2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2103</field>
		<field name="drug_name">Dioxyselenocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2104</field>
		<field name="drug_name">Methicillin Acyl-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2105</field>
		<field name="drug_name">2-Deoxy-2-Amino Glucitol-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2106</field>
		<field name="drug_name">Glutamine Hydroxamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2107</field>
		<field name="drug_name">3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2108</field>
		<field name="drug_name">N-Tridecanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2109</field>
		<field name="drug_name">3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2110</field>
		<field name="drug_name">2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2111</field>
		<field name="drug_name">Thymidine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2112</field>
		<field name="drug_name">Trihydroxyantimonite(Iii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2113</field>
		<field name="drug_name">5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2114</field>
		<field name="drug_name">Fluoresceinylthioureido</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2115</field>
		<field name="drug_name">Cytosine Arabinose-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2116</field>
		<field name="drug_name">Undecyl-Phosphinic Acid Butyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2117</field>
		<field name="drug_name">Glutathione S-(2,4 Dinitrobenzene)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2118</field>
		<field name="drug_name">4-Guanidinobenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2119</field>
		<field name="drug_name">Hydrogenobyrinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2120</field>
		<field name="drug_name">S-Methyl Phosphocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2121</field>
		<field name="drug_name">Thiocoumarin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2122</field>
		<field name="drug_name">2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2123</field>
		<field name="drug_name">Benzylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2124</field>
		<field name="drug_name">Methoxy arachidonyl fluorophosphonate</field>
		<field name="description">Methoxy arachidonyl fluorophosphonate, commonly referred as MAFP, is an irreversible active site-directed enzyme inhibitor that inhibits nearly all serine hydrolases and serine proteases. It inhibits phospholipase A2 and fatty acid amide hydrolase with special potency, displaying IC50 values in the low-nanomolar range.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2125</field>
		<field name="drug_name">4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2126</field>
		<field name="drug_name">S-Oxymethionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2127</field>
		<field name="drug_name">12-Phenylheme</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2128</field>
		<field name="drug_name">4,6-Dideoxy-4-Amino-Beta-D-Glucopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2129</field>
		<field name="drug_name">D-Glycero-D-Mannopyranose-7-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2130</field>
		<field name="drug_name">Nojirimycine Tetrazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2131</field>
		<field name="drug_name">6-Hydroxy-7,8-Dihydro Purine Nucleoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2132</field>
		<field name="drug_name">6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2133</field>
		<field name="drug_name">Bmsc-0013</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2134</field>
		<field name="drug_name">Deoxyguanidinoproclavaminic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2135</field>
		<field name="drug_name">[Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2136</field>
		<field name="drug_name">(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2137</field>
		<field name="drug_name">(S)-4-Bromo-3-Hydroxy-3-Methylbutyl Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2138</field>
		<field name="drug_name">N-Benzylformamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2139</field>
		<field name="drug_name">Phosphonothreonine</field>
		<field name="description">The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins, and enzymes. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2140</field>
		<field name="drug_name">Etheno-Nad</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2141</field>
		<field name="drug_name">Cytidine 5'-Diphosphoglycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2142</field>
		<field name="drug_name">Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid</field>
		<field name="description">A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2143</field>
		<field name="drug_name">2-Hydroxyethyl Disulfide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2144</field>
		<field name="drug_name">1-(2-Ethanone)-2-Hydroxy-2-(1-Amino-2-Methyl-2-Ethanol)-4-(2-Dimethyl)Ethane-Imidazoline-5-One;Chromophore (Thr-Leu-Gly)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2145</field>
		<field name="drug_name">9-Methylguanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2146</field>
		<field name="drug_name">(Diaminomethyl-Methyl-Amino)-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2147</field>
		<field name="drug_name">4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2148</field>
		<field name="drug_name">Ghavamiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2149</field>
		<field name="drug_name">Hydantocidin-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2150</field>
		<field name="drug_name">Alpha-Hydroxy-Beta-Phenyl-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2151</field>
		<field name="drug_name">9-(4-Hydroxybutyl)-N2-Phenylguanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2152</field>
		<field name="drug_name">1-Deoxy-D-Xylulose-5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2153</field>
		<field name="drug_name">L-Alpha-Glycerophosphorylserine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2154</field>
		<field name="drug_name">Carba-Nicotinamide-Adenine-Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2155</field>
		<field name="drug_name">Dinor-N(Omega)-Hydroxy-L-Arginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2156</field>
		<field name="drug_name">6-(Dihydroxy-Isobutyl)-Thymine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2157</field>
		<field name="drug_name">N~2~-Succinylarginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2158</field>
		<field name="drug_name">8-Hydroxy-2'-Deoxyguanosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2159</field>
		<field name="drug_name">4-(Carboxyvin-2-Yl)Phenylboronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2160</field>
		<field name="drug_name">[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2161</field>
		<field name="drug_name">N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2162</field>
		<field name="drug_name">2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2163</field>
		<field name="drug_name">4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2164</field>
		<field name="drug_name">Isopentyl Pyrophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2165</field>
		<field name="drug_name">Farnesol</field>
		<field name="description">A colorless liquid extracted from oils of plants such as citronella, neroli, cyclamen, and tuberose. It is an intermediate step in the biological synthesis of cholesterol from mevalonic acid in vertebrates. It has a delicate odor and is used in perfumery. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2166</field>
		<field name="drug_name">'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2167</field>
		<field name="drug_name">2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2168</field>
		<field name="drug_name">1,6-Fructose Diphosphate (Linear Form)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2169</field>
		<field name="drug_name">5-Methyl-2-(1-Methylethyl)Phenol</field>
		<field name="description">A phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. (Dorland, 28th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2170</field>
		<field name="drug_name">(2z)-3-{[Oxido(Oxo)Phosphino]Oxy}-2-Phenylacrylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2171</field>
		<field name="drug_name">3-Phosphoglycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2172</field>
		<field name="drug_name">O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2173</field>
		<field name="drug_name">D-Glutamic Acid</field>
		<field name="description">A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the central nervous system. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2174</field>
		<field name="drug_name">N-Acetylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2175</field>
		<field name="drug_name">Indirubin-5-Sulphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2176</field>
		<field name="drug_name">Diethylcarbamodithioic Acid</field>
		<field name="description">A chelating agent that has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of DISULFIRAM. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2177</field>
		<field name="drug_name">2,5,7-Trihydroxynaphthoquinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2178</field>
		<field name="drug_name">Phosphonopyruvate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2179</field>
		<field name="drug_name">5'-[[2-(Aminooxy)Ethyl]Methylsulfonio]-5'-Deoxy-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2180</field>
		<field name="drug_name">Spiro(2,4,6-Trinitrobenzene[1,2a]-2o',3o'-Methylene-Adenine-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2181</field>
		<field name="drug_name">D-Galactohydroximo-1,5-Lactam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2182</field>
		<field name="drug_name">CRA_10655</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2183</field>
		<field name="drug_name">Cyclic Adenosine Monophosphate</field>
		<field name="description">Cyclic adenosine monophosphate (cAMP, cyclic AMP or 3'-5'-cyclic adenosine monophosphate) is a molecule that is important in many biological processes; it is derived from adenosine triphosphate (ATP).</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2184</field>
		<field name="drug_name">Tetrazolyl Histidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2185</field>
		<field name="drug_name">5-N-Acetyl-4-Amino-6-Diethylcarboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2186</field>
		<field name="drug_name">Gamma(Amino)-Butyric Acid</field>
		<field name="description">The most common inhibitory neurotransmitter in the central nervous system. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2187</field>
		<field name="drug_name">Isobutyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2188</field>
		<field name="drug_name">2,4,6-Triaminoquinazoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2189</field>
		<field name="drug_name">Aminoguanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2190</field>
		<field name="drug_name">2-Allylphenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2191</field>
		<field name="drug_name">Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2192</field>
		<field name="drug_name">(2r)-2,3-Dihydroxypropanal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2193</field>
		<field name="drug_name">2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2194</field>
		<field name="drug_name">N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2195</field>
		<field name="drug_name">S-Ethylisothiourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2196</field>
		<field name="drug_name">(10S)-10-Formyl-5,8,10-Trideazafolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2197</field>
		<field name="drug_name">4-Hydroxybutan-1-Aminium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2198</field>
		<field name="drug_name">(4s)-5-Fluoro-L-Leucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2199</field>
		<field name="drug_name">Pyrrole-2-Carboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2200</field>
		<field name="drug_name">N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2201</field>
		<field name="drug_name">Fexaramine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2202</field>
		<field name="drug_name">Vorinostat</field>
		<field name="description">Vorinostat (rINN) or suberoylanilide hydroxamic acid (SAHA), is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors.  A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned in which vorinostat will be combined with other drugs. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2203</field>
		<field name="drug_name">Guanosine-5'-Diphosphate-Rhamnose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2204</field>
		<field name="drug_name">Sorbitol 6-phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2205</field>
		<field name="drug_name">3'-O-Acetylthymidine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2206</field>
		<field name="drug_name">8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2207</field>
		<field name="drug_name">6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2208</field>
		<field name="drug_name">Geranyl Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2209</field>
		<field name="drug_name">Glutathionylspermidine Disulfide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2210</field>
		<field name="drug_name">Sulfoquinovose-Uridine-C1,5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2211</field>
		<field name="drug_name">SP4160</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2212</field>
		<field name="drug_name">D-Phenylalanine</field>
		<field name="description">An essential aromatic amino acid that is a precursor of melanin; dopamine; noradrenalin (norepinephrine), and thyroxine. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2213</field>
		<field name="drug_name">Phosphoramidon</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2214</field>
		<field name="drug_name">N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2215</field>
		<field name="drug_name">6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2216</field>
		<field name="drug_name">D-Para-Chlorophenyl-1-Acteamidoboronic Acid Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2217</field>
		<field name="drug_name">Beta-D-Fructopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2218</field>
		<field name="drug_name">Quinonoid 7,8-Tetrahydrobiopterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2219</field>
		<field name="drug_name">Hexanoyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2220</field>
		<field name="drug_name">4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2221</field>
		<field name="drug_name">8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2222</field>
		<field name="drug_name">PD173955</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2223</field>
		<field name="drug_name">Peldesine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2224</field>
		<field name="drug_name">2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2225</field>
		<field name="drug_name">PD150606</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2226</field>
		<field name="drug_name">2-Amino-6-Oxo-Hexanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2227</field>
		<field name="drug_name">BV4</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2228</field>
		<field name="drug_name">2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2229</field>
		<field name="drug_name">BV2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2230</field>
		<field name="drug_name">F-Loop of Vitamin B12</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2231</field>
		<field name="drug_name">Mesoheme</field>
		<field name="description">The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2232</field>
		<field name="drug_name">Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2233</field>
		<field name="drug_name">Acrylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2234</field>
		<field name="drug_name">1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2235</field>
		<field name="drug_name">5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2236</field>
		<field name="drug_name">D-(L-a-Aminoadipoyl)-L-Cysteinyl-D-Isodehydrovaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2237</field>
		<field name="drug_name">N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2238</field>
		<field name="drug_name">4-(Hydroxymethyl)Benzamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2239</field>
		<field name="drug_name">4,7-Dimethyl-[1,10]Phenanthroline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2240</field>
		<field name="drug_name">Forskolin</field>
		<field name="description">Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant Coleus forskohlii. Has antihypertensive, positive ionotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2241</field>
		<field name="drug_name">Moxalactam Derivative</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2242</field>
		<field name="drug_name">Se-Ethyl-Isoselenourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2243</field>
		<field name="drug_name">Abequose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2244</field>
		<field name="drug_name">5,6-Dimethylbenzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2245</field>
		<field name="drug_name">Carbaphosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2246</field>
		<field name="drug_name">7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2247</field>
		<field name="drug_name">2'-Deoxycytidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2248</field>
		<field name="drug_name">Bulgecin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2249</field>
		<field name="drug_name">Alpha,Beta-Methyleneadenosine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2250</field>
		<field name="drug_name">[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2251</field>
		<field name="drug_name">N-Alpha-Acetyl-3,5-Diiodotyrosylglycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2252</field>
		<field name="drug_name">2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2253</field>
		<field name="drug_name">5-N-Acetyl-3-(1-Ethylpropyl)-1-Cyclohexene-1-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2254</field>
		<field name="drug_name">4-Hydroxyphenylglycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2255</field>
		<field name="drug_name">AL7182</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2256</field>
		<field name="drug_name">1-Amino-6-Cyclohex-3-Enylmethyloxypurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2257</field>
		<field name="drug_name">2-Deoxy-Glucose-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2258</field>
		<field name="drug_name">2-Butanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2259</field>
		<field name="drug_name">Adenosine Phosphonoacetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2260</field>
		<field name="drug_name">N-Acetyl-P-Nitrophenylserinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2261</field>
		<field name="drug_name">4-Hydroxy-L-Threonine-5-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2262</field>
		<field name="drug_name">N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2263</field>
		<field name="drug_name">Balanol Analog 1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2264</field>
		<field name="drug_name">Decylamine-N,N-Dimethyl-N-Oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2265</field>
		<field name="drug_name">1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2266</field>
		<field name="drug_name">Compound 19</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2267</field>
		<field name="drug_name">FR117016</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2268</field>
		<field name="drug_name">1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2269</field>
		<field name="drug_name">Ethyl Dimethyl Ammonio Propane Sulfonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2270</field>
		<field name="drug_name">Bromo-Dodecanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2271</field>
		<field name="drug_name">Sp7343-Sp7964</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2272</field>
		<field name="drug_name">Latrunculin A</field>
		<field name="description">Latrunculin A is an actin binding macrolide purified from the red sea sponge Latrunculia magnifica. It is under investigation for the treatment of cancer. It disrupts actin polymerization, prevents mitotic spindle formation and thus cell replication.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2273</field>
		<field name="drug_name">2-(Oxalyl-Amino)-Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2274</field>
		<field name="drug_name">Aminophosphonic Acid-Guanylate Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2275</field>
		<field name="drug_name">Homoserine Lactone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2276</field>
		<field name="drug_name">(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2277</field>
		<field name="drug_name">Phenylferricrocin-Iron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2278</field>
		<field name="drug_name">4,4'-Biphenyldiboronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2279</field>
		<field name="drug_name">1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2280</field>
		<field name="drug_name">Inhibitor Bea403</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2281</field>
		<field name="drug_name">L-Xylitol 5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2282</field>
		<field name="drug_name">5-Chloro-6-[(2-Iminopyrrolidin-1-Yl)Methyl]Pyrimidine-2,4(1h,3h)-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2283</field>
		<field name="drug_name">1-O-[P-Nitrophenyl]-Beta-D-Galactopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2284</field>
		<field name="drug_name">Cibacron Blue</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2285</field>
		<field name="drug_name">N-[O-Phosphono-Pyridoxyl]-Isoleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2286</field>
		<field name="drug_name">9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2287</field>
		<field name="drug_name">Oxaloacetate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2288</field>
		<field name="drug_name">Terlipressin</field>
		<field name="description">Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2289</field>
		<field name="drug_name">4-Methylumbelliferyl-Alpha-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2290</field>
		<field name="drug_name">Fumagillin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2291</field>
		<field name="drug_name">Heptanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2292</field>
		<field name="drug_name">[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2293</field>
		<field name="drug_name">N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2294</field>
		<field name="drug_name">N-Omega-Propyl-L-Arginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2295</field>
		<field name="drug_name">3,4-Epoxybutyl-Alpha-D-Glucopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2296</field>
		<field name="drug_name">Nitrosoethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2297</field>
		<field name="drug_name">N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2298</field>
		<field name="drug_name">(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium</field>
		<field name="description">Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2299</field>
		<field name="drug_name">3-Amino-3-Oxopropanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2300</field>
		<field name="drug_name">Tri-Chloro-Acetaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2301</field>
		<field name="drug_name">{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2302</field>
		<field name="drug_name">L-[(N-Hydroxyamino)Carbonyl]Phenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2303</field>
		<field name="drug_name">Delta-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C2-Adamantane Ruthenium (Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2304</field>
		<field name="drug_name">6-Hydroxy-Flavin-Adenine Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2305</field>
		<field name="drug_name">D-Aspartic Acid</field>
		<field name="description">The D-isomer of aspartic acid. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2306</field>
		<field name="drug_name">2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2307</field>
		<field name="drug_name">Glucosamine 6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2308</field>
		<field name="drug_name">2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2309</field>
		<field name="drug_name">Cholic Acid</field>
		<field name="description">A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2310</field>
		<field name="drug_name">Filaminast</field>
		<field name="description">Filaminast is a phosphodiesterase 4 inhibitor (PDE4 inhibitor). As such, has potential in the treatment of asthma and chronic obstructive pulmonary disease (COPD).</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2311</field>
		<field name="drug_name">Adenosine-5'-Diphosphate-2',3'-Vanadate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2312</field>
		<field name="drug_name">Novo Nordisk a/S Compound</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2313</field>
		<field name="drug_name">2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2314</field>
		<field name="drug_name">1-Butane Boronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2315</field>
		<field name="drug_name">Trans-2-Phenylcyclopropylamine</field>
		<field name="description">A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2316</field>
		<field name="drug_name">(C8-R)-Hydantocidin 5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2317</field>
		<field name="drug_name">Factor IIIm</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2318</field>
		<field name="drug_name">Je-2147, Ag1776, Kni-764</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2319</field>
		<field name="drug_name">RB106</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2320</field>
		<field name="drug_name">4-Deoxy-Alpha-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2321</field>
		<field name="drug_name">1-Methylimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2322</field>
		<field name="drug_name">(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2323</field>
		<field name="drug_name">4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2324</field>
		<field name="drug_name">(4-Hydroxymaltosephenyl)Glycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2325</field>
		<field name="drug_name">2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2326</field>
		<field name="drug_name">D-Naphthyl-1-Acetamido Boronic Acid Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2327</field>
		<field name="drug_name">2-Deoxy-2-Aminogalactose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2328</field>
		<field name="drug_name">Cyanamide</field>
		<field name="description">A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2329</field>
		<field name="drug_name">Dinitrophenylene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2330</field>
		<field name="drug_name">Meta Vanadate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2331</field>
		<field name="drug_name">2-Deamino-6-Deoxy-6thiophosphite-5'-Phosphate Guanosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2332</field>
		<field name="drug_name">Inhibitor Bea428</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2333</field>
		<field name="drug_name">5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2334</field>
		<field name="drug_name">3-Methylphenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2335</field>
		<field name="drug_name">Undecyl-Beta-D-Maltopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2336</field>
		<field name="drug_name">Beta-D-Mannose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2337</field>
		<field name="drug_name">2,3-Didehydroalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2338</field>
		<field name="drug_name">S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2339</field>
		<field name="drug_name">NU1025</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2340</field>
		<field name="drug_name">N-Cholylglycine</field>
		<field name="description">The glycine conjugate of cholic acid. It acts as a detergent to solubilize fats for absorption and is itself absorbed. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2341</field>
		<field name="drug_name">(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2342</field>
		<field name="drug_name">(4s,5s)-1,2-Dithiane-4,5-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2343</field>
		<field name="drug_name">Pantoyl Adenylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2344</field>
		<field name="drug_name">O1-Pentyl-Mannose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2345</field>
		<field name="drug_name">6-Aminohexyl-Uridine-C1,5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2346</field>
		<field name="drug_name">Hydroxyaminovaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2347</field>
		<field name="drug_name">N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2348</field>
		<field name="drug_name">4-Oxoretinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2349</field>
		<field name="drug_name">3-Deoxy-D-Glucosamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2350</field>
		<field name="drug_name">Nicotinamide</field>
		<field name="description">An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2351</field>
		<field name="drug_name">XV638</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2352</field>
		<field name="drug_name">(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2353</field>
		<field name="drug_name">6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2354</field>
		<field name="drug_name">Mercaptocarboxylate Inhibitor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2355</field>
		<field name="drug_name">Pentyl Trihydrogen Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2356</field>
		<field name="drug_name">Resveratrol</field>
		<field name="description">Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin. It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene synthase. It exists as two structural isomers: cis-(Z) and trans-(E), with the trans-isomer shown in the top image. The trans- form can undergo isomerisation to the cis- form when heated or exposed to ultraviolet irradiation. In a 2004 issue of Science, Dr. Sinclair of Harvard University said resveratrol is not an easy molecule to protect from oxidation. It has been claimed that it is readily degraded by exposure to light, heat, and oxygen. However, studies find that Trans-resveratrol undergoes negligible oxidation in normal atmosphere at room temperature. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2357</field>
		<field name="drug_name">2,3,-Dihydroxybenzoylserine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2358</field>
		<field name="drug_name">4-{2,6,8-Trioxo-9-[(2s,3r,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2359</field>
		<field name="drug_name">Sorbinil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2360</field>
		<field name="drug_name">Acetylamino-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2361</field>
		<field name="drug_name">3'-Uridinemonophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2362</field>
		<field name="drug_name">Compound 18</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2363</field>
		<field name="drug_name">7-Methyl-Guanosine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2364</field>
		<field name="drug_name">Cellotetraose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2365</field>
		<field name="drug_name">5-Formyl-6-Hydrofolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2366</field>
		<field name="drug_name">C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2367</field>
		<field name="drug_name">Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2368</field>
		<field name="drug_name">4-Iodopyrazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2369</field>
		<field name="drug_name">4-O-Methyl-Beta-D-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2370</field>
		<field name="drug_name">4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2371</field>
		<field name="drug_name">Delta-2-Albomycin A1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2372</field>
		<field name="drug_name">2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2373</field>
		<field name="drug_name">2-Phosphoglycolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2374</field>
		<field name="drug_name">N-Butyl-N'-Hydroxyguanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2375</field>
		<field name="drug_name">7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2376</field>
		<field name="drug_name">SD146</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2377</field>
		<field name="drug_name">4-Methylthio-Alpha-D-Mannose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2378</field>
		<field name="drug_name">Thimerosal</field>
		<field name="description">A topical antiseptic used on skin and mucous membranes. It is also used as a preservative in pharmaceuticals. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2379</field>
		<field name="drug_name">Nicotinamide Adenine Dinucleotide Acetone Adduct</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2380</field>
		<field name="drug_name">Purvalanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2381</field>
		<field name="drug_name">4-Deoxy-D-Mannuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2382</field>
		<field name="drug_name">2-Amino-3-Oxo-4-Sulfo-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2383</field>
		<field name="drug_name">Acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2384</field>
		<field name="drug_name">Adenosine-5'-Pentaphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2385</field>
		<field name="drug_name">3-Indolebutyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2386</field>
		<field name="drug_name">CD564</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2387</field>
		<field name="drug_name">Kifunensine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2388</field>
		<field name="drug_name">Beta-1,4-Galactobioside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2389</field>
		<field name="drug_name">RPR131247</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2390</field>
		<field name="drug_name">Uridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2391</field>
		<field name="drug_name">Phthalic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2392</field>
		<field name="drug_name">N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)Glycyl-L-Arginine-N-Phenylamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2393</field>
		<field name="drug_name">Pyromellitic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2394</field>
		<field name="drug_name">S-(Methylmercury)-L-Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2395</field>
		<field name="drug_name">N-[Amino(Imino)Methyl]Glycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2396</field>
		<field name="drug_name">Tosyl-D-Proline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2397</field>
		<field name="drug_name">Selenoinosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2398</field>
		<field name="drug_name">9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2399</field>
		<field name="drug_name">1-3 Sugar Ring of Pentamannosyl 6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2400</field>
		<field name="drug_name">1,2,5,6-Tetrahydro-4h-Pyrrolo(3,2,1-Ij)Quinolin-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2401</field>
		<field name="drug_name">Pyrazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2402</field>
		<field name="drug_name">Indolylpropionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2403</field>
		<field name="drug_name">4-Methylumbelliferyl Chitobiose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2404</field>
		<field name="drug_name">1,6-Di-O-Phosphono-D-Allitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2405</field>
		<field name="drug_name">S-Mercaptocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2406</field>
		<field name="drug_name">RU79072</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2407</field>
		<field name="drug_name">5-Mercapto-2-Nitro-Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2408</field>
		<field name="drug_name">Hexane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2409</field>
		<field name="drug_name">9-Hydroxypropyladenine, R-Isomer</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2410</field>
		<field name="drug_name">(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2411</field>
		<field name="drug_name">3-Hydroxy-Myristic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2412</field>
		<field name="drug_name">Tert-Butyloxycarbonyl Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2413</field>
		<field name="drug_name">7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2414</field>
		<field name="drug_name">Dodecane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2415</field>
		<field name="drug_name">Sucrose</field>
		<field name="description">A nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons. It is obtained commercially from sugarcane, sugar beet (beta vulgaris), and other plants and used extensively as a food and a sweetener. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2416</field>
		<field name="drug_name">(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2417</field>
		<field name="drug_name">1,3-Propandiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2418</field>
		<field name="drug_name">Benzoic Acid Phenylmethylester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2419</field>
		<field name="drug_name">1-Hexadecanosulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2420</field>
		<field name="drug_name">Diundecyl Phosphatidyl Choline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2421</field>
		<field name="drug_name">2,5-Anhydroglucitol-1,6-Biphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2422</field>
		<field name="drug_name">Dodecane-Trimethylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2423</field>
		<field name="drug_name">Beta-3-Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2424</field>
		<field name="drug_name">4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2425</field>
		<field name="drug_name">4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2426</field>
		<field name="drug_name">N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2427</field>
		<field name="drug_name">N-[2(S)-Cyclopentyl-1(R)-Hydroxy-3(R)Methyl]-5-[(2(S)-Tertiary-Butylamino-Carbonyl)-4-(N1-(2)-(N-Methylpiperazinyl)-3-Chloro-Pyrazinyl-5-Carbonyl)-Piperazino]-4(S)-Hydroxy-2(R)-Phenylmethyl-Pentanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2428</field>
		<field name="drug_name">2-Anhydro-3-Fluoro-Quinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2429</field>
		<field name="drug_name">N-Acetylmannosaminitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2430</field>
		<field name="drug_name">S,3-Hydroxybutan-2-One</field>
		<field name="description">A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2431</field>
		<field name="drug_name">Pregnenolone</field>
		<field name="description">A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2432</field>
		<field name="drug_name">Phenyl-Uridine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2433</field>
		<field name="drug_name">Tetraphenylphosphonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2434</field>
		<field name="drug_name">Deglucobalhimycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2435</field>
		<field name="drug_name">Isochorismic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2436</field>
		<field name="drug_name">N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2437</field>
		<field name="drug_name">P-Anisic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2438</field>
		<field name="drug_name">9-Deazainosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2439</field>
		<field name="drug_name">3-Nitrophenylboronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2440</field>
		<field name="drug_name">Alpha-Methylene Adenosine Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2441</field>
		<field name="drug_name">N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2442</field>
		<field name="drug_name">5-Hydroxymethylene-6-Hydrofolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2443</field>
		<field name="drug_name">2,3 -Anhydro-Quinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2444</field>
		<field name="drug_name">5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2445</field>
		<field name="drug_name">3-Phenyl-1,2-Propandiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2446</field>
		<field name="drug_name">A-98881</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2447</field>
		<field name="drug_name">1-(3-O-Phosphono-Beta-L-Arabinofuranosyl)Pyrimidine-2,4(1h,3h)-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2448</field>
		<field name="drug_name">2-Methoxyethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2449</field>
		<field name="drug_name">D-2-Keto-3-Deoxygalactonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2450</field>
		<field name="drug_name">Trifluorofurnesyl Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2451</field>
		<field name="drug_name">Brodimoprim-4,6-Dicarboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2452</field>
		<field name="drug_name">N-(2-Acetamido)Iminodiacetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2453</field>
		<field name="drug_name">Diethylphosphono Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2454</field>
		<field name="drug_name">(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2455</field>
		<field name="drug_name">2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2456</field>
		<field name="drug_name">3'-Deazo-Thiamin Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2457</field>
		<field name="drug_name">Indene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2458</field>
		<field name="drug_name">7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2459</field>
		<field name="drug_name">5-Exo-Hydroxycamphor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2460</field>
		<field name="drug_name">Iodo-Willardiine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2461</field>
		<field name="drug_name">Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2462</field>
		<field name="drug_name">1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2463</field>
		<field name="drug_name">Canaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2464</field>
		<field name="drug_name">Para-Bromobenzyl Alcohol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2465</field>
		<field name="drug_name">Phosphonoacetic Acid</field>
		<field name="description">A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2466</field>
		<field name="drug_name">N-Pyridoxyl-Glycine-5-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2467</field>
		<field name="drug_name">Methylphosphonic Acid Ester Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2468</field>
		<field name="drug_name">Decane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2469</field>
		<field name="drug_name">7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2470</field>
		<field name="drug_name">5-Fluorolevulinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2471</field>
		<field name="drug_name">4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2472</field>
		<field name="drug_name">FR236913</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2473</field>
		<field name="drug_name">Dihydrogenphosphate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2474</field>
		<field name="drug_name">Siroheme</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2475</field>
		<field name="drug_name">[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2476</field>
		<field name="drug_name">IDD552</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2477</field>
		<field name="drug_name">Alpha-D-Glucose 1,6-Bisphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2478</field>
		<field name="drug_name">Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2479</field>
		<field name="drug_name">O4-Sulfonylgalactose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2480</field>
		<field name="drug_name">3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2481</field>
		<field name="drug_name">2,4-Dihydroxybenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2482</field>
		<field name="drug_name">4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2483</field>
		<field name="drug_name">[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2484</field>
		<field name="drug_name">Aminacrine</field>
		<field name="description">A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2485</field>
		<field name="drug_name">Alpha-D-Glucose-1-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2486</field>
		<field name="drug_name">S-Adenosyl-1,8-Diamino-3-Thiooctane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2487</field>
		<field name="drug_name">Methylphosphinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2488</field>
		<field name="drug_name">Thioproline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2489</field>
		<field name="drug_name">(2s,3r)-1-Amino-2-Methylbutane-2,3-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2490</field>
		<field name="drug_name">{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2491</field>
		<field name="drug_name">N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2492</field>
		<field name="drug_name">(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2493</field>
		<field name="drug_name">Thiocamphor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2494</field>
		<field name="drug_name">Domoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2495</field>
		<field name="drug_name">D-Proline</field>
		<field name="description">A non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2496</field>
		<field name="drug_name">Aetiocholanolone</field>
		<field name="description">The 5-beta-reduced isomer of androsterone. Etiocholanolone is a major metabolite of testosterone and androstenedione in many mammalian species including humans. It is excreted in the urine. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2497</field>
		<field name="drug_name">N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2498</field>
		<field name="drug_name">Methyl-Carbamic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2499</field>
		<field name="drug_name">Guanosine</field>
		<field name="description">Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a ?-N9-glycosidic bond. Guanosine can be phosphorylated to become GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate) and GTP (guanosine triphosphate). [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2500</field>
		<field name="drug_name">3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2501</field>
		<field name="drug_name">Soraphen A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2502</field>
		<field name="drug_name">Calyculin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2503</field>
		<field name="drug_name">4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2504</field>
		<field name="drug_name">Gluco-Phenylimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2505</field>
		<field name="drug_name">Alpha Chlorophyll A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2506</field>
		<field name="drug_name">Biliverdin Ix Gamma Chromophore</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2507</field>
		<field name="drug_name">Glucosamine 4-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2508</field>
		<field name="drug_name">Dansylamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2509</field>
		<field name="drug_name">D-Mannose 1-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2510</field>
		<field name="drug_name">3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2511</field>
		<field name="drug_name">3-Amino-5-Phenylpentane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2512</field>
		<field name="drug_name">N-Allyl-Aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2513</field>
		<field name="drug_name">3-Butylthiolane 1-Oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2514</field>
		<field name="drug_name">Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2515</field>
		<field name="drug_name">1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2516</field>
		<field name="drug_name">CRA_1802</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2517</field>
		<field name="drug_name">3-(4-Carbamoyl-1-Carboxy-2-Methylsulfonyl-Buta-1,3-Dienylamino)-Indolizine-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2518</field>
		<field name="drug_name">TTNPB</field>
		<field name="description">TTNPB is a retinoic acid analog which acts as a selective RAR agonist.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2519</field>
		<field name="drug_name">3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2520</field>
		<field name="drug_name">2,3-Di-O-Sulfo-Alpha-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2521</field>
		<field name="drug_name">N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2522</field>
		<field name="drug_name">4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2523</field>
		<field name="drug_name">Cyanocinnoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2524</field>
		<field name="drug_name">2',3'-Dideoxycytidine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2525</field>
		<field name="drug_name">Beta-Cyclohexyl-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2526</field>
		<field name="drug_name">4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2527</field>
		<field name="drug_name">2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2528</field>
		<field name="drug_name">FKB-001</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2529</field>
		<field name="drug_name">4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2530</field>
		<field name="drug_name">6-Hydroxyuridine-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2531</field>
		<field name="drug_name">Tricyclazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2532</field>
		<field name="drug_name">L-2-Amino-6-Methylene-Pimelic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2533</field>
		<field name="drug_name">D-Methionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2534</field>
		<field name="drug_name">Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2535</field>
		<field name="drug_name">3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2536</field>
		<field name="drug_name">Methylthioinosine</field>
		<field name="description">An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2537</field>
		<field name="drug_name">Acetylphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2538</field>
		<field name="drug_name">5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2539</field>
		<field name="drug_name">N-Carboxymethionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2540</field>
		<field name="drug_name">Alpha-D-Mannose-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2541</field>
		<field name="drug_name">Dihydrotestosterone</field>
		<field name="description">A potent androgenic metabolite of testosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2542</field>
		<field name="drug_name">3'-Phosphate-Adenosine-5'-Phosphate Sulfate</field>
		<field name="description">3&amp;#39;-Phosphoadenosine-5&amp;#39;-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2543</field>
		<field name="drug_name">BV3</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2544</field>
		<field name="drug_name">Beta-3-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2545</field>
		<field name="drug_name">Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2546</field>
		<field name="drug_name">(2s,4s)-Alpha-Campholinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2547</field>
		<field name="drug_name">2-Amino-Vinyl-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2548</field>
		<field name="drug_name">RU78783</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2549</field>
		<field name="drug_name">5-(2-Chlorophenyl)Furan-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2550</field>
		<field name="drug_name">Octanoyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2551</field>
		<field name="drug_name">2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2552</field>
		<field name="drug_name">Propionyl Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2553</field>
		<field name="drug_name">(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2554</field>
		<field name="drug_name">4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2555</field>
		<field name="drug_name">[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2556</field>
		<field name="drug_name">N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2557</field>
		<field name="drug_name">6-(4-Difluoromethoxy-3-Methoxy-Phenyl)-2h-Pyridazin-3-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2558</field>
		<field name="drug_name">2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2559</field>
		<field name="drug_name">Zn(Ii)-(20-Oxo-Protoporphyrin Ix)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2560</field>
		<field name="drug_name">(South)-Methanocarba-Thymidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2561</field>
		<field name="drug_name">Hexafluoroacetone Hydrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2562</field>
		<field name="drug_name">Biphenyl-2,3-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2563</field>
		<field name="drug_name">D-Limonene 1,2-Epoxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2564</field>
		<field name="drug_name">Piretanide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2565</field>
		<field name="drug_name">2-Oxo-Glutaric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2566</field>
		<field name="drug_name">Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2567</field>
		<field name="drug_name">3-Amino-6-Hydroxy-Tyrosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2568</field>
		<field name="drug_name">K201</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2569</field>
		<field name="drug_name">Phosphothiophosphoric Acid-Adenylate Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2570</field>
		<field name="drug_name">Coa-S-Acetyl Tryptamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2571</field>
		<field name="drug_name">(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2572</field>
		<field name="drug_name">5'-Deoxy-5'-(Methylthio)-Tubercidin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2573</field>
		<field name="drug_name">9-(6-Deoxy-Alpha-L-Talofuranosyl)-6-Methylpurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2574</field>
		<field name="drug_name">1-Methoxy-2-(2-Methoxyethoxy)Ethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2575</field>
		<field name="drug_name">4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2576</field>
		<field name="drug_name">Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate</field>
		<field name="description">Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2&amp;#39;-, 3&amp;#39;-, or 5&amp;#39;-position. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2577</field>
		<field name="drug_name">Heptanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2578</field>
		<field name="drug_name">[(1e)-4-Phenylbut-1-Enyl]Benzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2579</field>
		<field name="drug_name">(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2580</field>
		<field name="drug_name">3-(1-Aminoethyl)Nonanedioic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2581</field>
		<field name="drug_name">Inositol 1,3-Bisphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2582</field>
		<field name="drug_name">N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2583</field>
		<field name="drug_name">Alpha-D-Mannose</field>
		<field name="description">A hexose or fermentable monosaccharide and isomer of glucose from manna, the ash Fraxinus ornus and related plants. (From Grant &amp; Hackh&amp;#39;s Chemical Dictionary, 5th ed &amp; Random House Unabridged Dictionary, 2d ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2584</field>
		<field name="drug_name">L-Iduronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2585</field>
		<field name="drug_name">Carpropamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2586</field>
		<field name="drug_name">2-Fluoro-2'-Deoxyadenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2587</field>
		<field name="drug_name">Fosmidomycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2588</field>
		<field name="drug_name">2-Acetyl-Protoporphyrin Ix</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2589</field>
		<field name="drug_name">Hymenialdisine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2590</field>
		<field name="drug_name">3-Hydroxypyruvic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2591</field>
		<field name="drug_name">Alpha-Aminoisobutyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2592</field>
		<field name="drug_name">2-Thiomethyl-3-Phenylpropanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2593</field>
		<field name="drug_name">(Carboxyhydroxyamino)Ethanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2594</field>
		<field name="drug_name">Ricinoleic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2595</field>
		<field name="drug_name">Pentasulfide-Sulfur</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2596</field>
		<field name="drug_name">Orotidine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2597</field>
		<field name="drug_name">Selenomethionine Selenoxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2598</field>
		<field name="drug_name">Oxitriptan</field>
		<field name="description">5-Hydroxytryptophan (5-HTP), also known as oxitriptan (INN), is a naturally occurring amino acid and chemical precursor as well as a metabolic intermediate in the biosynthesis of the neurotransmitters serotonin and melatonin from tryptophan. 5-HTP is sold over-the-counter in the United Kingdom, United States and Canada as a dietary supplement for use as an antidepressant, appetite suppressant, and sleep aid, and is also marketed in many European countries for the indication of major depression under trade names like Cincofarm, Levothym, Levotonine, Oxyfan, Telesol, Tript-OH, and Triptum. Several double-blind placebo-controlled clinical trials have demonstrated the effectiveness of 5-HTP in the treatment of depression, though a lack of high quality studies has been noted. More and larger studies are needed to determine if 5-HTP is truly effective in treating depression.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2599</field>
		<field name="drug_name">1-Carboxyethylaminomethyl-4-Aminomethylbenzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2600</field>
		<field name="drug_name">L-Rhamnose</field>
		<field name="description">A methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2601</field>
		<field name="drug_name">Benzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2602</field>
		<field name="drug_name">(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2603</field>
		<field name="drug_name">8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2604</field>
		<field name="drug_name">Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2605</field>
		<field name="drug_name">Fluoro-Willardiine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2606</field>
		<field name="drug_name">N-Ethylmaleimide</field>
		<field name="description">A sulfhydryl reagent that is widely used in experimental biochemical studies. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2607</field>
		<field name="drug_name">Penicillin G Acyl-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2608</field>
		<field name="drug_name">4-Methyl-5-Hydroxyethylthiazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2609</field>
		<field name="drug_name">2-Propyl-Aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2610</field>
		<field name="drug_name">2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2611</field>
		<field name="drug_name">1-Benzyl-(R)-Propylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2612</field>
		<field name="drug_name">4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2613</field>
		<field name="drug_name">4-(4-Chlorophenyl)Imidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2614</field>
		<field name="drug_name">Ge2270a</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2615</field>
		<field name="drug_name">Uridine-5'-Monophosphate 2-Deoxy-2-Fluoro-Galactopyranosyl-Monophosphate Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2616</field>
		<field name="drug_name">PNU177836</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2617</field>
		<field name="drug_name">Beta-Hydroxyleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2618</field>
		<field name="drug_name">N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2619</field>
		<field name="drug_name">Thymidine-5'-(Dithio)Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2620</field>
		<field name="drug_name">Vitamin B6 Complexed with 2-Amino-Hexanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2621</field>
		<field name="drug_name">Bombykol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2622</field>
		<field name="drug_name">Para-Mercury-Benzenesulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2623</field>
		<field name="drug_name">4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2624</field>
		<field name="drug_name">8-Iodo-Guanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2625</field>
		<field name="drug_name">N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2626</field>
		<field name="drug_name">Cysteine-S-Acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2627</field>
		<field name="drug_name">Imino-Tryptophan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2628</field>
		<field name="drug_name">CRA_10972</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2629</field>
		<field name="drug_name">C16-Fatty-Acyl-Substrate-Mimic</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2630</field>
		<field name="drug_name">S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2631</field>
		<field name="drug_name">1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2632</field>
		<field name="drug_name">8-Methyl-9-Oxoguanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2633</field>
		<field name="drug_name">Hydroxydimethylarsine Oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2634</field>
		<field name="drug_name">Cyclohexylammonium Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2635</field>
		<field name="drug_name">2-(Thiomethylene)-4-Methylpentanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2636</field>
		<field name="drug_name">Methyltrienolone</field>
		<field name="description">A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2637</field>
		<field name="drug_name">Quisqualate</field>
		<field name="description">An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2638</field>
		<field name="drug_name">9-Hydroxypropyladenine, S-Isomer</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2639</field>
		<field name="drug_name">Peridinin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2640</field>
		<field name="drug_name">4-Iodophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2641</field>
		<field name="drug_name">Glutathione Sulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2642</field>
		<field name="drug_name">1-[(1s)-Carboxy-2-(Methylsulfinyl)Ethyl]-(3r)-[(5s)-5-Amino-5-Carboxypentanamido]-(4r)-Sulfanylazetidin-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2643</field>
		<field name="drug_name">3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2644</field>
		<field name="drug_name">4-Aminophenylarsonic Acid</field>
		<field name="description">An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2645</field>
		<field name="drug_name">9r,13r-Opda</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2646</field>
		<field name="drug_name">5-Fluoro-Beta-L-Gulosyl Fluoride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2647</field>
		<field name="drug_name">2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2648</field>
		<field name="drug_name">Epothilone B</field>
		<field name="description">Epothilone B is a 16-membered macrolide that mimics the biological effects of taxol.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2649</field>
		<field name="drug_name">Adenosine-5'-(Dithio)Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2650</field>
		<field name="drug_name">Phenylalanine-N-Sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2651</field>
		<field name="drug_name">Di(N-Acetyl-D-Glucosamine)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2652</field>
		<field name="drug_name">Heme</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2653</field>
		<field name="drug_name">6-Hydroxy-1,6-Dihydro Purine Nucleoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2654</field>
		<field name="drug_name">CRA_1801</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2655</field>
		<field name="drug_name">3,4-Dimethylaniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2656</field>
		<field name="drug_name">4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2657</field>
		<field name="drug_name">5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2658</field>
		<field name="drug_name">Ulapualide A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2659</field>
		<field name="drug_name">3-{2,6,8-Trioxo-9-[(2r,3s,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2660</field>
		<field name="drug_name">1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2661</field>
		<field name="drug_name">2-Methyl-3-(2-Aminothiazolo)Propanal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2662</field>
		<field name="drug_name">1-Octen-3-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2663</field>
		<field name="drug_name">Phosphoglycolohydroxamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2664</field>
		<field name="drug_name">1h-Benoximidazole-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2665</field>
		<field name="drug_name">Ortho-Xylene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2666</field>
		<field name="drug_name">4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2667</field>
		<field name="drug_name">Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2668</field>
		<field name="drug_name">S-Octylglutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2669</field>
		<field name="drug_name">1-Methyloxy-4-Sulfone-Benzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2670</field>
		<field name="drug_name">Dextrofloxacine</field>
		<field name="description">A synthetic fluoroquinolone (FLUOROQUINOLONES) antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2671</field>
		<field name="drug_name">1,8-Di-Hydroxy-4-Nitro-Anthraquinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2672</field>
		<field name="drug_name">Oxidized Acetyl Dithranol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2673</field>
		<field name="drug_name">LY341770</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2674</field>
		<field name="drug_name">4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2675</field>
		<field name="drug_name">Nitrilotriacetic Acid</field>
		<field name="description">A derivative of acetic acid, N(CH2COOH)3. It is a complexing (sequestering) agent that forms stable complexes with Zn2+. (From Miall&amp;#39;s Dictionary of Chemistry, 5th ed.)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2676</field>
		<field name="drug_name">Udp-Glucuronic Acid</field>
		<field name="description">A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2677</field>
		<field name="drug_name">5-Phosphoarabinonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2678</field>
		<field name="drug_name">(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2679</field>
		<field name="drug_name">1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2680</field>
		<field name="drug_name">Pantothenyl-Aminoethanol-Acetate Pivalic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2681</field>
		<field name="drug_name">7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2682</field>
		<field name="drug_name">L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2683</field>
		<field name="drug_name">6-Carboxymethyluracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2684</field>
		<field name="drug_name">S-Selanyl Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2685</field>
		<field name="drug_name">Geran-8-Yl Geran</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2686</field>
		<field name="drug_name">Tetrahydrofuran-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2687</field>
		<field name="drug_name">Dazoxiben</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2688</field>
		<field name="drug_name">1-Aminocyclopropylphosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2689</field>
		<field name="drug_name">Tribromomethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2690</field>
		<field name="drug_name">4-Piperidino-Piperidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2691</field>
		<field name="drug_name">Malonaldehyde</field>
		<field name="description">The dialdehyde of malonic acid. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2692</field>
		<field name="drug_name">Isatoic Anhydride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2693</field>
		<field name="drug_name">Acetoacetyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2694</field>
		<field name="drug_name">Sri-9662</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2695</field>
		<field name="drug_name">(R)-N-(1-Methyl-Hexyl)-Formamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2696</field>
		<field name="drug_name">(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2697</field>
		<field name="drug_name">N-(1-Benzyl-3-{[3-(1,3-Dioxo-1,3-Dihydro-Isoindol-2-Yl)-Propionyl]-[2-(Hexahydro-Benzo[1,3]Dioxol-5-Yl)-Ethyl]-Amino}-2-Hydroxy-Propyl)-4-Benzyloxy-3,5-Dimethoxy-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2698</field>
		<field name="drug_name">3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2699</field>
		<field name="drug_name">7-Nitroindazole-2-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2700</field>
		<field name="drug_name">D-Lactic Acid</field>
		<field name="description">A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2701</field>
		<field name="drug_name">4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2702</field>
		<field name="drug_name">Zebularine</field>
		<field name="description">A chemically stable, cytidine analog that displays anti-tumor properties.  Acts as a transition state analog inhibitor of cytidine deaminase by binding to the active size as covalent hydrates.  Also shown to inhibit DNA methylation and tumor growth both in vitro and in vivo.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2703</field>
		<field name="drug_name">Cytidine-5'-Diphospho-Beta-D-Xylose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2704</field>
		<field name="drug_name">Selenazole-4-Carboxyamide-Adenine Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2705</field>
		<field name="drug_name">4-Methylidene-5-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2706</field>
		<field name="drug_name">2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2707</field>
		<field name="drug_name">3-Methoxybenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2708</field>
		<field name="drug_name">7-Deaza-7-Cyano-Guanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2709</field>
		<field name="drug_name">(Diphosphono)Aminophosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2710</field>
		<field name="drug_name">AHA047</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2711</field>
		<field name="drug_name">3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2712</field>
		<field name="drug_name">PASBN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2713</field>
		<field name="drug_name">Alpha-Ribazole-5'-Phosphate Derivative</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2714</field>
		<field name="drug_name">17-Dmag</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2715</field>
		<field name="drug_name">Crc200 (Chiron-Behring)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2716</field>
		<field name="drug_name">6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2717</field>
		<field name="drug_name">IC261</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2718</field>
		<field name="drug_name">Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2719</field>
		<field name="drug_name">Hydroxyacetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2720</field>
		<field name="drug_name">N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2721</field>
		<field name="drug_name">2-(Sec-Butyl)Thiazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2722</field>
		<field name="drug_name">Pyroglutamic Acid</field>
		<field name="description">A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2723</field>
		<field name="drug_name">L-Iso-Aspartate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2724</field>
		<field name="drug_name">Ethylaminobenzylmethylcarbonyl Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2725</field>
		<field name="drug_name">4-Amido-4-Carbamoyl-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2726</field>
		<field name="drug_name">5-Hydroxymethyl-Chonduritol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2727</field>
		<field name="drug_name">8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2728</field>
		<field name="drug_name">3,5-Dihydro-5-Methylidene-4h-Imidazol-4-On</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2729</field>
		<field name="drug_name">Tetramethylammonium Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2730</field>
		<field name="drug_name">N-Aminoethylmorpholine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2731</field>
		<field name="drug_name">Pmp-Hydroxyisoxazole, Pyridoxamine-5-Phosphate-Hydroxyisoxazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2732</field>
		<field name="drug_name">[Methylseleno]Acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2733</field>
		<field name="drug_name">5-Amino 6-Nitro Uracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2734</field>
		<field name="drug_name">6-Nitroindazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2735</field>
		<field name="drug_name">Ribose-1-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2736</field>
		<field name="drug_name">2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2737</field>
		<field name="drug_name">Thymidine-5'- Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2738</field>
		<field name="drug_name">RU82129</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2739</field>
		<field name="drug_name">5-Hydroxy Norvaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2740</field>
		<field name="drug_name">Myo-Inositol</field>
		<field name="description">An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2741</field>
		<field name="drug_name">Beta-Alanine</field>
		<field name="description">An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2742</field>
		<field name="drug_name">4-Phospho-D-Erythronate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2743</field>
		<field name="drug_name">N-Acetyl-D-Allosamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2744</field>
		<field name="drug_name">2-Chlorophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2745</field>
		<field name="drug_name">Glucosamine 1-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2746</field>
		<field name="drug_name">6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2747</field>
		<field name="drug_name">3-Fluoro-2-(Phosphonooxy)Propanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2748</field>
		<field name="drug_name">PAS219</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2749</field>
		<field name="drug_name">5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2750</field>
		<field name="drug_name">5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2751</field>
		<field name="drug_name">2-Carboxypropyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2752</field>
		<field name="drug_name">1-(5-Chloroindol-3-Yl)-3-Hydroxy-3-(2h-Tetrazol-5-Yl)-Propenone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2753</field>
		<field name="drug_name">Pentane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2754</field>
		<field name="drug_name">Para-Toluene Sulfonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2755</field>
		<field name="drug_name">1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2756</field>
		<field name="drug_name">5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2757</field>
		<field name="drug_name">2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2758</field>
		<field name="drug_name">Mant-Adp</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2759</field>
		<field name="drug_name">Benzamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2760</field>
		<field name="drug_name">Acetylcholine</field>
		<field name="description">A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2761</field>
		<field name="drug_name">[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2762</field>
		<field name="drug_name">S-P-Nitrobenzyloxycarbonylglutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2763</field>
		<field name="drug_name">3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2764</field>
		<field name="drug_name">2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2765</field>
		<field name="drug_name">2-Aminopimelic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2766</field>
		<field name="drug_name">[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2767</field>
		<field name="drug_name">4-Iodobenzo[B]Thiophene-2-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2768</field>
		<field name="drug_name">8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2769</field>
		<field name="drug_name">Perchlorate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2770</field>
		<field name="drug_name">6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2771</field>
		<field name="drug_name">4-Carboxyphenylboronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2772</field>
		<field name="drug_name">3-({5-Benzyl-6-Hydroxy-2,4-Bis-(4-Hydroxy-Benzyl)-3-Oxo-[1,2,4]-Triazepane-1-Sulfonyl)-Benzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2773</field>
		<field name="drug_name">Alpha-L-Arabinose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2774</field>
		<field name="drug_name">Nonan-1-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2775</field>
		<field name="drug_name">N-Omega-Hydroxy-L-Arginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2776</field>
		<field name="drug_name">4-Methyl-5-Hydroxyethylthiazole Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2777</field>
		<field name="drug_name">2-Deazo-6-Thiophosphate Guanosine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2778</field>
		<field name="drug_name">Flavin-Adenine Dinucleotide</field>
		<field name="description">A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2779</field>
		<field name="drug_name">Phosphomethylphosphonic Acid Adenosyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2780</field>
		<field name="drug_name">Phenylalanylmethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2781</field>
		<field name="drug_name">2',3'-Dideoxythymidine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2782</field>
		<field name="drug_name">(Mu-4-Sulfido)-Tetra-Nuclear Copper Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2783</field>
		<field name="drug_name">B-2-Octylglucoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2784</field>
		<field name="drug_name">3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2785</field>
		<field name="drug_name">{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2786</field>
		<field name="drug_name">1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2787</field>
		<field name="drug_name">D-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2788</field>
		<field name="drug_name">N,O-Didansyl-L-Tyrosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2789</field>
		<field name="drug_name">D-Myo-Inositol-1,4-Bisphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2790</field>
		<field name="drug_name">CRA_8696</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2791</field>
		<field name="drug_name">N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2792</field>
		<field name="drug_name">Thymidine-5'-Diphospho-Beta-D-Xylose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2793</field>
		<field name="drug_name">4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2794</field>
		<field name="drug_name">(2-[2-Ketopropylthio]Ethanesulfonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2795</field>
		<field name="drug_name">6-Amino-1-Methylpurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2796</field>
		<field name="drug_name">2-Dimethylamino-Ethyl-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2797</field>
		<field name="drug_name">Pentabromophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2798</field>
		<field name="drug_name">Nicotinamide Adenine Dinucleotide Cyclohexanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2799</field>
		<field name="drug_name">(S)-Hmg-Coa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2800</field>
		<field name="drug_name">Dephospho Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2801</field>
		<field name="drug_name">Indole-3-Propanol Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2802</field>
		<field name="drug_name">Tubercidin</field>
		<field name="description">An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2803</field>
		<field name="drug_name">CRA_10433</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2804</field>
		<field name="drug_name">Phosphonoacetaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2805</field>
		<field name="drug_name">1-Proponol</field>
		<field name="description">A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2806</field>
		<field name="drug_name">3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2807</field>
		<field name="drug_name">Guanosine-2',3'-Cyclophosphorothioate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2808</field>
		<field name="drug_name">Sinapoyl Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2809</field>
		<field name="drug_name">4,5-Dimethyl-1,2-Phenylenediamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2810</field>
		<field name="drug_name">2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2811</field>
		<field name="drug_name">Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2812</field>
		<field name="drug_name">1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2813</field>
		<field name="drug_name">5-Amino-3-Methyl-Pyrrolidine-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2814</field>
		<field name="drug_name">1-Beta-Ribofuranosyl-1,3-Diazepinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2815</field>
		<field name="drug_name">U-Pi-a-Pi</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2816</field>
		<field name="drug_name">6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2817</field>
		<field name="drug_name">4-Thio-Beta-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2818</field>
		<field name="drug_name">Cu-Cyclam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2819</field>
		<field name="drug_name">N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2820</field>
		<field name="drug_name">3-Oxiran-2ylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2821</field>
		<field name="drug_name">3r-Hydroxydecanoyl-Coa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2822</field>
		<field name="drug_name">Stearic acid</field>
		<field name="description">Stearic acid (IUPAC systematic name: octadecanoic acid) is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is a waxy solid. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2823</field>
		<field name="drug_name">Beta-L-Methyl-Fucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2824</field>
		<field name="drug_name">Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2825</field>
		<field name="drug_name">4-Nitrophenyl-Ara</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2826</field>
		<field name="drug_name">6-Hydroxymethylpterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2827</field>
		<field name="drug_name">Thio-Maltohexaose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2828</field>
		<field name="drug_name">4-Methoxy-E-Rhodomycin T</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2829</field>
		<field name="drug_name">7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2830</field>
		<field name="drug_name">D-Cysteine</field>
		<field name="description">A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2831</field>
		<field name="drug_name">2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2832</field>
		<field name="drug_name">Sphingosine</field>
		<field name="description">An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2833</field>
		<field name="drug_name">5-(Aminomethyl)-2-Methylpyrimidin-4-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2834</field>
		<field name="drug_name">Pyrroloquinoline Quinone</field>
		<field name="description">A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2835</field>
		<field name="drug_name">1-Deoxynojirimycin</field>
		<field name="description">An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2836</field>
		<field name="drug_name">2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2837</field>
		<field name="drug_name">Beta-1,2,3,4,6-Penta-O-Galloyl-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2838</field>
		<field name="drug_name">Oxonic Acid</field>
		<field name="description">Oxonic Acid is an antagonist of urate oxidase. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2839</field>
		<field name="drug_name">4-Aminohydrocinnamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2840</field>
		<field name="drug_name">(3-Formyl-but-3-Enyl)-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2841</field>
		<field name="drug_name">4-Deoxyglucarate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2842</field>
		<field name="drug_name">Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2843</field>
		<field name="drug_name">Vinylglycine</field>
		<field name="description">Vinylglycine is an irreversible inhibitor of aspartate aminotransferase.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2844</field>
		<field name="drug_name">(2s,5s)-5-Carboxymethylproline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2845</field>
		<field name="drug_name">(1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2846</field>
		<field name="drug_name">DPI59</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2847</field>
		<field name="drug_name">N-Acetyl-N'-Beta-D-Glucopyranosyl Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2848</field>
		<field name="drug_name">11-Deoxy-Beta-Rhodomycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2849</field>
		<field name="drug_name">FR233623</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2850</field>
		<field name="drug_name">AL7099A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2851</field>
		<field name="drug_name">2'-Deoxyadenosine 5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2852</field>
		<field name="drug_name">Diphthamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2853</field>
		<field name="drug_name">2-Formyl-Protoporphryn Ix</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2854</field>
		<field name="drug_name">D-Tryptophan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2855</field>
		<field name="drug_name">Trifluoroethanol</field>
		<field name="description">A non-aqueous co-solvent that serves as tool to study protein folding. It is also used in various pharmaceutical, chemical and engineering applications. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2856</field>
		<field name="drug_name">Nicotinamide Mononucleotide</field>
		<field name="description">3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5&amp;#39;phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2857</field>
		<field name="drug_name">5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2858</field>
		<field name="drug_name">2-Oxo-4-Methylpentanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2859</field>
		<field name="drug_name">Adenosine-5'-Propylphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2860</field>
		<field name="drug_name">3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-[2-(2-(Hydroxymethyl-Phenylsulfanyl)-Benzyl]-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2861</field>
		<field name="drug_name">2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2862</field>
		<field name="drug_name">Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2863</field>
		<field name="drug_name">(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2864</field>
		<field name="drug_name">N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-Nitro-5-(Galactopyranosyl)-Alpha-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2865</field>
		<field name="drug_name">(2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2866</field>
		<field name="drug_name">2,3-Dihydroxy-5-Oxo-Hexanedioate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2867</field>
		<field name="drug_name">3,5-Difluoroaniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2868</field>
		<field name="drug_name">3',5'-Dinitro-N-Acetyl-L-Thyronine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2869</field>
		<field name="drug_name">(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2870</field>
		<field name="drug_name">1-Amino-1-Carbonyl Pentane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2871</field>
		<field name="drug_name">P-Aminophenyl-Alpha-D-Galactopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2872</field>
		<field name="drug_name">4-Fluorobenzylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2873</field>
		<field name="drug_name">(S)-2-[4-(Aminomethyl)-1h-1,2,3-Triazol-1-Yl]-4-Methylpentanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2874</field>
		<field name="drug_name">S-4-Nitrobutyryl-Coa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2875</field>
		<field name="drug_name">Beta-L-Arabinose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2876</field>
		<field name="drug_name">Riboflavin Monophosphate</field>
		<field name="description">A coenzyme for a number of oxidative enzymes including NADH DEHYDROGENASE. It is the principal form in which RIBOFLAVIN is found in cells and tissues. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2877</field>
		<field name="drug_name">2-(Phosphonooxy)Butanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2878</field>
		<field name="drug_name">2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2879</field>
		<field name="drug_name">2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2880</field>
		<field name="drug_name">RWJ-51084</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2881</field>
		<field name="drug_name">D-Lysine</field>
		<field name="description">An essential amino acid. It is often added to animal feed. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2882</field>
		<field name="drug_name">(2s)-Pyrrolidin-2-Ylmethylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2883</field>
		<field name="drug_name">4-Phenyl-1h-Imidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2884</field>
		<field name="drug_name">Phenol</field>
		<field name="description">Phenol is an antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. Phenol has been used to disinfect skin and to relieve itching. Phenol is also used as an oral analgesic or anesthetic in products such as Chloraseptic to treat pharyngitis. Additionally, phenol and its related compounds are used in surgical ingrown toenail treatment, a process termed phenolization. Research indicates that parental exposure to phenol and its related compounds are positively associated with spontaneous abortion. During the second world war, phenol injections were used as a means of execution by the Nazis. Phenol is a toxic compound whose vapours are corrosive to the skin, eyes, and respiratory tract.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">2885</field>
		<field name="drug_name">5-Formyl-5,6,7,8-Tetrahydrofolate</field>
		<field name="description">The active metabolite of FOLIC ACID. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2886</field>
		<field name="drug_name">5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2887</field>
		<field name="drug_name">2'-Deoxycytidine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2888</field>
		<field name="drug_name">2',6'-Dichloro-Biphenyl-2,6-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2889</field>
		<field name="drug_name">1,6-Diaminohexane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2890</field>
		<field name="drug_name">Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2891</field>
		<field name="drug_name">Thiocellobiose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2892</field>
		<field name="drug_name">Dodecyl-Coa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2893</field>
		<field name="drug_name">Pentanedial</field>
		<field name="description">One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2894</field>
		<field name="drug_name">1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2895</field>
		<field name="drug_name">RU82197</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2896</field>
		<field name="drug_name">4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5,6-Enyl)Amino)Fructose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2897</field>
		<field name="drug_name">2,6-Difluorobenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2898</field>
		<field name="drug_name">7,8-Dihydro-L-Biopterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2899</field>
		<field name="drug_name">4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2900</field>
		<field name="drug_name">3'-Oxo-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2901</field>
		<field name="drug_name">2'-5'dideoxyuridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2902</field>
		<field name="drug_name">2-Amino-3-Mercapto-Propionamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2903</field>
		<field name="drug_name">4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2904</field>
		<field name="drug_name">Amylotriose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2905</field>
		<field name="drug_name">D-Treitol</field>
		<field name="description">A four-carbon sugar that is found in algae, fungi, and lichens. It is twice as sweet as sucrose and can be used as a coronary vasodilator. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2906</field>
		<field name="drug_name">Dodecyl-Alpha-D-Maltoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2907</field>
		<field name="drug_name">P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2908</field>
		<field name="drug_name">2'-Deoxymaltose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2909</field>
		<field name="drug_name">beta-L-fucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2910</field>
		<field name="drug_name">2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2911</field>
		<field name="drug_name">2',4,4'-Trihydroxychalcone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2912</field>
		<field name="drug_name">C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2913</field>
		<field name="drug_name">4-(2-Amino-Ethoxy)-2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-but-3-Enoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2914</field>
		<field name="drug_name">5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2915</field>
		<field name="drug_name">Thiarsa Dihydroxy Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2916</field>
		<field name="drug_name">L-Naphthyl-1-Acetamido Boronic Acid Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2917</field>
		<field name="drug_name">4-Deoxy-4-Amino-Beta-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2918</field>
		<field name="drug_name">D-2-Amino-3-Phosphono-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2919</field>
		<field name="drug_name">9-Methyl Uric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2920</field>
		<field name="drug_name">1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2921</field>
		<field name="drug_name">Glutathionylspermidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2922</field>
		<field name="drug_name">Lactose Sialic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2923</field>
		<field name="drug_name">Benzylsulfinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2924</field>
		<field name="drug_name">Phenylphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2925</field>
		<field name="drug_name">N-Succinyl Phenylglycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2926</field>
		<field name="drug_name">Pterin Cytosine Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2927</field>
		<field name="drug_name">2-Allyl-6-Methyl-Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2928</field>
		<field name="drug_name">4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2929</field>
		<field name="drug_name">D-2-Keto-3-Deoxygluconate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2930</field>
		<field name="drug_name">7-Deaza-7-Aminomethyl-Guanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2931</field>
		<field name="drug_name">N5-Iminoethyl-L-Ornithine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2932</field>
		<field name="drug_name">RU78300</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2933</field>
		<field name="drug_name">4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2934</field>
		<field name="drug_name">L-Leucyl-Hydroxylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2935</field>
		<field name="drug_name">N-Cyclohexyltaurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2936</field>
		<field name="drug_name">Oxidized Glutathione Disulfide</field>
		<field name="description">A GLUTATHIONE dimer formed by a disulfide bond between the cysteine sulfhydryl side chains during the course of being oxidized. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2937</field>
		<field name="drug_name">3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2938</field>
		<field name="drug_name">5-Bromovinyldeoxyuridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2939</field>
		<field name="drug_name">Cephalosporin C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2940</field>
		<field name="drug_name">Fluorotryptophane</field>
		<field name="description">Fluorotryptophane can be used as substrate analogue to study enzyme mechanisms by NMR spectroscopy.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2941</field>
		<field name="drug_name">Guanosine-3'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2942</field>
		<field name="drug_name">1,4-Diethylene Dioxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2943</field>
		<field name="drug_name">Heme C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2944</field>
		<field name="drug_name">6-Hydro-1-Methyladenosine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2945</field>
		<field name="drug_name">(S)-ATPA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2946</field>
		<field name="drug_name">3-Amino-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2947</field>
		<field name="drug_name">4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2948</field>
		<field name="drug_name">1-(Isopropylamino)-3-(1-Naphthyloxy)-2-Propanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2949</field>
		<field name="drug_name">Maltose</field>
		<field name="description">A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing. (Grant &amp; Hackh&amp;#39;s Chemical Dictionary, 5th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2950</field>
		<field name="drug_name">Tyrosyladenylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2951</field>
		<field name="drug_name">deoxycytidylyl-3',5'-guanosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2952</field>
		<field name="drug_name">{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2953</field>
		<field name="drug_name">dioxothiomolybdenum(VI) ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2954</field>
		<field name="drug_name">2-Pyridinethiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2955</field>
		<field name="drug_name">S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2956</field>
		<field name="drug_name">N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2957</field>
		<field name="drug_name">5,6-Cyclic-Tetrahydropteridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2958</field>
		<field name="drug_name">(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2959</field>
		<field name="drug_name">1-Bromopropane-2-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2960</field>
		<field name="drug_name">BIA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2961</field>
		<field name="drug_name">1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2962</field>
		<field name="drug_name">Heptyl-Beta-D-Glucopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2963</field>
		<field name="drug_name">3-Iodo-Benzyl Alcohol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2964</field>
		<field name="drug_name">3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2965</field>
		<field name="drug_name">Coa-S-Acetyl 5-Bromotryptamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2966</field>
		<field name="drug_name">4-(Acetylamino)-3-Guanidinobenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2967</field>
		<field name="drug_name">Malate Like Intermediate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2968</field>
		<field name="drug_name">Inositol-(1,3,4,5,6)-Pentakisphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2969</field>
		<field name="drug_name">Beta-Mercaptoethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2970</field>
		<field name="drug_name">3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2971</field>
		<field name="drug_name">Triethyl Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2972</field>
		<field name="drug_name">8-Bromo-Adenosine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2973</field>
		<field name="drug_name">Cobalt Hexammine Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2974</field>
		<field name="drug_name">Sri-9439</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2975</field>
		<field name="drug_name">S-Arsonocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2976</field>
		<field name="drug_name">2-Iminobiotin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2977</field>
		<field name="drug_name">2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2978</field>
		<field name="drug_name">5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2979</field>
		<field name="drug_name">(S)-Mandelic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2980</field>
		<field name="drug_name">7n-Methyl-8-Hydroguanosine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2981</field>
		<field name="drug_name">M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2982</field>
		<field name="drug_name">N-Acetylproline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2983</field>
		<field name="drug_name">2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2984</field>
		<field name="drug_name">N-Dimethyl-Lysine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2985</field>
		<field name="drug_name">3-Acetylpyridine Adenine Dinucleotide</field>
		<field name="description">A coenzyme composed of ribosylnicotinamide 5&amp;#39;-diphosphate coupled to adenosine 5&amp;#39;-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2986</field>
		<field name="drug_name">N-Carbamyl-D-Methionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2987</field>
		<field name="drug_name">4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2988</field>
		<field name="drug_name">PF-00356231</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2989</field>
		<field name="drug_name">5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2990</field>
		<field name="drug_name">9-Aminophenanthrene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2991</field>
		<field name="drug_name">FR239087</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2992</field>
		<field name="drug_name">Modified Ribosylated Glutamyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2993</field>
		<field name="drug_name">3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2994</field>
		<field name="drug_name">ZK-806711</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2995</field>
		<field name="drug_name">3,5-Diiodotyrosine</field>
		<field name="description">A product from the iodination of MONOIODOTYROSINE.  In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other  monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (THYROXINE and TRIIODOTHYRONINE). [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2996</field>
		<field name="drug_name">'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2997</field>
		<field name="drug_name">4-Amino-1-[(1s,3r,4r,7s)-7-Hydroxy-1-(Hydroxymethyl)-2,5-Dioxabicyclo[2.2.1]Hept-3-Yl]-5-Methylpyrimidin-2(1h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2998</field>
		<field name="drug_name">2-Carboxyethylphosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">2999</field>
		<field name="drug_name">L-Tyrosinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3000</field>
		<field name="drug_name">Hexadecanal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3001</field>
		<field name="drug_name">S-Oxy Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3002</field>
		<field name="drug_name">5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3003</field>
		<field name="drug_name">Fica</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3004</field>
		<field name="drug_name">4-Methylimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3005</field>
		<field name="drug_name">4-Fluorotryptophane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3006</field>
		<field name="drug_name">N-Hydroxy-N-Isopropyloxamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3007</field>
		<field name="drug_name">3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3008</field>
		<field name="drug_name">alpha-D-Xylopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3009</field>
		<field name="drug_name">N-Propyl-Tartramic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3010</field>
		<field name="drug_name">Chromophore (Met-Tyr-Gly)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3011</field>
		<field name="drug_name">(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3012</field>
		<field name="drug_name">(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3013</field>
		<field name="drug_name">Enalkiren</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3014</field>
		<field name="drug_name">(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3015</field>
		<field name="drug_name">Uridine-Diphosphate-N-Acetylglucosamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3016</field>
		<field name="drug_name">Ethyl Isocyanide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3017</field>
		<field name="drug_name">3-(P-Tolyl)Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3018</field>
		<field name="drug_name">D-Myo-Inositol-1,4,5-Triphosphate</field>
		<field name="description">Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell&amp;#39;s endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3019</field>
		<field name="drug_name">1,2-Di-1-(3,7,11,15-Tetramethyl-Hexadecane)-Sn-Glycero-3-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3020</field>
		<field name="drug_name">Cytidine-5'-Monophosphate</field>
		<field name="description">Cytidine (dihydrogen phosphate). A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2&amp;#39;, 3&amp;#39; or 5&amp;#39; position. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3021</field>
		<field name="drug_name">6,7-Dicarboxyl-1,2,3,4,5,8-Hexamethylhemin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3022</field>
		<field name="drug_name">1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3023</field>
		<field name="drug_name">O1-Methyl-4-Deoxy-4-Thio-Alpha-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3024</field>
		<field name="drug_name">4-Nitrocatechol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3025</field>
		<field name="drug_name">Gamma-Glutamylcysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3026</field>
		<field name="drug_name">Octahydroindole-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3027</field>
		<field name="drug_name">4-hydroxycoumarin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3028</field>
		<field name="drug_name">2-Hydroxymethyl-Pyrrolidine-3,4-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3029</field>
		<field name="drug_name">6-Hydroxy-L-Norleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3030</field>
		<field name="drug_name">Deoxyuridine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3031</field>
		<field name="drug_name">5-Thio-a/B-D-Mannopyranosylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3032</field>
		<field name="drug_name">3-Thiaoctanoyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3033</field>
		<field name="drug_name">Thiamin Phosphate</field>
		<field name="description">Thiamine dihydrogen phosphate ester. The monophosphate ester of thiamine. Synonyms: monophosphothiamine; vitamin B1 monophosphate. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3034</field>
		<field name="drug_name">1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3035</field>
		<field name="drug_name">Diacetyldeuteroheme</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3036</field>
		<field name="drug_name">Uracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3037</field>
		<field name="drug_name">2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3038</field>
		<field name="drug_name">2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3039</field>
		<field name="drug_name">1,3-Thiazole-4-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3040</field>
		<field name="drug_name">S-Adenosyl-L-Homoselenocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3041</field>
		<field name="drug_name">Bestatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3042</field>
		<field name="drug_name">2s,4r-4-Methylglutamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3043</field>
		<field name="drug_name">Digalactosyl Diacyl Glycerol (Dgdg)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3044</field>
		<field name="drug_name">Delta-(L-Alpha-Aminoadipoyl)-L-Cysteinyl-D-Vinylglycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3045</field>
		<field name="drug_name">SU9516</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3046</field>
		<field name="drug_name">Cardiolipin</field>
		<field name="description">Cardiolipin (bisphosphatidyl glycerol) is an important component of the inner mitochondrial membrane, where it constitutes about 20% of the total lipid. It is typically present in metabolically active cells of the heart and skeletal muscle, in the membranes of their mitochondria, mostly in the inner membrane, and consists roughly 20% of its lipids. It has also been observed in certain bacterial membranes. It serves as an insulator and stabilizes the activity of protein complexes important to the electron transport chain. It also &quot;glues&quot; them together. Cardiolipin is a &quot;double&quot; phospholipid because it has four fatty acid tails, instead of the usual two. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3047</field>
		<field name="drug_name">(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3048</field>
		<field name="drug_name">Adenosine-5'-Diphosphate</field>
		<field name="description">Adenosine 5&amp;#39;-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5&amp;#39;-position. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3049</field>
		<field name="drug_name">Beta-Amino Isobutyrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3050</field>
		<field name="drug_name">{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3051</field>
		<field name="drug_name">3[N-Morpholino]Propane Sulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3052</field>
		<field name="drug_name">Uridine-5'-Diphosphate</field>
		<field name="description">A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3053</field>
		<field name="drug_name">Gallichrome</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3054</field>
		<field name="drug_name">2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3055</field>
		<field name="drug_name">Lysophosphatidylglycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3056</field>
		<field name="drug_name">4,6-Dideoxy-4-Amino-Alpha-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3057</field>
		<field name="drug_name">N-Hexadecanoylglycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3058</field>
		<field name="drug_name">2-Benzyl-3-Iodopropanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3059</field>
		<field name="drug_name">2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3060</field>
		<field name="drug_name">Bis(5-Amidino-Benzimidazolyl)Methanone Zinc</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3061</field>
		<field name="drug_name">(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3062</field>
		<field name="drug_name">Tazobactam Trans-Enamine Intermediate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3063</field>
		<field name="drug_name">3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3064</field>
		<field name="drug_name">Uridylyl-2'-5'-Phospho-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3065</field>
		<field name="drug_name">2'-Deoxyuridine 3'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3066</field>
		<field name="drug_name">N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3067</field>
		<field name="drug_name">Cephalothin Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3068</field>
		<field name="drug_name">1alpha,25-Dihydroxyl-20-Epi-22-Oxa-24,26,27-Trihomovitamin D3</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3069</field>
		<field name="drug_name">3-Trimethylsilylsuccinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3070</field>
		<field name="drug_name">(R)-N-[2-[1-(Aminoiminomethyl)-3-Piperidinyl]-1-Oxoethyl]-4-(Phenylethynyl)-L-Phenylalanine Methylester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3071</field>
		<field name="drug_name">3-Methyl-Benzene-1,2-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3072</field>
		<field name="drug_name">(1h-Indol-3-Yl)-(2-Mercapto-Ethoxyimino)-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3073</field>
		<field name="drug_name">N2-[(Benzyloxy)Carbonyl]-N1-[(3s)-1-Cyanopyrrolidin-3-Yl]-L-Leucinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3074</field>
		<field name="drug_name">N(4)-adenosyl-N(4)-methyl-2,4-diaminobutanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3075</field>
		<field name="drug_name">N-(Phosphonacetyl)-L-Aspartic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3076</field>
		<field name="drug_name">Violaxanthin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3077</field>
		<field name="drug_name">2'-Monophosphoadenosine 5'-Diphosphoribose</field>
		<field name="description">Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5&amp;#39;-phosphate (NMN) coupled by pyrophosphate linkage to the 5&amp;#39;-phosphate adenosine 2&amp;#39;,5&amp;#39;-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3078</field>
		<field name="drug_name">Thymine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3079</field>
		<field name="drug_name">Para-Xylene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3080</field>
		<field name="drug_name">Formycin-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3081</field>
		<field name="drug_name">2-Phospho-D-Glyceric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3082</field>
		<field name="drug_name">BMS184394</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3083</field>
		<field name="drug_name">Naringenin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3084</field>
		<field name="drug_name">1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3085</field>
		<field name="drug_name">Heme D</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3086</field>
		<field name="drug_name">Trypanothione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3087</field>
		<field name="drug_name">6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3088</field>
		<field name="drug_name">Cyclohexyl-Hexyl-Beta-D-Maltoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3089</field>
		<field name="drug_name">N5-Methylglutamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3090</field>
		<field name="drug_name">Reactive Red 1 Dye</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3091</field>
		<field name="drug_name">1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3092</field>
		<field name="drug_name">Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3093</field>
		<field name="drug_name">1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3094</field>
		<field name="drug_name">2'-O-Acetyl Adenosine-5-Diphosphoribose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3095</field>
		<field name="drug_name">8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3096</field>
		<field name="drug_name">Brequinar Analog</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3097</field>
		<field name="drug_name">5,10-Dimethylene Tetrahydromethanopterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3098</field>
		<field name="drug_name">8-Demethyl-8-Dimethylamino-Flavin-Adenine-Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3099</field>
		<field name="drug_name">4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3100</field>
		<field name="drug_name">L-Alpha-Glycerophosphorylethanolamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3101</field>
		<field name="drug_name">Alpha-D-Fucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3102</field>
		<field name="drug_name">Phosphomethylphosphonic Acid Guanosyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3103</field>
		<field name="drug_name">3-Aminosuccinimide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3104</field>
		<field name="drug_name">Uridine-5'-Diphosphate-2-Deoxy-2-Fluoro-Alpha-D-Galactose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3105</field>
		<field name="drug_name">2-Keto-3-Deoxygluconate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3106</field>
		<field name="drug_name">3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3107</field>
		<field name="drug_name">2'-Deoxyguanosine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3108</field>
		<field name="drug_name">Lambda-Bis(2,2'-Bipyridine)Imidazole Osmium (Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3109</field>
		<field name="drug_name">7-Methylguanosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3110</field>
		<field name="drug_name">CRA_10950</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3111</field>
		<field name="drug_name">4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1-&gt;4)-Alpha-D-Threo-Hexopyranosyl-(1-&gt;6)-Alpha-L-Threo-Hexopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3112</field>
		<field name="drug_name">Flavopiridol</field>
		<field name="description">Flavopiridol is a synthetic flavonoid based on an extract from an Indian plant for the potential treatment of cancer. It works by inhibiting cyclin-dependent kinases, arresting cell division and causing apoptosis in non-small lung cancer cells.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3113</field>
		<field name="drug_name">O-Sulfo-L-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3114</field>
		<field name="drug_name">Mercaptomethyl Phosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3115</field>
		<field name="drug_name">Malate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3116</field>
		<field name="drug_name">Tricosanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3117</field>
		<field name="drug_name">Uridine Diphosphate Galactose</field>
		<field name="description">A nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3118</field>
		<field name="drug_name">(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3119</field>
		<field name="drug_name">4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3120</field>
		<field name="drug_name">9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3121</field>
		<field name="drug_name">2,6-Diaminoquinazolin-4(3h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3122</field>
		<field name="drug_name">9-Deazaadenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3123</field>
		<field name="drug_name">6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3124</field>
		<field name="drug_name">1-Ethoxy-2-(2-Methoxyethoxy)Ethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3125</field>
		<field name="drug_name">2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3126</field>
		<field name="drug_name">6-O-Phosphoryl Inosine Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3127</field>
		<field name="drug_name">Galacturonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3128</field>
		<field name="drug_name">Uridine-2',3'-Vanadate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3129</field>
		<field name="drug_name">(S)-2-Amino-3-(4h-Selenolo[3,2-B]-Pyrrol-6-Yl)-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3130</field>
		<field name="drug_name">2-Methoxy-4-Vinyl-Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3131</field>
		<field name="drug_name">Equilenin</field>
		<field name="description">An estrogenic steroid produced by HORSES. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the URINE of pregnant mares. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3132</field>
		<field name="drug_name">[Methylthio]Acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3133</field>
		<field name="drug_name">(R)-Mevalonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3134</field>
		<field name="drug_name">2-Amino-Pentanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3135</field>
		<field name="drug_name">6-Chloro-2-Fluoropurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3136</field>
		<field name="drug_name">Aspartic Acid-4-Carboxymethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3137</field>
		<field name="drug_name">6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3138</field>
		<field name="drug_name">N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-(2-Thiophen-2-Yl-Acetylamino)-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3139</field>
		<field name="drug_name">RU79073</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3140</field>
		<field name="drug_name">AL5927</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3141</field>
		<field name="drug_name">9-Beta-D-Xylofuranosyl-Adenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3142</field>
		<field name="drug_name">Acylated Ceftazidime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3143</field>
		<field name="drug_name">Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3144</field>
		<field name="drug_name">Phosphomethylphosphonic Acid Guanylate Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3145</field>
		<field name="drug_name">Glycoluril</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3146</field>
		<field name="drug_name">3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3147</field>
		<field name="drug_name">Z-Pro-Prolinal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3148</field>
		<field name="drug_name">Benzoyl-Arginine-Alanine-Methyl Ketone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3149</field>
		<field name="drug_name">[4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3150</field>
		<field name="drug_name">2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3151</field>
		<field name="drug_name">Norcamphor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3152</field>
		<field name="drug_name">10-Propargyl-5,8-Dideazafolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3153</field>
		<field name="drug_name">L-Myo-Inositol-1-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3154</field>
		<field name="drug_name">1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3155</field>
		<field name="drug_name">S-Phosphocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3156</field>
		<field name="drug_name">10-CF3C(OH)2-DDACTHF</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3157</field>
		<field name="drug_name">3-Deoxy-D-Manno-Oct-2-Ulosonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3158</field>
		<field name="drug_name">Biotinyl P-Nitroaniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3159</field>
		<field name="drug_name">Isopenicillin N</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3160</field>
		<field name="drug_name">4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3161</field>
		<field name="drug_name">Meta-Tyrosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3162</field>
		<field name="drug_name">Glutaric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3163</field>
		<field name="drug_name">5-Iodouracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3164</field>
		<field name="drug_name">CRA_11092</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3165</field>
		<field name="drug_name">2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3166</field>
		<field name="drug_name">N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3167</field>
		<field name="drug_name">Sp-876</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3168</field>
		<field name="drug_name">Cyclohexylformamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3169</field>
		<field name="drug_name">P-Hydroxybenzaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3170</field>
		<field name="drug_name">Cyclohexane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3171</field>
		<field name="drug_name">Tetrahydrodeoxyuridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3172</field>
		<field name="drug_name">Tetradecane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3173</field>
		<field name="drug_name">(4r)-2-Methylpentane-2,4-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3174</field>
		<field name="drug_name">1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3175</field>
		<field name="drug_name">Spermidine</field>
		<field name="description">Spermidine is a polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3176</field>
		<field name="drug_name">N-Acetyl-2-Deoxy-2-Amino-Galactose</field>
		<field name="description">The N-acetyl derivative of galactosamine. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3177</field>
		<field name="drug_name">Butanoic Acid</field>
		<field name="description">A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3178</field>
		<field name="drug_name">4,5-Dehydro-L-Iduronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3179</field>
		<field name="drug_name">Tris-Hydroxymethyl-Methyl-Ammonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3180</field>
		<field name="drug_name">3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3181</field>
		<field name="drug_name">FR230513</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3182</field>
		<field name="drug_name">WRR-99</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3183</field>
		<field name="drug_name">Ferricrocin-Iron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3184</field>
		<field name="drug_name">Phencyclidine</field>
		<field name="description">A hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to ketamine in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (receptors, N-methyl-D-aspartate). As a drug of abuse, it is known as PCP and Angel Dust. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3185</field>
		<field name="drug_name">N-Pyridoxyl-Threonine-5-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3186</field>
		<field name="drug_name">Alpha-Benzyl-Aminobenzyl-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3187</field>
		<field name="drug_name">Pyruvamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3188</field>
		<field name="drug_name">Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3189</field>
		<field name="drug_name">Glucose-6-Phosphate</field>
		<field name="description">An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3190</field>
		<field name="drug_name">N~2~-Succinylornithine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3191</field>
		<field name="drug_name">(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3192</field>
		<field name="drug_name">4-Deoxy-4-Thio-Beta-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3193</field>
		<field name="drug_name">Oxyphenbutazone</field>
		<field name="description">Oxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">3194</field>
		<field name="drug_name">5(R)-5-Fluoro-Beta-D-Xylopyranosyl-Enzyme Intermediate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3195</field>
		<field name="drug_name">Pyruvoyl Group</field>
		<field name="description">An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3196</field>
		<field name="drug_name">Diphenylacetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3197</field>
		<field name="drug_name">Alpha-Ketomalonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3198</field>
		<field name="drug_name">2,6-Diaminopimelic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3199</field>
		<field name="drug_name">RU82209</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3200</field>
		<field name="drug_name">Pterin-6-Yl-Methyl-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3201</field>
		<field name="drug_name">N7-Methyl-Guanosine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3202</field>
		<field name="drug_name">1,2,4-Triazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3203</field>
		<field name="drug_name">CRA_9785</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3204</field>
		<field name="drug_name">N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3205</field>
		<field name="drug_name">Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3206</field>
		<field name="drug_name">Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3207</field>
		<field name="drug_name">4-Thio-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3208</field>
		<field name="drug_name">Decanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3209</field>
		<field name="drug_name">5-Deoxyflavanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3210</field>
		<field name="drug_name">S-Benzyl-Glutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3211</field>
		<field name="drug_name">Glucarate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3212</field>
		<field name="drug_name">[4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3213</field>
		<field name="drug_name">(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3214</field>
		<field name="drug_name">(S)-Rolipram</field>
		<field name="description">A phosphodiesterase inhibitor with antidepressant properties. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3215</field>
		<field name="drug_name">D-Para-Chlorophenyl-1-Acetamidoboronic Acid Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3216</field>
		<field name="drug_name">Diminazene</field>
		<field name="description">An effective trypanocidal agent.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3217</field>
		<field name="drug_name">3-Deoxyguanosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3218</field>
		<field name="drug_name">Alpha,Alpha,Alpha-Trifluoro-P-Cresol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3219</field>
		<field name="drug_name">L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3220</field>
		<field name="drug_name">3-Hydroxybutyryl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3221</field>
		<field name="drug_name">4-Hydroxyphenacyl Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3222</field>
		<field name="drug_name">Co-Methylcobalamin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3223</field>
		<field name="drug_name">Ribostamycin</field>
		<field name="description">A broad-spectrum antimicrobial isolated from &lt;i&gt;Streptomyces ribosifidicus&lt;/i&gt;. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3224</field>
		<field name="drug_name">Kabiramide C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3225</field>
		<field name="drug_name">Modified Acarbose Hexasaccharide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3226</field>
		<field name="drug_name">2-(Acetylamino)-2-Deoxy-4-O-Beta-D-Galactopyranosyl-Alpha-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3227</field>
		<field name="drug_name">Deoxycholic Acid</field>
		<field name="description">A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3228</field>
		<field name="drug_name">L-709,587</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3229</field>
		<field name="drug_name">2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3230</field>
		<field name="drug_name">9-(4-Hydroxyphenyl)-2,7-Phenanthroline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3231</field>
		<field name="drug_name">7-(Carboxyamino)-8-Amino-Nonanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3232</field>
		<field name="drug_name">5,10-Dideazatetrahydrofolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3233</field>
		<field name="drug_name">5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3234</field>
		<field name="drug_name">Adamantane</field>
		<field name="description">A tricyclo bridged hydrocarbon. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3235</field>
		<field name="drug_name">ISO24</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3236</field>
		<field name="drug_name">Pyridoxal-5'-Phosphate-N-Oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3237</field>
		<field name="drug_name">2-Iodobenzylthio Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3238</field>
		<field name="drug_name">3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3239</field>
		<field name="drug_name">Argifin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3240</field>
		<field name="drug_name">Lpc-Ether</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3241</field>
		<field name="drug_name">1,3-Di(N-Propyloxy-a-Mannopyranosyl)-Carbomyl 5-Methyazido-Benzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3242</field>
		<field name="drug_name">Ethanesulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3243</field>
		<field name="drug_name">Glycinamid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3244</field>
		<field name="drug_name">Guanidine-3-Propanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3245</field>
		<field name="drug_name">Cytidyl-2'-5'-Phospho-Guanosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3246</field>
		<field name="drug_name">1-Guanidinium-7-Aminoheptane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3247</field>
		<field name="drug_name">Beta-Hydroxyaspartic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3248</field>
		<field name="drug_name">2'-deoxyuridine 5'-alpha,beta-imido-diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3249</field>
		<field name="drug_name">Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3250</field>
		<field name="drug_name">CRA_1144</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3251</field>
		<field name="drug_name">3-Hydroxyanthranilic Acid</field>
		<field name="description">An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3252</field>
		<field name="drug_name">Phosphonoacetohydroxamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3253</field>
		<field name="drug_name">1,2-Di-1-(3,7,11,15-Tetramethyl-Hexadecane)-Sn-Glycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3254</field>
		<field name="drug_name">3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3255</field>
		<field name="drug_name">2-{N'-[2-(5-Amino-1-Phenylcarbamoyl-Pentylcarbamoyl)-Hexyl]-Hydrazinomethyl}-Hexanoic Acid(5-Amino-1-Phenylcarbamoyl-Pentyl)-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3256</field>
		<field name="drug_name">[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3257</field>
		<field name="drug_name">(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3258</field>
		<field name="drug_name">2,4,6-Trinitrophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3259</field>
		<field name="drug_name">L-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3260</field>
		<field name="drug_name">5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3261</field>
		<field name="drug_name">S,S-Propylthiocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3262</field>
		<field name="drug_name">Bcx-1812</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3263</field>
		<field name="drug_name">Tribenuron Methyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3264</field>
		<field name="drug_name">1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3265</field>
		<field name="drug_name">2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3266</field>
		<field name="drug_name">Butylamine</field>
		<field name="description">Butylamine is an organic compound, specifically, an amine. This colourless liquid is one of the four isomeric amines of butane, the others being sec-butylamine, tert-butylamine and isobutylamine. At standard temperature and pressure, n-butylamine is a liquid having the fishy, ammonia-like odor common to amines. The liquid acquires a yellow colour upon storage in air. It is soluble in all organic solvents. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3267</field>
		<field name="drug_name">Iodo-Phenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3268</field>
		<field name="drug_name">Cysteinesulfonic Acid</field>
		<field name="description">Beta-Sulfoalanine. An amino acid with a C-terminal sulfonic acid group which has been isolated from human hair oxidized with permanganate. It occurs normally in the outer part of the sheep&amp;#39;s fleece, where the wool is exposed to light and weather. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3269</field>
		<field name="drug_name">Vitamin B6 Complexed with 2-Amino-Pentanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3270</field>
		<field name="drug_name">1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3271</field>
		<field name="drug_name">P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3272</field>
		<field name="drug_name">3'-Azido-3'-Deoxythymidine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3273</field>
		<field name="drug_name">Acetic Acid Salicyloyl-Amino-Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3274</field>
		<field name="drug_name">1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3275</field>
		<field name="drug_name">4-Fluorophenethyl Alcohol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3276</field>
		<field name="drug_name">2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3277</field>
		<field name="drug_name">4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-CyclopentaPhenanthren-17-Yl)-5h-Furan-2-One</field>
		<field name="description">3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3278</field>
		<field name="drug_name">9-N-Phenylmethylamino-Tacrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3279</field>
		<field name="drug_name">Beta(2-Thienyl)Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3280</field>
		<field name="drug_name">Methyl Mercury Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3281</field>
		<field name="drug_name">2,3-Dihydroxy-Valerianic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3282</field>
		<field name="drug_name">Cystein-S-Yl Cacodylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3283</field>
		<field name="drug_name">N-Cyclohexyl-N'-Decylurea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3284</field>
		<field name="drug_name">(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3285</field>
		<field name="drug_name">2-Hydroxy-Tryptophan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3286</field>
		<field name="drug_name">Tartronate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3287</field>
		<field name="drug_name">Chloro Diiron-Oxo Moiety</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3288</field>
		<field name="drug_name">Dibenzofuran-4,6-Dicarboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3289</field>
		<field name="drug_name">2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3290</field>
		<field name="drug_name">Uridine-5'-Monophosphate</field>
		<field name="description">5&amp;#39;-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2&amp;#39;, 3&amp;#39; or 5&amp;#39; position. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3291</field>
		<field name="drug_name">S-(P-Nitrobenzyl)Glutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3292</field>
		<field name="drug_name">4-Diphosphocytidyl-2-C-Methyl-D-Erythritol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3293</field>
		<field name="drug_name">3-Hydroxy-Propanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3294</field>
		<field name="drug_name">(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3295</field>
		<field name="drug_name">WRR-112</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3296</field>
		<field name="drug_name">1-Hexadecanosulfonyl-O-L-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3297</field>
		<field name="drug_name">N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3298</field>
		<field name="drug_name">N-Phenylthiourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3299</field>
		<field name="drug_name">6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3300</field>
		<field name="drug_name">Lanosterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3301</field>
		<field name="drug_name">4-Sulfonamide-[1-(4-Aminobutane)]Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3302</field>
		<field name="drug_name">5-Mercaptoethanol-2-Decenoyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3303</field>
		<field name="drug_name">Succinyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3304</field>
		<field name="drug_name">D-Threonine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3305</field>
		<field name="drug_name">Vanoxerine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3306</field>
		<field name="drug_name">2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3307</field>
		<field name="drug_name">Cyclohexanol</field>
		<field name="description">Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3308</field>
		<field name="drug_name">12-Hydroxydodecanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3309</field>
		<field name="drug_name">6-Methylamino-5-Nitroisocytosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3310</field>
		<field name="drug_name">1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3311</field>
		<field name="drug_name">S-Ethyl-N-Phenyl-Isothiourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3312</field>
		<field name="drug_name">Adenosine-5'-Phosphosulfate</field>
		<field name="description">5&amp;#39;-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3313</field>
		<field name="drug_name">Bicine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3314</field>
		<field name="drug_name">N5-(1-Imino-3-Butenyl)-L-Ornithine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3315</field>
		<field name="drug_name">6-Hydroxy-6-Methyl-Heptan-3-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3316</field>
		<field name="drug_name">RU85053</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3317</field>
		<field name="drug_name">4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3318</field>
		<field name="drug_name">Pentadecane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3319</field>
		<field name="drug_name">5'-Fluoro-5'-Deoxyadenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3320</field>
		<field name="drug_name">3-Hydroxy-4-(3,4,5-Trihydroxy-Tetrahydro-Pyran-2-Yloxy)-Piperidin-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3321</field>
		<field name="drug_name">6-Aza-Ump</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3322</field>
		<field name="drug_name">N-Ethyl-5'-Carboxamido Adenosine</field>
		<field name="description">A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3323</field>
		<field name="drug_name">Z-Dehydrobutyrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3324</field>
		<field name="drug_name">O-Sialic Acid</field>
		<field name="description">An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3325</field>
		<field name="drug_name">3,4-Dihydro-5-Methyl-Isoquinolinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3326</field>
		<field name="drug_name">2'-Deoxy-Thymidine-Beta-L-Rhamnose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3327</field>
		<field name="drug_name">(1s,2s)-1-Amino-1-(1,3-Thiazol-2-Yl)Propan-2-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3328</field>
		<field name="drug_name">Phosphomethylphosphonic Acid-Guanylate Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3329</field>
		<field name="drug_name">Purine Riboside-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3330</field>
		<field name="drug_name">Coproporphyrin I</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3331</field>
		<field name="drug_name">4-Chlorobenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3332</field>
		<field name="drug_name">2-Amino-5-Hydroxy-Benzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3333</field>
		<field name="drug_name">3,9-Dimethyladenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3334</field>
		<field name="drug_name">S-2-(Boronoethyl)-L-Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3335</field>
		<field name="drug_name">Etheno-Nadp</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3336</field>
		<field name="drug_name">Ethylene Dichloride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3337</field>
		<field name="drug_name">Xylarohydroxamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3338</field>
		<field name="drug_name">9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3339</field>
		<field name="drug_name">2-Cyclopropylmethylenepropanal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3340</field>
		<field name="drug_name">4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3341</field>
		<field name="drug_name">Pantothenoylaminoethenethiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3342</field>
		<field name="drug_name">3-Hydroxyimino Quinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3343</field>
		<field name="drug_name">2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose</field>
		<field name="description">The N-acetyl derivative of glucosamine. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3344</field>
		<field name="drug_name">2-Methylbutanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3345</field>
		<field name="drug_name">Compound 4-D</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3346</field>
		<field name="drug_name">Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3347</field>
		<field name="drug_name">Arabinose-5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3348</field>
		<field name="drug_name">3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3349</field>
		<field name="drug_name">3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3350</field>
		<field name="drug_name">Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3351</field>
		<field name="drug_name">4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3352</field>
		<field name="drug_name">Isovaleric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3353</field>
		<field name="drug_name">2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3354</field>
		<field name="drug_name">P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3355</field>
		<field name="drug_name">Flurbiprofen Methyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3356</field>
		<field name="drug_name">Tris(Hydroxymethyl)Aminomethane</field>
		<field name="description">An organic amine proton acceptor. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer. (From Merck, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p1424)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3357</field>
		<field name="drug_name">Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3358</field>
		<field name="drug_name">Docosa-4,7,10,13,16,19-Hexaenoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3359</field>
		<field name="drug_name">(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3360</field>
		<field name="drug_name">Radicicol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3361</field>
		<field name="drug_name">Dnqx</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3362</field>
		<field name="drug_name">Dihydrolipoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3363</field>
		<field name="drug_name">5-Fluoro-2'-Deoxyuridine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3364</field>
		<field name="drug_name">5-Methyl-2'-Deoxypseudouridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3365</field>
		<field name="drug_name">4-Hydroperoxy-2-Methoxy-Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3366</field>
		<field name="drug_name">Cytidine-2'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3367</field>
		<field name="drug_name">Propanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3368</field>
		<field name="drug_name">Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3369</field>
		<field name="drug_name">N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3370</field>
		<field name="drug_name">D-Eritadenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3371</field>
		<field name="drug_name">N-Hydroxyguanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3372</field>
		<field name="drug_name">Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3373</field>
		<field name="drug_name">2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3374</field>
		<field name="drug_name">6-Deoxy-Alpha-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3375</field>
		<field name="drug_name">Glutamyl Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3376</field>
		<field name="drug_name">D-Dethiobiotin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3377</field>
		<field name="drug_name">Lactaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3378</field>
		<field name="drug_name">Rbt205 Inhibitor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3379</field>
		<field name="drug_name">Glucosaminyl-(Alpha-6)-D-Myo-Inositol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3380</field>
		<field name="drug_name">2-Aminoquinazolin-4(3h)-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3381</field>
		<field name="drug_name">2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3382</field>
		<field name="drug_name">N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3383</field>
		<field name="drug_name">Phenacetin</field>
		<field name="description">Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3384</field>
		<field name="drug_name">Elaidoylamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3385</field>
		<field name="drug_name">(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3386</field>
		<field name="drug_name">L-Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3387</field>
		<field name="drug_name">GC-24</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3388</field>
		<field name="drug_name">2,3-Dimethylimidazolium Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3389</field>
		<field name="drug_name">S-Dioxymethionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3390</field>
		<field name="drug_name">(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3391</field>
		<field name="drug_name">5-Amino-1h-Pyrimidine-2,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3392</field>
		<field name="drug_name">Benzoic Acid</field>
		<field name="description">A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3393</field>
		<field name="drug_name">Trifluoroalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3394</field>
		<field name="drug_name">2-Dehydropantoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3395</field>
		<field name="drug_name">Palmitic Acid</field>
		<field name="description">A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3396</field>
		<field name="drug_name">3-Aminomethyl-Pyridinium-Adenine-Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3397</field>
		<field name="drug_name">2'-Deoxycytidine-5'-Monophosphate</field>
		<field name="description">Deoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2&amp;#39;-,3&amp;#39;- or 5- positions. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3398</field>
		<field name="drug_name">Trifluoromethionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3399</field>
		<field name="drug_name">2'-deoxyuridylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3400</field>
		<field name="drug_name">Lysine Nz-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3401</field>
		<field name="drug_name">1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3402</field>
		<field name="drug_name">Inhibitor Msa367</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3403</field>
		<field name="drug_name">5-Bromothienyldeoxyuridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3404</field>
		<field name="drug_name">Antiproliferative Agent A771726</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3405</field>
		<field name="drug_name">1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3406</field>
		<field name="drug_name">4,4'[1,6-Hexanediylbis(Oxy)]Bisbenzenecarboximidamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3407</field>
		<field name="drug_name">9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3408</field>
		<field name="drug_name">(3r)-3-Methyl-L-Glutamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3409</field>
		<field name="drug_name">Histidinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3410</field>
		<field name="drug_name">3-{2,6,8-Trioxo-9-[(2s,3r,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3411</field>
		<field name="drug_name">2-Decenoyl N-Acetyl Cysteamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3412</field>
		<field name="drug_name">2-(N-Morpholino)-Ethanesulfonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3413</field>
		<field name="drug_name">Fucitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3414</field>
		<field name="drug_name">Difluoromethionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3415</field>
		<field name="drug_name">2,4-Diaminobutyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3416</field>
		<field name="drug_name">N-[Tosyl-D-Prolinyl]Amino-Ethanethiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3417</field>
		<field name="drug_name">Salicylhydroxamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3418</field>
		<field name="drug_name">(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3419</field>
		<field name="drug_name">2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3420</field>
		<field name="drug_name">Ethyl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3421</field>
		<field name="drug_name">Epigallocatechin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3422</field>
		<field name="drug_name">7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3423</field>
		<field name="drug_name">Rhodamine 6g</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3424</field>
		<field name="drug_name">5,6-Diaminouracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3425</field>
		<field name="drug_name">(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3426</field>
		<field name="drug_name">RU78299</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3427</field>
		<field name="drug_name">Pseudouridine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3428</field>
		<field name="drug_name">Phosphorylated Dihydropteroate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3429</field>
		<field name="drug_name">1-Monooleoyl-Rac-Glycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3430</field>
		<field name="drug_name">3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3431</field>
		<field name="drug_name">2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3432</field>
		<field name="drug_name">Tazobactam Intermediate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3433</field>
		<field name="drug_name">N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3434</field>
		<field name="drug_name">1,3,5-Trichloro-Benzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3435</field>
		<field name="drug_name">Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3436</field>
		<field name="drug_name">D-Tyrosine</field>
		<field name="description">A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3437</field>
		<field name="drug_name">Tetra(Imidazole)Diaquacopper (Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3438</field>
		<field name="drug_name">Y-700</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3439</field>
		<field name="drug_name">2-Chloro-6-Methyl-Aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3440</field>
		<field name="drug_name">Formaldehyde</field>
		<field name="description">A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3441</field>
		<field name="drug_name">N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3442</field>
		<field name="drug_name">P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3443</field>
		<field name="drug_name">5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3444</field>
		<field name="drug_name">Gamma-Carboxy-Glutamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3445</field>
		<field name="drug_name">Benzenesulfonyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3446</field>
		<field name="drug_name">Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3447</field>
		<field name="drug_name">Jaspisamide A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3448</field>
		<field name="drug_name">Carbazole Butanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3449</field>
		<field name="drug_name">Eucalyptol</field>
		<field name="description">Eucalyptol is a natural organic compound which is a colorless liquid. It is a cyclic ether and a monoterpenoid. Eucalyptol is an ingredient in many brands of mouthwash and cough suppressant. It controls airway mucus hypersecretion and asthma via anti-inflammatory cytokine inhibition. Eucalyptol is an effective treatment for nonpurulent rhinosinusitis. Eucalyptol reduces inflammation and pain when applied topically. It kills leukaemia cells in vitro.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3450</field>
		<field name="drug_name">Azo-Dye Hapten</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3451</field>
		<field name="drug_name">Pentane-1,5-Diamine</field>
		<field name="description">A foul-smelling diamine formed by bacterial decarboxylation of lysine. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3452</field>
		<field name="drug_name">L-Threonohydroxamate 4-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3453</field>
		<field name="drug_name">Alpha-Difluoromethylornithine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3454</field>
		<field name="drug_name">1,4-Deoxy-1,4-Dithio-Beta-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3455</field>
		<field name="drug_name">S-Acetonylcysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3456</field>
		<field name="drug_name">1-Thio-Beta-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3457</field>
		<field name="drug_name">N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-CyclopentaPhenanthren-7-Yl]-N-Methylundecanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3458</field>
		<field name="drug_name">(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3459</field>
		<field name="drug_name">Tetrahydrooxazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3460</field>
		<field name="drug_name">2-O-Methyl Fucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3461</field>
		<field name="drug_name">Monothioglycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3462</field>
		<field name="drug_name">6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3463</field>
		<field name="drug_name">Prostaglandin G2</field>
		<field name="description">A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3464</field>
		<field name="drug_name">Meta-Nitro-Tyrosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3465</field>
		<field name="drug_name">3-Dehydroquinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3466</field>
		<field name="drug_name">5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3467</field>
		<field name="drug_name">Ara-Alpha(1,3)-Xyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3468</field>
		<field name="drug_name">Lambda-Bis(2,2'-Bipyridine)Imidazole Ruthenium (Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3469</field>
		<field name="drug_name">2,3-Dideoxyfucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3470</field>
		<field name="drug_name">N-(5,5,8,8-Tetramethyl-5,8-Dihydro-Naphthalen-2-Yl)-Terephthalamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3471</field>
		<field name="drug_name">(4e,8e,12z,16z)-N,N,4,8,13,17,21-Heptamethyldocosa-4,8,12,16,20-Pentaen-1-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3472</field>
		<field name="drug_name">Delta-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C9-Adamantane Ruthenium (Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3473</field>
		<field name="drug_name">Thieno[2,3-B]Pyridine-2-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3474</field>
		<field name="drug_name">AL4623</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3475</field>
		<field name="drug_name">N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3476</field>
		<field name="drug_name">Alpha-L-Methyl-Fucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3477</field>
		<field name="drug_name">Batimastat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3478</field>
		<field name="drug_name">MT-Immucillin-H</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3479</field>
		<field name="drug_name">5-Alpha-Androstane-3-Beta,17beta-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3480</field>
		<field name="drug_name">Carboxyethyllumazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3481</field>
		<field name="drug_name">3-Phenylpyruvic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3482</field>
		<field name="drug_name">1-Menaphthyl Glutathione Conjugate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3483</field>
		<field name="drug_name">Biopterin</field>
		<field name="description">A natural product that has been considered as a growth factor for some insects. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3484</field>
		<field name="drug_name">Alpha-Adenosine Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3485</field>
		<field name="drug_name">Allyl-{6-[3-(4-Bromo-Phenyl)-1-Methyl-1h-Indazol-6-Yl]Oxy}Hexyl)-N-Methylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3486</field>
		<field name="drug_name">S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3487</field>
		<field name="drug_name">N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3488</field>
		<field name="drug_name">1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3489</field>
		<field name="drug_name">5-N-Allyl-Arginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3490</field>
		<field name="drug_name">Thionicotinamide-Adenine-Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3491</field>
		<field name="drug_name">N-Propargyl-1(S)-Aminoindan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3492</field>
		<field name="drug_name">Malachite Green</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3493</field>
		<field name="drug_name">Triphospate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3494</field>
		<field name="drug_name">Hydroxyphenyl Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3495</field>
		<field name="drug_name">3-Chloro-4-Hydroxyphenylglycine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3496</field>
		<field name="drug_name">9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3497</field>
		<field name="drug_name">2-Methyl-2-Propanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3498</field>
		<field name="drug_name">5-Oxo-Pyrrolidine-2-Carbaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3499</field>
		<field name="drug_name">Oxalic Acid</field>
		<field name="description">A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3500</field>
		<field name="drug_name">Tmr</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3501</field>
		<field name="drug_name">Urea</field>
		<field name="description">A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3502</field>
		<field name="drug_name">Succinamide-Coa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3503</field>
		<field name="drug_name">2-Phenylheme</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3504</field>
		<field name="drug_name">N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3505</field>
		<field name="drug_name">Inhibitor Bea322</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3506</field>
		<field name="drug_name">Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3507</field>
		<field name="drug_name">S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3508</field>
		<field name="drug_name">L-Xylopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3509</field>
		<field name="drug_name">4'-Phosphopantetheine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3510</field>
		<field name="drug_name">Coenzyme F420</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3511</field>
		<field name="drug_name">[2-(1-Amino-2-Hydroxy-Propyl)-4-(1h-Indol-3-Ylmethylene)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3512</field>
		<field name="drug_name">2-Amino-3-Ketobutyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3513</field>
		<field name="drug_name">4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3514</field>
		<field name="drug_name">N-Ethyl Retinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3515</field>
		<field name="drug_name">6s-5,6,7,8-Tetrahydrobiopterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3516</field>
		<field name="drug_name">Ethyl-Carbamic Acid Methyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3517</field>
		<field name="drug_name">N-Methyl-Alpha-Beta-Dehydroalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3518</field>
		<field name="drug_name">4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3519</field>
		<field name="drug_name">Feruloyl Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3520</field>
		<field name="drug_name">5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3521</field>
		<field name="drug_name">ONO-6818</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3522</field>
		<field name="drug_name">5-Alpha-Androstane-3-Beta,17-Alpha-Diol</field>
		<field name="description">The unspecified form of the steroid, normally a major metabolite of TESTOSTERONE with androgenic activity. It has been implicated as a regulator of gonadotropin secretion. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3523</field>
		<field name="drug_name">Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3524</field>
		<field name="drug_name">Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3525</field>
		<field name="drug_name">D-Serine</field>
		<field name="description">A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3526</field>
		<field name="drug_name">4-Methyl-Pyrroline-5-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3527</field>
		<field name="drug_name">Diguanosine-5'-Triphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3528</field>
		<field name="drug_name">LFA703</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3529</field>
		<field name="drug_name">C-1027 Aromatized Chromophore</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3530</field>
		<field name="drug_name">Protoporphyrin Ix Containing Zn</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3531</field>
		<field name="drug_name">1,4-Dideoxy-O2-Sulfo-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3532</field>
		<field name="drug_name">1-Deoxy-Ribofuranose-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3533</field>
		<field name="drug_name">Erythose-4-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3534</field>
		<field name="drug_name">Deacetoxycephalosporin-C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3535</field>
		<field name="drug_name">4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3536</field>
		<field name="drug_name">Oxamic Acid</field>
		<field name="description">Amino-substituted glyoxylic acid derivative. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3537</field>
		<field name="drug_name">Heptanyl-P-Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3538</field>
		<field name="drug_name">Carboxylic PRPP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3539</field>
		<field name="drug_name">D-Asparagine</field>
		<field name="description">A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3540</field>
		<field name="drug_name">5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3541</field>
		<field name="drug_name">Phosphocholine</field>
		<field name="description">Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3542</field>
		<field name="drug_name">3,4-Dihydroxybenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3543</field>
		<field name="drug_name">D-Xylulose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3544</field>
		<field name="drug_name">6-Chloropurine Riboside, 5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3545</field>
		<field name="drug_name">(2-Sulfanyl-3-Phenylpropanoyl)-Phe-Tyr</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3546</field>
		<field name="drug_name">(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3547</field>
		<field name="drug_name">16g</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3548</field>
		<field name="drug_name">9-(6-Deoxy-Beta-D-Allofuranosyl)-6-Methylpurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3549</field>
		<field name="drug_name">L-Thiocitrulline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3550</field>
		<field name="drug_name">1,5-Dideoxy-1,5-Imino-D-Mannitol</field>
		<field name="description">An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3551</field>
		<field name="drug_name">D-Myo-Inositol-2,4,5-Trisphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3552</field>
		<field name="drug_name">SP2456</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3553</field>
		<field name="drug_name">Mrna Cap Analog N7-Methyl Gpppg</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3554</field>
		<field name="drug_name">N,O6-Disulfo-Glucosamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3555</field>
		<field name="drug_name">Cp-Coeleneterazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3556</field>
		<field name="drug_name">2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3557</field>
		<field name="drug_name">Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3558</field>
		<field name="drug_name">S-(Dimethylarsenic)Cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3559</field>
		<field name="drug_name">4-Hydroxy-Aconitate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3560</field>
		<field name="drug_name">Dodecyl Sulfate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3561</field>
		<field name="drug_name">1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3562</field>
		<field name="drug_name">3-Acetyl Pyridine Adenine Dinucleotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3563</field>
		<field name="drug_name">(6,7-Dihydro-5h-Cyclopenta[D]Imidazo[2,1-B]Thiazol-2-Yl]-4,7-Dihydro[1,4]Thiazepine-3,6-Dicarboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3564</field>
		<field name="drug_name">Acarbose Derived Hexasaccharide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3565</field>
		<field name="drug_name">2-Amino-4h-1,3-Benzoxathiin-4-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3566</field>
		<field name="drug_name">3-{2,6,8-Trioxo-9-[(2r,3r,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3567</field>
		<field name="drug_name">L-Homoarginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3568</field>
		<field name="drug_name">Mercuribenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3569</field>
		<field name="drug_name">Phosphorylisopropane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3570</field>
		<field name="drug_name">N-Trimethyllysine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3571</field>
		<field name="drug_name">Tyrosinal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3572</field>
		<field name="drug_name">1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3573</field>
		<field name="drug_name">4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3574</field>
		<field name="drug_name">1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3575</field>
		<field name="drug_name">Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3576</field>
		<field name="drug_name">(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3577</field>
		<field name="drug_name">Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3578</field>
		<field name="drug_name">R-azabisabolene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3579</field>
		<field name="drug_name">6-Methyl-Formycin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3580</field>
		<field name="drug_name">2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3581</field>
		<field name="drug_name">2,6-Diamino-Hexanoic Acid Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3582</field>
		<field name="drug_name">D-Allopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3583</field>
		<field name="drug_name">4'-Nitrophenyl-3i-Thiolaminaritrioside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3584</field>
		<field name="drug_name">2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3585</field>
		<field name="drug_name">3-(Benzoylamino)-L-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3586</field>
		<field name="drug_name">4-Methyl Valeric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3587</field>
		<field name="drug_name">Ethanolamine</field>
		<field name="description">A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3588</field>
		<field name="drug_name">Cyclo-Hepta-Amylose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3589</field>
		<field name="drug_name">3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3590</field>
		<field name="drug_name">Phosphoric Acid Mono-[2-Amino-3-(3h-Imidazol-4-Yl)-Propyl]Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3591</field>
		<field name="drug_name">[2-(Methyleneamine)-4-(4-Hydroxy-Benzylidine)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3592</field>
		<field name="drug_name">Butylphosphonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3593</field>
		<field name="drug_name">Bromo-Willardiine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3594</field>
		<field name="drug_name">6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3595</field>
		<field name="drug_name">4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3596</field>
		<field name="drug_name">(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3597</field>
		<field name="drug_name">2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3598</field>
		<field name="drug_name">Uridine 5'-Triphosphate</field>
		<field name="description">Uridine 5&amp;#39;-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3599</field>
		<field name="drug_name">[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3600</field>
		<field name="drug_name">Bromo-WR99210</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3601</field>
		<field name="drug_name">Bis(5-Amidino-Benzimidazolyl)Methane Zinc</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3602</field>
		<field name="drug_name">Dimethyl Propionate Ester Heme</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3603</field>
		<field name="drug_name">2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3604</field>
		<field name="drug_name">2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3605</field>
		<field name="drug_name">(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3606</field>
		<field name="drug_name">1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3607</field>
		<field name="drug_name">Alsterpaullone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3608</field>
		<field name="drug_name">Methionine Phosphinate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3609</field>
		<field name="drug_name">2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3610</field>
		<field name="drug_name">N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine</field>
		<field name="description">An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3611</field>
		<field name="drug_name">S-Isopropyl-Isothiourea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3612</field>
		<field name="drug_name">4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3613</field>
		<field name="drug_name">MF268</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3614</field>
		<field name="drug_name">Guanosine-5',3'-Tetraphosphate</field>
		<field name="description">Guanosine 5&amp;#39;-diphosphate 2&amp;#39;(3&amp;#39;)-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5&amp;#39; position and the other two in the 2&amp;#39; or 3&amp;#39; position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3615</field>
		<field name="drug_name">Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3616</field>
		<field name="drug_name">N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3617</field>
		<field name="drug_name">Pseudotropine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3618</field>
		<field name="drug_name">D-Arginine</field>
		<field name="description">An essential amino acid that is physiologically active in the L-form. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3619</field>
		<field name="drug_name">Tyvelose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3620</field>
		<field name="drug_name">Phenylalanine Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3621</field>
		<field name="drug_name">1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3622</field>
		<field name="drug_name">Serine Vanadate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3623</field>
		<field name="drug_name">Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3624</field>
		<field name="drug_name">Z-Ala Prolinal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3625</field>
		<field name="drug_name">Ribulose-5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3626</field>
		<field name="drug_name">Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3627</field>
		<field name="drug_name">Coenzyme a Persulfide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3628</field>
		<field name="drug_name">N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3629</field>
		<field name="drug_name">Ergosterol</field>
		<field name="description">A steroid of interest both because its biosynthesis in FUNGI is a target of ANTIFUNGAL AGENTS, notably AZOLES, and because when it is present in SKIN of animals, ULTRAVIOLET RAYS break a bond to result in ERGOCALCIFEROL. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3630</field>
		<field name="drug_name">3-Oxo-Pentadecanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3631</field>
		<field name="drug_name">N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3632</field>
		<field name="drug_name">Nitrocefin Acyl-Serine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3633</field>
		<field name="drug_name">2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3634</field>
		<field name="drug_name">Carboxymycobactin T</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3635</field>
		<field name="drug_name">4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3636</field>
		<field name="drug_name">Methylmalonyl-Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3637</field>
		<field name="drug_name">Methyl beta-galactoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3638</field>
		<field name="drug_name">[Pterin-6-Yl Methanyl]-Phosphonophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3639</field>
		<field name="drug_name">N-Carbamoyl-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3640</field>
		<field name="drug_name">Coelenteramide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3641</field>
		<field name="drug_name">N-Propyl Isocyanide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3642</field>
		<field name="drug_name">5-Phenylvaleric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3643</field>
		<field name="drug_name">3,4-Dimethylphenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3644</field>
		<field name="drug_name">Hypophosphite</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3645</field>
		<field name="drug_name">9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3646</field>
		<field name="drug_name">2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3647</field>
		<field name="drug_name">6-Aminobenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3648</field>
		<field name="drug_name">Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3649</field>
		<field name="drug_name">D-[(Amino)Carbonyl]Phenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3650</field>
		<field name="drug_name">8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3651</field>
		<field name="drug_name">(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3652</field>
		<field name="drug_name">Alpha-Amino-2-Indanacetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3653</field>
		<field name="drug_name">Beta-D-Fucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3654</field>
		<field name="drug_name">2-Methylleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3655</field>
		<field name="drug_name">Nogalaviketone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3656</field>
		<field name="drug_name">N-Cyclopentyl-N-Cyclobutylformamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3657</field>
		<field name="drug_name">Para-Coumaric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3658</field>
		<field name="drug_name">4-Hydroxybenzyl Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3659</field>
		<field name="drug_name">Fudp</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3660</field>
		<field name="drug_name">5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3661</field>
		<field name="drug_name">6-Deoxyerythronolide B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3662</field>
		<field name="drug_name">Cpad</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3663</field>
		<field name="drug_name">Alpha-Methylisocitric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3664</field>
		<field name="drug_name">N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-Nitro-5-(Galactopyranosyl)-Beta-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3665</field>
		<field name="drug_name">Alpha-ketoisovalerate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3666</field>
		<field name="drug_name">N-Acetyl-L-Glutamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3667</field>
		<field name="drug_name">Hypoxanthine</field>
		<field name="description">A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3668</field>
		<field name="drug_name">Glycerol</field>
		<field name="description">A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3669</field>
		<field name="drug_name">Isobutylbenzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3670</field>
		<field name="drug_name">Heptane-1,2,3-Triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3671</field>
		<field name="drug_name">RU78191</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3672</field>
		<field name="drug_name">(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3673</field>
		<field name="drug_name">Decyloxy-Methanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3674</field>
		<field name="drug_name">N'-Pyridoxyl-Lysine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3675</field>
		<field name="drug_name">2-Deoxy-2-Fluoro-Alpha-D-Mannose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3676</field>
		<field name="drug_name">1-[Pyrrol-1-Yl-2,5-Dione-Methoxymethyl]-Pyrrole-2,5-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3677</field>
		<field name="drug_name">2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3678</field>
		<field name="drug_name">Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3679</field>
		<field name="drug_name">N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3680</field>
		<field name="drug_name">AL5300</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3681</field>
		<field name="drug_name">2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3682</field>
		<field name="drug_name">Alpha-L-1-Methyl-Fucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3683</field>
		<field name="drug_name">Apstatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3684</field>
		<field name="drug_name">Undecanal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3685</field>
		<field name="drug_name">4-Hydroxy-2-Butanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3686</field>
		<field name="drug_name">9-Deazahypoxanthine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3687</field>
		<field name="drug_name">5-Amino-5-Deoxy-Cellobiono-1,5-Lactam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3688</field>
		<field name="drug_name">Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3689</field>
		<field name="drug_name">Balanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3690</field>
		<field name="drug_name">Deamido-Nad+</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3691</field>
		<field name="drug_name">(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3692</field>
		<field name="drug_name">N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3693</field>
		<field name="drug_name">2-Amino-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3694</field>
		<field name="drug_name">3-Methylcytosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3695</field>
		<field name="drug_name">3-Methyladenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3696</field>
		<field name="drug_name">N-Heptylformamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3697</field>
		<field name="drug_name">Fotemustine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3698</field>
		<field name="drug_name">[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3699</field>
		<field name="drug_name">(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3700</field>
		<field name="drug_name">[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3701</field>
		<field name="drug_name">2-Nitro-P-Cresol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3702</field>
		<field name="drug_name">Balhimycin</field>
		<field name="description">Balhimycin is a novel glycopeptide antibiotic.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3703</field>
		<field name="drug_name">1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3704</field>
		<field name="drug_name">N-Formylpiperidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3705</field>
		<field name="drug_name">3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3706</field>
		<field name="drug_name">Berberine</field>
		<field name="description">An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3707</field>
		<field name="drug_name">Allolactose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3708</field>
		<field name="drug_name">4-(N,N-Dimethylamino)Cinnamoyl-Coa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3709</field>
		<field name="drug_name">N-Coeleneterazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3710</field>
		<field name="drug_name">Hexatantalum Dodecabromide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3711</field>
		<field name="drug_name">4-Methyl-1,2-Benzenediol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3712</field>
		<field name="drug_name">Guanosine-3'-Monophosphate-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3713</field>
		<field name="drug_name">Beta-D-Glucose-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3714</field>
		<field name="drug_name">(P-Iodophenylacetylamino)Methylphosphinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3715</field>
		<field name="drug_name">Aurodox</field>
		<field name="description">Aurodox is an antibiotic obtained from a streptomyces variant considered as possibly effective against streptococcus pyogenes infections. It may promote growth in poultry.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3716</field>
		<field name="drug_name">N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3717</field>
		<field name="drug_name">N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3718</field>
		<field name="drug_name">Beta-D-Arabinofuranose-5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3719</field>
		<field name="drug_name">5-Nitroso-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3720</field>
		<field name="drug_name">Willardiine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3721</field>
		<field name="drug_name">5-Methoxybenzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3722</field>
		<field name="drug_name">10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3723</field>
		<field name="drug_name">S-Hexylglutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3724</field>
		<field name="drug_name">Degraded Cephaloridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3725</field>
		<field name="drug_name">6-Amino Hexanoic Acid</field>
		<field name="description">An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3726</field>
		<field name="drug_name">5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3727</field>
		<field name="drug_name">Lysophosphotidylserine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3728</field>
		<field name="drug_name">Guanosine-5'-Triphosphate</field>
		<field name="description">Guanosine 5&amp;#39;-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3729</field>
		<field name="drug_name">2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3730</field>
		<field name="drug_name">6-Hydroxypropylthymine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3731</field>
		<field name="drug_name">1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3732</field>
		<field name="drug_name">2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3733</field>
		<field name="drug_name">3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3734</field>
		<field name="drug_name">Indole-3-Glycerol Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3735</field>
		<field name="drug_name">Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3736</field>
		<field name="drug_name">Pyridin-3-Ylmethanol</field>
		<field name="description">A direct-acting peripheral vasodilator that causes flushing and may decrease blood pressure. It is used in vasospasm and threatened gangrene. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3737</field>
		<field name="drug_name">I-Coeleneterazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3738</field>
		<field name="drug_name">Lauryl Dimethylamine-N-Oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3739</field>
		<field name="drug_name">(R)-Rolipram</field>
		<field name="description">A phosphodiesterase inhibitor with antidepressant properties. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3740</field>
		<field name="drug_name">Threonine Derivative</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3741</field>
		<field name="drug_name">4-Methyl-Histidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3742</field>
		<field name="drug_name">2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3743</field>
		<field name="drug_name">S-Hydroxymethyl Glutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3744</field>
		<field name="drug_name">N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3745</field>
		<field name="drug_name">2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3746</field>
		<field name="drug_name">Aspartate Beryllium Trifluoride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3747</field>
		<field name="drug_name">N-[(Aminooxy)Carbonyl]Aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3748</field>
		<field name="drug_name">6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3749</field>
		<field name="drug_name">Beta-Hydroxytryptophane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3750</field>
		<field name="drug_name">Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3751</field>
		<field name="drug_name">Propionamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3752</field>
		<field name="drug_name">5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3753</field>
		<field name="drug_name">5-Phenylsulfanyl-2,4-Quinazolinediamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3754</field>
		<field name="drug_name">1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3755</field>
		<field name="drug_name">Valpromide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3756</field>
		<field name="drug_name">2-Aminobenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3757</field>
		<field name="drug_name">N-Acetyl-L-Glutamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3758</field>
		<field name="drug_name">2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3759</field>
		<field name="drug_name">3,5-Diaminophthalhydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3760</field>
		<field name="drug_name">4-Bromo-3-Hydroxy-3-Methyl Butyl Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3761</field>
		<field name="drug_name">D-Isovaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3762</field>
		<field name="drug_name">[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3763</field>
		<field name="drug_name">Fructose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3764</field>
		<field name="drug_name">3'-1-Carboxy-1-Phosphonooxy-Ethoxy-Uridine-Diphosphate-N-Acetylglucosamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3765</field>
		<field name="drug_name">Mdl-29951</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3766</field>
		<field name="drug_name">Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3767</field>
		<field name="drug_name">4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-CyclopentaPhenanthren-17-Yl)-5h-Furan-2-One</field>
		<field name="description">3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3768</field>
		<field name="drug_name">Di-Stearoyl-3-Sn-Phosphatidylcholine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3769</field>
		<field name="drug_name">Benzofuran</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3770</field>
		<field name="drug_name">4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3771</field>
		<field name="drug_name">Cefotaxime Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3772</field>
		<field name="drug_name">(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3773</field>
		<field name="drug_name">Methylmalonic Acid</field>
		<field name="description">A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3774</field>
		<field name="drug_name">Norvaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3775</field>
		<field name="drug_name">N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3776</field>
		<field name="drug_name">(9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3777</field>
		<field name="drug_name">MDL72527</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3778</field>
		<field name="drug_name">N2-(Carboxyethyl)-L-Arginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3779</field>
		<field name="drug_name">Inhibitor Bea425</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3780</field>
		<field name="drug_name">Skf 107457</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3781</field>
		<field name="drug_name">L-Homoserine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3782</field>
		<field name="drug_name">Chitotriose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3783</field>
		<field name="drug_name">Heptulose-2-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3784</field>
		<field name="drug_name">Pteroic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3785</field>
		<field name="drug_name">Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3786</field>
		<field name="drug_name">Formycin B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3787</field>
		<field name="drug_name">1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3788</field>
		<field name="drug_name">Matairesinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3789</field>
		<field name="drug_name">Histidyl-Adenosine Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3790</field>
		<field name="drug_name">Isoformononetin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3791</field>
		<field name="drug_name">3-Mercuri-4-Aminobenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3792</field>
		<field name="drug_name">[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3793</field>
		<field name="drug_name">Thymidine-3',5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3794</field>
		<field name="drug_name">Nz2-Tryptophan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3795</field>
		<field name="drug_name">N-(5-Amino-5-Carboxypentyl)Glutamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3796</field>
		<field name="drug_name">3-(3,4-Dimethoxyphenyl)Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3797</field>
		<field name="drug_name">Dequadin</field>
		<field name="description">A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3798</field>
		<field name="drug_name">BV1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3799</field>
		<field name="drug_name">3-Fluorosialic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3800</field>
		<field name="drug_name">2-Iminiopropanoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3801</field>
		<field name="drug_name">N-Cyclohexyl-N'-(Propyl)Phenyl Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3802</field>
		<field name="drug_name">4-Nitrophenyl Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3803</field>
		<field name="drug_name">CRA_9076</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3804</field>
		<field name="drug_name">Quercetin</field>
		<field name="description">A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3805</field>
		<field name="drug_name">L-2-amino-3-butynoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3806</field>
		<field name="drug_name">1-Deaza-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3807</field>
		<field name="drug_name">Trivanadate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3808</field>
		<field name="drug_name">Rifamycin Cgp 4832</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3809</field>
		<field name="drug_name">Didecyl-Dimethyl-Ammonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3810</field>
		<field name="drug_name">Sparsomycin</field>
		<field name="description">An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3811</field>
		<field name="drug_name">Nitroarginine</field>
		<field name="description">An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3812</field>
		<field name="drug_name">Oleic Acid</field>
		<field name="description">An unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (Stedman, 26th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3813</field>
		<field name="drug_name">N-Methyldehydrobutyrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3814</field>
		<field name="drug_name">Dihydro-Acarbose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3815</field>
		<field name="drug_name">9-Amino-2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3816</field>
		<field name="drug_name">(2r)-Amino(3,5-Dihydroxyphenyl)Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3817</field>
		<field name="drug_name">7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3818</field>
		<field name="drug_name">Nitromethyldethia Coenzyme A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3819</field>
		<field name="drug_name">Tetra(Imidazole)Diaquacopper (I)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3820</field>
		<field name="drug_name">N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3821</field>
		<field name="drug_name">(Hydroxyethyloxy)Tri(Ethyloxy)Octane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3822</field>
		<field name="drug_name">N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3823</field>
		<field name="drug_name">4-Amino Hexanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3824</field>
		<field name="drug_name">2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3825</field>
		<field name="drug_name">Tris(Hydroxyethyl)Aminomethane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3826</field>
		<field name="drug_name">N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3827</field>
		<field name="drug_name">2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3828</field>
		<field name="drug_name">1,2-Hydro-1-Oxy-3,4-Hydro-3-(1-Methoxy-2-Oxy-3,4-Dihydroxypentyl)-8,9-Dihydroxy-7-(Sec-Butyl)-Anthracene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3829</field>
		<field name="drug_name">N-Pyridoxyl-2-Methylalanine-5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3830</field>
		<field name="drug_name">P-Hydroxybenzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3831</field>
		<field name="drug_name">5-Methyluridine 5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3832</field>
		<field name="drug_name">1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3833</field>
		<field name="drug_name">2-Hydroxy-3-Amino-4-Phenyl Butane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3834</field>
		<field name="drug_name">CRA_23653</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3835</field>
		<field name="drug_name">Beta-1,4-Galactotrioside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3836</field>
		<field name="drug_name">Zinc Substituted Heme C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3837</field>
		<field name="drug_name">Butyrylthiocholine</field>
		<field name="description">A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3838</field>
		<field name="drug_name">Monoisopropyl Ester Phosphonic Acid Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3839</field>
		<field name="drug_name">N-Carbamoyl-L-Aspartate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3840</field>
		<field name="drug_name">CB1954</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3841</field>
		<field name="drug_name">8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3842</field>
		<field name="drug_name">Inhibitor Bea388</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3843</field>
		<field name="drug_name">4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3844</field>
		<field name="drug_name">Palmitoleic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3845</field>
		<field name="drug_name">Seocalcitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3846</field>
		<field name="drug_name">7n-Methyl-8-Hydroguanosine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3847</field>
		<field name="drug_name">9-(5,5-Difluoro-5-Phosphonopentyl)Guanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3848</field>
		<field name="drug_name">Carbamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3849</field>
		<field name="drug_name">3-(7-Hydroxy-8-Ribityllumazine-6-Yl) Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3850</field>
		<field name="drug_name">G418</field>
		<field name="description">G418 (also known as Geneticin) is an aminoglycoside antibiotic similar in structure to gentamicin B1. It is produced by Micromonospora rhodorangea. G418 blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells. Resistance to G418 is conferred by the neo gene from Tn5 encoding an aminoglycoside 3‘-phosphotransferase, APH 3‘ II. G418 is commonly used in laboratory research to select genetically engineered cells.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3851</field>
		<field name="drug_name">(10R)-10-Formyl-5,8,10-Trideazafolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3852</field>
		<field name="drug_name">Beta-Sialic Acid</field>
		<field name="description">An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3853</field>
		<field name="drug_name">5-(6-D-Ribitylamino-2,4-Dihydroxypyrimidin-5-Yl)-1-Pentyl-Phosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3854</field>
		<field name="drug_name">Dipicolinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3855</field>
		<field name="drug_name">Methylumbelliferyl Chitotriose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3856</field>
		<field name="drug_name">Cyclotheonamide A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3857</field>
		<field name="drug_name">(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3858</field>
		<field name="drug_name">3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3859</field>
		<field name="drug_name">Citric Acid</field>
		<field name="description">A key intermediate in metabolism.  It is an acid compound found in citrus fruits.  The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3860</field>
		<field name="drug_name">8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3861</field>
		<field name="drug_name">5,4'-Dideoxyflavanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3862</field>
		<field name="drug_name">N-Acetyl Serotonin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3863</field>
		<field name="drug_name">N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3864</field>
		<field name="drug_name">Fructose -6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3865</field>
		<field name="drug_name">2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3866</field>
		<field name="drug_name">3-Isopropylmalic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3867</field>
		<field name="drug_name">((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3868</field>
		<field name="drug_name">2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3869</field>
		<field name="drug_name">2-Deoxy-2fluoro-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3870</field>
		<field name="drug_name">2-Bromo-6-Hydroxy-Purine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3871</field>
		<field name="drug_name">Proline Betaine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3872</field>
		<field name="drug_name">{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3873</field>
		<field name="drug_name">beta-D-Ribopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3874</field>
		<field name="drug_name">(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3875</field>
		<field name="drug_name">2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3876</field>
		<field name="drug_name">Genz-10850</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3877</field>
		<field name="drug_name">[2-Cytidylate-O'-Phosphonyloxyl]-Ethyl-Trimethyl-Ammonium</field>
		<field name="description">Donor of choline in biosynthesis of choline-containing phosphoglycerides. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3878</field>
		<field name="drug_name">(2s)-Amino(4-Hydroxyphenyl)Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3879</field>
		<field name="drug_name">4-[(Isopropylamino)Methyl]Phenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3880</field>
		<field name="drug_name">7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3881</field>
		<field name="drug_name">5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3882</field>
		<field name="drug_name">N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3883</field>
		<field name="drug_name">5-Oxo-L-Norleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3884</field>
		<field name="drug_name">7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3885</field>
		<field name="drug_name">3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3886</field>
		<field name="drug_name">Maleic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3887</field>
		<field name="drug_name">(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3888</field>
		<field name="drug_name">Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3889</field>
		<field name="drug_name">4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3890</field>
		<field name="drug_name">4-O-Methyl-Alpha-D-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3891</field>
		<field name="drug_name">Gluconic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3892</field>
		<field name="drug_name">5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3893</field>
		<field name="drug_name">5-Hydroxy-N-Propargyl-1(R)-Aminoindan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3894</field>
		<field name="drug_name">(2r)-Amino(4-Hydroxyphenyl)Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3895</field>
		<field name="drug_name">2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3896</field>
		<field name="drug_name">4-Phenylbutylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3897</field>
		<field name="drug_name">2,3-Difluorobenzyl Alcohol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3898</field>
		<field name="drug_name">3-Methyl-Aspartic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3899</field>
		<field name="drug_name">1-Methylcytosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3900</field>
		<field name="drug_name">Guanosine-5'-Diphosphate</field>
		<field name="description">A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3901</field>
		<field name="drug_name">D-[(N-Hydroxyamino)Carbonyl]Phenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3902</field>
		<field name="drug_name">3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3903</field>
		<field name="drug_name">1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3904</field>
		<field name="drug_name">6-Deoxyglucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3905</field>
		<field name="drug_name">2-Bromo-2-Propene-1-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3906</field>
		<field name="drug_name">N-Hexylphosphonate Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3907</field>
		<field name="drug_name">LY249543</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3908</field>
		<field name="drug_name">2-Amino-3-(Cystein-S-Yl)-Isoxazolidin-5-Yl-Acetic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3909</field>
		<field name="drug_name">Ovalicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3910</field>
		<field name="drug_name">2-Phenylethylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3911</field>
		<field name="drug_name">1,3-Dihydroxyacetonephosphate</field>
		<field name="description">An important intermediate in lipid biosynthesis and in glycolysis. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3912</field>
		<field name="drug_name">Phosphatidylethanolamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3913</field>
		<field name="drug_name">Shikimate-3-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3914</field>
		<field name="drug_name">Isoquinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3915</field>
		<field name="drug_name">Bilh 434</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3916</field>
		<field name="drug_name">Monastrol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3917</field>
		<field name="drug_name">2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3918</field>
		<field name="drug_name">Octamethylenediamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3919</field>
		<field name="drug_name">6-hydroxydopa quinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3920</field>
		<field name="drug_name">1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3921</field>
		<field name="drug_name">Methyl Isocyanide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3922</field>
		<field name="drug_name">SB220025</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3923</field>
		<field name="drug_name">Carboxymethylenecysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3924</field>
		<field name="drug_name">2-[(Dioxidophosphino)Oxy]Benzoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3925</field>
		<field name="drug_name">S-(3-Iodobenzyl)Glutathione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3926</field>
		<field name="drug_name">7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3927</field>
		<field name="drug_name">Glyoxalate, Glyoxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3928</field>
		<field name="drug_name">7,8-dimethylalloxazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3929</field>
		<field name="drug_name">(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3930</field>
		<field name="drug_name">3-Dehydroshikimate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3931</field>
		<field name="drug_name">Taurocholic Acid</field>
		<field name="description">The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3932</field>
		<field name="drug_name">S-1,2-Propanediol</field>
		<field name="description">A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3933</field>
		<field name="drug_name">Argadin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3934</field>
		<field name="drug_name">Aconitate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3935</field>
		<field name="drug_name">[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3936</field>
		<field name="drug_name">{(1s)-1-Benzyl-4-[3-Carbamoyl-1-(1-Carbamoyl-2-Phenyl-Ethylcarbamoyl)-(S)-Propylcarbamoyl]-2-Oxo-5-Phenyl-Pentyl}-Carbamic Acid Tert-Butyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3937</field>
		<field name="drug_name">Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester</field>
		<field name="description">A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3938</field>
		<field name="drug_name">9-Deazaguanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3939</field>
		<field name="drug_name">Pteric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3940</field>
		<field name="drug_name">Vinylsulphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3941</field>
		<field name="drug_name">Benzo[B]Thiophene-2-Boronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3942</field>
		<field name="drug_name">Methylhydrazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3943</field>
		<field name="drug_name">Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3944</field>
		<field name="drug_name">Mesobiliverdin Iv Alpha</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3945</field>
		<field name="drug_name">R,3-Hydroxybutan-2-One</field>
		<field name="description">A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3946</field>
		<field name="drug_name">Arecoline</field>
		<field name="description">An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3947</field>
		<field name="drug_name">3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3948</field>
		<field name="drug_name">Debromohymenialdisine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3949</field>
		<field name="drug_name">Bb-3497</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3950</field>
		<field name="drug_name">1,3,2-Dioxaborolan-2-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3951</field>
		<field name="drug_name">S-sulphocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3952</field>
		<field name="drug_name">AL6528</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3953</field>
		<field name="drug_name">Di-Linoleoyl-3-Sn-Phosphatidylcholine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3954</field>
		<field name="drug_name">4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3955</field>
		<field name="drug_name">4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3956</field>
		<field name="drug_name">5-Methyl-5,6,7,8-Tetrahydrofolic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3957</field>
		<field name="drug_name">13-Acetylphorbol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3958</field>
		<field name="drug_name">3-Hydroxy-3-Methyl-Glutaric Acid</field>
		<field name="description">An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3959</field>
		<field name="drug_name">3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3960</field>
		<field name="drug_name">N-Methyl-N-(Methylbenzyl)Formamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3961</field>
		<field name="drug_name">Diureido-Acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3962</field>
		<field name="drug_name">Crotonaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3963</field>
		<field name="drug_name">2-Deoxy-Beta-D-Galactose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3964</field>
		<field name="drug_name">L-Valinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3965</field>
		<field name="drug_name">Fe-Mesopone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3966</field>
		<field name="drug_name">3-Deazacytidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3967</field>
		<field name="drug_name">4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3968</field>
		<field name="drug_name">1-Hydroxy-2-Amino-3-Cyclohexylpropane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3969</field>
		<field name="drug_name">4-Carboxy-4-Aminobutanal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3970</field>
		<field name="drug_name">Ado-P-Ch2-P-Ps-Ado</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3971</field>
		<field name="drug_name">Aeruginosin 98-B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3972</field>
		<field name="drug_name">Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3973</field>
		<field name="drug_name">Diclosan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3974</field>
		<field name="drug_name">3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3975</field>
		<field name="drug_name">Phosphoaminophosphonic Acid-Adenylate Ester</field>
		<field name="description">5&amp;#39;-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3976</field>
		<field name="drug_name">Thiodigalactoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3977</field>
		<field name="drug_name">Alpha-D-Glucose-1-Phosphate-6-Vanadate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3978</field>
		<field name="drug_name">Lactic Acid</field>
		<field name="description">A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3979</field>
		<field name="drug_name">7,8-Dihydrobiopterin</field>
		<field name="description">7,8-dihydrobiopterin is an inhibitor of the enzyme dihydroneopterin aldolase (DHNA), which catalyzes the conversion of 7,8-dihydroneopterin to 6-hydroxymethyl-7,8-dihydropterin and glycolaldehyde.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3980</field>
		<field name="drug_name">[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3981</field>
		<field name="drug_name">Allosamizoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3982</field>
		<field name="drug_name">2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3983</field>
		<field name="drug_name">3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3984</field>
		<field name="drug_name">4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3985</field>
		<field name="drug_name">Ncs-Chromophore</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3986</field>
		<field name="drug_name">Naphthalene Trisulfonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3987</field>
		<field name="drug_name">3-Phenylpropylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3988</field>
		<field name="drug_name">Alpha-N-Dichloroacetyl-P-Aminophenylserinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3989</field>
		<field name="drug_name">Heptamolybdate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3990</field>
		<field name="drug_name">3-Amino-1-Chloro-4-Phenyl-Butanol-2-Yl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3991</field>
		<field name="drug_name">R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3992</field>
		<field name="drug_name">P-Nitrophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3993</field>
		<field name="drug_name">Adenylosuccinic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3994</field>
		<field name="drug_name">Norleucine</field>
		<field name="description">An unnatural amino acid that is used experimentally to study protein structure and function. It is structurally similar to METHIONINE, however it does not contain SULFUR. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3995</field>
		<field name="drug_name">Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3996</field>
		<field name="drug_name">2-Amino-4-Mercapto-Butyric Acid</field>
		<field name="description">A thiol-containing amino acid formed by a demethylation of METHIONINE. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3997</field>
		<field name="drug_name">Coproporphyrin I Containing Co(Iii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3998</field>
		<field name="drug_name">RPR128515</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">3999</field>
		<field name="drug_name">7,8-Dihydroneopterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4000</field>
		<field name="drug_name">Alpha-Methyl-N-Acetyl-D-Glucosamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4001</field>
		<field name="drug_name">3-[[N-[4-Methyl-Piperazinyl]Carbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid Benzyloxy-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4002</field>
		<field name="drug_name">Tungstopterin Cofactor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4003</field>
		<field name="drug_name">4'-Hydroxyflavanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4004</field>
		<field name="drug_name">3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4005</field>
		<field name="drug_name">4-Epi-Vancosaminyl Derivative of Vancomycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4006</field>
		<field name="drug_name">ZK-805623</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4007</field>
		<field name="drug_name">N''-{3-[(3s,8ar)-1,4-Dioxooctahydropyrrolo[1,2-a]Pyrazin-3-Yl]Propyl}Guanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4008</field>
		<field name="drug_name">Naphthyridine Inhibitor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4009</field>
		<field name="drug_name">Tetraphenyl-Arsonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4010</field>
		<field name="drug_name">3-Fluorotyrosine</field>
		<field name="description">3-Fluorotyrosine is a tyrosine analogue.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4011</field>
		<field name="drug_name">Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4012</field>
		<field name="drug_name">BVDU-MP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4013</field>
		<field name="drug_name">Modified Acarbose Pentasaccharide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4014</field>
		<field name="drug_name">Purine Riboside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4015</field>
		<field name="drug_name">2-Fluoroadenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4016</field>
		<field name="drug_name">2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4017</field>
		<field name="drug_name">Tetrafluoroaluminate Ion</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4018</field>
		<field name="drug_name">Mercury Diiodide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4019</field>
		<field name="drug_name">Benzo[B]Thiophene-2-Carboxamidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4020</field>
		<field name="drug_name">1,4-Dithiothreitol</field>
		<field name="description">A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4021</field>
		<field name="drug_name">2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4022</field>
		<field name="drug_name">5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4023</field>
		<field name="drug_name">Heptyl 1-Thiohexopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4024</field>
		<field name="drug_name">4-Methylpiperazin-1-Yl Carbonyl Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4025</field>
		<field name="drug_name">N,N'-Bis(4-Amino-2-Methylquinolin-6-Yl)Urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4026</field>
		<field name="drug_name">4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4027</field>
		<field name="drug_name">Alpha-Aminobutyric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4028</field>
		<field name="drug_name">Trimethyl Glycine</field>
		<field name="description">A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4029</field>
		<field name="drug_name">Trihydroxyarsenite(Iii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4030</field>
		<field name="drug_name">2'-Deoxyguanosine-5'-Monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4031</field>
		<field name="drug_name">2,2-Dichloro-1-Methanesulfinyl-3-Methyl-Cyclopropanecarboxylic Acid [1-(4-Bromo-Phenyl)-Ethyl]-Amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4032</field>
		<field name="drug_name">3,4-Dichloroisocoumarin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4033</field>
		<field name="drug_name">(C8-S)-Hydantocidin 5'-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4034</field>
		<field name="drug_name">Coproporphyrin Iii</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4035</field>
		<field name="drug_name">Tetrabromo-2-Benzotriazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4036</field>
		<field name="drug_name">3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4037</field>
		<field name="drug_name">N-Formylmethionine</field>
		<field name="description">Effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4038</field>
		<field name="drug_name">Lactose</field>
		<field name="description">A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4039</field>
		<field name="drug_name">SR12813</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4040</field>
		<field name="drug_name">Pyridoxyl-Alanine-5-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4041</field>
		<field name="drug_name">1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4042</field>
		<field name="drug_name">CRA_10656</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4043</field>
		<field name="drug_name">2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4044</field>
		<field name="drug_name">(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4045</field>
		<field name="drug_name">Alpha-L-Fucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4046</field>
		<field name="drug_name">1-Anilino-8-Naphthalene Sulfonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4047</field>
		<field name="drug_name">Trencam-3,2-Hopo</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4048</field>
		<field name="drug_name">N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4049</field>
		<field name="drug_name">Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4050</field>
		<field name="drug_name">4-Nitro-Inden-1-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4051</field>
		<field name="drug_name">3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4052</field>
		<field name="drug_name">Meso-Erythritol</field>
		<field name="description">A four-carbon sugar that is found in algae, fungi, and lichens. It is twice as sweet as sucrose and can be used as a coronary vasodilator. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4053</field>
		<field name="drug_name">Cmp-2-Keto-3-Deoxy-Octulosonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4054</field>
		<field name="drug_name">2-Deoxy-2-Fluoro-Beta-D-Mannose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4055</field>
		<field name="drug_name">L-Phenylalaninol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4056</field>
		<field name="drug_name">Deoxythymidine</field>
		<field name="description">Deoxythymidine is a pyrimidine deoxynucleoside. Deoxythymidine is the DNA nucleoside T, which pairs with deoxyadenosine (A) in double-stranded DNA. In cell biology it is used to synchronize the cells in S phase.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4057</field>
		<field name="drug_name">(2s)-2,8-Diaminooctanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4058</field>
		<field name="drug_name">N-Methylleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4059</field>
		<field name="drug_name">(6r,7r)-3-[(Acetyloxy)Methyl]-7-{[(6s)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Octane-2-Carboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4060</field>
		<field name="drug_name">Guanidinoethylmercaptosuccinic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4061</field>
		<field name="drug_name">3-(Mercaptomethylene)Pyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4062</field>
		<field name="drug_name">Diisopropylphosphono Group</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4063</field>
		<field name="drug_name">2-(Acetylamino)-2-Deoxy-4-O-Sulfo-Alpha-D-Galactopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4064</field>
		<field name="drug_name">Fructose-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4065</field>
		<field name="drug_name">Mo(Vi)(=O)(Oh)2 Cluster</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4066</field>
		<field name="drug_name">RU81843</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4067</field>
		<field name="drug_name">4-Phospho-D-Erythronohydroxamic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4068</field>
		<field name="drug_name">2'-Monophosphoadenosine-5'-Diphosphoribose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4069</field>
		<field name="drug_name">Aspartate Semialdehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4070</field>
		<field name="drug_name">R-Styrene Oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4071</field>
		<field name="drug_name">4-acetamidobenzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4072</field>
		<field name="drug_name">Camphane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4073</field>
		<field name="drug_name">WRR-204</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4074</field>
		<field name="drug_name">Sp-722</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4075</field>
		<field name="drug_name">(3s)-2,3,4,5-Tetrahydropyridin-3-Amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4076</field>
		<field name="drug_name">8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4077</field>
		<field name="drug_name">Chlorophyll B</field>
		<field name="description">A light, silvery, metallic element. It has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. Its salts are essential in nutrition, being required for the activity of many enzymes, especially those concerned with oxidative phosphorylation. It is a component of both intra- and extracellular fluids and is excreted in the urine and feces. Deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior. (From Dorland, 27th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4078</field>
		<field name="drug_name">Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4079</field>
		<field name="drug_name">N-Methylnaloxonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4080</field>
		<field name="drug_name">3-Phosphoglyceric Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4081</field>
		<field name="drug_name">N-Succinyl Methionine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4082</field>
		<field name="drug_name">2-Isobutyl-3-Methoxypyrazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4083</field>
		<field name="drug_name">N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4084</field>
		<field name="drug_name">Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4085</field>
		<field name="drug_name">6-Deoxy-2-O-Methyl-Alpha-L-Galactopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4086</field>
		<field name="drug_name">2-Deoxy-Glucitol-6-Phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4087</field>
		<field name="drug_name">Dipyrromethane Cofactor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4088</field>
		<field name="drug_name">3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4089</field>
		<field name="drug_name">Caprylic acid</field>
		<field name="description">Caprylic acid is the common name for the eight-carbon straight chain fatty acid known by the systematic name octanoic acid. It is found naturally in coconuts and breast milk. It is an oily liquid with a slightly unpleasant rancid-like smell that is minimally soluble in water.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4090</field>
		<field name="drug_name">(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4091</field>
		<field name="drug_name">GSHNA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4092</field>
		<field name="drug_name">Phosphonoserine</field>
		<field name="description">The phosphoric acid ester of serine. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4093</field>
		<field name="drug_name">Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4094</field>
		<field name="drug_name">Malonyl-Coenzyme A</field>
		<field name="description">A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4095</field>
		<field name="drug_name">2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4096</field>
		<field name="drug_name">L-Glycero-D-Manno-Heptopyranose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4097</field>
		<field name="drug_name">Beta-Hydroxyasparagine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4098</field>
		<field name="drug_name">2,4-Dinitrophenol</field>
		<field name="description">A toxic dye, chemically related to trinitrophenol (picric acid), used in biochemical studies of oxidative processes where it uncouples oxidative phosphorylation. It is also used as a metabolic stimulant. (Stedman, 26th ed)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4099</field>
		<field name="drug_name">Desvancosaminyl Vancomycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4100</field>
		<field name="drug_name">S,S-(2-Hydroxyethyl)Thiocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4101</field>
		<field name="drug_name">Benzylcysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4102</field>
		<field name="drug_name">Indole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4103</field>
		<field name="drug_name">2-Amino-P-Cresol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4104</field>
		<field name="drug_name">5-Nitroindazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4105</field>
		<field name="drug_name">L-Tryptophanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4106</field>
		<field name="drug_name">2s,3s-3-Methylaspartic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4107</field>
		<field name="drug_name">Glyphosate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4108</field>
		<field name="drug_name">Cholesterol</field>
		<field name="description">The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4109</field>
		<field name="drug_name">(8ar)-Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4110</field>
		<field name="drug_name">3'-Azido-3'-Deoxythymidine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4111</field>
		<field name="drug_name">2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4112</field>
		<field name="drug_name">1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4113</field>
		<field name="drug_name">(3r,4r,5r)-5-(Hydroxymethyl)Piperidine-3,4-Diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4114</field>
		<field name="drug_name">3-Deaza-Adenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4115</field>
		<field name="drug_name">Inhibitor Bea409</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4116</field>
		<field name="drug_name">4-Deoxy-D-Glucuronic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4117</field>
		<field name="drug_name">4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4118</field>
		<field name="drug_name">Delta-Bis(2,2'-Bipyridine)Imidazole Osmium (Ii)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4119</field>
		<field name="drug_name">Fructose-1,6-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4120</field>
		<field name="drug_name">Niflumic Acid</field>
		<field name="description">An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4121</field>
		<field name="drug_name">2-Oxobutanoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4122</field>
		<field name="drug_name">8-Bromoadenosine-5'-Diphosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4123</field>
		<field name="drug_name">Cytidine-5'-Diphosphate</field>
		<field name="description">Cytidine 5&amp;#39;-(trihydrogen diphosphate). A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4124</field>
		<field name="drug_name">3-[(1s)-1-(Dimethylamino)Ethyl]Phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4125</field>
		<field name="drug_name">Arachidonic Acid</field>
		<field name="description">An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4126</field>
		<field name="drug_name">Phenylmercury</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4127</field>
		<field name="drug_name">N-(Chlorophenyl)-N'-Hydroxyguanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4128</field>
		<field name="drug_name">4,7-Dioxosebacic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4129</field>
		<field name="drug_name">4-Acetamido-2,4-Didexoy-D-Glycero-Beta-D-Galacto-Octopyranosylphosphonic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4130</field>
		<field name="drug_name">Tricarballylic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4131</field>
		<field name="drug_name">CRA_9678</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4132</field>
		<field name="drug_name">Gluconolactone</field>
		<field name="description">Gluconolactone is a naturally-occurring food additive used as a sequestrant, an acidifier, or a curing, pickling, or leavening agent. It is a cyclic ester of D-gluconic acid. Pure gluconolactone is a white odorless crystalline powder.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4133</field>
		<field name="drug_name">4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4134</field>
		<field name="drug_name">Inosinic Acid</field>
		<field name="description">Inosine 5&amp;#39;-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4135</field>
		<field name="drug_name">Chromophore (Gly-Tyr-Gly)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4136</field>
		<field name="drug_name">5-Aminoimidazole Ribonucleoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4137</field>
		<field name="drug_name">Formic Acid Benzyl Ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4138</field>
		<field name="drug_name">Latamoxef</field>
		<field name="description">Broad- spectrum beta-lactam antibiotic similar in structure to the cephalosporins except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain cephalosporins. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4139</field>
		<field name="drug_name">Trioxsalen</field>
		<field name="description">Trioxsalen (trimethylpsoralen, trioxysalen or trisoralen) is a furanocoumarin and a psoralen derivative. It is obtained from several plants, mainly Psoralea corylifolia. Like other psoralens it causes photosensitization of the skin. It is administered either topically or orally in conjunction with UV-A (the least damaging form of ultraviolet light) for phototherapy treatment of vitiligo[1] and hand eczema.[2] After photoactivation it creates interstrand cross-links in DNA, which can cause programmed cell death unless repaired by cellular mechanisms. In research it can be conjugated to dyes for confocal microscopy and used to visualize sites of DNA damage.[3] The compound is also being explored for development of antisense oligonucleotides that can be cross-linked specifically to a mutant mRNA sequence without affecting normal transcripts differing at even a single base pair.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4140</field>
		<field name="drug_name">Thiotepa</field>
		<field name="description">N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. It is also used as conditioning for Bone marrow transplantation. Its main toxicity is myelosuppression.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4141</field>
		<field name="drug_name">Estriol</field>
		<field name="description">A hydroxylated metabolite of estradiol or estrone that has a hydroxyl group at C3-beta, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During pregnancy, large amount of estriol is produced by the placenta. Isomers with inversion of the hydroxyl group or groups are called epiestriol. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not approved for use by the FDA or Health Canada. It is however available in the United States by prescription filled only by compounding pharmacies. It has also been approved and marketed throughout Europe and Asia for approximately 40 years for the treatment of post-menopausal hot flashes.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4142</field>
		<field name="drug_name">Estropipate</field>
		<field name="description">Estropipate is a form of estrogen. It has several uses such as: Alleviate symptoms of menopause as hormone replacement therapy, treatment some types of infertility, treatment of some conditions leading to underdevelopment of female sexual characteristics,treatment of vaginal atrophy,treatment of some types of breast cancer (particularly in men and postmenopausal women), treatment of prostate cancer and prevention of osteoporosis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4143</field>
		<field name="drug_name">Quinestrol</field>
		<field name="description">The 3-cyclopentyl ether of ethinyl estradiol.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4144</field>
		<field name="drug_name">Fleroxacin</field>
		<field name="description">Fleroxacin is a broad-spectrum antimicrobial fluoroquinolone. It strongly inhibits the DNA-supercoiling activity of DNA gyrase.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4145</field>
		<field name="drug_name">1-(1-phenylcyclopentyl)methylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4146</field>
		<field name="drug_name">(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4147</field>
		<field name="drug_name">N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4148</field>
		<field name="drug_name">1-Methyl-2-quinolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4149</field>
		<field name="drug_name">1-benzylimidazole</field>
		<field name="description">1-benzylimidazole, an N-imidazole derivative, has been shown to have strong cardiotonic activity.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4150</field>
		<field name="drug_name">IMAZAQUIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4151</field>
		<field name="drug_name">5-(AMINOCARBONYL)-1,1':4',1''-TERPHENYL-3-CARBOXYLICACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4152</field>
		<field name="drug_name">Phenyldehydroalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4153</field>
		<field name="drug_name">DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4154</field>
		<field name="drug_name">2-bromophenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4155</field>
		<field name="drug_name">2'-O-BUTYL-5-METHYLURIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4156</field>
		<field name="drug_name">N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4157</field>
		<field name="drug_name">(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4158</field>
		<field name="drug_name">N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4159</field>
		<field name="drug_name">3-Bromo-3-buten-1-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4160</field>
		<field name="drug_name">3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4161</field>
		<field name="drug_name">3-hydroxyglutaric acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4162</field>
		<field name="drug_name">(E)-(4S,6S)-8-METHYL-6-((S)-3-METHYL-2-{(S)-2-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID BENZYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4163</field>
		<field name="drug_name">4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE-(1-&gt;4)-BETA-D-GLUCURONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4164</field>
		<field name="drug_name">[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4165</field>
		<field name="drug_name">2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4166</field>
		<field name="drug_name">Aniracetam</field>
		<field name="description">Compound with anti-depressive properties used as a mental performance enhancer.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4167</field>
		<field name="drug_name">4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4168</field>
		<field name="drug_name">4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4169</field>
		<field name="drug_name">PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4170</field>
		<field name="drug_name">2'-DEOXY-5-FORMYLCYTIDINE-5'-MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4171</field>
		<field name="drug_name">5-iodotubercidin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4172</field>
		<field name="drug_name">5-Aminoisoquinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4173</field>
		<field name="drug_name">2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4174</field>
		<field name="drug_name">PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4175</field>
		<field name="drug_name">9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4176</field>
		<field name="drug_name">INHIBITOR Q8467 OF DUPONT MERCK</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4177</field>
		<field name="drug_name">7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4178</field>
		<field name="drug_name">N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4179</field>
		<field name="drug_name">(E)-(4S,6S)-6-((S)-2-{(S)-2-[(FURAN-2-CARBONYL)-AMINO]-3-METHYL-BUTYRYLAMINO}-3-METHYL-BUTYRYLAMINO)-8-METHYL-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID ETHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4180</field>
		<field name="drug_name">(R)-tacrine(10)-hupyridone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4181</field>
		<field name="drug_name">(S)-tacrine(10)-hupyridone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4182</field>
		<field name="drug_name">TACRINE(8)-4-AMINOQUINOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4183</field>
		<field name="drug_name">(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4184</field>
		<field name="drug_name">4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1-&gt;4)HEXOPYRANOSYL-(1-&gt;4)HEXOPYRANOSE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4185</field>
		<field name="drug_name">ACETOPHENONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4186</field>
		<field name="drug_name">Cycloleucine</field>
		<field name="description">Cycloleucine is an amino acid formed by cyclization of leucine. Cycloleucine is a non-metabolisable amino acid and is a specific and reversible inhibitor of nucleic acid methylation, and as such is widely used in biochemical experiments. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4187</field>
		<field name="drug_name">N-ACETYLHISTAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4188</field>
		<field name="drug_name">2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4189</field>
		<field name="drug_name">DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4190</field>
		<field name="drug_name">Cyclouridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4191</field>
		<field name="drug_name">Allosamidin</field>
		<field name="description">Allosamidin exhibits extremely potent inhibitory activity against chitinases from a number of sources, particularly from &lt;i&gt;Candida albicans&lt;/i&gt;, and can be utilized as potent antifungal agent.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4192</field>
		<field name="drug_name">Aplyronine A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4193</field>
		<field name="drug_name">Aldosterone</field>
		<field name="description">A hormone secreted by the adrenal cortex that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4194</field>
		<field name="drug_name">Atpenin A5</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4195</field>
		<field name="drug_name">4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4196</field>
		<field name="drug_name">N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4197</field>
		<field name="drug_name">N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4198</field>
		<field name="drug_name">Glutamine t-butyl ester</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4199</field>
		<field name="drug_name">6-Bromo-1-hexanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4200</field>
		<field name="drug_name">2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4201</field>
		<field name="drug_name">Biphenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4202</field>
		<field name="drug_name">Naphthalene-2,6-disulfonic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4203</field>
		<field name="drug_name">3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4204</field>
		<field name="drug_name">7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4205</field>
		<field name="drug_name">4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4206</field>
		<field name="drug_name">4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4207</field>
		<field name="drug_name">5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4208</field>
		<field name="drug_name">Dibromothymoquinone</field>
		<field name="description">At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4209</field>
		<field name="drug_name">BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4210</field>
		<field name="drug_name">S-propylamine-L-cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4211</field>
		<field name="drug_name">TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4212</field>
		<field name="drug_name">5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4213</field>
		<field name="drug_name">BIOTINOL-5-AMP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4214</field>
		<field name="drug_name">(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE</field>
		<field name="description">An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman&amp;#39;s The Pharmacological Basis of Therapeutics, 8th ed, p1437)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4215</field>
		<field name="drug_name">CBZ-LEU-LEU-TYR-CH2F</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4216</field>
		<field name="drug_name">4-PIPERIDIN-4-YLBUTANAL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4217</field>
		<field name="drug_name">METOPRINE, METHODICHLOROPHEN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4218</field>
		<field name="drug_name">1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4219</field>
		<field name="drug_name">Carboxin</field>
		<field name="description">A systemic agricultural fungicide and seed treatment agent.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4220</field>
		<field name="drug_name">(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4221</field>
		<field name="drug_name">(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4222</field>
		<field name="drug_name">Glycerylphosphorylcholine</field>
		<field name="description">A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids. (From Stedman, 26th ed) It counteracts the effects of urea on enzymes and other macromolecules. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4223</field>
		<field name="drug_name">Cis-tetracosenoyl sulfatide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4224</field>
		<field name="drug_name">OLOMOUCINE II</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4225</field>
		<field name="drug_name">2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4226</field>
		<field name="drug_name">Cyclohexyl-pentyl-maltoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4227</field>
		<field name="drug_name">2H-1-BENZOPYRAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4228</field>
		<field name="drug_name">CHROMOPHORE (LYS-TYR-GLY)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4229</field>
		<field name="drug_name">CHROMOPHORE (HIS-TYR-GLY)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4230</field>
		<field name="drug_name">CHROMOPHORE (GLU-TYR-GLY)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4231</field>
		<field name="drug_name">TRIAZOLOPYRIMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4232</field>
		<field name="drug_name">L-CYSTEIN-S-1-(IMINOMETHYL)-L-ORNITHINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4233</field>
		<field name="drug_name">cyclic 3',5'-thymidine monophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4234</field>
		<field name="drug_name">4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4235</field>
		<field name="drug_name">2-HYDROXY-3,5-DIIODOBENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4236</field>
		<field name="drug_name">(2S,5R,8S,11R,12S,15S,18S,19S,E)-8-ISOBUTYL-18-((5S,6S)-6-METHOXY-3,5-DIMETHYL-7-PHENYLHEPTYL)-1,2,5,12,15,19-HEXAMETHYL-3,6,9,13,16,20,25-HEPTAOXO-1,4,7,10,14,17,21-HEPTAAZACYCLOPENTACOS-21-ENE-11,22-DICARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4237</field>
		<field name="drug_name">Dansyllysine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4238</field>
		<field name="drug_name">N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4239</field>
		<field name="drug_name">H TYPE II TRISACCHARIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4240</field>
		<field name="drug_name">H TYPE I TRISACCHARIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4241</field>
		<field name="drug_name">GALACTOSE GREASE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4242</field>
		<field name="drug_name">BETA-METHYLLACTOSIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4243</field>
		<field name="drug_name">Octylphenoxy polyethoxyethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4244</field>
		<field name="drug_name">(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4245</field>
		<field name="drug_name">BIS(HEXAMETHYLENE)TRIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4246</field>
		<field name="drug_name">1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4247</field>
		<field name="drug_name">CHROMOPHORE (ASP-TYR-GLY)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4248</field>
		<field name="drug_name">DIMETHYL THIOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4249</field>
		<field name="drug_name">ECGONINE METHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4250</field>
		<field name="drug_name">2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4251</field>
		<field name="drug_name">Camptothecin</field>
		<field name="description">An alkaloid isolated from the stem wood of the Chinese tree, &lt;i&gt;Camptotheca acuminata&lt;/i&gt;. This compound selectively inhibits the nuclear enzyme DNA topoisomerase, type I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4252</field>
		<field name="drug_name">2'-O-[1-ETHYL-1H-IMIDAZOL)] THYMIDINE-5'-MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4253</field>
		<field name="drug_name">(E)-(S)-4-[(S)-2-((S)-2-TERT-BUTOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-2-PHENYL-ACETYLAMINO]-5-(2-OXO-PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4254</field>
		<field name="drug_name">(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4255</field>
		<field name="drug_name">2,6-anhydro-3-deoxy-3-fluoronononic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4256</field>
		<field name="drug_name">FARNESYL THIOPYROPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4257</field>
		<field name="drug_name">4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4258</field>
		<field name="drug_name">TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4259</field>
		<field name="drug_name">N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4260</field>
		<field name="drug_name">4-Butyrolactone</field>
		<field name="description">One of the FURANS with a carbonyl thereby forming a cyclic lactone.  It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate.  It is also used as a pharmacological agent and solvent. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4261</field>
		<field name="drug_name">GLUTATHIONE SULFINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4262</field>
		<field name="drug_name">S-METHYL-GLUTATHIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4263</field>
		<field name="drug_name">S-[(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] TRIHYDROGENTHIODIPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4264</field>
		<field name="drug_name">HESPERIDIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4265</field>
		<field name="drug_name">(3BETA,20R)-CHOLEST-5-ENE-3,20-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4266</field>
		<field name="drug_name">(3BETA)-CHOLEST-5-ENE-3,25-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4267</field>
		<field name="drug_name">(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4268</field>
		<field name="drug_name">HYDROXYFASUDIL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4269</field>
		<field name="drug_name">(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4270</field>
		<field name="drug_name">(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4271</field>
		<field name="drug_name">(E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5-METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO-PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4272</field>
		<field name="drug_name">Iodipamide</field>
		<field name="description">Iodipamide is a water-soluble radiographic contrast media for cholecystography and intravenous cholangiography. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4273</field>
		<field name="drug_name">ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4274</field>
		<field name="drug_name">4-IODOPHENYLALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4275</field>
		<field name="drug_name">ISOPENTENYL PYROPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4276</field>
		<field name="drug_name">IMIDAZOPYRIDAZIN 1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4277</field>
		<field name="drug_name">2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4278</field>
		<field name="drug_name">2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4279</field>
		<field name="drug_name">(2S,3S,4R,5R,6R)-5-Amino-2-(Aminomethyl)-6-((2R,3R,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-Diamino-2-((2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-hydroxycyclohexyloxy)-2-(hydroxymethyl)-4-(2-((R)-piperidin-3-ylmethylamin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4280</field>
		<field name="drug_name">DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4281</field>
		<field name="drug_name">S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4282</field>
		<field name="drug_name">N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4283</field>
		<field name="drug_name">2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4284</field>
		<field name="drug_name">2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4285</field>
		<field name="drug_name">(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4286</field>
		<field name="drug_name">7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4287</field>
		<field name="drug_name">N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4288</field>
		<field name="drug_name">Lividomycin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4289</field>
		<field name="drug_name">GENTAMICIN C1A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4290</field>
		<field name="drug_name">1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4291</field>
		<field name="drug_name">N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4292</field>
		<field name="drug_name">1,6-DI-O-PHOSPHONO-D-MANNITOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4293</field>
		<field name="drug_name">Citraconic acid</field>
		<field name="description">Citraconic acid is one of the isomeric dicarboxylic acids produced by the distillation of citric acid, or as metabolites by microorganisms, cis-CH3-C(CO2H)=CHCO2H; the trans-isomer is mesaconic acid.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4294</field>
		<field name="drug_name">MONOGALACTOSYL-DIACYLGLYCEROL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4295</field>
		<field name="drug_name">2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4296</field>
		<field name="drug_name">(S)-HYDROXY(PHENYL)ACETONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4297</field>
		<field name="drug_name">Motuporin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4298</field>
		<field name="drug_name">4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4299</field>
		<field name="drug_name">MOXALACTAM (HYDROLYZED)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4300</field>
		<field name="drug_name">Myxothiazol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4301</field>
		<field name="drug_name">NITROCEFIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4302</field>
		<field name="drug_name">Nimesulide</field>
		<field name="description">Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4303</field>
		<field name="drug_name">2-HYDROXY-1,4-NAPHTHOQUINONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4304</field>
		<field name="drug_name">2-OXOQUINOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4305</field>
		<field name="drug_name">(10E,12Z)-octadeca-10,12-dienoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4306</field>
		<field name="drug_name">11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4307</field>
		<field name="drug_name">OXIMINOARYLSULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4308</field>
		<field name="drug_name">2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4309</field>
		<field name="drug_name">OREGON GREEN 488 CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4310</field>
		<field name="drug_name">Purvalanol A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4311</field>
		<field name="drug_name">Phosphatidyl ethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4312</field>
		<field name="drug_name">9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4313</field>
		<field name="drug_name">GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4314</field>
		<field name="drug_name">PROPYL-1-PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4315</field>
		<field name="drug_name">2-[3,5-DICHLORO-4-(2-{2-[2(2-MERCAPTOETHOXY)ETHOXY]ETHOXY}ETHOXY)PHENYLAMINO]BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4316</field>
		<field name="drug_name">GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4317</field>
		<field name="drug_name">2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4318</field>
		<field name="drug_name">PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4319</field>
		<field name="drug_name">PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4320</field>
		<field name="drug_name">PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4321</field>
		<field name="drug_name">N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4322</field>
		<field name="drug_name">1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4323</field>
		<field name="drug_name">[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4324</field>
		<field name="drug_name">N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4325</field>
		<field name="drug_name">N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4326</field>
		<field name="drug_name">Pyrithiamine Pyrophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4327</field>
		<field name="drug_name">5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4328</field>
		<field name="drug_name">O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4329</field>
		<field name="drug_name">1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4330</field>
		<field name="drug_name">1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4331</field>
		<field name="drug_name">METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4332</field>
		<field name="drug_name">Reidispongiolide A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4333</field>
		<field name="drug_name">Reidispongiolide C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4334</field>
		<field name="drug_name">N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4335</field>
		<field name="drug_name">(R)-4-Nitrostyrene oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4336</field>
		<field name="drug_name">SC45647</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4337</field>
		<field name="drug_name">ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4338</field>
		<field name="drug_name">Sulfatide</field>
		<field name="description">Any of a class of cerebroside sulfuric esters, they are found largely in the medullated nerve fibers and may accumulate in metachromatic leukodystrophy.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4339</field>
		<field name="drug_name">5-hydroxyvaleric acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4340</field>
		<field name="drug_name">(S)-4-Nitrostyrene oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4341</field>
		<field name="drug_name">Sphinxolide B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4342</field>
		<field name="drug_name">Methylphenyl carbinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4343</field>
		<field name="drug_name">Tanaproget</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4344</field>
		<field name="drug_name">Tagetitoxin</field>
		<field name="description">Tagetitoxin is a bacterial phytotoxin. It preferentially inhibits eukaryotic RNA polymerase.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4345</field>
		<field name="drug_name">5-methyltetrahydrofolate</field>
		<field name="description">5-Methyltetrahydrofolate is a methylated derivate of tetrahydrofolate. It is generated by methylenetetrahydrofolate reductase from 5,10-methylenetetrahydrofolate and used to recycle homocysteine back to methionine by 5-methyltetrahydrofolate-homocysteine methyltransferases (also called methionine synthases).</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4346</field>
		<field name="drug_name">2,5-bis-o-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-d-glucitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4347</field>
		<field name="drug_name">2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4348</field>
		<field name="drug_name">2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4349</field>
		<field name="drug_name">2-O-(3'-AMIDINOPHENYL)-5-O-(4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4350</field>
		<field name="drug_name">Thenoyltrifluoroacetone</field>
		<field name="description">Thenoyltrifluoroacetone is a chelating agent and inhibitor of cellular respiration. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4351</field>
		<field name="drug_name">Inecalcitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4352</field>
		<field name="drug_name">Triazolopyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4353</field>
		<field name="drug_name">THIO-ATPA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4354</field>
		<field name="drug_name">5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4355</field>
		<field name="drug_name">1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4356</field>
		<field name="drug_name">(11E)-OCTADEC-11-ENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4357</field>
		<field name="drug_name">D-ERITHRO-2,3-DIAMINO-BUTYRIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4358</field>
		<field name="drug_name">Verdoheme</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4359</field>
		<field name="drug_name">L-threo-2,3-diamino-butyric acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4360</field>
		<field name="drug_name">Virginiamycin factor S1</field>
		<field name="description">One of the components of virginiamycin, a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. Loidensis, s. Mitakaensis, s. Pristina-spiralis, s. Ostreogriseus, and others. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4361</field>
		<field name="drug_name">(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4362</field>
		<field name="drug_name">4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4363</field>
		<field name="drug_name">Neamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4364</field>
		<field name="drug_name">SALOPHEN-10-PROPIONATE IRON CHELATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4365</field>
		<field name="drug_name">Salophen-10-carboxylate iron chelate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4366</field>
		<field name="drug_name">Salophen iron chelate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4367</field>
		<field name="drug_name">Benoxaprofen</field>
		<field name="description">The use of benoxaprofen, formerly marketed as Oraflex tablets, was associated with fatal cholestatic jaundice among other serious adverse reactions. The holder of the approved application voluntarily withdrew Oraflex tablets from the market on August 5, 1982.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4368</field>
		<field name="drug_name">Bithionol</field>
		<field name="description">Bithionol, formerly marketed as an active ingredient in various topical drug  products, was shown to be a potent photosensitizer with the potential  to cause serious skin disorders. Approvals of the NDA's for bithionol  drug products were withdrawn on October 24, 1967 (see the Federal  Register of October 31, 1967 (32 FR 15046)).</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4369</field>
		<field name="drug_name">Bunamiodyl</field>
		<field name="description">Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4370</field>
		<field name="drug_name">Clioquinol</field>
		<field name="description">Clioquinol was withdrawn in 1983 due to neurotoxicity.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4371</field>
		<field name="drug_name">Dantron</field>
		<field name="description">Withdrawn from the Canadian, US, and UK markets in 1998 due to genotoxicity.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4372</field>
		<field name="drug_name">Dipyrone</field>
		<field name="description">Dipyrone, formerly marketed as Dimethone tablets and injection, Protemp oral liquid, and other drug products, was associated with potentially fatal agranulocytosis. Approvals of the NDA's for dipyrone drug products were withdrawn on June 27, 1977 (see the Federal Register of June 17, 1977 (42 FR 30893)). Withdrawn from the Canadian market in 1963.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4373</field>
		<field name="drug_name">Iproniazid</field>
		<field name="description">Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4374</field>
		<field name="drug_name">Methapyrilene</field>
		<field name="description">Methapyrilene, formerly marketed in many drug products, was shown to be  a potent carcinogen. Manufacturers voluntarily withdrew methapyriline  drug products from the market in May and June 1979.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4375</field>
		<field name="drug_name">Nialamide</field>
		<field name="description">Withdrawn from the Canadian, US, and UK markets in 1963 due to interactions with food products containing tyrosine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4376</field>
		<field name="drug_name">Nomifensine</field>
		<field name="description">Nomifensine, formerly marketed as Merital capsules, was associated with an increased incidence of hemolytic anemia. The approved application holder removed Merital capsules from the market on January 23, 1986. FDA published a notice of its determination that Merital capsules were removed from the market for safety reasons (see the Federal Register of June 17, 1986 (51 FR 21981)). Approval of the NDA for Merital capsules was withdrawn on March 20, 1992 (see the Federal Register of March 20, 1992 (57 FR 9729)). Also withdrawn from the Canadian and UK markets.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4377</field>
		<field name="drug_name">Oxeladin</field>
		<field name="description">Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4378</field>
		<field name="drug_name">Oxyphenisatin</field>
		<field name="description">A laxative that undergoes enterohepatic circulation. It may cause jaundice.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4379</field>
		<field name="drug_name">Phenolphthalein</field>
		<field name="description">Phenolphthalein was withdrawn in Canada due to concerns with carcinogenicity in 1997.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4380</field>
		<field name="drug_name">Prenylamine</field>
		<field name="description">Prenylamine was withdrawn from the Canadian, US, and UK markets in 1988 due to concerns regarding cardiac arrhythmias.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4381</field>
		<field name="drug_name">Thenalidine</field>
		<field name="description">Withdrawn from the Canadian, US, and UK markets in 1963 due to concerns involving neutropenia.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4382</field>
		<field name="drug_name">Ethyl carbamate</field>
		<field name="description">Ethyl carbamate (also known as urethan and urethane), formerly marketed as an inactive ingredient in Profenil injection, was determined to be carcinogenic and was removed from the Canadian, US, and UK markets in 1963.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4383</field>
		<field name="drug_name">Zomepirac</field>
		<field name="description">Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4384</field>
		<field name="drug_name">Lysergic Acid Diethylamide</field>
		<field name="description">Debate continues over the nature and causes of chronic flashbacks. Explanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by experimental evidence. Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action of LSD on brain chemistry, and varies according to the susceptibility of the individual to the disorder. Many emotionally intense experiences can lead to flashbacks when a person is reminded acutely of the original experience. However, not all published case reports of chronic flashbacks appear to describe an anxious hyper-vigilant state reminiscent of post-traumatic stress disorder.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4385</field>
		<field name="drug_name">Buformin</field>
		<field name="description">Buformin is an anti-diabetic drug of the biguanide class, chemically related to metformin and phenformin. It was withdrawn from the market in most countries due to a high risk of causing lactic acidosis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4386</field>
		<field name="drug_name">Ticrynafen</field>
		<field name="description">Ticrynafen, or tienilic acid, is a diuretic drug with uric acid-lowering (uricosuric) action, formerly marketed for the treatment of hypertension. It was withdrawn in 1982, shortly after its introduction to the market, after case reports in the United States indicated a link between the use of ticrynafen and hepatitis. (Manier et al., 1982)</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4387</field>
		<field name="drug_name">Zimelidine</field>
		<field name="description">Zimelidine has been banned worldwide due to serious, sometimes fatal, cases of central and/or peripheral neuropathy known as Guillain-Barré syndrome and due to a peculiar hypersensitivity reaction involving many organs including skin exanthema, flu-like symptoms, arthralgias, and sometimes eosinophilia. Additionally, zimelidine was charged to cause an increase in suicidal ideation and/or attempts among depressive patients. After its ban, it was succeeded by fluvoxamine and fluoxetine (derived from the antihistamine diphenhydramine) in that order, and the other SSRIs.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4388</field>
		<field name="drug_name">Methaqualone</field>
		<field name="description">Methaqualone is a sedative-hypnotic drug that is similar in effect to barbiturates, a general central nervous system depressant. The sedative-hypnotic activity was first noted by Indian researchers in the 1950s and in 1962 methaqualone itself was patented in the US by Wallace and Tiernan. Its use peaked in the early 1970s as a hypnotic, for the treatment of insomnia, and as a sedative and muscle relaxant. It has also been used illegally as a recreational drug, commonly known as Quaaludes, Sopors, Ludes or Mandrax (particularly in the 1970s in North America) depending on the manufacturer. Since at least 2001, it has been widely used in South Africa, where it is commonly referred to as &quot;smarties&quot; or &quot;geluk-tablette&quot; (meaning happy tablets). Clandestinely produced methaqualone is still seized by government agencies and police forces around the world. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4389</field>
		<field name="drug_name">Rapacuronium</field>
		<field name="description">Rapacuronium was withdrawn in 2001 in many countries due to risk of fatal bronchospasm.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4390</field>
		<field name="drug_name">Amineptine</field>
		<field name="description">The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until 2005.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4391</field>
		<field name="drug_name">Chlophedianol</field>
		<field name="description">Chlophedianol is a centrally-acting cough suppressant available in Canada under the trade name Ulone. It is not available in the United States.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4392</field>
		<field name="drug_name">Cyclandelate</field>
		<field name="description">A direct-acting smooth muscle relaxant used to dilate blood vessels. It may cause gastrointestinal distress and tachycardia. Cyclandelate is not approved for use in the U.S. or Canada, but is approved in various European countries.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4393</field>
		<field name="drug_name">Cyproterone</field>
		<field name="description">An anti-androgen that, in the form of its acetate (cyproterone acetate), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. [Pubchem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4394</field>
		<field name="drug_name">Debrisoquin</field>
		<field name="description">An adrenergic neuron-blocking drug similar in effects to guanethidine. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. [PubChem]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4395</field>
		<field name="drug_name">Flunarizine</field>
		<field name="description">Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4396</field>
		<field name="drug_name">Fluspirilene</field>
		<field name="description">A long-acting injectable antipsychotic agent used for chronic schizophrenia.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4397</field>
		<field name="drug_name">Mepenzolate</field>
		<field name="description">Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4398</field>
		<field name="drug_name">Tetrabenazine</field>
		<field name="description">A drug formerly used as an antipsychotic but now used primarily in the symptomatic treatment of various hyperkinetic disorders. It is a monoamine depletor and used as symptomatic treatment of chorea associated with Huntington's disease. FDA approved on August 15, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4399</field>
		<field name="drug_name">Ixabepilone</field>
		<field name="description">Ixabepilone is an epothilone B analog developed by Bristol-Myers Squibb as a cancer drug. On October 16, 2007, the U.S. Food and Drug Administration approved ixabepilone for the treatment of aggressive metastatic or locally advanced breast cancer no longer responding to currently available chemotherapies. Ixabepilone is administered through injection, and will be marketed under the trade name Ixempra. [Wikipedia] Ixabepilone is a semisynthetic analogue of epothilone B. It has a lactone–lactam modification that  minimizes susceptibility to esterase degradation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4400</field>
		<field name="drug_name">Dronedarone</field>
		<field name="description">Dronedarone is a sinus rhythm controller for management of paroxysmal or persistent atrial fibrillation. Classified as a Class III antiarrhythmic but displays properties of all four Vaughan-Williams classes, dronedarone blocks a multitude of channels (sodium, potassium, calcium), and demonstrates antiadrenergic properties. Chemically, it is a benzofuran derivative. FDA approved on July 1, 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4401</field>
		<field name="drug_name">Nebivolol</field>
		<field name="description">Nebivolol is a highly cardioselective vasodilatory beta1 receptor blocker used in treatment of hypertension. In most countries, this medication is available only by prescription. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4402</field>
		<field name="drug_name">Homoharringtonine</field>
		<field name="description">Homoharringtonine, AKA HHT or omacetaxine mepesuccinate, is a cephalotaxine ester and protein synthesis inhibitor with established clinical activity as a single agent in hematological malignancies. Homoharringtonine  is synthesized from cephalotaxine, which is an extract from the leaves of the plant, Cephalotaxus species. In October 2005, homoharringtonine received Orphan Drug designation from the EMEA for the treatment of chronic myeloid leukemia (CML). Then in March 2006, homoharringtonine received Orphan Drug status from the FDA for the treatment of CML. In November 2006, homoharringtonine, for the treatment of CML, was granted Fast Track designation by the FDA. Most recently, in October 2012, homoharringtonine was marketed under the brand name Synribo™ and FDA approved for patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4403</field>
		<field name="drug_name">Nilotinib</field>
		<field name="description">Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). In June 2006, a Phase I clinical trial found nilotinib has a relatively favorable safety profile and shows activity in cases of CML resistant to treatment with imatinib (Gleevec&amp;reg;), another tyrosine kinase inhibitor currently used as a first-line treatment. [Wikipedia];Abl Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4404</field>
		<field name="drug_name">Lorcaserin</field>
		<field name="description">Lorcaserin (previously APD-356), a highly selective 5HT2C receptor agonist, is used for the treatment of obesity. It has been shown to reduce body weight and food intake in animal models of obesity, and it is thought that targeting the 5HT2C receptor may alter body weight by regulating satiety. Lorcaserin is marketed as a salt form called Belviq, which is lorcaserin hydrochloride.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4405</field>
		<field name="drug_name">Vildagliptin</field>
		<field name="description">Vildagliptin, previously identified as LAF237, is a new oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucaon release by the alpha cells of the islets of Langerhans in the pancreas. It is currently in clinical trials in the U.S. and has been shown to reduce hyperglycemia in type 2 diabetes mellitus. While the drug is still not approved for use in the US, it was approved in Feb 2008 by European Medicines Agency for use within the EU and is listed on the Australian PBS with certain restrictions.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4406</field>
		<field name="drug_name">Voglibose</field>
		<field name="description">Voglibose (INN and USAN) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4407</field>
		<field name="drug_name">Enoximone</field>
		<field name="description">Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4408</field>
		<field name="drug_name">Bepotastine</field>
		<field name="description">Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion. It is available in oral and opthalmic dosage forms in Japan. The opthalmic solution is FDA approved since Sept 8, 2009 and is under the brand name Bepreve.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4409</field>
		<field name="drug_name">Vapreotide</field>
		<field name="description">Vapreotide is a synthetic octapeptide somatostatin analog. It was being studied  for the treatment of cancer.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4410</field>
		<field name="drug_name">Pegaptanib</field>
		<field name="description">Pegaptanib is a pegylated anti-VEGF aptamer, a single strand of nucleic acid that binds with specificity to a particular target. Pegaptanib specifically binds to VEGF 165, a protein that plays a critical role in angiogenesis (the formation of new blood vessels) and increased permeability (leakage from blood vessels), two of the primary pathological processes responsible for the vision loss associated with neovascular AMD. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4411</field>
		<field name="drug_name">Milnacipran</field>
		<field name="description">Milnacipran is an antidepressant of the serotonin-norepinephrine reuptake inhibitor class. It more potently inhibits norepinephrine uptake than serotonin. It is provided as a racemic mixture. FDA approved in January 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4412</field>
		<field name="drug_name">Lucinactant</field>
		<field name="description">Lucinactant is a new synthetic peptide-containing surfactant for intratracheal use. It contains sinapultide, a novel, hydrophobic, 21-amino acid peptide (leucine and lysine repeating units, KL4 peptide) designed to mimic human surfactant protein-B (SB-P). More specifically, it mimics the C-terminal amphipathic helical domain of this protein. It also consists of phospholipids (dipalmitoylphosphatidylcholine, DPPC and palmitoyloleoyl phosphatidylglycerol, POPG) and a fatty acid (palmitic acid). It is completely devoid of animal-derived components. FDA approved on March 6, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4413</field>
		<field name="drug_name">Ximelagatran</field>
		<field name="description">Ximelagatran (Exanta® or Exarta®, H 376/95) is an anticoagulant that has been investigated extensively as a replacement for warfarin that would overcome the problematic dietary, drug interaction, and monitoring issues associated with warfarin therapy. In 2006, its manufacturer AstraZeneca announced that it would not attempt to market ximelagatran after reports of hepatotoxicity (liver damage) during trials, and to discontinue its distribution in countries where the drug had been approved.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4414</field>
		<field name="drug_name">Nesiritide</field>
		<field name="description">Nesiritide is a medication used to treat acutely decompensated congestive heart failure with dyspnea at rest or with minimal exertion (such as talk, eating or bathing). Nesiritide is the recombinant form of the 32 amino acid human B-type natriuretic peptide, which is normally produced by the ventricular myocardium.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4415</field>
		<field name="drug_name">Thymalfasin</field>
		<field name="description">Thymalfasin is a chemically synthesized thymosin alpha 1 identical to human thymosin alpha 1. Thymosin alpha 1 is an acetylated polypeptide.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4416</field>
		<field name="drug_name">Clevidipine</field>
		<field name="description">Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4417</field>
		<field name="drug_name">Defibrotide</field>
		<field name="description">Defibrotide is the sodium salt of a mixture of single-stranded oligodeoxyribonucleotides derived from porcine mucosal DNA. It has been shown to have antithrombotic, anti-inflammatory and anti-ischemic properties (but without associated significant systemic anticoagulant effects). It is marketed under the brand names Dasovas (FM), Noravid, and Prociclide in a variety of countries, but is currently not approved in the USA. The manufacturer is Gentium.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4418</field>
		<field name="drug_name">Ospemifene</field>
		<field name="description">Ospemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4419</field>
		<field name="drug_name">Crofelemer</field>
		<field name="description">Crofelemer, previously known as the investigational drug SP-303, is a novel proanthocyanidin purified from the bark latex of the Amazonian Croton tree &lt;i&gt;Croton lechleri&lt;/i&gt;. It is marketed under the brand name Fulyzaq and indicated for the symptomatic treatment of non-infectious diarrhea in adult patients with HIV/AIDS who are taking antiretroviral therapy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4420</field>
		<field name="drug_name">Tamibarotene</field>
		<field name="description">Tamibarotene is a novel synthetic retinoid for acute promyelocytic leukaemia (APL). Tamibarotene is currently approved in Japan for treatment of recurrent APL, and is undergoing clinical trials in the United States.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4421</field>
		<field name="drug_name">Iloperidone</field>
		<field name="description">Iloperidone is an atypical antipsychotic for the treatment of schizophrenia symptoms. Hoechst Marion Roussel Inc. made initial inquiries into the drug; however, in May 1996, they discontinued research, and in June 1997 gave research rights to Titan Pharmaceuticals. Titan then handed over worldwide development, manufacturing and marketing rights to Novartis in August 1998. On June 9, 2004, Titan Pharmaceuticals announced that the Phase III development rights have been acquired by Vanda Pharmaceuticals. FDA approved on May 9, 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4422</field>
		<field name="drug_name">Lofexidine</field>
		<field name="description">Lofexidine is an alpha2-adrenergic receptor agonist. It can be used as a short acting anti-hypertensive, but is mostly used to help relieve symptoms of heroin or opiate withdrawal in opiate dependency. It is approved in the United Kingdom, but is still undergoing clinical trials in the United States.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4423</field>
		<field name="drug_name">Ezogabine</field>
		<field name="description">Ezogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in adult patients with refractory epilepsy. FDA approved in June 10, 2011 under the name of ezogabine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4424</field>
		<field name="drug_name">Lucanthone</field>
		<field name="description">One of the schistosomicides, it has been replaced largely by hycanthone and more recently praziquantel. (From Martindale The Extrapharmacopoeia, 30th ed., p46). It is currently being tested as a radiation sensitizer.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4425</field>
		<field name="drug_name">Ingenol Mebutate</field>
		<field name="description">Ingenol mebutate was approved by the FDA in January 2012, and it is marketed under the name Picato®. Picato gel is indicated for the topical treatment of actinic keratosis. Before approval, ingenol mebutate was called PEP005 as an investigational drug. PEP005 is a selective small molecule activator of protein kinase C (PKC) extracted from the plant Euphorbia peplus, whose sap has been used as a traditional medicine for the treatment of skin conditions including warts and cancer. PEP005 also has potent anti-leukemic effects, inducing apoptosis in myeloid leukemia cell lines and primary AML cells at nanomolar concentrations.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4426</field>
		<field name="drug_name">Indacaterol</field>
		<field name="description">Indacaterol is a novel, ultra-long-acting, rapid onset ?(2)-adrenoceptor agonist developed for Novartis for the once-daily management of asthma and chronic obstructive pulmonary disease. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez on November 30, 2009, and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler, on July 1, 2011. Indacaterol is provided as its maleate salt form. Indacaterol is also a chiral molecule but only the pure R-enantiomer is dispensed.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4427</field>
		<field name="drug_name">Fenretinide</field>
		<field name="description">A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4428</field>
		<field name="drug_name">Trabectedin</field>
		<field name="description">Trabectedin, also referred as ET-743 during its development, is a marine derived antitumoral agent discovered in the Carribean tunicate _Ecteinascidia turbinata_ and now produced synthetically. Trabectedin has a unique mechanism of action. It binds to the minor groove of DNA interfering with cell division and genetic transcription processes and DNA repair machinery. It is approved for use in Europe, Russia and South Korea for the treatment of advanced soft tissue sarcoma refractory to or unsuitable to receive anthracycline or ifosfamide chemotherapy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4429</field>
		<field name="drug_name">Methsuximide</field>
		<field name="description">Mesuximide (or methsuximide) is an anticonvulsant medication. It is sold by Pfizer under the name Petinutin. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4430</field>
		<field name="drug_name">5-bromo-cytidinemonophosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4431</field>
		<field name="drug_name">Glatiramer Acetate</field>
		<field name="description">Glatiramer acetate consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. The average molecular weight of glatiramer acetate is 5,000-9,000 daltons.  It is an immunomodulator, licensed in much of the world for reduced frequency of relapses in relapsing-remitting multiple sclerosis</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4432</field>
		<field name="drug_name">Gallium nitrate</field>
		<field name="description">Gallium nitrate is a drug that is used to treat hyper-calcemia, or too much calcium in the blood. This condition may occur when individuals develop various types of cancer. Gallium nitrate is also known by the common brand name Ganite.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4433</field>
		<field name="drug_name">Ecabet</field>
		<field name="description">Ecabet is a prescription eye drop for the treatment of dry eye syndrome. Ecabet represents a new class of molecules that increases the quantity and quality of mucin produced by conjunctival goblet cells and corneal epithelia. Mucin is a glycoprotein component of tear film that lubricates while retarding moisture loss from tear evaporation. Ecabet is currently marketed in Japan as an oral agent for treatment of gastric ulcers and gastritis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4434</field>
		<field name="drug_name">Ibudilast</field>
		<field name="description">Ibudilast is an anti-inflammatory and neuroprotective oral agent which shows an excellent safety profile at 60 mg/day and provides significantly prolonged time-to-first relapse and attenuated brain volume shrinkage in patients with relapsing-remitting (RR) and/or secondary progressive (SP) multiple sclerosis (MS). Ibudilast is currently in development in the U.S. (codes: AV-411 or MN-166), but is approved for use as an antiinflammatory in Japan.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4435</field>
		<field name="drug_name">Rotigotine</field>
		<field name="description">Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours.    Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well.    Rotigotine was developed by Aderis Pharmaceuticals. In 1998, Aderis licensed worldwide development and commercialization rights for rotigotine to the German pharmaceutical company Schwarz Pharma (today a subsidiary of the Belgian company UCB S.A.). The drug has been approved by the EMEA for use in Europe in 2006 and is today being sold in several European countries. In 2007, the Neupro patch was approved by the Food and Drug Administration (FDA) as the first transdermal treatment of Parkinson's disease in the United States. Howev...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4436</field>
		<field name="drug_name">Vandetanib</field>
		<field name="description">Vandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the potential for use in a broad range of tumour types.    On April 6 2011, vandetanib was approved by the FDA to treat nonresectable, locally advanced, or metastatic medullary thyroid cancer in adult patients. ;Multi-kinase inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4437</field>
		<field name="drug_name">Romiplostim</field>
		<field name="description">Romiplostim is a thrombopoiesis stimulating dimer Fc-peptide fusion protein (peptibody) to increase platelet production through activation of the thrombopoietin receptor. The peptibody molecule has two identical single-chain subunits, each one is made up of 269 amino acid residues. Each subunit consists of an IgG1 Fc carrier domain that is covalently attached to a polypeptide sequence that contains two binding domains to interact with thrombopoietin receptor c-Mpl. Each domain consists of 14 amino acids. Interestingly, romiplostim's amino acid sequence is not similar to that of endogenous thrombopoietin. Romiplostim is produced by recombinant DNA technology in Escherichia coli. FDA approved on August 22, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4438</field>
		<field name="drug_name">Mipomersen</field>
		<field name="description">Mipomersen sodium, which was known as the investigational drug, isis-301012, is the salt form of a synthetic phosphorothioate oligonucleotide. Mipomersen sodium prevents the formation of apo B-100, resulting in a decrease in the levels of apolipoprotein B (apo B), low density lipoprotein (LDL), and total cholesterol. Mipomersen is indicated in patients with homozygous familial hypercholesterolemia as an adjunct to diet and other lipid-lowering medications. It is marketed under the brand name Kynamro in the United States, and the FDA label includes a black box warning of hepatoxicity. Specifically, elevations in the liver enzymes, i.e. transaminases, and in liver  fat (hepatic steatosis) have been reported. Due to this serious risk of liver toxicity, mipomersen sodium is only available to patients under the restricted program called Kynamro™ Risk Evaluation and Mitigation Strategy program.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4439</field>
		<field name="drug_name">Sodium stibogluconate</field>
		<field name="description">Sodium stibogluconate is a medicine used to treat leishmaniasis and is only available for administration by injection. It belongs to the class of medicines known as the pentavalent antimonials. Sodium stibogluconate is sold in the UK as Pentostam (manufactured by GlaxoSmithKline). Widespread resistance has limited the utility of sodium stibogluconate, and in many parts of the world, amphotericin or miltefosine are used instead. It is also being investigated as an anti-tumor agent.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4440</field>
		<field name="drug_name">ado-trastuzumab emtansine</field>
		<field name="description">Ado-trastuzumab emtansine, formerly called Trastuzumab-DM1 (T-DM1) as an investigational drug, is a first-in-class HER2 antibody drug conjugate (ADC) comprised of Genentech's trastuzumab antibody linked to ImmunoGen's cell-killing agent, DM1. T-DM1 combines two strategies-- anti-HER2 activity and targeted intracellular delivery of the potent anti-microtubule agent, DM1 (a maytansine derivative)--to produce cell cycle arrest and apoptosis. Ado-trastuzumab emtansine is marketed under the brand name Kadcyla and is indicated for use in HER2-positive, metastatic breast cancer patients who have already used taxane and/or trastuzumab for metastatic disease or had their cancer recur within 6 months of adjuvant treatment. The FDA label has two precautions. First that ado-trastuzumab emtansine and trastuzumab cannot be interchanged. Second that there is a black box warning of serious side effects such as hepatotoxicity, embryo-fetal toxicity, and cardiac toxicity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4441</field>
		<field name="drug_name">Abiraterone</field>
		<field name="description">Abiraterone is a derivative of steroidal progesterone and is an innovative drug that offers clinical benefit to patients with hormone refractory prostate cancer. Abiraterone is administered as an acetate salt prodrug because it has a higher bioavailability and less susceptible to hydrolysis than abiraterone itself. FDA approved on April 28, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4442</field>
		<field name="drug_name">Preotact</field>
		<field name="description">Preotact is a pharmaceutical form of parathyroid hormone (PTH). PTH is a single-chain polypeptide composed of 84 amino acids. Preotact contains recombinant human parathyroid hormone which is identical to the full-length native 84-amino acid polypeptide. It is produced as a fusion protein. Post-translational processing involves the cleavage of the OmpA leader sequence, leaving the mature protein as a single-chain 84 amino-acids polypeptide (9.4 kDa) whose sequence is identical to that of the full-length native endogenous human PTH. It has no disulfide bonds and no glycosylation sites.    Preotact is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. Preotact is marketed in Europe by Nycomed. Preos is a registered trade mark owned by NPS Pharmaceuticals, Inc. The name Preos and the New Drug Application is pending approval by the U.S. Food and Drug Administration (FDA).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4443</field>
		<field name="drug_name">Sertindole</field>
		<field name="description">Sertindole, a neuroleptic, is one of the newer antipsychotic medications available. Serdolect is developed by the Danish pharmaceutical company H. Lundbeck. Like the other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia. It is classified chemically as a phenylindole derivative. It was first marketed in 1996 in several European countries before being withdrawn two years later because of numerous cardiac adverse effects. It has once again been approved and should soon be available on the French and Australian market.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4444</field>
		<field name="drug_name">Sulfathiazole</field>
		<field name="description">Sulfathiazole is a short-acting sulfa drug. It used to be a common oral and topical antimicrobial until less toxic alternatives were discovered. It is still occasionally used, sometimes in combination with sulfabenzamide and sulfacetamide.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4445</field>
		<field name="drug_name">Mianserin</field>
		<field name="description">A tetracyclic compound with antidepressant effects. Mianserin was previously available internationally, however in most markets it has been phased out in favor of Mirtazapine.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4446</field>
		<field name="drug_name">Sulfadimethoxine</field>
		<field name="description">Sulfadimethoxine (trade name Di-Methox, Albon) is a sulfonamide antibiotic. Sulfadimethoxine is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4447</field>
		<field name="drug_name">Acetylcysteine</field>
		<field name="description">Acetylcysteine is the N-acetyl derivative of cysteine. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates. [PubChem]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4448</field>
		<field name="drug_name">Rimonabant</field>
		<field name="description">Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil.  It was rejected for approval for use in the United States. This decision was made after a U.S. advisory panel recommended the medicine not be approved because it may increase suicidal thinking and depression.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4449</field>
		<field name="drug_name">Canakinumab</field>
		<field name="description">Canakinumab is a recombinant, human anti-human-IL-1? monoclonal antibody that belongs to the IgG1/? isotype subclass. It is expressed in a murine Sp2/0-Ag14 cell line and comprised of two 447- (or 448-) residue heavy chains and two 214-residue light chains, with a molecular mass of 145157 Daltons when deglycosylated. Both heavy chains of canakinumab contain oligosaccharide chains linked to the protein backbone at asparagine 298 (Asn 298). Canakinumab binds to human IL-1? and neutralizes its inflammatory activity by blocking its interaction with IL-1 receptors, but it does not bind IL-1alpha or IL-1 receptor antagonist (IL-1ra). Canakinumab is marketed under the brand name Ilaris and indicated for patients 4 years of age and older to treat Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), which are both part of the Cryopyrin-Associated Periodic Syndromes (CAPS) as well as for patients 2 years of age and older to treat systemic juvenile idiopathic arthritis ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4450</field>
		<field name="drug_name">Icatibant</field>
		<field name="description">Icatibant (Firazyr) is a synthetic peptidomimetic drug consisting of ten amino acids, and acts as an effective and specific antagonist of bradykinin B2 receptors. It has been approved in the EU for use in hereditary angioedema, and is under investigation for a number of other conditions in which bradykinin is thought to play a significant role. Icatibant currently has orphan drug status in the United States and FDA approved on August 25, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4451</field>
		<field name="drug_name">Rufinamide</field>
		<field name="description">Rufinamide is a triazole derivative and an anticonvulsant medication to treat seizure disorders like Lennox-Gastuat syndrome, a form of childhood epilepsy. Clinical trials suggest its efficacy in the treatment of partial seizures.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4452</field>
		<field name="drug_name">Alogliptin</field>
		<field name="description">Alogliptin is a selective, orally-bioavailable inhibitor of enzymatic activity of dipeptidyl peptidase-4 (DPP-4). Chemically, alogliptin is prepared as a benzoate salt and exists predominantly as the R-enantiomer (&gt;99%). It undergoes little or no chiral conversion in vivo to the (S)-enantiomer.  FDA approved January 25, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4453</field>
		<field name="drug_name">Tapentadol</field>
		<field name="description">Opioid analgesic for treatment of moderate to severe pain. FDA approved on Nov 20, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4454</field>
		<field name="drug_name">Silodosin</field>
		<field name="description">Silodosin is an ?1-adrenoceptor antagonist that is selective for the prostate. Silodosin is for symptomatic treatment of benign prostatic hyperplasia. FDA approved Oct 9, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4455</field>
		<field name="drug_name">Prasugrel</field>
		<field name="description">Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine. Similar to clopidogrel, prasugrel is a prodrug that requires enzymatic transformation in the liver to its active metabolite, R-138727. R-138727 irreversibly binds to P2Y12 type ADP receptors on platelets thus preventing activation of the GPIIb/IIIa receptor complex. As a result, inhibition of ADP-mediated platelet activation and aggregation occurs. Prasugrel was developed by Daiichi Sankyo Co. and is currently marketed in the United States and Canada in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). FDA approved in 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4456</field>
		<field name="drug_name">Eltrombopag</field>
		<field name="description">Eltrombopag is used to treat low blood platelet counts in adults with chronic immune (idiopathic) thrombocytopenia (ITP), when certain other medicines, or surgery to remove the spleen, have not worked well enough. ITP is a condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood. Eltrombopag has also been recently approved (late 2012) for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4457</field>
		<field name="drug_name">Tolvaptan</field>
		<field name="description">Tolvaptan is used to treat low blood sodium levels (hyponatremia) associated with various conditions like congestive heart failure, cirrhosis, and syndrome of inappropriate antidiuretic hormones (SIADH). FDA approved on May 19, 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4458</field>
		<field name="drug_name">Regadenoson</field>
		<field name="description">Regadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4459</field>
		<field name="drug_name">Asenapine</field>
		<field name="description">Developed by Schering-Plough after its merger with Organon International, asenapine is a sublingually administered, atypical antipsychotic for treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine also belongs to the dibenzo-oxepino pyrrole class. It is also for severe post-traumatic stress disorder nightmares in soldiers as an off-label use. FDA approved on August 13, 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4460</field>
		<field name="drug_name">Lacosamide</field>
		<field name="description">Lacosamide is a functionalized amino acid that has activity in the maximal electroshock seizure test, and is indicated for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Recent studies indicate that Lacosamide only affects those neurons which are depolarized or active for long periods of time, typical of neurons at the focus of an epileptic seizure, as opposed to other antiepileptic drugs such as carbamazepine or lamotrigine which slow the recovery from inactivation and reduce the ability of neurons to fire action potentials.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4461</field>
		<field name="drug_name">Rivaroxaban</field>
		<field name="description">Rivaroxaban is an anticoagulant and the first orally active direct factor Xa inhibitor. Unlike warfarin, routine lab monitoring of INR is not necessary. However there is no antidote available in the event of a major bleed. Only the 10 mg tablet can be taken without regard to food. The 15 mg and 20 mg tablet should be taken with food. FDA approved on July 1, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4462</field>
		<field name="drug_name">Avanafil</field>
		<field name="description">Avanafil is a new phosphodiesterase-5 inhibitor that is faster acting and more selective than other drugs belonging to the same class. Chemically, it is a derivative of pyrimidine and is only available as the S-enantiomer. FDA approved on April 27, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4463</field>
		<field name="drug_name">Droxidopa</field>
		<field name="description">Droxidopa is a precursor of noradrenaline that is used in the treatment of Parkinsonism. It is approved for use in Japan and is currently in trials in the U.S. The racaemic form (dl-threo-3,4-dihydroxyphenylserine) has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson's disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4464</field>
		<field name="drug_name">Udenafil</field>
		<field name="description">Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4465</field>
		<field name="drug_name">Sitaxentan</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4466</field>
		<field name="drug_name">Sulodexide</field>
		<field name="description">Sulodexide is a mixture of glycosaminoglycans (GAGs) composed of dermatan sulfate (DS) and fast moving heparin (FMH).</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4467</field>
		<field name="drug_name">Tocilizumab</field>
		<field name="description">Tocilizumab is a recombinant, humanized, anti-human interleukin 6 (IL-6) receptor monoclonal antibody that achieves a significant therapeutic response rate. The light chain is made up of 214 amino acids. The heavy chain is made up of 448 amino acids. The four polypeptide chains are linked intra- and inter-molecularly by disulfide bonds. FDA approved on January 8, 2010.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4468</field>
		<field name="drug_name">Alvimopan</field>
		<field name="description">Alvimopan is a peripherally acting ? opioid antagonist. It is used to avoid postoperative ileus following small or large bowel resection and accelerates the gastrointestinal recovery period.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4469</field>
		<field name="drug_name">Teriparatide</field>
		<field name="description">Teriparatide (recombinant human parathyroid hormone) is a potent anabolic agent used in the treatment of osteoporosis. It is manufactured and marketed by Eli Lilly and Company.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4470</field>
		<field name="drug_name">Temsirolimus</field>
		<field name="description">Temsirolimus is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the FDA in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative of sirolimus and is sold as Torisel.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4471</field>
		<field name="drug_name">Amisulpride</field>
		<field name="description">Amisulpride (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4472</field>
		<field name="drug_name">Saxagliptin</field>
		<field name="description">Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4473</field>
		<field name="drug_name">Pertuzumab</field>
		<field name="description">Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). It consists of two heavy chains and two lights chains that have 448 and 214 residues respectively. FDA approved June 8, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4474</field>
		<field name="drug_name">Rilonacept</field>
		<field name="description">Rilonacept is a dimeric fusion protein consisting of portions of IL-1R and the IL-1R accessory  protein linked to the Fc portion of immunoglobulin G1. Rilonacept functions as an interleukin 1 inhibitor and is used in the treatment of CAPS, also known as cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome (FCAS) and Muckle-Wells Syndrome (MWS), in adults and children greater than 12 years old.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4475</field>
		<field name="drug_name">Tyloxapol</field>
		<field name="description">Tyloxapol is a non-ionic detergent often used as a surfactant.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4476</field>
		<field name="drug_name">Pazopanib</field>
		<field name="description">Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4477</field>
		<field name="drug_name">Agomelatine</field>
		<field name="description">Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression. Agomelatine was discovered and developed by the European pharmaceutical company Servier Laboratories Ltd. Servier continue to develop the drug and conduct phase III trials in the European Union. In 2005 Servier submitted Agomelatine to the European Medicines Agency (EMEA). On 27 July 2006 the Committee for Medical Products for Human Use (CHMP) of the EMEA recommended a refusal of the marketing authorisation of Valdoxan/Thymanax. The major concern was that efficacy had not been sufficiently shown. In 2006 Servier sold the rights to develop Agomelatine in the US to Novartis.    The development for the US market was discontinued in October 2011. It is currently sold in Australia under the Valdoxan trade name.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4478</field>
		<field name="drug_name">Apixaban</field>
		<field name="description">Apixaban is an oral, direct, and highly selective factor Xa (FXa) inhibitor (of both free and prothrombinase-bound FXa independently of antithrombin III) for the prevention and treatment of thromboembolic diseases. It is marketed under the name Eliquis. FDA approved on December 28, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4479</field>
		<field name="drug_name">Bosutinib</field>
		<field name="description">Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Compared to other tyrosine kinase inhibitors, it has a more favourable hematologic toxicity profile. FDA approved on September 4, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4480</field>
		<field name="drug_name">Axitinib</field>
		<field name="description">Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3. Axitinib is marketed under the name Inlyta®, and if one previous systemic therapy for kidney cell cancer has failed, axitinib is indicated.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4481</field>
		<field name="drug_name">Dalfampridine</field>
		<field name="description">Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4482</field>
		<field name="drug_name">Denosumab</field>
		<field name="description">Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption markers in patients with a variety of metastatic tumors and is being investigated in multiple clinical trials for the prevention and treatment of bone metastases. Chemically, it consists of 2 heavy and 2 light chains. Each light chain consists of 215 amino acids. Each heavy chain consists of 448 amino acids with 4 intramolecular disulfides. FDA approved on June 1, 2010.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4483</field>
		<field name="drug_name">Liraglutide</field>
		<field name="description">Victoza contains liraglutide, an analog of human GLP-1 and acts as a GLP-1 receptor agonist. The peptide precursor of liraglutide, produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae, has been engineered to be 97% homologous to native human GLP-1 by substituting arginine for lysine at position 34. Liraglutide is made by attaching a C-16 fatty acid (palmitic acid) with a glutamic acid spacer on the remaining lysine residue at position 26 of the peptide precursor.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4484</field>
		<field name="drug_name">Pasireotide</field>
		<field name="description">Pasireotide is a synthetic long-acting cyclic hexapeptide with somatostatin-like activity. It is marketed as a diaspartate salt called Signifor®, which is used in the treatment of Cushing's disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4485</field>
		<field name="drug_name">golimumab</field>
		<field name="description">Golimumab is a human IgG1? monoclonal antibody derived from immunizing genetically engineered mice with human TNF?. Golimumab binds and inhibits soluble and transmembrane human TNF?. Increased TNF? is associated with chronic inflammation. Thus golimumab is indicated for use in adults (i) as an adjunct to methotrexate treatment in patients with moderate to severe active rheumatoid arthritis (RA), (ii) alone or as an adjunct to methotrexate treatment in patients with active psoriatic arthritis (PsA), (iii) as a single agent in patients with active ankylosing spondylitis (AS), and (iv) as a single agent in patients with moderate to severe ulcerative colitis (UC) who require chronic steroids or have experienced intolerance or only a partial response to previous medications. In the U.S. and Canada, golimumab is marketed under the brand name Simponi®. The FDA label includes a black box warning of serious infections and malignancy. Additionally in children and adolescents taking golimumab, th...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4486</field>
		<field name="drug_name">Belatacept</field>
		<field name="description">Belatacept is a recombinant fusion protein composed of the Fc fragment of a human IgG1 immunoglobulin linked to the extracellular domain of CTLA-4, which is a molecule crucial for T-cell costimulation. Belatacept selectively blocks the process of T-cell activation. It was developed by Bristol-Myers-Squibb. It differs from abatacept (Orencia) by only 2 amino acids. FDA approved on June 15, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4487</field>
		<field name="drug_name">Vilazodone</field>
		<field name="description">Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine (5-HT) transporter and 5-HT(1A) receptors. It has been shown to be equally efficacious as other antidepressants with similar gastrointestinal side effects and possibly with reduced sexual side effects and weight gain. Vilazodone is an antidepressant agent that can used as an alternative for patients who cannot tolerate therapy with other antidepressant classes such as selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors. Treatment should be titrated towards the target dose, which is 40mg per day.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4488</field>
		<field name="drug_name">Ethanolamine Oleate</field>
		<field name="description">Ethanolamine Oleate is a mild sclerosing agent.  It is composed of ethanolamine, a basic substance, which when combined with oleic acid forms a clear, straw to pale yellow colored, deliquescent oleate.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4489</field>
		<field name="drug_name">Mepyramine</field>
		<field name="description">Mepyramine (also known as pyrilamine) is a first generation antihistamine, targeting the H1 receptor. However, it rapidly permeates the brain and so often causes drowsiness as a side effect.  It is used in over-the-counter combination products for colds and menstrual symptoms.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4490</field>
		<field name="drug_name">Aprotinin</field>
		<field name="description">Aprotinin, also known as bovine pancreatic trypsin inhibitor, BPTI (Trasylol, Bayer) is a protein, that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss. The drug was temporarily withdrawn worldwide in 2007 after studies suggested that its use increased the risk of complications or death; after this was confirmed by follow-up studies, Trasylol was entirely and permanently withdrawn in May 2008, except - at least for the time being - for very restricted research use. [Wikipedia]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4491</field>
		<field name="drug_name">Mevastatin</field>
		<field name="description">Mevastatin or compactin is a cholesterol-lowering agent isolated from &lt;i&gt;Penicillium citinium&lt;/i&gt;. It was the first discovered agent belonging to the class of cholesterol-lowering medications known as statins. During a search for antibiotic compounds produced by fungi in 1971, Akira Endo at Sankyo Co. (Japan) discovered a class of compounds that appeared to lower plasma cholesterol levels. Two years later, the research group isolated a compound structurally similar to hydroxymethylglutarate (HMG) that inhibited the incorporation of acetate. The compound was proposed to bind to the reductase enzyme and was named compactin. Mevastatin is a competitive inhibitor of HMG-Coenzyme A (HMG-CoA) reductase with a binding affinity 10,000 times greater than the HMG-CoA substrate itself. Mevastatin is a pro-drug that is activated by &lt;i&gt;in vivo&lt;/i&gt; hydrolysis of the lactone ring. It has served as one of the lead compounds for the development of the synthetic compounds used today.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4492</field>
		<field name="drug_name">Xylometazoline</field>
		<field name="description">A nasal vasoconstricting decongestant drug which acts by binding to the same receptors as adrenaline. It is applied as a spray or as drops into the nose to ease inflammation and congestion of the nasal passageways. It binds alpha-adrenergic receptors to activate the adrenal system which causes systemic vasoconstriction, thereby easing nasal congestion.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4493</field>
		<field name="drug_name">Dabigatran etexilate</field>
		<field name="description">Dabigatran etexilate is an oral prodrug that is metabolized by a serum esterase to dabigatran. It is a synthetic, competitive and reversible direct thrombin inhibitor. Inhibition of thrombin disrupts the coagulation cascade and inhibits the formation of clots. Dabigatran etexilate may be used to decrease the risk of venous thromboembolic events in patients who have undergone total hip or knee replacement surgery, or to prevent stroke and systemic embolism in patients with atrial fibrillation, in whom anticoagulation therapy is indicated. In contrast to warfarin, because its anticoagulant effects are predictable, lab monitoring is not necessary. FDA approved on October 19, 2010.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4494</field>
		<field name="drug_name">Betahistine</field>
		<field name="description">Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière's disease. It is also commonly used for patients with balance disorders.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4495</field>
		<field name="drug_name">Degarelix</field>
		<field name="description">Degarelix is used for the treatment of advanced prostate cancer. Degarelix is a synthetic peptide derivative drug which binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocks interaction with GnRH. This antagonism reduces luteinising hormone (LH) and follicle-stimulating hormone (FSH) which ultimately causes testosterone suppression. Reduction in testosterone is important in treating men with advanced prostate cancer. Chemically, it is a synthetic linear decapeptide amide with seven unnatural amino acids, five of which are D-amino acids. FDA approved on December 24, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4496</field>
		<field name="drug_name">Desvenlafaxine</field>
		<field name="description">Desvenlafaxine (O-desmethylvenlafaxine) the major active metabolite of venlafaxine, is an antidepressant from the serotonin-norepinephrine reuptake inhibitor (SNRI class). Desvenlafaxine may be used to treat major depressive disorder and is being studied for use in the management of vasomotor symptoms in postmenopausal women. It is formulated as an extended release tablet. FDA approved in 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4497</field>
		<field name="drug_name">Dexmethylphenidate</field>
		<field name="description">Dexmethylphenidate is the dextrorotary form of methylphenidate. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4498</field>
		<field name="drug_name">Fesoterodine</field>
		<field name="description">Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4499</field>
		<field name="drug_name">Gadobutrol</field>
		<field name="description">Intravenous gadobutrol is a second-generation extracellular non-ionic macrocyclic GBCA (gadolinium-based contrast agent) used in magnetic resonance imaging (MRI) in adults and children older than 2 years of age. It may help visualize and detect vascular abnormalities in the blood brain barrier (BBB) and central nervous system (CNS).     In patients with impaired renal function, gadolinium based contrast agents increase the risk of nephrogenic systemic fibrosis (NSF). A physician should be contacted if symptoms of NSF are encountered, such as burning, itching, swelling, scaling, hardening and tightening of skin; dark or red patches on the skin; stiffness in joints or trouble moving, bending or straightening arms, hands, legs or feet; pain in hip bones or ribs; or muscle weakness.     Common adverse reactions that may be experienced are warmth, burning or pain local to the injection site, headache, nausea, abnormal taste and feeling hot.     General precautions should be taken in patient...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4500</field>
		<field name="drug_name">Iobenguane</field>
		<field name="description">Synthetic guanethidine derivative that locates phaeochromocytomas and neuroblastomas. The radioisotope used can either be iodine-123 for imaging or iodine-131 for destruction of tissues that metabolize noradrenaline. Iodine 123 is a cyclotron-produced radionuclide that decays to Te 123 by electron capture. Images are produced by a I123 MIBG scintigraphy. FDA approved on September 19, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4501</field>
		<field name="drug_name">Gadofosveset trisodium</field>
		<field name="description">Gadofosveset trisodium is an intravenous contrast agent used with magnetic resonance angiography(MRA), which is a non-invasive way of imaging blood vessels. The agent allows for the vascular system to be imaged more clearly by the MRA. In this way, gadofosveset trisodium is used to help diagnose certain disorders of the heart and blood vessels.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4502</field>
		<field name="drug_name">Isometheptene</field>
		<field name="description">Isometheptene is a sympathomimetic drug which causes vasoconstriction. It is used for treating migraines and tension headaches.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4503</field>
		<field name="drug_name">Levonordefrin</field>
		<field name="description">Levonordefrin acts as a topical nasal decongestant and vasoconstrictor, most often used in dentistry.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4504</field>
		<field name="drug_name">Methacholine</field>
		<field name="description">Methacholine acts as a non-selective muscarinic receptor agonist to stimulate the parasympathetic nervous system. It is most commonly used for diagnosing bronchial hyperreactivity, using the bronchial challenge test. Through this test, the drug causes bronchoconstriction and people with pre-existing airway hyperreactivity, such as asthmatics, will react to lower doses of drug.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4505</field>
		<field name="drug_name">Methyltestosterone</field>
		<field name="description">A synthetic anabolic steroid used for treating men with testosterone deficiency or similar androgen replacement therapies. Also, has antineoplastic properties and so has been used secondarily in women with advanced breast cancer. Methyltestosterone is a schedule III drug in the US.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4506</field>
		<field name="drug_name">Naphazoline</field>
		<field name="description">Naphazoline is a rapid acting sympathomimetic vasoconstrictor of occular artierioles. It acts to decrease congestion of the conjunctiva and is found in many over-the-counter eye drops.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4507</field>
		<field name="drug_name">Nilvadipine</field>
		<field name="description">Nilvadipine is a calcium channel blocker (CCB) for treatment of hypertension.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4508</field>
		<field name="drug_name">Norelgestromin</field>
		<field name="description">Norelgestromin is a drug used in contraception. Norelgestromin is the active progestin responsible for the progestational activity that occurs in women after application of ORTHO EVRA patch.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4509</field>
		<field name="drug_name">Propylhexedrine</field>
		<field name="description">Propylhexedrine is an alpha-adrenergic agonist often used in nasal decongestant inhalers. It is used to give temporary relief for nasal congestion from colds, allergic rhinitis, or allergies.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4510</field>
		<field name="drug_name">Potassium Iodide</field>
		<field name="description">Saturated solution of Potassium Iodide (SSKI) is used pharmaceutically for emergency use in patients experiencing acute symptoms of severe hyperglycemia (also known as thyroid storm or thyrotoxic crisis). SSKI can also be used for radioiodine-contamination emergencies or in preparation of thyrotoxic patients for thyroidectomy.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4511</field>
		<field name="drug_name">Fospropofol</field>
		<field name="description">Fospropofol is a water soluble prodrug and is converted to propofol in the liver. Fospropofol is a short acting hypnotic/sedative/anesthetic agent. Unlike propofol, does not cause injection-site pain as it is unable to activate TRPA1. FDA approved in December 2008.  Fospropofol is classified as a Schedule IV controlled substance in the United States' Controlled Substances Act.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4512</field>
		<field name="drug_name">Fosaprepitant</field>
		<field name="description">Fosaprepitant is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4513</field>
		<field name="drug_name">Stanozolol</field>
		<field name="description">Stanozolol is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Stanozolol is derived from testosterone, and has been abused by several high profile professional athletes.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4514</field>
		<field name="drug_name">Buserelin</field>
		<field name="description">Buserelin is a luteinizing hormone-releasing hormone (LHRH) agonist, a synthetic hormone which stimulates the pituitary gland's gonadotrophin-releasing hormone receptor (GnRHR). It is used in prostate cancer treatment.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4515</field>
		<field name="drug_name">Velaglucerase alfa</field>
		<field name="description">Velaglucerase alfa is a gene-activated human recombinant glucocerebrosidase used for the treatment of Type 1 Gaucher disease, caused by a deficiency of the lysosomal enzyme glucocerebrosidase. Additionally, Velaglucerase alfa has also been investigated for use in Type 3 Gaucher disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4516</field>
		<field name="drug_name">Aluminum hydroxide</field>
		<field name="description">Aluminum hydroxide is an inorganic salt used as an antacid. It is a basic compound that acts by neutralizing hydrochloric acid in gastric secretions. Subsequent increases in pH may inhibit the action of pepsin. An increase in bicarbonate ions and prostaglandins may also confer cytoprotective effects.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4517</field>
		<field name="drug_name">Calcium carbonate</field>
		<field name="description">Calcium carbonate is an inorganic salt used as an antacid. It is a basic compound that acts by neutralizing hydrochloric acid in gastric secretions. Subsequent increases in pH may inhibit the action of pepsin. An increase in bicarbonate ions and prostaglandins may also confer cytoprotective effects. Calcium carbonate may also be used as a nutritional supplement or to treat hypocalcemia.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4518</field>
		<field name="drug_name">Lornoxicam</field>
		<field name="description">Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug. Lornoxicam is approved for use in Japan.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4519</field>
		<field name="drug_name">Bufuralol</field>
		<field name="description">Bufuralol is a new, non-selective -adrenoceptor blocking agent.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4520</field>
		<field name="drug_name">Sparteine</field>
		<field name="description">Sparteine is a class 1a antiarrhythmic agent; a sodium channel blocker. It is an alkaloid and can be extracted from scotch broom. It is the predominant alkaloid in Lupinus mutabilis, and is thought to chelate the bivalents calcium and magnesium. It is not FDA approved for human use as an antiarrhythmic agent, and it is not included in the Vaughn Williams classification of antiarrhythmic drugs.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4521</field>
		<field name="drug_name">Aniline</field>
		<field name="description">Aniline, phenylamine or aminobenzene is an organic compound with the formula C6H5NH2. Consisting of a phenyl group attached to an amino group, aniline is the prototypical aromatic amine. Being a precursor to many industrial chemicals, its main use is in the manufacture of precursors to polyurethane. Like most volatile amines, it possesses the somewhat unpleasant odour of rotten fish. It ignites readily, burning with a smoky flame characteristic of aromatic compounds. Aniline is colorless, but it slowly oxidizes and resinifies in air, giving a red-brown tint to aged samples.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4522</field>
		<field name="drug_name">Gestodene</field>
		<field name="description">Gestodene is a progestogen hormonal contraceptive. Products containing gestoden include Meliane, which contains 20 mcg of ethinylestradiol and 75 mcg of gestodene; and Gynera, which contains 30 mcg of ethinylestradiol and 75 mcg of gestodene.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4523</field>
		<field name="drug_name">Seproxetine</field>
		<field name="description">Seproxetine, also known as (S)-norfluoxetine, is a selective serotonin reuptake inhibitor (SSRI). It is an active metabolite of fluoxetine. Seproxetine was being investigated by Eli Lilly as an antidepressant but development was never completed and the drug was never marketed.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4524</field>
		<field name="drug_name">beta-Naphthoflavone</field>
		<field name="description">beta-Naphthoflavone, also known as 5,6-benzoflavone, is a potent agonist of the aryl hydrocarbon receptor and as such is an inducer of such detoxification enzymes as cytochromes P450 (CYPs) and uridine 5'-diphospho-glucuronosyltransferases (UGTs). ?-Naphthoflavone is a putative chemopreventive agent.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4525</field>
		<field name="drug_name">Bafilomycin A1</field>
		<field name="description">The bafilomycins are a family of toxic macrolide antibiotic derived from Streptomyces griseus. These compounds all appear in the same fermentation and have quite similar biological activity. Bafilomycins are specific inhibitors of vacuolar-type H+-ATPase. (V-ATPase). The most used bafilomycin is bafilomycin A1. This is a useful tool as it can prevent the re-acidification of synaptic vesicles once they have undergone exocytosis. [Wikipedia]</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4526</field>
		<field name="drug_name">Bafilomycin B1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4527</field>
		<field name="drug_name">ginkgolide-A</field>
		<field name="description">A highly active PAF antagonist cage molecule that is isolated from the leaves of the Ginkgo biloba tree. Shows potential in a wide variety of inflammatory and immunological disorders.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4528</field>
		<field name="drug_name">ginkgolide-B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4529</field>
		<field name="drug_name">ginkgolide-C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4530</field>
		<field name="drug_name">ginkgolide-J</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4531</field>
		<field name="drug_name">ginkgolide-M</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4532</field>
		<field name="drug_name">ginsenoside C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4533</field>
		<field name="drug_name">ginsenoside Rb1</field>
		<field name="description">Ginsenosides are a class of steroid glycosides, and triterpene saponins, found exclusively in the plant genus Panax (ginseng). Ginsenosides have been the target of research, as they are viewed as the active compounds behind the claims of ginseng's efficacy. Because ginsenosides appear to affect multiple pathways, their effects are complex and difficult to isolate. Rb1 appears to be most abundant in Panax quinquefolius (American Ginseng). Rb1 seems to affect the reproductive system in animal testicles. Recent research shows that Rb1 affects rat embryo development and has teratogenic effects, causing birth defects. Another study shows that Rb1 may increase testosterone production in male rats indirectly through the stimulation of the luteinizing hormone. Traditional Chinese medicine asserts that Panax quinquefolius promotes yin in the body. It also inhibits chemoinvasion and angiogenesis.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4534</field>
		<field name="drug_name">Ginsenoside Rg1</field>
		<field name="description">Ginsenosides are a class of steroid glycosides, and triterpene saponins, found exclusively in the plant genus Panax (ginseng). Ginsenosides have been the target of research, as they are viewed as the active compounds behind the claims of ginseng's efficacy. Because ginsenosides appear to affect multiple pathways, their effects are complex and difficult to isolate. Rg1 Appears to be most abundant in Panax ginseng (Chinese/Korean Ginseng). It improves spatial learning and increase hippocampal synaptophysin level in mice, plus demonstrates estrogen-like activity.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4535</field>
		<field name="drug_name">Drotaverine</field>
		<field name="description">Drotaverine (INN, also known as drotaverin) is an antispasmodic drug, structurally related to papaverine. Drotaverine is a selective inhibitor of phosphodiesterase 4, and has no anticholinergic effects. Drotaverine has been shown to possess dose-dependant analgesic effects in animal models. One small study has shown drotaverine to be eliminated mainly non-renally.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4536</field>
		<field name="drug_name">Alcaftadine</field>
		<field name="description">Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4537</field>
		<field name="drug_name">Ammonium lactate</field>
		<field name="description">Ammonium lactate is the ammonium salt of lactic acid.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4538</field>
		<field name="drug_name">Cabazitaxel</field>
		<field name="description">Cabazitaxel is an anti-neoplastic used with the steroid medicine prednisone. Cabazitaxel is used to treat people with prostate cancer that has progressed despite treatment with docetaxel. Cabazitaxel is prepared by semi-synthesis with a precursor extracted from yew needles (10-deacetylbaccatin III). It was approved by the U.S. Food and Drug Administration (FDA) on June 17, 2010.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4539</field>
		<field name="drug_name">Carglumic Acid</field>
		<field name="description">Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood–brain barrier and cause neurologic problems, cerebral edema, coma, and death. Carglumic acid was approved by the U.S. Food and Drug Administration (FDA) on 18 March 2010.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4540</field>
		<field name="drug_name">Chenodeoxycholic acid</field>
		<field name="description">Chenodeoxycholic acid (or Chenodiol) is an epimer of ursodeoxycholic acid (DB01586). Chenodeoxycholic acid is a bile acid naturally found in the body. It works by dissolving the cholesterol that makes gallstones and inhibiting production of cholesterol in the liver and absorption in the intestines, which helps to decrease the formation of gallstones. It can also reduce the amount of other bile acids that can be harmful to liver cells when levels are elevated.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4541</field>
		<field name="drug_name">Dalteparin</field>
		<field name="description">Dalteparin, a low molecular weight heparin (LMWH) prepared by nitrous acid degradation of unfractionated heparin of porcine intestinal mucosa origin, is an anticoagulant. It is composed of strongly acidic sulphated polysaccharide chains with an average molecular weight of 5000 and about 90% of the material within the range of 2000-9000. LMWHs have a more predictable response, a greater bioavailability, and a longer anti-Xa half life than unfractionated heparin. Dalteparin can also be safely used in most pregnant women. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4542</field>
		<field name="drug_name">Difluprednate</field>
		<field name="description">Difluprednate is a topical corticosteroid indicated for the treatment of infammation and pain associated with ocular surgery. It is a butyrate ester of 6(?), 9(?)-difluoro prednisolone acetate. Difluprednate is abbreviated DFBA, or difluoroprednisolone butyrate acetate. It is indicated for treatment of endogenous anterior uveiti.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4543</field>
		<field name="drug_name">Dimercaprol</field>
		<field name="description">Dimercaprol is a traditional chelating agent developed by British biochemists at Oxford University during World War II. It was developed as an experimental antidote against the arsenic-based poison gas Lewisite. It has been used clinically since 1949 in arsenic, cadmium and mercury poisoning. In addition, it has in the past been used for the treatment of Wilson's disease, a genetic disorder in which the body tends to retain copper. Dimercaprol is a potentially toxic drug, and its use may be accompanied by multiple side effects.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4544</field>
		<field name="drug_name">Methylnaltrexone</field>
		<field name="description">Methylnaltrexone is a pheriphally-acting ?-opioid antagonists that acts on the gastrointestinal tract to decrease opioid-induced constipation without producing analgesic effects or withdrawal symptoms. It is also a weak CYP2D6 inhibitor. FDA approved in 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4545</field>
		<field name="drug_name">Nepafenac</field>
		<field name="description">Nepafenac is a non-steroidal anti-inflammatory prodrug (NSAID) usually sold as a prescription eye drop. It is used to treat pain and inflammation associated with cataract surgery.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4546</field>
		<field name="drug_name">Nonoxynol-9</field>
		<field name="description">Nonoxynol-9 (N-9) is a typical surfactant used as a vaginal spermicide. Spermicides are locally acting non-hormonal contraceptives. When present in the vagina during intercourse, they immobilize/inactivate/damage and/or kill sperms without eliciting systemic effects. N-9 has been in use for more than 30 years as an over-the-counter (OTC) drug in creams, gels, foams and condom lubricants. It is the most commonly used spermicidal contraceptive in the UK and the USA. In several European countries, spermicides are no longer on the market.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4547</field>
		<field name="drug_name">Plerixafor</field>
		<field name="description">Plerixafor is a hematopoietic stem cell mobilizer. It is used to stimulate the release of stem cells from the bone marrow into the blood in patients with non-Hodgkin lymphoma and multiple myeloma for the purpose of stimulating the immune system. These stem cells are then collected and used in autologous stem cell transplantation to replace blood-forming cells that were destroyed by chemotherapy. Plerixafor has orphan drug status in the United States and European Union; it was approved by the U.S. Food and Drug Administration on December 15, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4548</field>
		<field name="drug_name">Plicamycin</field>
		<field name="description">Plicamycin is an antineoplastic antibiotic produced by Streptomyces plicatus. It has been used in the treatment of testicular cancer, Paget's disease of bone, and, rarely, the management of hypercalcemia. The manufacturer discontinued plicamycin in 2000.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4549</field>
		<field name="drug_name">Polidocanol</field>
		<field name="description">Polidocanol is a sclerosing agent indicated to treat uncomplicated spider veins (varicose veins ?1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4550</field>
		<field name="drug_name">Pralatrexate</field>
		<field name="description">Pralatrexate is an antimetabolite for the treatment of relapsed or refractory peripheral T-cell lymphoma. It is more efficiently retained in cancer cells than methotrexate. FDA approved on September 24, 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4551</field>
		<field name="drug_name">Tinzaparin</field>
		<field name="description">Tinzaparin is a low molecular weight heparin (LMWH), produced by enzymatic depolymerization of unfractionated heparin from porcine intestinal mucosa. It is a heterogeneous mixture of with an average molecular weight between 5500 and 7500 daltons. Tinzaparin is composed of molecules with and without a special site for high affinity binding to antithrombin III (ATIII). This complex greatly accelerates the inhibition of factor Xa. It is an anticoagulant and considered an antithrombotic. Tinzaparin must be given either subcutaneously or parenterally. LMWHs are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">4552</field>
		<field name="drug_name">5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4553</field>
		<field name="drug_name">4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4554</field>
		<field name="drug_name">(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4555</field>
		<field name="drug_name">2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4556</field>
		<field name="drug_name">2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4557</field>
		<field name="drug_name">1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4558</field>
		<field name="drug_name">N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4559</field>
		<field name="drug_name">(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4560</field>
		<field name="drug_name">N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4561</field>
		<field name="drug_name">(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4562</field>
		<field name="drug_name">methyl L-phenylalaninate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4563</field>
		<field name="drug_name">N-(ethoxycarbonyl)-L-leucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4564</field>
		<field name="drug_name">diethyl [(1R)-1,5-diaminopentyl]boronate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4565</field>
		<field name="drug_name">D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4566</field>
		<field name="drug_name">(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4567</field>
		<field name="drug_name">2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4568</field>
		<field name="drug_name">4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4569</field>
		<field name="drug_name">(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4570</field>
		<field name="drug_name">7-[3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOL-2-YL]-3,5-DIHYDROXY-HEPTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4571</field>
		<field name="drug_name">5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4572</field>
		<field name="drug_name">1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4573</field>
		<field name="drug_name">1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4574</field>
		<field name="drug_name">(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4575</field>
		<field name="drug_name">N-(pyridin-3-ylmethyl)aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4576</field>
		<field name="drug_name">4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4577</field>
		<field name="drug_name">N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4578</field>
		<field name="drug_name">2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4579</field>
		<field name="drug_name">6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4580</field>
		<field name="drug_name">6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4581</field>
		<field name="drug_name">N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4582</field>
		<field name="drug_name">N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4583</field>
		<field name="drug_name">N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4584</field>
		<field name="drug_name">2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4585</field>
		<field name="drug_name">6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4586</field>
		<field name="drug_name">2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4587</field>
		<field name="drug_name">2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4588</field>
		<field name="drug_name">6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4589</field>
		<field name="drug_name">6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4590</field>
		<field name="drug_name">3,6,9,12,15,18-HEXAOXAICOSANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4591</field>
		<field name="drug_name">N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4592</field>
		<field name="drug_name">1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4593</field>
		<field name="drug_name">17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4594</field>
		<field name="drug_name">17-METHYL-17-ALPHA-DIHYDROEQUILENIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4595</field>
		<field name="drug_name">1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4596</field>
		<field name="drug_name">1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4597</field>
		<field name="drug_name">(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4598</field>
		<field name="drug_name">3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4599</field>
		<field name="drug_name">N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4600</field>
		<field name="drug_name">N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4601</field>
		<field name="drug_name">1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4602</field>
		<field name="drug_name">5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4603</field>
		<field name="drug_name">(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4604</field>
		<field name="drug_name">(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4605</field>
		<field name="drug_name">1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4606</field>
		<field name="drug_name">1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4607</field>
		<field name="drug_name">4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4608</field>
		<field name="drug_name">3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4609</field>
		<field name="drug_name">N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4610</field>
		<field name="drug_name">3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4611</field>
		<field name="drug_name">(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4612</field>
		<field name="drug_name">3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4613</field>
		<field name="drug_name">(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4614</field>
		<field name="drug_name">5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4615</field>
		<field name="drug_name">(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4616</field>
		<field name="drug_name">1-DECANE-SULFONIC-ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4617</field>
		<field name="drug_name">1-DODECANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4618</field>
		<field name="drug_name">1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4619</field>
		<field name="drug_name">3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4620</field>
		<field name="drug_name">4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4621</field>
		<field name="drug_name">N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4622</field>
		<field name="drug_name">1-[4-(hydroxymethyl)phenyl]guanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4623</field>
		<field name="drug_name">2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4624</field>
		<field name="drug_name">4-(1-methyl-1-phenylethyl)phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4625</field>
		<field name="drug_name">(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopentapentalene-4-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4626</field>
		<field name="drug_name">(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4627</field>
		<field name="drug_name">(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4628</field>
		<field name="drug_name">2-AMINO-4-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4629</field>
		<field name="drug_name">2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4630</field>
		<field name="drug_name">(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4631</field>
		<field name="drug_name">1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4632</field>
		<field name="drug_name">[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4633</field>
		<field name="drug_name">D-leucyl-N-(3-chlorobenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4634</field>
		<field name="drug_name">UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4635</field>
		<field name="drug_name">(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4636</field>
		<field name="drug_name">1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4637</field>
		<field name="drug_name">naphthalene-1,2,4,5,7-pentol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4638</field>
		<field name="drug_name">N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4639</field>
		<field name="drug_name">(4-fluorophenyl)(pyridin-4-yl)methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4640</field>
		<field name="drug_name">2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4641</field>
		<field name="drug_name">D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4642</field>
		<field name="drug_name">(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4643</field>
		<field name="drug_name">(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4644</field>
		<field name="drug_name">2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4645</field>
		<field name="drug_name">2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4646</field>
		<field name="drug_name">(2R)-2-benzyl-3-nitropropanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4647</field>
		<field name="drug_name">3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4648</field>
		<field name="drug_name">(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4649</field>
		<field name="drug_name">[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4650</field>
		<field name="drug_name">(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4651</field>
		<field name="drug_name">1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4652</field>
		<field name="drug_name">N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4653</field>
		<field name="drug_name">(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4654</field>
		<field name="drug_name">10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4655</field>
		<field name="drug_name">N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4656</field>
		<field name="drug_name">(1R)-3-chloro-1-phenylpropan-1-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4657</field>
		<field name="drug_name">2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4658</field>
		<field name="drug_name">N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4659</field>
		<field name="drug_name">4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4660</field>
		<field name="drug_name">4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4661</field>
		<field name="drug_name">N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4662</field>
		<field name="drug_name">N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4663</field>
		<field name="drug_name">(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4664</field>
		<field name="drug_name">N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4665</field>
		<field name="drug_name">(3S)-1-{[4-(BUT-2-YN-1-YLOXY)PHENYL]SULFONYL}PYRROLIDINE-3-THIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4666</field>
		<field name="drug_name">N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4667</field>
		<field name="drug_name">N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4668</field>
		<field name="drug_name">(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4669</field>
		<field name="drug_name">1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4670</field>
		<field name="drug_name">2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4671</field>
		<field name="drug_name">N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4672</field>
		<field name="drug_name">4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4673</field>
		<field name="drug_name">(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4674</field>
		<field name="drug_name">(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4675</field>
		<field name="drug_name">2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4676</field>
		<field name="drug_name">2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4677</field>
		<field name="drug_name">3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4678</field>
		<field name="drug_name">N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4679</field>
		<field name="drug_name">4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4680</field>
		<field name="drug_name">5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4681</field>
		<field name="drug_name">(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4682</field>
		<field name="drug_name">N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4683</field>
		<field name="drug_name">5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4684</field>
		<field name="drug_name">(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4685</field>
		<field name="drug_name">3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4686</field>
		<field name="drug_name">5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4687</field>
		<field name="drug_name">HEXYLPHOSPHONIC ACID (R)-2-METHYL-3-PHENYLPROPYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4688</field>
		<field name="drug_name">HEXYLPHOSPHONIC ACID (S)-2-METHYL-3-PHENYLPROPYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4689</field>
		<field name="drug_name">6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4690</field>
		<field name="drug_name">1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4691</field>
		<field name="drug_name">2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4692</field>
		<field name="drug_name">2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4693</field>
		<field name="drug_name">N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4694</field>
		<field name="drug_name">7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4695</field>
		<field name="drug_name">4,4'-PROPANE-2,2-DIYLDIPHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4696</field>
		<field name="drug_name">5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4697</field>
		<field name="drug_name">1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4698</field>
		<field name="drug_name">(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4699</field>
		<field name="drug_name">N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4700</field>
		<field name="drug_name">5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4701</field>
		<field name="drug_name">(2S)-2-(1H-indol-3-yl)hexanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4702</field>
		<field name="drug_name">(2S)-2-(1H-indol-3-yl)pentanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4703</field>
		<field name="drug_name">(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4704</field>
		<field name="drug_name">(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4705</field>
		<field name="drug_name">(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4706</field>
		<field name="drug_name">2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4707</field>
		<field name="drug_name">2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4708</field>
		<field name="drug_name">2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4709</field>
		<field name="drug_name">2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4710</field>
		<field name="drug_name">{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4711</field>
		<field name="drug_name">4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4712</field>
		<field name="drug_name">N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4713</field>
		<field name="drug_name">(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4714</field>
		<field name="drug_name">(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4715</field>
		<field name="drug_name">(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4716</field>
		<field name="drug_name">N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4717</field>
		<field name="drug_name">D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4718</field>
		<field name="drug_name">2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4719</field>
		<field name="drug_name">[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4720</field>
		<field name="drug_name">N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4721</field>
		<field name="drug_name">N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4722</field>
		<field name="drug_name">(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4723</field>
		<field name="drug_name">4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4724</field>
		<field name="drug_name">(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4725</field>
		<field name="drug_name">2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4726</field>
		<field name="drug_name">D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4727</field>
		<field name="drug_name">9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4728</field>
		<field name="drug_name">(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4729</field>
		<field name="drug_name">4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4730</field>
		<field name="drug_name">2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4731</field>
		<field name="drug_name">N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4732</field>
		<field name="drug_name">(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4733</field>
		<field name="drug_name">6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4734</field>
		<field name="drug_name">TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4735</field>
		<field name="drug_name">2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4736</field>
		<field name="drug_name">(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4737</field>
		<field name="drug_name">(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4738</field>
		<field name="drug_name">(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4739</field>
		<field name="drug_name">5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4740</field>
		<field name="drug_name">N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4741</field>
		<field name="drug_name">N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4742</field>
		<field name="drug_name">(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4743</field>
		<field name="drug_name">3-HYDROXYPROPYL 3-[({7-[AMINO(IMINO)METHYL]-1-NAPHTHYL}AMINO)CARBONYL]BENZENESULFONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4744</field>
		<field name="drug_name">(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4745</field>
		<field name="drug_name">2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4746</field>
		<field name="drug_name">3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4747</field>
		<field name="drug_name">(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4748</field>
		<field name="drug_name">D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4749</field>
		<field name="drug_name">(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4750</field>
		<field name="drug_name">4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4751</field>
		<field name="drug_name">(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4752</field>
		<field name="drug_name">R-3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4753</field>
		<field name="drug_name">2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4754</field>
		<field name="drug_name">5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4755</field>
		<field name="drug_name">2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4756</field>
		<field name="drug_name">(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4757</field>
		<field name="drug_name">(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopentachromen-8-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4758</field>
		<field name="drug_name">(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4759</field>
		<field name="drug_name">2-(cyclohexylamino)benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4760</field>
		<field name="drug_name">(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4761</field>
		<field name="drug_name">2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4762</field>
		<field name="drug_name">N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4763</field>
		<field name="drug_name">7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4764</field>
		<field name="drug_name">7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4765</field>
		<field name="drug_name">3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4766</field>
		<field name="drug_name">(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4767</field>
		<field name="drug_name">2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4768</field>
		<field name="drug_name">2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4769</field>
		<field name="drug_name">N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4770</field>
		<field name="drug_name">(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4771</field>
		<field name="drug_name">5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4772</field>
		<field name="drug_name">3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4773</field>
		<field name="drug_name">5'-S-ethyl-5'-thioadenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4774</field>
		<field name="drug_name">2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4775</field>
		<field name="drug_name">(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4776</field>
		<field name="drug_name">2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4777</field>
		<field name="drug_name">2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4778</field>
		<field name="drug_name">(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4779</field>
		<field name="drug_name">5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4780</field>
		<field name="drug_name">N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4781</field>
		<field name="drug_name">3-(INDOL-3-YL) LACTATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4782</field>
		<field name="drug_name">1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4783</field>
		<field name="drug_name">N-{3-[4-hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4784</field>
		<field name="drug_name">{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4785</field>
		<field name="drug_name">(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4786</field>
		<field name="drug_name">5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4787</field>
		<field name="drug_name">2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4788</field>
		<field name="drug_name">(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4789</field>
		<field name="drug_name">(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4790</field>
		<field name="drug_name">3-Hydroxyhippuric acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4791</field>
		<field name="drug_name">(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4792</field>
		<field name="drug_name">(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4793</field>
		<field name="drug_name">(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4794</field>
		<field name="drug_name">5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4795</field>
		<field name="drug_name">6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4796</field>
		<field name="drug_name">3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4797</field>
		<field name="drug_name">6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4798</field>
		<field name="drug_name">(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4799</field>
		<field name="drug_name">(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4800</field>
		<field name="drug_name">3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4801</field>
		<field name="drug_name">N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4802</field>
		<field name="drug_name">(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4803</field>
		<field name="drug_name">1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4804</field>
		<field name="drug_name">beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4805</field>
		<field name="drug_name">N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4806</field>
		<field name="drug_name">2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4807</field>
		<field name="drug_name">4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4808</field>
		<field name="drug_name">4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4809</field>
		<field name="drug_name">(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4810</field>
		<field name="drug_name">N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4811</field>
		<field name="drug_name">(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4812</field>
		<field name="drug_name">(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4813</field>
		<field name="drug_name">(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4814</field>
		<field name="drug_name">{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4815</field>
		<field name="drug_name">1-(2,2'-bithiophen-5-yl)methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4816</field>
		<field name="drug_name">(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4817</field>
		<field name="drug_name">6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4818</field>
		<field name="drug_name">4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4819</field>
		<field name="drug_name">4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4820</field>
		<field name="drug_name">N-[4-(benzyloxy)phenyl]glycinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4821</field>
		<field name="drug_name">4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4822</field>
		<field name="drug_name">N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4823</field>
		<field name="drug_name">(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4824</field>
		<field name="drug_name">2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4825</field>
		<field name="drug_name">4-amino-N-[4-(benzyloxy)phenyl]butanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4826</field>
		<field name="drug_name">2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4827</field>
		<field name="drug_name">4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4828</field>
		<field name="drug_name">(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4829</field>
		<field name="drug_name">4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4830</field>
		<field name="drug_name">(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4831</field>
		<field name="drug_name">4-(4-FLUOROBENZYL)PIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4832</field>
		<field name="drug_name">(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4833</field>
		<field name="drug_name">N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4834</field>
		<field name="drug_name">(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4835</field>
		<field name="drug_name">4-[(METHYLSULFONYL)AMINO]BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4836</field>
		<field name="drug_name">N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4837</field>
		<field name="drug_name">1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4838</field>
		<field name="drug_name">5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4839</field>
		<field name="drug_name">7-hydroxy-4-methyl-2H-chromen-2-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4840</field>
		<field name="drug_name">1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4841</field>
		<field name="drug_name">N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4842</field>
		<field name="drug_name">4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4843</field>
		<field name="drug_name">1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4844</field>
		<field name="drug_name">N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4845</field>
		<field name="drug_name">(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4846</field>
		<field name="drug_name">4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4847</field>
		<field name="drug_name">O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4848</field>
		<field name="drug_name">{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4849</field>
		<field name="drug_name">N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4850</field>
		<field name="drug_name">(2R)-1-(2,6-dimethylphenoxy)propan-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4851</field>
		<field name="drug_name">4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4852</field>
		<field name="drug_name">(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4853</field>
		<field name="drug_name">1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4854</field>
		<field name="drug_name">D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4855</field>
		<field name="drug_name">5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4856</field>
		<field name="drug_name">(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4857</field>
		<field name="drug_name">(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4858</field>
		<field name="drug_name">(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4859</field>
		<field name="drug_name">5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4860</field>
		<field name="drug_name">3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4861</field>
		<field name="drug_name">5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4862</field>
		<field name="drug_name">5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4863</field>
		<field name="drug_name">5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4864</field>
		<field name="drug_name">D-phenylalanyl-N-benzyl-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4865</field>
		<field name="drug_name">5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4866</field>
		<field name="drug_name">(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4867</field>
		<field name="drug_name">2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4868</field>
		<field name="drug_name">methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4869</field>
		<field name="drug_name">(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4870</field>
		<field name="drug_name">(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4871</field>
		<field name="drug_name">4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4872</field>
		<field name="drug_name">4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4873</field>
		<field name="drug_name">N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4874</field>
		<field name="drug_name">6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4875</field>
		<field name="drug_name">(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4876</field>
		<field name="drug_name">(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4877</field>
		<field name="drug_name">(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4878</field>
		<field name="drug_name">(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4879</field>
		<field name="drug_name">5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4880</field>
		<field name="drug_name">6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4881</field>
		<field name="drug_name">N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4882</field>
		<field name="drug_name">5-phenyl-1H-indazol-3-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4883</field>
		<field name="drug_name">4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4884</field>
		<field name="drug_name">5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4885</field>
		<field name="drug_name">N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4886</field>
		<field name="drug_name">N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4887</field>
		<field name="drug_name">5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4888</field>
		<field name="drug_name">[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4889</field>
		<field name="drug_name">5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4890</field>
		<field name="drug_name">5'-FLUORO-2',5'-DIDEOXYADENOSINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4891</field>
		<field name="drug_name">5-(2-hydroxyethyl)nonane-1,9-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4892</field>
		<field name="drug_name">(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4893</field>
		<field name="drug_name">7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4894</field>
		<field name="drug_name">6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4895</field>
		<field name="drug_name">N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4896</field>
		<field name="drug_name">5-aminonaphthalene-1-sulfonic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4897</field>
		<field name="drug_name">(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4898</field>
		<field name="drug_name">5-PENTYL-2-PHENOXYPHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4899</field>
		<field name="drug_name">3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4900</field>
		<field name="drug_name">5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4901</field>
		<field name="drug_name">4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4902</field>
		<field name="drug_name">(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4903</field>
		<field name="drug_name">N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4904</field>
		<field name="drug_name">6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4905</field>
		<field name="drug_name">2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4906</field>
		<field name="drug_name">4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4907</field>
		<field name="drug_name">6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4908</field>
		<field name="drug_name">(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4909</field>
		<field name="drug_name">(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4910</field>
		<field name="drug_name">3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4911</field>
		<field name="drug_name">4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4912</field>
		<field name="drug_name">(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4913</field>
		<field name="drug_name">(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4914</field>
		<field name="drug_name">2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4915</field>
		<field name="drug_name">4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4916</field>
		<field name="drug_name">N-methyl-1-(2-thiophen-2-ylphenyl)methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4917</field>
		<field name="drug_name">4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4918</field>
		<field name="drug_name">5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4919</field>
		<field name="drug_name">(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4920</field>
		<field name="drug_name">(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4921</field>
		<field name="drug_name">(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4922</field>
		<field name="drug_name">6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4923</field>
		<field name="drug_name">6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4924</field>
		<field name="drug_name">(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4925</field>
		<field name="drug_name">N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4926</field>
		<field name="drug_name">6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4927</field>
		<field name="drug_name">2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4928</field>
		<field name="drug_name">(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4929</field>
		<field name="drug_name">(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4930</field>
		<field name="drug_name">3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4931</field>
		<field name="drug_name">(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4932</field>
		<field name="drug_name">N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4933</field>
		<field name="drug_name">(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4934</field>
		<field name="drug_name">2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4935</field>
		<field name="drug_name">(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4936</field>
		<field name="drug_name">N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4937</field>
		<field name="drug_name">6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4938</field>
		<field name="drug_name">BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4939</field>
		<field name="drug_name">N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4940</field>
		<field name="drug_name">(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4941</field>
		<field name="drug_name">(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4942</field>
		<field name="drug_name">METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4943</field>
		<field name="drug_name">N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4944</field>
		<field name="drug_name">N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4945</field>
		<field name="drug_name">N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4946</field>
		<field name="drug_name">4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4947</field>
		<field name="drug_name">1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4948</field>
		<field name="drug_name">3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4949</field>
		<field name="drug_name">3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4950</field>
		<field name="drug_name">N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4951</field>
		<field name="drug_name">(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4952</field>
		<field name="drug_name">N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4953</field>
		<field name="drug_name">3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4954</field>
		<field name="drug_name">N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4955</field>
		<field name="drug_name">3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4956</field>
		<field name="drug_name">{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4957</field>
		<field name="drug_name">5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4958</field>
		<field name="drug_name">7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4959</field>
		<field name="drug_name">3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4960</field>
		<field name="drug_name">7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4961</field>
		<field name="drug_name">(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4962</field>
		<field name="drug_name">(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4963</field>
		<field name="drug_name">5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4964</field>
		<field name="drug_name">6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4965</field>
		<field name="drug_name">(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4966</field>
		<field name="drug_name">[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4967</field>
		<field name="drug_name">7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4968</field>
		<field name="drug_name">N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4969</field>
		<field name="drug_name">N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4970</field>
		<field name="drug_name">N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4971</field>
		<field name="drug_name">3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4972</field>
		<field name="drug_name">N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4973</field>
		<field name="drug_name">N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4974</field>
		<field name="drug_name">N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4975</field>
		<field name="drug_name">3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4976</field>
		<field name="drug_name">4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4977</field>
		<field name="drug_name">(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4978</field>
		<field name="drug_name">1-(4-thiophen-2-ylphenyl)methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4979</field>
		<field name="drug_name">N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4980</field>
		<field name="drug_name">THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4981</field>
		<field name="drug_name">1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4982</field>
		<field name="drug_name">[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4983</field>
		<field name="drug_name">(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4984</field>
		<field name="drug_name">3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4985</field>
		<field name="drug_name">8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4986</field>
		<field name="drug_name">2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4987</field>
		<field name="drug_name">2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4988</field>
		<field name="drug_name">(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4989</field>
		<field name="drug_name">N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4990</field>
		<field name="drug_name">(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4991</field>
		<field name="drug_name">N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4992</field>
		<field name="drug_name">1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4993</field>
		<field name="drug_name">N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4994</field>
		<field name="drug_name">3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4995</field>
		<field name="drug_name">5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4996</field>
		<field name="drug_name">2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4997</field>
		<field name="drug_name">2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4998</field>
		<field name="drug_name">N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">4999</field>
		<field name="drug_name">5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5000</field>
		<field name="drug_name">N~3~-BENZYLPYRIDINE-2,3-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5001</field>
		<field name="drug_name">3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5002</field>
		<field name="drug_name">9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5003</field>
		<field name="drug_name">N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5004</field>
		<field name="drug_name">(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5005</field>
		<field name="drug_name">2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5006</field>
		<field name="drug_name">2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5007</field>
		<field name="drug_name">N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5008</field>
		<field name="drug_name">5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5009</field>
		<field name="drug_name">(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5010</field>
		<field name="drug_name">5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5011</field>
		<field name="drug_name">4-(2-amino-1,3-thiazol-4-yl)phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5012</field>
		<field name="drug_name">benzyl (2-oxopropyl)carbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5013</field>
		<field name="drug_name">3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5014</field>
		<field name="drug_name">2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5015</field>
		<field name="drug_name">(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5016</field>
		<field name="drug_name">5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5017</field>
		<field name="drug_name">3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5018</field>
		<field name="drug_name">4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5019</field>
		<field name="drug_name">2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[2,7]naphthyridin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5020</field>
		<field name="drug_name">9H-CARBAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5021</field>
		<field name="drug_name">(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5022</field>
		<field name="drug_name">N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5023</field>
		<field name="drug_name">5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5024</field>
		<field name="drug_name">5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5025</field>
		<field name="drug_name">ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5026</field>
		<field name="drug_name">N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5027</field>
		<field name="drug_name">5-(2-CHLOROBENZYL)-2-FUROIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5028</field>
		<field name="drug_name">5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5029</field>
		<field name="drug_name">(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5030</field>
		<field name="drug_name">18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5031</field>
		<field name="drug_name">2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5032</field>
		<field name="drug_name">5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5033</field>
		<field name="drug_name">1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5034</field>
		<field name="drug_name">5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5035</field>
		<field name="drug_name">N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5036</field>
		<field name="drug_name">(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5037</field>
		<field name="drug_name">N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5038</field>
		<field name="drug_name">6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5039</field>
		<field name="drug_name">4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5040</field>
		<field name="drug_name">2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5041</field>
		<field name="drug_name">2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5042</field>
		<field name="drug_name">2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5043</field>
		<field name="drug_name">3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5044</field>
		<field name="drug_name">N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5045</field>
		<field name="drug_name">6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5046</field>
		<field name="drug_name">(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5047</field>
		<field name="drug_name">METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5048</field>
		<field name="drug_name">1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5049</field>
		<field name="drug_name">trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5050</field>
		<field name="drug_name">2-(4-NITROPHENYL)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5051</field>
		<field name="drug_name">ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5052</field>
		<field name="drug_name">N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5053</field>
		<field name="drug_name">N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5054</field>
		<field name="drug_name">3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5055</field>
		<field name="drug_name">4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5056</field>
		<field name="drug_name">4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5057</field>
		<field name="drug_name">5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROBENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5058</field>
		<field name="drug_name">(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5059</field>
		<field name="drug_name">N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5060</field>
		<field name="drug_name">octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5061</field>
		<field name="drug_name">1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5062</field>
		<field name="drug_name">4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5063</field>
		<field name="drug_name">3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5064</field>
		<field name="drug_name">4-(2-aminoethyl)-2-cyclohexylphenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5065</field>
		<field name="drug_name">4-(2-aminoethyl)-2-ethylphenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5066</field>
		<field name="drug_name">4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5067</field>
		<field name="drug_name">1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5068</field>
		<field name="drug_name">(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5069</field>
		<field name="drug_name">(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5070</field>
		<field name="drug_name">O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5071</field>
		<field name="drug_name">5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5072</field>
		<field name="drug_name">4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5073</field>
		<field name="drug_name">2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5074</field>
		<field name="drug_name">3-(heptyloxy)benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5075</field>
		<field name="drug_name">(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5076</field>
		<field name="drug_name">4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5077</field>
		<field name="drug_name">2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5078</field>
		<field name="drug_name">3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5079</field>
		<field name="drug_name">1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5080</field>
		<field name="drug_name">1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5081</field>
		<field name="drug_name">1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5082</field>
		<field name="drug_name">THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5083</field>
		<field name="drug_name">6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5084</field>
		<field name="drug_name">NAPHTHALEN-2-YL-3-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5085</field>
		<field name="drug_name">2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5086</field>
		<field name="drug_name">(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5087</field>
		<field name="drug_name">4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5088</field>
		<field name="drug_name">N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5089</field>
		<field name="drug_name">(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5090</field>
		<field name="drug_name">3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5091</field>
		<field name="drug_name">ANTHRACENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5092</field>
		<field name="drug_name">ANDROSTA-1,4-DIENE-3,17-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5093</field>
		<field name="drug_name">ANISOMYCIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5094</field>
		<field name="drug_name">5-BETA-ANDROSTANE-3,17-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5095</field>
		<field name="drug_name">5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5096</field>
		<field name="drug_name">N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5097</field>
		<field name="drug_name">4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5098</field>
		<field name="drug_name">(2S)-2-({6-[(3-AMINO-5-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5099</field>
		<field name="drug_name">1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5100</field>
		<field name="drug_name">S-Atrolactic Acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5101</field>
		<field name="drug_name">N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5102</field>
		<field name="drug_name">N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5103</field>
		<field name="drug_name">1-ACETYL-2-CARBOXYPIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5104</field>
		<field name="drug_name">3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5105</field>
		<field name="drug_name">3-(BUTYLSULPHONYL)-PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5106</field>
		<field name="drug_name">ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5107</field>
		<field name="drug_name">N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5108</field>
		<field name="drug_name">2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5109</field>
		<field name="drug_name">(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5110</field>
		<field name="drug_name">2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5111</field>
		<field name="drug_name">2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5112</field>
		<field name="drug_name">AUROVERTIN B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5113</field>
		<field name="drug_name">4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5114</field>
		<field name="drug_name">1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5115</field>
		<field name="drug_name">(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5116</field>
		<field name="drug_name">2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5117</field>
		<field name="drug_name">1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5118</field>
		<field name="drug_name">METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5119</field>
		<field name="drug_name">AZAPROPAZONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5120</field>
		<field name="drug_name">4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5121</field>
		<field name="drug_name">(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5122</field>
		<field name="drug_name">1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5123</field>
		<field name="drug_name">(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5124</field>
		<field name="drug_name">5-(2-METHOXYPHENYL)-2-FUROIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5125</field>
		<field name="drug_name">5-(2-NITROPHENYL)-2-FUROIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5126</field>
		<field name="drug_name">(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5127</field>
		<field name="drug_name">[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5128</field>
		<field name="drug_name">PHENYLALANINE BORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5129</field>
		<field name="drug_name">1-biphenyl-2-ylmethanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5130</field>
		<field name="drug_name">5'-S-[2-(decylamino)ethyl]-5'-thioadenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5131</field>
		<field name="drug_name">(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5132</field>
		<field name="drug_name">4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5133</field>
		<field name="drug_name">(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5134</field>
		<field name="drug_name">bis(4-nitrophenyl) hydrogen phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5135</field>
		<field name="drug_name">(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5136</field>
		<field name="drug_name">(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5137</field>
		<field name="drug_name">4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5138</field>
		<field name="drug_name">(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5139</field>
		<field name="drug_name">(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5140</field>
		<field name="drug_name">tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5141</field>
		<field name="drug_name">{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5142</field>
		<field name="drug_name">[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5143</field>
		<field name="drug_name">2-[(2-methoxy-5-methylphenoxy)methyl]pyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5144</field>
		<field name="drug_name">4-[(5-methoxy-2-methylphenoxy)methyl]pyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5145</field>
		<field name="drug_name">2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5146</field>
		<field name="drug_name">(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5147</field>
		<field name="drug_name">(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5148</field>
		<field name="drug_name">[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5149</field>
		<field name="drug_name">(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5150</field>
		<field name="drug_name">HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5151</field>
		<field name="drug_name">1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5152</field>
		<field name="drug_name">N-(1-PHENYL-PROPYL)-FORMAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5153</field>
		<field name="drug_name">1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5154</field>
		<field name="drug_name">1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5155</field>
		<field name="drug_name">4-TERT-BUTYLBENZENESULFONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5156</field>
		<field name="drug_name">3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5157</field>
		<field name="drug_name">(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5158</field>
		<field name="drug_name">6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5159</field>
		<field name="drug_name">N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5160</field>
		<field name="drug_name">N-(biphenyl-4-ylsulfonyl)-D-leucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5161</field>
		<field name="drug_name">5-beta-DIHYDROTESTOSTERONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5162</field>
		<field name="drug_name">(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5163</field>
		<field name="drug_name">N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5164</field>
		<field name="drug_name">2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5165</field>
		<field name="drug_name">1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5166</field>
		<field name="drug_name">2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5167</field>
		<field name="drug_name">2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5168</field>
		<field name="drug_name">(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5169</field>
		<field name="drug_name">N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5170</field>
		<field name="drug_name">3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5171</field>
		<field name="drug_name">3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5172</field>
		<field name="drug_name">3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5173</field>
		<field name="drug_name">4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5174</field>
		<field name="drug_name">2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5175</field>
		<field name="drug_name">3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5176</field>
		<field name="drug_name">(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5177</field>
		<field name="drug_name">(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5178</field>
		<field name="drug_name">1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5179</field>
		<field name="drug_name">(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5180</field>
		<field name="drug_name">(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5181</field>
		<field name="drug_name">4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5182</field>
		<field name="drug_name">(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5183</field>
		<field name="drug_name">(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5184</field>
		<field name="drug_name">(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5185</field>
		<field name="drug_name">5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5186</field>
		<field name="drug_name">(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5187</field>
		<field name="drug_name">(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5188</field>
		<field name="drug_name">3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5189</field>
		<field name="drug_name">N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5190</field>
		<field name="drug_name">N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5191</field>
		<field name="drug_name">BIPHENYL-4-YL-ACETALDEHYDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5192</field>
		<field name="drug_name">1,1'-BIPHENYL-3,4-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5193</field>
		<field name="drug_name">(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5194</field>
		<field name="drug_name">4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5195</field>
		<field name="drug_name">tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5196</field>
		<field name="drug_name">(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5197</field>
		<field name="drug_name">1,1'-BIPHENYL-2-SULFINIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5198</field>
		<field name="drug_name">(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5199</field>
		<field name="drug_name">4,4'-cyclohexane-1,1-diyldiphenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5200</field>
		<field name="drug_name">3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5201</field>
		<field name="drug_name">(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5202</field>
		<field name="drug_name">{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5203</field>
		<field name="drug_name">{[4-AMINO-2-(3-CHLOROANILINO)-1,3-THIAZOL-5-YL](4-FLUOROPHENYL)METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5204</field>
		<field name="drug_name">2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5205</field>
		<field name="drug_name">5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5206</field>
		<field name="drug_name">BROMAMPHENICOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5207</field>
		<field name="drug_name">(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5208</field>
		<field name="drug_name">(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5209</field>
		<field name="drug_name">5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5210</field>
		<field name="drug_name">1,3-DIPHENYLUREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5211</field>
		<field name="drug_name">5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5212</field>
		<field name="drug_name">4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5213</field>
		<field name="drug_name">N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5214</field>
		<field name="drug_name">(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5215</field>
		<field name="drug_name">(2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5216</field>
		<field name="drug_name">4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5217</field>
		<field name="drug_name">(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5218</field>
		<field name="drug_name">(2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5219</field>
		<field name="drug_name">N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5220</field>
		<field name="drug_name">L-BENZYLSUCCINIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5221</field>
		<field name="drug_name">2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5222</field>
		<field name="drug_name">4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5223</field>
		<field name="drug_name">difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5224</field>
		<field name="drug_name">3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5225</field>
		<field name="drug_name">4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5226</field>
		<field name="drug_name">7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5227</field>
		<field name="drug_name">7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5228</field>
		<field name="drug_name">3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5229</field>
		<field name="drug_name">1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5230</field>
		<field name="drug_name">(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5231</field>
		<field name="drug_name">3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5232</field>
		<field name="drug_name">(2R)-2-ETHYL-1-HEXANESULFONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5233</field>
		<field name="drug_name">(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5234</field>
		<field name="drug_name">N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5235</field>
		<field name="drug_name">6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5236</field>
		<field name="drug_name">N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5237</field>
		<field name="drug_name">N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5238</field>
		<field name="drug_name">3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5239</field>
		<field name="drug_name">N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5240</field>
		<field name="drug_name">N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5241</field>
		<field name="drug_name">3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5242</field>
		<field name="drug_name">2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5243</field>
		<field name="drug_name">(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5244</field>
		<field name="drug_name">4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5245</field>
		<field name="drug_name">N-hexanoyl-L-homoserine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5246</field>
		<field name="drug_name">4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5247</field>
		<field name="drug_name">4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5248</field>
		<field name="drug_name">2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5249</field>
		<field name="drug_name">N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5250</field>
		<field name="drug_name">N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5251</field>
		<field name="drug_name">4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5252</field>
		<field name="drug_name">4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5253</field>
		<field name="drug_name">4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5254</field>
		<field name="drug_name">4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5255</field>
		<field name="drug_name">5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5256</field>
		<field name="drug_name">(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5257</field>
		<field name="drug_name">N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5258</field>
		<field name="drug_name">N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5259</field>
		<field name="drug_name">[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5260</field>
		<field name="drug_name">5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5261</field>
		<field name="drug_name">2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5262</field>
		<field name="drug_name">2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5263</field>
		<field name="drug_name">2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5264</field>
		<field name="drug_name">2-CHLORO-4-ETHYLAMINO-6-(S(-)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5265</field>
		<field name="drug_name">2-CHLORO-4-ETHYLAMINO-6-(R(+)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5266</field>
		<field name="drug_name">9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5267</field>
		<field name="drug_name">1-(2-nitrophenyl)-2,2,2-trifluoroethyl]-arsenocholine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5268</field>
		<field name="drug_name">N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5269</field>
		<field name="drug_name">(5BETA)-PREGNANE-3,20-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5270</field>
		<field name="drug_name">2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5271</field>
		<field name="drug_name">(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5272</field>
		<field name="drug_name">N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5273</field>
		<field name="drug_name">(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5274</field>
		<field name="drug_name">N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5275</field>
		<field name="drug_name">1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5276</field>
		<field name="drug_name">6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5277</field>
		<field name="drug_name">CHLORAMPHENICOL SUCCINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5278</field>
		<field name="drug_name">(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5279</field>
		<field name="drug_name">(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5280</field>
		<field name="drug_name">CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5281</field>
		<field name="drug_name">3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5282</field>
		<field name="drug_name">N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5283</field>
		<field name="drug_name">3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5284</field>
		<field name="drug_name">(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5285</field>
		<field name="drug_name">2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5286</field>
		<field name="drug_name">2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5287</field>
		<field name="drug_name">6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5288</field>
		<field name="drug_name">3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5289</field>
		<field name="drug_name">BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5290</field>
		<field name="drug_name">BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5291</field>
		<field name="drug_name">5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5292</field>
		<field name="drug_name">N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5293</field>
		<field name="drug_name">(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5294</field>
		<field name="drug_name">N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5295</field>
		<field name="drug_name">5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5296</field>
		<field name="drug_name">5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5297</field>
		<field name="drug_name">N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5298</field>
		<field name="drug_name">3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5299</field>
		<field name="drug_name">N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5300</field>
		<field name="drug_name">S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5301</field>
		<field name="drug_name">N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5302</field>
		<field name="drug_name">(1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)-1-FORMYLPENTYL]CARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5303</field>
		<field name="drug_name">1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5304</field>
		<field name="drug_name">4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5305</field>
		<field name="drug_name">(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5306</field>
		<field name="drug_name">(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5307</field>
		<field name="drug_name">CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5308</field>
		<field name="drug_name">2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5309</field>
		<field name="drug_name">[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5310</field>
		<field name="drug_name">4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5311</field>
		<field name="drug_name">S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5312</field>
		<field name="drug_name">N-hexanoyl-L-homocysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5313</field>
		<field name="drug_name">(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5314</field>
		<field name="drug_name">2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5315</field>
		<field name="drug_name">6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5316</field>
		<field name="drug_name">4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5317</field>
		<field name="drug_name">N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5318</field>
		<field name="drug_name">N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5319</field>
		<field name="drug_name">NAPHTHALENE-1,2-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5320</field>
		<field name="drug_name">DECANE-1-THIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5321</field>
		<field name="drug_name">6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5322</field>
		<field name="drug_name">3-phenyl-5-(1H-pyrazol-3-yl)isoxazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5323</field>
		<field name="drug_name">PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5324</field>
		<field name="drug_name">2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5325</field>
		<field name="drug_name">4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5326</field>
		<field name="drug_name">N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5327</field>
		<field name="drug_name">2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5328</field>
		<field name="drug_name">N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5329</field>
		<field name="drug_name">2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5330</field>
		<field name="drug_name">(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5331</field>
		<field name="drug_name">1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5332</field>
		<field name="drug_name">4,4'-DIPYRIDYL DISULFIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5333</field>
		<field name="drug_name">1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5334</field>
		<field name="drug_name">4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5335</field>
		<field name="drug_name">4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5336</field>
		<field name="drug_name">(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5337</field>
		<field name="drug_name">6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5338</field>
		<field name="drug_name">N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5339</field>
		<field name="drug_name">N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5340</field>
		<field name="drug_name">N-DODECYL-N,N-DIMETHYLGLYCINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5341</field>
		<field name="drug_name">5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5342</field>
		<field name="drug_name">octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5343</field>
		<field name="drug_name">(2,6-DIMETHYL-PHENOXY)-ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5344</field>
		<field name="drug_name">bis(4-hydroxyphenyl)methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5345</field>
		<field name="drug_name">5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5346</field>
		<field name="drug_name">3,5 DIBROMOTYROSINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5347</field>
		<field name="drug_name">(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5348</field>
		<field name="drug_name">3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5349</field>
		<field name="drug_name">2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5350</field>
		<field name="drug_name">DECYL(DIMETHYL)PHOSPHINE OXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5351</field>
		<field name="drug_name">5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5352</field>
		<field name="drug_name">5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5353</field>
		<field name="drug_name">5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5354</field>
		<field name="drug_name">SEBACIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5355</field>
		<field name="drug_name">UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5356</field>
		<field name="drug_name">(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5357</field>
		<field name="drug_name">(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5358</field>
		<field name="drug_name">(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5359</field>
		<field name="drug_name">DECYL FORMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5360</field>
		<field name="drug_name">N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5361</field>
		<field name="drug_name">1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5362</field>
		<field name="drug_name">N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5363</field>
		<field name="drug_name">(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5364</field>
		<field name="drug_name">3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5365</field>
		<field name="drug_name">N-[4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL]-3-PYRIDIN-3-YLPROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5366</field>
		<field name="drug_name">PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5367</field>
		<field name="drug_name">AC-(D)PHE-PRO-BOROLYS-OH</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5368</field>
		<field name="drug_name">AC-(D)PHE-PRO-BOROHOMOLYS-OH</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5369</field>
		<field name="drug_name">AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5370</field>
		<field name="drug_name">1,6-DIHYDROXY NAPHTHALENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5371</field>
		<field name="drug_name">N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5372</field>
		<field name="drug_name">2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5373</field>
		<field name="drug_name">5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5374</field>
		<field name="drug_name">N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5375</field>
		<field name="drug_name">(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5376</field>
		<field name="drug_name">2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5377</field>
		<field name="drug_name">3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5378</field>
		<field name="drug_name">2,3-DIMETHYL-1,4-NAPHTHOQUINONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5379</field>
		<field name="drug_name">4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5380</field>
		<field name="drug_name">2-[1-METHYLHEXYL]-4,6-DINITROPHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5381</field>
		<field name="drug_name">TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5382</field>
		<field name="drug_name">DEAMINO-METHYL-PHENYLALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5383</field>
		<field name="drug_name">O,O-DIETHYL HYDROGEN THIOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5384</field>
		<field name="drug_name">(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5385</field>
		<field name="drug_name">3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5386</field>
		<field name="drug_name">2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5387</field>
		<field name="drug_name">(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5388</field>
		<field name="drug_name">(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5389</field>
		<field name="drug_name">[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5390</field>
		<field name="drug_name">DODECANESULFONATE ION</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5391</field>
		<field name="drug_name">N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5392</field>
		<field name="drug_name">5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5393</field>
		<field name="drug_name">4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5394</field>
		<field name="drug_name">4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5395</field>
		<field name="drug_name">4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5396</field>
		<field name="drug_name">4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5397</field>
		<field name="drug_name">METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5398</field>
		<field name="drug_name">(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5399</field>
		<field name="drug_name">2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5400</field>
		<field name="drug_name">1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5401</field>
		<field name="drug_name">N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5402</field>
		<field name="drug_name">2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5403</field>
		<field name="drug_name">N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5404</field>
		<field name="drug_name">methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5405</field>
		<field name="drug_name">1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5406</field>
		<field name="drug_name">3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5407</field>
		<field name="drug_name">3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5408</field>
		<field name="drug_name">1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5409</field>
		<field name="drug_name">(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5410</field>
		<field name="drug_name">(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5411</field>
		<field name="drug_name">6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5412</field>
		<field name="drug_name">1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5413</field>
		<field name="drug_name">2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5414</field>
		<field name="drug_name">(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5415</field>
		<field name="drug_name">3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5416</field>
		<field name="drug_name">PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5417</field>
		<field name="drug_name">(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5418</field>
		<field name="drug_name">3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5419</field>
		<field name="drug_name">(1S)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5420</field>
		<field name="drug_name">6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5421</field>
		<field name="drug_name">3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5422</field>
		<field name="drug_name">(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5423</field>
		<field name="drug_name">(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5424</field>
		<field name="drug_name">3-(4-HYDROXY-PHENYL)PYRUVIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5425</field>
		<field name="drug_name">3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5426</field>
		<field name="drug_name">EPIBATIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5427</field>
		<field name="drug_name">DIETHYL 4-METHOXYPHENYL PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5428</field>
		<field name="drug_name">3-(4-NITRO-PHENOXY)-PROPAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5429</field>
		<field name="drug_name">3-(5-methoxy-1H-indol-3-yl)propanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5430</field>
		<field name="drug_name">3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5431</field>
		<field name="drug_name">2-tert-butylbenzene-1,4-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5432</field>
		<field name="drug_name">2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5433</field>
		<field name="drug_name">3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5434</field>
		<field name="drug_name">5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5435</field>
		<field name="drug_name">4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5436</field>
		<field name="drug_name">2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5437</field>
		<field name="drug_name">1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5438</field>
		<field name="drug_name">N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5439</field>
		<field name="drug_name">N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5440</field>
		<field name="drug_name">(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5441</field>
		<field name="drug_name">(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5442</field>
		<field name="drug_name">N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5443</field>
		<field name="drug_name">(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5444</field>
		<field name="drug_name">(3R,5S,7R,12S,13R)-13-FORMYL-12,14-DIHYDROXY-3,5,7-TRIMETHYLTETRADECANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5445</field>
		<field name="drug_name">4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5446</field>
		<field name="drug_name">N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5447</field>
		<field name="drug_name">S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5448</field>
		<field name="drug_name">3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5449</field>
		<field name="drug_name">2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5450</field>
		<field name="drug_name">3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5451</field>
		<field name="drug_name">(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5452</field>
		<field name="drug_name">2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5453</field>
		<field name="drug_name">2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5454</field>
		<field name="drug_name">(2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5455</field>
		<field name="drug_name">(2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5456</field>
		<field name="drug_name">FARNESYL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5457</field>
		<field name="drug_name">3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5458</field>
		<field name="drug_name">N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5459</field>
		<field name="drug_name">(2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5460</field>
		<field name="drug_name">1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5461</field>
		<field name="drug_name">(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5462</field>
		<field name="drug_name">5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5463</field>
		<field name="drug_name">5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5464</field>
		<field name="drug_name">3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5465</field>
		<field name="drug_name">(2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5466</field>
		<field name="drug_name">4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5467</field>
		<field name="drug_name">(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5468</field>
		<field name="drug_name">FLUORESCIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5469</field>
		<field name="drug_name">METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5470</field>
		<field name="drug_name">(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5471</field>
		<field name="drug_name">3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5472</field>
		<field name="drug_name">(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5473</field>
		<field name="drug_name">S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5474</field>
		<field name="drug_name">5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5475</field>
		<field name="drug_name">[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5476</field>
		<field name="drug_name">(1R)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5477</field>
		<field name="drug_name">5-FLUOROINDOLE PROPANOL PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5478</field>
		<field name="drug_name">3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5479</field>
		<field name="drug_name">2-PHENYL-4H-CHROMEN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5480</field>
		<field name="drug_name">FAMOXADONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5481</field>
		<field name="drug_name">N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5482</field>
		<field name="drug_name">FARNESYL DIPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5483</field>
		<field name="drug_name">N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5484</field>
		<field name="drug_name">4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5485</field>
		<field name="drug_name">1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5486</field>
		<field name="drug_name">[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5487</field>
		<field name="drug_name">1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5488</field>
		<field name="drug_name">1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5489</field>
		<field name="drug_name">5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5490</field>
		<field name="drug_name">(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5491</field>
		<field name="drug_name">1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5492</field>
		<field name="drug_name">N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5493</field>
		<field name="drug_name">4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5494</field>
		<field name="drug_name">(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5495</field>
		<field name="drug_name">(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5496</field>
		<field name="drug_name">5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5497</field>
		<field name="drug_name">3,7,3',4'-TETRAHYDROXYFLAVONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5498</field>
		<field name="drug_name">(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5499</field>
		<field name="drug_name">N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5500</field>
		<field name="drug_name">(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5501</field>
		<field name="drug_name">N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5502</field>
		<field name="drug_name">N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5503</field>
		<field name="drug_name">3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5504</field>
		<field name="drug_name">2-phenyl-1H-imidazole-4-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5505</field>
		<field name="drug_name">5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5506</field>
		<field name="drug_name">3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5507</field>
		<field name="drug_name">(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5508</field>
		<field name="drug_name">(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5509</field>
		<field name="drug_name">(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5510</field>
		<field name="drug_name">4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5511</field>
		<field name="drug_name">3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5512</field>
		<field name="drug_name">N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5513</field>
		<field name="drug_name">N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5514</field>
		<field name="drug_name">GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5515</field>
		<field name="drug_name">GIBBERELLIN A3</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5516</field>
		<field name="drug_name">GIBBERELLIN A4</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5517</field>
		<field name="drug_name">N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5518</field>
		<field name="drug_name">1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5519</field>
		<field name="drug_name">(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5520</field>
		<field name="drug_name">(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5521</field>
		<field name="drug_name">6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5522</field>
		<field name="drug_name">(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5523</field>
		<field name="drug_name">(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5524</field>
		<field name="drug_name">(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5525</field>
		<field name="drug_name">4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5526</field>
		<field name="drug_name">(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5527</field>
		<field name="drug_name">2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5528</field>
		<field name="drug_name">4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5529</field>
		<field name="drug_name">4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5530</field>
		<field name="drug_name">(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5531</field>
		<field name="drug_name">2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5532</field>
		<field name="drug_name">4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5533</field>
		<field name="drug_name">N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5534</field>
		<field name="drug_name">N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5535</field>
		<field name="drug_name">N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5536</field>
		<field name="drug_name">1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5537</field>
		<field name="drug_name">[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5538</field>
		<field name="drug_name">(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5539</field>
		<field name="drug_name">N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5540</field>
		<field name="drug_name">(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5541</field>
		<field name="drug_name">GERANYLGERANYL DIPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5542</field>
		<field name="drug_name">(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5543</field>
		<field name="drug_name">5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5544</field>
		<field name="drug_name">6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5545</field>
		<field name="drug_name">2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5546</field>
		<field name="drug_name">1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5547</field>
		<field name="drug_name">6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5548</field>
		<field name="drug_name">5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5549</field>
		<field name="drug_name">S-NONYL-CYSTEINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5550</field>
		<field name="drug_name">(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5551</field>
		<field name="drug_name">(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5552</field>
		<field name="drug_name">1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5553</field>
		<field name="drug_name">[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5554</field>
		<field name="drug_name">N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5555</field>
		<field name="drug_name">(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5556</field>
		<field name="drug_name">6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5557</field>
		<field name="drug_name">(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5558</field>
		<field name="drug_name">(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5559</field>
		<field name="drug_name">4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5560</field>
		<field name="drug_name">(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5561</field>
		<field name="drug_name">(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5562</field>
		<field name="drug_name">7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5563</field>
		<field name="drug_name">2-chloro-5-nitro-N-phenylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5564</field>
		<field name="drug_name">4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5565</field>
		<field name="drug_name">3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5566</field>
		<field name="drug_name">(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5567</field>
		<field name="drug_name">6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5568</field>
		<field name="drug_name">6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5569</field>
		<field name="drug_name">6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5570</field>
		<field name="drug_name">(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5571</field>
		<field name="drug_name">6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5572</field>
		<field name="drug_name">5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5573</field>
		<field name="drug_name">(1-HYDROXYDODECANE-1,1-DIYL)BIS(PHOSPHONIC ACID)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5574</field>
		<field name="drug_name">(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5575</field>
		<field name="drug_name">5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5576</field>
		<field name="drug_name">(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5577</field>
		<field name="drug_name">8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5578</field>
		<field name="drug_name">N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5579</field>
		<field name="drug_name">N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5580</field>
		<field name="drug_name">2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5581</field>
		<field name="drug_name">N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5582</field>
		<field name="drug_name">4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5583</field>
		<field name="drug_name">(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5584</field>
		<field name="drug_name">ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5585</field>
		<field name="drug_name">(S)-4-ISOPROPOXYCARBONYL-6-METHOXY-3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN-2(1H)-THIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5586</field>
		<field name="drug_name">(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5587</field>
		<field name="drug_name">(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5588</field>
		<field name="drug_name">3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5589</field>
		<field name="drug_name">1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5590</field>
		<field name="drug_name">4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5591</field>
		<field name="drug_name">4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5592</field>
		<field name="drug_name">1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5593</field>
		<field name="drug_name">PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5594</field>
		<field name="drug_name">4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5595</field>
		<field name="drug_name">ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5596</field>
		<field name="drug_name">(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5597</field>
		<field name="drug_name">1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5598</field>
		<field name="drug_name">2-(BUTYRYLOXY)-1-{[(TETRAHYDROXYPHOSPHORANYL)OXY]METHYL}ETHYL BUTYRATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5599</field>
		<field name="drug_name">(2S) N-ACETYL-L-ALANYL-ALPHAL-PHENYLALANYL-CHLOROETHYLKETONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5600</field>
		<field name="drug_name">3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5601</field>
		<field name="drug_name">5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5602</field>
		<field name="drug_name">TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5603</field>
		<field name="drug_name">3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5604</field>
		<field name="drug_name">(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[2]benzoxacyclotetradecine-6,12(1aH)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5605</field>
		<field name="drug_name">[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5606</field>
		<field name="drug_name">(2S)-2-HYDROXYOCTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5607</field>
		<field name="drug_name">7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5608</field>
		<field name="drug_name">(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5609</field>
		<field name="drug_name">PHENYLALANINDIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5610</field>
		<field name="drug_name">(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5611</field>
		<field name="drug_name">2-OXOHEPTYLPHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5612</field>
		<field name="drug_name">HOMOPHENYLALANINYLMETHANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5613</field>
		<field name="drug_name">(2Z,4E)-2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5614</field>
		<field name="drug_name">(2E,4E)-2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5615</field>
		<field name="drug_name">3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5616</field>
		<field name="drug_name">4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5617</field>
		<field name="drug_name">2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5618</field>
		<field name="drug_name">7-METHOXY-1-METHYL-9H-BETA-CARBOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5619</field>
		<field name="drug_name">N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5620</field>
		<field name="drug_name">2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5621</field>
		<field name="drug_name">N-oxo-2-(phenylsulfonylamino)ethanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5622</field>
		<field name="drug_name">octyl alpha-L-altropyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5623</field>
		<field name="drug_name">octyl beta-D-galactopyranoside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5624</field>
		<field name="drug_name">4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5625</field>
		<field name="drug_name">N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5626</field>
		<field name="drug_name">3-{[(4-CARBOXY-2-HYDROXYANILINE]SULFONYL}THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5627</field>
		<field name="drug_name">N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5628</field>
		<field name="drug_name">N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5629</field>
		<field name="drug_name">(3R)-3-HYDROXYDODECANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5630</field>
		<field name="drug_name">4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5631</field>
		<field name="drug_name">dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5632</field>
		<field name="drug_name">(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5633</field>
		<field name="drug_name">[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5634</field>
		<field name="drug_name">5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5635</field>
		<field name="drug_name">N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5636</field>
		<field name="drug_name">2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5637</field>
		<field name="drug_name">5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5638</field>
		<field name="drug_name">N-(3-MERCAPTOPROPANOYL)-D-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5639</field>
		<field name="drug_name">9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5640</field>
		<field name="drug_name">3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5641</field>
		<field name="drug_name">2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5642</field>
		<field name="drug_name">2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5643</field>
		<field name="drug_name">N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5644</field>
		<field name="drug_name">5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocycloheptaindole-4-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5645</field>
		<field name="drug_name">N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5646</field>
		<field name="drug_name">ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5647</field>
		<field name="drug_name">({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5648</field>
		<field name="drug_name">1H-INDOL-3-YLACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5649</field>
		<field name="drug_name">N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5650</field>
		<field name="drug_name">N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5651</field>
		<field name="drug_name">N-[1H-INDOL-3-YL-ACETYL]VALINE ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5652</field>
		<field name="drug_name">3-ISOBUTYL-1-METHYLXANTHINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5653</field>
		<field name="drug_name">(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5654</field>
		<field name="drug_name">[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5655</field>
		<field name="drug_name">METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5656</field>
		<field name="drug_name">(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5657</field>
		<field name="drug_name">3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5658</field>
		<field name="drug_name">5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5659</field>
		<field name="drug_name">1-(4-CYANO-PHENYL)-3-[2-(2,6-DICHLORO-PHENYL)-1-IMINO-ETHYL]-THIOUREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5660</field>
		<field name="drug_name">METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5661</field>
		<field name="drug_name">N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5662</field>
		<field name="drug_name">(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5663</field>
		<field name="drug_name">6-(CYCLOHEXYLAMINO)-9-[2-(4-METHYLPIPERAZIN-1-YL)-ETHYL]-9H-PURINE-2-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5664</field>
		<field name="drug_name">[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5665</field>
		<field name="drug_name">9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5666</field>
		<field name="drug_name">N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5667</field>
		<field name="drug_name">3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5668</field>
		<field name="drug_name">5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5669</field>
		<field name="drug_name">5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5670</field>
		<field name="drug_name">1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5671</field>
		<field name="drug_name">N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5672</field>
		<field name="drug_name">1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5673</field>
		<field name="drug_name">2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5674</field>
		<field name="drug_name">3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5675</field>
		<field name="drug_name">3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5676</field>
		<field name="drug_name">2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5677</field>
		<field name="drug_name">(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5678</field>
		<field name="drug_name">(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5679</field>
		<field name="drug_name">2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5680</field>
		<field name="drug_name">2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5681</field>
		<field name="drug_name">1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5682</field>
		<field name="drug_name">2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5683</field>
		<field name="drug_name">+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5684</field>
		<field name="drug_name">[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5685</field>
		<field name="drug_name">[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5686</field>
		<field name="drug_name">2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5687</field>
		<field name="drug_name">2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5688</field>
		<field name="drug_name">(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5689</field>
		<field name="drug_name">N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5690</field>
		<field name="drug_name">3-SULFOOXY-1H-INDOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5691</field>
		<field name="drug_name">N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5692</field>
		<field name="drug_name">N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5693</field>
		<field name="drug_name">N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5694</field>
		<field name="drug_name">1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5695</field>
		<field name="drug_name">N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5696</field>
		<field name="drug_name">{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5697</field>
		<field name="drug_name">2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5698</field>
		<field name="drug_name">5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5699</field>
		<field name="drug_name">ISOTHIAZOLIDINONE ANALOG</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5700</field>
		<field name="drug_name">(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5701</field>
		<field name="drug_name">4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5702</field>
		<field name="drug_name">N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5703</field>
		<field name="drug_name">(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5704</field>
		<field name="drug_name">5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5705</field>
		<field name="drug_name">5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5706</field>
		<field name="drug_name">(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5707</field>
		<field name="drug_name">(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5708</field>
		<field name="drug_name">(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5709</field>
		<field name="drug_name">(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5710</field>
		<field name="drug_name">(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5711</field>
		<field name="drug_name">(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5712</field>
		<field name="drug_name">4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5713</field>
		<field name="drug_name">3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5714</field>
		<field name="drug_name">N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5715</field>
		<field name="drug_name">N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5716</field>
		<field name="drug_name">(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5717</field>
		<field name="drug_name">5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5718</field>
		<field name="drug_name">(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5719</field>
		<field name="drug_name">N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5720</field>
		<field name="drug_name">1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5721</field>
		<field name="drug_name">N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5722</field>
		<field name="drug_name">2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5723</field>
		<field name="drug_name">1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5724</field>
		<field name="drug_name">BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5725</field>
		<field name="drug_name">N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5726</field>
		<field name="drug_name">3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5727</field>
		<field name="drug_name">N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5728</field>
		<field name="drug_name">N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5729</field>
		<field name="drug_name">(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5730</field>
		<field name="drug_name">(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5731</field>
		<field name="drug_name">1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5732</field>
		<field name="drug_name">6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5733</field>
		<field name="drug_name">(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5734</field>
		<field name="drug_name">L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5735</field>
		<field name="drug_name">(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5736</field>
		<field name="drug_name">N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5737</field>
		<field name="drug_name">3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5738</field>
		<field name="drug_name">N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5739</field>
		<field name="drug_name">1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5740</field>
		<field name="drug_name">(1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5741</field>
		<field name="drug_name">4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5742</field>
		<field name="drug_name">2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5743</field>
		<field name="drug_name">4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5744</field>
		<field name="drug_name">4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5745</field>
		<field name="drug_name">7,8-dihydroxy-4-phenyl-2H-chromen-2-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5746</field>
		<field name="drug_name">5-PHENYL-2-KETO-VALERIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5747</field>
		<field name="drug_name">(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5748</field>
		<field name="drug_name">1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5749</field>
		<field name="drug_name">1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5750</field>
		<field name="drug_name">1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5751</field>
		<field name="drug_name">N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5752</field>
		<field name="drug_name">N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5753</field>
		<field name="drug_name">N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5754</field>
		<field name="drug_name">4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5755</field>
		<field name="drug_name">(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5756</field>
		<field name="drug_name">4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5757</field>
		<field name="drug_name">4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5758</field>
		<field name="drug_name">3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5759</field>
		<field name="drug_name">1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5760</field>
		<field name="drug_name">N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5761</field>
		<field name="drug_name">2-(1H-pyrazol-3-yl)-1H-benzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5762</field>
		<field name="drug_name">N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5763</field>
		<field name="drug_name">4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5764</field>
		<field name="drug_name">N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5765</field>
		<field name="drug_name">4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5766</field>
		<field name="drug_name">2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5767</field>
		<field name="drug_name">(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5768</field>
		<field name="drug_name">4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5769</field>
		<field name="drug_name">(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5770</field>
		<field name="drug_name">3-(3-methylbut-2-en-1-yl)-3H-purin-6-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5771</field>
		<field name="drug_name">4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5772</field>
		<field name="drug_name">4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5773</field>
		<field name="drug_name">2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5774</field>
		<field name="drug_name">{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5775</field>
		<field name="drug_name">7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5776</field>
		<field name="drug_name">LATRUNCULIN B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5777</field>
		<field name="drug_name">3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5778</field>
		<field name="drug_name">N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5779</field>
		<field name="drug_name">2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5780</field>
		<field name="drug_name">IDD594</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5781</field>
		<field name="drug_name">1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5782</field>
		<field name="drug_name">N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5783</field>
		<field name="drug_name">4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5784</field>
		<field name="drug_name">2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5785</field>
		<field name="drug_name">6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5786</field>
		<field name="drug_name">(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5787</field>
		<field name="drug_name">3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5788</field>
		<field name="drug_name">3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5789</field>
		<field name="drug_name">3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5790</field>
		<field name="drug_name">(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5791</field>
		<field name="drug_name">3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5792</field>
		<field name="drug_name">8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5793</field>
		<field name="drug_name">2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5794</field>
		<field name="drug_name">{[5-(5-NITRO-2-FURYL)-1,3,4-OXADIAZOL-2-YL]THIO}ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5795</field>
		<field name="drug_name">6-ETHYL-5-[(2S)-1-(3-METHOXYPROPYL)-2-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-7-YL]PYRIMIDINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5796</field>
		<field name="drug_name">2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5797</field>
		<field name="drug_name">2,6-dibromo-4-[(E)-2-phenylethenyl]phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5798</field>
		<field name="drug_name">3,5-dibromobiphenyl-4-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5799</field>
		<field name="drug_name">2,6-dibromo-4-phenoxyphenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5800</field>
		<field name="drug_name">N-(3,5-dibromo-4-hydroxyphenyl)benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5801</field>
		<field name="drug_name">N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-L-GLUTAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5802</field>
		<field name="drug_name">N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-D-GLUTAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5803</field>
		<field name="drug_name">N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5804</field>
		<field name="drug_name">N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5805</field>
		<field name="drug_name">(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5806</field>
		<field name="drug_name">(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5807</field>
		<field name="drug_name">4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5808</field>
		<field name="drug_name">N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5809</field>
		<field name="drug_name">3-pyridin-4-yl-1H-indazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5810</field>
		<field name="drug_name">5-benzyl-1,3-thiazol-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5811</field>
		<field name="drug_name">2-aminoethyl naphthalen-1-ylacetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5812</field>
		<field name="drug_name">(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5813</field>
		<field name="drug_name">2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5814</field>
		<field name="drug_name">1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5815</field>
		<field name="drug_name">6,8-DIMERCAPTO-OCTANOIC ACID AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5816</field>
		<field name="drug_name">(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5817</field>
		<field name="drug_name">N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5818</field>
		<field name="drug_name">N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5819</field>
		<field name="drug_name">3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5820</field>
		<field name="drug_name">4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5821</field>
		<field name="drug_name">3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5822</field>
		<field name="drug_name">1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5823</field>
		<field name="drug_name">(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5824</field>
		<field name="drug_name">(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5825</field>
		<field name="drug_name">N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5826</field>
		<field name="drug_name">2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5827</field>
		<field name="drug_name">5-hydroxynaphthalene-1-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5828</field>
		<field name="drug_name">N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5829</field>
		<field name="drug_name">4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5830</field>
		<field name="drug_name">N-phenyl-1H-pyrazole-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5831</field>
		<field name="drug_name">4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5832</field>
		<field name="drug_name">(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5833</field>
		<field name="drug_name">{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5834</field>
		<field name="drug_name">5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5835</field>
		<field name="drug_name">5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5836</field>
		<field name="drug_name">4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5837</field>
		<field name="drug_name">4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5838</field>
		<field name="drug_name">5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5839</field>
		<field name="drug_name">6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5840</field>
		<field name="drug_name">6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5841</field>
		<field name="drug_name">7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5842</field>
		<field name="drug_name">4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5843</field>
		<field name="drug_name">1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5844</field>
		<field name="drug_name">1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5845</field>
		<field name="drug_name">4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5846</field>
		<field name="drug_name">(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5847</field>
		<field name="drug_name">{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5848</field>
		<field name="drug_name">(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5849</field>
		<field name="drug_name">3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5850</field>
		<field name="drug_name">N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5851</field>
		<field name="drug_name">3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5852</field>
		<field name="drug_name">ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5853</field>
		<field name="drug_name">2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5854</field>
		<field name="drug_name">4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5855</field>
		<field name="drug_name">(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5856</field>
		<field name="drug_name">(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5857</field>
		<field name="drug_name">5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5858</field>
		<field name="drug_name">5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5859</field>
		<field name="drug_name">(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5860</field>
		<field name="drug_name">indane-5-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5861</field>
		<field name="drug_name">(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5862</field>
		<field name="drug_name">3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5863</field>
		<field name="drug_name">7-AMINO-4-METHYL-CHROMEN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5864</field>
		<field name="drug_name">(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5865</field>
		<field name="drug_name">(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5866</field>
		<field name="drug_name">11-MERCAPTOUNDECANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5867</field>
		<field name="drug_name">(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5868</field>
		<field name="drug_name">5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5869</field>
		<field name="drug_name">5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5870</field>
		<field name="drug_name">(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5871</field>
		<field name="drug_name">(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5872</field>
		<field name="drug_name">(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5873</field>
		<field name="drug_name">4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5874</field>
		<field name="drug_name">methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5875</field>
		<field name="drug_name">2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5876</field>
		<field name="drug_name">2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5877</field>
		<field name="drug_name">4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5878</field>
		<field name="drug_name">3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5879</field>
		<field name="drug_name">2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5880</field>
		<field name="drug_name">2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5881</field>
		<field name="drug_name">(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5882</field>
		<field name="drug_name">METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5883</field>
		<field name="drug_name">6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5884</field>
		<field name="drug_name">N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5885</field>
		<field name="drug_name">4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5886</field>
		<field name="drug_name">2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5887</field>
		<field name="drug_name">2-(3-NITROPHENYL)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5888</field>
		<field name="drug_name">4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5889</field>
		<field name="drug_name">(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5890</field>
		<field name="drug_name">2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5891</field>
		<field name="drug_name">(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5892</field>
		<field name="drug_name">[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5893</field>
		<field name="drug_name">N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5894</field>
		<field name="drug_name">(1R)-MENTHYL HEXYL PHOSPHONATE GROUP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5895</field>
		<field name="drug_name">(1S)-MENTHYL HEXYL PHOSPHONATE GROUP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5896</field>
		<field name="drug_name">4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5897</field>
		<field name="drug_name">7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5898</field>
		<field name="drug_name">3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5899</field>
		<field name="drug_name">4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5900</field>
		<field name="drug_name">4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5901</field>
		<field name="drug_name">2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5902</field>
		<field name="drug_name">2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5903</field>
		<field name="drug_name">2-(4-DIMETHYLAMINOPHENYL)DIAZENYLBENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5904</field>
		<field name="drug_name">2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5905</field>
		<field name="drug_name">5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5906</field>
		<field name="drug_name">1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5907</field>
		<field name="drug_name">1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5908</field>
		<field name="drug_name">4-(1H-IMIDAZOL-1-YL)PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5909</field>
		<field name="drug_name">2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5910</field>
		<field name="drug_name">2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5911</field>
		<field name="drug_name">2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5912</field>
		<field name="drug_name">HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5913</field>
		<field name="drug_name">4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5914</field>
		<field name="drug_name">(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5915</field>
		<field name="drug_name">N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5916</field>
		<field name="drug_name">METHOXYUNDECYLPHOSPHINIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5917</field>
		<field name="drug_name">N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5918</field>
		<field name="drug_name">(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5919</field>
		<field name="drug_name">Myxopyronin B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5920</field>
		<field name="drug_name">1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5921</field>
		<field name="drug_name">5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5922</field>
		<field name="drug_name">[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5923</field>
		<field name="drug_name">5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5924</field>
		<field name="drug_name">MYRISTIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5925</field>
		<field name="drug_name">{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5926</field>
		<field name="drug_name">6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5927</field>
		<field name="drug_name">5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5928</field>
		<field name="drug_name">N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5929</field>
		<field name="drug_name">(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5930</field>
		<field name="drug_name">2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5931</field>
		<field name="drug_name">5-AMINO-NAPHTALENE-2-MONOSULFONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5932</field>
		<field name="drug_name">(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5933</field>
		<field name="drug_name">N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5934</field>
		<field name="drug_name">4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5935</field>
		<field name="drug_name">N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5936</field>
		<field name="drug_name">(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5937</field>
		<field name="drug_name">1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5938</field>
		<field name="drug_name">(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5939</field>
		<field name="drug_name">6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5940</field>
		<field name="drug_name">3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5941</field>
		<field name="drug_name">3,6,9,12,15-PENTAOXATRICOSAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5942</field>
		<field name="drug_name">(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5943</field>
		<field name="drug_name">4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5944</field>
		<field name="drug_name">2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5945</field>
		<field name="drug_name">NAM NAPTHYLAMINOALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5946</field>
		<field name="drug_name">2-NAPHTHALENESULFONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5947</field>
		<field name="drug_name">(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5948</field>
		<field name="drug_name">N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5949</field>
		<field name="drug_name">4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5950</field>
		<field name="drug_name">6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5951</field>
		<field name="drug_name">7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5952</field>
		<field name="drug_name">(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5953</field>
		<field name="drug_name">2-HYDROXY-7-METHOXY-5-METHYL-NAPHTHALENE-1-CARBOXYLIC ACID MESO-2,5-DIHYDROXY-CYCLOPENT-3-ENYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5954</field>
		<field name="drug_name">2,6-DICARBOXYNAPHTHALENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5955</field>
		<field name="drug_name">N-(CARBOXYCARBONYL)-D-PHENYLALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5956</field>
		<field name="drug_name">(1R, 2S)-CIS 1,2 DIHYDROXY-1,2-DIHYDRONAPHTHALENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5957</field>
		<field name="drug_name">2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5958</field>
		<field name="drug_name">methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5959</field>
		<field name="drug_name">6-AMINO-4-(2-PHENYLETHYL)-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5960</field>
		<field name="drug_name">6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5961</field>
		<field name="drug_name">N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5962</field>
		<field name="drug_name">N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5963</field>
		<field name="drug_name">(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5964</field>
		<field name="drug_name">4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5965</field>
		<field name="drug_name">6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5966</field>
		<field name="drug_name">N-DODECANOYL-L-TYROSINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5967</field>
		<field name="drug_name">N-METHYL O-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5968</field>
		<field name="drug_name">2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5969</field>
		<field name="drug_name">1-(2-CYCLOPROPYLETHYL)-3-(1,1-DIOXIDO-2H-1,2,4-BENZOTHIADIAZIN-3-YL)-6-FLUORO-4-HYDROXYQUINOLIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5970</field>
		<field name="drug_name">3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5971</field>
		<field name="drug_name">(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5972</field>
		<field name="drug_name">O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5973</field>
		<field name="drug_name">O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5974</field>
		<field name="drug_name">(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5975</field>
		<field name="drug_name">O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5976</field>
		<field name="drug_name">(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5977</field>
		<field name="drug_name">NAPHTHYLOXYACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5978</field>
		<field name="drug_name">(1R,2R)-N-(2-AMINOETHYL)-2-{[(4-METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5979</field>
		<field name="drug_name">CYCLOHEXYL-NORSTATINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5980</field>
		<field name="drug_name">N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5981</field>
		<field name="drug_name">N-(3-AMINOPROPYL)-2-NITROBENZENAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5982</field>
		<field name="drug_name">(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5983</field>
		<field name="drug_name">(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5984</field>
		<field name="drug_name">2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5985</field>
		<field name="drug_name">4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5986</field>
		<field name="drug_name">5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5987</field>
		<field name="drug_name">ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5988</field>
		<field name="drug_name">(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5989</field>
		<field name="drug_name">4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5990</field>
		<field name="drug_name">1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5991</field>
		<field name="drug_name">N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5992</field>
		<field name="drug_name">3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5993</field>
		<field name="drug_name">(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5994</field>
		<field name="drug_name">(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5995</field>
		<field name="drug_name">(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5996</field>
		<field name="drug_name">3-{[(3-NITROANILINE]SULFONYL}THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5997</field>
		<field name="drug_name">2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5998</field>
		<field name="drug_name">SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">5999</field>
		<field name="drug_name">3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6000</field>
		<field name="drug_name">N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6001</field>
		<field name="drug_name">6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6002</field>
		<field name="drug_name">nocodazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6003</field>
		<field name="drug_name">(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6004</field>
		<field name="drug_name">2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6005</field>
		<field name="drug_name">4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6006</field>
		<field name="drug_name">5-methyl-6-phenylquinazoline-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6007</field>
		<field name="drug_name">6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6008</field>
		<field name="drug_name">2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6009</field>
		<field name="drug_name">DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6010</field>
		<field name="drug_name">(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6011</field>
		<field name="drug_name">2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6012</field>
		<field name="drug_name">3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6013</field>
		<field name="drug_name">N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6014</field>
		<field name="drug_name">2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6015</field>
		<field name="drug_name">2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6016</field>
		<field name="drug_name">2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6017</field>
		<field name="drug_name">PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6018</field>
		<field name="drug_name">SULTHIAME</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6019</field>
		<field name="drug_name">METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6020</field>
		<field name="drug_name">N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6021</field>
		<field name="drug_name">[2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6022</field>
		<field name="drug_name">4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6023</field>
		<field name="drug_name">3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6024</field>
		<field name="drug_name">4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6025</field>
		<field name="drug_name">TERT-BUTYL [(1R)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6026</field>
		<field name="drug_name">TERT-BUTYL [(1S)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6027</field>
		<field name="drug_name">19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6028</field>
		<field name="drug_name">6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6029</field>
		<field name="drug_name">N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6030</field>
		<field name="drug_name">4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6031</field>
		<field name="drug_name">S-PALMITOYL-L-CYSTEINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6032</field>
		<field name="drug_name">4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6033</field>
		<field name="drug_name">4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6034</field>
		<field name="drug_name">(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6035</field>
		<field name="drug_name">4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6036</field>
		<field name="drug_name">N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6037</field>
		<field name="drug_name">N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6038</field>
		<field name="drug_name">5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6039</field>
		<field name="drug_name">N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6040</field>
		<field name="drug_name">6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6041</field>
		<field name="drug_name">2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6042</field>
		<field name="drug_name">2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6043</field>
		<field name="drug_name">1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6044</field>
		<field name="drug_name">4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6045</field>
		<field name="drug_name">1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6046</field>
		<field name="drug_name">2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6047</field>
		<field name="drug_name">2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6048</field>
		<field name="drug_name">2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6049</field>
		<field name="drug_name">2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6050</field>
		<field name="drug_name">N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6051</field>
		<field name="drug_name">1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6052</field>
		<field name="drug_name">1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6053</field>
		<field name="drug_name">8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6054</field>
		<field name="drug_name">3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6055</field>
		<field name="drug_name">(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6056</field>
		<field name="drug_name">OCTANE-1,3,5,7-TETRACARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6057</field>
		<field name="drug_name">1-(biphenyl-4-ylmethyl)-1H-imidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6058</field>
		<field name="drug_name">S-(4-BROMOBENZYL)CYSTEINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6059</field>
		<field name="drug_name">PARA-(BENZOYL)-PHENYLALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6060</field>
		<field name="drug_name">1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6061</field>
		<field name="drug_name">4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6062</field>
		<field name="drug_name">PHENYLALANYLMETHYLCHLORIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6063</field>
		<field name="drug_name">PCNOTAXIME GROUP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6064</field>
		<field name="drug_name">(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6065</field>
		<field name="drug_name">PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6066</field>
		<field name="drug_name">4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6067</field>
		<field name="drug_name">6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6068</field>
		<field name="drug_name">PHENANTHRENE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6069</field>
		<field name="drug_name">2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6070</field>
		<field name="drug_name">4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6071</field>
		<field name="drug_name">2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6072</field>
		<field name="drug_name">4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6073</field>
		<field name="drug_name">2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6074</field>
		<field name="drug_name">2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6075</field>
		<field name="drug_name">5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6076</field>
		<field name="drug_name">6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6077</field>
		<field name="drug_name">(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6078</field>
		<field name="drug_name">6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6079</field>
		<field name="drug_name">2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6080</field>
		<field name="drug_name">2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6081</field>
		<field name="drug_name">PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6082</field>
		<field name="drug_name">2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6083</field>
		<field name="drug_name">4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE)METHYL]AMINO}BUTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6084</field>
		<field name="drug_name">6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6085</field>
		<field name="drug_name">2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6086</field>
		<field name="drug_name">PICEATANNOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6087</field>
		<field name="drug_name">4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6088</field>
		<field name="drug_name">(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6089</field>
		<field name="drug_name">2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6090</field>
		<field name="drug_name">METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6091</field>
		<field name="drug_name">S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6092</field>
		<field name="drug_name">S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6093</field>
		<field name="drug_name">[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6094</field>
		<field name="drug_name">PLATENSIMYCIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6095</field>
		<field name="drug_name">(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6096</field>
		<field name="drug_name">4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6097</field>
		<field name="drug_name">PARA-NITROBENZYL GLUTARYL GLYCINIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6098</field>
		<field name="drug_name">PARA-NITROPHENYL PHOSPHONOBUTANOYL L-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6099</field>
		<field name="drug_name">6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6100</field>
		<field name="drug_name">METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6101</field>
		<field name="drug_name">6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6102</field>
		<field name="drug_name">(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6103</field>
		<field name="drug_name">(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6104</field>
		<field name="drug_name">(1S)-1-(PHENOXYMETHYL)PROPYL METHYLPHOSPHONOCHLORIDOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6105</field>
		<field name="drug_name">1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6106</field>
		<field name="drug_name">PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6107</field>
		<field name="drug_name">[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6108</field>
		<field name="drug_name">[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6109</field>
		<field name="drug_name">[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6110</field>
		<field name="drug_name">3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6111</field>
		<field name="drug_name">THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6112</field>
		<field name="drug_name">PREPHENIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6113</field>
		<field name="drug_name">3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6114</field>
		<field name="drug_name">N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6115</field>
		<field name="drug_name">PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6116</field>
		<field name="drug_name">[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6117</field>
		<field name="drug_name">THYMIDINE-5'-THIOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6118</field>
		<field name="drug_name">phenyl ethenesulfonate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6119</field>
		<field name="drug_name">2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6120</field>
		<field name="drug_name">(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6121</field>
		<field name="drug_name">8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6122</field>
		<field name="drug_name">PUROMYCIN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6123</field>
		<field name="drug_name">(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6124</field>
		<field name="drug_name">parecoxib</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6125</field>
		<field name="drug_name">N-1,10-phenanthrolin-5-ylacetamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6126</field>
		<field name="drug_name">6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6127</field>
		<field name="drug_name">4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6128</field>
		<field name="drug_name">2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6129</field>
		<field name="drug_name">3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6130</field>
		<field name="drug_name">(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6131</field>
		<field name="drug_name">3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6132</field>
		<field name="drug_name">3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6133</field>
		<field name="drug_name">(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6134</field>
		<field name="drug_name">2-(3-((4,5,7-trifluorobenzothiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6135</field>
		<field name="drug_name">N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6136</field>
		<field name="drug_name">N-(QUINOLIN-8-YL)METHANESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6137</field>
		<field name="drug_name">2-NONYL-4-HYDROXYQUINOLINE N-OXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6138</field>
		<field name="drug_name">N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6139</field>
		<field name="drug_name">9-(4-HYDROXY-2,6-DIMETHYL-PHENYL)-3,7-DIMETHYL-NONA-4,6,8-TRIENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6140</field>
		<field name="drug_name">3-{[(2,2,5,5-TETRAMETHYL-1-OXO-4-PHENYL-2,5-DIHYDRO-1H-PYRROLIUM-3-YL)METHYL]DISULFANYL}-D-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6141</field>
		<field name="drug_name">4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6142</field>
		<field name="drug_name">(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6143</field>
		<field name="drug_name">3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6144</field>
		<field name="drug_name">3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6145</field>
		<field name="drug_name">3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6146</field>
		<field name="drug_name">N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6147</field>
		<field name="drug_name">(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6148</field>
		<field name="drug_name">METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6149</field>
		<field name="drug_name">2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6150</field>
		<field name="drug_name">5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6151</field>
		<field name="drug_name">6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6152</field>
		<field name="drug_name">2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6153</field>
		<field name="drug_name">tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6154</field>
		<field name="drug_name">3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6155</field>
		<field name="drug_name">1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6156</field>
		<field name="drug_name">(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6157</field>
		<field name="drug_name">5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6158</field>
		<field name="drug_name">3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6159</field>
		<field name="drug_name">[(4R)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]METHYL HYDROGEN HEX-5-ENYLPHOSPHONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6160</field>
		<field name="drug_name">3-AMINO-AZACYCLOTRIDECAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6161</field>
		<field name="drug_name">5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6162</field>
		<field name="drug_name">N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6163</field>
		<field name="drug_name">N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6164</field>
		<field name="drug_name">4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6165</field>
		<field name="drug_name">4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6166</field>
		<field name="drug_name">[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6167</field>
		<field name="drug_name">4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6168</field>
		<field name="drug_name">(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6169</field>
		<field name="drug_name">2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6170</field>
		<field name="drug_name">3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6171</field>
		<field name="drug_name">4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6172</field>
		<field name="drug_name">N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6173</field>
		<field name="drug_name">4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6174</field>
		<field name="drug_name">N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6175</field>
		<field name="drug_name">(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6176</field>
		<field name="drug_name">5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6177</field>
		<field name="drug_name">S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6178</field>
		<field name="drug_name">4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6179</field>
		<field name="drug_name">(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6180</field>
		<field name="drug_name">(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6181</field>
		<field name="drug_name">N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6182</field>
		<field name="drug_name">(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6183</field>
		<field name="drug_name">DIETHYL PROPANE-1,3-DIYLBISCARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6184</field>
		<field name="drug_name">5-(3,5-DICHLOROPHENYL)THIO-4-ISOPROPYL-1-(PYRIDIN-4-YL-METHYL)-1H-IMIDAZOL-2-YL-METHYL CARBAMATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6185</field>
		<field name="drug_name">(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6186</field>
		<field name="drug_name">6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6187</field>
		<field name="drug_name">methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6188</field>
		<field name="drug_name">N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6189</field>
		<field name="drug_name">N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6190</field>
		<field name="drug_name">N-BENZOYL-D-ALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6191</field>
		<field name="drug_name">1-[6-(2-CHLORO-4-METHYXYPHENOXY)-HEXYL]-IMIDAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6192</field>
		<field name="drug_name">5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6193</field>
		<field name="drug_name">6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6194</field>
		<field name="drug_name">6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6195</field>
		<field name="drug_name">[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6196</field>
		<field name="drug_name">6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6197</field>
		<field name="drug_name">(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6198</field>
		<field name="drug_name">(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6199</field>
		<field name="drug_name">(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6200</field>
		<field name="drug_name">N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6201</field>
		<field name="drug_name">(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6202</field>
		<field name="drug_name">4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6203</field>
		<field name="drug_name">4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6204</field>
		<field name="drug_name">[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6205</field>
		<field name="drug_name">2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6206</field>
		<field name="drug_name">HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6207</field>
		<field name="drug_name">CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6208</field>
		<field name="drug_name">1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6209</field>
		<field name="drug_name">2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6210</field>
		<field name="drug_name">(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6211</field>
		<field name="drug_name">7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6212</field>
		<field name="drug_name">5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6213</field>
		<field name="drug_name">6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6214</field>
		<field name="drug_name">3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6215</field>
		<field name="drug_name">5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6216</field>
		<field name="drug_name">3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6217</field>
		<field name="drug_name">3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6218</field>
		<field name="drug_name">3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6219</field>
		<field name="drug_name">N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6220</field>
		<field name="drug_name">3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6221</field>
		<field name="drug_name">2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6222</field>
		<field name="drug_name">[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzoisochromen-3-yl]acetic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6223</field>
		<field name="drug_name">3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6224</field>
		<field name="drug_name">1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6225</field>
		<field name="drug_name">(3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6226</field>
		<field name="drug_name">(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6227</field>
		<field name="drug_name">4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6228</field>
		<field name="drug_name">PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6229</field>
		<field name="drug_name">[(4S)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]METHYL HYDROGEN HEX-5-ENYLPHOSPHONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6230</field>
		<field name="drug_name">(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6231</field>
		<field name="drug_name">7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6232</field>
		<field name="drug_name">(1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6233</field>
		<field name="drug_name">(1R)-1-(2-THIENYLACETYLAMINO)-1-PHENYLMETHYLBORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6234</field>
		<field name="drug_name">(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6235</field>
		<field name="drug_name">N-(3-CARBOXYPROPANOYL)-L-NORVALINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6236</field>
		<field name="drug_name">1-(3-BROMOPHENYL)-7-CHLORO-6-METHOXY-3,4-DIHYDROISOQUINOLINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6237</field>
		<field name="drug_name">5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6238</field>
		<field name="drug_name">2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6239</field>
		<field name="drug_name">2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6240</field>
		<field name="drug_name">N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)-4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~-THIA-1-AZABICYCLO[3.2.0]HEPT-6-YL]-2-PHENYLACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6241</field>
		<field name="drug_name">3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6242</field>
		<field name="drug_name">BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6243</field>
		<field name="drug_name">4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6244</field>
		<field name="drug_name">(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6245</field>
		<field name="drug_name">L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6246</field>
		<field name="drug_name">D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6247</field>
		<field name="drug_name">(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6248</field>
		<field name="drug_name">(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6249</field>
		<field name="drug_name">3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6250</field>
		<field name="drug_name">4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6251</field>
		<field name="drug_name">4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6252</field>
		<field name="drug_name">4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6253</field>
		<field name="drug_name">3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6254</field>
		<field name="drug_name">(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6255</field>
		<field name="drug_name">2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6256</field>
		<field name="drug_name">1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6257</field>
		<field name="drug_name">3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6258</field>
		<field name="drug_name">4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6259</field>
		<field name="drug_name">4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6260</field>
		<field name="drug_name">4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6261</field>
		<field name="drug_name">4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6262</field>
		<field name="drug_name">N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6263</field>
		<field name="drug_name">2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6264</field>
		<field name="drug_name">6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6265</field>
		<field name="drug_name">S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6266</field>
		<field name="drug_name">S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6267</field>
		<field name="drug_name">SINAPINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6268</field>
		<field name="drug_name">2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6269</field>
		<field name="drug_name">SYRINGATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6270</field>
		<field name="drug_name">1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6271</field>
		<field name="drug_name">5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6272</field>
		<field name="drug_name">4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6273</field>
		<field name="drug_name">1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6274</field>
		<field name="drug_name">TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6275</field>
		<field name="drug_name">4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6276</field>
		<field name="drug_name">5'-deoxy-5'-piperidin-1-ylthymidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6277</field>
		<field name="drug_name">6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6278</field>
		<field name="drug_name">4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6279</field>
		<field name="drug_name">N-[(4-methoxyphenyl)sulfonyl]-D-alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6280</field>
		<field name="drug_name">5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6281</field>
		<field name="drug_name">tributylstannanyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6282</field>
		<field name="drug_name">3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6283</field>
		<field name="drug_name">N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6284</field>
		<field name="drug_name">TRICLOSAN</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6285</field>
		<field name="drug_name">6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6286</field>
		<field name="drug_name">(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6287</field>
		<field name="drug_name">(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6288</field>
		<field name="drug_name">4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6289</field>
		<field name="drug_name">(N-{4-[(ETHYLANILINO)SULFONYL]-2-METHYLPHENYL}-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6290</field>
		<field name="drug_name">N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6291</field>
		<field name="drug_name">2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6292</field>
		<field name="drug_name">1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6293</field>
		<field name="drug_name">2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6294</field>
		<field name="drug_name">3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6295</field>
		<field name="drug_name">2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6296</field>
		<field name="drug_name">4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6297</field>
		<field name="drug_name">3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6298</field>
		<field name="drug_name">TESTOSTERONE HEMISUCCINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6299</field>
		<field name="drug_name">{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6300</field>
		<field name="drug_name">THIAMPHENICOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6301</field>
		<field name="drug_name">4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6302</field>
		<field name="drug_name">2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6303</field>
		<field name="drug_name">BENZOTHIAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6304</field>
		<field name="drug_name">Thiorphan</field>
		<field name="description">A potent inhibitor of membrane metalloendopeptidase (enkephalinase). Thiorphan potentiates morphine-induced analgesia and attenuates naloxone-precipitated withdrawal symptoms.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6305</field>
		<field name="drug_name">(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6306</field>
		<field name="drug_name">(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6307</field>
		<field name="drug_name">N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6308</field>
		<field name="drug_name">N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6309</field>
		<field name="drug_name">1,3,5-BENZENETRICARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6310</field>
		<field name="drug_name">(CHLOROACETYL)CARBAMIC ACID (3R,4S,5S,5R)-5-METHOXY-4-[(2R,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL]-1-OXASPIRO[2.5]OCT-6-YL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6311</field>
		<field name="drug_name">6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6312</field>
		<field name="drug_name">N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6313</field>
		<field name="drug_name">(3E)-4-(2-HYDROXYPHENYL)-2-OXOBUT-3-ENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6314</field>
		<field name="drug_name">4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6315</field>
		<field name="drug_name">2-AMINO-3-(1-HYDROPEROXY-1H-INDOL-3-YL)PROPAN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6316</field>
		<field name="drug_name">4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6317</field>
		<field name="drug_name">(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6318</field>
		<field name="drug_name">(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6319</field>
		<field name="drug_name">(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6320</field>
		<field name="drug_name">2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6321</field>
		<field name="drug_name">{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6322</field>
		<field name="drug_name">6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6323</field>
		<field name="drug_name">TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6324</field>
		<field name="drug_name">TRAZEOLIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6325</field>
		<field name="drug_name">8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6326</field>
		<field name="drug_name">(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6327</field>
		<field name="drug_name">(1R,3S,5S,8R)-8-HYDROXY-2-OXABICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6328</field>
		<field name="drug_name">3'-THIO-THYMIDINE-5'-PHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6329</field>
		<field name="drug_name">2-(1H-INDOL-3-YL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6330</field>
		<field name="drug_name">2-(1H-INDOL-3-YL)ETHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6331</field>
		<field name="drug_name">TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6332</field>
		<field name="drug_name">9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6333</field>
		<field name="drug_name">5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6334</field>
		<field name="drug_name">2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6335</field>
		<field name="drug_name">ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6336</field>
		<field name="drug_name">2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6337</field>
		<field name="drug_name">1,2,5,8-tetrahydroxyanthracene-9,10-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6338</field>
		<field name="drug_name">1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6339</field>
		<field name="drug_name">3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6340</field>
		<field name="drug_name">4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6341</field>
		<field name="drug_name">({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6342</field>
		<field name="drug_name">6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6343</field>
		<field name="drug_name">5-IMINO-4-(3-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6344</field>
		<field name="drug_name">4-(4-FLUORO-PHENYLAZO)-5-IMINO-5H-PYRAZOL-3-YLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6345</field>
		<field name="drug_name">3-(5-AMINO-3-IMINO-3H-PYRAZOL-4-YLAZO)-BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6346</field>
		<field name="drug_name">METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6347</field>
		<field name="drug_name">METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6348</field>
		<field name="drug_name">5-IMINO-4-(2-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6349</field>
		<field name="drug_name">4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6350</field>
		<field name="drug_name">4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6351</field>
		<field name="drug_name">(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6352</field>
		<field name="drug_name">(6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6353</field>
		<field name="drug_name">(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6354</field>
		<field name="drug_name">N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6355</field>
		<field name="drug_name">(4-ETHYLPHENYL)SULFAMIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6356</field>
		<field name="drug_name">2-METHYL-FURAN-3-CARBOTHIOIC ACID [4-CHLORO-3-(3-METHYL-BUT-2-ENYLOXY)-PHENYL]-AMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6357</field>
		<field name="drug_name">N-[4-CLORO-3-(T-BUTYLOXOME)PHENYL-2-METHYL-3-FURAN-CARBOTHIAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6358</field>
		<field name="drug_name">1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6359</field>
		<field name="drug_name">1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6360</field>
		<field name="drug_name">REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6361</field>
		<field name="drug_name">O-DECYL HYDROGEN THIOCARBONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6362</field>
		<field name="drug_name">1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6363</field>
		<field name="drug_name">5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6364</field>
		<field name="drug_name">N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6365</field>
		<field name="drug_name">undecan-2-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6366</field>
		<field name="drug_name">UBIQUINONE-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6367</field>
		<field name="drug_name">UBIQUINONE-2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6368</field>
		<field name="drug_name">ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6369</field>
		<field name="drug_name">D-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6370</field>
		<field name="drug_name">L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6371</field>
		<field name="drug_name">9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6372</field>
		<field name="drug_name">3-(4-nitrophenyl)-1H-pyrazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6373</field>
		<field name="drug_name">5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6374</field>
		<field name="drug_name">4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6375</field>
		<field name="drug_name">1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6376</field>
		<field name="drug_name">1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6377</field>
		<field name="drug_name">3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6378</field>
		<field name="drug_name">2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6379</field>
		<field name="drug_name">2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6380</field>
		<field name="drug_name">12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6381</field>
		<field name="drug_name">[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6382</field>
		<field name="drug_name">6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6383</field>
		<field name="drug_name">(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6384</field>
		<field name="drug_name">4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6385</field>
		<field name="drug_name">N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6386</field>
		<field name="drug_name">2,3-diphenyl-1H-indole-7-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6387</field>
		<field name="drug_name">(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6388</field>
		<field name="drug_name">VANILLATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6389</field>
		<field name="drug_name">11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6390</field>
		<field name="drug_name">2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6391</field>
		<field name="drug_name">2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6392</field>
		<field name="drug_name">2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6393</field>
		<field name="drug_name">[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6394</field>
		<field name="drug_name">4-(3-ethylthiophen-2-yl)benzene-1,2-diol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6395</field>
		<field name="drug_name">5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6396</field>
		<field name="drug_name">5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6397</field>
		<field name="drug_name">5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-(HYDROXYETHYL OXYMETHYLENEOXYMETHYL) ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6398</field>
		<field name="drug_name">5-(7-(6-CHLORO-4-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6399</field>
		<field name="drug_name">5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6400</field>
		<field name="drug_name">5-(5-(4-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6401</field>
		<field name="drug_name">5-(7-(5-HYDRO-4-ETHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6402</field>
		<field name="drug_name">5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6403</field>
		<field name="drug_name">5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6404</field>
		<field name="drug_name">5-(3-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PROPYL)-3-METHYL ISOXAZOLE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6405</field>
		<field name="drug_name">5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6406</field>
		<field name="drug_name">3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6407</field>
		<field name="drug_name">2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6408</field>
		<field name="drug_name">NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6409</field>
		<field name="drug_name">(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6410</field>
		<field name="drug_name">6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6411</field>
		<field name="drug_name">4-HYDROXY-3-[(1S,3R)-3-HYDROXY-1-PHENYLBUTYL]-2H-CHROMEN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6412</field>
		<field name="drug_name">4-HYDROXY-3-[(1S,3S)-3-HYDROXY-1-PHENYLBUTYL]-2H-CHROMEN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6413</field>
		<field name="drug_name">(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6414</field>
		<field name="drug_name">1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6415</field>
		<field name="drug_name">2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6416</field>
		<field name="drug_name">CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6417</field>
		<field name="drug_name">5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6418</field>
		<field name="drug_name">1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6419</field>
		<field name="drug_name">2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6420</field>
		<field name="drug_name">6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6421</field>
		<field name="drug_name">4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6422</field>
		<field name="drug_name">1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6423</field>
		<field name="drug_name">(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6424</field>
		<field name="drug_name">4-(DIMETHYLAMINO)BENZOIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6425</field>
		<field name="drug_name">3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6426</field>
		<field name="drug_name">1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6427</field>
		<field name="drug_name">N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6428</field>
		<field name="drug_name">N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6429</field>
		<field name="drug_name">4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6430</field>
		<field name="drug_name">(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6431</field>
		<field name="drug_name">N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6432</field>
		<field name="drug_name">(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6433</field>
		<field name="drug_name">5-(2-chlorophenyl)furan-2-carbohydrazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6434</field>
		<field name="drug_name">IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6435</field>
		<field name="drug_name">[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6436</field>
		<field name="drug_name">(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6437</field>
		<field name="drug_name">(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6438</field>
		<field name="drug_name">O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6439</field>
		<field name="drug_name">[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6440</field>
		<field name="drug_name">4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6441</field>
		<field name="drug_name">6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6442</field>
		<field name="drug_name">L-PROLINE, 1-[(2S)-3-MERCAPTO-2-METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)-, 4S</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6443</field>
		<field name="drug_name">2-(4-METHOXYPHENYL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6444</field>
		<field name="drug_name">N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6445</field>
		<field name="drug_name">4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6446</field>
		<field name="drug_name">(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6447</field>
		<field name="drug_name">3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6448</field>
		<field name="drug_name">RALOXIFENE CORE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6449</field>
		<field name="drug_name">1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6450</field>
		<field name="drug_name">BENZOYL-TYROSINE-ALANINE-METHYL KETONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6451</field>
		<field name="drug_name">N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6452</field>
		<field name="drug_name">5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6453</field>
		<field name="drug_name">[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6454</field>
		<field name="drug_name">2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6455</field>
		<field name="drug_name">6-MORPHOLIN-4-YL-9H-PURINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6456</field>
		<field name="drug_name">1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6457</field>
		<field name="drug_name">4-(2-AMINOETHYL)BENZENESULFONAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6458</field>
		<field name="drug_name">(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6459</field>
		<field name="drug_name">2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6460</field>
		<field name="drug_name">4-METHYL-2H-CHROMEN-2-ONE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6461</field>
		<field name="drug_name">4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6462</field>
		<field name="drug_name">4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6463</field>
		<field name="drug_name">3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6464</field>
		<field name="drug_name">2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6465</field>
		<field name="drug_name">1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6466</field>
		<field name="drug_name">1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6467</field>
		<field name="drug_name">Ethyl biscoumacetate</field>
		<field name="description">Ethyl biscoumacetate is a courmarin that is used as an anticoagulant. It has actions similar to those of Warfarin. (From Martindale, The Extra Pharmacopoeia, 30th ed, p226)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6468</field>
		<field name="drug_name">Azidocillin</field>
		<field name="description">Azidocillin is a penicillin antibiotic similir to ampicillin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6469</field>
		<field name="drug_name">Pipazethate</field>
		<field name="description">A non-narcotic oral antitussive agent.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6470</field>
		<field name="drug_name">Salicylamide</field>
		<field name="description">Salicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl. Salicylamide is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of aspirin. Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedies</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6471</field>
		<field name="drug_name">Antazoline</field>
		<field name="description">Antazoline is a 1st generation antihistamine that also anticholinergic properties used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6472</field>
		<field name="drug_name">Chloropyramine</field>
		<field name="description">Chloropyramine is a first generation antihistamine drug approved in some Eastern European countries for the treatment of allergic conjunctivitis, allergic rhinitis, bronchial asthma, and other atopic (allergic) conditions. Related indications for clinical use include Quincke's edema, allergic reactions to insect bites, food and drug allergies, and anaphylactic shock.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6473</field>
		<field name="drug_name">Dimethindene</field>
		<field name="description">Dimetindene (Fenistil) is an antihistamine/anticholinergic used orally and locally as an antipruritic.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6474</field>
		<field name="drug_name">Isothipendyl</field>
		<field name="description">Isothipendyl is an antihistamine and anticholinergic used as an antipruritic.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6475</field>
		<field name="drug_name">Tymazoline</field>
		<field name="description">Tymazoline is a nasal preparation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6476</field>
		<field name="drug_name">Nandrolone decanoate</field>
		<field name="description">C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position. It is a schedule III drug in the U.S.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6477</field>
		<field name="drug_name">Metiamide</field>
		<field name="description">Metiamide is a histamine H2-receptor antagonist developed from another H2 antagonist, burimamide. It was an intermediate compound in the development of the successful anti-ulcer drug cimetidine.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6478</field>
		<field name="drug_name">Roxatidine acetate</field>
		<field name="description">Roxatidine acetate is a specific and competitive H2 receptor antagonist. It is currently approved in South Africa under the tradename Roxit.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6479</field>
		<field name="drug_name">Bopindolol</field>
		<field name="description">Bopindolol (INN) is a beta blocker. It is an ester which acts as a prodrug for &quot;pindolol&quot;:http://drugbank.ca/drugs/DB00960.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6480</field>
		<field name="drug_name">Bupranolol</field>
		<field name="description">Bupranolol is a non-selective beta blocker without intrinsic sympathomimetic activity (ISA), but with strong membrane stabilizing activity. Its potency is similar to &quot;propranolol&quot;:http://www.drugbank.ca/drugs/DB00571.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6481</field>
		<field name="drug_name">Dichloroacetic Acid</field>
		<field name="description">Dichloroacetic acid, often abbreviated DCA, is an acid analogue of acetic acid in which two of the three hydrogen atoms of the methyl group have been replaced by chlorine atoms. The salts and esters of dichloroacetic acid are called dichloroacetates. Salts of DCA are used as drugs since they inhibit the enzyme pyruvate dehydrogenase kinase. Early reports of its activity against brain cancer cells led patients to treat themselves with DCA, which is commercially available in non-pharmaceutical grade. A phase 1 study in 5 patients concluded that DCA was safe, but wasn't designed to establish effectiveness.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6482</field>
		<field name="drug_name">Cinitapride</field>
		<field name="description">Cinitapride is a gastroprokinetic agent and antiulcer agent of the benzamide class which is marketed in Spain and Mexico. It acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6483</field>
		<field name="drug_name">Tofisopam</field>
		<field name="description">Tofisopam (marketed under brand names Emandaxin and Grandaxin) is a 2,3-benzodiazepine drug which is a benzodiazepine derivative. In contrast to classical 1,4-benzodiazepines, the compound does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor and its psychopharmacological profile differs from such compounds. Although Tofisopam is not approved for sale in North America, it is approved for use in various countries worldwide, including parts of Europe. The D-enantiomer (dextofisopam) is currently in phase II trials in the U.S. for the treatment of irritable bowel syndrome.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6484</field>
		<field name="drug_name">Nadroparin</field>
		<field name="description">Nadroparin is a low molecular weight heparin (LMWH) which, when bound to antithrombin III (ATIII), accelerates the inactivation of factor II and factor Xa. Nadroparin halts the coagulation pathway by inhibiting the activation of thrombin (factor IIa) by factor Xa. The amplification of the fibrin clotting cascade is stopped once factors Xa and IIa are inactivated. It is derived from porcine sources and has a mean molecular size of 5000 daltons. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6485</field>
		<field name="drug_name">Triflusal</field>
		<field name="description">Approved by the European Stroke Organization, triflusal is recommended as lone therapy for the secondary prevention of atheroembotic stroke. Triflusal appears to be equally effective with a better safety profile than acetylsalicylic acid plus dypridamole and clopidogrel alone based on a double blind, randomized TACIP and TAPIRSS trials.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6486</field>
		<field name="drug_name">Lurasidone</field>
		<field name="description">Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States. (Wikipedia)</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6487</field>
		<field name="drug_name">Ticagrelor</field>
		<field name="description">Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. Unlike clopidogrel, ticagrelor is not a prodrug and does not require metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6488</field>
		<field name="drug_name">Hyaluronan</field>
		<field name="description">Sodium hyaluronate is the sodium salt of hyaluronan. The term hyaluronate also refers to the conjugate base of hyaluronic acid. Because the molecule typically exists in vivo in its polyanionic form, it is most commonly referred to as hyaluronan. It is a visco-elastic polymer normally found in the aqueous and vitreous humour. Sodium hyaluronate is a viscous solution consisting of a high molecular weight (500,000-730,000 daltons) fraction of purified natural sodium hyaluronate in buffered physiological sodium chloride. Hyaluronic acid is a natural complex sugar of the glycosaminoglycan family and is a long-chain polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. Sodium hyaluronate occurs naturally on the corneal endothelium, bound to specific receptors for which it has a high affinity.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6489</field>
		<field name="drug_name">Tafluprost</field>
		<field name="description">A prostaglandin analogue ester prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. Chemically, tafluprost is a fluorinated analog of prostaglandin F2-alpha. Tafluprost was approved for use in the U.S. on February 10, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6490</field>
		<field name="drug_name">Ivacaftor</field>
		<field name="description">Ivacaftor (also known as Kalydeco or VX-770) is a drug for the treatment of cystic fibrosis, developed by Vertex Pharmaceuticals and the Cystic Fibrosis Foundation. FDA approved on January 31, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6491</field>
		<field name="drug_name">Azilsartan medoxomil</field>
		<field name="description">Azilsartan medoxomil is an angiotensin II receptor antagonist indicated for the treatment of mild to moderate essential hypertension. Azilsartan medoxomil is a prodrug of Azilsartan marketed as &quot;Edarbi&quot; by Takeda. Azilsartan medoxomil has so far been shown to be superior to olmesartan and valsartan in lowering blood pressure.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6492</field>
		<field name="drug_name">Ioflupane I 123</field>
		<field name="description">Ioflupane (I-123) is a radiopharmaceutical used to image dopamine neurons and diagnose Parkinsonian syndromes.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6493</field>
		<field name="drug_name">Deferiprone</field>
		<field name="description">Deferiprone is an oral iron chelator used as a second line agent in thalassemia syndromes when iron overload from blood transfusions occurs. Thalassemias are a type of hereditary anaemia due a defect in the production of hemoglobin. As a result, erythropoiesis, the production of new red blood cells, is impaired. FDA approved on October 14, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6494</field>
		<field name="drug_name">Lomitapide</field>
		<field name="description">Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor used in homozygous familial hypercholesterolemia (HoFH) patients. It is marketed under the name Juxtapid.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6495</field>
		<field name="drug_name">Vismodegib</field>
		<field name="description">Vismodegib inhibits the hedgehog signalling pathway and is indicated for treatment of adult basal cell carcinoma. FDA approved on Jan 30, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6496</field>
		<field name="drug_name">Dehydroascorbic Acid</field>
		<field name="description">Dehydroascorbic acid is made from the oxidation of ascorbic acid. This reaction is reversible, but dehydroascorbic acid can instead undergo irreversible hydrolysis to 2,3-diketogulonic acid. Dehydroascorbic acid as well as ascorbic acid are both termed Vitamin C, but the latter is the main form found in humans. In the body, both dehydroascorbic acid and ascorbic acid have similar biological activity as antivirals but dehydroascorbic acid also has neuroprotective effects. Currently dehydroascorbic acid is an experimental drug with no known approved indications.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6497</field>
		<field name="drug_name">2-deoxyglucose</field>
		<field name="description">2-deoxyglucose is predominantly used as a diagnostic agent in its radiolabelled form (fluorine-18 is used as the radiolabel). By using positron emission tomography (PET), radiolabelled 2-deoxyglucose can determine glucose metabolism, which is altered in diseases such as cardiovascular disease, tumors, and Alzheimer's disease. Therapeutically, 2-deoxyglucose is an investigational drug that is being studied as an anticancer and antiviral agent. Concerning the former, 2- deoxyglucose was used as an adjunct to chemotherapy and radiotherapy in the treatment of solid tumors (lung, breast, pancreas, head, neck, and gastric tumors). The exact mechanisms of action of 2-deoxyglucose is still being investigated, but it is known that in hypoxic cancer cells, 2-deoxyglucose is a glycolysis inhibitor that prevents ATP production and, ultimately, cell survival. With respect to antiviral therapy, 2-deoxyglucose was shown to be effective against herpes simplex virus by affecting the virus' ability to p...</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6498</field>
		<field name="drug_name">Tauroursodeoxycholic acid</field>
		<field name="description">Tauroursodeoxycholic acid is the more hydrophilic form of ursodeoxycholic acid, which is the more abundant naturally produced bile acid in humans. Tauroursodeoxycholic acid, on the other hand, is produced abundantly in bears and has been used for centuries as a natural remedy in some Asian countries. It is approved in Italy and Turkey for the treatment of cholesterol gallstones and is an investigational drug in China, Unites States, and Italy. Tauroursodeoxycholic acid is being investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis. The only completed clinical trial thus far is a phase III clinical trial comparing tauroursodeoxycholic acid and ursofalk in PBC adult patients, but as of June 2013 no results of this trial have been published.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6499</field>
		<field name="drug_name">Spaglumic Acid</field>
		<field name="description">Spaglumic acid is the ?-aspartyl isoform of N-Acetyl-l-aspartylglutamate (isospaglumic Acid is N-(N-Acetyl-l-?-aspartyl)-l-glutamic acid). In eye drops, spaglumic acid is either a magnesium or sodium salt of N-Acetyl-l-aspartylglutamate. Spaglumic acid is a mast cell stabilizer. Thus it is used in allergic conditions such as allergic conjunctivitis. Specifically spaglumic acid is approved in Portugal under the brand name Naabak and in Greece under the brand name Naaxia for use in patients with allergic conjunctivitis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6500</field>
		<field name="drug_name">Temocapril</field>
		<field name="description">Temocapril is a prodrug-type angiotensin-I converting enzyme (ACE) inhibitor not approved for use in the United States, but is approved in Japan and South Korea. Temocapril can also be used in hemodialysis patients without risk of serious accumulation.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6501</field>
		<field name="drug_name">Tetraethylammonium</field>
		<field name="description">Tetraethylammonium is an experimental drug with no approved indication or marketed formulation. The only marketed drug containing tetraethylammonium was a combination drug called Fosglutamina B6, but this drug has now been discontinued. As an experimental agent, tetraethylammonium is used in its salt forms such as tetraethylammonium chloride and tetraethylammonium bromide. Its mechanism of action is still being investigated, but it is known that tetraethylammonium blocks autonomic ganglia, calcium- and voltage- activated potassium channels, and nicotinic acetylcholine receptors. Because of its inhibitory actions at the autonomic ganglia, tetraethylammonium was thought to be a potential therapeutic vasodilator but serious toxic effects were found. The most common use of tetraethylammonium presently is as a pharmacological research agent that blocks selective potassium channels. Structurally, tetraethylammonium is positively charged due to its central quaternary ammonium.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6502</field>
		<field name="drug_name">Agmatine</field>
		<field name="description">Agmantine is a natural metabolite of the amino acid arginine. It is formed when arginine is decarboxylated by the enzyme arginine decarboxylase and is found naturally in ragweed pollen, ergot fungi, octopus muscle, herring sperm, sponges, and the mammalian brain. Agmatine is both an experimental and investigational drug. As an investigational drug, it is being studied in a non-blinded prospective case study in the United States looking at patients who have been diagnosed with small fiber peripheral neuropathy between the ages of 18 to 75 years. Up to now (July 2013), the results of this study have not yet been published. As an experimental drug, agmatine is being studied for several indications such as cardioprotection, diabetes, decreased kidney function, neuroprotection (stroke, severe CNS injuries, epilepsy, glaucoma, and neuropathic pain), and psychiatric conditions (depression, anxiety, schizophrenia, and cognition). The exact mechanism of action is still being investigated for al...</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6503</field>
		<field name="drug_name">Ellagic Acid</field>
		<field name="description">Ellagic acid is present in several fruits such as cranberries, strawberries, raspberries, and pomegranates. In pomegranates, there are several therapeutic compounds but ellagic acid is the most active and abundant. Ellagic acid is also present in vegetables. Ellagic acid is an investigational drug studied for treatment of Follicular Lymphoma (phase 2 trial), protection from brain injury of intrauterine growth restricted babies (phase 1 and 2 trial), improvement of cardiovascular function in adolescents who are obese (phase 2 trial), and topical treatment of solar lentigines. Ellagic acid's therapeutic action mostly involves antioxidant and anti-proliferative effects.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6504</field>
		<field name="drug_name">Hydroxyproline</field>
		<field name="description">Hydroxyproline is a neutral heterocyclic protein amino acid. It is found in collagen and as such it is common in many gelatin products. Hydroxyproline is mostly used as a diagnostic marker of bone turnover and liver fibrosis. Therapeutically, hydroxyproline is being studied as an an experimental medicine but is approved in France as a combination topical gel product called Cicactive for small, superficial wounds.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6505</field>
		<field name="drug_name">Guvacine</field>
		<field name="description">Guvacine is a pyridine alkaloid found in the Areca nut (also known as the Betel nut). It is an experimental drug with no approved indication. Experimental studies are still being investigated to determine all of the physiological effects and mechanisms of action of guvacine. Currently it has been determined that guvacine is a specific GABA reuptake inhibitor with no significant affinity at GABA receptors.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6506</field>
		<field name="drug_name">Pitavastatin</field>
		<field name="description">Pitavastatin a lipid-lowering agent that belongs to the statin class of medications for treatment of dyslipidemia. It is also used for primary and secondary prevention of cardiovascular disease. FDA approved in Aug 3, 2009.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6507</field>
		<field name="drug_name">Estradiol valerate/Dienogest</field>
		<field name="description">Estradiol valerate/Dienogest is a Combined oral contraceptive (COC) indicated for use by women to prevent pregnancy. It is also indicated for the treatment of heavy menstrual bleeding in women.    The efficacy of Estradiol valerate/Dienogest in women with a body mass index of   &gt;30 kg/m2 has not been evaluated.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6508</field>
		<field name="drug_name">Fingolimod</field>
		<field name="description">Fingolimod is a sphingosine 1-phosphate receptor modulator indicated and approved for the treatment of relapsing-remitting multiple sclerosis.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6509</field>
		<field name="drug_name">Tesamorelin</field>
		<field name="description">Tesamorelin is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing Hormone (GHRH) indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Lipodystrophy is a metabolic condition characterized by insulin resistance, fat redistribution, and hyperlipidemia associated with antiretroviral therapy for HIV infection.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6510</field>
		<field name="drug_name">BRENTUXIMAB VEDOTIN</field>
		<field name="description">Brentuximag vedotin or Adcetris® is an antibody-drug conjugate that combines an anti-CD30 antibody and the drug monomethyl auristatin E (MMAE). It is an anti-neoplastic agent used in the treatment of Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Brentuximag vedotin was approved in 2011, and in January 2012, the drug label was revised to include a boxed warning of progressive multifocal leukoencephalopathy and death following JC virus infection.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6511</field>
		<field name="drug_name">Eribulin</field>
		<field name="description">Eribulin is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Eribulin was isolated from the marine sponge Halichondria okadai. Eribulin is also being investigated for use in the treatment of advanced solid tumors. [PMID: 23010853]</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6512</field>
		<field name="drug_name">gabapentin enacarbil</field>
		<field name="description">Gabapentin enacarbil is marketed under the name Horizant®. It is a prodrug of gabapentin, and indicated in adults for the treatment of Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6513</field>
		<field name="drug_name">Cabozantinib</field>
		<field name="description">Cabozantinib was approved in 2012 and is a non-specific tyrosine kinase inhibitor. It is marketed as COMETRIQ™, which is indicated for the treatment of metastatic medullary thyroid cancer. It's label includes a black box warning of gastrointestinal perforations, fistulas, and hemorrhage.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6514</field>
		<field name="drug_name">Taliglucerase Alfa</field>
		<field name="description">Taliglucerase alfa is the recombinant active form of the human lysosomal enzyme, ?-glucocerebrosidase. It was approved in 2012 and is marketed under the name Elelyso for use in patients with type 1 Gaucher's disease.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6515</field>
		<field name="drug_name">Ruxolitinib</field>
		<field name="description">Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis. FDA approved on November 16, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6516</field>
		<field name="drug_name">Aminopterin</field>
		<field name="description">Aminopterin is an amino derivative of folic acid, which was once used as an antineoplastic agent in the treatment of pediatric leukemia. In the 1950's its production was discontinued in favor of methotrexate, which is less potent but less toxic. Off label, aminopterin has also been used in the treatment of psoriasis. Clinicians need to be aware of the characteristic teratologic  effects of aminopterin and methotrexate.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6517</field>
		<field name="drug_name">Belimumab</field>
		<field name="description">Belimumab is an intravenous immunosupressant for the adjunctive treatment of systemic lupus erythematosus (SLE). More specifically, it is a fully human recombinant monoclonal IgG antibody and is the first biological treatment approved for this indication (SLE). Avoid concomitant use with live or inactivated vaccines. FDA approved on March 9, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6518</field>
		<field name="drug_name">Teriflunomide</field>
		<field name="description">Teriflunomide is the active metabolite of leflunomide, and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis. It is marketed under the name Aubagio® and is indicated for the treatment of multiple sclerosis, specifically relapsing forms. The FDA label states an important warning about the risk of hepatoxicity and teratogenicity for patients using teriflunomide.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6519</field>
		<field name="drug_name">Vemurafenib</field>
		<field name="description">Vemurafenib is a BRAF enzyme inhibitor developed by Plexxikon and Genentech for the treatment of late-stage melanoma. [Wikipedia] The cobas® 4800 BRAF B600 mutation test provided by Roche Molecular Systems is the diagnostic test to confirm eligibility for treatment. FDA approved on August 17, 2011 under the company Hoffmann La Roche.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6520</field>
		<field name="drug_name">Linagliptin</field>
		<field name="description">Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for the treatment of type II diabetes [Wikipedia]. Two pharmacological characteristics that sets linagliptin apart from other DPP-4 inhibitors is that it has a non-linear pharmacokinetic profile and is not primarily eliminated by the renal system. FDA approved on May 2, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6521</field>
		<field name="drug_name">Perampanel</field>
		<field name="description">Perampanel is a noncompetitive AMPA glutamate receptor antagonist. It is marketed under the name Fycompa™ and is indicated as an adjunct in patients over 12 years old for the treatment of partial-onset seizures that may or may not occur with generalized seizures. The FDA label includes an important black-boxed warning of serious or life-threatening behavioral and psychiatric reactions in patients taking Fycompa™.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6522</field>
		<field name="drug_name">Gadoxetate</field>
		<field name="description">Gadoxetate is a paramagnetic gadolinium-containing contrast agent in which its salt form, gadoxetate disodium, is used for intravenous injection. Ethoxybenzyl diethylenetriaminepentaacetic acid is the moiety that chelates with a gadolinium ion and forms a stable complex with it to make up the drug. It is marketed by Bayer HealthCare Pharmaceuticals and FDA approved on July 3, 2008.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6523</field>
		<field name="drug_name">Aflibercept</field>
		<field name="description">Aflibercept is a recombinant fusion protein that comprises of two main components: the vascular endothelial growth factor (VEGF) binding portions from the extracellular domains of human VEGF receptors 1 and 2 which is then fused to the Fc portion of human IgG1. Aflibercept, as an ophthalmic agent, is used in the treatment of macular edema following Central Retinal Vein Occlusion (CRVO) and neovascular Age-Related Macular Degeneration (AMD). Ziv-aflibercept, under the brand name Zaltrap, was developed as an injection for treatment of metastatic colorectal cancer. FDA approved in November 18, 2011 and EMA approved in November 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6524</field>
		<field name="drug_name">Asparaginase Erwinia chrysanthemi</field>
		<field name="description">Erwinaze (asparaginase Erwiniachryanthemi) contains an asparaginase specific enzyme derived from Erwiniachrysanthemi. L-asparaginase is a tetrameric enzyme consisting of four identical subunits, each having a molecular weight of about 35 kDa. The activity of Erwinaze is expressed in terms of International Units. It is an antineoplastic agent and was FDA approved in November 19, 2011.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6525</field>
		<field name="drug_name">Icosapent ethyl</field>
		<field name="description">Icosapent ethyl or ethyl eicosapentaenoic acid is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is used as adjunct therapy for severe hypertriglyceridemia (TG levels &gt; 500 mg/dL). FDA approved on July 26, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6526</field>
		<field name="drug_name">Ocriplasmin</field>
		<field name="description">Ocriplasmin is a recombinant truncated form of human plasmin with a molecular weight of 27.2 kDa produced by recombinant DNA technology in a Pichia pastoris expression system. Ocriplasmin is a protein made up of 249 amino acids and has two peptide chains.  Agent for pharmacologic vitreolysis; thrombolytic agent. FDA approved in October 17, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6527</field>
		<field name="drug_name">Carfilzomib</field>
		<field name="description">Carfilzomib is an injectable antineoplastic agent (IV only). Chemically, it is a modified tetrapeptidyl epoxide and an analog of epoxomicin. It is also a selective proteasome inhibitor. FDA approved on July 20, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6528</field>
		<field name="drug_name">Linaclotide</field>
		<field name="description">Linaclotide is an orally administered, peptide agonist of guanylate cyclase 2C for the treatment of irritable bowel syndrome. Chemically, it is a heterodetic cyclic peptide and consists of fourteen amino acids. The protein sequence is as follows: Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr. There are three disulfide bonds which are located between Cys1 and Cys6; between Cys2 and Cys10; and between Cys5 and Cys13. FDA approved on August 30, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6529</field>
		<field name="drug_name">Mirabegron</field>
		<field name="description">Mirabegron is a beta-3 adrenergic receptor agonist for the management of overactive bladder. It is an alternative to antimuscarinic drugs for this indication. FDA approved on June 28, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6530</field>
		<field name="drug_name">Peginesatide</field>
		<field name="description">Peginesatide is a synthetic peptide attached to polyethylene glycol for the treatment of anemia. The polyethylene glycol moiety helps make the drug less immunogenic and prolongs its plasma half-life. Chemically, peginesatide is designed to mimic the pharmacological activity of erythropoietin, but is not a replica of the structure itself. Peginesatide consists of two 21-amino acid chains that are covalently bonded by a linker derived from iminodiacetic acid and ?-alanine. FDA approved March 27, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6531</field>
		<field name="drug_name">Regorafenib</field>
		<field name="description">Regorafenib is an orally-administered inhibitor of multiple kinases. It is used for the treatment of metastatic colorectal cancer and advanced gastrointestinal stromal tumours. FDA approved on September 27, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6532</field>
		<field name="drug_name">Aclidinium</field>
		<field name="description">Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6533</field>
		<field name="drug_name">Glucarpidase</field>
		<field name="description">Glucarpidase is the recombinant form of the enzyme carboxypeptidase that is produced in Esherichia coli. In patients, glucarpidase inactivates methotrexate, and other antifolates, by hydrolyzing glutamate on the carboxyl terminal of these compounds. Therefore since methotrexate is elminated enzymatically and not by the kidneys, glucarpidase is indicated in patients on methotrexate treatment who have kidney dysfunction, and are experiencing an abnormally high plasma concentration of methotrexate (&gt;1 micromole per liter). Glucarpidase is marketed under the brand name Voraxaze®.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6534</field>
		<field name="drug_name">Enzalutamide</field>
		<field name="description">Enzalutamide is an androgen receptor inhibitor for the treatment of castration-resistant prostate cancer. FDA approved on August 31, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6535</field>
		<field name="drug_name">Teduglutide</field>
		<field name="description">Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue. It is made up of 33 amino acids and is manufactured using a strain of Escherichia coli modified by recombinant DNA technology. Teduglutide differs from GLP-2 by one amino acid (alanine is substituted by glycine). The significance of this substitution is that teduglutide is longer acting than endogenous GLP-2 as it is more resistant to proteolysis from dipeptidyl peptidase-4. FDA approved on December 21, 2012.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6536</field>
		<field name="drug_name">Ponatinib</field>
		<field name="description">Ponatinib is a novel Bcr-Abl tyrosine kinase inhibitor that is especially effective against the T315I mutation for the treatment of chronic myeloid leukemia. FDA approved on December 14, 2012.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6537</field>
		<field name="drug_name">Certolizumab pegol</field>
		<field name="description">Certolizumab pegol is a recombinant Fab' antibody fragment against tumor necrosis factor alpha which is conjugated to an approximately 40kDa polyethylene glycol (PEG2MAL40K). Polyethylene glycol helps to delay the metabolism and elimination of the drugs. Chemically, the light chain is made up of 214 amino acid residues while the heavy chain is composed of 229 amino acid residues. The molecular mass of the Fab' antibody fragment itself is 47.8 kDa. It is used for the treatment of rheumatoid arthritis and Crohn’s disease. FDA approved on April 22, 2008</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6538</field>
		<field name="drug_name">Formestane</field>
		<field name="description">Formestane was the first selective, type I, steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast cancer in post-menopausal women. Formestane suppresses estrogen production from anabolic steroids or prohormones. It also acts as a prohormone to 4-hydroxytestosterone, an active steroid which displays weak androgenic activity in addition to acting as a mild aromatase inhibitor. It is listed as a prohibited substance by the World Anti-Doping Agency for use in athletes.      Formestane has poor oral bioavailability, and thus must be administered forthnightly (bi-weekly) by intramuscular injection. Some clinical data has suggested that the clinically recommended dose of 250mg was too low. [5] With the discovery of newer, non-steroidal and steroidal, aromatase inhibitors which were orally active and less expensive than formestane, formestane lost popularity.     Currently, formestane (categorized as an anti-estrogenic agent) is prohibited from use in sports ...</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6539</field>
		<field name="drug_name">Fluticasone furoate</field>
		<field name="description">Fluticasone furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. Despite the similarity in the names,  fluticasone furoate and fluticasone propionate  are different drugs with different properties. It is marketed under the brand name, Veramyst in the US by GlaxoSmithKline for the management of chronic obstructive pulmonary disease (COPD). FDA approved on April 27, 2007.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6540</field>
		<field name="drug_name">Canagliflozin</field>
		<field name="description">Canagliflozin belongs to a new class of anti-diabetic drugs that works by inhibiting the sodium-glucose transport protein (SGLT2). This transport protein is found in the kidney and is responsible for reabsorbing glucose that has been filtered. FDA approved on March 29, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6541</field>
		<field name="drug_name">Dimethyl fumarate</field>
		<field name="description">Dimethyl fumarate is an anti-inflammatory. It is indicated for multiple sclerosis patients with relapsing forms and is also being investigated for the treatment of psoriasis. The mechanism of action of dimethyl fumarate in multiple sclerosis is not well understood. It is thought to involve dimethyl fumarate degradation to its active metabolite monomethyl fumarate (MMF) then MMF up-regulates the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway that is activated in response to oxidative stress. Dimethyl fumarate is marketed under the brand name Tecfidera.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6542</field>
		<field name="drug_name">Glycerol Phenylbutyrate</field>
		<field name="description">Glycerol phenylbutyrate is a nitrogen-binding agent. Chemically, it is a triglyceride in which three molecules of phenylbutyrate are linked to a glycerol backbone. FDA approved on February 1, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6543</field>
		<field name="drug_name">Pomalidomide</field>
		<field name="description">Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6544</field>
		<field name="drug_name">Trametinib</field>
		<field name="description">Trametinib dimethyl sulfoxide is a kinase inhibitor. Each 1-mg tablet contains 1.127 mg trametinib dimethyl sulfoxide equivalent to 1 mg of trametinib non-solvated parent. FDA approved on May 29, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6545</field>
		<field name="drug_name">Dabrafenib</field>
		<field name="description">Dabrafenib mesylate is a reversible ATP-competitive kinase inhibitor and targets the MAPK pathway. FDA approved on May 29, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6546</field>
		<field name="drug_name">Radium Ra 223 Dichloride</field>
		<field name="description">Radium Ra 223 Dichloride is a radiopharmaceutical containing the radioisotope radium-223 that emits short range but high linear energy alpha particles. As a cation, radium mimics calicum and binds to hydroxyapatite, which is a bone mineral found in areas of high bone turnover as seen in bone metastases. It was first approved by the FDA in May 2013 and is currently marketed under the brand name Xofigo, which was formerly called Alpharadin. Xofigo is indicated in patients who have metastatic bone cancer that is symptomatic with no visceral metastases and patients who have prostate cancer that is castration resistant. The FDA label includes a warning that Radium Ra 223 Dichloride should not be used in women who are pregnant or may become pregnant due to the high risk of fetal harm.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6547</field>
		<field name="drug_name">Insulin, isophane</field>
		<field name="description">Isophane insulin or NPH insulin (neutral protamine Hagedorn) is an intermediate-acting insulin to improve glycemic control. It is synthesized using a strain of Escherichia coli bacteria that has been genetically altered to produce human insulin. Human insulin isophane suspension consists of a crystalline suspension of human insulin with protamine and zinc. This combination results in an intermediate-acting insulin with a slower onset of action and longer duration of activity than regular human insulin.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6548</field>
		<field name="drug_name">ALEGLITAZAR</field>
		<field name="description">Aleglitazar is an investigational drug from the company Hoffmann–La Roche and is currently in a phase III clinical trial called ALECARDIO. It is being investigated for use in patients with type II diabetes to reduce their risks of cardiovascular mortality and morbidity. Aleglitazar is an agonist at the peroxisome proliferator-activated receptor (PPAR) for both the PPAR? and PPAR? receptor subtypes. In the phase II clinical trial called SYNCHRONY, with type II diabetic patients, aleglitazar was able to control both lipid and glucose levels in a synergistic manner while also having limited side effects and toxicity.</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6549</field>
		<field name="drug_name">Afatinib</field>
		<field name="description">Afatinib is a tyrosine kinase inhibitor which is a 4-anilinoquinazoline. It is prepared has the dimaleate salt. FDA approved on July 12, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6550</field>
		<field name="drug_name">Ferric Carboxymaltose</field>
		<field name="description">Ferric Carboxymaltose is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6551</field>
		<field name="drug_name">Levomilnacipran</field>
		<field name="description">Levomilnacipran is a selective serotonin and norepinephrine reuptake inhibitor. Chemically, levomilnacipran is the 1S,2R-enantiomer of milnacipran. FDA approved on July 25, 2013.</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6552</field>
		<field name="drug_name">DIVALPROEX SODIUM</field>
		<field name="description">Anticonvulsants; Antimanic Agents</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6553</field>
		<field name="drug_name">MARAVIROC</field>
		<field name="description">Anti-HIV Agents; Anti-viral</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6554</field>
		<field name="drug_name">BECLOMETHASONE</field>
		<field name="description">Anti-Inflammatory Agents; Glucocorticoids</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6555</field>
		<field name="drug_name">AMBRISENTAN</field>
		<field name="description">antihypertensive agent</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6556</field>
		<field name="drug_name">COLLAGENASE CLOSTRIDIUM HISTOLYTICUM</field>
		<field name="description">enzyme replacement for Dupuytren's contracture</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6557</field>
		<field name="drug_name">ROMIDEPSIN</field>
		<field name="description">Antineoplastic Agents</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6558</field>
		<field name="drug_name">USTEKINUMAB</field>
		<field name="description">Antipsoriatic Agents</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6559</field>
		<field name="drug_name">DOXACURIUM</field>
		<field name="description">Muscle Relaxants</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6560</field>
		<field name="drug_name">INSULIN</field>
		<field name="description">Antidiabetic agents</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6561</field>
		<field name="drug_name">FEBUXOSTAT</field>
		<field name="description">Gout Suppressants</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6562</field>
		<field name="drug_name">ECALLANTIDE</field>
		<field name="description">Treatment for Hereditary Angiooedema</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6563</field>
		<field name="drug_name">FONDAPARINUX</field>
		<field name="description">Antithrombotic Agents</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6564</field>
		<field name="drug_name">ISOSORBIDE-5-MONONITRATE</field>
		<field name="description">Antianginal Agents; Vasodilator Agents</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6565</field>
		<field name="drug_name">LIRAGLUTIDE RECOMBINANT</field>
		<field name="description">Antidiabetic agent</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6566</field>
		<field name="drug_name">METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA</field>
		<field name="description">Erythropoiesis-stimulating agent</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6567</field>
		<field name="drug_name">METHYLNALTREXONE BROMIDE</field>
		<field name="description">OIC treatment</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6568</field>
		<field name="drug_name">NANDROLONE</field>
		<field name="description">Antianemic Agents; anti-osteoporosis agents</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6569</field>
		<field name="drug_name">NORGESTREL</field>
		<field name="description">Contraceptives, Oral, Synthetic</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6570</field>
		<field name="drug_name">PODOFILOX</field>
		<field name="description">Antineoplastic Agents, Phytogenic; Keratolytic Agents</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6571</field>
		<field name="drug_name">LANREOTIDE</field>
		<field name="description">Hormone Replacement Agents</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6572</field>
		<field name="drug_name">ULIPRISTAL</field>
		<field name="description">Abortificant</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6573</field>
		<field name="drug_name">Aceclidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6574</field>
		<field name="drug_name">Acotiamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6575</field>
		<field name="drug_name">Alvameline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6576</field>
		<field name="drug_name">Esoxybutynin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6577</field>
		<field name="drug_name">Imidafenacin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6578</field>
		<field name="drug_name">Talsaclidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6579</field>
		<field name="drug_name">Xanomeline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6580</field>
		<field name="drug_name">Camylofin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6581</field>
		<field name="drug_name">Tiquizium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6582</field>
		<field name="drug_name">Mebeverine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6583</field>
		<field name="drug_name">Trimebutine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6584</field>
		<field name="drug_name">Dihexyverine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6585</field>
		<field name="drug_name">Piperidolate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6586</field>
		<field name="drug_name">Glycopyrronium</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6587</field>
		<field name="drug_name">Hexocyclium</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6588</field>
		<field name="drug_name">Tiemonium iodide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6589</field>
		<field name="drug_name">Prifinium bromide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6590</field>
		<field name="drug_name">Timepidium bromide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6591</field>
		<field name="drug_name">Butylscopolamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6592</field>
		<field name="drug_name">Methylatropine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6593</field>
		<field name="drug_name">Fentonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6594</field>
		<field name="drug_name">Cimetropium bromide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6595</field>
		<field name="drug_name">Propiverine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6596</field>
		<field name="drug_name">Orphenadrine (citrate)</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6597</field>
		<field name="drug_name">Dexetimide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6598</field>
		<field name="drug_name">Mazaticol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6599</field>
		<field name="drug_name">Orphenadrine (chloride)</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6600</field>
		<field name="drug_name">Etybenzatropine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6601</field>
		<field name="drug_name">Oxitropium bromide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6602</field>
		<field name="drug_name">Pimethixene</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6603</field>
		<field name="drug_name">Homatropine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6604</field>
		<field name="drug_name">Aclatonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6605</field>
		<field name="drug_name">Benzetimide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6606</field>
		<field name="drug_name">Butropium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6607</field>
		<field name="drug_name">Carpronium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6608</field>
		<field name="drug_name">Darotropium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6609</field>
		<field name="drug_name">Diphenylpiperidinomethyldioxolan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6610</field>
		<field name="drug_name">Diponium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6611</field>
		<field name="drug_name">Etomidoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6612</field>
		<field name="drug_name">Eucatropine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6613</field>
		<field name="drug_name">Flutropium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6614</field>
		<field name="drug_name">Methylbenactyzium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6615</field>
		<field name="drug_name">Milameline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6616</field>
		<field name="drug_name">Methyloctatropine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6617</field>
		<field name="drug_name">Oxapium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6618</field>
		<field name="drug_name">Pipethanate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6619</field>
		<field name="drug_name">Piroheptine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6620</field>
		<field name="drug_name">Sabcomeline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6621</field>
		<field name="drug_name">Tazomeline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6622</field>
		<field name="drug_name">Tiemonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6623</field>
		<field name="drug_name">Umeclidinium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6624</field>
		<field name="drug_name">Valethamate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6625</field>
		<field name="drug_name">Dabuzalgron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6626</field>
		<field name="drug_name">Fiduxosin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6627</field>
		<field name="drug_name">Garomefrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6628</field>
		<field name="drug_name">Adrenalone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6629</field>
		<field name="drug_name">Etilefrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6630</field>
		<field name="drug_name">Norfenefrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6631</field>
		<field name="drug_name">Oxedrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6632</field>
		<field name="drug_name">Indoramin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6633</field>
		<field name="drug_name">Trimazosin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6634</field>
		<field name="drug_name">Urapidil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6635</field>
		<field name="drug_name">Ketanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6636</field>
		<field name="drug_name">Moxisylyte</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6637</field>
		<field name="drug_name">Ifenprodil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6638</field>
		<field name="drug_name">Ergot alkaloids</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6639</field>
		<field name="drug_name">Tetryzoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6640</field>
		<field name="drug_name">Tramazoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6641</field>
		<field name="drug_name">Amidephrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6642</field>
		<field name="drug_name">Amosulalol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6643</field>
		<field name="drug_name">Arotinolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6644</field>
		<field name="drug_name">Bunazosin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6645</field>
		<field name="drug_name">Bunitrolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6646</field>
		<field name="drug_name">Medroxalol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6647</field>
		<field name="drug_name">Methylephedrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6648</field>
		<field name="drug_name">Naftopidil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6649</field>
		<field name="drug_name">Pelanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6650</field>
		<field name="drug_name">Setiptiline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6651</field>
		<field name="drug_name">Imiloxan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6652</field>
		<field name="drug_name">Rilmenidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6653</field>
		<field name="drug_name">Piribedil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6654</field>
		<field name="drug_name">Aptazapine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6655</field>
		<field name="drug_name">Atipamezole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6656</field>
		<field name="drug_name">Delequamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6657</field>
		<field name="drug_name">Detomidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6658</field>
		<field name="drug_name">Fluparoxan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6659</field>
		<field name="drug_name">Romifidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6660</field>
		<field name="drug_name">Xylazine; Veterinary</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6661</field>
		<field name="drug_name">Prenalterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6662</field>
		<field name="drug_name">Xamoterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6663</field>
		<field name="drug_name">Buphenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6664</field>
		<field name="drug_name">Mepindolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6665</field>
		<field name="drug_name">Tertatolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6666</field>
		<field name="drug_name">Cloranolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6667</field>
		<field name="drug_name">Celiprolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6668</field>
		<field name="drug_name">Epanolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6669</field>
		<field name="drug_name">S-atenolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6670</field>
		<field name="drug_name">Talinolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6671</field>
		<field name="drug_name">Befunolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6672</field>
		<field name="drug_name">Adaprolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6673</field>
		<field name="drug_name">Alprenoxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6674</field>
		<field name="drug_name">Bucindolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6675</field>
		<field name="drug_name">Bucumolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6676</field>
		<field name="drug_name">Bufetolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6677</field>
		<field name="drug_name">Bunolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6678</field>
		<field name="drug_name">Butopamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6679</field>
		<field name="drug_name">Cetamolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6680</field>
		<field name="drug_name">Cicloprolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6681</field>
		<field name="drug_name">Cimaterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6682</field>
		<field name="drug_name">Denopamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6683</field>
		<field name="drug_name">Dexpropranolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6684</field>
		<field name="drug_name">Diacetolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6685</field>
		<field name="drug_name">Flestolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6686</field>
		<field name="drug_name">Indenolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6687</field>
		<field name="drug_name">Landiolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6688</field>
		<field name="drug_name">Levdobutamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6689</field>
		<field name="drug_name">Levobetaxolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6690</field>
		<field name="drug_name">Nipradilol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6691</field>
		<field name="drug_name">Pamatolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6692</field>
		<field name="drug_name">Primidolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6693</field>
		<field name="drug_name">Talibegron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6694</field>
		<field name="drug_name">Tilisolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6695</field>
		<field name="drug_name">Dopexamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6696</field>
		<field name="drug_name">Isoxsuprine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6697</field>
		<field name="drug_name">Rimiterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6698</field>
		<field name="drug_name">Hexoprenaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6699</field>
		<field name="drug_name">Tretoquinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6700</field>
		<field name="drug_name">Carbuterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6701</field>
		<field name="drug_name">Tulobuterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6702</field>
		<field name="drug_name">Reproterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6703</field>
		<field name="drug_name">Methoxyphenamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6704</field>
		<field name="drug_name">Abediterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6705</field>
		<field name="drug_name">Butoxamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6706</field>
		<field name="drug_name">Carazolol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6707</field>
		<field name="drug_name">Clorprenaline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6708</field>
		<field name="drug_name">Colterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6709</field>
		<field name="drug_name">Milveterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6710</field>
		<field name="drug_name">Levosalbutamol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6711</field>
		<field name="drug_name">Mabuterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6712</field>
		<field name="drug_name">Olodaterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6713</field>
		<field name="drug_name">Picumeterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6714</field>
		<field name="drug_name">Ractopamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6715</field>
		<field name="drug_name">Sibenadet</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6716</field>
		<field name="drug_name">Soterenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6717</field>
		<field name="drug_name">Vilanterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6718</field>
		<field name="drug_name">Zinterol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6719</field>
		<field name="drug_name">Amibegron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6720</field>
		<field name="drug_name">Fasobegron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6721</field>
		<field name="drug_name">Ritobegron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6722</field>
		<field name="drug_name">Solabegron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6723</field>
		<field name="drug_name">Clebopride</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6724</field>
		<field name="drug_name">Ibopamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6725</field>
		<field name="drug_name">Clopenthixol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6726</field>
		<field name="drug_name">Adrogolide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6727</field>
		<field name="drug_name">Butaclamol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6728</field>
		<field name="drug_name">Ciladopa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6729</field>
		<field name="drug_name">Ecopipam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6730</field>
		<field name="drug_name">Oxiperomide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6731</field>
		<field name="drug_name">Bromopride</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6732</field>
		<field name="drug_name">Metopimazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6733</field>
		<field name="drug_name">Quinagolide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6734</field>
		<field name="drug_name">Terguride</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6735</field>
		<field name="drug_name">Trifluperidol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6736</field>
		<field name="drug_name">Moperone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6737</field>
		<field name="drug_name">Pipamperone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6738</field>
		<field name="drug_name">Bromperidol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6739</field>
		<field name="drug_name">Sultopride</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6740</field>
		<field name="drug_name">Tiapride</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6741</field>
		<field name="drug_name">Mosapramine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6742</field>
		<field name="drug_name">Zotepine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6743</field>
		<field name="drug_name">Opipramol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6744</field>
		<field name="drug_name">Aplindore</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6745</field>
		<field name="drug_name">Bifeprunox</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6746</field>
		<field name="drug_name">Blonanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6747</field>
		<field name="drug_name">Brexpiprazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6748</field>
		<field name="drug_name">Cariprazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6749</field>
		<field name="drug_name">Carvotroline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6750</field>
		<field name="drug_name">Clocapramine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6751</field>
		<field name="drug_name">Gevotroline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6752</field>
		<field name="drug_name">Lergotrile</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6753</field>
		<field name="drug_name">Mazapertine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6754</field>
		<field name="drug_name">Methoxypromazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6755</field>
		<field name="drug_name">Nemonapride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6756</field>
		<field name="drug_name">Pardoprunox</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6757</field>
		<field name="drug_name">Perospirone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6758</field>
		<field name="drug_name">Piquindone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6759</field>
		<field name="drug_name">Pridopidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6760</field>
		<field name="drug_name">Quinelorane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6761</field>
		<field name="drug_name">Quinpirole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6762</field>
		<field name="drug_name">Spiperone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6763</field>
		<field name="drug_name">Talipexole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6764</field>
		<field name="drug_name">Timiperone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6765</field>
		<field name="drug_name">Tiospirone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6766</field>
		<field name="drug_name">Raclopride C11</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6767</field>
		<field name="drug_name">Fananserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6768</field>
		<field name="drug_name">Sonepiprazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6769</field>
		<field name="drug_name">Thonzylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6770</field>
		<field name="drug_name">Dimetindene</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6771</field>
		<field name="drug_name">Bamipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6772</field>
		<field name="drug_name">Chlorphenoxamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6773</field>
		<field name="drug_name">Dimetotiazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6774</field>
		<field name="drug_name">Oxatomide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6775</field>
		<field name="drug_name">Levocetirizine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6776</field>
		<field name="drug_name">Acrivastine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6777</field>
		<field name="drug_name">Ebastine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6778</field>
		<field name="drug_name">Rupatadine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6779</field>
		<field name="drug_name">Bilastine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6780</field>
		<field name="drug_name">Dioxopromethazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6781</field>
		<field name="drug_name">Homochlorcyclizine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6782</field>
		<field name="drug_name">Icotidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6783</field>
		<field name="drug_name">Mizolastine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6784</field>
		<field name="drug_name">Noberastine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6785</field>
		<field name="drug_name">Rocastine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6786</field>
		<field name="drug_name">Tecastemizole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6787</field>
		<field name="drug_name">Temelastine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6788</field>
		<field name="drug_name">Niperotidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6789</field>
		<field name="drug_name">Ranitidine bismuth citrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6790</field>
		<field name="drug_name">Lafutidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6791</field>
		<field name="drug_name">Osutidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6792</field>
		<field name="drug_name">Dalcotidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6793</field>
		<field name="drug_name">Donetidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6794</field>
		<field name="drug_name">Etintidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6795</field>
		<field name="drug_name">Impromidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6796</field>
		<field name="drug_name">Lavoltidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6797</field>
		<field name="drug_name">Lupitidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6798</field>
		<field name="drug_name">Oxmetidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6799</field>
		<field name="drug_name">Pibutidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6800</field>
		<field name="drug_name">Sufotidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6801</field>
		<field name="drug_name">Tiotidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6802</field>
		<field name="drug_name">Zaltidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6803</field>
		<field name="drug_name">Cipralisant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6804</field>
		<field name="drug_name">Irdabisant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6805</field>
		<field name="drug_name">Gepirone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6806</field>
		<field name="drug_name">Adatanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6807</field>
		<field name="drug_name">Binospirone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6808</field>
		<field name="drug_name">Eptapirone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6809</field>
		<field name="drug_name">Flesinoxan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6810</field>
		<field name="drug_name">Flibanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6811</field>
		<field name="drug_name">Ipsapirone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6812</field>
		<field name="drug_name">Lecozotan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6813</field>
		<field name="drug_name">Naluzotan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6814</field>
		<field name="drug_name">Sarizotan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6815</field>
		<field name="drug_name">Tandospirone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6816</field>
		<field name="drug_name">Vortioxetine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6817</field>
		<field name="drug_name">Avitriptan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6818</field>
		<field name="drug_name">Elzasonan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6819</field>
		<field name="drug_name">Lasmiditan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6820</field>
		<field name="drug_name">Metergoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6821</field>
		<field name="drug_name">Pizotifen</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6822</field>
		<field name="drug_name">Indorenate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6823</field>
		<field name="drug_name">Naftidrofuryl</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6824</field>
		<field name="drug_name">Altanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6825</field>
		<field name="drug_name">Amesergide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6826</field>
		<field name="drug_name">Eplivanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6827</field>
		<field name="drug_name">Lubazodone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6828</field>
		<field name="drug_name">Nelotanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6829</field>
		<field name="drug_name">Pimavanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6830</field>
		<field name="drug_name">Pruvanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6831</field>
		<field name="drug_name">Ritanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6832</field>
		<field name="drug_name">Sarpogrelate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6833</field>
		<field name="drug_name">Temanogrel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6834</field>
		<field name="drug_name">Vabicaserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6835</field>
		<field name="drug_name">Tedatioxetine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6836</field>
		<field name="drug_name">Cinanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6837</field>
		<field name="drug_name">Glemanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6838</field>
		<field name="drug_name">Metrenperone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6839</field>
		<field name="drug_name">Tropanserin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6840</field>
		<field name="drug_name">Cilansetron</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6841</field>
		<field name="drug_name">Tropisetron</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6842</field>
		<field name="drug_name">Azasetron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6843</field>
		<field name="drug_name">Batanopride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6844</field>
		<field name="drug_name">Indisetron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6845</field>
		<field name="drug_name">Itasetron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6846</field>
		<field name="drug_name">Quipazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6847</field>
		<field name="drug_name">Ramosetron</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6848</field>
		<field name="drug_name">Prucalopride</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6849</field>
		<field name="drug_name">Mosapride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6850</field>
		<field name="drug_name">Naronapride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6851</field>
		<field name="drug_name">Piboserod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6852</field>
		<field name="drug_name">Renzapride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6853</field>
		<field name="drug_name">Sulamserod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6854</field>
		<field name="drug_name">Velusetrag</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6855</field>
		<field name="drug_name">Zacopride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6856</field>
		<field name="drug_name">Cerlapirdine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6857</field>
		<field name="drug_name">Casopitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6858</field>
		<field name="drug_name">Befetupitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6859</field>
		<field name="drug_name">Ezlopitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6860</field>
		<field name="drug_name">Maropitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6861</field>
		<field name="drug_name">Orvepitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6862</field>
		<field name="drug_name">Rolapitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6863</field>
		<field name="drug_name">Serlopitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6864</field>
		<field name="drug_name">Telmapitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6865</field>
		<field name="drug_name">Vofopitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6866</field>
		<field name="drug_name">Vestipitant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6867</field>
		<field name="drug_name">Talnetant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6868</field>
		<field name="drug_name">Anamorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6869</field>
		<field name="drug_name">Capromorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6870</field>
		<field name="drug_name">Pralmorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6871</field>
		<field name="drug_name">Rismorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6872</field>
		<field name="drug_name">Ulimorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6873</field>
		<field name="drug_name">Almorexant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6874</field>
		<field name="drug_name">Filorexant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6875</field>
		<field name="drug_name">Velneperit</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6876</field>
		<field name="drug_name">Tilidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6877</field>
		<field name="drug_name">Meptazinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6878</field>
		<field name="drug_name">Nalorphine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6879</field>
		<field name="drug_name">Brifentanil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6880</field>
		<field name="drug_name">Bevenopran</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6881</field>
		<field name="drug_name">Cebranopadol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6882</field>
		<field name="drug_name">Cyclazocine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6883</field>
		<field name="drug_name">Eluxadoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6884</field>
		<field name="drug_name">Eptazocine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6885</field>
		<field name="drug_name">Levomethadone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6886</field>
		<field name="drug_name">Lofentanil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6887</field>
		<field name="drug_name">Methadyl</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6888</field>
		<field name="drug_name">Methylsamidorphan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6889</field>
		<field name="drug_name">Mirfentanil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6890</field>
		<field name="drug_name">Naldemedine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6891</field>
		<field name="drug_name">Nalmefene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6892</field>
		<field name="drug_name">Naloxegol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6893</field>
		<field name="drug_name">Ocfentanil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6894</field>
		<field name="drug_name">Quadazocine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6895</field>
		<field name="drug_name">Trimeperidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6896</field>
		<field name="drug_name">Enadoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6897</field>
		<field name="drug_name">Ketazocine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6898</field>
		<field name="drug_name">Spiradoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6899</field>
		<field name="drug_name">Metkephamid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6900</field>
		<field name="drug_name">Igmesine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6901</field>
		<field name="drug_name">Rimcazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6902</field>
		<field name="drug_name">Angiotensinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6903</field>
		<field name="drug_name">Angiotensin II</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6904</field>
		<field name="drug_name">Angiotensin II (human type)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6905</field>
		<field name="drug_name">Pratosartan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6906</field>
		<field name="drug_name">Saralasin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6907</field>
		<field name="drug_name">Deltibant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6908</field>
		<field name="drug_name">Labradimil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6909</field>
		<field name="drug_name">Sitaxentan [C02KX03]</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6910</field>
		<field name="drug_name">Atrasentan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6911</field>
		<field name="drug_name">Clazosentan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6912</field>
		<field name="drug_name">Edonentan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6913</field>
		<field name="drug_name">Macitentan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6914</field>
		<field name="drug_name">Chorionic gonadotrophin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6915</field>
		<field name="drug_name">Human menopausal gonadotrophin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6916</field>
		<field name="drug_name">Serum gonadotrophin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6917</field>
		<field name="drug_name">Follitropin alfa</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6918</field>
		<field name="drug_name">Corifollitropin alfa</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6919</field>
		<field name="drug_name">Atosiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6920</field>
		<field name="drug_name">Demoxytocin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6921</field>
		<field name="drug_name">Atosiban acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6922</field>
		<field name="drug_name">Cargutocin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6923</field>
		<field name="drug_name">Epelsiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6924</field>
		<field name="drug_name">Retosiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6925</field>
		<field name="drug_name">Lypressin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6926</field>
		<field name="drug_name">Ornipressin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6927</field>
		<field name="drug_name">Argipressin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6928</field>
		<field name="drug_name">Lixivaptan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6929</field>
		<field name="drug_name">Mozavaptane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6930</field>
		<field name="drug_name">Alsactide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6931</field>
		<field name="drug_name">Bremelanotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6932</field>
		<field name="drug_name">Giractide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6933</field>
		<field name="drug_name">Seractide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6934</field>
		<field name="drug_name">Histrelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6935</field>
		<field name="drug_name">Ganirelix</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6936</field>
		<field name="drug_name">Triptorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6937</field>
		<field name="drug_name">Deslorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6938</field>
		<field name="drug_name">Detirelix</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6939</field>
		<field name="drug_name">Elagolix</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6940</field>
		<field name="drug_name">Fertirelin; Veterinary</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6941</field>
		<field name="drug_name">Iturelix</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6942</field>
		<field name="drug_name">Lutrelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6943</field>
		<field name="drug_name">Prazarelix</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6944</field>
		<field name="drug_name">Somatostatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6945</field>
		<field name="drug_name">Indium (111In) pentetreotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6946</field>
		<field name="drug_name">Thyrotropin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6947</field>
		<field name="drug_name">Protirelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6948</field>
		<field name="drug_name">Montirelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6949</field>
		<field name="drug_name">Taltirelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6950</field>
		<field name="drug_name">Proglumide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6951</field>
		<field name="drug_name">Devazepide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6952</field>
		<field name="drug_name">Panazepide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6953</field>
		<field name="drug_name">Tarazepide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6954</field>
		<field name="drug_name">Alemcinal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6955</field>
		<field name="drug_name">Atilmotin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6956</field>
		<field name="drug_name">Camicinal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6957</field>
		<field name="drug_name">Idremcinal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6958</field>
		<field name="drug_name">Mitemcinal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6959</field>
		<field name="drug_name">Vorapaxar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6960</field>
		<field name="drug_name">Atopaxar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6961</field>
		<field name="drug_name">Cangrelor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6962</field>
		<field name="drug_name">Elinogrel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6963</field>
		<field name="drug_name">Regrelor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6964</field>
		<field name="drug_name">Proxyphylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6965</field>
		<field name="drug_name">Bamifylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6966</field>
		<field name="drug_name">Doxofylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6967</field>
		<field name="drug_name">Apaxifylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6968</field>
		<field name="drug_name">Rolofylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6969</field>
		<field name="drug_name">Selodenoson</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6970</field>
		<field name="drug_name">Tecadenoson</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6971</field>
		<field name="drug_name">Tonapofylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6972</field>
		<field name="drug_name">Ancriviroc</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6973</field>
		<field name="drug_name">Apadenoson</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6974</field>
		<field name="drug_name">Binodenoson</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6975</field>
		<field name="drug_name">Evodenoson</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6976</field>
		<field name="drug_name">Istradefylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6977</field>
		<field name="drug_name">Preladenant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6978</field>
		<field name="drug_name">Sonedenoson</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6979</field>
		<field name="drug_name">Tozadenant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6980</field>
		<field name="drug_name">Vipadenant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6981</field>
		<field name="drug_name">Laropiprant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6982</field>
		<field name="drug_name">Ramatroban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6983</field>
		<field name="drug_name">Setipiprant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6984</field>
		<field name="drug_name">Vidupiprant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6985</field>
		<field name="drug_name">Gemeprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6986</field>
		<field name="drug_name">Limaprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6987</field>
		<field name="drug_name">Ornoprostil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6988</field>
		<field name="drug_name">Enprostil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6989</field>
		<field name="drug_name">Sulprostone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6990</field>
		<field name="drug_name">Butaprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6991</field>
		<field name="drug_name">Rioprostil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6992</field>
		<field name="drug_name">Dinoprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6993</field>
		<field name="drug_name">Latanoprostene bunod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6994</field>
		<field name="drug_name">Unoprostone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6995</field>
		<field name="drug_name">Rosaprostol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6996</field>
		<field name="drug_name">Tiaprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6997</field>
		<field name="drug_name">Beraprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">6998</field>
		<field name="drug_name">Clinprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">6999</field>
		<field name="drug_name">Pimilprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7000</field>
		<field name="drug_name">Selexipag</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7001</field>
		<field name="drug_name">Etalocib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7002</field>
		<field name="drug_name">Moxilubant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7003</field>
		<field name="drug_name">Ticolubant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7004</field>
		<field name="drug_name">Picotamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7005</field>
		<field name="drug_name">Seratrodast</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7006</field>
		<field name="drug_name">Daltroban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7007</field>
		<field name="drug_name">Ifetroban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7008</field>
		<field name="drug_name">Imitrodast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7009</field>
		<field name="drug_name">Sulotroban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7010</field>
		<field name="drug_name">Vapiprost</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7011</field>
		<field name="drug_name">Fasiglifam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7012</field>
		<field name="drug_name">Ibipinabant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7013</field>
		<field name="drug_name">Levonantradol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7014</field>
		<field name="drug_name">Otenabant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7015</field>
		<field name="drug_name">Taranabant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7016</field>
		<field name="drug_name">Apafant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7017</field>
		<field name="drug_name">Israpafant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7018</field>
		<field name="drug_name">Lexipafant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7019</field>
		<field name="drug_name">Perlapine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7020</field>
		<field name="drug_name">Tasimelteon</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7021</field>
		<field name="drug_name">Ablukast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7022</field>
		<field name="drug_name">Pobilukast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7023</field>
		<field name="drug_name">Ritolukast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7024</field>
		<field name="drug_name">Sulukast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7025</field>
		<field name="drug_name">Tipelukast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7026</field>
		<field name="drug_name">Tomelukast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7027</field>
		<field name="drug_name">Verlukast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7028</field>
		<field name="drug_name">Calcitonin (salmon synthetic)</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7029</field>
		<field name="drug_name">Davalintide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7030</field>
		<field name="drug_name">Elcatonin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7031</field>
		<field name="drug_name">Telcagepant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7032</field>
		<field name="drug_name">Corticorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7033</field>
		<field name="drug_name">Emicerfont</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7034</field>
		<field name="drug_name">Pexacerfont</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7035</field>
		<field name="drug_name">Verucerfont</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7036</field>
		<field name="drug_name">Somatorelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7037</field>
		<field name="drug_name">Albiglutide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7038</field>
		<field name="drug_name">Dulaglutide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7039</field>
		<field name="drug_name">Lixisenatide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7040</field>
		<field name="drug_name">Semaglutide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7041</field>
		<field name="drug_name">Taspoglutide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7042</field>
		<field name="drug_name">Glucagon</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7043</field>
		<field name="drug_name">Fenobam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7044</field>
		<field name="drug_name">Pomaglumetad</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7045</field>
		<field name="drug_name">Talaglumetad</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7046</field>
		<field name="drug_name">Aminobutyric acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7047</field>
		<field name="drug_name">Arbaclofen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7048</field>
		<field name="drug_name">Acesulfame potassium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7049</field>
		<field name="drug_name">Saccharin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7050</field>
		<field name="drug_name">Ronacaleret</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7051</field>
		<field name="drug_name">Erismodegib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7052</field>
		<field name="drug_name">Saridegib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7053</field>
		<field name="drug_name">Celmoleukin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7054</field>
		<field name="drug_name">Teceleukin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7055</field>
		<field name="drug_name">Daniplestim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7056</field>
		<field name="drug_name">Leridistim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7057</field>
		<field name="drug_name">Muplestim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7058</field>
		<field name="drug_name">Dupilumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7059</field>
		<field name="drug_name">Benralizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7060</field>
		<field name="drug_name">Sarilumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7061</field>
		<field name="drug_name">Molgramostim</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7062</field>
		<field name="drug_name">Mavrilimumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7063</field>
		<field name="drug_name">Regramostim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7064</field>
		<field name="drug_name">Lipegfilgrastim</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7065</field>
		<field name="drug_name">Milodistim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7066</field>
		<field name="drug_name">Nartograstim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7067</field>
		<field name="drug_name">Metreleptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7068</field>
		<field name="drug_name">Erythropoietin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7069</field>
		<field name="drug_name">Somatrem</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7070</field>
		<field name="drug_name">Lusutrombopag</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7071</field>
		<field name="drug_name">Totrombopag</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7072</field>
		<field name="drug_name">Interferon alfa natural</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7073</field>
		<field name="drug_name">Interferon beta natural</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7074</field>
		<field name="drug_name">Albinterferon alfa-2b</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7075</field>
		<field name="drug_name">Peginterferon beta-1a</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7076</field>
		<field name="drug_name">Interferon gamma</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7077</field>
		<field name="drug_name">Peginterferon lambda-1a</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7078</field>
		<field name="drug_name">Canertinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7079</field>
		<field name="drug_name">Imgatuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7080</field>
		<field name="drug_name">Necitumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7081</field>
		<field name="drug_name">Neratinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7082</field>
		<field name="drug_name">Pelitinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7083</field>
		<field name="drug_name">Varlitinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7084</field>
		<field name="drug_name">Zalutumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7085</field>
		<field name="drug_name">Mubritinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7086</field>
		<field name="drug_name">Nelipepimut</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7087</field>
		<field name="drug_name">Insulin (human)</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7088</field>
		<field name="drug_name">Insulin (pork)</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7089</field>
		<field name="drug_name">Insulin degludec</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7090</field>
		<field name="drug_name">Insulin peglispro</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7091</field>
		<field name="drug_name">Insulin zinc</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7092</field>
		<field name="drug_name">Cixutumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7093</field>
		<field name="drug_name">Dalotuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7094</field>
		<field name="drug_name">Figitumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7095</field>
		<field name="drug_name">Ganitumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7096</field>
		<field name="drug_name">Linsitinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7097</field>
		<field name="drug_name">Robatumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7098</field>
		<field name="drug_name">Cediranib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7099</field>
		<field name="drug_name">Crenolanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7100</field>
		<field name="drug_name">Lenvatinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7101</field>
		<field name="drug_name">Linifanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7102</field>
		<field name="drug_name">Motesanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7103</field>
		<field name="drug_name">Nintedanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7104</field>
		<field name="drug_name">Olaratumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7105</field>
		<field name="drug_name">Toceranib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7106</field>
		<field name="drug_name">Tovetumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7107</field>
		<field name="drug_name">Dovitinib</field>
		<field name="description">Multi-kinase inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7108</field>
		<field name="drug_name">Midostaurin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7109</field>
		<field name="drug_name">Tandutinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7110</field>
		<field name="drug_name">Vatalanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7111</field>
		<field name="drug_name">Masitinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7112</field>
		<field name="drug_name">Semaxanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7113</field>
		<field name="drug_name">Lestaurtinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7114</field>
		<field name="drug_name">Quizartinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7115</field>
		<field name="drug_name">Tozasertib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7116</field>
		<field name="drug_name">Brivanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7117</field>
		<field name="drug_name">Icrucumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7118</field>
		<field name="drug_name">Tivozanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7119</field>
		<field name="drug_name">Foretinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7120</field>
		<field name="drug_name">Golvatinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7121</field>
		<field name="drug_name">Pegdinetanib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7122</field>
		<field name="drug_name">Ramucirumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7123</field>
		<field name="drug_name">Narnatumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7124</field>
		<field name="drug_name">Crizotinib</field>
		<field name="description">c-MET and ALK Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7125</field>
		<field name="drug_name">Alectinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7126</field>
		<field name="drug_name">Erlizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7127</field>
		<field name="drug_name">Dacetuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7128</field>
		<field name="drug_name">Lucatumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7129</field>
		<field name="drug_name">Teneliximab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7130</field>
		<field name="drug_name">Iratumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7131</field>
		<field name="drug_name">Urelumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7132</field>
		<field name="drug_name">Conatumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7133</field>
		<field name="drug_name">Drozitumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7134</field>
		<field name="drug_name">Lexatumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7135</field>
		<field name="drug_name">Mapatumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7136</field>
		<field name="drug_name">Enavatuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7137</field>
		<field name="drug_name">Brodalumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7138</field>
		<field name="drug_name">Ixekizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7139</field>
		<field name="drug_name">Dalantercept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7140</field>
		<field name="drug_name">Sotatercept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7141</field>
		<field name="drug_name">Mogamulizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7142</field>
		<field name="drug_name">Aplaviroc</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7143</field>
		<field name="drug_name">Cenicriviroc</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7144</field>
		<field name="drug_name">Vicriviroc</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7145</field>
		<field name="drug_name">Vercirnon</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7146</field>
		<field name="drug_name">Navarixin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7147</field>
		<field name="drug_name">Reparixin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7148</field>
		<field name="drug_name">Danirixin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7149</field>
		<field name="drug_name">Elubrixin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7150</field>
		<field name="drug_name">Tiratricol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7151</field>
		<field name="drug_name">Thyroid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7152</field>
		<field name="drug_name">Sobetirome</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7153</field>
		<field name="drug_name">Palovarotene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7154</field>
		<field name="drug_name">Aluminium clofibrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7155</field>
		<field name="drug_name">Ciprofibrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7156</field>
		<field name="drug_name">Etofibrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7157</field>
		<field name="drug_name">Choline fenofibrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7158</field>
		<field name="drug_name">Indeglitazar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7159</field>
		<field name="drug_name">Muraglitazar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7160</field>
		<field name="drug_name">Naveglitazar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7161</field>
		<field name="drug_name">Arhalofenate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7162</field>
		<field name="drug_name">Ciglitazone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7163</field>
		<field name="drug_name">Darglitazone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7164</field>
		<field name="drug_name">Edaglitazone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7165</field>
		<field name="drug_name">Rivoglitazone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7166</field>
		<field name="drug_name">Mifobate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7167</field>
		<field name="drug_name">Netoglitazone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7168</field>
		<field name="drug_name">Obeticholic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7169</field>
		<field name="drug_name">Turofexorate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7170</field>
		<field name="drug_name">Tacalcitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7171</field>
		<field name="drug_name">Becocalcidiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7172</field>
		<field name="drug_name">Eldecalcitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7173</field>
		<field name="drug_name">Falecalcitriol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7174</field>
		<field name="drug_name">Maxacalcitol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7175</field>
		<field name="drug_name">Promestriene</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7176</field>
		<field name="drug_name">Tibolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7177</field>
		<field name="drug_name">Bazedoxifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7178</field>
		<field name="drug_name">Lasofoxifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7179</field>
		<field name="drug_name">Polyestradiol phosphate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7180</field>
		<field name="drug_name">Acolbifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7181</field>
		<field name="drug_name">Afimoxifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7182</field>
		<field name="drug_name">Arzoxifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7183</field>
		<field name="drug_name">Droloxifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7184</field>
		<field name="drug_name">Enclomiphene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7185</field>
		<field name="drug_name">Epitiostanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7186</field>
		<field name="drug_name">Fispemifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7187</field>
		<field name="drug_name">Idoxifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7188</field>
		<field name="drug_name">Mepitiostane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7189</field>
		<field name="drug_name">Nafoxidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7190</field>
		<field name="drug_name">Nitromifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7191</field>
		<field name="drug_name">Ormeloxifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7192</field>
		<field name="drug_name">Trioxifene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7193</field>
		<field name="drug_name">Erteberel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7194</field>
		<field name="drug_name">Tixocortol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7195</field>
		<field name="drug_name">Beclometasone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7196</field>
		<field name="drug_name">Fluocortolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7197</field>
		<field name="drug_name">Clobetasone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7198</field>
		<field name="drug_name">Flumetasone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7199</field>
		<field name="drug_name">Fluocortin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7200</field>
		<field name="drug_name">Fluprednidene</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7201</field>
		<field name="drug_name">Diflucortolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7202</field>
		<field name="drug_name">Halometasone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7203</field>
		<field name="drug_name">Methylprednisolone aceponate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7204</field>
		<field name="drug_name">Hydrocortisone aceponate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7205</field>
		<field name="drug_name">Fluticasone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7206</field>
		<field name="drug_name">Ulobetasol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7207</field>
		<field name="drug_name">Cortisone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7208</field>
		<field name="drug_name">Prednylidene</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7209</field>
		<field name="drug_name">Deflazacort</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7210</field>
		<field name="drug_name">Cloprednol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7211</field>
		<field name="drug_name">Meprednisone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7212</field>
		<field name="drug_name">Cortivazol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7213</field>
		<field name="drug_name">Cortodoxone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7214</field>
		<field name="drug_name">Fluprednisolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7215</field>
		<field name="drug_name">Halopredone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7216</field>
		<field name="drug_name">Mapracorat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7217</field>
		<field name="drug_name">Proligestone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7218</field>
		<field name="drug_name">Resocortol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7219</field>
		<field name="drug_name">Potassium canrenoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7220</field>
		<field name="drug_name">Canrenone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7221</field>
		<field name="drug_name">Desoxycortone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7222</field>
		<field name="drug_name">Dicirenone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7223</field>
		<field name="drug_name">Mexrenoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7224</field>
		<field name="drug_name">Prorenoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7225</field>
		<field name="drug_name">Lynestrenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7226</field>
		<field name="drug_name">Quingestanol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7227</field>
		<field name="drug_name">Norgestrienone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7228</field>
		<field name="drug_name">Gestonorone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7229</field>
		<field name="drug_name">Hydroxyprogesterone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7230</field>
		<field name="drug_name">Medrogestone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7231</field>
		<field name="drug_name">Nomegestrol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7232</field>
		<field name="drug_name">Demegestone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7233</field>
		<field name="drug_name">Chlormadinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7234</field>
		<field name="drug_name">Promegestone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7235</field>
		<field name="drug_name">Aglepristone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7236</field>
		<field name="drug_name">Altrenogest</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7237</field>
		<field name="drug_name">Asoprisnil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7238</field>
		<field name="drug_name">Dienogest</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7239</field>
		<field name="drug_name">Lonaprisan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7240</field>
		<field name="drug_name">Methynodiol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7241</field>
		<field name="drug_name">Onapristone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7242</field>
		<field name="drug_name">Metandienone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7243</field>
		<field name="drug_name">Metenolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7244</field>
		<field name="drug_name">Oxymetholone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7245</field>
		<field name="drug_name">Quinbolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7246</field>
		<field name="drug_name">Norethandrolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7247</field>
		<field name="drug_name">Oxabolone cipionate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7248</field>
		<field name="drug_name">Undecylenic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7249</field>
		<field name="drug_name">Mesterolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7250</field>
		<field name="drug_name">Enobosarm</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7251</field>
		<field name="drug_name">Methandriol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7252</field>
		<field name="drug_name">Mibolerone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7253</field>
		<field name="drug_name">Oxendolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7254</field>
		<field name="drug_name">Silandrone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7255</field>
		<field name="drug_name">Medazepam</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7256</field>
		<field name="drug_name">Potassium clorazepate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7257</field>
		<field name="drug_name">Nordazepam</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7258</field>
		<field name="drug_name">Etizolam</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7259</field>
		<field name="drug_name">Lormetazepam</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7260</field>
		<field name="drug_name">Brotizolam</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7261</field>
		<field name="drug_name">Loprazolam</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7262</field>
		<field name="drug_name">Pentetrazol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7263</field>
		<field name="drug_name">Abecarnil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7264</field>
		<field name="drug_name">Alpidem</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7265</field>
		<field name="drug_name">Bretazenil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7266</field>
		<field name="drug_name">Dextofisopam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7267</field>
		<field name="drug_name">Flutazolam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7268</field>
		<field name="drug_name">Flutoprazepam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7269</field>
		<field name="drug_name">Iomazenil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7270</field>
		<field name="drug_name">Levotofisopam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7271</field>
		<field name="drug_name">Mexazolam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7272</field>
		<field name="drug_name">Nimetazepam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7273</field>
		<field name="drug_name">Oxazolam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7274</field>
		<field name="drug_name">Rilmazafone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7275</field>
		<field name="drug_name">Sarmazenil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7276</field>
		<field name="drug_name">Adipiplon</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7277</field>
		<field name="drug_name">Gaboxadol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7278</field>
		<field name="drug_name">Ganaxolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7279</field>
		<field name="drug_name">Ocinaplon</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7280</field>
		<field name="drug_name">Pagoclone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7281</field>
		<field name="drug_name">Remimazolam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7282</field>
		<field name="drug_name">D10470  Strychnine nitrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7283</field>
		<field name="drug_name">Lobeline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7284</field>
		<field name="drug_name">Suxamethonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7285</field>
		<field name="drug_name">Dimethyltubocurarine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7286</field>
		<field name="drug_name">Gallamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7287</field>
		<field name="drug_name">Mivacurium chloride</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7288</field>
		<field name="drug_name">Cisatracurium</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7289</field>
		<field name="drug_name">Gantacurium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7290</field>
		<field name="drug_name">Hexamethonium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7291</field>
		<field name="drug_name">Dexmecamylamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7292</field>
		<field name="drug_name">Ispronicline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7293</field>
		<field name="drug_name">Pozanicline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7294</field>
		<field name="drug_name">Rivanicline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7295</field>
		<field name="drug_name">Sofinicline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7296</field>
		<field name="drug_name">Kainic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7297</field>
		<field name="drug_name">Tezampanel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7298</field>
		<field name="drug_name">Farampator</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7299</field>
		<field name="drug_name">Talampanel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7300</field>
		<field name="drug_name">Zonampanel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7301</field>
		<field name="drug_name">Besonprodil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7302</field>
		<field name="drug_name">Traxoprodil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7303</field>
		<field name="drug_name">Ketobemidone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7304</field>
		<field name="drug_name">Flupirtine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7305</field>
		<field name="drug_name">Aptiganel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7306</field>
		<field name="drug_name">Delucemine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7307</field>
		<field name="drug_name">Dextrorphan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7308</field>
		<field name="drug_name">Dizocilpine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7309</field>
		<field name="drug_name">Gavestinel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7310</field>
		<field name="drug_name">Licostinel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7311</field>
		<field name="drug_name">Latrepirdine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7312</field>
		<field name="drug_name">Neramexane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7313</field>
		<field name="drug_name">Perzinfotel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7314</field>
		<field name="drug_name">Remacemide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7315</field>
		<field name="drug_name">Selfotel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7316</field>
		<field name="drug_name">Tiletamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7317</field>
		<field name="drug_name">Suramin sodium</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7318</field>
		<field name="drug_name">Cibenzoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7319</field>
		<field name="drug_name">Tetracaine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7320</field>
		<field name="drug_name">Aminobenzoic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7321</field>
		<field name="drug_name">Eslicarbazepine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7322</field>
		<field name="drug_name">Ambroxol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7323</field>
		<field name="drug_name">Hydroquinidine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7324</field>
		<field name="drug_name">Pilsicainide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7325</field>
		<field name="drug_name">Pirmenol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7326</field>
		<field name="drug_name">Cilnidipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7327</field>
		<field name="drug_name">Ziconotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7328</field>
		<field name="drug_name">Manidipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7329</field>
		<field name="drug_name">Barnidipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7330</field>
		<field name="drug_name">Benidipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7331</field>
		<field name="drug_name">Gallopamil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7332</field>
		<field name="drug_name">Fendiline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7333</field>
		<field name="drug_name">Aranidipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7334</field>
		<field name="drug_name">Azelnidipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7335</field>
		<field name="drug_name">Darodipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7336</field>
		<field name="drug_name">Efonidipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7337</field>
		<field name="drug_name">Kirenidipine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7338</field>
		<field name="drug_name">Penfluridol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7339</field>
		<field name="drug_name">Clofilium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7340</field>
		<field name="drug_name">Tedisamil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7341</field>
		<field name="drug_name">Nifekalant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7342</field>
		<field name="drug_name">Linopirdine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7343</field>
		<field name="drug_name">Azimilide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7344</field>
		<field name="drug_name">Terikalant</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7345</field>
		<field name="drug_name">Dexsotalol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7346</field>
		<field name="drug_name">Sematilide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7347</field>
		<field name="drug_name">Nicorandil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7348</field>
		<field name="drug_name">Pinacidil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7349</field>
		<field name="drug_name">Levcromakalim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7350</field>
		<field name="drug_name">Capsaicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7351</field>
		<field name="drug_name">Zucapsaicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7352</field>
		<field name="drug_name">Mavatrep</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7353</field>
		<field name="drug_name">Nonivamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7354</field>
		<field name="drug_name">Camphora</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7355</field>
		<field name="drug_name">Glibornuride</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7356</field>
		<field name="drug_name">Carbutamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7357</field>
		<field name="drug_name">Metahexamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7358</field>
		<field name="drug_name">Glyclopyramide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7359</field>
		<field name="drug_name">Lumacaftor</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7360</field>
		<field name="drug_name">Dapagliflozin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7361</field>
		<field name="drug_name">Ertugliflozin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7362</field>
		<field name="drug_name">Ipragliflozin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7363</field>
		<field name="drug_name">Luseogliflozin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7364</field>
		<field name="drug_name">Remogliflozin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7365</field>
		<field name="drug_name">Tofogliflozin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7366</field>
		<field name="drug_name">Lofepramine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7367</field>
		<field name="drug_name">Dosulepin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7368</field>
		<field name="drug_name">Viloxazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7369</field>
		<field name="drug_name">Dexamfetamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7370</field>
		<field name="drug_name">Amitifadine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7371</field>
		<field name="drug_name">Amitriptylinoxide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7372</field>
		<field name="drug_name">Edivoxetine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7373</field>
		<field name="drug_name">Esreboxetine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7374</field>
		<field name="drug_name">Imipraminoxid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7375</field>
		<field name="drug_name">Liafensine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7376</field>
		<field name="drug_name">Nisoxetine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7377</field>
		<field name="drug_name">Pyrovalerone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7378</field>
		<field name="drug_name">Amfonelic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7379</field>
		<field name="drug_name">Bicifadine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7380</field>
		<field name="drug_name">Dapoxetine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7381</field>
		<field name="drug_name">Bitopertin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7382</field>
		<field name="drug_name">Cariporide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7383</field>
		<field name="drug_name">Zoniporide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7384</field>
		<field name="drug_name">Muzolimine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7385</field>
		<field name="drug_name">Alilusem</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7386</field>
		<field name="drug_name">Azosemide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7387</field>
		<field name="drug_name">Tripamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7388</field>
		<field name="drug_name">Mefruside</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7389</field>
		<field name="drug_name">Meticrane</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7390</field>
		<field name="drug_name">Benzylhydrochlorothiazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7391</field>
		<field name="drug_name">Penflutizide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7392</field>
		<field name="drug_name">Lesinurad</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7393</field>
		<field name="drug_name">Dilazep</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7394</field>
		<field name="drug_name">Brivaracetam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7395</field>
		<field name="drug_name">Piracetam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7396</field>
		<field name="drug_name">Seletracetam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7397</field>
		<field name="drug_name">Rozrolimupab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7398</field>
		<field name="drug_name">Epalrestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7399</field>
		<field name="drug_name">Lidorestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7400</field>
		<field name="drug_name">Minalrestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7401</field>
		<field name="drug_name">Ponalrestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7402</field>
		<field name="drug_name">Zenarestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7403</field>
		<field name="drug_name">Zopolrestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7404</field>
		<field name="drug_name">Crilvastatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7405</field>
		<field name="drug_name">Dalvastatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7406</field>
		<field name="drug_name">Tenivastatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7407</field>
		<field name="drug_name">Epostane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7408</field>
		<field name="drug_name">Enoxolone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7409</field>
		<field name="drug_name">Merimepodib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7410</field>
		<field name="drug_name">Mizoribine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7411</field>
		<field name="drug_name">Clorindione</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7412</field>
		<field name="drug_name">Diphenadione</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7413</field>
		<field name="drug_name">Tioclomarol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7414</field>
		<field name="drug_name">Fluindione</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7415</field>
		<field name="drug_name">Flocoumafen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7416</field>
		<field name="drug_name">Tecarfarin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7417</field>
		<field name="drug_name">Eniluracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7418</field>
		<field name="drug_name">Gimeracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7419</field>
		<field name="drug_name">Brequinar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7420</field>
		<field name="drug_name">Bexlosteride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7421</field>
		<field name="drug_name">Epristeride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7422</field>
		<field name="drug_name">Idronoxil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7423</field>
		<field name="drug_name">Amezinium metilsulfate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7424</field>
		<field name="drug_name">Isoniazid</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7425</field>
		<field name="drug_name">Iproniazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7426</field>
		<field name="drug_name">Iproclozide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7427</field>
		<field name="drug_name">Caroxazone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7428</field>
		<field name="drug_name">Ladostigil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7429</field>
		<field name="drug_name">Safrazine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7430</field>
		<field name="drug_name">Toloxatone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7431</field>
		<field name="drug_name">Befloxatone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7432</field>
		<field name="drug_name">Brofaromine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7433</field>
		<field name="drug_name">Cimoxatone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7434</field>
		<field name="drug_name">Clorgiline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7435</field>
		<field name="drug_name">Pirlindole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7436</field>
		<field name="drug_name">Lazabemide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7437</field>
		<field name="drug_name">Milacemide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7438</field>
		<field name="drug_name">Mofegiline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7439</field>
		<field name="drug_name">Safinamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7440</field>
		<field name="drug_name">Edatrexate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7441</field>
		<field name="drug_name">Methylthiouracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7442</field>
		<field name="drug_name">Benzylthiouracil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7443</field>
		<field name="drug_name">Atreleuton</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7444</field>
		<field name="drug_name">Darbufelone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7445</field>
		<field name="drug_name">Docebenone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7446</field>
		<field name="drug_name">Enazadrem</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7447</field>
		<field name="drug_name">Fenleuton</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7448</field>
		<field name="drug_name">Lonapalene</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7449</field>
		<field name="drug_name">Setileuton</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7450</field>
		<field name="drug_name">Lufironil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7451</field>
		<field name="drug_name">Cindunistat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7452</field>
		<field name="drug_name">Tilarginine acetate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7453</field>
		<field name="drug_name">Cobicistat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7454</field>
		<field name="drug_name">Vorozole</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7455</field>
		<field name="drug_name">Fadrozole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7456</field>
		<field name="drug_name">Liarozole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7457</field>
		<field name="drug_name">Plomestane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7458</field>
		<field name="drug_name">Nepicastat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7459</field>
		<field name="drug_name">Hydroquinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7460</field>
		<field name="drug_name">Benzydamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7461</field>
		<field name="drug_name">Indobufen</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7462</field>
		<field name="drug_name">Aloxiprin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7463</field>
		<field name="drug_name">Indometacin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7464</field>
		<field name="drug_name">Acemetacin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7465</field>
		<field name="drug_name">Proglumetacin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7466</field>
		<field name="drug_name">Dexibuprofen</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7467</field>
		<field name="drug_name">Alminoprofen</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7468</field>
		<field name="drug_name">Dexketoprofen</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7469</field>
		<field name="drug_name">Tolfenamic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7470</field>
		<field name="drug_name">Felbinac</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7471</field>
		<field name="drug_name">Pranoprofen</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7472</field>
		<field name="drug_name">Amfenac</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7473</field>
		<field name="drug_name">Ampiroxicam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7474</field>
		<field name="drug_name">Firocoxib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7475</field>
		<field name="drug_name">Loxoprofen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7476</field>
		<field name="drug_name">Mofezolac</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7477</field>
		<field name="drug_name">Pamicogrel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7478</field>
		<field name="drug_name">Piketoprofen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7479</field>
		<field name="drug_name">Pravadoline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7480</field>
		<field name="drug_name">Zaltoprofen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7481</field>
		<field name="drug_name">Aceclofenac</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7482</field>
		<field name="drug_name">Floctafenine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7483</field>
		<field name="drug_name">Apricoxib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7484</field>
		<field name="drug_name">Deracoxib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7485</field>
		<field name="drug_name">Eltenac</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7486</field>
		<field name="drug_name">Mavacoxib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7487</field>
		<field name="drug_name">Tilmacoxib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7488</field>
		<field name="drug_name">Ketoconazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7489</field>
		<field name="drug_name">Galeterone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7490</field>
		<field name="drug_name">Orteronel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7491</field>
		<field name="drug_name">Oxypurinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7492</field>
		<field name="drug_name">Topiroxostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7493</field>
		<field name="drug_name">Caracemide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7494</field>
		<field name="drug_name">Phloroglucinol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7495</field>
		<field name="drug_name">Flopropione</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7496</field>
		<field name="drug_name">Nitecapone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7497</field>
		<field name="drug_name">Tegafur</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7498</field>
		<field name="drug_name">Carmofur</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7499</field>
		<field name="drug_name">Doxifluridine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7500</field>
		<field name="drug_name">Metesind</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7501</field>
		<field name="drug_name">Pelitrexol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7502</field>
		<field name="drug_name">Oxfenicine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7503</field>
		<field name="drug_name">Avasimibe</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7504</field>
		<field name="drug_name">Eldacimibe</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7505</field>
		<field name="drug_name">Lecimibide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7506</field>
		<field name="drug_name">Acivicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7507</field>
		<field name="drug_name">Ingliforib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7508</field>
		<field name="drug_name">Eliglustat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7509</field>
		<field name="drug_name">Forodesine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7510</field>
		<field name="drug_name">Ulodesine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7511</field>
		<field name="drug_name">Teglarinad</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7512</field>
		<field name="drug_name">Rucaparib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7513</field>
		<field name="drug_name">Iniparib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7514</field>
		<field name="drug_name">Olaparib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7515</field>
		<field name="drug_name">Veliparib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7516</field>
		<field name="drug_name">Niraparib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7517</field>
		<field name="drug_name">Ezatiostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7518</field>
		<field name="drug_name">Incadronic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7519</field>
		<field name="drug_name">Minodronic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7520</field>
		<field name="drug_name">Lonafarnib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7521</field>
		<field name="drug_name">Tipifarnib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7522</field>
		<field name="drug_name">Pictilisib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7523</field>
		<field name="drug_name">Varespladib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7524</field>
		<field name="drug_name">Ecopladib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7525</field>
		<field name="drug_name">Efipladib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7526</field>
		<field name="drug_name">Giripladib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7527</field>
		<field name="drug_name">Dimetacrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7528</field>
		<field name="drug_name">Ecothiopate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7529</field>
		<field name="drug_name">Obidoxime</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7530</field>
		<field name="drug_name">Besipirdine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7531</field>
		<field name="drug_name">Icopezil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7532</field>
		<field name="drug_name">Ipidacrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7533</field>
		<field name="drug_name">Itopride</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7534</field>
		<field name="drug_name">Velnacrine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7535</field>
		<field name="drug_name">Ibrolipim</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7536</field>
		<field name="drug_name">Darapladib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7537</field>
		<field name="drug_name">Goxalapladib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7538</field>
		<field name="drug_name">Rilapladib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7539</field>
		<field name="drug_name">Voclosporin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7540</field>
		<field name="drug_name">Ertiprotafib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7541</field>
		<field name="drug_name">Moxaverine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7542</field>
		<field name="drug_name">Trapidil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7543</field>
		<field name="drug_name">Propentofylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7544</field>
		<field name="drug_name">Tibenelast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7545</field>
		<field name="drug_name">Imazodan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7546</field>
		<field name="drug_name">Indolidan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7547</field>
		<field name="drug_name">Isomazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7548</field>
		<field name="drug_name">Lixazinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7549</field>
		<field name="drug_name">Olprinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7550</field>
		<field name="drug_name">Pimobendan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7551</field>
		<field name="drug_name">Toborinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7552</field>
		<field name="drug_name">Vesnarinone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7553</field>
		<field name="drug_name">Apremilast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7554</field>
		<field name="drug_name">Arofylline</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7555</field>
		<field name="drug_name">Catramilast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7556</field>
		<field name="drug_name">Cilomilast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7557</field>
		<field name="drug_name">Tofimilast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7558</field>
		<field name="drug_name">Dasantafil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7559</field>
		<field name="drug_name">Gisadenafil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7560</field>
		<field name="drug_name">Irosustat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7561</field>
		<field name="drug_name">Duvoglustat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7562</field>
		<field name="drug_name">Emiglitate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7563</field>
		<field name="drug_name">Tosedostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7564</field>
		<field name="drug_name">Ubenimex</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7565</field>
		<field name="drug_name">Anagliptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7566</field>
		<field name="drug_name">Carmegliptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7567</field>
		<field name="drug_name">Denagliptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7568</field>
		<field name="drug_name">Dutogliptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7569</field>
		<field name="drug_name">Gosogliptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7570</field>
		<field name="drug_name">Teneligliptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7571</field>
		<field name="drug_name">Trelagliptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7572</field>
		<field name="drug_name">Omarigliptin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7573</field>
		<field name="drug_name">Delapril</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7574</field>
		<field name="drug_name">Zofenopril</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7575</field>
		<field name="drug_name">Imidapril</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7576</field>
		<field name="drug_name">Alacepril</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7577</field>
		<field name="drug_name">Benazeprilat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7578</field>
		<field name="drug_name">Ceronapril</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7579</field>
		<field name="drug_name">Enalaprilat (USP)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7580</field>
		<field name="drug_name">Fosinoprilat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7581</field>
		<field name="drug_name">Indolapril</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7582</field>
		<field name="drug_name">Libenzapril</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7583</field>
		<field name="drug_name">Pentopril</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7584</field>
		<field name="drug_name">Pivopril</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7585</field>
		<field name="drug_name">Quinaprilat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7586</field>
		<field name="drug_name">Spiraprilat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7587</field>
		<field name="drug_name">Teprotide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7588</field>
		<field name="drug_name">Zofenoprilat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7589</field>
		<field name="drug_name">Ulinastatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7590</field>
		<field name="drug_name">Desirudin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7591</field>
		<field name="drug_name">Melagatran</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7592</field>
		<field name="drug_name">Efegatran</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7593</field>
		<field name="drug_name">Napsagatran</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7594</field>
		<field name="drug_name">Antithrombin alfa</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7595</field>
		<field name="drug_name">Betrixaban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7596</field>
		<field name="drug_name">Darexaban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7597</field>
		<field name="drug_name">Edoxaban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7598</field>
		<field name="drug_name">Eribaxaban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7599</field>
		<field name="drug_name">Idraparinux</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7600</field>
		<field name="drug_name">Letaxaban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7601</field>
		<field name="drug_name">Razaxaban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7602</field>
		<field name="drug_name">Pegnivacogin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7603</field>
		<field name="drug_name">Gabexate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7604</field>
		<field name="drug_name">Sivelestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7605</field>
		<field name="drug_name">Depelestat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7606</field>
		<field name="drug_name">Thrombomodulin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7607</field>
		<field name="drug_name">Alirocumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7608</field>
		<field name="drug_name">Belnacasan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7609</field>
		<field name="drug_name">Pralnacasan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7610</field>
		<field name="drug_name">Odanacatib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7611</field>
		<field name="drug_name">Relacatib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7612</field>
		<field name="drug_name">Ditekiren</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7613</field>
		<field name="drug_name">Terlakiren</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7614</field>
		<field name="drug_name">Zankiren</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7615</field>
		<field name="drug_name">Ecadotril</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7616</field>
		<field name="drug_name">Cipemastat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7617</field>
		<field name="drug_name">Ilomastat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7618</field>
		<field name="drug_name">Prinomastat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7619</field>
		<field name="drug_name">Tanomastat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7620</field>
		<field name="drug_name">Aderbasib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7621</field>
		<field name="drug_name">Apratastat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7622</field>
		<field name="drug_name">Delanzomib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7623</field>
		<field name="drug_name">Marizomib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7624</field>
		<field name="drug_name">Ixazomib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7625</field>
		<field name="drug_name">Oprozomib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7626</field>
		<field name="drug_name">Panobinostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7627</field>
		<field name="drug_name">Abexinostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7628</field>
		<field name="drug_name">Belinostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7629</field>
		<field name="drug_name">Entinostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7630</field>
		<field name="drug_name">Mocetinostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7631</field>
		<field name="drug_name">Acetyldigoxin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7632</field>
		<field name="drug_name">Lanatoside C</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7633</field>
		<field name="drug_name">Metildigoxin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7634</field>
		<field name="drug_name">Gitoformate</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7635</field>
		<field name="drug_name">Proscillaridin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7636</field>
		<field name="drug_name">beta-Acetyldigoxin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7637</field>
		<field name="drug_name">Omeprazol</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7638</field>
		<field name="drug_name">Dexlansoprazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7639</field>
		<field name="drug_name">Leminoprazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7640</field>
		<field name="drug_name">Tenatoprazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7641</field>
		<field name="drug_name">Timoprazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7642</field>
		<field name="drug_name">Picoprazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7643</field>
		<field name="drug_name">Tariquidar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7644</field>
		<field name="drug_name">Zosuquidar</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7645</field>
		<field name="drug_name">Indium (111In) capromab pendetide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7646</field>
		<field name="drug_name">Brocresine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7647</field>
		<field name="drug_name">Benserazide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7648</field>
		<field name="drug_name">Clofenamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7649</field>
		<field name="drug_name">Sezolamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7650</field>
		<field name="drug_name">Girentuximab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7651</field>
		<field name="drug_name">Colforsin daropate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7652</field>
		<field name="drug_name">Cenderitide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7653</field>
		<field name="drug_name">Plecanatide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7654</field>
		<field name="drug_name">Cinaciguat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7655</field>
		<field name="drug_name">Riociguat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7656</field>
		<field name="drug_name">Dazmegrel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7657</field>
		<field name="drug_name">Furegrelate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7658</field>
		<field name="drug_name">Ozagrel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7659</field>
		<field name="drug_name">Pirmagrel</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7660</field>
		<field name="drug_name">Lapaquistat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7661</field>
		<field name="drug_name">Aclarubicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7662</field>
		<field name="drug_name">Belotecan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7663</field>
		<field name="drug_name">Cositecan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7664</field>
		<field name="drug_name">Edotecarin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7665</field>
		<field name="drug_name">Etirinotecan pegol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7666</field>
		<field name="drug_name">Exatecan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7667</field>
		<field name="drug_name">Firtecan pegol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7668</field>
		<field name="drug_name">Lurtotecan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7669</field>
		<field name="drug_name">Rubitecan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7670</field>
		<field name="drug_name">Tenifatecan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7671</field>
		<field name="drug_name">Pirarubicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7672</field>
		<field name="drug_name">Amrubicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7673</field>
		<field name="drug_name">Amonafide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7674</field>
		<field name="drug_name">Berubicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7675</field>
		<field name="drug_name">Crisnatol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7676</field>
		<field name="drug_name">Ledoxantrone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7677</field>
		<field name="drug_name">Sedoxantrone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7678</field>
		<field name="drug_name">Sobuzoxane</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7679</field>
		<field name="drug_name">Vosaroxin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7680</field>
		<field name="drug_name">Aprinocarsen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7681</field>
		<field name="drug_name">Enzastaurin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7682</field>
		<field name="drug_name">Sotrastaurin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7683</field>
		<field name="drug_name">Afuresertib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7684</field>
		<field name="drug_name">Fasudil</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7685</field>
		<field name="drug_name">Dapiclermin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7686</field>
		<field name="drug_name">Dinaciclib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7687</field>
		<field name="drug_name">Palbociclib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7688</field>
		<field name="drug_name">Tanzisertib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7689</field>
		<field name="drug_name">Dilmapimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7690</field>
		<field name="drug_name">Doramapimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7691</field>
		<field name="drug_name">Losmapimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7692</field>
		<field name="drug_name">Pamapimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7693</field>
		<field name="drug_name">Talmapimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7694</field>
		<field name="drug_name">Pimasertib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7695</field>
		<field name="drug_name">Selumetinib</field>
		<field name="description">MEK1 and MEK2 Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7696</field>
		<field name="drug_name">Alisertib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7697</field>
		<field name="drug_name">Rigosertib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7698</field>
		<field name="drug_name">Volasertib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7699</field>
		<field name="drug_name">Ridaforolimus</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7700</field>
		<field name="drug_name">Bafetinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7701</field>
		<field name="drug_name">Rebastinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7702</field>
		<field name="drug_name">Saracatinib</field>
		<field name="description">Src and Abl inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7703</field>
		<field name="drug_name">Momelotinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7704</field>
		<field name="drug_name">Gandotinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7705</field>
		<field name="drug_name">Tofacitinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7706</field>
		<field name="drug_name">Fostamatinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7707</field>
		<field name="drug_name">Ibrutinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7708</field>
		<field name="drug_name">D10352  Dusigitumab (USAN)</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7709</field>
		<field name="drug_name">Onartuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7710</field>
		<field name="drug_name">Tivantinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7711</field>
		<field name="drug_name">Enokizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7712</field>
		<field name="drug_name">Mepolizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7713</field>
		<field name="drug_name">Reslizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7714</field>
		<field name="drug_name">Siltuximab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7715</field>
		<field name="drug_name">Sirukumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7716</field>
		<field name="drug_name">Briakinumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7717</field>
		<field name="drug_name">Apilimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7718</field>
		<field name="drug_name">Anrukinzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7719</field>
		<field name="drug_name">Guselkumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7720</field>
		<field name="drug_name">Lebrikizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7721</field>
		<field name="drug_name">Tralokinumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7722</field>
		<field name="drug_name">Tildrakizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7723</field>
		<field name="drug_name">Rontalizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7724</field>
		<field name="drug_name">Sifalimumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7725</field>
		<field name="drug_name">Fontolizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7726</field>
		<field name="drug_name">Fezakinumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7727</field>
		<field name="drug_name">Bevasiranib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7728</field>
		<field name="drug_name">Fulranumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7729</field>
		<field name="drug_name">Tanezumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7730</field>
		<field name="drug_name">Ficlatuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7731</field>
		<field name="drug_name">Rilotumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7732</field>
		<field name="drug_name">Trebananib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7733</field>
		<field name="drug_name">Nesvacumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7734</field>
		<field name="drug_name">Afelimomab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7735</field>
		<field name="drug_name">Lenercept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7736</field>
		<field name="drug_name">Nerelimomab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7737</field>
		<field name="drug_name">Onercept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7738</field>
		<field name="drug_name">Ozoralizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7739</field>
		<field name="drug_name">Pegsunercept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7740</field>
		<field name="drug_name">Placulumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7741</field>
		<field name="drug_name">Pateclizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7742</field>
		<field name="drug_name">Baminercept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7743</field>
		<field name="drug_name">Oxelumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7744</field>
		<field name="drug_name">Ruplizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7745</field>
		<field name="drug_name">Toralizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7746</field>
		<field name="drug_name">Vorsetuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7747</field>
		<field name="drug_name">Atacicept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7748</field>
		<field name="drug_name">Briobacept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7749</field>
		<field name="drug_name">Tabalumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7750</field>
		<field name="drug_name">Gevokizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7751</field>
		<field name="drug_name">Secukinumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7752</field>
		<field name="drug_name">Stamulumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7753</field>
		<field name="drug_name">Ramatercept</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7754</field>
		<field name="drug_name">Fresolimumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7755</field>
		<field name="drug_name">Carlumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7756</field>
		<field name="drug_name">Siplizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7757</field>
		<field name="drug_name">Cedelizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7758</field>
		<field name="drug_name">Ibalizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7759</field>
		<field name="drug_name">Priliximab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7760</field>
		<field name="drug_name">Zanolimumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7761</field>
		<field name="drug_name">Valategrast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7762</field>
		<field name="drug_name">Etrolizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7763</field>
		<field name="drug_name">Vedolizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7764</field>
		<field name="drug_name">Volociximab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7765</field>
		<field name="drug_name">Cilengitide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7766</field>
		<field name="drug_name">Etaracizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7767</field>
		<field name="drug_name">Rovelizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7768</field>
		<field name="drug_name">Elarofiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7769</field>
		<field name="drug_name">Lamifiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7770</field>
		<field name="drug_name">Lotrafiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7771</field>
		<field name="drug_name">Orbofiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7772</field>
		<field name="drug_name">Roxifiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7773</field>
		<field name="drug_name">Sibrafiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7774</field>
		<field name="drug_name">Tadocizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7775</field>
		<field name="drug_name">Xemilofiban</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7776</field>
		<field name="drug_name">Demcizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7777</field>
		<field name="drug_name">Zolimomab aritox</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7778</field>
		<field name="drug_name">Blinatumomab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7779</field>
		<field name="drug_name">Ibritumomab tiuxetan</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7780</field>
		<field name="drug_name">Obinutuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7781</field>
		<field name="drug_name">Ocaratuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7782</field>
		<field name="drug_name">Ocrelizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7783</field>
		<field name="drug_name">Ofatumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7784</field>
		<field name="drug_name">Veltuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7785</field>
		<field name="drug_name">Firategrast</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7786</field>
		<field name="drug_name">Intetumumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7787</field>
		<field name="drug_name">Alicaforsen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7788</field>
		<field name="drug_name">Enlimomab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7789</field>
		<field name="drug_name">Inclacumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7790</field>
		<field name="drug_name">Technetium Tc 99m arcitumomab (USP)</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7791</field>
		<field name="drug_name">Labetuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7792</field>
		<field name="drug_name">Milatuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7793</field>
		<field name="drug_name">Galiximab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7794</field>
		<field name="drug_name">Ipilimumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7795</field>
		<field name="drug_name">Tremelimumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7796</field>
		<field name="drug_name">Samalizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7797</field>
		<field name="drug_name">clivatuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7798</field>
		<field name="drug_name">Pidilizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7799</field>
		<field name="drug_name">Nivolumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7800</field>
		<field name="drug_name">Elotuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7801</field>
		<field name="drug_name">Edrecolomab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7802</field>
		<field name="drug_name">Catumaxomab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7803</field>
		<field name="drug_name">Tucotuzumab celmoleukin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7804</field>
		<field name="drug_name">Oregovomab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7805</field>
		<field name="drug_name">Apolizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7806</field>
		<field name="drug_name">Rintatolimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7807</field>
		<field name="drug_name">Eritoran</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7808</field>
		<field name="drug_name">Entolimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7809</field>
		<field name="drug_name">Isatoribine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7810</field>
		<field name="drug_name">Loxoribine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7811</field>
		<field name="drug_name">Agatolimod</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7812</field>
		<field name="drug_name">Otelixizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7813</field>
		<field name="drug_name">Teplizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7814</field>
		<field name="drug_name">Visilizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7815</field>
		<field name="drug_name">Lumiliximab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7816</field>
		<field name="drug_name">Bectumomab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7817</field>
		<field name="drug_name">Epratuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7818</field>
		<field name="drug_name">Inotuzumab ozogamicin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7819</field>
		<field name="drug_name">Moxetumomab pasudotox</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7820</field>
		<field name="drug_name">Gemtuzumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7821</field>
		<field name="drug_name">Lorvotuzumab mertansine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7822</field>
		<field name="drug_name">Parnaparin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7823</field>
		<field name="drug_name">Reviparin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7824</field>
		<field name="drug_name">Danaparoid</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7825</field>
		<field name="drug_name">Bemiparin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7826</field>
		<field name="drug_name">Delparantag</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7827</field>
		<field name="drug_name">Anacetrapib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7828</field>
		<field name="drug_name">Dalcetrapib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7829</field>
		<field name="drug_name">Evacetrapib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7830</field>
		<field name="drug_name">Torcetrapib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7831</field>
		<field name="drug_name">Imciromab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7832</field>
		<field name="drug_name">Podophyllotoxin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7833</field>
		<field name="drug_name">Paclitaxel poliglumex</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7834</field>
		<field name="drug_name">Vintafolide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7835</field>
		<field name="drug_name">Maytansine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7836</field>
		<field name="drug_name">Verubulin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7837</field>
		<field name="drug_name">Ispinesib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7838</field>
		<field name="drug_name">Litronesib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7839</field>
		<field name="drug_name">Incobotulinumtoxin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7840</field>
		<field name="drug_name">Pexelizumab</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7841</field>
		<field name="drug_name">Gataparsen</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7842</field>
		<field name="drug_name">Sepantronium</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7843</field>
		<field name="drug_name">PHA-665752</field>
		<field name="description">c-MET Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7844</field>
		<field name="drug_name">TAE684</field>
		<field name="description">ALK Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7845</field>
		<field name="drug_name">PD-0332991</field>
		<field name="description">CDK4/6 Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7846</field>
		<field name="drug_name">AEW541</field>
		<field name="description">IGF-1R Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7847</field>
		<field name="drug_name">RAF265</field>
		<field name="description">Raf kinase B and KDR Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7848</field>
		<field name="drug_name">PLX4720</field>
		<field name="description">Raf kinase B Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7849</field>
		<field name="drug_name">PD-0325901</field>
		<field name="description">MEK1 and MEK2 Inhibitor; Kinase inhibitor</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7850</field>
		<field name="drug_name">Nutlin-3</field>
		<field name="description">MDM2 Inhibitor; Other targeted therapies</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7851</field>
		<field name="drug_name">LBW242</field>
		<field name="description">Inhibitor of Apoptosis Proteins (IAP) Inhibitor; Other targeted therapies</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7852</field>
		<field name="drug_name">17-AAG</field>
		<field name="description">Heat Shock Protein 90 (hsp90) Inhibitor; Other targeted therapies</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7853</field>
		<field name="drug_name">L-685458</field>
		<field name="description">gamma-Secretase Inhibitor; Other targeted therapies</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7854</field>
		<field name="drug_name">Panobinostat��</field>
		<field name="description">Histone Deacetylase (HDAC) Inhibitor; Other targeted therapies</field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7855</field>
		<field name="drug_name">681640</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7856</field>
		<field name="drug_name">A-443654</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7857</field>
		<field name="drug_name">A-770041</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7858</field>
		<field name="drug_name">ABT-263</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7859</field>
		<field name="drug_name">ABT-888</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7860</field>
		<field name="drug_name">AG-014699</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7861</field>
		<field name="drug_name">AKT inhibitor VIII</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7862</field>
		<field name="drug_name">AMG-706</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7863</field>
		<field name="drug_name">AP-24534</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7864</field>
		<field name="drug_name">AS601245</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7865</field>
		<field name="drug_name">AUY922</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7866</field>
		<field name="drug_name">AZ628</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7867</field>
		<field name="drug_name">AZD-0530</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7868</field>
		<field name="drug_name">AZD-2281</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7869</field>
		<field name="drug_name">AZD6244</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7870</field>
		<field name="drug_name">AZD6482</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7871</field>
		<field name="drug_name">AZD7762</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7872</field>
		<field name="drug_name">AZD8055</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7873</field>
		<field name="drug_name">BAY 61-3606</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7874</field>
		<field name="drug_name">BI-2536</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7875</field>
		<field name="drug_name">BI-D1870</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7876</field>
		<field name="drug_name">BIBW2992</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7877</field>
		<field name="drug_name">BIRB 0796</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7878</field>
		<field name="drug_name">BMS-509744</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7879</field>
		<field name="drug_name">BMS-536924</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7880</field>
		<field name="drug_name">BMS-708163</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7881</field>
		<field name="drug_name">BMS-754807</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7882</field>
		<field name="drug_name">Bryostatin 1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7883</field>
		<field name="drug_name">BX-795</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7884</field>
		<field name="drug_name">CCT007093</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7885</field>
		<field name="drug_name">CCT018159</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7886</field>
		<field name="drug_name">CEP-701</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7887</field>
		<field name="drug_name">CGP-082996</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7888</field>
		<field name="drug_name">CGP-60474</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7889</field>
		<field name="drug_name">CHIR-99021</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7890</field>
		<field name="drug_name">CI-1040</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7891</field>
		<field name="drug_name">CMK</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7892</field>
		<field name="drug_name">Cyclopamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7893</field>
		<field name="drug_name">DMOG</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7894</field>
		<field name="drug_name">EHT 1864</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7895</field>
		<field name="drug_name">Elesclomol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7896</field>
		<field name="drug_name">Embelin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7897</field>
		<field name="drug_name">FTI-277</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7898</field>
		<field name="drug_name">GDC0941</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7899</field>
		<field name="drug_name">GNF-2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7900</field>
		<field name="drug_name">GSK-1904529A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7901</field>
		<field name="drug_name">GSK-650394</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7902</field>
		<field name="drug_name">GSK269962A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7903</field>
		<field name="drug_name">GW 441756</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7904</field>
		<field name="drug_name">GW843682X</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7905</field>
		<field name="drug_name">IPA-3</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7906</field>
		<field name="drug_name">JNJ-26854165</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7907</field>
		<field name="drug_name">JNK Inhibitor VIII</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7908</field>
		<field name="drug_name">JNK-9L</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7909</field>
		<field name="drug_name">JW-7-52-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7910</field>
		<field name="drug_name">KIN001-135</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7911</field>
		<field name="drug_name">KU-55933</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7912</field>
		<field name="drug_name">LAQ824</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7913</field>
		<field name="drug_name">LFM-A13</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7914</field>
		<field name="drug_name">MK-2206</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7915</field>
		<field name="drug_name">MS-275</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7916</field>
		<field name="drug_name">NSC-87877</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7917</field>
		<field name="drug_name">NU-7441</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7918</field>
		<field name="drug_name">Nutlin-3a</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7919</field>
		<field name="drug_name">NVP-BEZ235</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7920</field>
		<field name="drug_name">NVP-TAE684</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7921</field>
		<field name="drug_name">Obatoclax Mesylate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7922</field>
		<field name="drug_name">OSI-906</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7923</field>
		<field name="drug_name">OSU-03012</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7924</field>
		<field name="drug_name">PAC-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7925</field>
		<field name="drug_name">Parthenolide</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">7926</field>
		<field name="drug_name">PD-173074</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7927</field>
		<field name="drug_name">PF-02341066</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7928</field>
		<field name="drug_name">PF-4708671</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7929</field>
		<field name="drug_name">PF-562271</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7930</field>
		<field name="drug_name">Pyrimethamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7931</field>
		<field name="drug_name">QS11</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7932</field>
		<field name="drug_name">RDEA119</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7933</field>
		<field name="drug_name">RO-3306</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7934</field>
		<field name="drug_name">Roscovitine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7935</field>
		<field name="drug_name">S-Trityl-L-cysteine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7936</field>
		<field name="drug_name">Salubrinal</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7937</field>
		<field name="drug_name">SB 216763</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7938</field>
		<field name="drug_name">SB590885</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7939</field>
		<field name="drug_name">SL 0101-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7940</field>
		<field name="drug_name">TGX221</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7941</field>
		<field name="drug_name">TW 37</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7942</field>
		<field name="drug_name">VX-680</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7943</field>
		<field name="drug_name">VX-702</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7944</field>
		<field name="drug_name">WH-4-023</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7945</field>
		<field name="drug_name">WZ-1-84</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7946</field>
		<field name="drug_name">XMD8-85</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7947</field>
		<field name="drug_name">Z-LLNle-CHO</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7948</field>
		<field name="drug_name">ZM-447439</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7949</field>
		<field name="drug_name">(-)-gallocatechin-3-monogallate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7950</field>
		<field name="drug_name">10-DEBC</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7951</field>
		<field name="drug_name">16,16-dimethylprostaglandin-E2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7952</field>
		<field name="drug_name">16-beta-bromoandrosterone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7953</field>
		<field name="drug_name">1-methyl-DL-tryptophan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7954</field>
		<field name="drug_name">1S,3R-RSL-3</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7955</field>
		<field name="drug_name">2,4-dideoxy-DC-45-A2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7956</field>
		<field name="drug_name">2-bromopyruvate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7957</field>
		<field name="drug_name">2-fluoropalmitic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7958</field>
		<field name="drug_name">3-aminobenzamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7959</field>
		<field name="drug_name">3-chloro-L-alanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7960</field>
		<field name="drug_name">4-IPP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7961</field>
		<field name="drug_name">4-methylfasudil</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7962</field>
		<field name="drug_name">5-benzyl-9-tert-butyl-paullone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7963</field>
		<field name="drug_name">6-diazo-5-oxo-L-norleucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7964</field>
		<field name="drug_name">6-methoxyharmalan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7965</field>
		<field name="drug_name">6-NBDG</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7966</field>
		<field name="drug_name">AA-COCF3</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7967</field>
		<field name="drug_name">ABH</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7968</field>
		<field name="drug_name">ABT-737</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7969</field>
		<field name="drug_name">ABT-751</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7970</field>
		<field name="drug_name">AC55649</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7971</field>
		<field name="drug_name">AG14361</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7972</field>
		<field name="drug_name">AGK-2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7973</field>
		<field name="drug_name">Alda-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7974</field>
		<field name="drug_name">alpha-cyano-4-hydroxycinnamic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7975</field>
		<field name="drug_name">AM-580</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7976</field>
		<field name="drug_name">ASN 05257430</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7977</field>
		<field name="drug_name">austocystin D</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7978</field>
		<field name="drug_name">avrainvillamide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7979</field>
		<field name="drug_name">AZD-7545</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7980</field>
		<field name="drug_name">B02</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7981</field>
		<field name="drug_name">Bax channel blocker</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7982</field>
		<field name="drug_name">BEC</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7983</field>
		<field name="drug_name">BIBR-1532</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7984</field>
		<field name="drug_name">bistramide A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7985</field>
		<field name="drug_name">BIX-01294</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7986</field>
		<field name="drug_name">BIX-01338</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7987</field>
		<field name="drug_name">blebbistatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7988</field>
		<field name="drug_name">BML-259</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7989</field>
		<field name="drug_name">BMS-191011</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7990</field>
		<field name="drug_name">BMS-299897</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7991</field>
		<field name="drug_name">BMS-641988</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7992</field>
		<field name="drug_name">bovinocidin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7993</field>
		<field name="drug_name">BRD0476</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7994</field>
		<field name="drug_name">BRD0713</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7995</field>
		<field name="drug_name">BRD1429</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7996</field>
		<field name="drug_name">BRD1566</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7997</field>
		<field name="drug_name">BRD1812</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7998</field>
		<field name="drug_name">BRD2296</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">7999</field>
		<field name="drug_name">BRD2572</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8000</field>
		<field name="drug_name">BRD2649</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8001</field>
		<field name="drug_name">BRD2662</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8002</field>
		<field name="drug_name">BRD2762</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8003</field>
		<field name="drug_name">BRD32048</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8004</field>
		<field name="drug_name">BRD4046</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8005</field>
		<field name="drug_name">BRD4132</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8006</field>
		<field name="drug_name">BRD4354</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8007</field>
		<field name="drug_name">BRD4372</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8008</field>
		<field name="drug_name">BRD4470</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8009</field>
		<field name="drug_name">BRD4479</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8010</field>
		<field name="drug_name">BRD4770</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8011</field>
		<field name="drug_name">BRD55319</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8012</field>
		<field name="drug_name">BRD5586</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8013</field>
		<field name="drug_name">BRD5802</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8014</field>
		<field name="drug_name">BRD6150</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8015</field>
		<field name="drug_name">BRD6340</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8016</field>
		<field name="drug_name">BRD63610</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8017</field>
		<field name="drug_name">BRD6368</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8018</field>
		<field name="drug_name">BRD6413</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8019</field>
		<field name="drug_name">BRD6430</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8020</field>
		<field name="drug_name">BRD6825</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8021</field>
		<field name="drug_name">BRD7137</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8022</field>
		<field name="drug_name">BRD8097</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8023</field>
		<field name="drug_name">BRD8418</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8024</field>
		<field name="drug_name">BRD8899</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8025</field>
		<field name="drug_name">BRD8958</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8026</field>
		<field name="drug_name">BRD9571</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8027</field>
		<field name="drug_name">BRD9647</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8028</field>
		<field name="drug_name">BRD9658</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8029</field>
		<field name="drug_name">BRD9786</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8030</field>
		<field name="drug_name">BRD9876</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8031</field>
		<field name="drug_name">brefeldin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8032</field>
		<field name="drug_name">CAY10594</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8033</field>
		<field name="drug_name">CAY10618</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8034</field>
		<field name="drug_name">CCT036477</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8035</field>
		<field name="drug_name">CD-1530</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8036</field>
		<field name="drug_name">CD-437</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8037</field>
		<field name="drug_name">chaetocin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8038</field>
		<field name="drug_name">CHEMBL1222381</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8039</field>
		<field name="drug_name">CHEMBL374350</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8040</field>
		<field name="drug_name">CHEMBL399379</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8041</field>
		<field name="drug_name">CHM-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8042</field>
		<field name="drug_name">CI-976</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8043</field>
		<field name="drug_name">CID 2853753</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8044</field>
		<field name="drug_name">CIL41</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8045</field>
		<field name="drug_name">CIL55</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8046</field>
		<field name="drug_name">CIL55A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8047</field>
		<field name="drug_name">CIL56</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8048</field>
		<field name="drug_name">CIL70</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8049</field>
		<field name="drug_name">Compound 10b</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8050</field>
		<field name="drug_name">Compound 110</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8051</field>
		<field name="drug_name">Compound 11e</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8052</field>
		<field name="drug_name">Compound 1541A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8053</field>
		<field name="drug_name">Compound 2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8054</field>
		<field name="drug_name">Compound 23 citrate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8055</field>
		<field name="drug_name">Compound 4</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8056</field>
		<field name="drug_name">Compound 44</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8057</field>
		<field name="drug_name">Compound 7d-cis</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8058</field>
		<field name="drug_name">CR-1-31B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8059</field>
		<field name="drug_name">curcumin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8060</field>
		<field name="drug_name">cyanoquinoline 11</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8061</field>
		<field name="drug_name">CYT-997</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8062</field>
		<field name="drug_name">cytochalasin B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8063</field>
		<field name="drug_name">cytosporone B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8064</field>
		<field name="drug_name">darinaparsin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8065</field>
		<field name="drug_name">DC-45-A2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8066</field>
		<field name="drug_name">DG-041</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8067</field>
		<field name="drug_name">DL-TBOA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8068</field>
		<field name="drug_name">eflornithine</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">8069</field>
		<field name="drug_name">ELCPK</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8070</field>
		<field name="drug_name">endo-IWR-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8071</field>
		<field name="drug_name">erastin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8072</field>
		<field name="drug_name">erastin-A8</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8073</field>
		<field name="drug_name">ethylidene glucose</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8074</field>
		<field name="drug_name">etomoxir</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8075</field>
		<field name="drug_name">EX-527</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8076</field>
		<field name="drug_name">fatostatin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8077</field>
		<field name="drug_name">FGIN-1-27</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8078</field>
		<field name="drug_name">FK866</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8079</field>
		<field name="drug_name">fluoropyruvate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8080</field>
		<field name="drug_name">FMK-PA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8081</field>
		<field name="drug_name">fosfomycin</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">8082</field>
		<field name="drug_name">FQI-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8083</field>
		<field name="drug_name">FQI-2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8084</field>
		<field name="drug_name">fumagillol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8085</field>
		<field name="drug_name">fumonisin B1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8086</field>
		<field name="drug_name">GANT-58</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8087</field>
		<field name="drug_name">Gly-Gly-PALO</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8088</field>
		<field name="drug_name">GMX-1778</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8089</field>
		<field name="drug_name">gossypol</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8090</field>
		<field name="drug_name">GSK-2334470</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8091</field>
		<field name="drug_name">GW-405833</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8092</field>
		<field name="drug_name">GW-843682X</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8093</field>
		<field name="drug_name">HA-1004</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8094</field>
		<field name="drug_name">HLI 373</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8095</field>
		<field name="drug_name">importazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8096</field>
		<field name="drug_name">indisulam</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8097</field>
		<field name="drug_name">iso-DC-45-A2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8098</field>
		<field name="drug_name">isoevodiamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8099</field>
		<field name="drug_name">isoliquiritigenin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8100</field>
		<field name="drug_name">ISOX</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8101</field>
		<field name="drug_name">itraconazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">8102</field>
		<field name="drug_name">IWP-2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8103</field>
		<field name="drug_name">JQ-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8104</field>
		<field name="drug_name">JZL-184</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8105</field>
		<field name="drug_name">kahalalide F</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8106</field>
		<field name="drug_name">kinetin riboside</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8107</field>
		<field name="drug_name">Ko-143</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8108</field>
		<field name="drug_name">KU 0060648</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8109</field>
		<field name="drug_name">LDN-193189</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8110</field>
		<field name="drug_name">LE-135</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8111</field>
		<field name="drug_name">leucascandrolide A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8112</field>
		<field name="drug_name">lonidamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8113</field>
		<field name="drug_name">lovastatin acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000001</field>
	</row>

	<row>
		<field name="drug_id">8114</field>
		<field name="drug_name">LY-2183240</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8115</field>
		<field name="drug_name">LY-2365109</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8116</field>
		<field name="drug_name">m-3M3-FBS</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8117</field>
		<field name="drug_name">manumycin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8118</field>
		<field name="drug_name">MDV-3100</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8119</field>
		<field name="drug_name">Merck60</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8120</field>
		<field name="drug_name">MK 1775</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8121</field>
		<field name="drug_name">MK-591</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8122</field>
		<field name="drug_name">ML006</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8123</field>
		<field name="drug_name">ML007</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8124</field>
		<field name="drug_name">ML013</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8125</field>
		<field name="drug_name">ML030</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8126</field>
		<field name="drug_name">ML037</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8127</field>
		<field name="drug_name">ML038</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8128</field>
		<field name="drug_name">ML039</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8129</field>
		<field name="drug_name">ML050</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8130</field>
		<field name="drug_name">ML052</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8131</field>
		<field name="drug_name">ML090</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8132</field>
		<field name="drug_name">ML100</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8133</field>
		<field name="drug_name">ML101</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8134</field>
		<field name="drug_name">ML150</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8135</field>
		<field name="drug_name">ML159</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8136</field>
		<field name="drug_name">ML160</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8137</field>
		<field name="drug_name">ML162</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8138</field>
		<field name="drug_name">ML203</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8139</field>
		<field name="drug_name">ML210</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8140</field>
		<field name="drug_name">ML214</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8141</field>
		<field name="drug_name">MLN2238</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8142</field>
		<field name="drug_name">MLN-4924</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8143</field>
		<field name="drug_name">MPEP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8144</field>
		<field name="drug_name">MST-312</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8145</field>
		<field name="drug_name">myriocin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8146</field>
		<field name="drug_name">N9-isopropylolomoucine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8147</field>
		<field name="drug_name">nakiterpiosin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8148</field>
		<field name="drug_name">narciclasine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8149</field>
		<field name="drug_name">navitoclax</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8150</field>
		<field name="drug_name">necrostatin-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8151</field>
		<field name="drug_name">neopeltolide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8152</field>
		<field name="drug_name">N-oxalyl-D-phenylalanine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8153</field>
		<field name="drug_name">NPC-26</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8154</field>
		<field name="drug_name">NSC 74859</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8155</field>
		<field name="drug_name">NSC23766</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8156</field>
		<field name="drug_name">NSC632839</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8157</field>
		<field name="drug_name">NSC95397</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8158</field>
		<field name="drug_name">NU 1025</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8159</field>
		<field name="drug_name">NVP-AUY922</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8160</field>
		<field name="drug_name">oligomycin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8161</field>
		<field name="drug_name">OSW-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8162</field>
		<field name="drug_name">oxythiamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8163</field>
		<field name="drug_name">P-0850</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8164</field>
		<field name="drug_name">pandacostat</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8165</field>
		<field name="drug_name">panduratin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8166</field>
		<field name="drug_name">parbendazole</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8167</field>
		<field name="drug_name">PDMP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8168</field>
		<field name="drug_name">PF-04217903</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8169</field>
		<field name="drug_name">PF-3845</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8170</field>
		<field name="drug_name">PF-750</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8171</field>
		<field name="drug_name">phloretin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8172</field>
		<field name="drug_name">PI-103</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8173</field>
		<field name="drug_name">pifithrin-alpha</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8174</field>
		<field name="drug_name">pifithrin-mu</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8175</field>
		<field name="drug_name">PIK-75</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8176</field>
		<field name="drug_name">PIK-90</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8177</field>
		<field name="drug_name">piperlongumine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8178</field>
		<field name="drug_name">PJ 34</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8179</field>
		<field name="drug_name">PK-11195</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8180</field>
		<field name="drug_name">PL-DI</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8181</field>
		<field name="drug_name">pluripotin</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8182</field>
		<field name="drug_name">PNU-74654</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8183</field>
		<field name="drug_name">PP-30</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8184</field>
		<field name="drug_name">PRIMA-1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8185</field>
		<field name="drug_name">PRIMA-1-Met</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8186</field>
		<field name="drug_name">PRL-3 Inhibitor I</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8187</field>
		<field name="drug_name">PT-630</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8188</field>
		<field name="drug_name">purmorphamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8189</field>
		<field name="drug_name">PX-12</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8190</field>
		<field name="drug_name">pyrvinium pamoate</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8191</field>
		<field name="drug_name">QS-11</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8192</field>
		<field name="drug_name">quinoclamine</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8193</field>
		<field name="drug_name">racemic-2,4-dideoxy-DC-45-A2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8194</field>
		<field name="drug_name">RepSox</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8195</field>
		<field name="drug_name">RG-108</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8196</field>
		<field name="drug_name">RITA</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8197</field>
		<field name="drug_name">Ro-28-1675</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8198</field>
		<field name="drug_name">rotenone</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8199</field>
		<field name="drug_name">RS-23597-190</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8200</field>
		<field name="drug_name">salermide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8201</field>
		<field name="drug_name">SB-225002</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8202</field>
		<field name="drug_name">SCH-529074</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8203</field>
		<field name="drug_name">SCH-79797</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8204</field>
		<field name="drug_name">serdemetan</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8205</field>
		<field name="drug_name">SID 26681509</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8206</field>
		<field name="drug_name">SJ-172550</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8207</field>
		<field name="drug_name">SKI-II</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8208</field>
		<field name="drug_name">SN-38</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8209</field>
		<field name="drug_name">SNX-2112</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8210</field>
		<field name="drug_name">sparfosic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8211</field>
		<field name="drug_name">SR-II-138A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8212</field>
		<field name="drug_name">T-5345967</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8213</field>
		<field name="drug_name">tamatinib</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8214</field>
		<field name="drug_name">TG-101348</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8215</field>
		<field name="drug_name">TGX-115</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8216</field>
		<field name="drug_name">tipifarnib-P1</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8217</field>
		<field name="drug_name">tipifarnib-P2</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8218</field>
		<field name="drug_name">trans-C 75</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8219</field>
		<field name="drug_name">triacsin C</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8220</field>
		<field name="drug_name">triptolide</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8221</field>
		<field name="drug_name">TTNBP</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8222</field>
		<field name="drug_name">tubastatin A</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8223</field>
		<field name="drug_name">TW-37</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8224</field>
		<field name="drug_name">tyrphostin AG-1478</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8225</field>
		<field name="drug_name">ubistatin B</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8226</field>
		<field name="drug_name">UK 356618</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8227</field>
		<field name="drug_name">UNC0321</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8228</field>
		<field name="drug_name">UNC0638</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8229</field>
		<field name="drug_name">ursolic acid</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8230</field>
		<field name="drug_name">VER-155008</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8231</field>
		<field name="drug_name">WT-161</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8232</field>
		<field name="drug_name">XAV-939</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8233</field>
		<field name="drug_name">YK 4-279</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8234</field>
		<field name="drug_name">YM-022</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8235</field>
		<field name="drug_name">YM-155</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8236</field>
		<field name="drug_name">ZM336372</field>
		<field name="description"></field>
		<field name="fda_approved">00000000</field>
	</row>

	<row>
		<field name="drug_id">8237</field>
		<field name="drug_name">GSK2141795</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8238</field>
		<field name="drug_name">BAY 1125976</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8239</field>
		<field name="drug_name">Akt1/2 inhibitor-VIII</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8240</field>
		<field name="drug_name">BAY1125976</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8241</field>
		<field name="drug_name">Akt Inhibitor MK2206</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8242</field>
		<field name="drug_name">AZD5363</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8243</field>
		<field name="drug_name">Ipatasertib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8244</field>
		<field name="drug_name">Ceritinib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8245</field>
		<field name="drug_name">Alectinib/CH5424802</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8246</field>
		<field name="drug_name">AP26113</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8247</field>
		<field name="drug_name">NMS-E628/RXDX-101</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8248</field>
		<field name="drug_name">PF-06463922</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8249</field>
		<field name="drug_name">TSR-011</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8250</field>
		<field name="drug_name">CEP-37440</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8251</field>
		<field name="drug_name">X-396</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8252</field>
		<field name="drug_name">Crizotinib (PF-02341066)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8253</field>
		<field name="drug_name">LDK378</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8254</field>
		<field name="drug_name">Rifampin</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8255</field>
		<field name="drug_name">RO5452802</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8256</field>
		<field name="drug_name">erlotinib [Tarceva]</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8257</field>
		<field name="drug_name">RO5424802</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8258</field>
		<field name="drug_name">RXDX-101</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8259</field>
		<field name="drug_name">radiation</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8260</field>
		<field name="drug_name">Antibodies</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8261</field>
		<field name="drug_name">Antibodies, Monoclonal</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8262</field>
		<field name="drug_name">Mitogens</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8263</field>
		<field name="drug_name">Dabrafenib 150 mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8264</field>
		<field name="drug_name">Trametinib 2.0 mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8265</field>
		<field name="drug_name">Hydroxychloroquine (HCQ)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8266</field>
		<field name="drug_name">Vemurafenib (VEM)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8267</field>
		<field name="drug_name">Hydroxychloroquine</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8268</field>
		<field name="drug_name">LGX818</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8269</field>
		<field name="drug_name">LGX818+MEK162</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8270</field>
		<field name="drug_name">Placebos</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8271</field>
		<field name="drug_name">Part 1 Cohort 1: Dabrafenib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8272</field>
		<field name="drug_name">Part 1 Cohort 2: Dabrafenib plus Trametinib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8273</field>
		<field name="drug_name">Part 1 Cohort 3A: Dabrafenib plus Trametinib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8274</field>
		<field name="drug_name">Part 1 Cohort 3B: Dabrafenib plus Trametinib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8275</field>
		<field name="drug_name">Part 1 Cohort 4: Dabrafenib plus Trametinib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8276</field>
		<field name="drug_name">Part 2 Cohort 1: Dabrafenib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8277</field>
		<field name="drug_name">Part 2 Cohort 2: Dabrafenib plus Trametinib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8278</field>
		<field name="drug_name">Part 3 Cohort 1: Dabrafenib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8279</field>
		<field name="drug_name">Part 3 Cohort 2: Dabrafenib plus Trametinib plus Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8280</field>
		<field name="drug_name">Part 3 Cohort 3: 5-fluorouracil-based chemotherapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8281</field>
		<field name="drug_name">CEP-32496</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8282</field>
		<field name="drug_name">TAK-632</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8283</field>
		<field name="drug_name">PLX7904</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8284</field>
		<field name="drug_name">LY2835219</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8285</field>
		<field name="drug_name">MEK162</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8286</field>
		<field name="drug_name">LEE011</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8287</field>
		<field name="drug_name">BGJ398</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8288</field>
		<field name="drug_name">BKM120</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8289</field>
		<field name="drug_name">INC280</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8290</field>
		<field name="drug_name">WNT974</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8291</field>
		<field name="drug_name">vemurafenib [Zelboraf]</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8292</field>
		<field name="drug_name">TAK-733</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8293</field>
		<field name="drug_name">PB03</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8294</field>
		<field name="drug_name">PB04</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8295</field>
		<field name="drug_name">BYL719</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8296</field>
		<field name="drug_name">PRI-724</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8297</field>
		<field name="drug_name">MGCD516</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8298</field>
		<field name="drug_name">Nilotinib (400 mg BID)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8299</field>
		<field name="drug_name">Everolimus (10 mg QD)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8300</field>
		<field name="drug_name">Sorafenib (400 mg BID)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8301</field>
		<field name="drug_name">Lapatinib (1500 mg QD)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8302</field>
		<field name="drug_name">Pazopanib (800 mg QD)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8303</field>
		<field name="drug_name">AG1478</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8304</field>
		<field name="drug_name">FOLFIRI</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8305</field>
		<field name="drug_name">Erlotinib and Panitumumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8306</field>
		<field name="drug_name">/- Chemotherapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8307</field>
		<field name="drug_name">Sym004</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8308</field>
		<field name="drug_name">Sorafenib Plus Cetuximab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8309</field>
		<field name="drug_name">erlotinib hydrochloride</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8310</field>
		<field name="drug_name">irinotecan hydrochloride</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8311</field>
		<field name="drug_name">BAY 43-9006</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8312</field>
		<field name="drug_name">Fluorouracil (5-FU)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8313</field>
		<field name="drug_name">Rindopepimut</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8314</field>
		<field name="drug_name">avastin</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8315</field>
		<field name="drug_name">afatinib - adjuvant setting</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8316</field>
		<field name="drug_name">dacomitinib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8317</field>
		<field name="drug_name">CO-1686</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8318</field>
		<field name="drug_name">AZD9291</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8319</field>
		<field name="drug_name">Enzyme Inhibitors</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8320</field>
		<field name="drug_name">Immunoglobulins</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8321</field>
		<field name="drug_name">Rociletinib Mono-Therapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8322</field>
		<field name="drug_name">Erlotinib Mono-Therapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8323</field>
		<field name="drug_name">Rifampicin</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8324</field>
		<field name="drug_name">AZD9291 tablet dosing</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8325</field>
		<field name="drug_name">Selumetinib+Docetaxel</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8326</field>
		<field name="drug_name">AZD9291 in combination with MEDI4736</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8327</field>
		<field name="drug_name">AZD9291 in combination with AZD6094</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8328</field>
		<field name="drug_name">AZD9291 in combinatin with selumetinib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8329</field>
		<field name="drug_name">AZD9291 in combination with selumetinib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8330</field>
		<field name="drug_name">Omeprazole tablet dosing</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8331</field>
		<field name="drug_name">adjuvant erlotinib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8332</field>
		<field name="drug_name">ASP8273</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8333</field>
		<field name="drug_name">EGF816</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8334</field>
		<field name="drug_name">Rociletinib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8335</field>
		<field name="drug_name">AZD9291 tablets</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8336</field>
		<field name="drug_name">AZD9291 80 mg/40 mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8337</field>
		<field name="drug_name">placebo</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8338</field>
		<field name="drug_name">Placebo Erlotinib 150/100mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8339</field>
		<field name="drug_name">Placebo Gefitinib 250 mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8340</field>
		<field name="drug_name">Erlotinib 150/100 mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8341</field>
		<field name="drug_name">Gefitinib 250 mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8342</field>
		<field name="drug_name">Placebo AZD9291 80 mg/ 40 mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8343</field>
		<field name="drug_name">margetuximab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8344</field>
		<field name="drug_name">CUDC-101</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8345</field>
		<field name="drug_name">LJM716</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8346</field>
		<field name="drug_name">a fluoropyrimidine</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8347</field>
		<field name="drug_name">212Pb-TCMC-trastuzumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8348</field>
		<field name="drug_name">AVX901</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8349</field>
		<field name="drug_name">Standard Therapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8350</field>
		<field name="drug_name">AMG 386</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8351</field>
		<field name="drug_name">MK-2206 with or without Trastuzumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8352</field>
		<field name="drug_name">AMG 386 and Trastuzumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8353</field>
		<field name="drug_name">T-DM1 and Pertuzumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8354</field>
		<field name="drug_name">Pertuzumab and Trastuzumab</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8355</field>
		<field name="drug_name">Ganetespib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8356</field>
		<field name="drug_name">Aromatase inhibitor</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8357</field>
		<field name="drug_name">Aromatase Inhibitors</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8358</field>
		<field name="drug_name">Hormones</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8359</field>
		<field name="drug_name">rapamycin</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8360</field>
		<field name="drug_name">Taxol</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8361</field>
		<field name="drug_name">Antitubulin chemotherapeutics</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8362</field>
		<field name="drug_name">NVP-BGJ398</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8363</field>
		<field name="drug_name">Cediranib Maleate</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8364</field>
		<field name="drug_name">Debio 1347 (CH5183284)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8365</field>
		<field name="drug_name">TKI258</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8366</field>
		<field name="drug_name">GP369</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8367</field>
		<field name="drug_name">AZD 4547</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8368</field>
		<field name="drug_name">lucitanib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8369</field>
		<field name="drug_name">SU5402</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8370</field>
		<field name="drug_name">PD173074</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8371</field>
		<field name="drug_name">AZD4547</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8372</field>
		<field name="drug_name">MFGR1877A</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8373</field>
		<field name="drug_name">TKI-258</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8374</field>
		<field name="drug_name">sulfatinib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8375</field>
		<field name="drug_name">GSK3052230</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8376</field>
		<field name="drug_name">BAY1163877</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8377</field>
		<field name="drug_name">Endothelial Growth Factors</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8378</field>
		<field name="drug_name">Dovitinib (TKI258)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8379</field>
		<field name="drug_name">Anti-FGFR4 antibody</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8380</field>
		<field name="drug_name">FGFR4 trap protein</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8381</field>
		<field name="drug_name">FGFR4 shRNA</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8382</field>
		<field name="drug_name">paclitaxel albumin-stabilized nanoparticle</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8383</field>
		<field name="drug_name">10F10 anti-FGFR4 antibody</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8384</field>
		<field name="drug_name">LY2874455</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8385</field>
		<field name="drug_name">GSK2126458</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8386</field>
		<field name="drug_name">AEB071</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8387</field>
		<field name="drug_name">Trametinib (GSK1120212)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8388</field>
		<field name="drug_name">SCH66336</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8389</field>
		<field name="drug_name">EGFR directed antibodies</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8390</field>
		<field name="drug_name">AG-120</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8391</field>
		<field name="drug_name">AG-221</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8392</field>
		<field name="drug_name">BIIB021</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8393</field>
		<field name="drug_name">Imatinib Mesylate</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8394</field>
		<field name="drug_name">radiotherapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8395</field>
		<field name="drug_name">Pazopanib Hydrochloride</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8396</field>
		<field name="drug_name">nilotinib (AMN107)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8397</field>
		<field name="drug_name">midostaurin (PKC412)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8398</field>
		<field name="drug_name">4'-N-benzoylstaurosporine</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8399</field>
		<field name="drug_name">NOVE-HiDAC</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8400</field>
		<field name="drug_name">Etoposide phosphate</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8401</field>
		<field name="drug_name">LOP628</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8402</field>
		<field name="drug_name">PD0325901</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8403</field>
		<field name="drug_name">VS-6063</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8404</field>
		<field name="drug_name">antroquinonol</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8405</field>
		<field name="drug_name">MMB</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8406</field>
		<field name="drug_name">BIND-014 (Docetaxel Nanoparticles for Injectable Suspension)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8407</field>
		<field name="drug_name">Pegylated G-CSF</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8408</field>
		<field name="drug_name">defactinib (VS-6063)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8409</field>
		<field name="drug_name">Selumetinib 75 mg</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8410</field>
		<field name="drug_name">Docetaxel 75 mg/m2</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8411</field>
		<field name="drug_name">Docetaxel 60 mg/m2</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8412</field>
		<field name="drug_name">FOLFOX</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8413</field>
		<field name="drug_name">Radiation Therapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8414</field>
		<field name="drug_name">MEK inhibitor MEK162</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8415</field>
		<field name="drug_name">leucovorin calcium</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8416</field>
		<field name="drug_name">Calcium, Dietary</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8417</field>
		<field name="drug_name">Levoleucovorin</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8418</field>
		<field name="drug_name">GDC 0941</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8419</field>
		<field name="drug_name">GSK1120212</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8420</field>
		<field name="drug_name">GSK690693</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8421</field>
		<field name="drug_name">BEZ-235</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8422</field>
		<field name="drug_name">PF-05212384</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8423</field>
		<field name="drug_name">BRAF inhibitor dabrafenib and MEK inhibitor trametinib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8424</field>
		<field name="drug_name">Trametinib and GSK2141795</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8425</field>
		<field name="drug_name">E6201</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8426</field>
		<field name="drug_name">MEK162 and  BYL719</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8427</field>
		<field name="drug_name">BYL719 plus MEK162</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8428</field>
		<field name="drug_name">SU11274</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8429</field>
		<field name="drug_name">Met inhibition</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8430</field>
		<field name="drug_name">AZD6094</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8431</field>
		<field name="drug_name">PF-03084014</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8432</field>
		<field name="drug_name">R04929097</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8433</field>
		<field name="drug_name">BMS-906024</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8434</field>
		<field name="drug_name">BB 1101</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8435</field>
		<field name="drug_name">Dexamethasone 21-phosphate</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8436</field>
		<field name="drug_name">Dexamethasone acetate</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8437</field>
		<field name="drug_name">gamma-secretase/Notch signalling pathway inhibitor RO4929097</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8438</field>
		<field name="drug_name">5-Fluorouracil (5FU)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8439</field>
		<field name="drug_name">docetaxol</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8440</field>
		<field name="drug_name">LEE011 and MEK162</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8441</field>
		<field name="drug_name">radioiodine uptake therapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8442</field>
		<field name="drug_name">Cadexomer iodine</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8443</field>
		<field name="drug_name">Iodine</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8444</field>
		<field name="drug_name">Radioactive Iodine Therapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8445</field>
		<field name="drug_name">MEKi</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8446</field>
		<field name="drug_name">PIKi</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8447</field>
		<field name="drug_name">BCL-XLi</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8448</field>
		<field name="drug_name">Goserelin Acetate</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8449</field>
		<field name="drug_name">GDC-0941</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8450</field>
		<field name="drug_name">GDC-0980</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8451</field>
		<field name="drug_name">PD0332991</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8452</field>
		<field name="drug_name">Estrogens</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8453</field>
		<field name="drug_name">BKM120 matching placebo</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8454</field>
		<field name="drug_name">MK2206</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8455</field>
		<field name="drug_name">BKM120 Combined with Vemurafenib (PLX4032)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8456</field>
		<field name="drug_name">Buparlisib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8457</field>
		<field name="drug_name">MLN1117</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8458</field>
		<field name="drug_name">PKI-587</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8459</field>
		<field name="drug_name">BEZ235</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8460</field>
		<field name="drug_name">LY3023414</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8461</field>
		<field name="drug_name">MLN1117 Arm A</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8462</field>
		<field name="drug_name">MLN0128</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8463</field>
		<field name="drug_name">MLN1117 Arm B</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8464</field>
		<field name="drug_name">AZD8835</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8465</field>
		<field name="drug_name">AZD8835 in combination with fulvestrant</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8466</field>
		<field name="drug_name">CLR457</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8467</field>
		<field name="drug_name">TGX-221</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8468</field>
		<field name="drug_name">AS-604850</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8469</field>
		<field name="drug_name">IC87114</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8470</field>
		<field name="drug_name">RAD001</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8471</field>
		<field name="drug_name">sonidegib</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8472</field>
		<field name="drug_name">LDE225</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8473</field>
		<field name="drug_name">LDE225, Etoposide and Cisplatin</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8474</field>
		<field name="drug_name">GSK2636771</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8475</field>
		<field name="drug_name">KU0058948</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8476</field>
		<field name="drug_name">LY294002</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8477</field>
		<field name="drug_name">ZSTK474</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8478</field>
		<field name="drug_name">protein synthesis inhibitor</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8479</field>
		<field name="drug_name">Androgen deprivation</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8480</field>
		<field name="drug_name">Chemotherapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8481</field>
		<field name="drug_name">BKM120 +temozolomide with/without radiotherapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8482</field>
		<field name="drug_name">PD1/PD-L1 blocking agents</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8483</field>
		<field name="drug_name">Metformin XR</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8484</field>
		<field name="drug_name">Delayed Metformin</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8485</field>
		<field name="drug_name">AZD8186</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8486</field>
		<field name="drug_name">Anti-EGFR antibodies</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8487</field>
		<field name="drug_name">EKB-569</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8488</field>
		<field name="drug_name">Gamma-secretase inhibitors</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8489</field>
		<field name="drug_name">PI3K inhibitor</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8490</field>
		<field name="drug_name">E7080 capsule</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8491</field>
		<field name="drug_name">E7080</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8492</field>
		<field name="drug_name">Placebo 24mg administered orally, once a day</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8493</field>
		<field name="drug_name">AMG 706</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8494</field>
		<field name="drug_name">sonidegib/</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8495</field>
		<field name="drug_name">BMS-833923</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8496</field>
		<field name="drug_name">PF-04449913</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8497</field>
		<field name="drug_name">LY2940680</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8498</field>
		<field name="drug_name">LEQ506</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8499</field>
		<field name="drug_name">TAK-441</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8500</field>
		<field name="drug_name">BMS-833923 (XL139)</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8501</field>
		<field name="drug_name">docetaxel monotherapy</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8502</field>
		<field name="drug_name">APR-246</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	<row>
		<field name="drug_id">8503</field>
		<field name="drug_name">Crolibulin</field>
		<field name="description" xsi:nil="true" />
		<field name="fda_approved" xsi:nil="true" />
	</row>

	</table_data>

</database>
</mysqldump>
